https://evidence-hub.com/study/60000-serotonin-syndrome-in-patients-with-headache-disorders2026-10-06 https://evidence-hub.com/study/60001-migraine-after-electroconvulsive-therapy2026-10-06 https://evidence-hub.com/study/60002-alternating-hemiplegic-migraine-in-childhood2026-10-06 https://evidence-hub.com/study/60003-functional-abdominal-pain-get-the-function-loose-the-pain2026-10-06 https://evidence-hub.com/study/60004-hemiplegic-migraine-with-csf-abnormalities2026-10-06 https://evidence-hub.com/study/60005-pure-sensory-stroke-and-allied-conditions2026-10-06 https://evidence-hub.com/study/60006-nonmedication-alternative-and-complementary-treatments-for-migraine2026-10-08 https://evidence-hub.com/study/60007-migraine-fusional-eye-movement-stress2026-10-06 https://evidence-hub.com/study/60008-migraine-madness-recurrent-psychosis-after-migraine2026-10-06 https://evidence-hub.com/study/60009-cough-induced-hemiplegic-migraine-with-impaired-consciousness-in2026-10-06 https://evidence-hub.com/study/60010-clinical-signs-of-food-allergy2026-10-06 https://evidence-hub.com/study/60011-multisystem-manifestations-of-benign-ovarian-teratomas2026-10-06 https://evidence-hub.com/study/60012-case-report-retinal-infarction-associated-with-migraine2026-10-06 https://evidence-hub.com/study/60013-extracephalic-stabbing-pain-temporally-related-to-cephalic-ones2026-10-06 https://evidence-hub.com/study/60015-a-possible-new-option-for-migraine-management-agomelatine2026-10-06 https://evidence-hub.com/study/60016-intravenous-dihydroergotamine-therapy-for-pediatric-abdominal2026-10-06 https://evidence-hub.com/study/60017-sustained-hypotension-following-intravenous-metoclopramide2026-10-06 https://evidence-hub.com/study/60018-autonomic-dysreflexia-due-to-medication-misadventure-in-the-use-of-an2026-10-06 https://evidence-hub.com/study/60019-recurrent-migraine-cost-effective-care2026-10-06 https://evidence-hub.com/study/60020-hearing-symptoms-in-migrainous-infarction2026-10-06 https://evidence-hub.com/study/60021-acute-and-preventive-treatment-of-migraine2026-10-06 https://evidence-hub.com/study/60022-sudden-cardiac-death-in-a-young-man-with-migraine-associated2026-10-06 https://evidence-hub.com/study/60023-a-spectrum-of-exertional-headaches2026-10-06 https://evidence-hub.com/study/60024-the-tension-headache-component-of-chronic-daily-headache2026-10-06 https://evidence-hub.com/study/60025-unilateral-nasal-pain-with-migraine-features2026-10-06 https://evidence-hub.com/study/60026-chronic-migraine-treatment-multidisciplinary-approach-case-report2026-10-06 https://evidence-hub.com/study/60027-achromatopsia-in-the-aura-of-migraine2026-10-06 https://evidence-hub.com/study/60028-ictal-headache-and-visual-sensitivity2026-10-06 https://evidence-hub.com/study/60029-central-retinal-vein-occlusion-in-a-migraine-patient2026-10-06 https://evidence-hub.com/study/60030-migraine-headaches-and-depression2026-10-06 https://evidence-hub.com/study/60031-chronic-migraine-reversal-and-prevention-with-the-life-diet-a2026-10-08 https://evidence-hub.com/study/60032-reversible-cerebral-vasoconstriction-syndrome-associated-with2026-10-06 https://evidence-hub.com/study/60033-arteriovenous-malformations-and-migraine-case-reports-and-an-analysis2026-10-06 https://evidence-hub.com/study/60034-physical-therapy-management-of-vestibular-migraine-of-childhood-a2026-10-06 https://evidence-hub.com/study/60035-trauma-precipitated-migrainous-hemiparesis2026-10-06 https://evidence-hub.com/study/60036-vestibular-migraine-a-case-report-and-review-of-the-literature2026-10-06 https://evidence-hub.com/study/60037-arterial-stenosis-in-migraine-spasm-or-arteriopathy2026-10-06 https://evidence-hub.com/study/60038-reversible-white-matter-abnormalities-in-a-patient-with-migraine2026-10-06 https://evidence-hub.com/study/60039-migraine-infarct-in-patients-treated-with-beta-blockers2026-10-06 https://evidence-hub.com/study/60040-management-of-chronic-migraine-without-aura-with-classical-unani2026-10-06 https://evidence-hub.com/study/60041-suspected-reversible-cerebral-vasoconstriction-syndrome-following2026-10-06 https://evidence-hub.com/study/60042-a-woman-in-her-40s-with-an-unusual-migraine-attack2026-10-06 https://evidence-hub.com/study/60043-bridging-the-gap-translating-microemboli-induced-spreading2026-10-06 https://evidence-hub.com/study/60044-expanding-the-neurological-phenotype-of-zttk-syndrome-a-case-of2026-10-06 https://evidence-hub.com/study/60045-late-onset-cerebral-autosomal-dominant-arteriopathy-with-subcortical2026-10-06 https://evidence-hub.com/study/60046-eleven-year-diagnostic-delay-in-episodic-cluster-headache-with-a2026-10-06 https://evidence-hub.com/study/60047-response-to-galcanezumab-in-a-patient-with-complex-neuropsychiatric2026-10-06 https://evidence-hub.com/study/60048-therapeutic-evaluation-of-herbal-poultice-dimad-in-the-management-of2026-10-06 https://evidence-hub.com/study/60049-prolonged-coma-and-cerebral-oedema-in-a-patient-with-an-atp1a2-variant2026-10-06 https://evidence-hub.com/study/60050-migraine-with-focal-cortical-dysplasia-a-case-report2026-10-06 https://evidence-hub.com/study/60051-high-altitude-headache-resolving-after-self-administration-of2026-10-06 https://evidence-hub.com/study/60052-benign-episodic-unilateral-mydriasis-presenting-as-acute2026-10-06 https://evidence-hub.com/study/60053-delayed-diagnosis-of-primary-sjogren-s-syndrome-presenting-as2026-10-06 https://evidence-hub.com/study/60054-migraine-headaches-in-a-pediatric-patient-with-setd5-related2026-10-06 https://evidence-hub.com/study/60055-chronic-migraine-resistance-a-case-report-highlights-an-overlooked2026-10-06 https://evidence-hub.com/study/60056-branched-chain-amino-acid-supplementation-as-a-potential-trigger-for2026-10-08 https://evidence-hub.com/study/60057-clinical-and-radiological-variability-in-episodic-ataxia-type-2-a2026-10-06 https://evidence-hub.com/study/60058-paracentral-acute-middle-maculopathy-following-physical-exertion-a2026-10-06 https://evidence-hub.com/study/60059-early-vascular-lesion-tracking-in-moyamoya-disease-a-case-report-with2026-10-06 https://evidence-hub.com/study/60060-migrainous-thoracalgia-in-a-patient-with-chronic-migraine-and2026-10-08 https://evidence-hub.com/study/60061-how-would-you-manage-this-patient-with-frequent-migraine-headaches2026-10-06 https://evidence-hub.com/study/60062-menopausal-hot-flashes-night-sweats-and-insomnia-disappeared-with2026-10-06 https://evidence-hub.com/study/60063-left-main-spontaneous-coronary-artery-dissection-in-a-young-woman2026-10-06 https://evidence-hub.com/study/60064-topiramate-s-ocular-trap-acute-angle-closure-rescued-by-early2026-10-06 https://evidence-hub.com/study/60065-homozygous-notch3-c-3373g-a-p-glu1125lys-in-a-consanguineous-chinese2026-10-06 https://evidence-hub.com/study/60066-chronic-relapsing-inflammatory-optic-neuropathy-misdiagnosed-as2026-10-06 https://evidence-hub.com/study/60067-a-rare-case-of-co-occurring-meniere-s-disease-and-red-ear-syndrome2026-10-06 https://evidence-hub.com/study/60068-stroke-like-migraine-attacks-after-radiation-therapy-smart-syndrome-a2026-10-06 https://evidence-hub.com/study/60069-slow-diaphragmatic-breathing-for-chronic-migraine-prevention-and2026-10-08 https://evidence-hub.com/study/60070-intracranial-hypertension-after-mect-successful-transition-to-rtms2026-10-06 https://evidence-hub.com/study/60071-a-novel-missense-variant-cys559gly-in-notch3-in-cadasil-family-and2026-10-06 https://evidence-hub.com/study/60072-dissociated-neurovascular-dynamics-in-atp1a2-related-familial2026-10-06 https://evidence-hub.com/study/60073-ruptured-orbital-dermoid-cyst-masked-as-a-migraine-in-a-25-year-old2026-10-06 https://evidence-hub.com/study/60074-downbeat-nystagmus-without-ataxia-as-an-early-manifestation-of2026-10-06 https://evidence-hub.com/study/60075-unusual-presentation-of-scleroderma-case-report2026-10-06 https://evidence-hub.com/study/60076-menstruation-triggered-paroxysmal-hemicrania2026-10-06 https://evidence-hub.com/study/60077-eletriptan-associated-coronary-vasospasm-in-a-heart-transplant2026-10-06 https://evidence-hub.com/study/60078-case-report-smart-syndrome-mimicking-todd-s-paralysis-after2026-10-06 https://evidence-hub.com/study/60079-case-report-longitudinal-imaging-in-a-patient-with-smart-syndrome2026-10-06 https://evidence-hub.com/study/60080-when-time-precludes-certainty-intravenous-tenecteplase-for-acute2026-10-06 https://evidence-hub.com/study/60081-vertebral-artery-dissection-and-cerebellar-stroke-in-a-young-patient2026-10-06 https://evidence-hub.com/study/60082-kleine-levin-syndrome-accompanied-with-complex-headache-report-of-one2026-10-06 https://evidence-hub.com/study/60083-visual-epilepsy-mimicking-migraine-aura-leading-to-delayed-diagnosis2026-10-06 https://evidence-hub.com/study/60084-tolosa-hunt-syndrome-with-highly-elevated-interleukin-6-levels2026-10-06 https://evidence-hub.com/study/60085-herpes-zoster-ophthalmicus-following-endodontic-treatment-a-case2026-10-06 https://evidence-hub.com/study/60086-neurological-puzzles-after-radiotherapy-mysterious-clues-of-smart2026-10-06 https://evidence-hub.com/study/60087-superior-sagittal-sinus-thrombosis-presented-as-a-migraine-headache2026-10-06 https://evidence-hub.com/study/60088-late-onset-ocular-myasthenia-gravis-like-symptoms-during-erenumab2026-10-06 https://evidence-hub.com/study/60089-acephalgic-retinal-migraine-a-6-year-follow-up-case-report-and2026-10-06 https://evidence-hub.com/study/60090-pediatric-migraine-aura-status-and-cortical-laminar-necrosis-a2026-10-06 https://evidence-hub.com/study/60091-botulinum-toxin-type-a-for-chronic-neurovascular-and-myofascial2026-10-06 https://evidence-hub.com/study/60092-atypical-bilateral-iris-transillumination-without-pigment-dispersion2026-10-06 https://evidence-hub.com/study/60093-resolution-of-treatment-resistant-vertigo-and-suspected-meniere-s2026-10-06 https://evidence-hub.com/study/60094-hrt-induced-primary-headache-associated-with-sexual-activity-a-case2026-10-06 https://evidence-hub.com/study/60095-styloidogenic-internal-carotid-artery-dissection-presenting-as-severe2026-10-06 https://evidence-hub.com/study/60096-reduced-frequency-of-prolonged-sporadic-hemiplegic-migraine-attacks2026-10-06 https://evidence-hub.com/study/60097-chronic-migraine-characterized-by-prolonged-bilateral-visual-and2026-10-06 https://evidence-hub.com/study/60098-case-report-lidocaine-toxicity-presenting-with-focal-neurologic2026-10-06 https://evidence-hub.com/study/60099-when-recurrent-pancreatitis-is-not-pancreatitis-cyclic-vomiting2026-10-06 https://evidence-hub.com/study/60100-spinal-cord-stimulation-for-painful-neuropathic-cauda-equina-syndrome2026-10-06 https://evidence-hub.com/study/60101-ischemic-stroke-in-a-28-year-old-young-adult-associated-with-chronic2026-10-06 https://evidence-hub.com/study/60102-normal-delivery-following-use-of-galcanezumab-until-the-first-and2026-10-06 https://evidence-hub.com/study/60103-unexplained-positional-hypoxemia-in-an-elderly-patient-a-case-of2026-10-06 https://evidence-hub.com/study/60104-multiple-sclerosis-with-migraine-and-pyoderma-gangrenosum-treated2026-10-06 https://evidence-hub.com/study/60105-the-overlap-of-migraine-and-transient-global-amnesia-a-case-report2026-10-06 https://evidence-hub.com/study/60106-clinicopathologic-correlates-progressive-downbeat-nystagmus-in2026-10-06 https://evidence-hub.com/study/60107-bizarre-astrocytes-with-cytoplasmic-intranuclear-inclusions-in-an2026-10-06 https://evidence-hub.com/study/60108-internal-carotid-artery-dissection-in-a-young-healthy-male-patient2026-10-06 https://evidence-hub.com/study/60109-high-dose-biotin-supplementation-exacerbates-chronic-migraine-a-case2026-10-08 https://evidence-hub.com/study/60110-a-notch3-p-gly1105cys-variant-in-cadasil-clinical-characterization2026-10-06 https://evidence-hub.com/study/60111-de-novo-chronic-cluster-headache-following-occupational-inhalational2026-10-06 https://evidence-hub.com/study/60112-late-lyme-neuroborreliosis-with-multifocal-neurological-symptoms-and2026-10-06 https://evidence-hub.com/study/60113-central-neurocytoma-of-the-lateral-ventricle-presenting-with-chronic2026-10-06 https://evidence-hub.com/study/60114-case-report-treatment-of-temporomandibular-joint-disorder-pain-with2026-10-06 https://evidence-hub.com/study/60115-suspected-murine-typhus-associated-with-neurologic-symptoms-and2026-10-06 https://evidence-hub.com/study/60116-reversible-cerebral-vasoconstriction-syndrome-presenting-with2026-10-06 https://evidence-hub.com/study/60117-photobiomodulation-therapy-for-symptom-management-in-essential2026-10-06 https://evidence-hub.com/study/60118-hemiplegic-migraine-an-imitator-of-cerebrovascular-disease2026-10-06 https://evidence-hub.com/study/60119-case-based-lessons-on-remote-patient-monitoring-in-neurology-using2026-10-06 https://evidence-hub.com/study/60120-the-bustelo-bolus-caffeine-withdrawal-mimicking-status-migrainosus-in2026-10-06 https://evidence-hub.com/study/60121-vertebral-artery-dissection-presenting-as-a-migrainous-visual-aura2026-10-06 https://evidence-hub.com/study/60122-cortical-spreading-depression-mimicking-ischemic-stroke-a-case-report2026-10-06 https://evidence-hub.com/study/60123-an-unusual-presentation-of-frontal-pneumosinus-dilatans-as-flight2026-10-06 https://evidence-hub.com/study/60124-a-case-of-atypical-presentation-of-paroxysmal-movement-disorder2026-10-06 https://evidence-hub.com/study/60125-prolotherapy-in-the-treatment-of-chronic-migraine-case-report2026-10-06 https://evidence-hub.com/study/60126-chronic-migraine-case-report2026-10-06 https://evidence-hub.com/study/60127-hemolacria-in-severe-migraine-case-report2026-10-06 https://evidence-hub.com/study/60128-child-with-sporadic-hemiplegic-migraine-case-report2026-10-06 https://evidence-hub.com/study/60130-giant-virchow-robin-spaces-in-a-patient-with-migraine-case-report2026-10-06 https://evidence-hub.com/study/60131-ayurveda-management-of-migraine-a-case-report2026-10-06 https://evidence-hub.com/study/60132-synesthesia-and-migraine-case-report2026-10-06 https://evidence-hub.com/study/60135-obsessive-compulsive-disorder-and-migraine-case-report-diagnosis-and2026-10-06 https://evidence-hub.com/study/60137-a-case-report-of-neuronal-intranuclear-inclusion-disease-presenting2026-10-06 https://evidence-hub.com/study/60138-the-use-of-erenumab-for-migraine-prophylaxis-during-pregnancy-a-case2026-10-06 https://evidence-hub.com/study/60139-cognitive-behavioral-therapy-in-the-treatment-of-chronic-migraine-a2026-10-06 https://evidence-hub.com/study/60141-treatment-of-chronic-migraine-and-neck-pain-with-cognitive-behavioral2026-10-06 https://evidence-hub.com/study/60143-vascular-changes-with-optical-coherence-tomography-angiography-during2026-10-06 https://evidence-hub.com/study/60145-r1352q-cacna1a-variant-in-a-patient-with-sporadic-hemiplegic-migraine2026-10-06 https://evidence-hub.com/study/60146-impaired-wound-healing-in-a-migraine-patient-as-a-possible-side2026-10-06 https://evidence-hub.com/study/60147-paracentral-acute-middle-maculopathy-in-a-patient-with-frequent2026-10-06 https://evidence-hub.com/study/60148-treatment-refractory-headache-in-the-setting-of-covid-19-pneumonia2026-10-06 https://evidence-hub.com/study/60149-ischemic-stroke-associated-with-calcitonin-gene-related-peptide2026-10-06 https://evidence-hub.com/study/60150-erenumab-during-pregnancy-a-case-report-in-a-patient-with-chronic2026-10-06 https://evidence-hub.com/study/60152-pulsed-radiofrequency-of-c2-dorsal-root-ganglion-under-ultrasound2026-10-06 https://evidence-hub.com/study/60153-neuronal-injuries-evidenced-by-transient-cortical-magnetic-resonance2026-10-06 https://evidence-hub.com/study/60154-familial-hemiplegic-migraine-type-3-fhm3-with-an-scn1a-mutation-in-a2026-10-06 https://evidence-hub.com/study/60155-stroke-like-migraine-attacks-after-radiation-therapy-syndrome-a-case2026-10-06 https://evidence-hub.com/study/60158-spontaneous-migraine-attack-causes-alterations-in-default-mode2026-10-06 https://evidence-hub.com/study/60160-hemiplegic-migraine-presenting-with-prolonged-somnolence-a-case-report2026-10-06 https://evidence-hub.com/study/60162-resolution-of-chronic-migraine-headaches-with-intrathecal-ziconotide2026-10-06 https://evidence-hub.com/study/60163-myocardial-infarction-associated-with-erenumab-a-case-report2026-10-06 https://evidence-hub.com/study/60165-occipital-ischaemic-stroke-after-visual-snow-phenomenon-a-case-report2026-10-06 https://evidence-hub.com/study/60166-could-the-new-anti-cgrp-monoclonal-antibodies-be-effective-in2026-10-06 https://evidence-hub.com/study/60167-persistent-negative-visual-aura-in-migraine-without-headache-a-case2026-10-06 https://evidence-hub.com/study/60168-status-migrainosus-a-potential-adverse-reaction-to-comirnaty-bnt162b22026-10-06 https://evidence-hub.com/study/60169-an-unusual-case-report-on-the-possible-role-of-warfarin-in-migraine2026-10-06 https://evidence-hub.com/study/60174-migrainous-infarction-and-cerebral-vasospasm-case-report-and2026-10-06 https://evidence-hub.com/study/60175-propofol-alleviates-intractable-migraine-headache-a-case-report2026-10-06 https://evidence-hub.com/study/60176-eagle-s-syndrome-from-clinical-presentation-to-diagnosis-and-surgical2026-10-06 https://evidence-hub.com/study/60177-acute-cerebellitis-in-adults-a-case-report-and-review-of-the2026-10-06 https://evidence-hub.com/study/60178-susceptibility-weighted-imaging-and-magnetic-resonance-angiography2026-10-06 https://evidence-hub.com/study/60181-a-migraine-variant-with-abdominal-colic-and-alice-in-wonderland2026-10-06 https://evidence-hub.com/study/60183-topiramate-associated-acute-glaucoma-in-a-migraine-patient-receiving2026-10-06 https://evidence-hub.com/study/60185-ophthalmoplegic-migraine-in-a-15-year-old-ethiopian-case-report-and2026-10-06 https://evidence-hub.com/study/60193-pontine-capillary-telangiectasia-as-visualized-on-mr-imaging-causing2026-10-06 https://evidence-hub.com/study/60216-evidence-based-guidelines-for-the-pharmacological-treatment-of2026-10-06 https://evidence-hub.com/study/60217-clinical-practice-guideline-meniere-s-disease2026-10-06 https://evidence-hub.com/study/60218-north-american-society-for-pediatric-gastroenterology-hepatology-and2026-10-13 https://evidence-hub.com/study/60219-evidence-based-guidelines-for-the-pharmacological-treatment-of2026-10-06 https://evidence-hub.com/study/60220-prescription-of-therapeutic-exercise-in-migraine-an-evidence-based2026-10-08 https://evidence-hub.com/study/60221-prevention-of-episodic-migraine-headache-using-pharmacologic2026-10-06 https://evidence-hub.com/study/60222-guidelines-on-management-of-cyclic-vomiting-syndrome-in-adults-by-the2026-10-06 https://evidence-hub.com/study/60223-migraine-treatment-position-paper-of-the-french-headache-society2026-10-06 https://evidence-hub.com/study/60224-pharmacologic-treatments-of-acute-episodic-migraine-headache-in2026-10-06 https://evidence-hub.com/study/60225-concussion-guidelines-step-2-evidence-for-subtype-classification2026-10-06 https://evidence-hub.com/study/60226-evidence-based-guideline-update-pharmacologic-treatment-for-episodic2026-10-06 https://evidence-hub.com/study/60227-aids-to-management-of-headache-disorders-in-primary-care-2nd-edition2026-10-06 https://evidence-hub.com/study/60228-practice-guideline-update-summary-botulinum-neurotoxin-for-the2026-10-06 https://evidence-hub.com/study/60229-acr-appropriateness-criteria-cerebrovascular-disease-child2026-10-06 https://evidence-hub.com/study/60230-2023-u-s-department-of-veterans-affairs-and-u-s-department-of-defense2026-10-08 https://evidence-hub.com/study/60231-acr-appropriateness-criteria-headache-child2026-10-06 https://evidence-hub.com/study/60232-pharmacologic-treatment-for-migraine-prevention-in-adults-practice2026-10-06 https://evidence-hub.com/study/60233-acr-appropriateness-criteria-ataxia-child2026-10-06 https://evidence-hub.com/study/60234-international-headache-society-evidence-based-guidelines-on-the-use2026-10-06 https://evidence-hub.com/study/60235-management-of-the-acute-migraine-headache2026-10-06 https://evidence-hub.com/study/60236-guidelines-for-the-primary-prevention-of-stroke-a-guideline-for2026-10-06 https://evidence-hub.com/study/60237-medical-treatment-guidelines-for-preventive-treatment-of-migraine2026-10-06 https://evidence-hub.com/study/60238-canadian-headache-society-guideline-acute-drug-therapy-for-migraine2026-10-06 https://evidence-hub.com/study/60239-effectiveness-and-use-of-hormonal-contraceptives-except-for2026-10-06 https://evidence-hub.com/study/60240-north-american-society-for-pediatric-gastroenterology-hepatology-and2026-10-06 https://evidence-hub.com/study/60241-new-guidelines-for-the-management-of-migraine-in-primary-care2026-10-06 https://evidence-hub.com/study/60242-neurophysiological-tests-and-neuroimaging-procedures-in-non-acute2026-10-06 https://evidence-hub.com/study/60243-international-headache-society-classification-new-proposals-about2026-10-06 https://evidence-hub.com/study/60244-over-the-counter-drugs-for-acute-migraine-attacks-literature-review2026-10-06 https://evidence-hub.com/study/60245-latin-american-consensus-on-guidelines-for-chronic-migraine-treatment2026-10-06 https://evidence-hub.com/study/60246-neuromodulation-of-chronic-headaches-position-statement-from-the2026-10-06 https://evidence-hub.com/study/60247-evidence-based-guidelines-for-the-chiropractic-treatment-of-adults2026-10-06 https://evidence-hub.com/study/60248-hormonal-contraception-and-vascular-risk-cngof-contraception2026-10-06 https://evidence-hub.com/study/60249-european-academy-of-neurology-guideline-on-the-management-of2026-10-06 https://evidence-hub.com/study/60250-acog-practice-bulletin-the-use-of-hormonal-contraception-in-women2026-10-06 https://evidence-hub.com/study/60251-treatment-of-medication-overuse-headache-guideline-of-the-efns2026-10-06 https://evidence-hub.com/study/60252-benign-paroxysmal-positional-vertigo-diagnostic-criteria-consensus2026-10-06 https://evidence-hub.com/study/60253-efns-guideline-on-the-drug-treatment-of-migraine-revised-report-of-an2026-10-06 https://evidence-hub.com/study/60254-new-appendix-criteria-open-for-a-broader-concept-of-chronic-migraine2026-10-06 https://evidence-hub.com/study/60255-canadian-association-of-emergency-physicians-guidelines-for-the-acute2026-10-06 https://evidence-hub.com/study/60256-efns-guideline-on-the-drug-treatment-of-migraine-report-of-an-efns2026-10-06 https://evidence-hub.com/study/60257-guidelines-for-the-diagnosis-and-management-of-migraine-in-clinical2026-10-06 https://evidence-hub.com/study/60258-guidelines-for-the-nonpharmacologic-management-of-migraine-in2026-10-06 https://evidence-hub.com/study/60259-guidelines-for-controlled-trials-of-prophylactic-treatment-of-chronic2026-10-06 https://evidence-hub.com/study/60260-a-clinical-guide-for-physiotherapists-to-assess-and-manage-cervical2026-10-06 https://evidence-hub.com/study/60261-percutaneous-interventional-strategies-for-migraine-prevention-a2026-10-08 https://evidence-hub.com/study/60262-transcranial-magnetic-stimulation-for-pain-headache-and-comorbid2026-10-06 https://evidence-hub.com/study/60263-french-guidelines-for-the-diagnosis-and-management-of-migraine-in2026-10-06 https://evidence-hub.com/study/60264-use-misuse-and-abuse-of-androgens-the-endocrine-society-of-australia2026-10-06 https://evidence-hub.com/study/60265-recommendations-guide-for-the-treatment-of-migraine-in-the-clinical2026-10-06 https://evidence-hub.com/study/60266-consensus-paper-of-the-german-migraine-and-headache-society-on-the2026-10-06 https://evidence-hub.com/study/60267-efns-guidelines-on-the-molecular-diagnosis-of-channelopathies2026-10-06 https://evidence-hub.com/study/60268-sclerotherapy-of-varicose-veins-with-polidocanol-based-on-the2026-10-06 https://evidence-hub.com/study/60269-summary-of-the-practice-guideline-headache-from-the-dutch-college-of2026-10-06 https://evidence-hub.com/study/60270-recommendations-for-prophylactic-treatment-of-migraine-consensus-of2026-10-06 https://evidence-hub.com/study/60271-canadian-headache-society-guideline-for-migraine-prophylaxis2026-10-06 https://evidence-hub.com/study/60272-self-medication-of-migraine-and-tension-type-headache-summary-of-the2026-10-06 https://evidence-hub.com/study/60273-guidelines-of-the-international-headache-society-for-real-world2026-10-06 https://evidence-hub.com/study/60274-guidelines-of-the-international-headache-society-for-controlled2026-10-06 https://evidence-hub.com/study/60275-guidelines-of-the-international-headache-society-for-controlled2026-10-06 https://evidence-hub.com/study/60276-practice-parameter-pharmacological-treatment-of-migraine-headache-in2026-10-06 https://evidence-hub.com/study/60277-primary-prevention-of-ischemic-stroke-a-guideline-from-the-american2026-10-06 https://evidence-hub.com/study/60278-chronic-recurrent-headache-without-neurological-abnormalities2026-10-06 https://evidence-hub.com/study/60279-therapy-and-care-of-patients-with-chronic-migraine-expert2026-10-06 https://evidence-hub.com/study/60280-latest-clinical-recommendations-on-valproate-use-for-migraine2026-10-06 https://evidence-hub.com/study/60281-combined-oral-contraceptives-migraine-and-ischaemic-stroke-clinical2026-10-06 https://evidence-hub.com/study/60282-practice-parameter-evaluation-of-children-and-adolescents-with2026-10-06 https://evidence-hub.com/study/60283-is-there-an-indication-for-the-use-of-barbiturate-containing2026-10-06 https://evidence-hub.com/study/60284-the-canadian-network-for-mood-and-anxiety-treatments-canmat-task2026-10-06 https://evidence-hub.com/study/60285-saudi-clinical-practice-guidelines-for-the-treatment-and-prevention2026-10-06 https://evidence-hub.com/study/60286-experts-and-national-consultants-recommendations-regarding-management2026-10-06 https://evidence-hub.com/study/60287-experts-and-national-consultants-recommendations-regarding-management2026-10-06 https://evidence-hub.com/study/60288-migraine-management-in-saudi-arabia-an-expert-consensus2026-10-06 https://evidence-hub.com/study/60289-joint-practical-guideline-of-the-hungarian-pain-society-chronic2026-10-06 https://evidence-hub.com/study/60290-croatian-guidelines-for-specific-preventive-treatment-of-migraine2026-10-06 https://evidence-hub.com/study/60291-practice-guideline-update-summary-pharmacologic-treatment-for2026-10-06 https://evidence-hub.com/study/60292-guidelines-of-the-international-headache-society-for-controlled2026-10-06 https://evidence-hub.com/study/60293-joint-guideline-of-the-headache-working-group-of-the-hungarian2026-10-06 https://evidence-hub.com/study/60294-therapeutic-strategies-for-benign-paroxysmal-positional-vertigo-of2026-10-06 https://evidence-hub.com/study/60295-headache-management-in-portugal-consensus-among-the-portuguese2026-10-06 https://evidence-hub.com/study/60296-acute-migraine-treatment-recommendations-to-optimize-management2026-10-06 https://evidence-hub.com/study/60297-approach-to-headache-disorders-and-the-management-of-migraine2026-10-06 https://evidence-hub.com/study/60298-headaches-in-over-12s-diagnosis-and-management2026-10-06 https://evidence-hub.com/study/60299-action-collaborative-on-traumatic-brain-injury-care-adapted-clinical2026-10-06 https://evidence-hub.com/study/60300-initial-physical-health-assessment-for-psychosis-in-australia-and-new2026-10-06 https://evidence-hub.com/study/60301-espghan-naspghan-guidelines-for-treatment-of-irritable-bowel-syndrome2026-10-06 https://evidence-hub.com/study/60302-practical-brain-mri-guidelines-for-anti-a-antibody-treatment-in-early2026-10-06 https://evidence-hub.com/study/60303-american-academy-of-audiology-clinical-consensus-statement-assessment2026-10-06 https://evidence-hub.com/study/60304-european-guideline-on-chronic-nausea-and-vomiting-a-ueg-and-esnm2026-10-13 https://evidence-hub.com/study/60305-2025-focused-update-of-the-2020-isth-guidelines-for-management-of2026-10-06 https://evidence-hub.com/study/60306-brazilian-public-health-system-protocol-for-the-diagnosis-treatment2026-10-06 https://evidence-hub.com/study/60307-understanding-the-pain-experience-and-treatment-considerations-along2026-10-06 https://evidence-hub.com/study/60308-european-stroke-organisation-eso-guidelines-on-the-diagnosis-and2026-10-06 https://evidence-hub.com/study/60309-investigation-and-management-of-resistant-hypertension-british-and2026-10-06 https://evidence-hub.com/study/60310-u-s-selected-practice-recommendations-for-contraceptive-use-20242026-10-13 https://evidence-hub.com/study/60311-multidisciplinary-consensus-guideline-for-the-diagnosis-and2026-10-06 https://evidence-hub.com/study/60312-guidelines-of-the-french-society-of-otorhinolaryngology-sforl-for2026-10-06 https://evidence-hub.com/study/60313-task-force-of-the-brazilian-society-of-otology-evaluation-and2026-10-06 https://evidence-hub.com/study/60314-standard-headache-and-neuralgia-treatments-and-sars-cov-2-opinion-of2026-10-06 https://evidence-hub.com/study/60315-clinical-pharmacogenetics-implementation-consortium-guideline-cpic2026-10-06 https://evidence-hub.com/study/60316-south-pacific-underwater-medicine-society-spums-position-statement2026-10-06 https://evidence-hub.com/study/60317-infarction-related-cardiogenic-shock-diagnosis-monitoring-and-therapy2026-10-06 https://evidence-hub.com/study/60318-chinese-stroke-association-guidelines-for-clinical-management-of2026-10-06 https://evidence-hub.com/study/60319-european-headache-federation-guideline-on-idiopathic-intracranial2026-10-06 https://evidence-hub.com/study/60320-the-2023-society-for-vascular-surgery-american-venous-forum-and2026-10-06 https://evidence-hub.com/study/60321-diagnostic-and-therapeutic-guidelines-for-plaque-psoriasis-brazilian2026-10-06 https://evidence-hub.com/study/60322-obesity-in-south-and-southeast-asia-a-new-consensus-on-care-and2026-10-08 https://evidence-hub.com/study/60323-vestibular-rehabilitation-for-peripheral-vestibular-hypofunction-an2026-10-06 https://evidence-hub.com/study/60324-cdc-guideline-on-mild-traumatic-brain-injury-in-children-important2026-10-06 https://evidence-hub.com/study/60325-the-management-of-adult-patients-with-severe-chronic-small-intestinal2026-10-13 https://evidence-hub.com/study/60326-guidelines-for-the-primary-prevention-of-stroke-a-statement-for2026-10-18 https://evidence-hub.com/study/60327-cdc-guideline-for-opioid-prescribing-associated-with-reduced2026-10-06 https://evidence-hub.com/study/60328-reference-programme-diagnosis-and-treatment-of-headache-disorders-and2026-10-06 https://evidence-hub.com/study/60329-the-grade-working-group-clarifies-the-construct-of-certainty-of2026-10-06 https://evidence-hub.com/study/60330-evidence-based-recommendations-on-pharmacologic-treatment-for2026-10-06 https://evidence-hub.com/study/60337-sign-updates-its-guideline-on-the-management-of-migraine2026-10-06 https://evidence-hub.com/study/60338-low-adherence-to-the-guideline-for-the-acute-treatment-of-migraine2026-10-06 https://evidence-hub.com/study/60341-practice-guideline-update-summary-acute-treatment-of-migraine-in2026-10-06 https://evidence-hub.com/study/60343-guideline-on-the-use-of-onabotulinumtoxina-in-chronic-migraine-a2026-10-06 https://evidence-hub.com/study/60345-correction-to-european-headache-federation-guideline-on-the-use-of2026-10-06 https://evidence-hub.com/study/60346-acute-treatment-of-migraine-in-children-and-adolescents-review-of-the2026-10-06 https://evidence-hub.com/study/60347-letter-to-the-editor-regarding-european-headache-federation-guideline2026-10-06 https://evidence-hub.com/study/60348-guideline-on-the-preventive-treatment-of-chronic-migraine-chronic2026-10-06 https://evidence-hub.com/study/60349-clinical-practice-guideline-for-headache-disorders-20212026-10-06 https://evidence-hub.com/study/60354-migraine-management-in-chinese-headache-centers-a-national-survey-and2026-10-06 https://evidence-hub.com/study/60355-acupuncture-recommendations-for-migraine-in-headache-treatment2026-10-06 https://evidence-hub.com/study/60356-patients-values-and-preferences-regarding-the-pharmacologic-treatment2026-10-06 https://evidence-hub.com/study/60357-characterizing-barriers-to-care-in-migraine-multicountry-results-from2026-10-06 https://evidence-hub.com/study/60358-calcitonin-gene-related-peptide-targeting-drugs-efficiently-treat2026-10-06 https://evidence-hub.com/study/60359-a-discrete-choice-experiment-assessing-the-patient-preferences-and2026-10-06 https://evidence-hub.com/study/60360-the-2023-protocol-for-update-to-acute-treatment-of-adults-with2026-10-06 https://evidence-hub.com/study/60361-methodology-of-drug-trials-in-migraine-history-and-suggestions-for2026-10-06 https://evidence-hub.com/study/60362-no-association-between-rs6295-of-and-risk-of-migraine-evidence-from2026-10-06 https://evidence-hub.com/study/60363-pharmacologic-prevention-of-migraine2026-10-08 https://evidence-hub.com/study/60365-remote-electrical-neuromodulation-ren-wearable-device-for-adolescents2026-10-06 https://evidence-hub.com/study/60366-digital-therapeutics-in-migraine-management-a-novel-treatment-option2026-10-06 https://evidence-hub.com/study/60367-therapeutic-overlap-between-bipolar-disorder-and-migraine-a2026-10-06 https://evidence-hub.com/study/60370-abstract-number-esoc2026a534-prognosis-of-apparent-tias-with2026-10-06 https://evidence-hub.com/study/60371-performance-comparison-of-large-language-models-in-interpreting2026-10-06 https://evidence-hub.com/study/60372-contraceptive-decision-making-in-women-with-migraine-integrating2026-10-06 https://evidence-hub.com/study/60373-navigating-migraine-care-during-pregnancy-and-lactation2026-10-06 https://evidence-hub.com/study/60374-migraine-and-multiple-sclerosis-across-the-female-reproductive2026-10-06 https://evidence-hub.com/study/60375-a-global-comparison-of-clinical-guidelines-for-the-diagnosis-and2026-10-06 https://evidence-hub.com/study/60376-fu-s-subcutaneous-needling-treatment-for-migraine-without-aura-a2026-10-06 https://evidence-hub.com/study/60378-effectiveness-of-mindfulness-based-stress-reduction-as-a-nondrug2026-10-06 https://evidence-hub.com/study/60379-effect-of-short-term-air-pollution-exposure-on-migraine-a-protocol2026-10-06 https://evidence-hub.com/study/60380-comprehensive-analysis-of-genes-associated-with-migraine-in-the2026-10-06 https://evidence-hub.com/study/60382-management-of-medication-overuse-mo-and-medication-overuse-headache2026-10-06 https://evidence-hub.com/study/60383-the-effect-of-implementation-of-guideline-order-bundles-into-a2026-10-06 https://evidence-hub.com/study/60385-the-effectiveness-and-safety-of-cranial-nerve-block-in-migraine-a2026-10-06 https://evidence-hub.com/study/60386-trajectory-of-health-care-resources-among-adults-stopping-or-reducing2026-10-06 https://evidence-hub.com/study/60387-sumatriptan-naproxen-sodium-fix-dose-combination-for-acute-migraine2026-10-06 https://evidence-hub.com/study/60388-results-obtained-with-cranial-nerve-block-in-the-treatment-of2026-10-06 https://evidence-hub.com/study/60390-canadian-headache-society-guideline-for-migraine-prophylaxis2026-10-08 https://evidence-hub.com/study/60394-manual-joint-mobilisation-techniques-supervised-physical-activity2026-10-06 https://evidence-hub.com/study/60395-pathophysiology-and-therapy-of-associated-features-of-migraine2026-10-06 https://evidence-hub.com/study/60396-migraine-aura-without-headache-corrected2026-10-06 https://evidence-hub.com/study/60397-managing-and-preventing-migraine-in-the-emergency-department-a-review2026-10-06 https://evidence-hub.com/study/60398-migraine-in-women-a-review2026-10-06 https://evidence-hub.com/study/60399-review-of-aromatherapy-essential-oils-and-their-mechanism-of-action2026-10-06 https://evidence-hub.com/study/60400-dietary-patterns-and-migraine-insights-and-impact2026-10-08 https://evidence-hub.com/study/60401-genetics-of-migraine2026-10-06 https://evidence-hub.com/study/60407-pathophysiology-of-migraine-aura2026-10-06 https://evidence-hub.com/study/60408-migraine-in-pregnancy2026-10-06 https://evidence-hub.com/study/60409-prevention-of-migraine2026-10-08 https://evidence-hub.com/study/60410-borderlands-of-migraine-and-epilepsy2026-10-06 https://evidence-hub.com/study/60411-benign-paroxysmal-vertigo-of-childhood2026-10-06 https://evidence-hub.com/study/60412-headache-in-behcet-s-disease2026-10-06 https://evidence-hub.com/study/60413-migraine-and-epilepsy-review-of-the-literature2026-10-06 https://evidence-hub.com/study/60414-an-overview-of-the-current-and-emerging-treatment-options-for2026-10-06 https://evidence-hub.com/study/60415-migraine-associated-vestibulopathy2026-10-06 https://evidence-hub.com/study/60416-review-of-migraine-incidence-and-management-in-obstetrics-and2026-10-06 https://evidence-hub.com/study/60417-the-cerebellum-and-migraine2026-10-06 https://evidence-hub.com/study/60418-neuro-otological-emergencies2026-10-06 https://evidence-hub.com/study/60419-headaches-in-parkinson-s-disease-a-comprehensive-review2026-10-06 https://evidence-hub.com/study/60420-characteristics-and-diagnostic-approach-of-vestibular-migraine-in2026-10-06 https://evidence-hub.com/study/60421-prophylaxis-of-migraine-headaches-with-riboflavin-a-systematic-review2026-10-08 https://evidence-hub.com/study/60422-acute-migraine-management-in-children2026-10-06 https://evidence-hub.com/study/60423-diagnosis-and-treatment-of-migraine2026-10-06 https://evidence-hub.com/study/60424-diagnosis-and-treatment-of-migraine2026-10-06 https://evidence-hub.com/study/60425-erenumab-first-global-approval2026-10-06 https://evidence-hub.com/study/60426-premenstrual-syndrome-and-migraine2026-10-06 https://evidence-hub.com/study/60427-neuroactive-properties-of-reproductive-steroids2026-10-06 https://evidence-hub.com/study/60428-chronic-pain-syndromes-in-women2026-10-06 https://evidence-hub.com/study/60429-migraine-and-psychiatric-comorbidity-a-review-of-clinical-findings2026-10-06 https://evidence-hub.com/study/60430-experimental-and-clinical-investigation-of-cytokines-in-migraine-a2026-10-04 https://evidence-hub.com/study/60431-migraine-and-vascular-risk2026-10-06 https://evidence-hub.com/study/60432-a-narrative-review-of-intestinal-microbiota-s-impact-on-migraine-with2026-10-04 https://evidence-hub.com/study/60433-spreading-depolarization-may-link-migraine-and-stroke2026-10-06 https://evidence-hub.com/study/60434-triptans-over-the-migraine2026-10-06 https://evidence-hub.com/study/60435-migraine-vertigo-and-migrainous-vertigo-links-between-vestibular-and2026-10-06 https://evidence-hub.com/study/60436-diagnosis-and-management-of-migraines-and-migraine-variants2026-10-06 https://evidence-hub.com/study/60437-migraine-diagnosis-and-treatment2026-10-06 https://evidence-hub.com/study/60438-visual-processing-during-the-interictal-period-between-migraines-a2026-10-06 https://evidence-hub.com/study/60439-migraine-and-menopause-a-narrative-review2026-10-04 https://evidence-hub.com/study/60440-migraine-and-stroke-in-search-of-shared-mechanisms2026-10-06 https://evidence-hub.com/study/60441-to-eat-or-not-to-eat-a-review-of-the-relationship-between-chocolate2026-10-08 https://evidence-hub.com/study/60442-peripheral-neuromodulation-in-chronic-migraine2026-10-06 https://evidence-hub.com/study/60443-migraine-related-vertigo-diagnosis-and-treatment2026-10-06 https://evidence-hub.com/study/60444-pediatric-migraine-recognition-and-treatment2026-10-06 https://evidence-hub.com/study/60445-migraine-epidemiology-risk-factors-pathophysiology-and-treatment2026-10-06 https://evidence-hub.com/study/60446-the-microgenderome-in-migraine-integrating-sex-hormones-microbial2026-10-06 https://evidence-hub.com/study/60447-dopaminergic-dysregulation-in-migraine-from-hypothalamic-a112026-10-04 https://evidence-hub.com/study/60448-efficacy-and-safety-of-fremanezumab-in-episodic-migraine-a-systematic2026-10-06 https://evidence-hub.com/study/60449-managing-headache-in-primary-care-choosing-therapies-that-treat-the2026-10-06 https://evidence-hub.com/study/60450-photobiomodulation-and-migraine-mechanisms-and-therapeutic-potential2026-10-06 https://evidence-hub.com/study/60451-persistence-and-reasons-for-treatment-discontinuation-of-anti-cgrp2026-10-06 https://evidence-hub.com/study/60452-neural-circuit-dysfunctions-in-migraine-a-stage-specific-dynamic2026-10-06 https://evidence-hub.com/study/60453-acupuncture-modulates-migraine-related-neural-and-neuroendocrine2026-10-06 https://evidence-hub.com/study/60454-efficacy-and-safety-of-cannabinoid-based-interventions-for-low-back2026-10-06 https://evidence-hub.com/study/60455-mechanisms-of-acupuncture-on-the-neurovascular-unit-in-migraine-a2026-10-04 https://evidence-hub.com/study/60456-the-estrogen-cgrp-axis-in-migraine-neuroimmune-mechanisms-sex2026-10-06 https://evidence-hub.com/study/60457-a-global-perspective-on-migraine-attack-triggers-understanding2026-10-06 https://evidence-hub.com/study/60458-common-mechanisms-in-migraine-migraine-related-neck-pain-and-low-back2026-10-06 https://evidence-hub.com/study/60459-therapeutic-applications-of-rtms-in-migraine-prophylaxis2026-10-06 https://evidence-hub.com/study/60460-pharmacotherapy-for-chronic-migraine-prevention-a-narrative-review2026-10-06 https://evidence-hub.com/study/60461-migraine-with-visual-aura-unilateral-mydriasis-and-takotsubo-syndrome2026-10-06 https://evidence-hub.com/study/60462-novel-targets-in-headache-a-narrative-review2026-10-06 https://evidence-hub.com/study/60463-beyond-pain-relief-rethinking-sleep-outcomes-in-cgrp-targeted2026-10-06 https://evidence-hub.com/study/60464-considerations-for-understanding-systematic-reviews-and-network-meta2026-10-06 https://evidence-hub.com/study/60465-phenotype-guided-selection-of-venlafaxine-and-topiramate-for2026-10-06 https://evidence-hub.com/study/60466-the-association-between-parental-migraine-infantile-colic-and-later2026-10-06 https://evidence-hub.com/study/60467-fully-biodegradable-versus-nitinol-occluder-devices-for-transcatheter2026-10-06 https://evidence-hub.com/study/60468-retinal-connections-to-migraine2026-10-04 https://evidence-hub.com/study/60469-ubrogepant-ubrelvy-indication-for-the-acute-treatment-of-migraine2026-10-06 https://evidence-hub.com/study/60470-hypothalamus-as-a-conductor-of-the-migraine-prodrome-a-narrative2026-10-04 https://evidence-hub.com/study/60471-efficacy-and-safety-of-gepants-in-migraine-management-a-narrative2026-10-06 https://evidence-hub.com/study/60472-a-delayed-endothelial-glial-mechanism-for-cgrp-induced-migraine2026-10-06 https://evidence-hub.com/study/60473-persistent-postural-perceptual-dizziness-a-phenotype-oriented2026-10-06 https://evidence-hub.com/study/60474-botulinum-toxins-therapeutic2026-10-06 https://evidence-hub.com/study/60475-nose-to-brain-nanocarriers-for-migraine-management-a-comprehensive2026-10-06 https://evidence-hub.com/study/60476-migraine-and-auditory-dysfunction-beyond-comorbidity2026-10-08 https://evidence-hub.com/study/60477-migraine-in-children-and-adolescents2026-10-06 https://evidence-hub.com/study/60478-calcitonin-gene-related-peptide-as-a-neuroimmune-amplifier-in2026-10-06 https://evidence-hub.com/study/60479-beyond-aqp-4-convergent-glymphatic-meningeal-lymphatic-dysfunction2026-10-06 https://evidence-hub.com/study/60480-headache-as-a-sentinel-signal-after-cranial-radiotherapy-a-symptom2026-10-06 https://evidence-hub.com/study/60481-evaluating-the-complementary-nature-of-randomized-controlled-trials2026-10-06 https://evidence-hub.com/study/60482-pediatric-migraine-neurodevelopmental-mechanisms-clinical-phenotypes2026-10-08 https://evidence-hub.com/study/60483-migraine-relief-solutions-from-natural-bioactive-products-of2026-10-06 https://evidence-hub.com/study/60484-migraine-and-menopause-as-converging-factors-in-brain-vulnerability-a2026-10-06 https://evidence-hub.com/study/60485-headache-education-in-africa-a-narrative-review-of-educational2026-10-06 https://evidence-hub.com/study/60486-migraine-advanced-preventative-treatments-the-british-association-for2026-10-06 https://evidence-hub.com/study/60487-engineered-extracellular-vesicles-as-a-new-delivery-platform-for2026-10-06 https://evidence-hub.com/study/60488-the-social-life-of-migraine-a-meta-ethnography-of-lived-experience-in2026-10-06 https://evidence-hub.com/study/60489-headache-psychiatry-a-structured-narrative-review-and-integrative2026-10-08 https://evidence-hub.com/study/60490-diagnosis-and-management-of-patients-with-migraines-and-other2026-10-06 https://evidence-hub.com/study/60491-oxidative-stress-in-migraine-effect-or-cause2026-10-06 https://evidence-hub.com/study/60492-when-headache-meets-visual-disturbance-an-evidence-based-review-of2026-10-06 https://evidence-hub.com/study/60493-non-pharmacological-treatments-of-migraine-current-evidence-and2026-10-06 https://evidence-hub.com/study/60494-migraine-and-cardiovascular-risk-a-scoping-review-of-vascular2026-10-06 https://evidence-hub.com/study/60495-trpv1-mediated-central-sensitisation-core-mechanisms-of-migraine2026-10-06 https://evidence-hub.com/study/60496-mechanism-of-sgcs-hmgb1-axis-mediated-peripheral-sensitization-in2026-10-06 https://evidence-hub.com/study/60497-from-bench-to-bedside-relevant-animal-models-across-the-migraine2026-10-04 https://evidence-hub.com/study/60498-what-s-needed-for-a-migraine-cost-of-illness-study-in-aotearoa-new2026-10-06 https://evidence-hub.com/study/60499-a-profile-on-the-cefaly-dual-trigeminal-neurostimulator-for-acute-and2026-10-06 https://evidence-hub.com/study/60500-headache-in-mitochondrial-diseases-from-migraine-to-stroke-like2026-10-06 https://evidence-hub.com/study/60501-the-role-of-kynurenine-pituitary-adenylate-cyclase-activating2026-10-06 https://evidence-hub.com/study/60502-efficacy-and-cardiovascular-safety-of-lasmiditan-in-patients-with2026-10-06 https://evidence-hub.com/study/60503-migraine-aura-differential-diagnostics-between-ophthalmology-and2026-10-06 https://evidence-hub.com/study/60504-migraine-migraine-aura-and-cervical-artery-dissection-a-systematic2026-10-04 https://evidence-hub.com/study/60506-migraine-and-cardiovascular-disease-systematic-review-and-meta2026-10-04 https://evidence-hub.com/study/60508-manual-therapies-for-migraine-a-systematic-review2026-10-04 https://evidence-hub.com/study/60509-efficacy-of-biofeedback-for-migraine-a-meta-analysis2026-10-04 https://evidence-hub.com/study/60511-meningeal-mechanisms-and-the-migraine-connection2026-10-04 https://evidence-hub.com/study/60513-the-effect-of-aerobic-exercise-on-the-number-of-migraine-days2026-10-04 https://evidence-hub.com/study/60514-cadasil-and-migraine-a-narrative-review2026-10-04 https://evidence-hub.com/study/60515-the-role-of-cytokines-in-migraine-a-systematic-review2026-10-04 https://evidence-hub.com/study/60516-calcitonin-gene-related-peptide-cgrp-a-new-target-for-migraine2026-10-04 https://evidence-hub.com/study/60517-sex-and-gender-differences-in-migraines-a-narrative-review2026-10-04 https://evidence-hub.com/study/60519-multimodal-migraine-management-and-the-pursuit-of-migraine-freedom-a2026-10-04 https://evidence-hub.com/study/60520-migraine-in-menopausal-women-a-systematic-review2026-10-04 https://evidence-hub.com/study/60522-mindfulness-in-migraine-a-narrative-review2026-10-04 https://evidence-hub.com/study/60523-population-variation-in-migraine-prevalence-a-meta-analysis2026-10-04 https://evidence-hub.com/study/60524-epidemiology-and-treatment-of-menstrual-migraine-and-migraine-during2026-10-04 https://evidence-hub.com/study/60525-serotonergic-mechanisms-in-the-migraine-brain-a-systematic-review2026-10-04 https://evidence-hub.com/study/60529-a-systematic-review-of-the-psychosocial-difficulties-relevant-to2026-10-04 https://evidence-hub.com/study/60530-cutaneous-allodynia-in-migraine-a-narrative-review2026-10-04 https://evidence-hub.com/study/60531-psychological-interventions-for-migraine-a-systematic-review2026-10-04 https://evidence-hub.com/study/60532-prevalence-of-headache-and-migraine-in-children-and-adolescents-a2026-10-04 https://evidence-hub.com/study/60533-migraine-and-cognitive-dysfunction-a-narrative-review2026-10-04 https://evidence-hub.com/study/60535-migraine-and-light-a-narrative-review2026-10-04 https://evidence-hub.com/study/60537-grey-matter-alterations-in-migraine-a-systematic-review-and-meta2026-10-04 https://evidence-hub.com/study/60538-migraine-and-mortality-a-systematic-review-and-meta-analysis2026-10-04 https://evidence-hub.com/study/60540-association-betweenhelicobacter-pyloriinfection-and-migraine-a-meta2026-10-04 https://evidence-hub.com/study/60541-global-prevalence-of-chronic-migraine-a-systematic-review2026-10-04 https://evidence-hub.com/study/60542-the-epidemiology-of-migraine-headache-in-arab-countries-a-systematic2026-10-04 https://evidence-hub.com/study/60545-shift-work-and-migraine-a-systematic-review2026-10-04 https://evidence-hub.com/study/60546-quantitative-sensory-testing-in-patients-with-migraine-a-systematic2026-10-04 https://evidence-hub.com/study/60547-the-migraine-anxiety-comorbidity-among-migraineurs-a-systematic-review2026-10-04 https://evidence-hub.com/study/60551-migraine-biomarkers-in-cerebrospinal-fluid-a-systematic-review-and2026-10-04 https://evidence-hub.com/study/60552-the-not-so-hidden-impact-of-interictal-burden-in-migraine-a-narrative2026-10-04 https://evidence-hub.com/study/60554-migraine-advances-in-treatment2026-10-04 https://evidence-hub.com/study/60556-effectiveness-and-safety-of-acupuncture-for-migraine-an-overview-of2026-10-04 https://evidence-hub.com/study/60558-association-of-the-c677t-polymorphism-in-the-mthfr-gene-with-migraine2026-10-04 https://evidence-hub.com/study/60559-sex-specific-pharmacotherapy-for-migraine-a-narrative-review2026-10-04 https://evidence-hub.com/study/60560-role-of-cgrp-pathway-polymorphisms-in-migraine-a-systematic-review2026-10-04 https://evidence-hub.com/study/60562-pyridoxine-folate-and-cobalamin-for-migraine-a-systematic-review2026-10-04 https://evidence-hub.com/study/60565-efficacy-of-coq10-as-supplementation-for-migraine-a-meta-analysis2026-10-08 https://evidence-hub.com/study/60567-the-emerging-importance-of-cortical-spreading-depression-in-migraine2026-10-06 https://evidence-hub.com/study/60568-the-episodic-syndromes-that-maybe-associated-with-migraines2026-10-06 https://evidence-hub.com/study/60570-chronic-migrainous-vertigo2026-10-06 https://evidence-hub.com/study/60571-why-do-migraines-often-decrease-as-we-age2026-10-06 https://evidence-hub.com/study/60572-complications-of-migraine-migrainous-infarction2026-10-06 https://evidence-hub.com/study/60573-benign-recurrent-vertigo-in-japanese2026-10-06 https://evidence-hub.com/study/60574-migraine-definitions-mechanisms-and-treatment2026-10-06 https://evidence-hub.com/study/60575-migraine-disease-evolution-and-progression2026-10-06 https://evidence-hub.com/study/60577-migraine-a-genetic-disease2026-10-06 https://evidence-hub.com/study/60578-vertigo-as-a-symptom-of-migraine2026-10-06 https://evidence-hub.com/study/60579-exercise-and-migraine-a-critical-review2026-10-06 https://evidence-hub.com/study/60580-fifty-years-of-migraine-research2026-10-06 https://evidence-hub.com/study/60581-transient-global-amnesia-and-migraine2026-10-06 https://evidence-hub.com/study/60582-how-imaging-can-help-us-better-understand-the-migraine-stroke2026-10-06 https://evidence-hub.com/study/60583-5-hydroxytryptamine-levels-and-platelet-aggregation-responses-in2026-10-06 https://evidence-hub.com/study/60584-a-pharmacogenomic-evaluation-of-migraine-therapy2026-10-06 https://evidence-hub.com/study/60585-migrainous-vertigo-development-of-a-pathogenetic-model-and-structured2026-10-06 https://evidence-hub.com/study/60586-flunarizine-increases-prl-secretion-in-normal-and-in-migraineous-women2026-10-06 https://evidence-hub.com/study/60587-episodic-migraines-in-children-limited-evidence-on-preventive2026-10-06 https://evidence-hub.com/study/60588-propranolol-in-the-management-of-recurrent-migraine-a-meta-analytic2026-10-06 https://evidence-hub.com/study/60589-migraine-and-ischemic-stroke-deciphering-the-bidirectional-pathway2026-10-06 https://evidence-hub.com/study/60590-diabetes-mellitus-as-a-risk-factor-in-recurrent-vestibular-disorders2026-10-06 https://evidence-hub.com/study/60591-case-report-mechanical-thrombectomy-of-cerebral-venous-sinuses-using2026-10-06 https://evidence-hub.com/study/60592-design-and-evaluation-of-multi-electrode-configurations-for2026-10-06 https://evidence-hub.com/study/60593-vitamin-d-deficiency-and-supplementation-in-migraine-a-scoping-review2026-10-06 https://evidence-hub.com/study/60594-vagus-nerve-stimulation-in-rheumatic-diseases-linking-autonomic2026-10-06 https://evidence-hub.com/study/60595-atogepant-modulates-brain-connectivity-in-episodic-migraine-a2026-10-06 https://evidence-hub.com/study/60596-prevalence-of-the-photic-sneeze-reflex-a-systematic-review-and-meta2026-10-06 https://evidence-hub.com/study/60597-integrated-anatomical-and-functional-connectivity-mapping-in-episodic2026-10-06 https://evidence-hub.com/study/60598-predicting-pharmacological-treatment-response-in-migraine-using-ai-ml2026-10-06 https://evidence-hub.com/study/60599-integrative-multi-omics-analysis-identifies-endocrine-disrupting2026-10-06 https://evidence-hub.com/study/60600-facial-expressions-as-a-nexus-for-health-assessment2026-10-06 https://evidence-hub.com/study/60601-decoding-the-neurological-connection-between-rosacea-and-migraines2026-10-06 https://evidence-hub.com/study/60602-new-directions-in-migraine-pathophysiology-the-glymphatic-system-and2026-10-08 https://evidence-hub.com/study/60603-association-between-homocysteine-vitamin-b12-folate-and-migraine-an2026-10-06 https://evidence-hub.com/study/60604-triple-network-disruption-in-medication-overuse-headache-functional2026-10-06 https://evidence-hub.com/study/60605-antinociceptive-effects-of-exogenous-and-endogenous-carbon-monoxide2026-10-06 https://evidence-hub.com/study/60606-botulinum-toxin-for-chronic-migraine-beyond-headache-reduction-and2026-10-06 https://evidence-hub.com/study/60607-tonabersat-blocks-gap-junctions-and-alleviates-thermal-pain-behavior2026-10-06 https://evidence-hub.com/study/60608-medial-prefrontal-cortex-targeted-low-intensity-focused-ultrasound2026-10-06 https://evidence-hub.com/study/60609-the-design-and-reporting-of-sham-acupuncture-and-its-association-with2026-10-06 https://evidence-hub.com/study/60610-practice-based-consensus-amongst-indian-neurologists-adopting-remote2026-10-06 https://evidence-hub.com/study/60611-integrated-atac-seq-and-rna-seq-analysis-identifies-grid2-and-reln-as2026-10-04 https://evidence-hub.com/study/60612-long-term-follow-up-results-of-percutaneous-closure-of-atrial-septal2026-10-06 https://evidence-hub.com/study/60613-efficacy-of-melatonin-as-a-promising-intervention-for-migraine2026-10-08 https://evidence-hub.com/study/60614-pvncrf-neurons-regulate-migraine-like-allodynia-by-activating-crfr22026-10-06 https://evidence-hub.com/study/60615-safety-and-efficacy-of-transcatheter-embolization-for-pulmonary2026-10-06 https://evidence-hub.com/study/60616-effects-of-proton-pump-inhibitor-ppi-use-on-migraine-a-critical-review2026-10-08 https://evidence-hub.com/study/60617-a-review-of-the-biochemical-diagnostic-biomarkers-in-migraine-new2026-10-06 https://evidence-hub.com/study/60618-research-progress-of-transcutaneous-auricular-vagus-nerve-stimulation2026-10-06 https://evidence-hub.com/study/60619-gpt-meets-pubmed-a-novel-approach-to-literature-review-using-a-large2026-10-06 https://evidence-hub.com/study/60620-posterior-insular-cortex-hyperactivation-drives-vestibular-migraine2026-10-06 https://evidence-hub.com/study/60621-from-trigeminal-ganglion-to-cortex-atg7-emerges-as-a-key-integrator2026-10-06 https://evidence-hub.com/study/60622-the-effectiveness-of-educational-behavioural-and-cognitive-self2026-10-06 https://evidence-hub.com/study/60623-the-emerging-role-of-glucagon-like-peptide-1-receptor-agonists-in2026-10-06 https://evidence-hub.com/study/60624-economic-value-of-physiotherapy-interventions-in-headache-management2026-10-06 https://evidence-hub.com/study/60625-serum-inflammatory-cytokines-as-biomarkers-for-predicting-chronic2026-10-06 https://evidence-hub.com/study/60626-right-to-left-shunt-and-transcranial-doppler-as-a-diagnostic-tool2026-10-06 https://evidence-hub.com/study/60627-advances-in-intranasal-cns-targeting-integrating-formulations-devices2026-10-06 https://evidence-hub.com/study/60628-association-between-maternal-migraine-and-infantile-colic-a-narrative2026-10-06 https://evidence-hub.com/study/60629-sexually-dimorphic-neuroimmune-pathways-in-chronic-pain-a2026-10-06 https://evidence-hub.com/study/60630-contraception-related-topics-in-chat-dialogues-between-healthcare2026-10-06 https://evidence-hub.com/study/60631-aura-phenomenon-a-proposal-for-an-etiology-based-clinical2026-10-06 https://evidence-hub.com/study/60632-combined-effects-of-cannabidiol-and-9-tetrahydrocannabinol-alleviate2026-10-06 https://evidence-hub.com/study/60633-neuroimaging-biomarkers-for-predicting-acupuncture-treatment-response2026-10-06 https://evidence-hub.com/study/60634-epidemiology-diagnosis-management-and-prevention-of-stroke-a2026-10-06 https://evidence-hub.com/study/60635-3t-mri-thalamic-segmentation-reveals-no-macrostructural-changes-in2026-10-06 https://evidence-hub.com/study/60636-review-an-update-on-cgrp-monoclonal-antibodies-for-the-preventive2026-10-06 https://evidence-hub.com/study/60637-the-hypometabolic-state-of-the-migraine-brain-is-a-ketogenic-diet-the2026-10-06 https://evidence-hub.com/study/60638-risk-of-suicidal-behaviors-following-sport-related-and-non-sport2026-10-06 https://evidence-hub.com/study/60639-systematic-acupuncture-explains-acupuncture-at-baihui-gv20-and2026-10-06 https://evidence-hub.com/study/60640-a-scaffold-degradable-single-rivet-asd-occluder-with-amplatzer-like2026-10-06 https://evidence-hub.com/study/60641-primary-headache-content-on-online-community-platforms-a-scoping2026-10-06 https://evidence-hub.com/study/60642-balance-control-and-vestibular-disorders-in-pregnant-women-a2026-10-06 https://evidence-hub.com/study/60643-migraine-with-and-without-aura-two-distinct-entities-a-narrative2026-10-06 https://evidence-hub.com/study/60644-morphotype-based-risk-stratification-in-patients-with-patent-foramen2026-10-06 https://evidence-hub.com/study/60645-relationship-between-sleep-apnea-and-dizziness-a-scoping-review2026-10-06 https://evidence-hub.com/study/60646-neurological-involvement-in-children-with-familial-mediterranean2026-10-06 https://evidence-hub.com/study/60647-cold-receptor-trpm8-as-a-target-for-migraine-associated-pain-and2026-10-06 https://evidence-hub.com/study/60648-neural-oscillation-mechanisms-of-repetitive-subconcussive-impacts-a2026-10-06 https://evidence-hub.com/study/60649-association-of-temporomandibular-disorders-and-other-jaw-anomalies-in2026-10-06 https://evidence-hub.com/study/60650-research-progress-on-abdominal-epilepsy-in-children2026-10-06 https://evidence-hub.com/study/60651-reduced-neurovascular-coupling-of-the-visual-network-in-migraine2026-10-06 https://evidence-hub.com/study/60652-long-term-effectiveness-of-three-anti-cgrp-monoclonal-antibodies-in2026-10-06 https://evidence-hub.com/study/60655-cervical-musculoskeletal-impairments-in-the-4-phases-of-the-migraine2026-10-06 https://evidence-hub.com/study/60656-impact-of-monthly-headache-days-on-anxiety-depression-and-disability2026-10-06 https://evidence-hub.com/study/60657-clinical-correlates-of-hypothalamic-functional-changes-in-migraine2026-10-04 https://evidence-hub.com/study/60658-erenumab-in-highly-therapy-refractory-migraine-patients-first-german2026-10-06 https://evidence-hub.com/study/60659-multidimensional-assessment-of-the-effects-of-erenumab-in-chronic2026-10-06 https://evidence-hub.com/study/60660-migraine-patients-with-cardiovascular-disease-and-contraindications2026-10-06 https://evidence-hub.com/study/60661-quality-of-life-of-migraine-patients-followed-in-neurology-clinics-in2026-10-06 https://evidence-hub.com/study/60662-calcitonin-gene-related-peptide-levels-in-tear-fluid-are-elevated-in2026-10-06 https://evidence-hub.com/study/60663-pacap27-induces-migraine-like-attacks-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60664-a-randomized-double-blind-cross-over-trial-of-very-low-calorie-diet2026-10-06 https://evidence-hub.com/study/60665-increased-neck-muscle-stiffness-in-migraine-patients-with-ictal-neck2026-10-06 https://evidence-hub.com/study/60666-effects-of-smartphone-overuse-on-headache-sleep-and-quality-of-life2026-10-06 https://evidence-hub.com/study/60667-direct-and-indirect-healthcare-resource-utilization-and-costs-among2026-10-04 https://evidence-hub.com/study/60668-musculoskeletal-dysfunction-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60669-blocking-cgrp-in-migraine-patients-a-review-of-pros-and-cons2026-10-04 https://evidence-hub.com/study/60670-modulation-of-brainstem-activity-and-connectivity-by-respiratory2026-10-06 https://evidence-hub.com/study/60672-efficacy-and-safety-of-erenumab-amg334-in-chronic-migraine-patients2026-10-06 https://evidence-hub.com/study/60674-genetic-insights-into-the-causal-role-of-metabolic-immune-and2026-10-04 https://evidence-hub.com/study/60678-stratifying-migraine-patients-based-on-dynamic-pain-provocation-over2026-10-06 https://evidence-hub.com/study/60679-non-headache-symptoms-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60684-amylin-analog-pramlintide-induces-migraine-like-attacks-in-patients2026-10-06 https://evidence-hub.com/study/60685-ocular-pulse-amplitude-and-retina-nerve-fiber-layer-thickness-in2026-10-06 https://evidence-hub.com/study/60686-restless-legs-syndrome-in-migraine-patients-prevalence-and-severity2026-10-04 https://evidence-hub.com/study/60687-right-fronto-insular-white-matter-tracts-link-cognitive-reserve-and2026-10-06 https://evidence-hub.com/study/60689-efficacy-and-safety-of-eptinezumab-in-patients-with-chronic-migraine2026-10-06 https://evidence-hub.com/study/60690-impact-of-coronavirus-disease-2019-covid-19-pandemic-on-patients-with2026-10-06 https://evidence-hub.com/study/60692-quality-of-life-and-migraine-disability-among-female-migraine2026-10-04 https://evidence-hub.com/study/60693-gender-influences-headache-characteristics-with-increasing-age-in2026-10-04 https://evidence-hub.com/study/60694-integrated-care-for-chronic-migraine-patients-epidemiology-burden2026-10-06 https://evidence-hub.com/study/60695-high-sensitivity-c-reactive-protein-and-cerebral-white-matter2026-10-06 https://evidence-hub.com/study/60696-white-matter-microstructure-abnormalities-in-pediatric-migraine2026-10-04 https://evidence-hub.com/study/60697-effect-of-vitamin-d-supplementation-on-symptoms-and-c-reactive2026-10-06 https://evidence-hub.com/study/60702-responsiveness-of-the-autonomic-nervous-system-during-paced-breathing2026-10-06 https://evidence-hub.com/study/60704-patterns-of-medicinal-cannabis-use-strain-analysis-and-substitution2026-10-06 https://evidence-hub.com/study/60705-a-randomized-double-blinded-placebo-controlled-parallel-trial-of2026-10-08 https://evidence-hub.com/study/60706-patients-perspective-on-the-burden-of-migraine-in-europe-a-cross2026-10-06 https://evidence-hub.com/study/60708-prevalence-and-clinical-factors-of-migraine-in-patients-with2026-10-06 https://evidence-hub.com/study/60709-migraine-related-disability-impact-and-health-related-quality-of-life2026-10-06 https://evidence-hub.com/study/60710-the-frequency-of-patent-foramen-ovale-and-migraine-in-patients-with2026-10-06 https://evidence-hub.com/study/60712-acupuncture-modulates-the-abnormal-brainstem-activity-in-migraine2026-10-06 https://evidence-hub.com/study/60714-altered-brain-structure-and-function-correlate-with-disease-severity2026-10-06 https://evidence-hub.com/study/60715-persistence-and-switching-patterns-of-oral-migraine-prophylactic2026-10-06 https://evidence-hub.com/study/60720-odorant-substances-that-trigger-headaches-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60721-autonomic-function-in-migraine-patients-ictal-and-interictal2026-10-04 https://evidence-hub.com/study/60723-migraine-and-cardiovascular-disease-what-cardiologists-should-know2026-10-06 https://evidence-hub.com/study/60724-oxidative-stress-and-dna-damage-in-patients-with-migraine2026-10-06 https://evidence-hub.com/study/60729-structural-and-functional-abnormalities-in-migraine-patients-without2026-10-04 https://evidence-hub.com/study/60733-lateral-inhibition-in-visual-cortex-of-migraine-patients-between2026-10-04 https://evidence-hub.com/study/60735-trigger-factors-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60736-effect-of-serotonin-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60737-endothelin-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60738-trigger-factors-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60739-migraine-patients-cognitively-impaired2026-10-04 https://evidence-hub.com/study/60740-prevalence-of-fibromyalgia-syndrome-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60741-cutaneous-allodynia-in-transformed-migraine-patients2026-10-04 https://evidence-hub.com/study/60742-the-doctor-and-the-migraine-patient2026-10-04 https://evidence-hub.com/study/60743-apomorphine-induced-yawning-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60744-interictal-dysfunction-of-a-brainstem-descending-modulatory-center-in2026-10-04 https://evidence-hub.com/study/60745-decreased-stnf-ri-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60746-quality-of-life-in-migraine-patients-a-qualitative-study2026-10-04 https://evidence-hub.com/study/60747-fatigue-in-chronic-migraine-patients2026-10-04 https://evidence-hub.com/study/60748-brain-gray-matter-changes-in-migraine-patients-with-t2-visible-lesions2026-10-04 https://evidence-hub.com/study/60749-what-kind-of-habituation-is-impaired-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60751-motor-and-occipital-cortex-excitability-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60752-saccade-behaviour-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60753-procalcitonin-levels-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60754-vascular-diseases-mortality-and-migraine-in-the-parents-of-migraine2026-10-04 https://evidence-hub.com/study/60755-increased-nitrosative-and-oxidative-stress-in-platelets-of-migraine2026-10-04 https://evidence-hub.com/study/60756-trigger-point-evaluation-in-migraine-patients-an-indication-of2026-10-04 https://evidence-hub.com/study/60757-the-evaluation-of-atherosclerosis-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60758-severe-vascular-events-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60759-salivary-levels-of-cgrp-and-vip-in-rhinosinusitis-and-migraine2026-10-04 https://evidence-hub.com/study/60760-communication-with-the-migraine-patient2026-10-04 https://evidence-hub.com/study/60761-personality-traits-and-stress-sensitivity-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60762-increased-plasma-histamine-levels-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60763-drug-abuse-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60764-central-effects-of-erenumab-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60765-endothelium-dependent-vasodilatation-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60766-excessive-daytime-sleepiness-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60767-oculosympathetic-alterations-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60768-excitatory-neurotransmitters-in-brain-regions-in-interictal-migraine2026-10-04 https://evidence-hub.com/study/60769-otoneurologic-dysfunctions-in-migraine-patients-with-or-without2026-10-04 https://evidence-hub.com/study/60770-the-aura-a-tertiary-care-study-of-952-migraine-patients2026-10-04 https://evidence-hub.com/study/60771-gerd-prevalence-in-migraine-patients-and-the-implication-for-acute2026-10-04 https://evidence-hub.com/study/60772-cerebrospinal-fluid-analyses-in-migraine-patients-and-controls2026-10-04 https://evidence-hub.com/study/60775-impairment-of-parasympathetic-baroreflex-responses-in-migraine2026-10-04 https://evidence-hub.com/study/60776-subtle-grey-matter-changes-between-migraine-patients-and-healthy2026-10-04 https://evidence-hub.com/study/60777-trigeminal-stimulation-elicits-a-peripheral-vestibular-imbalance-in2026-10-04 https://evidence-hub.com/study/60778-migraine-and-somnambulism-a-survey-of-122-migraine-patients2026-10-04 https://evidence-hub.com/study/60780-migraine-patients-exhibit-abnormalities-in-the-visual-evoked-potential2026-10-04 https://evidence-hub.com/study/60782-cardiovascular-reflexes-in-young-migraine-patients2026-10-04 https://evidence-hub.com/study/60783-migraine-patients-exhibit-abnormalities-in-the-visual-evoked-potential2026-10-04 https://evidence-hub.com/study/60785-the-frequency-of-fibromyalgia-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60786-central-neuromodulation-in-chronic-migraine-patients-with2026-10-04 https://evidence-hub.com/study/60787-il-6-levels-in-migraine-patients-receiving-topiramate2026-10-04 https://evidence-hub.com/study/60788-platelet-fibrinogen-receptors-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60789-the-uk-migraine-patient-survey-quality-of-life-and-treatment2026-10-04 https://evidence-hub.com/study/60790-electroencephalographic-abnormalities-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60792-red-blood-cell-magnesium-levels-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60793-orofacial-pain-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60795-retinal-nerve-fiber-layer-thickness-is-unaffected-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60796-management-of-the-migraine-patient2026-10-04 https://evidence-hub.com/study/60797-spatial-contrast-sensitivity-of-migraine-patients-without-aura2026-10-04 https://evidence-hub.com/study/60798-therapeutic-blockade-of-greater-occipital-and-supraorbital-nerves-in2026-10-04 https://evidence-hub.com/study/60799-hyperresponsiveness-of-migraine-patients-to-the-hypotensive-action-of2026-10-04 https://evidence-hub.com/study/60800-psychophysiological-response-patterns-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60801-frequency-of-depression-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60802-a-comparison-of-migraine-patients-with-and-without-allodynic-symptoms2026-10-04 https://evidence-hub.com/study/60803-smooth-pursuit-in-migraine-patients2026-10-04 https://evidence-hub.com/study/60804-migraine-patient-perspectives2026-10-04 https://evidence-hub.com/study/60807-clinical-and-psychological-characteristics-of-migraine-patients2026-10-04 https://evidence-hub.com/study/60808-can-allodynic-migraine-patients-be-identified-interictally-using-a2026-10-04 https://evidence-hub.com/study/60809-weekend-attacks-in-migraine-patients-caused-by-caffeine-withdrawal2026-10-04 https://evidence-hub.com/study/60810-vestibular-migraine-an-update2026-10-08 https://evidence-hub.com/study/60811-migraine-headache-prophylaxis2026-10-06 https://evidence-hub.com/study/60812-resistant-and-refractory-migraine-clinical-presentation2026-10-06 https://evidence-hub.com/study/60813-vestibular-migraine-and-persistent-postural-perceptual-dizziness2026-10-06 https://evidence-hub.com/study/60815-advances-in-diagnosis-and-treatment-of-vestibular-migraine-and-the2026-10-08 https://evidence-hub.com/study/60816-trigeminal-ganglion-neurons-are-directly-activated-by-influx-of-csf2026-10-06 https://evidence-hub.com/study/60817-ominous-causes-of-headache2026-10-06 https://evidence-hub.com/study/60818-vestibular-migraine-clinical-and-diagnostic-challenges-and-emerging2026-10-06 https://evidence-hub.com/study/60819-plasma-pqtl-and-brain-eqtl-integration-identifies-pnkp-as-a2026-10-06 https://evidence-hub.com/study/60820-nonspecific-analgesics-combination-analgesics-and-antiemetics2026-10-06 https://evidence-hub.com/study/60821-single-nucleus-transcriptomics-reveals-glial-metabolic-immune2026-10-06 https://evidence-hub.com/study/60822-steps-to-manage-treatment-refractory-migraine-in-adults2026-10-06 https://evidence-hub.com/study/60823-light-therapy-in-chronic-migraine2026-10-06 https://evidence-hub.com/study/60824-the-lung-microbiome-modulates-pain-like-behavior-via-the-lung-brain2026-10-06 https://evidence-hub.com/study/60825-migraine-and-psychosomatic-comorbidity2026-10-06 https://evidence-hub.com/study/60826-meningeal-lymphatic-vessel-dysfunction-driven-by-cgrp-signaling2026-10-06 https://evidence-hub.com/study/60827-headache-and-glp-1-receptor-agonists-when-medications-are-therapeutic2026-10-06 https://evidence-hub.com/study/60828-sleep-symptoms-in-migraine2026-10-04 https://evidence-hub.com/study/60829-evidence-based-preventive-treatment-of-migraine2026-10-06 https://evidence-hub.com/study/60830-cost-effectiveness-analysis-of-ubrogepant-rimegepant-and-zavegepant2026-10-06 https://evidence-hub.com/study/60832-posttraumatic-headache-is-a-distinct-headache-type-from-migraine2026-10-06 https://evidence-hub.com/study/60833-whether-weather-matters-with-migraine2026-10-04 https://evidence-hub.com/study/60834-oxidative-stress-in-the-pathogenesis-of-chronic-headache2026-10-06 https://evidence-hub.com/study/60835-systematic-review-suggests-nutraceuticals-containing-vitamin-b2-could2026-10-08 https://evidence-hub.com/study/60836-calcium-signaling-related-genes-in-migraine2026-10-06 https://evidence-hub.com/study/60837-association-between-waist-to-height-ratio-and-headache-symptoms-in-u2026-10-06 https://evidence-hub.com/study/60838-relationship-of-migraine-and-other-forms-of-chronic-pain2026-10-06 https://evidence-hub.com/study/60839-zavegepant-intranasal-spray-for-migraines2026-10-06 https://evidence-hub.com/study/60840-mglur5-promotes-oxidative-stress-and-central-sensitization-in-chronic2026-10-06 https://evidence-hub.com/study/60841-interdisciplinary-multimodal-pain-therapy-in-headache-disorders2026-10-06 https://evidence-hub.com/study/60842-the-role-of-the-amy1-receptor-signaling-cascade-in-the-protective2026-10-06 https://evidence-hub.com/study/60843-vagus-nerve-stimulation-potential-for-treating-chronic-wounds2026-10-06 https://evidence-hub.com/study/60844-food-as-migraine-trigger2026-10-04 https://evidence-hub.com/study/60845-biochemical-features-of-migraine-pathogenesis2026-10-06 https://evidence-hub.com/study/60846-somatosensory-cortical-progesterone-receptor-signaling-regulates-the2026-10-06 https://evidence-hub.com/study/60847-trigeminal-nerve-driven-neurogenic-inflammation-linking-migraine-to2026-10-06 https://evidence-hub.com/study/60848-iron-in-the-migraine-brain2026-10-04 https://evidence-hub.com/study/60849-molecular-and-cellular-neurobiology-of-spreading-depolarization2026-10-04 https://evidence-hub.com/study/60850-treating-the-uninsured-and-underinsured-with-migraine-in-the-usa2026-10-06 https://evidence-hub.com/study/60851-study-design-and-rationale-of-compete-comparison-of-the-effect-of2026-10-06 https://evidence-hub.com/study/60852-development-of-migraine-self-care-scale2026-10-06 https://evidence-hub.com/study/60853-migraine-and-neuroinflammation-correlation-of-adipokines-and2026-10-06 https://evidence-hub.com/study/60854-towards-zebrafish-models-of-migraine2026-10-04 https://evidence-hub.com/study/60855-cortical-network-dysfunction-in-migraine-linking-genes-metabolism-and2026-10-06 https://evidence-hub.com/study/60856-upregulation-of-mir-22-3p-alleviates-hyperalgesia-and2026-10-04 https://evidence-hub.com/study/60857-insights-into-the-lactylation-immune-regulatory-axis-as-a-mechanistic2026-10-06 https://evidence-hub.com/study/60858-migraine-and-pregnancy-gender-specific-aspects-and-current-knowledge2026-10-06 https://evidence-hub.com/study/60859-focused-update-on-migraine-and-vertigo-comorbidity2026-10-06 https://evidence-hub.com/study/60860-advances-in-headache-and-future-prospects2026-10-06 https://evidence-hub.com/study/60861-dopamine-and-prolactin-in-migraine-mechanisms-and-potential2026-10-06 https://evidence-hub.com/study/60862-special-considerations-in-management-of-migraine-in-the-elderly2026-10-06 https://evidence-hub.com/study/60863-characteristics-of-visual-snow-syndrome-in-japan-and-its-association2026-10-06 https://evidence-hub.com/study/60864-correlation-between-endometriosis-and-migraine-headache-a-review-of2026-10-06 https://evidence-hub.com/study/60865-the-role-of-hypertension-in-the-relationship-between-leisure-screen2026-10-06 https://evidence-hub.com/study/60866-inflammatory-cytokine-signatures-are-associated-with-disease-burden2026-10-06 https://evidence-hub.com/study/60867-impact-of-dietary-patterns-on-migraine-management-mechanisms-of2026-10-08 https://evidence-hub.com/study/60868-time-from-migraine-onset-to-surgery-predicts-postoperative-headache2026-10-06 https://evidence-hub.com/study/60869-long-term-safety-of-cgrp-pathway-inhibitors-in-migraine-patients-with2026-10-06 https://evidence-hub.com/study/60870-multimodal-7t-mri-reveals-subcortical-structural-functional-iron2026-10-06 https://evidence-hub.com/study/60871-cognitive-functions-in-patients-with-vestibular-migraine-is-there-any2026-10-06 https://evidence-hub.com/study/60872-the-effectiveness-of-clinical-hypnosis-on-migraine-headache-symptoms2026-10-06 https://evidence-hub.com/study/60873-setting-higher-standards-for-migraine-prevention-a-position-statement2026-10-08 https://evidence-hub.com/study/60874-calcitonin-gene-related-peptide-targeted-therapy-in-migraine-current2026-10-06 https://evidence-hub.com/study/60876-giant-a-prospective-multicenter-real-world-study-on-the-effectiveness2026-10-06 https://evidence-hub.com/study/60877-effectiveness-and-tolerability-of-rimegepant-in-the-acute-treatment2026-10-06 https://evidence-hub.com/study/60878-metabolic-dysfunction-and-dietary-interventions-in-migraine2026-10-08 https://evidence-hub.com/study/60879-the-global-burden-of-migraine-a-30-year-trend-review-and-future2026-10-06 https://evidence-hub.com/study/60880-current-trends-in-pediatric-migraine-clinical-insights-and2026-10-08 https://evidence-hub.com/study/60882-menopause-perimenopause-and-migraine-understanding-the-intersections2026-10-06 https://evidence-hub.com/study/60883-revisiting-substance-p-in-migraine-a-methodological-approach-inspired2026-10-08 https://evidence-hub.com/study/60884-cardiovascular-safety-of-anti-cgrp-monoclonal-antibodies-in-older2026-10-06 https://evidence-hub.com/study/60885-the-role-and-interaction-of-hypothalamic-related-neurotransmitters-in2026-10-04 https://evidence-hub.com/study/60886-ido1-modulates-pain-sensitivity-and-comorbid-anxiety-in-chronic2026-10-06 https://evidence-hub.com/study/60888-early-treatment-in-migraine-a-call-to-shift-prevention-from-attacks2026-10-06 https://evidence-hub.com/study/60889-three-year-treatment-with-anti-cgrp-monoclonal-antibodies-modifies2026-10-06 https://evidence-hub.com/study/60890-the-role-of-inflammation-in-migraine-headaches-a-review2026-10-04 https://evidence-hub.com/study/60891-update-on-neuromodulation-for-migraine-and-other-primary-headache2026-10-06 https://evidence-hub.com/study/60892-digital-phenotyping-for-migraine-a-game-changer-for-research-and2026-10-06 https://evidence-hub.com/study/60893-the-current-role-of-artificial-intelligence-in-the-field-of-headache2026-10-06 https://evidence-hub.com/study/60894-cardiovascular-risk-and-triptan-usage-among-patients-with-migraine2026-10-04 https://evidence-hub.com/study/60895-the-vessel-to-neuron-trigeminovascular-hypothesis-of-migraine2026-10-06 https://evidence-hub.com/study/60896-pacap-versus-cgrp-in-migraine-from-mouse-models-to-clinical2026-10-06 https://evidence-hub.com/study/60897-trigeminal-nerve-microstructure-is-linked-with-neuroinflammation-and2026-10-06 https://evidence-hub.com/study/60898-the-epidemiology-and-unmet-need-of-migraine-in-five-european2026-10-06 https://evidence-hub.com/study/60899-application-of-machine-learning-in-migraine-classification-a-call-for2026-10-06 https://evidence-hub.com/study/60900-anxiety-disorders-anxious-symptomology-and-related-behaviors2026-10-06 https://evidence-hub.com/study/60901-exploring-vestibulocerebellum-vestibular-nuclei-spinal-trigeminal2026-10-06 https://evidence-hub.com/study/60902-gepants-targeting-the-cgrp-pathway-for-migraine-relief2026-10-08 https://evidence-hub.com/study/60903-head-to-head-relief-ubrogepant-rimegepant-and-zavegepant-in-migraine2026-10-06 https://evidence-hub.com/study/60904-the-burden-of-migraine-and-tension-type-headache-in-asia-from-1990-to2026-10-06 https://evidence-hub.com/study/60905-unmasking-the-relationship-between-cgrp-and-glutamate-from-peripheral2026-10-08 https://evidence-hub.com/study/60906-unveiling-new-insights-into-migraine-risk-stratification-using2026-10-06 https://evidence-hub.com/study/60907-serial-systemic-immune-inflammation-indices-markers-of-acute-migraine2026-10-06 https://evidence-hub.com/study/60908-magnesium-and-migraine2026-10-08 https://evidence-hub.com/study/60909-cgrp-and-migraine-real-world-insights-and-future-therapeutic2026-10-04 https://evidence-hub.com/study/60910-rizatriptan-vs-placebo-for-attacks-of-vestibular-migraine-a2026-10-06 https://evidence-hub.com/study/60911-cgrp-targeted-migraine-therapies-in-patients-with-vascular-risk2026-10-06 https://evidence-hub.com/study/60912-peripherally-acting-anti-cgrp-monoclonal-antibodies-attenuate2026-10-06 https://evidence-hub.com/study/60913-onabotulinumtoxina-treatment-for-chronic-migraine-in-pregnancy-an2026-10-06 https://evidence-hub.com/study/60914-effectiveness-and-tolerability-of-liraglutide-as-add-on-treatment-in2026-10-06 https://evidence-hub.com/study/60915-multi-omics-mendelian-randomization-integrating-gwas-eqtl-and-pqtl2026-10-06 https://evidence-hub.com/study/60916-migraine-is-the-most-disabling-neurological-disease-among-children2026-10-06 https://evidence-hub.com/study/60917-a-monoclonal-antibody-to-pacap-for-migraine-prevention2026-10-06 https://evidence-hub.com/study/60919-burden-of-migraine-among-egyptian-people-prevalence-and-comorbidities2026-10-06 https://evidence-hub.com/study/60920-serum-gfap-and-nfl-levels-in-migraine-a-registry-for-migraine-reform2026-10-04 https://evidence-hub.com/study/60921-the-global-and-regional-burden-and-trends-of-migraine-from-1990-to2026-10-06 https://evidence-hub.com/study/60922-migraine-and-increased-cardiovascular-disease-risk-interaction-with2026-10-06 https://evidence-hub.com/study/60923-migraine-in-men-differences-in-phenotype-and-treatment-patterns2026-10-06 https://evidence-hub.com/study/60924-the-burden-of-migraine-and-predictions-in-the-asia-pacific-region2026-10-06 https://evidence-hub.com/study/60925-mechanistic-intersections-between-migraine-and-major-depressive2026-10-04 https://evidence-hub.com/study/60926-impaired-glymphatic-function-contributes-to-high-frequency-attacks-in2026-10-06 https://evidence-hub.com/study/60927-an-analysis-of-the-burden-of-migraine-and-tension-type-headache2026-10-06 https://evidence-hub.com/study/60928-insights-into-vestibular-migraine-diagnostic-challenges-differential2026-10-06 https://evidence-hub.com/study/60929-deciphering-the-mechanisms-pathophysiology-of-migraine-related2026-10-06 https://evidence-hub.com/study/60930-effectiveness-of-anti-cgrp-monoclonal-antibodies-and2026-10-06 https://evidence-hub.com/study/60931-a-24-week-prospective-multicenter-real-world-study-on-eptinezumab-s2026-10-08 https://evidence-hub.com/study/60932-sex-difference-in-trpm3-channel-functioning-in-nociceptive-and2026-10-06 https://evidence-hub.com/study/60934-effectiveness-and-tolerability-of-atogepant-as-preventive-treatment2026-10-06 https://evidence-hub.com/study/60935-migraine-and-functional-neurological-disorder-fnd-a-review-of2026-10-06 https://evidence-hub.com/study/60936-migraine-through-puberty-and-menopausal-transition-data-from-the2026-10-06 https://evidence-hub.com/study/60937-glutamate-as-a-therapeutic-substrate-in-migraine2026-10-06 https://evidence-hub.com/study/60938-the-effect-of-foot-reflexology-on-pain-disability-anxiety2026-10-04 https://evidence-hub.com/study/60939-a-randomized-controlled-trial-of-a-transcutaneous-electrical-nerve2026-10-04 https://evidence-hub.com/study/60940-development-validity-and-reliability-study-of-the-health-belief-model2026-10-04 https://evidence-hub.com/study/60941-interventional-randomized-double-blind-placebo-controlled-trial2026-10-04 https://evidence-hub.com/study/60942-a-phase-3-randomized-double-blind-placebo-controlled-study-to2026-10-04 https://evidence-hub.com/study/60943-clinical-outcomes-of-sphenopalatine-ganglion-pulsed-radiofrequency-in2026-10-04 https://evidence-hub.com/study/60944-foot-reflexology-as-an-adjunctive-therapy-in-migraine-management-a2026-10-04 https://evidence-hub.com/study/60945-a-phase-i-randomized-double-blind-placebo-controlled-single-and2026-10-04 https://evidence-hub.com/study/60946-effectivity-and-safety-of-gb20-acupoint-pharmacopuncture-with2026-10-04 https://evidence-hub.com/study/60947-exploring-the-effect-of-the-transcendental-meditation-technique-on2026-10-04 https://evidence-hub.com/study/60948-the-effect-of-treatment-onset-time-on-acute-treatment-efficacy-in2026-10-04 https://evidence-hub.com/study/60949-treatment-patterns-medication-usage-effectiveness-and-safety-among-us2026-10-04 https://evidence-hub.com/study/60950-effectiveness-of-manual-lymphatic-drainage-in-the-physiotherapeutic2026-10-04 https://evidence-hub.com/study/60951-the-effect-of-cervical-stabilization-training-and-vestibular-training2026-10-04 https://evidence-hub.com/study/60952-vibrant-vm-vestibular-investigation-of-bone-conducted-resonant2026-10-04 https://evidence-hub.com/study/60953-phase-2-double-blind-randomized-placebo-controlled-efficacy-and2026-10-04 https://evidence-hub.com/study/60954-evaluation-of-the-effectiveness-of-virtual-reality-based-vestibular2026-10-04 https://evidence-hub.com/study/60955-efficacy-of-carotenoids-on-blood-biomarkers-following-a-collision2026-10-04 https://evidence-hub.com/study/60956-personalised-process-based-psychological-intervention-for-paediatric2026-10-04 https://evidence-hub.com/study/60957-a-phase-1-open-label-single-dose-randomized-crossover-study-to2026-10-04 https://evidence-hub.com/study/60958-impact-of-promoting-physical-exercise-on-migraine-a-video-based2026-10-04 https://evidence-hub.com/study/60959-efficacy-of-traditional-integrated-islamic-psychotherapy-and2026-10-04 https://evidence-hub.com/study/60960-effects-of-transcutaneous-electrical-nerve-stimulat-on-and-exercise2026-10-04 https://evidence-hub.com/study/60961-a-single-center-randomized-double-blind-placebo-controlled-parallel2026-10-04 https://evidence-hub.com/study/60962-synergistic-impact-of-postural-correction-interventions-and-sustained2026-10-04 https://evidence-hub.com/study/60963-effects-of-hemp-derived-cannabinoids-on-menopause-symptoms2026-10-04 https://evidence-hub.com/study/60964-melatonin-for-chronic-back-pain-the-mocha-trial-a-randomized-double2026-10-04 https://evidence-hub.com/study/60965-interventional-randomized-double-blind-parallel-group-placebo2026-10-04 https://evidence-hub.com/study/60966-comparison-of-the-efficacy-of-unilateral-and-bilateral-proximal2026-10-04 https://evidence-hub.com/study/60967-prochlorperazine-maleate-versus-placebo-for-the-prophylaxis-of-acute2026-10-04 https://evidence-hub.com/study/60968-repeated-bilateral-greater-occipital-nerve-blockade-in-chronic2026-10-04 https://evidence-hub.com/study/60969-a-prospective-double-blind-sham-controlled-randomized-clinical-trial2026-10-04 https://evidence-hub.com/study/60970-clinical-exploration-of-neuromark-system-in-participants-with-chronic2026-10-04 https://evidence-hub.com/study/60971-a-prospective-open-label-study-examining-the-use-of-rimegepant-odt-752026-10-04 https://evidence-hub.com/study/60972-sense-vm-safety-and-effectiveness-of-a-novel-medical-device-for2026-10-04 https://evidence-hub.com/study/60973-migraine-prevention-with-the-remote-electrical-neuromodulation-ren2026-10-04 https://evidence-hub.com/study/60974-the-effect-of-transcutaneous-auricular-trigeminal-nerve-stimulation2026-10-04 https://evidence-hub.com/study/60975-rimegepant-a-cgrp-antagonist-in-the-treatment-of-visceral-sensation2026-10-04 https://evidence-hub.com/study/60976-a-phase-1-double-blind-randomised-placebo-controlled-study-evaluating2026-10-04 https://evidence-hub.com/study/60977-effects-of-craniocervical-flexion-training-on-headache-frequency2026-10-04 https://evidence-hub.com/study/60978-short-term-effects-of-acupuncture-on-balance-and-quality-of-life-in2026-10-04 https://evidence-hub.com/study/60979-patient-satisfaction-and-postoperative-pain-after-diagnostic2026-10-04 https://evidence-hub.com/study/60980-evaluating-the-effects-of-omega-3-polyunsaturated-fatty-acids-in2026-10-04 https://evidence-hub.com/study/60981-a-phase-iia-multicenter-randomized-double-blind-placebo-controlled2026-10-04 https://evidence-hub.com/study/60982-a-randomized-controlled-pilot-exploratory-study-on-the-impact-of2026-10-04 https://evidence-hub.com/study/60983-migrafit-evaluating-a-group-therapy-program-combining-physical2026-10-04 https://evidence-hub.com/study/60984-interventional-open-label-trial-investigating-the-effectiveness-of2026-10-04 https://evidence-hub.com/study/60985-comparative-efficacy-of-greater-occipital-nerve-blockade-and2026-10-04 https://evidence-hub.com/study/60986-kf2022-4-tutkimus-beetasalpaajan-ja-tulehduskipulaakkeen-vaikutus-cyp2026-10-04 https://evidence-hub.com/study/60987-safety-and-efficacy-of-zonisamide-versus-topiramate-in-migraine2026-10-04 https://evidence-hub.com/study/60988-interactive-music-and-guided-imagery-for-nonpharma-headache-ease2026-10-04 https://evidence-hub.com/study/60989-exploring-the-mechanism-of-osteopathic-manual-therapy-omt-on-brain2026-10-04 https://evidence-hub.com/study/60990-randomized-double-blind-placebo-controlled-multiple-attack-study-with2026-10-04 https://evidence-hub.com/study/60991-perimenstrual-repetitive-greater-occipital-nerve-blockade-for2026-10-04 https://evidence-hub.com/study/60992-efficacy-of-nasal-migraine-cocktail-used-in-pediatric-emergency2026-10-04 https://evidence-hub.com/study/60993-effect-of-a-sequence-of-specific-manual-therapy-techniques-targeting2026-10-04 https://evidence-hub.com/study/60994-development-and-evaluation-of-an-ai-empowered-voice-interactive2026-10-04 https://evidence-hub.com/study/60995-effects-of-foot-reflexology-massage-in-pain-sleep-and-quality-of-life2026-10-04 https://evidence-hub.com/study/60996-a-randomized-controlled-trial-of-a-low-histamine-based-modified2026-10-04 https://evidence-hub.com/study/60997-high-intensity-interval-training-and-progressive-muscle-relaxation-as2026-10-04 https://evidence-hub.com/study/60998-acute-analgesic-effects-of-dmt-on-experimentally-induced-acute2026-10-04 https://evidence-hub.com/study/60999-ultrasound-guided-stellate-ganglion-block-for-refractory-chronic2026-10-04 https://evidence-hub.com/study/61000-migraine-comorbidities2026-10-04 https://evidence-hub.com/study/61001-oxidative-stress-and-migraine2026-10-04 https://evidence-hub.com/study/61002-molecular-nociceptive-mechanisms-in-migraine-the-migraine-cascade2026-10-04 https://evidence-hub.com/study/61004-the-mysterious-link-between-migraine-aura-and-migraine-headache2026-10-04 https://evidence-hub.com/study/61008-migraine-and-pregnancy2026-10-04 https://evidence-hub.com/study/61011-nutraceuticals-in-migraine2026-10-04 https://evidence-hub.com/study/61014-psychiatric-comorbidities-of-migraine2026-10-04 https://evidence-hub.com/study/61017-an-update-on-migraine-current-and-new-treatment-options2026-10-04 https://evidence-hub.com/study/61019-evaluating-migraine-trigger-surprisal-associations-with-migraine2026-10-04 https://evidence-hub.com/study/61020-multiomic-based-immune-response-profiling-in-migraine-vestibular2026-10-04 https://evidence-hub.com/study/61022-female-selective-mechanisms-promoting-migraine2026-10-04 https://evidence-hub.com/study/61023-the-glymphatic-system-in-migraine-and-other-headaches2026-10-04 https://evidence-hub.com/study/61026-a-study-on-triggers-of-migraine-and-quality-of-life-of-migraine2026-10-04 https://evidence-hub.com/study/61029-the-impacts-of-migraine-on-functioning-results-from-two-qualitative2026-10-04 https://evidence-hub.com/study/61030-migraine-neuroscience2026-10-04 https://evidence-hub.com/study/61031-acute-treatment-of-migraine2026-10-04 https://evidence-hub.com/study/61035-the-clinical-relevance-of-artificial-intelligence-in-migraine2026-10-08 https://evidence-hub.com/study/61038-migraine-and-homoeopathy2026-10-04 https://evidence-hub.com/study/61042-plasma-adrenomedullin-levels-in-migraine-a-registry-for-migraine2026-10-04 https://evidence-hub.com/study/61043-investigations-of-the-migraine-provoking-effect-of-levcromakalim-in2026-10-04 https://evidence-hub.com/study/61046-migraine-stigma-and-general-knowledge-of-migraine-a-cross-sectional2026-10-04 https://evidence-hub.com/study/61049-investigating-heritable-stroke-genes-in-migraine-and-migraine-related2026-10-04 https://evidence-hub.com/study/61050-understanding-the-biological-relationship-between-migraine-and2026-10-04 https://evidence-hub.com/study/61053-migraine-a-borderland-disease-to-epilepsy-near-it-but-not-of-it2026-10-04 https://evidence-hub.com/study/61054-telecoaching-and-migraine-digital-approach-to-physical-activity-in2026-10-04 https://evidence-hub.com/study/61055-assessment-of-sacculocollic-and-vestibulomasseteric-reflex-pathways2026-10-04 https://evidence-hub.com/study/61057-treatment-of-migraine-with-phytocannabinoids-the-involvement-of2026-10-04 https://evidence-hub.com/study/61059-high-risk-area-for-migraine-attacks-a-new-concept-in-migraine2026-10-04 https://evidence-hub.com/study/61062-impact-of-migraine-on-daily-life-results-of-the-observational-survey2026-10-04 https://evidence-hub.com/study/61063-migraine-with-different-phases-and-various-therapies-used-to-treat2026-10-04 https://evidence-hub.com/study/61067-parkinson-s-disease-and-migraine2026-10-04 https://evidence-hub.com/study/61068-migraine-and-stroke-a-scoping-review2026-10-04 https://evidence-hub.com/study/61070-alternative-and-complementary-treatments-for-migraine2026-10-04 https://evidence-hub.com/study/61073-the-role-of-androgens-in-migraine-pathophysiology2026-10-04 https://evidence-hub.com/study/61077-prevalence-of-migraine-in-iceland2026-10-04 https://evidence-hub.com/study/61080-diagnosis-and-treatment-of-migraines2026-10-04 https://evidence-hub.com/study/61081-a-detail-review-on-migraine2026-10-04 https://evidence-hub.com/study/61082-migraine-and-the-menopause-transition2026-10-04 https://evidence-hub.com/study/61083-mistaken-for-migraine-coccidioidal-meningitis2026-10-04 https://evidence-hub.com/study/61084-characterization-of-a-novel-model-of-chronic-migraine2026-10-06 https://evidence-hub.com/study/61085-peripheral-ccl2-ccr2-signalling-contributes-to-chronic-headache2026-10-06 https://evidence-hub.com/study/61086-brain-wide-mapping-of-c-fos-expression-in-nitroglycerin-induced2026-10-04 https://evidence-hub.com/study/61087-behavioral-and-cognitive-animal-models-in-headache-research2026-10-06 https://evidence-hub.com/study/61088-animal-models-of-chronic-migraine2026-10-04 https://evidence-hub.com/study/61089-chronic-migraine-caused-a-higher-rate-of-tendency-to-cannabinoid2026-10-06 https://evidence-hub.com/study/61090-a-midbrain-circuit-that-mediates-headache-aversiveness-in-rats2026-10-06 https://evidence-hub.com/study/61091-targeting-igf1-igf1r-signaling-relieve-pain-and-autophagic2026-10-06 https://evidence-hub.com/study/61093-update-on-animal-models-of-migraine2026-10-04 https://evidence-hub.com/study/61094-involvement-of-cgrp-receptors-in-retinal-spreading-depression2026-10-06 https://evidence-hub.com/study/61095-p2x7r-nlrp3-signaling-pathway-mediated-pyroptosis-and2026-10-06 https://evidence-hub.com/study/61096-ampa-receptor-glua1-ser831-phosphorylation-is-critical-for2026-10-06 https://evidence-hub.com/study/61097-peripheral-and-central-sensitization-during-migraine2026-10-06 https://evidence-hub.com/study/61098-inhibition-of-nociceptive-dural-input-to-the-trigeminocervical2026-10-06 https://evidence-hub.com/study/61099-the-neurotrophic-factor-artemin-and-its-receptor-gfr-3-mediate2026-10-06 https://evidence-hub.com/study/61100-unveiling-the-therapeutic-potential-of-dl-3-n-butylphthalide-in-ntg2026-10-06 https://evidence-hub.com/study/61101-sumatriptan-succinate-loaded-chitosan-solid-lipid-nanoparticles-for2026-10-06 https://evidence-hub.com/study/61102-the-anti-migraine-agent-sumatriptan-induces-a-calcium-dependent2026-10-06 https://evidence-hub.com/study/61103-effects-of-oestrogen-on-trigeminal-ganglia-in-culture-implications2026-10-06 https://evidence-hub.com/study/61104-neuroendocrine-signaling-modulates-specific-neural-networks-relevant2026-10-06 https://evidence-hub.com/study/61105-propranolol-prevents-cerebral-blood-flow-changes-and-pain-related2026-10-06 https://evidence-hub.com/study/61106-cannabinoids-rescue-migraine-symptoms-caused-by-central-cgrp2026-10-06 https://evidence-hub.com/study/61107-hyperleptinemia-increases-the-susceptibility-of-the-cortex-to2026-10-06 https://evidence-hub.com/study/61108-application-of-cgrp-related-monoclonal-antibodies-in-migraine2026-10-06 https://evidence-hub.com/study/61109-assessment-of-spanlastic-vesicles-of-zolmitriptan-for-treating2026-10-06 https://evidence-hub.com/study/61110-animal-model-of-chronic-migraine-associated-pain2026-10-04 https://evidence-hub.com/study/61111-interleukin-6-induces-spatially-dependent-whole-body-hypersensitivity2026-10-06 https://evidence-hub.com/study/61112-modulation-of-tetrodotoxin-resistant-na-channels-by-amitriptyline-in2026-10-06 https://evidence-hub.com/study/61113-migraine-mutations-increase-stroke-vulnerability-by-facilitating2026-10-06 https://evidence-hub.com/study/61114-xiongshao-zhitong-granules-alleviate-nitroglycerin-induced-migraine2026-10-04 https://evidence-hub.com/study/61115-neuropeptide-y-inhibits-the-trigeminovascular-pathway-through-npy-y12026-10-06 https://evidence-hub.com/study/61116-increased-metabolite-concentration-in-migraine-rat-model-by-proton-mr2026-10-06 https://evidence-hub.com/study/61117-proinflammatory-activated-trigeminal-satellite-cells-promote-neuronal2026-10-06 https://evidence-hub.com/study/61118-serotonin-depletion-can-enhance-the-cerebrovascular-responses-induced2026-10-06 https://evidence-hub.com/study/61119-hypoxia-facilitates-neurogenic-dural-plasma-protein-extravasation-in2026-10-04 https://evidence-hub.com/study/61120-systemic-nitroglycerin-increases-nnos-levels-in-rat-trigeminal2026-10-06 https://evidence-hub.com/study/61121-unexpected-effects-of-peripherally-administered-kynurenic-acid-on2026-10-06 https://evidence-hub.com/study/61122-enhanced-circadian-phase-resetting-in-r192q-cav2-1-calcium-channel2026-10-06 https://evidence-hub.com/study/61123-could-experimental-inflammation-provide-better-understanding-of2026-10-06 https://evidence-hub.com/study/61124-gabaa-receptor-modulation-of-trigeminovascular-nociceptive2026-10-06 https://evidence-hub.com/study/61125-activation-of-the-trigeminovascular-system-by-mechanical-distension2026-10-06 https://evidence-hub.com/study/61126-inhibitory-effect-of-lomerizine-a-prophylactic-drug-for-migraines-on2026-10-06 https://evidence-hub.com/study/61127-effect-of-migrepin-on-activity-of-trigeminal-nucleus-caudalis-neurons2026-10-06 https://evidence-hub.com/study/61128-sec-butylpropylacetamide-spd-has-antimigraine-properties2026-10-06 https://evidence-hub.com/study/61129-ro-64-6198-a-selective-nop-receptor-agonist-attenuates-social2026-10-06 https://evidence-hub.com/study/61130-botulinum-toxin-in-migraine-role-of-transport-in-trigemino-somatic2026-10-06 https://evidence-hub.com/study/61131-fibroblast-reprogramming-in-the-dura-mater-of-ntg-induced-migraine2026-10-06 https://evidence-hub.com/study/61132-differential-medication-overuse-risk-of-novel-anti-migraine2026-10-06 https://evidence-hub.com/study/61133-trigeminal-satellite-cells-modulate-neuronal-responses-to-triptans2026-10-06 https://evidence-hub.com/study/61134-phenylethylamine-and-cerebral-blood-flow-possible-involvement-of2026-10-06 https://evidence-hub.com/study/61135-evidence-for-orexinergic-mechanisms-in-migraine2026-10-06 https://evidence-hub.com/study/61136-astrocytic-glutamate-transporters-and-migraine2026-10-06 https://evidence-hub.com/study/61137-caveolin-1-negatively-regulates-the-calcitonin-receptor-like-receptor2026-10-06 https://evidence-hub.com/study/61138-orexin-one-receptors-within-the-basolateral-amygdala-are-involved-in2026-10-06 https://evidence-hub.com/study/61139-cortical-mechanisms-of-single-pulse-transcranial-magnetic-stimulation2026-10-06 https://evidence-hub.com/study/61140-characterization-of-the-biochemical-and-behavioral-effects-of2026-10-06 https://evidence-hub.com/study/61141-the-use-of-focused-ultrasound-for-the-treatment-of-cutaneous2026-10-06 https://evidence-hub.com/study/61142-dysregulation-of-the-peripheral-glutamatergic-system-a-key-player-in2026-10-06 https://evidence-hub.com/study/61143-enhancement-of-erk-phosphorylation-and-photic-responses-in-vc-c12026-10-06 https://evidence-hub.com/study/61144-serotonin-type-1d-receptors-5htr-are-differentially-distributed-in2026-10-06 https://evidence-hub.com/study/61145-effect-of-goreisan-a-japanese-traditional-medicine-on-cortical2026-10-06 https://evidence-hub.com/study/61146-colocalization-of-cgrp-with-5-ht1b-1d-receptors-and-substance-p-in2026-10-06 https://evidence-hub.com/study/61147-analgesic-triptan-action-in-an-animal-model-of-intracranial-pain-a2026-10-06 https://evidence-hub.com/study/61148-effect-of-paeonia-lactiflora-a-traditional-chinese-herb-on-migraines2026-10-06 https://evidence-hub.com/study/61149-neuroeffector-functions-of-sensory-fibres-implications-for-headache2026-10-06 https://evidence-hub.com/study/61150-targeting-reactive-nitroxidative-species-in-preclinical-models-of2026-10-06 https://evidence-hub.com/study/61151-cortical-spreading-depression-produces-increased-cgmp-levels-in2026-10-06 https://evidence-hub.com/study/61152-anti-migraine-effect-of-9-tetrahydrocannabinol-in-the-female-rat2026-10-06 https://evidence-hub.com/study/61153-enhanced-subcortical-spreading-depression-in-familial-hemiplegic2026-10-06 https://evidence-hub.com/study/61154-genistein-mitigates-nitroglycerine-induced-migraine-modulation-of2026-10-06 https://evidence-hub.com/study/61155-alterations-in-metabolic-flux-in-migraine-and-the-translational2026-10-08 https://evidence-hub.com/study/61156-blockade-of-nav1-8-currents-in-nociceptive-trigeminal-neurons2026-10-06 https://evidence-hub.com/study/61157-neuron-derived-extracellular-vesicles-reflect-adaptive-neuronal2026-10-06 https://evidence-hub.com/study/61158-divergent-influences-of-the-locus-coeruleus-on-migraine2026-10-06 https://evidence-hub.com/study/61159-stimulation-of-the-calcitonin-gene-related-peptide-enhancer-by2026-10-06 https://evidence-hub.com/study/61160-no-gastrointestinal-dysmotility-in-transgenic-mouse-models-of-migraine2026-10-06 https://evidence-hub.com/study/61161-functional-interactions-between-transient-receptor-potential-m8-and2026-10-06 https://evidence-hub.com/study/61162-tactile-induced-ultrasonic-vocalization-in-the-rat-a-novel-assay-to2026-10-06 https://evidence-hub.com/study/61163-propranolol-modulation-of-tetrodotoxin-resistant-na-channels-in-dural2026-10-06 https://evidence-hub.com/study/61164-a-bioinformatic-investigation-of-the-mechanism-underlying-migraine2026-10-06 https://evidence-hub.com/study/61165-naratriptan-is-as-effective-as-sumatriptan-for-the-treatment-of2026-10-06 https://evidence-hub.com/study/61166-nop-receptor-agonist-attenuates-nitroglycerin-induced-migraine-like2026-10-06 https://evidence-hub.com/study/61167-sirt1-activation-by-ligustrazine-ameliorates-migraine-via-the2026-10-04 https://evidence-hub.com/study/61168-possible-role-of-alpha-adrenoceptor-subtypes-in-acute-migraine-therapy2026-10-06 https://evidence-hub.com/study/61169-a-pre-existing-myogenic-temporomandibular-disorder-increases2026-10-06 https://evidence-hub.com/study/61170-metabolic-assessment-of-a-migraine-model-using-relaxation-enhanced-12026-10-06 https://evidence-hub.com/study/61171-cortico-nrm-influences-on-trigeminal-neuronal-sensation2026-10-06 https://evidence-hub.com/study/61172-astrocyte-dysfunction-increases-cortical-dendritic-excitability-and2026-10-06 https://evidence-hub.com/study/61173-impact-of-food-components-on-in-vitro-calcitonin-gene-related-peptide2026-10-06 https://evidence-hub.com/study/61174-caffeine-does-not-affect-susceptibility-to-cortical-spreading2026-10-06 https://evidence-hub.com/study/61175-effects-of-botulinum-toxin-type-a-in-a-migraine-specific-animal-model2026-10-04 https://evidence-hub.com/study/61176-po-85-alterations-in-gut-microbiota-and-the-endocannabinoid-system-in2026-10-04 https://evidence-hub.com/study/61177-effect-of-activated-autophagy-on-an-animal-model-of-vestibular2026-10-08 https://evidence-hub.com/study/61179-the-impact-of-the-migraine-treatment-onabotulinumtoxina-on2026-10-04 https://evidence-hub.com/study/61180-models-of-trigeminal-activation-is-there-an-animal-model-of-migraine2026-10-04 https://evidence-hub.com/study/61181-anti-hyperalgesic-activity-of-ficus-deltoidea-in-an-animal-model-of2026-10-04 https://evidence-hub.com/study/61183-antagonism-of-cgrp-receptor-central-and-peripheral-mechanisms-and2026-10-04 https://evidence-hub.com/study/61184-inhibiting-neuronal-ac1-for-treating-anxiety-and-headache-in-the2026-10-04 https://evidence-hub.com/study/61185-modelling-migraine-related-features-in-the-nitroglycerin-animal-model2026-10-04 https://evidence-hub.com/study/61186-dual-inhibition-of-faah-and-magl-counteracts-migraine-like-pain-and2026-10-04 https://evidence-hub.com/study/61187-evaluating-plasma-and-brain-trpv1-channels-in-the-animal-model-of2026-10-06 https://evidence-hub.com/study/61188-nitric-oxide-role-in-anxiety-like-behavior-memory-and-cognitive2026-10-04 https://evidence-hub.com/study/61189-the-role-of-the-transient-receptor-potential-ankyrin-type-1-trpa12026-10-04 https://evidence-hub.com/study/61190-a-novel-large-animal-model-of-recurrent-migraine-established-by2026-10-06 https://evidence-hub.com/study/61191-brain-network-alterations-in-the-inflammatory-soup-animal-model-of2026-10-04 https://evidence-hub.com/study/61192-comparative-effects-of-traditional-chinese-and-western-migraine2026-10-04 https://evidence-hub.com/study/61194-application-of-translational-medicine-in-syndrome-attributes-of2026-10-04 https://evidence-hub.com/study/61195-establishment-evaluation-and-proof-of-a-novel-migraine-animal-model2026-10-04 https://evidence-hub.com/study/61197-expression-of-artemin-and-gfr-3-in-an-animal-model-of-migraine2026-10-04 https://evidence-hub.com/study/61198-alcohol-triggered-signs-of-migraine-an-animal-model2026-10-04 https://evidence-hub.com/study/61199-effects-of-peripheral-faah-blockade-on-ntg-induced-hyperalgesia2026-10-04 https://evidence-hub.com/study/61201-the-current-research-on-migraine-animal-model2026-10-04 https://evidence-hub.com/study/61202-evaluation-of-adma-ddah-nos-axis-in-specific-brain-areas-following2026-10-04 https://evidence-hub.com/study/61203-study-on-the-migraine-animal-model-induced-by-chemical-stimulation-on2026-10-04 https://evidence-hub.com/study/61205-exploring-the-mechanism-of-active-ingredients-of-smilacis-glabrae2026-10-06 https://evidence-hub.com/study/61206-the-influence-of-nf-b-protein-expression-in-the-periaqueductal-gray2026-10-04 https://evidence-hub.com/study/61207-nitroglycerin-as-a-comparative-experimental-model-of-migraine-pain2026-10-04 https://evidence-hub.com/study/61208-dysregulated-autophagy-neural-signaling-pathways-and-gut-brain-axis2026-10-06 https://evidence-hub.com/study/61209-mechanisms-underlying-the-increased-susceptibility-to-initiation-of2026-10-04 https://evidence-hub.com/study/61210-histopathological-effects-of-repeated-14-day-administration-of2026-10-04 https://evidence-hub.com/study/61212-establishment-of-migraine-rheumatism-stasis-syndrome-animal-model2026-10-04 https://evidence-hub.com/study/61213-activation-of-cb2-receptors-as-a-potential-therapeutic-target-for2026-10-04 https://evidence-hub.com/study/61214-effect-of-genetic-deletion-and-pharmacological-antagonism-of-p2x72026-10-04 https://evidence-hub.com/study/61216-a-chronic-animal-model-of-migraine-induced-by-repeated-meningeal2026-10-04 https://evidence-hub.com/study/61217-the-search-for-non-evoked-markers-of-pain-in-the-gtn-mouse-model-of2026-10-08 https://evidence-hub.com/study/61218-ehmti-0141-urb937-as-a-potential-therapeutic-option-for-migraine2026-10-04 https://evidence-hub.com/study/61219-hypericum-perforatum-l-as-adjuvant-to-opioid-analgesia-in-an-animal2026-10-04 https://evidence-hub.com/study/61220-st-john-s-wort-relieves-pain-in-an-animal-model-of-migraine2026-10-04 https://evidence-hub.com/study/61222-effect-of-sex-and-estrogens-on-neuronal-activation-in-an-animal-model2026-10-04 https://evidence-hub.com/study/61224-effects-of-urb937-on-an-animal-model-of-migraine-pain2026-10-04 https://evidence-hub.com/study/61225-antidepressant-and-anti-amnesic-effects-of-the-aqueous-lyophilisate2026-10-06 https://evidence-hub.com/study/61226-towards-a-reliable-animal-model-of-migraine2026-10-04 https://evidence-hub.com/study/61227-characterization-of-the-peripheral-faah-inhibitor-urb937-in-animal2026-10-04 https://evidence-hub.com/study/61228-light-aversion-and-cephalic-allodynia-in-an-intravenous-cgrp-model-of2026-10-04 https://evidence-hub.com/study/61229-mismatch-negativity-like-responses-in-nitroglycerin-elicited-migraine2026-10-04 https://evidence-hub.com/study/61230-activity-of-faah-inhibitor-jzp327a-in-an-experimental-rat-model-of2026-10-06 https://evidence-hub.com/study/61231-nitroglycerin-as-a-model-of-migraine-clinical-and-preclinical-review2026-10-06 https://evidence-hub.com/study/61232-the-auditory-function-in-migraine-model-rats-induced-by-postauricular2026-10-06 https://evidence-hub.com/study/61233-effects-of-anandamide-in-migraine-data-from-an-animal-model2026-10-04 https://evidence-hub.com/study/61234-parthenolide-is-the-component-of-tanacetum-parthenium-that-inhibits2026-10-04 https://evidence-hub.com/study/61235-differential-effects-of-corticosteroids-on-the-expression-of2026-10-04 https://evidence-hub.com/study/61236-alterations-of-the-endocannabinoid-system-in-an-animal-model-of2026-10-04 https://evidence-hub.com/study/61237-evaluation-of-protective-effects-of-non-selective-cannabinoid2026-10-06 https://evidence-hub.com/study/61238-neurochemistry-of-trigeminal-activation-in-an-animal-model-of-migraine2026-10-04 https://evidence-hub.com/study/61239-estradiol-treatment-enhances-behavioral-and-molecular-changes-induced2026-10-06 https://evidence-hub.com/study/61241-microglia-p2x4r-bdnf-signalling-contributes-to-central-sensitization2026-10-08 https://evidence-hub.com/study/61242-potentiation-of-endocannabinoids-and-other-lipid-amides-prevents2026-10-06 https://evidence-hub.com/study/61244-advances-in-understanding-migraine-pathophysiology-a-bench-to-bedside2026-10-08 https://evidence-hub.com/study/61246-structural-elucidation-in-vivo-tracking-and-pharmacokinetic-profiling2026-10-06 https://evidence-hub.com/study/61249-neuroimmune-interactions-in-the-development-and-chronification-of2026-10-04 https://evidence-hub.com/study/61250-dual-enkephalinase-inhibitor-pl37-as-a-potential-novel-treatment-of2026-10-06 https://evidence-hub.com/study/61252-regulating-effect-of-xuanqi-drop-pills-on-no-and-5-ht-concentration2026-10-04 https://evidence-hub.com/study/61253-the-modulatory-effect-of-estrogen-on-the-caudal-trigeminal-nucleus-of2026-10-04 https://evidence-hub.com/study/61254-effects-of-ligustrazine-on-the-expression-of-neurotransmitters-in-the2026-10-06 https://evidence-hub.com/study/61255-meta-analysis-of-the-effects-of-clinically-effective-therapeutics-in2026-10-08 https://evidence-hub.com/study/61256-macrophages-and-inos-contribute-to-the-effects-of-dural-prolactin-and2026-10-04 https://evidence-hub.com/study/61257-inhibition-of-trigeminal-nociception-by-non-invasive-vagus-nerve2026-10-06 https://evidence-hub.com/study/61258-pd-l1-and-pd-1-expressed-in-trigeminal-ganglia-may-inhibit-pain-in-an2026-10-06 https://evidence-hub.com/study/61259-use-of-capsaicin-as-a-model-in-the-study-of-migraine-a-literature2026-10-06 https://evidence-hub.com/study/61260-alleviation-of-migraine-related-pain-and-anxiety-by-inhibiting2026-10-06 https://evidence-hub.com/study/61261-effects-of-tianshu-capsule-on-plasma-no-nos-cgrp-contents-and2026-10-04 https://evidence-hub.com/study/61262-pharmacokinetic-comparative-study-of-gas-with-different-concentration2026-10-06 https://evidence-hub.com/study/61263-effects-of-systemic-inhibitors-of-acid-sensing-ion-channels-1-asic12026-10-06 https://evidence-hub.com/study/61264-study-on-the-involvement-of-microglial-s100a8-in-neuroinflammation2026-10-04 https://evidence-hub.com/study/61266-a-unique-inbred-rat-strain-with-sustained-cephalic-hypersensitivity2026-10-06 https://evidence-hub.com/study/61267-il-17-crosses-the-blood-brain-barrier-to-trigger-neuroinflammation-a2026-10-06 https://evidence-hub.com/study/61268-activation-pattern-and-modulation-of-pain-related-structures-in2026-10-04 https://evidence-hub.com/study/61269-animal-models-of-migraine-headache-and-aura2026-10-04 https://evidence-hub.com/study/61271-animal-models-of-migraine2026-10-04 https://evidence-hub.com/study/61273-serotonin-in-migraine-theories-animal-models-and-emerging-therapies2026-10-04 https://evidence-hub.com/study/61275-animal-models-of-migraine-and-experimental-techniques-used-to-examine2026-10-04 https://evidence-hub.com/study/61278-animal-models-of-monogenic-migraine2026-10-04 https://evidence-hub.com/study/61279-sex-related-differences-in-animal-models-of-migraine-headache2026-10-04 https://evidence-hub.com/study/61280-animal-models-of-migraine-aura2026-10-04 https://evidence-hub.com/study/61281-the-current-research-situation-of-experimental-animal-models-of2026-10-04 https://evidence-hub.com/study/61282-current-situation-of-animal-experimental-models-of-migraine2026-10-04 https://evidence-hub.com/study/61283-the-status-quo-of-experimental-animal-models-of-migraine2026-10-04 https://evidence-hub.com/study/61284-animal-models-and-their-results-in-relation-to-the-therapy-of-migraine2026-10-04 https://evidence-hub.com/study/61285-activation-of-the-trigeminal-system-in-the-animal-models-of-migraine2026-10-04 https://evidence-hub.com/study/61289-recent-advance-in-experimental-animal-models-of-migraine2026-10-04 https://evidence-hub.com/study/61291-the-gut-brain-axis-in-migraine-insights-from-preclinical-animal-models2026-10-06 https://evidence-hub.com/study/61293-genetic-effects-of-atp1a2-in-familial-hemiplegic-migraine-type-ii-and2026-10-04 https://evidence-hub.com/study/61294-peripheral-and-central-activation-of-trigeminal-pain-pathways-in2026-10-04 https://evidence-hub.com/study/61296-the-role-of-the-brainstem-in-migraine-potential-brainstem-effects-of2026-10-04 https://evidence-hub.com/study/61297-effect-of-different-proportion-and-different-dosage-forms-of2026-10-04 https://evidence-hub.com/study/61298-effect-of-xiong-zhi-dilong-tang-on-plasma-and-brain-stem-ep-and-cgrp2026-10-04 https://evidence-hub.com/study/61299-modelling-migraine-related-features-in-the-nitroglycerin-animal-model2026-10-04 https://evidence-hub.com/study/61302-sex-differences-in-the-effects-of-calcitonin-gene-related-peptide2026-10-04 https://evidence-hub.com/study/61303-characterization-of-the-peripheral-faah-inhibitor-urb937-in-animal2026-10-04 https://evidence-hub.com/study/61304-cranial-dural-permeability-of-inflammatory-nociceptive-mediators2026-10-04 https://evidence-hub.com/study/61307-prevalence-of-chronic-pain-in-the-general-population-a-systematic2026-10-06 https://evidence-hub.com/study/61308-anxiety-and-depression-in-adults-with-vestibular-disorders-a2026-10-06 https://evidence-hub.com/study/61309-the-state-of-evidence-in-acupuncture-a-review-of-metaanalyses-and2026-10-06 https://evidence-hub.com/study/61310-effects-and-safety-of-transcranial-direct-current-stimulation-on2026-10-06 https://evidence-hub.com/study/61311-hmg-coa-reductase-is-a-potential-therapeutic-target-for-migraine-a2026-10-06 https://evidence-hub.com/study/61312-assessing-blood-pressure-changes-and-hypertension-related-outcomes-in2026-10-06 https://evidence-hub.com/study/61313-revisiting-the-effects-of-rtms-over-the-dorsolateral-prefrontal2026-10-06 https://evidence-hub.com/study/61314-network-meta-analysis-comparing-efficacy-of-different-strategies-on2026-10-08 https://evidence-hub.com/study/61315-comparison-of-eptinezumab-300-mg-with-100-mg-for-the-treatment-of2026-10-10 https://evidence-hub.com/study/61316-systematic-review-and-meta-analysis-of-the-importance-of-pre2026-10-06 https://evidence-hub.com/study/61317-comprehensive-safety-analysis-of-adverse-events-associated-with2026-10-06 https://evidence-hub.com/study/61318-neuropsychological-function-in-migraine-headaches-an-expanded2026-10-06 https://evidence-hub.com/study/61319-the-altered-functional-status-in-vestibular-migraine-a-meta-analysis2026-10-06 https://evidence-hub.com/study/61320-epidemiology-and-clinical-features-of-occipital-neuralgia-a2026-10-06 https://evidence-hub.com/study/61321-smoking-in-primary-headaches-a-systematic-review-and-meta-analysis2026-10-04 https://evidence-hub.com/study/61322-discordant-dry-eye-disease-and-chronic-pain-a-systematic-review-and2026-10-06 https://evidence-hub.com/study/61323-is-headache-a-risk-factor-for-dementia-a-systematic-review-and-meta2026-10-06 https://evidence-hub.com/study/61324-genome-wide-meta-analysis-of-quantitatively-measured-generalized2026-10-06 https://evidence-hub.com/study/61325-primary-headache-in-sle-systematic-review-and-meta-analysis2026-10-06 https://evidence-hub.com/study/61326-prognostic-factors-associated-with-progression-of-open-angle-glaucoma2026-10-06 https://evidence-hub.com/study/61327-ketorolac-use-in-the-emergency-department-in-children-a-systematic2026-10-06 https://evidence-hub.com/study/61328-levels-of-asymmetric-dimethylar-ginine-and-risk-of-neurovascular2026-10-06 https://evidence-hub.com/study/61329-investigating-the-prevalence-of-comorbidity-in-multiple-sclerosis2026-10-06 https://evidence-hub.com/study/61330-aberrant-spontaneous-low-frequency-brain-activity-in-migraine-a-meta2026-10-06 https://evidence-hub.com/study/61331-the-prevalence-and-nature-of-eating-and-swallowing-problems-in-adults2026-10-06 https://evidence-hub.com/study/61332-increased-infection-risk-in-patients-on-preventive-cgrp-targeting2026-10-06 https://evidence-hub.com/study/61333-cluster-headache-suicidality-a-systematic-review-with-a-meta-analysis2026-10-06 https://evidence-hub.com/study/61334-effectiveness-of-pain-medication-tapering-in-chronic-pain-patients-a2026-10-06 https://evidence-hub.com/study/61335-headache-disorders-in-multiple-sclerosis-is-there-an-association-a2026-10-06 https://evidence-hub.com/study/61336-zavegepant-for-acute-treatment-of-migraine-a-systematic-review-and2026-10-06 https://evidence-hub.com/study/61337-efficacy-and-safety-of-lactobacillus-reuteri-dsm-17938-in-pediatric2026-10-06 https://evidence-hub.com/study/61338-a-systematic-review-of-hypnosis-for-clinical-pain-relief2026-10-06 https://evidence-hub.com/study/61339-the-epidemiology-and-clinical-presentation-of-the-acute-imbalance2026-10-06 https://evidence-hub.com/study/61340-coordinates-based-meta-analysis-for-vestibular-migraine-and-the2026-10-06 https://evidence-hub.com/study/61343-migraine-in-saudi-arabia-prevalence-and-emerging-genetic-insights-a2026-10-06 https://evidence-hub.com/study/61345-clinical-efficacy-and-safety-of-auricular-acupuncture-for-migraine-a2026-10-06 https://evidence-hub.com/study/61346-the-use-of-vhit-in-the-differential-diagnosis-between-vestibular2026-10-06 https://evidence-hub.com/study/61347-systematic-review-and-meta-analysis-of-tanacetum-parthenium2026-10-08 https://evidence-hub.com/study/61348-prevalence-of-migraine-and-other-types-of-primary-headache-in-china-a2026-10-06 https://evidence-hub.com/study/61349-association-between-proton-pump-inhibitor-use-and-migraine-a2026-10-08 https://evidence-hub.com/study/61351-acupuncture-versus-standard-medical-care-in-the-prophylactic2026-10-08 https://evidence-hub.com/study/61352-association-between-migraine-and-risk-of-dementia-a-systematic-review2026-10-06 https://evidence-hub.com/study/61353-assessing-the-impact-of-unpublished-data-on-network-meta-analysis2026-10-06 https://evidence-hub.com/study/61354-sinus-migraine-a-systematic-review-and-meta-analysis2026-10-04 https://evidence-hub.com/study/61355-dropout-rate-of-participants-in-randomized-controlled-trials-using2026-10-06 https://evidence-hub.com/study/61356-po-75-network-meta-analysis-comparing-efficacy-and-safety-outcomes-of2026-10-06 https://evidence-hub.com/study/61357-association-of-atopic-dermatitis-with-migraine-a-systematic-review2026-10-04 https://evidence-hub.com/study/61358-the-short-and-long-term-efficacy-of-non-invasive-brain-stimulation2026-10-06 https://evidence-hub.com/study/61359-red-blood-cell-distribution-width-in-migraine-a-systematic-review-and2026-10-06 https://evidence-hub.com/study/61360-non-specific-effects-of-different-sham-acupuncture-methods-and-their2026-10-06 https://evidence-hub.com/study/61361-non-pharmacological-interventions-for-the-prevention-of-migraine-in2026-10-06 https://evidence-hub.com/study/61362-prevalence-of-migraine-and-its-clinical-presentation-in-egypt-a2026-10-06 https://evidence-hub.com/study/61364-critical-limitations-compromise-the-conclusions-of-a-recent-meta2026-10-06 https://evidence-hub.com/study/61365-understanding-the-impact-of-endometriosis-on-women-s-life-an2026-10-06 https://evidence-hub.com/study/61366-risk-factors-for-temporomandibular-disorders-a-systematic-review-of2026-10-06 https://evidence-hub.com/study/61367-chronic-pain-in-autism-a-systematic-review2026-10-06 https://evidence-hub.com/study/61368-glucagon-like-peptide-1-glp-1-receptor-agonists-for-headache-and-pain2026-10-06 https://evidence-hub.com/study/61369-outcomes-in-randomized-clinical-trials-testing-changes-in-daily-water2026-10-06 https://evidence-hub.com/study/61370-risk-factors-associated-to-disability-in-primary-headaches-a2026-10-06 https://evidence-hub.com/study/61371-effectiveness-and-safety-of-onabotulinumtoxina-in-adolescent-patients2026-10-06 https://evidence-hub.com/study/61372-systematic-review-of-late-onset-aura-related-to-migraine-an2026-10-06 https://evidence-hub.com/study/61373-l-carnitine-in-the-treatment-of-psychiatric-and-neurological2026-10-08 https://evidence-hub.com/study/61374-trends-and-hotspots-in-cupping-therapy-research-for-pain-a2026-10-06 https://evidence-hub.com/study/61375-gut-microbiome-based-interventions-for-the-management-of-obesity-in2026-10-18 https://evidence-hub.com/study/61376-epidemiology-and-clinical-characteristics-of-nummular-headache-in2026-10-06 https://evidence-hub.com/study/61377-bridging-the-gap-between-evidence-and-clinical-practice-for-migraine2026-10-06 https://evidence-hub.com/study/61378-headache-as-an-indication-for-surgery-in-non-functioning-pituitary2026-10-06 https://evidence-hub.com/study/61379-association-of-vestibular-disorders-and-cognitive-function-a2026-10-06 https://evidence-hub.com/study/61380-association-of-atopic-dermatitis-and-headache-disorder-a-systematic2026-10-06 https://evidence-hub.com/study/61381-coffee-and-health-outcomes-a-systematic-review-of-mendelian2026-10-06 https://evidence-hub.com/study/61382-evaluating-the-bidirectional-causal-effects-of-alzheimer-s-disease2026-10-06 https://evidence-hub.com/study/61383-noradrenergic-system-involvement-as-a-major-driver-of-tension-type2026-10-06 https://evidence-hub.com/study/61384-acupuncture-for-migraine-a-literature-review-of-neuroimaging-studies2026-10-06 https://evidence-hub.com/study/61385-botulinum-toxin-effects-on-biochemical-biomarkers-related-to2026-10-06 https://evidence-hub.com/study/61386-global-research-trends-and-frontiers-in-patent-foramen-ovale-closure2026-10-06 https://evidence-hub.com/study/61387-vascular-responses-to-molecular-migraine-triggers-a-systematic-review2026-10-08 https://evidence-hub.com/study/61388-prophylactic-management-of-vestibular-migraine-a-systematic-review2026-10-06 https://evidence-hub.com/study/61389-man-vs-machine-can-ml-algorithms-diagnose-headaches-as-accurately-as2026-10-06 https://evidence-hub.com/study/61390-practice-advisory-for-intravenous-management-of-headache-disorders-in2026-10-06 https://evidence-hub.com/study/61392-dosing-effects-of-omega-3-fatty-acid-interventions-in-adults-with2026-10-08 https://evidence-hub.com/study/61393-the-association-between-chronic-obstructive-pulmonary-disease-copd2026-10-06 https://evidence-hub.com/study/61394-patient-adherence-and-long-term-tolerability-of-anti-calcitonin-gene2026-10-08 https://evidence-hub.com/study/61395-ai-driven-therapeutics-and-novel-interventions-in-migraine-a2026-10-06 https://evidence-hub.com/study/61397-assessing-the-occurrence-of-hypertension-in-patients-receiving2026-10-06 https://evidence-hub.com/study/61399-recent-trends-in-the-pharmacological-treatment-of-chronic-migraine-a2026-10-06 https://evidence-hub.com/study/61400-acute-pharmacological-treatments-for-migraine-a-systematic-review2026-10-06 https://evidence-hub.com/study/61401-effect-of-exercise-on-chronic-tension-type-headache-and-chronic2026-10-06 https://evidence-hub.com/study/61402-efficacy-of-remote-electrical-neuromodulation-ren-on-migraine-induced2026-10-06 https://evidence-hub.com/study/61403-impact-of-barometric-pressure-changes-on-the-severity-frequency-and2026-10-06 https://evidence-hub.com/study/61404-efficacy-and-safety-of-acupuncture-compared-with-standard-treatment2026-10-06 https://evidence-hub.com/study/61405-neuroimmunological-mechanisms-linking-primary-dysmenorrhea-and2026-10-06 https://evidence-hub.com/study/61406-effectiveness-and-safety-of-anti-cgrp-monoclonal-antibodies-for2026-10-10 https://evidence-hub.com/study/61407-vestibular-migraine-as-a-central-multisensory-disorder-clinical2026-10-06 https://evidence-hub.com/study/61408-effects-of-probiotic-and-vitamin-d-co-supplementation-on-clinical2026-10-08 https://evidence-hub.com/study/61409-early-use-of-erenumab-vs-nonspecific-oral-migraine-preventives-the2026-10-06 https://evidence-hub.com/study/61410-efficacy-and-safety-of-eptinezumab-in-episodic-cluster-headache-a2026-10-06 https://evidence-hub.com/study/61411-efficacy-of-atogepant-in-chronic-migraine-with-and-without-acute2026-10-06 https://evidence-hub.com/study/61412-patent-foramen-ovale-closure-in-patients-with-and-without-nickel2026-10-06 https://evidence-hub.com/study/61413-effects-of-combining-manual-therapies-neck-muscle-exercises-and2026-10-06 https://evidence-hub.com/study/61414-induction-of-cgmp-mediated-migraine-attacks-is-independent-of-cgrp2026-10-10 https://evidence-hub.com/study/61415-individual-level-effects-of-a-digital-behavioural-treatment-for2026-10-06 https://evidence-hub.com/study/61416-early-improvements-with-atogepant-for-the-preventive-treatment-of2026-10-06 https://evidence-hub.com/study/61417-a-randomized-double-blind-placebo-controlled-pilot-study-to-assess2026-10-06 https://evidence-hub.com/study/61418-erenumab-versus-topiramate-migraine-related-disability-impact-and2026-10-06 https://evidence-hub.com/study/61419-safety-tolerability-and-pharmacokinetics-of-single-and-multiple2026-10-06 https://evidence-hub.com/study/61420-long-term-safety-of-cyclical-rozanolixizumab-in-patients-with2026-10-06 https://evidence-hub.com/study/61421-induction-of-cluster-headache-after-opening-of-adenosine-triphosphate2026-10-06 https://evidence-hub.com/study/61422-feasibility-of-adolescent-contraceptive-care-in-the-pediatric2026-10-06 https://evidence-hub.com/study/61423-a-new-neuromodulation-method-in-chronic-migraine-non-nvasive-pulsed2026-10-06 https://evidence-hub.com/study/61424-prochlorperazine-maleate-versus-placebo-for-the-prophylaxis-of-acute2026-10-06 https://evidence-hub.com/study/61425-effect-of-ubrogepant-on-patient-reported-outcomes-when-administered2026-10-06 https://evidence-hub.com/study/61426-a-randomized-open-label-study-to-evaluate-the-effectiveness-and2026-10-06 https://evidence-hub.com/study/61427-efficacy-of-a-dual-task-protocol-on-neurophysiological-and-clinical2026-10-06 https://evidence-hub.com/study/61428-rimegepant-orally-disintegrating-tablet-75-mg-for-acute-treatment-of2026-10-06 https://evidence-hub.com/study/61429-effect-of-preventive-treatment-with-atogepant-on-quality-of-life2026-10-06 https://evidence-hub.com/study/61430-responder-rates-with-eptinezumab-over-24-weeks-in-patients-with-prior2026-10-06 https://evidence-hub.com/study/61431-open-label-placebos-as-adjunct-for-the-preventive-treatment-of2026-10-06 https://evidence-hub.com/study/61432-ferritin-guided-iron-supplementation-as-an-alternative-or-complement2026-10-06 https://evidence-hub.com/study/61433-a-randomized-open-label-5-period-crossover-study-evaluating-the2026-10-06 https://evidence-hub.com/study/61434-pharmacokinetics-of-ubrogepant-in-healthy-japanese-and-white-adults2026-10-06 https://evidence-hub.com/study/61435-effects-of-substance-p-on-headache-induction-and-arterial-dilation-in2026-10-06 https://evidence-hub.com/study/61436-efficacy-and-safety-of-erenumab-in-participants-with-episodic2026-10-06 https://evidence-hub.com/study/61437-effect-of-sumatriptan-on-atp-sensitive-potassium-channel-opening-in2026-10-06 https://evidence-hub.com/study/61438-a-prescribed-digital-health-app-and-number-of-migraine-days-a2026-10-04 https://evidence-hub.com/study/61439-leveraging-a-randomized-trial-to-assess-relationships-between2026-10-06 https://evidence-hub.com/study/61440-high-definition-tdcs-over-primary-motor-cortex-modulates-brain-signal2026-10-06 https://evidence-hub.com/study/61441-migraine-and-risk-of-parkinson-disease-in-women-a-cohort-study2026-10-06 https://evidence-hub.com/study/61442-a-2-part-open-label-phase-1-bioequivalence-and-food-effect-study-of2026-10-06 https://evidence-hub.com/study/61443-pharmacokinetics-of-a-novel-piperaquine-dispersible-granules2026-10-06 https://evidence-hub.com/study/61444-exercise-training-reduces-systemic-inflammation-and-improves-general2026-10-06 https://evidence-hub.com/study/61445-characterisation-of-psychological-and-neurocognitive-processes2026-10-06 https://evidence-hub.com/study/61446-effectiveness-of-transcranial-direct-current-stimulation-and2026-10-08 https://evidence-hub.com/study/61447-comparison-of-the-efficacy-of-repeated-greater-occipital-nerve-block2026-10-06 https://evidence-hub.com/study/61448-long-term-treatment-with-lasmiditan-in-patients-with-migraine-post2026-10-06 https://evidence-hub.com/study/61449-effects-of-fremanezumab-on-migraine-associated-symptoms-and2026-10-06 https://evidence-hub.com/study/61450-coenzyme-q10-as-an-adjunctive-strategy-to-reduce-paclitaxel-induced2026-10-06 https://evidence-hub.com/study/61451-novel-conservative-therapies-in-migraine-management-the-impact-of2026-10-06 https://evidence-hub.com/study/61452-the-impact-of-neuroscience-education-therapy-behavioral-economics-and2026-10-06 https://evidence-hub.com/study/61453-effectiveness-of-distal-versus-proximal-greater-occipital-nerve2026-10-06 https://evidence-hub.com/study/61454-massage-therapy-by-trained-family-members-in-management-of-headache2026-10-06 https://evidence-hub.com/study/61455-the-efficacy-and-safety-of-electroacupuncture-for-prophylaxis-of2026-10-06 https://evidence-hub.com/study/61456-the-effects-of-transcutaneous-auricular-vagus-nerve-stimulation-in2026-10-06 https://evidence-hub.com/study/61457-efficacy-of-acupuncture-for-chronic-migraine-a-protocol-for-a2026-10-06 https://evidence-hub.com/study/61458-telemedicine-based-cognitive-behavioral-therapy-tenacity-for-veterans2026-10-06 https://evidence-hub.com/study/61459-combined-effect-of-lavender-oil-and-hot-foot-bath-on-migraine2026-10-06 https://evidence-hub.com/study/61460-a-randomized-controlled-trial-on-combining-therapeutic-patient2026-10-06 https://evidence-hub.com/study/61461-efficacy-of-foot-reflexology-in-reducing-migraine-pain-a-randomized2026-10-06 https://evidence-hub.com/study/61464-placebo-effect-of-verbal-instructions-coupled-with-pharmacological2026-10-06 https://evidence-hub.com/study/61466-the-effectiveness-of-agomelatine-on-headache-severity-and-frequency2026-10-06 https://evidence-hub.com/study/61467-enhancing-chronic-migraine-preventive-therapy-low-level-810-nm-laser2026-10-06 https://evidence-hub.com/study/61468-continuous-combined-oral-contraceptive-use-versus-vitamin-e-in-the2026-10-06 https://evidence-hub.com/study/61469-comparison-of-the-efficacy-of-propranolol-versus-valsartan-in-the2026-10-06 https://evidence-hub.com/study/61470-the-effect-of-aromatherapy-massage-on-the-pain-severity-and-quality2026-10-06 https://evidence-hub.com/study/61473-ultrasound-guided-pulsed-radiofrequency-of-the-greater-occipital2026-10-06 https://evidence-hub.com/study/61475-effectiveness-of-manual-therapy-as-a-prophylactic-treatment-for2026-10-06 https://evidence-hub.com/study/61477-reply-to-lunghi-c-baroni-f-comment-on-tekin-et-al-novel-conservative2026-10-06 https://evidence-hub.com/study/61479-effectiveness-of-cranio-cervical-osteopathic-techniques-in2026-10-06 https://evidence-hub.com/study/61480-efficacy-of-aerobic-training-on-resting-state-brain-wave-pain-sleep2026-10-06 https://evidence-hub.com/study/61481-effect-of-select-yoga-practices-on-clinical-biochemical-and-quality2026-10-06 https://evidence-hub.com/study/61483-lavender-essential-oil-as-treatment-for-chronic-migraine-a-protocol2026-10-06 https://evidence-hub.com/study/61484-efficacy-and-safety-of-pyridoxine-versus-propranolol-for-pediatric2026-10-06 https://evidence-hub.com/study/61486-efficacy-of-virechana-karma-in-the-management-of-migraine-a2026-10-06 https://evidence-hub.com/study/61487-efficacy-and-exploratory-treatment-response-modeling-of-acupuncture2026-10-06 https://evidence-hub.com/study/61493-a-randomized-double-blind-controlled-trial-protocol-for-therapeutic2026-10-06 https://evidence-hub.com/study/61494-the-effects-of-concurrent-alpha-linolenic-acid-l-carnitine2026-10-08 https://evidence-hub.com/study/61495-blood-pressure-lowering-for-prevention-of-episodic-migraine-results2026-10-06 https://evidence-hub.com/study/61496-sishun-formula-for-acute-migraine-attack-study-protocol-for-a-double2026-10-06 https://evidence-hub.com/study/61497-activation-of-atp-sensitive-potassium-channels-triggers-migraine2026-10-06 https://evidence-hub.com/study/61498-effects-of-cinnamon-on-anthropometric-indices-and-headache-related2026-10-06 https://evidence-hub.com/study/61499-efficacy-and-tolerability-of-valproate-versus-topiramate-in-migraine2026-10-08 https://evidence-hub.com/study/61500-clinical-evaluation-after-discontinuation-of-galcanezumab-in-japanese2026-10-06 https://evidence-hub.com/study/61501-biofeedback-therapy-using-cerebri-for-the-prevention-of-migraine2026-10-08 https://evidence-hub.com/study/61502-improving-migraine-headache-characteristics-with-high-dose-of2026-10-06 https://evidence-hub.com/study/61503-study-protocol-for-assessing-the-effectiveness-of-agomelatine-on-the2026-10-06 https://evidence-hub.com/study/61504-title-unveiling-the-artistry-of-triticum-aestivum-sprouts-tas2026-10-06 https://evidence-hub.com/study/61505-a-multicenter-open-label-long-term-safety-study-of-rimegepant-for-the2026-10-06 https://evidence-hub.com/study/61506-safety-and-tolerability-of-ubrogepant-for-the-acute-treatment-of2026-10-06 https://evidence-hub.com/study/61507-long-term-effectiveness-of-eptinezumab-in-the-treatment-of-patients2026-10-06 https://evidence-hub.com/study/61508-a-drug-drug-interaction-study-to-evaluate-the-impact-of-rimegepant-on2026-10-06 https://evidence-hub.com/study/61509-efficacy-of-an-educational-website-on-headaches-in-schoolchildren-a2026-10-06 https://evidence-hub.com/study/61510-effects-of-multiple-dose-administration-of-zavegepant-nasal-spray-on2026-10-06 https://evidence-hub.com/study/61511-the-impact-of-an-app-delivered-mindfulness-based-intervention-on2026-10-06 https://evidence-hub.com/study/61512-effect-and-neurophysiological-mechanisms-of-transcutaneous-auricular2026-10-06 https://evidence-hub.com/study/61513-a-multimodal-sleep-intervention-improves-sleep-quality-and2026-10-06 https://evidence-hub.com/study/61514-vanderbilt-integrated-community-tms-for-opioid-recovery-victory-study2026-10-06 https://evidence-hub.com/study/61515-efficacy-and-safety-of-transcutaneous-auricular-vagus-nerve2026-10-06 https://evidence-hub.com/study/61516-reenergizeme-intermittent-hypoxia-hyperoxia-treatment-for-myalgic2026-10-06 https://evidence-hub.com/study/61517-manual-therapy-for-chronic-migraine-a-randomized-clinical-trial2026-10-06 https://evidence-hub.com/study/61518-effects-of-grape-seed-extract-supplementation-on-inflammatory2026-10-06 https://evidence-hub.com/study/61519-individualized-and-structured-sleep-hygiene-guidance-for-individuals2026-10-06 https://evidence-hub.com/study/61520-fixed-combination-of-palmitoylethanolamide-and-melatonin-in2026-10-06 https://evidence-hub.com/study/61521-the-effectiveness-of-supplemental-oxygen-therapy-in-patients2026-10-06 https://evidence-hub.com/study/61522-the-effects-of-dry-needling-technique-on-clinical-parameters-of2026-10-06 https://evidence-hub.com/study/61523-effects-of-progressive-muscle-relaxation-pmr-on-reducing-migraine2026-10-06 https://evidence-hub.com/study/61524-the-effects-of-lacosamide-on-patients-with-chronic-migraine-a2026-10-06 https://evidence-hub.com/study/61525-a-clinical-study-of-kumkum-nasya-and-pathyadi-shadanga-kwatha-in-the2026-10-06 https://evidence-hub.com/study/61527-efficacy-of-emotion-focused-therapy-of-emotional-components-in-women2026-10-06 https://evidence-hub.com/study/61528-the-analgesic-effect-of-barley-tea-hordeum-vulgare-l-in-migraine2026-10-06 https://evidence-hub.com/study/61530-efficacy-and-safety-of-venlafaxine-versus-nortriptyline-for-the2026-10-06 https://evidence-hub.com/study/61531-the-effect-of-selenium-supplementation-on-oxidative-stress-clinical2026-10-08 https://evidence-hub.com/study/61532-the-effect-of-melatonin-on-reducing-the-frequency-and-severity-of2026-10-08 https://evidence-hub.com/study/61533-the-efficacy-of-repetitive-transcranial-magnetic-stimulation-rtms2026-10-06 https://evidence-hub.com/study/61534-preferences-and-perceptions-of-617-migraine-patients-on-acute-and2026-10-08 https://evidence-hub.com/study/61536-efficacy-of-nano-curcumin-supplementation-on-depression-anxiety2026-10-06 https://evidence-hub.com/study/61537-efficacy-of-probiotics-in-prevention-of-migraine-attacks-in-children2026-10-06 https://evidence-hub.com/study/61538-the-effect-of-selenium-supplementation-on-oxidative-stress-clinical2026-10-06 https://evidence-hub.com/study/61539-non-vascular-atp-sensitive-potassium-channel-activation-does-not2026-10-06 https://evidence-hub.com/study/61540-cabergoline-as-a-preventive-migraine-treatment-a-randomized-clinical2026-10-06 https://evidence-hub.com/study/61541-safety-and-tolerability-of-transnasal-evaporative-cooling-for-the2026-10-06 https://evidence-hub.com/study/61542-comparative-efficacy-of-chhinnadi-kwath-and-devdarvyadi-ghrit-nasya2026-10-06 https://evidence-hub.com/study/61543-the-efficacy-of-nasyakarma-and-snehapana-in-the-management-of2026-10-06 https://evidence-hub.com/study/61544-effect-of-cephagraine-tablets-and-nasal-drops-in-patients-with2026-10-06 https://evidence-hub.com/study/61545-impacts-of-cervical-exercise-and-mulligan-manual-therapy-on-headache2026-10-06 https://evidence-hub.com/study/61548-mass-balance-and-metabolism-of-14c-atogepant-in-healthy-male2026-10-06 https://evidence-hub.com/study/61549-a-randomized-crossover-trial-the-impact-of-ocular-lubrication-on2026-10-06 https://evidence-hub.com/study/61550-green-light-and-transcranial-direct-current-stimulation-in-migraine2026-10-06 https://evidence-hub.com/study/61551-optimizing-the-management-of-patients-with-chronic-migraine-and-neck2026-10-06 https://evidence-hub.com/study/61552-personalized-combination-treatment-including-cognitive-behavioural2026-10-06 https://evidence-hub.com/study/61553-effect-of-fasting-induced-headache-on-calcitonin-gene-related-peptide2026-10-06 https://evidence-hub.com/study/61554-a-clinical-evaluation-of-siddha-herbal-formulation-panchathaarai2026-10-06 https://evidence-hub.com/study/61555-efficacy-of-greater-occipital-nerve-block-treatment-for-migraine-and2026-10-06 https://evidence-hub.com/study/61556-development-of-the-continuous-ambulatory-vestibular-assessment-cava2026-10-06 https://evidence-hub.com/study/61557-sustained-response-to-atogepant-in-episodic-migraine-post-hoc2026-10-06 https://evidence-hub.com/study/61558-cognitive-behavioral-therapy-in-the-treatment-of-patients-with2026-10-06 https://evidence-hub.com/study/61560-migraine-inducing-effects-of-sildenafil-in-men-with-migraine-without2026-10-08 https://evidence-hub.com/study/61561-efficacy-of-cognitive-behavioral-therapy-in-chronic-migraine-and2026-10-06 https://evidence-hub.com/study/61562-cognitive-behavioral-therapy-in-the-treatment-of-patients-with2026-10-06 https://evidence-hub.com/study/61563-contralateral-acupuncture-for-migraine-without-aura-a-randomized2026-10-06 https://evidence-hub.com/study/61564-efficacy-and-safety-of-migspray-for-migraine-prevention-in-children2026-10-06 https://evidence-hub.com/study/61565-a-feasibility-trial-on-intranasal-evaporative-cooling-for-acute2026-10-06 https://evidence-hub.com/study/61566-migraine-headache-and-patent-foramen-ovale-observational-studies-the2026-10-06 https://evidence-hub.com/study/61567-eptinezumab-treatment-was-associated-with-longer-interictal-headache2026-10-06 https://evidence-hub.com/study/61568-sex-differences-in-the-clinical-features-of-2-841-patients-with2026-10-06 https://evidence-hub.com/study/61569-adverse-childhood-experiences-and-health-at-age-50-years-in-the2026-10-06 https://evidence-hub.com/study/61570-unmet-treatment-needs-in-migraine-results-of-the-overcome-us-study2026-10-06 https://evidence-hub.com/study/61571-recurrent-cervical-artery-dissection-prevalence-and-predictors-a2026-10-06 https://evidence-hub.com/study/61572-association-of-migraine-comorbidities-with-quality-of-life-work2026-10-06 https://evidence-hub.com/study/61573-possible-diagnostic-error-in-cervical-artery-dissection-analysis-of2026-10-06 https://evidence-hub.com/study/61574-improvement-of-comorbid-anxiety-and-depression-in-patients-with2026-10-06 https://evidence-hub.com/study/61575-signs-of-cortical-inflammation-in-migraine-measured-with-quantitative2026-10-06 https://evidence-hub.com/study/61576-development-of-the-migraine-related-stigma-mirs-questionnaire-results2026-10-06 https://evidence-hub.com/study/61577-prior-psychiatric-disorder-and-post-traumatic-stress-depressive-and2026-10-06 https://evidence-hub.com/study/61578-association-between-trigger-surprisal-and-tension-type-headache2026-10-06 https://evidence-hub.com/study/61579-item-level-psychometrics-of-the-dizziness-handicap-inventory-in2026-10-06 https://evidence-hub.com/study/61580-pain-medication-beliefs-in-individuals-with-headache2026-10-06 https://evidence-hub.com/study/61581-how-do-australian-osteopaths-manage-migraines-outcomes-from-a2026-10-06 https://evidence-hub.com/study/61582-investigating-the-interplay-of-chronotypes-neuropsychiatric2026-10-06 https://evidence-hub.com/study/61583-genetically-proxied-liability-to-migraine-and-risk-of-intracranial2026-10-06 https://evidence-hub.com/study/61584-safety-and-tolerability-of-atogepant-for-the-preventive-treatment-of2026-10-06 https://evidence-hub.com/study/61585-cost-effectiveness-of-rimegepant-oral-lyophilisate-compared-to-best2026-10-06 https://evidence-hub.com/study/61586-eptinezumab-demonstrated-efficacy-regardless-of-prior-preventive2026-10-06 https://evidence-hub.com/study/61587-prevalence-of-cranial-autonomic-symptoms-in-frequent-episodic-tension2026-10-06 https://evidence-hub.com/study/61588-migraine-associated-symptoms-change-with-improvement-in-youth-with2026-10-06 https://evidence-hub.com/study/61589-impact-of-migraine-on-productivity-and-efficiency-among-adult2026-10-06 https://evidence-hub.com/study/61590-a-study-to-investigate-the-prevalence-of-headache-disorders-and2026-10-06 https://evidence-hub.com/study/61591-post-traumatic-headache-in-children-and-genetic-risk-of-migraine-an2026-10-06 https://evidence-hub.com/study/61592-long-term-use-of-rimegepant-75-mg-for-the-acute-treatment-of-migraine2026-10-06 https://evidence-hub.com/study/61593-long-term-reductions-in-acute-headache-medication-use-after2026-10-06 https://evidence-hub.com/study/61594-headache-outcomes-after-treatment-of-cerebral-arteriovenous2026-10-06 https://evidence-hub.com/study/61595-effect-of-co-morbid-anxiety-and-depression-history-on-multidomain2026-10-06 https://evidence-hub.com/study/61596-effect-of-erenumab-on-the-reversion-from-chronic-migraine-to-episodic2026-10-06 https://evidence-hub.com/study/61597-effects-of-strength-training-on-neck-muscle-function-and-tenderness2026-10-06 https://evidence-hub.com/study/61598-patient-reported-symptoms-and-admission-pathways-in-stroke-mimics2026-10-06 https://evidence-hub.com/study/61599-maternal-migraine-vascular-comorbidities-and-prematurity-exploring2026-10-06 https://evidence-hub.com/study/61600-focused-narrative-review-non-pharmacological-noninvasive2026-10-06 https://evidence-hub.com/study/61601-impacts-of-different-treatment-methods-on-patients-with-covid-related2026-10-06 https://evidence-hub.com/study/61603-prussian-blue-doped-caco3-nanoparticle-labeled-secondary-antibodies2026-10-06 https://evidence-hub.com/study/61604-migraine-and-other-headache-syndromes-in-brazil-an-epidemiological2026-10-06 https://evidence-hub.com/study/61605-treatment-response-of-calcitonin-gene-related-peptide-monoclonal2026-10-06 https://evidence-hub.com/study/61606-stroke-like-migraine-attacks-after-radiation-therapy-smart-syndrome-a2026-10-06 https://evidence-hub.com/study/61607-evaluating-the-effectiveness-and-safety-of-a-remote-electrical2026-10-06 https://evidence-hub.com/study/61608-a-neurological-perspective-on-tarsila-do-amaral-s-abaporu-migraine2026-10-06 https://evidence-hub.com/study/61609-evaluating-the-effectiveness-tolerability-and-safety-of-eptinezumab2026-10-06 https://evidence-hub.com/study/61610-mechanisms-for-mindfulness-in-migraine-does-catastrophizing-matter2026-10-06 https://evidence-hub.com/study/61611-general-physical-impairments-in-migraine-patients-beyond-cervical2026-10-04 https://evidence-hub.com/study/61612-effectiveness-of-galcanezumab-and-traditional-oral-migraine2026-10-06 https://evidence-hub.com/study/61613-long-term-persistence-to-onabotulinumtoxina-to-prevent-chronic2026-10-06 https://evidence-hub.com/study/61614-atogepant-for-migraine-in-real-world-clinical-practice-insights-from2026-10-06 https://evidence-hub.com/study/61615-targeting-the-gut-brain-axis-in-migraine-effects-of-probiotic2026-10-08 https://evidence-hub.com/study/61616-hypothalamic-subregional-volume-in-relation-to-vss-c-total-symptom2026-10-06 https://evidence-hub.com/study/61617-effect-of-repetitive-transcranial-magnetic-stimulation-rtms-on-eeg2026-10-06 https://evidence-hub.com/study/61618-chronic-migraine-prevention-from-the-perspective-of-a-family-doctor-a2026-10-08 https://evidence-hub.com/study/61619-epidemiological-profile-and-impact-of-hospitalizations-for2026-10-06 https://evidence-hub.com/study/61620-risk-of-ischemic-and-hemorrhagic-stroke-following-migraine-a2026-10-06 https://evidence-hub.com/study/61621-neuroimaging-based-subtyping-of-migraine-identifies-clinically2026-10-06 https://evidence-hub.com/study/61623-three-year-interim-results-from-a-post-marketing-surveillance-study2026-10-06 https://evidence-hub.com/study/61624-anti-cgrp-monoclonal-antibody-therapy-for-migraine-is-not-associated2026-10-06 https://evidence-hub.com/study/61625-frequency-and-clinical-profile-of-pediatric-migraine-using-pedmidas2026-10-06 https://evidence-hub.com/study/61626-efficacy-of-real-acupuncture-compared-with-sham-acupuncture-for2026-10-06 https://evidence-hub.com/study/61629-value-of-lumbar-puncture-in-identifying-secondary-causes-of-visual2026-10-06 https://evidence-hub.com/study/61630-underdiagnosis-and-impact-of-menstrual-migraine-in-real-world2026-10-06 https://evidence-hub.com/study/61631-associations-of-type-2-diabetes-and-the-risk-of-migraine-in-chinese2026-10-06 https://evidence-hub.com/study/61632-ambient-nitrogen-dioxide-temperature-exposure-and-migraine-incidence2026-10-06 https://evidence-hub.com/study/61633-5-0-t-mri-reveals-characteristic-alterations-in-visual-and2026-10-06 https://evidence-hub.com/study/61634-clinical-characteristics-of-hemiplegic-migraine-a-clinical-study-of2026-10-06 https://evidence-hub.com/study/61635-real-world-achievement-of-higher-standards-for-migraine-prevention2026-10-06 https://evidence-hub.com/study/61636-gfap-as-a-marker-of-astrocytic-damage-correlated-with-medication2026-10-06 https://evidence-hub.com/study/61637-multimodal-serum-and-mri-signatures-of-neuroaxonal-injury-in-high2026-10-06 https://evidence-hub.com/study/61638-the-value-of-triglyceride-glucose-index-related-indices-in-evaluating2026-10-06 https://evidence-hub.com/study/61639-no-increase-in-blood-pressure-assessed-with-the-24-h-holter2026-10-06 https://evidence-hub.com/study/61640-effects-of-nonprescription-therapies-on-vestibular-migraine-a2026-10-06 https://evidence-hub.com/study/61641-decreases-in-hormone-levels-modulate-neurovascular-coupling-but-not2026-10-06 https://evidence-hub.com/study/61642-current-demography-and-treatment-strategy-of-vestibular-migraine-in2026-10-06 https://evidence-hub.com/study/61643-long-term-evolution-of-white-and-gray-matter-structural-properties-in2026-10-06 https://evidence-hub.com/study/61644-effects-of-onabotulinumtoxin-a-in-patients-concurrently-diagnosed2026-10-06 https://evidence-hub.com/study/61645-efficacy-of-low-dose-bont-a-acupoint-injections-in-managing-headache2026-10-06 https://evidence-hub.com/study/61646-impaired-meningeal-lymphatic-drainage-correlates-with-headache2026-10-06 https://evidence-hub.com/study/61647-assessment-of-micronutrient-levels-in-pediatric-migraine-patients2026-10-04 https://evidence-hub.com/study/61648-signatures-of-migraine-aura-in-high-density-eeg2026-10-06 https://evidence-hub.com/study/61649-migraine-and-the-risk-of-dementia-in-the-general-population2026-10-06 https://evidence-hub.com/study/61650-quality-of-sleep-in-chronic-migraine-patients-treated-with2026-10-06 https://evidence-hub.com/study/61651-analysis-of-retreatment-with-monoclonal-antibodies-in-chronic2026-10-06 https://evidence-hub.com/study/61652-peripapillary-and-subfoveal-choroidal-vascular-index-in-patients-with2026-10-06 https://evidence-hub.com/study/61653-neuronal-dynamics-of-menstrually-related-migraine-a-longitudinal-task2026-10-06 https://evidence-hub.com/study/61654-real-world-comparison-of-treatments-with-antibodies-targeting-the2026-10-06 https://evidence-hub.com/study/61655-management-of-migraine-in-children-and-adolescents2026-10-06 https://evidence-hub.com/study/61656-do-nerve-blocks-boost-mood-and-functional-activity-in-patients-with2026-10-06 https://evidence-hub.com/study/61657-adherence-status-and-influencing-factors-of-acute-and-preventive2026-10-06 https://evidence-hub.com/study/61658-use-of-antimigraine-medication-before-pregnancy-and-in-the-first2026-10-06 https://evidence-hub.com/study/61659-persistent-headache-attributed-to-past-ischemic-stroke-a-prospective2026-10-06 https://evidence-hub.com/study/61660-advancing-toward-precision-migraine-treatment-predicting-responses-to2026-10-06 https://evidence-hub.com/study/61661-comparison-of-the-efficacy-of-ultrasound-guided-repeated-greater2026-10-06 https://evidence-hub.com/study/61662-minimal-clinically-important-difference-of-vestibular-migraine2026-10-06 https://evidence-hub.com/study/61663-differences-between-vestibular-migraine-and-meniere-s-disease-based2026-10-06 https://evidence-hub.com/study/61664-efficacy-of-monoclonal-antibodies-against-cgrp-in-migraine-patients2026-10-06 https://evidence-hub.com/study/61665-efficacy-of-galcanezumab-in-migraine-central-sensitization2026-10-06 https://evidence-hub.com/study/61666-evaluating-associations-of-migraine-related-vertigo2026-10-06 https://evidence-hub.com/study/61667-combination-effect-of-ultrasound-guided-superior-cervical-ganglion2026-10-06 https://evidence-hub.com/study/61668-eptinezumab-to-prevent-difficult-to-treat-migraine-prospective-six2026-10-06 https://evidence-hub.com/study/61669-self-reported-physical-activity-differentiates-vestibular-migraine2026-10-06 https://evidence-hub.com/study/61670-multidimensional-feature-analysis-of-meniere-s-disease-and-vestibular2026-10-06 https://evidence-hub.com/study/61671-validation-of-a-portuguese-version-of-the-four-item-migraine2026-10-06 https://evidence-hub.com/study/61672-comparison-of-sensory-organisation-test-results-in-patients-with2026-10-06 https://evidence-hub.com/study/61673-treatment-effectiveness-of-galcanezumab-versus-traditional-oral2026-10-06 https://evidence-hub.com/study/61674-a-3-year-follow-up-study-of-outcomes-associated-with-patterns-of2026-10-06 https://evidence-hub.com/study/61675-lifetime-classic-psychedelic-use-and-headaches-a-cross-sectional-study2026-10-06 https://evidence-hub.com/study/61676-evaluation-of-the-effectiveness-of-greater-occipital-nerve-blockade2026-10-06 https://evidence-hub.com/study/61677-migraine-and-subsequent-head-and-neck-cancer-a-nationwide-population2026-10-06 https://evidence-hub.com/study/61678-onabotulinumtoxina-is-an-effective-treatment-for-reducing-the2026-10-06 https://evidence-hub.com/study/61679-pure-menstrual-tension-type-headache-demonstration-of-its-existence2026-10-06 https://evidence-hub.com/study/61680-real-world-treatment-patterns-and-unmet-needs-of-migraine-preventive2026-10-06 https://evidence-hub.com/study/61681-migraine-and-mri-uncovering-potential-associations2026-10-06 https://evidence-hub.com/study/61682-burden-of-episodic-migraine-chronic-migraine-and-medication-overuse2026-10-06 https://evidence-hub.com/study/61683-headache-a-potential-sequela-of-posterior-reversible-encephalopathy2026-10-06 https://evidence-hub.com/study/61684-correlating-migrainous-features-with-vestibular-evoked-myogenic2026-10-06 https://evidence-hub.com/study/61685-alterations-in-the-tear-film-and-ocular-surface-in-pediatric-migraine2026-10-04 https://evidence-hub.com/study/61686-treatment-patterns-of-galcanezumab-versus-standard-of-care-preventive2026-10-06 https://evidence-hub.com/study/61687-atogepant-reduces-psychological-dependence-on-acute-treatments2026-10-06 https://evidence-hub.com/study/61688-risk-of-two-sport-related-concussions-in-the-same-year-is-the-second2026-10-06 https://evidence-hub.com/study/61689-imaging-endolymphatic-space-of-the-inner-ear-in-vestibular-migraine2026-10-06 https://evidence-hub.com/study/61690-cumulative-adverse-childhood-experiences-increase-migraine-risk-in2026-10-06 https://evidence-hub.com/study/61691-clinical-characteristics-of-probable-vestibular-migraine2026-10-06 https://evidence-hub.com/study/61692-atogepant-reduces-triptan-use-a-pharmacoeconomic-analysis-in-migraine2026-10-08 https://evidence-hub.com/study/61693-prospective-early-adulthood-risk-factors-for-vasomotor-symptoms-in2026-10-06 https://evidence-hub.com/study/61694-clinical-characteristics-of-2378-patients-presenting-with-headache2026-10-06 https://evidence-hub.com/study/61695-retrospective-cohort-study-of-anti-cgrp-monoclonal-antibody2026-10-06 https://evidence-hub.com/study/61696-effectiveness-of-rimegepant-in-vestibular-migraine-a-prospective-self2026-10-06 https://evidence-hub.com/study/61697-cardiovascular-comorbidities-are-risk-factors-for-increased-oxidative2026-10-06 https://evidence-hub.com/study/61698-association-of-migraine-with-increased-risk-of-central-serous2026-10-06 https://evidence-hub.com/study/61699-comparative-efficacy-and-safety-of-nitinol-vs-novel-fully2026-10-06 https://evidence-hub.com/study/61700-comparative-effectiveness-of-weekly-versus-biweekly-combined-greater2026-10-06 https://evidence-hub.com/study/61701-the-association-between-migraine-and-glaucoma-diseases-a2026-10-06 https://evidence-hub.com/study/61702-association-between-seasons-with-substantial-atmospheric-pressure2026-10-06 https://evidence-hub.com/study/61703-association-between-obesity-and-the-risk-of-migraine-a-nationwide2026-10-06 https://evidence-hub.com/study/61704-the-cost-of-migraine-to-the-nhs-in-england-a-retrospective-cohort2026-10-06 https://evidence-hub.com/study/61705-prospective-cohort-study-of-the-impact-of-preventive-migraine2026-10-06 https://evidence-hub.com/study/61706-venous-thromboembolism-and-cancer-risk-in-patients-with-a-history-of2026-10-06 https://evidence-hub.com/study/61707-effect-of-erenumab-versus-other-migraine-preventive-medications-on2026-10-06 https://evidence-hub.com/study/61708-association-between-obstructive-sleep-apnea-and-migraine-a-united2026-10-06 https://evidence-hub.com/study/61709-carbon-monoxide-poisoning-is-associated-with-increased-risk-of2026-10-06 https://evidence-hub.com/study/61710-risk-of-stroke-myocardial-infarction-coronary-intervention-and-atrial2026-10-06 https://evidence-hub.com/study/61711-the-use-of-triptans-and-other-acute-treatments-for-the-management-of2026-10-06 https://evidence-hub.com/study/61712-the-role-of-inflammatory-markers-in-predicting-the-effectiveness-of2026-10-06 https://evidence-hub.com/study/61713-evaluating-treatment-success-in-cgrp-antibody-prophylaxis-a2026-10-08 https://evidence-hub.com/study/61714-sex-hormone-profiles-in-men-with-migraine-a-cross-sectional-matched2026-10-06 https://evidence-hub.com/study/61715-comparative-long-term-outcomes-of-pulsed-and-lesion-radiofrequency-of2026-10-06 https://evidence-hub.com/study/61716-patient-satisfaction-with-calcitonin-gene-related-peptide-monoclonal2026-10-06 https://evidence-hub.com/study/61717-a-retrospective-cohort-study-to-evaluate-the-effectiveness-and-safety2026-10-06 https://evidence-hub.com/study/61718-exploring-the-relationship-between-pain-catastrophizing-and-migraine2026-10-06 https://evidence-hub.com/study/61719-effect-of-migraine-on-suicide-mortality-in-young-adults-a-nationwide2026-10-06 https://evidence-hub.com/study/61720-effectiveness-and-safety-of-low-dose-propofol-for-the-treatment-of2026-10-06 https://evidence-hub.com/study/61721-still-relevant-still-effective-a-retrospective-observational-cohort2026-10-06 https://evidence-hub.com/study/61722-chinook-winds-and-migraine-attack-onset-in-children-and-adolescents-a2026-10-06 https://evidence-hub.com/study/61723-the-healthcare-cost-of-migraine-a-retrospective-cohort-study-from2026-10-06 https://evidence-hub.com/study/61724-migraine-prevalence-and-phenotype-in-autism-a-retrospective-cohort2026-10-06 https://evidence-hub.com/study/61725-lessons-from-the-coronavirus-disease-2019-pandemic-investigating-the2026-10-06 https://evidence-hub.com/study/61726-interaction-between-physical-frailty-and-sleep-quality-on-risk-of2026-10-06 https://evidence-hub.com/study/61727-clinical-practice-for-migraine-treatment-and-characteristics-of2026-10-06 https://evidence-hub.com/study/61728-real-world-observations-and-impacts-of-chinese-herbal-medicine-for2026-10-06 https://evidence-hub.com/study/61732-migraine-may-represent-an-independent-risk-factor-for-retinal-stroke2026-10-06 https://evidence-hub.com/study/61733-increased-risk-of-migraine-among-patients-with-hidradenitis2026-10-06 https://evidence-hub.com/study/61734-association-between-migraine-and-open-angle-glaucoma-a-12-year2026-10-06 https://evidence-hub.com/study/61735-efficacy-and-tolerability-of-erenumab-and-topiramate-for-prevention2026-10-08 https://evidence-hub.com/study/61736-association-of-in-situ-thrombus-within-the-patent-foramen-ovale-and2026-10-06 https://evidence-hub.com/study/61737-effectiveness-of-combination-therapy-of-magnesium-vitamin-b2-and-co2026-10-08 https://evidence-hub.com/study/61738-impact-of-migraine-on-changes-in-cardiovascular-health-profile-among2026-10-06 https://evidence-hub.com/study/61739-additional-effect-of-erenumab-for-patients-with-chronic-migraine2026-10-06 https://evidence-hub.com/study/61740-abstract-wp252-mars-migraine-and-retinal-stroke-a-population-based2026-10-06 https://evidence-hub.com/study/61741-abstract-4141518-disparities-in-associations-between-migraine-and2026-10-06 https://evidence-hub.com/study/61742-effect-of-smoking-on-the-development-of-migraine-in-women-nationwide2026-10-06 https://evidence-hub.com/study/61743-migraine-risk-in-multiple-sclerosis-and-neuromyelitis-optica-spectrum2026-10-06 https://evidence-hub.com/study/61744-the-effects-of-coronavirus-disease-2019-diagnosis-and-national2026-10-06 https://evidence-hub.com/study/61745-migraine-association-with-alzheimer-s-disease-risk-evidence-from-the2026-10-06 https://evidence-hub.com/study/61746-prevalence-and-preferred-medication-for-vestibular-migraine-in2026-10-06 https://evidence-hub.com/study/61747-the-combined-impact-of-migraine-and-gestational-diabetes-on-long-term2026-10-06 https://evidence-hub.com/study/61748-changes-in-use-of-acute-and-preventive-medications-for-migraine-after2026-10-06 https://evidence-hub.com/study/61749-comprehensive-analysis-of-migraine-burden-and-treatment-trends-a2026-10-06 https://evidence-hub.com/study/61750-increased-prevalence-of-headaches-and-migraine-in-patients-with2026-10-06 https://evidence-hub.com/study/61751-changes-in-migraine-symptoms-after-ischemic-stroke-a-cohort-study2026-10-06 https://evidence-hub.com/study/61752-blood-donation-and-migraine-relief-a-national-population-cohort-study2026-10-06 https://evidence-hub.com/study/61765-cohort-profile-and-representativeness-of-participants-in-the-danish2026-10-06 https://evidence-hub.com/study/61766-po-80-real-world-effectiveness-of-atogepant-for-the-preventive2026-10-06 https://evidence-hub.com/study/61767-migraine-mental-health-and-marginalization-a-study-of-psychiatric2026-10-06 https://evidence-hub.com/study/61768-the-dissociation-between-pathological-caloric-testing-and-a-normal2026-10-06 https://evidence-hub.com/study/61770-calcitonin-gene-related-peptide-inhibitors-and-cardiovascular-events2026-10-06 https://evidence-hub.com/study/61771-effectiveness-and-clinical-predictors-of-rimegepant-for-acute-vertigo2026-10-06 https://evidence-hub.com/study/61772-real-world-study-of-adverse-events-associated-with-triptan-use-in2026-10-06 https://evidence-hub.com/study/61773-bridging-cgrp-mabs-with-gepants-an-innovative-approach-to-address-the2026-10-06 https://evidence-hub.com/study/61774-eptinezumab-in-treatment-resistant-chronic-migraine-four-year-real2026-10-06 https://evidence-hub.com/study/61775-cerebrovascular-risk-with-calcitonin-gene-related-peptide-monoclonal2026-10-06 https://evidence-hub.com/study/61776-brain-activity-and-autonomic-regulation-in-untreated-migraine-patients2026-10-04 https://evidence-hub.com/study/61777-comparison-of-ocular-posterior-segment-parameters-in-the-pediatric2026-10-06 https://evidence-hub.com/study/61778-synchronize-real-world-retrospective-safety-analysis-of-patients2026-10-06 https://evidence-hub.com/study/61779-triptan-initiation-and-cerebrovascular-events-in-patients-with2026-10-06 https://evidence-hub.com/study/61780-evaluation-of-the-concomitant-use-of-prophylactic-treatments-in2026-10-06 https://evidence-hub.com/study/61781-integrated-diagnostic-algorithm-for-acute-vertigo-combining-titrate2026-10-06 https://evidence-hub.com/study/61782-oral-and-gut-dysbiosis-in-migraine-oral-microbial-signatures-as2026-10-06 https://evidence-hub.com/study/61783-up-regulation-of-mapk14-related-lncrnas-in-the-circulation-of2026-10-06 https://evidence-hub.com/study/61784-blood-pressure-elevation-in-erenumab-treated-patients-with-migraine-a2026-10-06 https://evidence-hub.com/study/61785-diagnostics-and-management-of-headache-in-general-practice2026-10-06 https://evidence-hub.com/study/61786-hypoperfusion-of-amygdala-in-chronic-migraine-an-exploratory2026-10-06 https://evidence-hub.com/study/61787-translation-and-tilt-perceptual-thresholds-are-elevated-in-meniere-s2026-10-06 https://evidence-hub.com/study/61788-switching-anti-cgrp-monoclonal-antibodies-in-chronic-migraine-real2026-10-06 https://evidence-hub.com/study/61789-making-recommendations-for-an-evaluation-and-treatment-algorithm-for2026-10-06 https://evidence-hub.com/study/61790-patient-reported-outcomes-and-the-real-world-use-of-calcitonin-gene2026-10-06 https://evidence-hub.com/study/61791-a-comparison-of-the-persistence-of-acute-treatment-with-rimegepant2026-10-06 https://evidence-hub.com/study/61792-migraines-the-multiple-sclerosis-prodrome-and-multiple-sclerosis2026-10-06 https://evidence-hub.com/study/61793-correlation-between-migraine-and-cerebral-small-vessel-disease-a-case2026-10-06 https://evidence-hub.com/study/61794-early-and-clinically-meaningful-functional-improvement-following-cgrp2026-10-06 https://evidence-hub.com/study/61795-evaluation-of-forward-head-posture-and-thoracic-kyphosis-in-migraine2026-10-06 https://evidence-hub.com/study/61796-preventive-treatment-effects-on-brain-structures-and-functions-in2026-10-06 https://evidence-hub.com/study/61797-initial-validation-of-the-12-item-tampa-scale-of-kinesiophobia-in-a2026-10-06 https://evidence-hub.com/study/61798-evaluation-of-posterior-ocular-structures-in-pediatric-migraine2026-10-04 https://evidence-hub.com/study/61799-changes-of-basilar-artery-in-patients-with-migraine-a-case-control2026-10-06 https://evidence-hub.com/study/61800-vestibular-migraine-vs-migraine-only-integrated-transcriptome2026-10-06 https://evidence-hub.com/study/61801-electroencephalographic-resting-state-microstates-are-unstable-in2026-10-06 https://evidence-hub.com/study/61802-persistent-effectiveness-of-cgrp-antibody-therapy-in-migraine-and2026-10-06 https://evidence-hub.com/study/61803-electroencephalographic-signatures-of-migraine-in-small-prospective2026-10-06 https://evidence-hub.com/study/61804-cacna1a-genetic-variants-and-their-potential-involvement-in-migraine2026-10-04 https://evidence-hub.com/study/61805-evolution-of-use-and-overuse-of-triptans-in-austria-what-has-changed2026-10-06 https://evidence-hub.com/study/61806-genetic-correlations-between-migraine-and-carpal-tunnel-syndrome2026-10-06 https://evidence-hub.com/study/61807-effectiveness-and-tolerability-of-eptinezumab-in-treating-patients2026-10-06 https://evidence-hub.com/study/61808-effect-of-galcanezumab-on-phq-9-and-gad-7-in-patients-with-migraine-a2026-10-06 https://evidence-hub.com/study/61810-a-real-world-study-of-cgrp-monoclonal-antibodies-for-migraine-long2026-10-06 https://evidence-hub.com/study/61811-transcatheter-closure-of-patent-foramen-ovale-in-children-with2026-10-06 https://evidence-hub.com/study/61812-clinical-characteristics-of-perimenopausal-migraine-and-its2026-10-06 https://evidence-hub.com/study/61813-primary-stabbing-headache-in-a-tertiary-headache-centre2026-10-06 https://evidence-hub.com/study/61814-cacna1a-c-5610del-in-a-three-generation-family-epilepsy-with-ataxia2026-10-06 https://evidence-hub.com/study/61815-migraine-patients-treated-with-erenumab-and-the-risk-of-hypertension2026-10-06 https://evidence-hub.com/study/61816-migraine-and-spontaneous-coronary-artery-dissection-a-retrospective2026-10-06 https://evidence-hub.com/study/61817-cerebrovascular-reactivity-to-hypercapnia-in-patients-with-migraine-a2026-10-06 https://evidence-hub.com/study/61818-computed-tomography-evaluation-of-frontal-sinus-volume-in-migraine2026-10-04 https://evidence-hub.com/study/61819-comparison-of-clinical-features-and-associated-comorbidities-of2026-10-06 https://evidence-hub.com/study/61820-higher-socioeconomic-status-is-associated-with-dispensation-of2026-10-06 https://evidence-hub.com/study/61821-migraine-and-tension-type-headache-are-associated-with-multiple2026-10-06 https://evidence-hub.com/study/61822-low-serum-25-hydroxyvitamin-d-levels-in-migraine-are-not-related-to2026-10-06 https://evidence-hub.com/study/61823-plasma-galectin-3-as-a-potential-predictor-of-chronic-insomnia-and2026-10-06 https://evidence-hub.com/study/61824-can-serum-neuropeptide-levels-help-diagnose-pediatric-migraine-a2026-10-06 https://evidence-hub.com/study/61825-investigating-risk-factors-for-migraine-in-syrian-women-a-cross2026-10-06 https://evidence-hub.com/study/61826-gender-based-discrimination-and-its-influence-on-mental-health2026-10-06 https://evidence-hub.com/study/61827-assessment-of-the-cortical-processing-of-pain-in-patients-with2026-10-06 https://evidence-hub.com/study/61828-assessing-the-relationship-between-migraine-and-sino-nasal-symptoms2026-10-06 https://evidence-hub.com/study/61829-association-of-chronic-periodontitis-with-migraine-in-a-korean-adult2026-10-08 https://evidence-hub.com/study/61830-serum-cytokines-in-primary-new-daily-persistent-headache-and-chronic2026-10-06 https://evidence-hub.com/study/61831-the-correlation-between-vitamin-b12-serum-levels-and-migraine-a-case2026-10-06 https://evidence-hub.com/study/61832-circulating-cgrp-as-a-diagnostic-biomarker-in-female-migraine2026-10-06 https://evidence-hub.com/study/61833-role-of-serum-vitamin-d-level-in-migraine-headache-in-jordanian-women2026-10-06 https://evidence-hub.com/study/61834-dose-dependent-association-between-proton-pump-inhibitor-use-and-the2026-10-06 https://evidence-hub.com/study/61835-changes-in-brainstem-habituation-during-onabotulinumtoxina-treatment2026-10-06 https://evidence-hub.com/study/61836-difficulties-in-emotion-regulation-and-psychiatric-symptoms-in2026-10-06 https://evidence-hub.com/study/61837-susceptibility-weighted-imaging-in-migraine-with-and-without-aura-a2026-10-06 https://evidence-hub.com/study/61838-assessment-of-eating-behavior-in-patients-with-migraine-a-case2026-10-06 https://evidence-hub.com/study/61841-the-relationship-between-maternal-migraine-and-infantile-colic-a-case2026-10-06 https://evidence-hub.com/study/61842-association-between-migraine-and-pre-eclampsia-among-pregnant-women-a2026-10-06 https://evidence-hub.com/study/61843-healthy-eating-index-2015-might-be-associated-with-migraine-headaches2026-10-06 https://evidence-hub.com/study/61844-lack-of-association-between-trpv1-gene-polymorphisms-and-risk-of2026-10-06 https://evidence-hub.com/study/61846-serum-vitamin-d-calcium-and-magnesium-levels-in-patients-with2026-10-08 https://evidence-hub.com/study/61847-the-impact-of-adverse-childhood-experiences-on-migraine-incidence-and2026-10-06 https://evidence-hub.com/study/61848-genetic-factors-in-migraine-with-aura-in-argentina-an-exploratory2026-10-06 https://evidence-hub.com/study/61849-association-between-migraine-and-cardiovascular-diseases-among-women2026-10-06 https://evidence-hub.com/study/61850-abstract-p248-women-with-migraine-had-higher-progression-of-10-year2026-10-06 https://evidence-hub.com/study/61851-a-randomized-case-control-study-on-plasma-serotonin-nitric-oxide-and2026-10-06 https://evidence-hub.com/study/61852-stroke-due-to-small-vessel-disease-and-migraine-a-case-control-study2026-10-06 https://evidence-hub.com/study/61853-morphological-and-mechanical-properties-of-cervical-muscles-in2026-10-06 https://evidence-hub.com/study/61854-poor-creativity-in-interictal-migraine-a-case-control-pilot-study2026-10-06 https://evidence-hub.com/study/61855-cycling-sensitivity-across-migraine-phases-a-longitudinal-case2026-10-06 https://evidence-hub.com/study/61857-interictal-thermal-pain-hypersensitivity-and-central-sensitization-in2026-10-06 https://evidence-hub.com/study/61858-migraine-associated-treatments-and-risk-of-miscarriage-a-matched2026-10-06 https://evidence-hub.com/study/61859-serum-otolin-1-and-otoconin-90-are-not-elevated-in-vestibular2026-10-06 https://evidence-hub.com/study/61860-association-of-transverse-sinus-stenosis-and-dominant-venous-sinus2026-10-06 https://evidence-hub.com/study/61861-clinical-characteristics-and-exploratory-serum-biomarker-findings-in2026-10-06 https://evidence-hub.com/study/61863-evaluation-of-gabbr2-gene-polymorphisms-rs230416-and-rs230429-in2026-10-06 https://evidence-hub.com/study/61864-interictal-serum-uric-acid-albumin-and-uric-acid-to-albumin-ratio-in2026-10-06 https://evidence-hub.com/study/61865-multi-drug-resistance-1-gene-c3435t-polymorphism-in-migraine-patients2026-10-06 https://evidence-hub.com/study/61866-identifying-the-role-of-calcitonin-gene-related-peptide-cgrp-in2026-10-06 https://evidence-hub.com/study/61867-abo-blood-group-distribution-in-migraine-patients-the-relationship-of2026-10-06 https://evidence-hub.com/study/61869-reduced-binaural-masking-release-in-women-with-migraine-despite2026-10-06 https://evidence-hub.com/study/61870-musculoskeletal-impairments-associated-with-migraine-in-young-adults2026-10-06 https://evidence-hub.com/study/61871-association-of-gabra1-polymorphisms-with-migraine-with-aura-a2026-10-06 https://evidence-hub.com/study/61872-episodic-migraine-is-associated-with-a-more-atherogenic-lipid-profile2026-10-06 https://evidence-hub.com/study/61873-anxiety-depression-and-sexual-dysfunction-in-drug-naive-female2026-10-06 https://evidence-hub.com/study/61874-exploring-the-relationship-between-migraine-and-blood-pressure-in2026-10-06 https://evidence-hub.com/study/61875-education-and-social-life-the-impact-of-headache-on-participation-in2026-10-06 https://evidence-hub.com/study/61876-three-month-treatment-with-monoclonal-antibodies-targeting-the-cgrp2026-10-06 https://evidence-hub.com/study/61877-thiamine-deficiency-in-patients-with-chronic-migraine-a-case-control2026-10-06 https://evidence-hub.com/study/61878-impaired-bone-status-in-high-frequency-episodic-or-chronic-migraine2026-10-06 https://evidence-hub.com/study/61879-genetic-factors-in-migraine-with-aura-in-argentina-an-exploratory2026-10-06 https://evidence-hub.com/study/61880-migraine-is-associated-with-altered-approach-avoidance-decision2026-10-06 https://evidence-hub.com/study/61881-serum-calcitonin-gene-related-peptide-and-inflammatory-marker2026-10-06 https://evidence-hub.com/study/61882-interictal-plasma-urotensin-ii-concentrations-in-migraine-and-tension2026-10-06 https://evidence-hub.com/study/61883-calcitonin-gene-related-peptide-in-newly-diagnosed-idiopathic2026-10-06 https://evidence-hub.com/study/61884-association-of-traditional-and-non-traditional-risk-factors-in-the2026-10-06 https://evidence-hub.com/study/61885-obesity-among-children-and-adolescents-with-primary-headache2026-10-06 https://evidence-hub.com/study/61886-oc-24-a-retrospective-case-control-study-aimed-at-analyzing-through2026-10-06 https://evidence-hub.com/study/61887-relationship-between-perceived-stress-resilience-mental-health-and2026-10-06 https://evidence-hub.com/study/61888-headache-in-optic-neuritis-a-retrospective-case-control-study2026-10-06 https://evidence-hub.com/study/61889-relationship-between-vertigo-and-consumption-of-psychotropic-drugs-a2026-10-06 https://evidence-hub.com/study/61890-adverse-life-events-and-psychosocial-stressors-in-functional2026-10-06 https://evidence-hub.com/study/61891-three-month-treatment-with-monoclonal-antibodies-targeting-the-cgrp2026-10-06 https://evidence-hub.com/study/61892-structural-damage-visual-field-loss-and-quality-of-life-in-optic-disc2026-10-06 https://evidence-hub.com/study/61893-relationship-between-occupational-exposure-to-noise-and-vibrations2026-10-06 https://evidence-hub.com/study/61894-alterations-of-the-alpha-rhythm-in-visual-snow-syndrome-a-case2026-10-06 https://evidence-hub.com/study/61895-vertebral-artery-hypoplasia-and-hemodynamic-impairment-in-transient2026-10-06 https://evidence-hub.com/study/61896-case-control-study-on-post-covid-19-conditions-reveals-severe-acute2026-10-06 https://evidence-hub.com/study/61897-familial-hemiplegic-migraine-due-to-cacna1a-and-pnkd-mutations-in2026-10-06 https://evidence-hub.com/study/61898-serum-magnesium-concentration-in-patients-with-bell-s-palsy-a-case2026-10-08 https://evidence-hub.com/study/61899-unforeseen-beneficial-effect-of-successful-pvc-ablation-achieving2026-10-06 https://evidence-hub.com/study/61900-involvement-of-plasma-melatonin-in-medication-overuse-headache-a2026-10-08 https://evidence-hub.com/study/61901-bilateral-vestibulopathy-loss-of-vestibular-function-and-experience2026-10-06 https://evidence-hub.com/study/61902-subcortical-nuclei-and-glymphatic-system-alterations-in-migraine-with2026-10-06 https://evidence-hub.com/study/61903-vestibular-assessment-in-children2026-10-06 https://evidence-hub.com/study/61904-extended-phenotyping-of-migraine-in-children-a-cross-sectional-study2026-10-06 https://evidence-hub.com/study/61905-characteristics-of-locus-coeruleus-functional-connectivity-network-in2026-10-06 https://evidence-hub.com/study/61906-evaluating-patient-and-family-preferences-for-acute-and-preventive2026-10-06 https://evidence-hub.com/study/61907-premonitory-symptoms-in-migraine-a-reform-study2026-10-06 https://evidence-hub.com/study/61908-hair-mercury-serum-omega-3-fatty-acids-and-menstrual-symptoms-among2026-10-08 https://evidence-hub.com/study/61909-normative-values-for-the-head-shake-sensory-organization-test-in-an2026-10-06 https://evidence-hub.com/study/61910-association-between-peripheral-inflammation-biomarkers-and-clinical2026-10-06 https://evidence-hub.com/study/61911-differences-in-cortical-morphometry-between-persistent-post-traumatic2026-10-06 https://evidence-hub.com/study/61912-diagnosing-migraine-from-genome-wide-genotype-data-a-machine-learning2026-10-06 https://evidence-hub.com/study/61913-association-between-headache-laterality-in-migraine-and-hemispheric2026-10-06 https://evidence-hub.com/study/61914-prevalence-and-risk-factors-of-de-novo-widespread-post-covid-pain-in2026-10-06 https://evidence-hub.com/study/61915-the-burden-of-headache-disorders-in-the-adult-general-population-of2026-10-06 https://evidence-hub.com/study/61916-clinical-and-social-burden-of-migraine-in-japanese-males-a-cross2026-10-06 https://evidence-hub.com/study/61917-analysis-of-the-center-of-pressure-variables-in-women-with-migraine2026-10-06 https://evidence-hub.com/study/61918-epidemiology-of-primary-headache-and-lifestyle-factors-among-children2026-10-06 https://evidence-hub.com/study/61919-neurological-abnormalities-in-individuals-with-marfan-syndrome2026-10-06 https://evidence-hub.com/study/61920-association-between-migraine-and-exclusive-breastfeeding-a-cross2026-10-06 https://evidence-hub.com/study/61921-baseline-symptoms-and-neurocognitive-performance-across-collision2026-10-06 https://evidence-hub.com/study/61922-impact-of-headache-frequency-and-preventive-treatment-failure-on2026-10-06 https://evidence-hub.com/study/61923-differential-resting-state-meg-microstate-patterns-in-migraineurs-a2026-10-06 https://evidence-hub.com/study/61924-coffee-consumption-and-migraine-a-population-based-study2026-10-06 https://evidence-hub.com/study/61925-clinical-characteristics-and-influencing-factors-of-vestibular2026-10-06 https://evidence-hub.com/study/61926-prediction-of-migraine-treatment-response-with-clinical-and-genetic2026-10-06 https://evidence-hub.com/study/61927-the-prevalence-of-headache-disorders-among-children-and-adolescents2026-10-06 https://evidence-hub.com/study/61928-clinical-features-of-chronic-primary-pain-in-individuals-presenting2026-10-06 https://evidence-hub.com/study/61929-hyperacusis-and-tinnitus-in-vestibular-migraine-patients2026-10-04 https://evidence-hub.com/study/61930-abnormal-functional-integration-and-effective-connectivity-in2026-10-06 https://evidence-hub.com/study/61931-deficient-inhibition-of-irrelevant-visual-information-in-migraine-a2026-10-06 https://evidence-hub.com/study/61932-cardiovascular-risk-scores-and-migraine-status2026-10-06 https://evidence-hub.com/study/61933-validation-of-the-spanish-version-of-the-headache-impact-test-hit-62026-10-06 https://evidence-hub.com/study/61934-sleep-quality-and-its-correlates-in-people-with-epilepsy-a2026-10-06 https://evidence-hub.com/study/61935-migraine-prevalence-environmental-risk-and-comorbidities-in-men-and2026-10-06 https://evidence-hub.com/study/61936-headache-knowledge-of-young-neurologists-in-germany2026-10-06 https://evidence-hub.com/study/61937-serum-levels-of-autotaxin-reveal-its-role-as-a-novel-biomarker-of2026-10-06 https://evidence-hub.com/study/61938-driving-after-concussion-symptom-clusters-and-neurocognition-uniquely2026-10-06 https://evidence-hub.com/study/61939-anxiety-and-depression-among-patients-with-migraine-a-single-center2026-10-06 https://evidence-hub.com/study/61940-shared-comorbidity-of-depression-migraine-insomnia-and-fibromyalgia2026-10-06 https://evidence-hub.com/study/61941-association-between-migraine-and-frailty-among-middle-aged-and-older2026-10-06 https://evidence-hub.com/study/61942-cervical-muscle-parameters-and-allodynia-in-migraine-and-cervical2026-10-06 https://evidence-hub.com/study/61943-factors-negatively-affecting-a-migraine-friendly-workplace-in2026-10-06 https://evidence-hub.com/study/61944-diagnostic-tests-and-headache-misdiagnoses-in-individuals-with2026-10-06 https://evidence-hub.com/study/61945-migraine-and-brain-structure-in-the-elderly-the-rotterdam-study2026-10-06 https://evidence-hub.com/study/61946-correlation-of-positive-signs-of-functional-neurological-disorder2026-10-06 https://evidence-hub.com/study/61947-the-burden-of-headache-disorders-in-the-adult-population-of-mongolia2026-10-06 https://evidence-hub.com/study/61948-abnormal-neurovascular-coupling-in-the-precuneus-associated-with2026-10-06 https://evidence-hub.com/study/61949-comparison-of-migraine-with-left-versus-right-sided-headache-a-cross2026-10-06 https://evidence-hub.com/study/61950-characterization-of-vestibular-perception-in-patients-with-persistent2026-10-06 https://evidence-hub.com/study/61951-comparative-analysis-of-gender-specific-patterns-of-traditional2026-10-06 https://evidence-hub.com/study/61952-phenotyping-of-somatosensory-tinnitus-and-its-associations-an2026-10-06 https://evidence-hub.com/study/61953-temporal-stability-and-neural-complexity-in-resting-state-meg-predict2026-10-06 https://evidence-hub.com/study/61954-clinical-features-of-migraine-with-aura-a-reform-study2026-10-06 https://evidence-hub.com/study/61955-imbalanced-temporal-states-of-cortical-blood-oxygen-level-dependent2026-10-06 https://evidence-hub.com/study/61956-association-between-serum-high-sensitivity-c-reactive-protein-levels2026-10-06 https://evidence-hub.com/study/61957-systemic-inflammation-and-oxidative-stress-markers-in-patients-with2026-10-06 https://evidence-hub.com/study/61958-impact-of-migraine-on-family-members-a-cross-sectional-study-in2026-10-06 https://evidence-hub.com/study/61959-migraine-chronification-as-an-allostatic-disorder-a-proof-of-concept2026-10-06 https://evidence-hub.com/study/61960-the-burden-of-headache-disorders-among-medical-students-in-vietnam2026-10-06 https://evidence-hub.com/study/61961-the-prevalence-of-headache-in-the-adult-population-of-morocco-a-cross2026-10-06 https://evidence-hub.com/study/61962-underrecognition-of-migraine-related-stigmatizing-attitudes-and2026-10-06 https://evidence-hub.com/study/61963-plasma-cgrp-levels-in-migraine-a-registry-for-migraine-study2026-10-04 https://evidence-hub.com/study/61964-visual-snow-syndrome-in-patients-with-migraine-widening-the-clinical2026-10-06 https://evidence-hub.com/study/61965-seventeen-year-national-pain-prevalence-trends-among-u-s-military2026-10-06 https://evidence-hub.com/study/61967-association-between-migraine-and-depression-anxiety-and-stress-in-the2026-10-06 https://evidence-hub.com/study/61968-association-between-dietary-index-for-gut-microbiota-and-self2026-10-06 https://evidence-hub.com/study/61969-burden-of-hidden-migraine-among-the-arab-general-population-a-cross2026-10-06 https://evidence-hub.com/study/61970-exploring-the-professional-and-personal-impact-of-migraine-a-cross2026-10-06 https://evidence-hub.com/study/61971-hypokalemia-in-chronic-migraine-with-medication-overuse-headache-a2026-10-08 https://evidence-hub.com/study/61972-burden-of-migraine-among-university-students-in-the-middle-east-and2026-10-06 https://evidence-hub.com/study/61973-cervical-musculoskeletal-dysfunctions-in-pediatric-migraine-a-cross2026-10-06 https://evidence-hub.com/study/61974-perceived-fear-and-exercise-difficulty-in-patients-with-migraine-and2026-10-06 https://evidence-hub.com/study/61975-association-between-magnesium-intake-and-migraine-among-pre-and2026-10-08 https://evidence-hub.com/study/61976-evaluation-of-brainstem-auditory-evoked-potentials-in-migraine2026-10-06 https://evidence-hub.com/study/61977-measuring-incremental-burdens-associated-with-increasing-preventive2026-10-08 https://evidence-hub.com/study/61978-migraine-and-physical-activity-prevalence-depression-and-anxiety-a2026-10-06 https://evidence-hub.com/study/61979-assessing-misophonia-as-a-potential-comorbidity-in-migraine-patients2026-10-06 https://evidence-hub.com/study/61980-association-between-screen-exposure-and-migraine-headache-among2026-10-06 https://evidence-hub.com/study/61981-investigation-of-sensory-and-neuropsychological-parameters-in2026-10-06 https://evidence-hub.com/study/61982-is-migraine-in-the-elderly-a-distinct-entity-a-comparative-cross2026-10-06 https://evidence-hub.com/study/61983-awareness-prevalence-causes-and-effects-of-migraine-among-medical2026-10-06 https://evidence-hub.com/study/61984-migraine-diagnosis-in-patients-with-sinus-headache-symptoms-a-cross2026-10-06 https://evidence-hub.com/study/61985-the-relationship-of-pain-disability-and-kinesiophobia-levels-with2026-10-06 https://evidence-hub.com/study/61986-impact-of-physical-exercise-on-reducing-the-frequency-and-severity-of2026-10-06 https://evidence-hub.com/study/61987-metabolic-abnormalities-in-the-insula-of-patients-with-interictal2026-10-06 https://evidence-hub.com/study/61988-migraine-attack-related-to-shift-work-in-emergency-residents-at2026-10-06 https://evidence-hub.com/study/61989-elevated-oxidative-stress-in-patients-with-coexisting-multiple2026-10-06 https://evidence-hub.com/study/61990-prevalence-of-migraine-among-medical-students-at-the-university-of2026-10-06 https://evidence-hub.com/study/61991-exploring-the-potential-role-of-glucose-metabolism-in-migraine-a2026-10-06 https://evidence-hub.com/study/61992-prevalence-pattern-and-associations-of-migraine-headaches-in-multiple2026-10-06 https://evidence-hub.com/study/61993-alexithymia-profile-across-migraine-subtypes-a-cross-sectional-study2026-10-06 https://evidence-hub.com/study/61994-prevalence-of-migraine-among-adults-with-mood-disorders-a-saudi-cross2026-10-06 https://evidence-hub.com/study/61995-exploring-the-link-between-prolactin-and-migraine-a-cross-sectional2026-10-06 https://evidence-hub.com/study/61996-association-of-hypertension-with-migraine-and-tension-type-headaches2026-10-06 https://evidence-hub.com/study/61997-impact-of-migraine-on-quality-of-life-and-well-being-among-king2026-10-06 https://evidence-hub.com/study/61998-oc-12-the-potential-role-of-sleep-quality-in-the-relationship-between2026-10-06 https://evidence-hub.com/study/61999-cranial-autonomic-symptoms-as-a-protective-mechanism-in-patients-with2026-10-06 https://evidence-hub.com/study/62000-association-between-serum-carotenoids-levels-and-severe-headache-or2026-10-06 https://evidence-hub.com/study/62002-association-between-multiple-sclerosis-lesion-location-migraine-and2026-10-06 https://evidence-hub.com/study/62005-gender-differences-in-the-association-between-weight-adjusted-waist2026-10-06 https://evidence-hub.com/study/62006-mindfulness-as-a-predictor-of-migraine-related-disability-evidence2026-10-06 https://evidence-hub.com/study/62007-migraine-headache-and-its-related-disability-factors-among-university2026-10-06 https://evidence-hub.com/study/62008-optic-nerve-head-parameters-and-retinal-nerve-fibre-layer-thickness2026-10-06 https://evidence-hub.com/study/62009-exploring-spiritual-well-being-and-quality-of-life-in-migraine-a2026-10-06 https://evidence-hub.com/study/62010-pharmacists-knowledge-attitudes-and-practices-toward-cgrp-inhibitors2026-10-08 https://evidence-hub.com/study/62011-po-68-bipolar-disorder-spectrum-and-psychopathology-in-cluster2026-10-06 https://evidence-hub.com/study/62012-factors-affecting-fear-of-attacks-in-patients-with-episodic-migraine2026-10-06 https://evidence-hub.com/study/62013-assessment-of-cognitive-functions-and-event-related-potentials-in2026-10-06 https://evidence-hub.com/study/62014-patient-satisfaction-with-aesthetic-outcomes-following2026-10-08 https://evidence-hub.com/study/62015-comparison-of-auditory-brainstem-evoked-responses-between-migraine2026-10-06 https://evidence-hub.com/study/62016-po-22-impact-of-sleep-disorders-on-anti-cgrp-monoclonal-antibodies2026-10-06 https://evidence-hub.com/study/62017-analytical-cross-sectional-study-on-lifestyle-factors-associated-with2026-10-06 https://evidence-hub.com/study/62019-efficacy-of-serum-magnesium-levels-in-migraine-attack-frequency-and2026-10-08 https://evidence-hub.com/study/62023-interictal-widespread-pressure-hyperalgesia-and-aura-associations2026-10-06 https://evidence-hub.com/study/62024-the-multifaceted-effects-of-migraine-on-syrian-society-insights-from2026-10-06 https://evidence-hub.com/study/62025-migraine-symptoms-and-association-of-triggers-coping-strategies-and2026-10-06 https://evidence-hub.com/study/62026-knowledge-and-perceptions-of-migraine-management-and-trigger-factors2026-10-06 https://evidence-hub.com/study/62027-association-between-dietary-folate-intake-and-severe-headache-or2026-10-06 https://evidence-hub.com/study/62028-gender-based-difference-in-quality-of-life-of-migraine-sufferers-a2026-10-06 https://evidence-hub.com/study/62030-association-between-serum-folate-levels-and-migraine-or-severe2026-10-06 https://evidence-hub.com/study/62031-exercise-in-early-pregnancy-among-women-with-migraine-a-hospital2026-10-06 https://evidence-hub.com/study/62032-medical-comorbidities-and-other-factors-associated-with-migraine2026-10-06 https://evidence-hub.com/study/62033-prevalence-characteristics-and-risk-factors-of-migraine-headache2026-10-06 https://evidence-hub.com/study/62034-the-association-between-plasma-trans-fatty-acids-level-and-migraine-a2026-10-06 https://evidence-hub.com/study/62035-the-prevalence-and-impact-of-migraine-among-physicians-in-saudi2026-10-06 https://evidence-hub.com/study/62036-telomere-length-exhibits-inverse-association-with-migraine-among2026-10-06 https://evidence-hub.com/study/62037-frequency-of-migraine-related-depression-among-migraineurs-in2026-10-06 https://evidence-hub.com/study/62038-pulsed-radiofrequency-treatment-evidence-for-and-applications-in2026-10-06 https://evidence-hub.com/study/62039-prosopagnosia-face-blindness-and-its-association-with-neurological2026-10-06 https://evidence-hub.com/study/62040-the-midfacial-segment-pain-little-known-disorder-in-need-of2026-10-06 https://evidence-hub.com/study/62041-mirtazapine-for-gastrointestinal-and-neuropsychological-symptoms-in2026-10-06 https://evidence-hub.com/study/62042-the-near-point-of-convergence-in-patients-with-vestibular-migraine2026-10-06 https://evidence-hub.com/study/62043-headache-characteristics-of-pediatric-sport-related-concussion2026-10-06 https://evidence-hub.com/study/62044-neuro-ophthalmic-presentations-of-polycythemia2026-10-06 https://evidence-hub.com/study/62045-efficacy-and-safety-of-switching-between-anti-cgrp-monoclonal2026-10-06 https://evidence-hub.com/study/62046-preoperative-visualization-of-the-greater-occipital-nerve-with2026-10-06 https://evidence-hub.com/study/62047-nerve-decompression-in-occipital-neuralgia-a-systematic-review-and2026-10-06 https://evidence-hub.com/study/62048-the-intersection-of-migraine-and-epistaxis-clinical-observations-and2026-10-06 https://evidence-hub.com/study/62049-severe-chronic-traumatic-encephalopathy-in-a-us-naval-special-warfare2026-10-06 https://evidence-hub.com/study/62050-tolosa-hunt-syndrome-in-children-and-adolescents-a-systematic-review2026-10-06 https://evidence-hub.com/study/62051-rescue-strategies-for-valproic-acid-overdose-poisoning-case-series2026-10-06 https://evidence-hub.com/study/62052-genetic-perspectives-on-transient-global-amnesia-a-narrative-review2026-10-06 https://evidence-hub.com/study/62053-case-series-vestibular-migraines-in-fragile-x-premutation-carriers2026-10-06 https://evidence-hub.com/study/62054-clinical-presentation-diagnostic-delays-and-treatment-outcomes-in2026-10-06 https://evidence-hub.com/study/62055-retinal-artery-occlusion-in-young-patients-without-typical2026-10-06 https://evidence-hub.com/study/62056-post-cochlear-implantation-vertigo-ictal-nystagmus-and2026-10-06 https://evidence-hub.com/study/62057-clinical-course-of-pregnancy-associated-spontaneous-coronary-artery2026-10-06 https://evidence-hub.com/study/62058-exploring-the-spectrum-of-headaches-in-neurocysticercosis-a2026-10-06 https://evidence-hub.com/study/62059-is-imaging-necessary-in-pediatric-patients-with-isolated-tinnitus2026-10-06 https://evidence-hub.com/study/62060-refractory-primary-and-secondary-headache-disorders-that-dramatically2026-10-06 https://evidence-hub.com/study/62061-at-home-tips-for-headache-management-the-use-of-self-trendelenburg-to2026-10-06 https://evidence-hub.com/study/62062-reliable-change-indices-for-the-serial-administration-of-the2026-10-06 https://evidence-hub.com/study/62063-improvement-of-chronic-tinnitus-following-personalized-parcel-guided2026-10-06 https://evidence-hub.com/study/62064-poor-effectiveness-of-occipital-nerve-stimulation-in-treating2026-10-06 https://evidence-hub.com/study/62065-safety-assessment-of-influenza-vaccination-for-neurological-outcomes2026-10-06 https://evidence-hub.com/study/62066-it-s-not-cyclic-vomiting-syndrome-until-dietl-s-is-ruled-out-a-case2026-10-06 https://evidence-hub.com/study/62067-beyond-coincidence-a-case-series-on-the-clinical-course-of-coinciding2026-10-06 https://evidence-hub.com/study/62068-desiderosmia-associated-iron-deficiency-a-case-report-and-review-of2026-10-06 https://evidence-hub.com/study/62069-greater-occipital-nerve-block-as-an-opioid-sparing-alternative-in2026-10-06 https://evidence-hub.com/study/62070-side-locked-headache-associated-with-habitual-neck-shoulder-mobile2026-10-06 https://evidence-hub.com/study/62071-migraine-impairs-the-auditory-protective-mechanism-a-potential2026-10-06 https://evidence-hub.com/study/62072-diagnostic-challenges-of-lrp4-antibody-testing-in-myasthenia-gravis-a2026-10-06 https://evidence-hub.com/study/62073-natural-neurostimulation-for-chronic-pain-management-a-case-series-of2026-10-06 https://evidence-hub.com/study/62074-ncmp-37-clinical-patterns-and-long-term-outcomes-in-stroke-like2026-10-06 https://evidence-hub.com/study/62080-onabotulinum-toxin-a-for-post-traumatic-headache-a-systematic-review2026-10-06 https://evidence-hub.com/study/62081-clinical-features-of-acute-coronary-syndrome-associated-with2026-10-06 https://evidence-hub.com/study/62082-migraine-surgery-in-india-early-experience-and-outcomes-from-a2026-10-06 https://evidence-hub.com/study/62083-headache-in-pregnancy-a-case-series-of-secondary-and-benign-causes2026-10-06 https://evidence-hub.com/study/62084-atypical-presentations-of-idiopathic-intracranial-hypertension-in2026-10-06 https://evidence-hub.com/study/62085-epicranial-headache-a-clinical-case-series-of-nummular-headache2026-10-06 https://evidence-hub.com/study/62086-iatrogenic-botulism-after-botulinum-meurotoxin-exposure-a2026-10-06 https://evidence-hub.com/study/62087-po-35-treatment-of-chronic-and-episodic-migraine-with-atogepant2026-10-08 https://evidence-hub.com/study/62088-histopathology-of-superior-turbinate-mucosal-contact-in-migraine2026-10-06 https://evidence-hub.com/study/62089-treatment-of-thoracic-outlet-syndrome-to-relieve-chronic-migraine2026-10-06 https://evidence-hub.com/study/62090-tolerability-of-calcitonin-gene-related-peptide-monoclonal-antibodies2026-10-06 https://evidence-hub.com/study/62091-multisensory-hallucinations-and-other-unusual-sensory-experiences-in2026-10-06 https://evidence-hub.com/study/62092-vestibular-laboratory-presentation-of-patients-with-definite2026-10-06 https://evidence-hub.com/study/62093-fasting-as-a-trigger-of-migraine-epidemiology-pathophysiological2026-10-06 https://evidence-hub.com/study/62095-expanding-the-phenotypic-spectrum-of-cacna1a-related-developmental2026-10-06 https://evidence-hub.com/study/62096-stroke-thrombolysis-in-tuberculous-meningitis2026-10-06 https://evidence-hub.com/study/62097-insulinoma-initially-misdiagnosed-as-migraine2026-10-06 https://evidence-hub.com/study/62098-amitriptyline-induced-hyperprolactinemia-in-a-pediatric-patient2026-10-06 https://evidence-hub.com/study/62099-acute-hypophysitis-with-pachymeningitis2026-10-06 https://evidence-hub.com/study/62100-amiodarone-induced-aseptic-meningitis2026-10-06 https://evidence-hub.com/study/62101-a-novel-homozygous-loss-of-function-notch3-variant-in-a-moroccan2026-10-06 https://evidence-hub.com/study/62102-metamorphopsia-with-smart-syndrome-a-case-report2026-10-06 https://evidence-hub.com/study/62103-a-rare-cause-of-headache-in-the-emergency-department-a-case-report2026-10-06 https://evidence-hub.com/study/62104-first-report-of-symmetrical-drug-related-intertriginous-and-flexural2026-10-08 https://evidence-hub.com/study/62105-hyperbaric-oxygen-therapy-for-thalamic-pain-syndrome-case-report2026-10-06 https://evidence-hub.com/study/62106-systemic-allergic-reaction-to-galcanezumab-emgality-a-case-report2026-10-06 https://evidence-hub.com/study/62107-first-successful-protocol-for-desensitization-to-eptinezumab2026-10-06 https://evidence-hub.com/study/62108-stroke-like-migraine-attacks-after-radiation-therapy-smart-syndrome-a2026-10-06 https://evidence-hub.com/study/62109-transient-central-facial-palsy-at-high-altitude-a-case-report2026-10-06 https://evidence-hub.com/study/62110-case-report-late-onset-type-3-hemiplegic-migraine-with-permanent2026-10-06 https://evidence-hub.com/study/62111-battlefield-acupuncture-for-the-treatment-of-chronic-migraines2026-10-06 https://evidence-hub.com/study/62112-cerebral-venous-sinus-thrombosis-following-varicella-infection-a-case2026-10-06 https://evidence-hub.com/study/62114-temporal-aneurysms-and-migraine-surgery2026-10-06 https://evidence-hub.com/study/62115-resolution-of-chronic-migraine-headaches-and-improvement-in-cervical2026-10-06 https://evidence-hub.com/study/62116-effects-of-electroacupuncture-on-treatment-resistant-chronic-migraine2026-10-06 https://evidence-hub.com/study/62117-therapeutic-observation-of-transcutaneous-auricular-vagus-nerve2026-10-06 https://evidence-hub.com/study/62118-bilateral-subdural-hygromas-following-dural-puncture2026-10-06 https://evidence-hub.com/study/62119-pediatric-parasagittal-meningioma-case-report2026-10-06 https://evidence-hub.com/study/62120-fatal-coronary-vasospasm-following-oral-triptan-intake2026-10-06 https://evidence-hub.com/study/62121-a-two-step-approach-using-the-national-health-institutes-of-health2026-10-06 https://evidence-hub.com/study/62122-retinal-migraine-a-case-report-with-brief-literature-review-and2026-10-06 https://evidence-hub.com/study/62123-a-rare-variation-of-the-infraorbital-nerve-entrapping-the2026-10-06 https://evidence-hub.com/study/62124-improvement-in-upper-limb-and-systemic-myalgic-encephalomyelitis2026-10-06 https://evidence-hub.com/study/62125-paracentral-acute-middle-maculopathy-associated-with-migraine-with2026-10-06 https://evidence-hub.com/study/62126-two-cases-of-ischemic-complications-in-abdominoplasty-after-use-of-a2026-10-06 https://evidence-hub.com/study/62127-complexities-in-managing-psychosis-in-a-patient-with-stiff-person2026-10-06 https://evidence-hub.com/study/62128-migraine-to-mesenteric-mishap-a-case-report-of-ischemic-colitis-due2026-10-06 https://evidence-hub.com/study/62129-contrast-induced-neurotoxicity-following-diagnostic-catheter-cerebral2026-10-06 https://evidence-hub.com/study/62130-botulinum-treatment-induced-dropped-head-syndrome-in-a-patient-with2026-10-06 https://evidence-hub.com/study/62131-unmasking-hemiplegic-migraine-a-diagnostic-dilemma-in-the-shadow-of2026-10-06 https://evidence-hub.com/study/62132-misophonia-an-underrecognized-disease-in-pediatric-patients2026-10-06 https://evidence-hub.com/study/62133-arterial-spin-labelling-perfusion-changes-in-persistent-migrainous2026-10-06 https://evidence-hub.com/study/62134-unusual-presentation-of-non-gestational-extragonadal-choriocarcinoma2026-10-06 https://evidence-hub.com/study/62135-acute-meningoencephalomyelitis-in-an-exacerbation-of-primary-sjogren2026-10-06 https://evidence-hub.com/study/62136-recurrent-severe-coital-headaches-associated-with-bilateral-carotid2026-10-06 https://evidence-hub.com/study/62137-painful-tender-localized-idiopathic-livedo-reticularis2026-10-06 https://evidence-hub.com/study/62138-dysphagia-and-muscle-weakness-caused-by-botulinum-toxin-poisoning2026-10-06 https://evidence-hub.com/study/62139-cacna1a-variant-associated-with-generalized-dystonia2026-10-06 https://evidence-hub.com/study/62140-symptomatic-idiopathic-intracranial-hypertension-triggered-by-ramadan2026-10-06 https://evidence-hub.com/study/62141-ictal-headache-a-case-report2026-10-06 https://evidence-hub.com/study/62142-case-report-inflammatory-cadasil-phenotype-associated-with-a-rare2026-10-06 https://evidence-hub.com/study/62143-myocardial-infarction-with-nonobstructive-coronary-arteries-a2026-10-06 https://evidence-hub.com/study/62144-recurrent-cutaneous-decompression-sickness-in-a-hyperbaric-chamber2026-10-06 https://evidence-hub.com/study/62145-a-case-of-alice-in-wonderland-syndrome-after-epstein-barr-virus-ebv2026-10-06 https://evidence-hub.com/study/62146-spreading-depolarisation-sd-a-potential-underlying-mechanism-in2026-10-06 https://evidence-hub.com/study/62147-generation-of-ipsc-line-fmcpghi003-a-from-human-pbmcs-of-a-patient2026-10-06 https://evidence-hub.com/study/62148-red-colour-of-a-painful-ear-red-ear-syndrome-in-paediatric-age2026-10-06 https://evidence-hub.com/study/62149-sleep-related-painful-erections-treated-with-sodium-oxybate2026-10-04 https://evidence-hub.com/study/62150-dramatic-effect-of-botox-injection-in-disabling-chronic-migraine2026-10-06 https://evidence-hub.com/study/62151-evaluating-the-impact-of-hyperbaric-oxygen-therapy-and-neurofeedback2026-10-06 https://evidence-hub.com/study/62152-focal-cerebral-arteriopathy-in-a-young-adult2026-10-06 https://evidence-hub.com/study/62153-severe-bilateral-glossopharyngeal-neuralgia-managed-with-nerve-blocks2026-10-06 https://evidence-hub.com/study/62154-pearls-oy-sters-attacks-of-hemiplegic-migraine-and-encephalopathy-in2026-10-06 https://evidence-hub.com/study/62155-a-case-of-alice-in-wonderland-syndrome-associated-with-topiramate-in2026-10-06 https://evidence-hub.com/study/62156-peculiar-cadasil-phenotype-in-monozygotic-twins-carrying-a-novel2026-10-06 https://evidence-hub.com/study/62157-migraine-symptoms-induced-by-an-auricular-piercing-in-a-27-year-old2026-10-06 https://evidence-hub.com/study/62158-neuronal-intranuclear-inclusion-disease-with-recurrent-encephalitis2026-10-06 https://evidence-hub.com/study/62159-a-rare-case-of-idiopathic-reversible-cerebral-vasoconstriction2026-10-06 https://evidence-hub.com/study/62160-abdominal-migraine-with-acute-watery-diarrhea-and-dehydration2026-10-06 https://evidence-hub.com/study/62161-nausea-and-vomiting-as-initial-manifestations-of-pediatric-nmosd2026-10-13 https://evidence-hub.com/study/62162-temporal-changes-in-cerebral-blood-flow-during-migraine-with-aura-of2026-10-06 https://evidence-hub.com/study/62163-headache-and-neurological-deficits-with-cerebrospinal-fluid2026-10-06 https://evidence-hub.com/study/62164-confirmation-bias-in-medical-referrals-an-unusual-presentation-of2026-10-06 https://evidence-hub.com/study/62165-a-case-report-of-hemiplegic-migraine-with-mutation-in-the-atp1a2-gene2026-10-06 https://evidence-hub.com/study/62166-retinal-capillary-ischemia-following-migraine-a-case-report2026-10-06 https://evidence-hub.com/study/62167-cerebral-autosomal-dominant-arteriopathy-with-subcortical-infarcts2026-10-06 https://evidence-hub.com/study/62168-three-fluoroscopy-guided-epidural-blood-patches-for-the-management-of2026-10-06 https://evidence-hub.com/study/62169-bilateral-sphenopalatine-ganglion-block-in-the-management-of-headache2026-10-06 https://evidence-hub.com/study/62170-rare-pyloric-stenosis-in-mitochondrial-disease-treated-with-hand2026-10-06 https://evidence-hub.com/study/62171-reversible-cerebral-vasoconstriction-syndrome-associated-with2026-10-06 https://evidence-hub.com/study/62172-intracerebral-haemorrhage-associated-with-collagen-type-iv-alpha-22026-10-06 https://evidence-hub.com/study/62174-extended-regular-use-of-kinetic-oscillation-stimulation-kos-in2026-10-06 https://evidence-hub.com/study/62175-visual-snow-syndrome-in-patient-with-migraine-case-report-and2026-10-06 https://evidence-hub.com/study/62176-successful-treatment-of-chronic-migraine-unresponsive-to-triptans2026-10-06 https://evidence-hub.com/study/62177-percutaneous-patent-foramen-ovale-closure-in-refractory-migraine-with2026-10-06 https://evidence-hub.com/study/62178-ayurvedic-management-of-ardhavbhedaka-migraine-a-case-report2026-10-06 https://evidence-hub.com/study/62179-thrombotic-thrombocytopenic-purpura-presenting-as-a-complex-migraine2026-10-06 https://evidence-hub.com/study/62180-acephalgic-migraine-presenting-as-episodic-fatigue-and-nausea-a-case2026-10-06 https://evidence-hub.com/study/62181-role-of-homoeopathy-in-treating-migraine-in-children-after2026-10-06 https://evidence-hub.com/study/62182-management-of-ardhavabhedaka-migraine-with-folklore-and-ayurveda2026-10-06 https://evidence-hub.com/study/62183-effective-management-of-migraine-through-ayurvedic-techniques-a-case2026-10-06 https://evidence-hub.com/study/62184-intravascular-large-b-cell-lymphoma-presenting-as-migraine-with-aura2026-10-06 https://evidence-hub.com/study/62185-corpalgia-associated-with-migraine-a-case-report2026-10-06 https://evidence-hub.com/study/62186-complex-neurological-interplay-adult-onset-migraine-triggered2026-10-06 https://evidence-hub.com/study/62188-spontaneous-posterior-vitreous-detachment-and-chronification-of2026-10-06 https://evidence-hub.com/study/62189-chilblains-after-galcanezumab-for-chronic-migraine-prevention-a-case2026-10-08 https://evidence-hub.com/study/62190-familial-hemiplegic-migraine-fhm-with-transient-psychotic-symptoms-a2026-10-06 https://evidence-hub.com/study/62191-stroke-like-migraine-attacks-after-radiation-therapy-smart-syndrome-a2026-10-06 https://evidence-hub.com/study/62192-efficacy-of-anti-calcitonin-gene-related-peptide-monoclonal2026-10-08 https://evidence-hub.com/study/62193-cytotoxic-lesion-of-the-corpus-callosum-related-to-migraine-with-aura2026-10-06 https://evidence-hub.com/study/62194-effect-of-a-classical-ayurvedic-regimen-on-migraine-ardhavabhedaka-a2026-10-06 https://evidence-hub.com/study/62195-treatment-of-abdominal-migraine-in-an-8-year-old-child-with2026-10-06 https://evidence-hub.com/study/62196-case-report-investigating-the-feasibility-of-virtual-reality2026-10-06 https://evidence-hub.com/study/62197-intrathecal-administration-of-ziconotide-as-a-resolution-of-resistant2026-10-06 https://evidence-hub.com/study/62198-an-adolescent-with-undiagnosed-inattentive-type-attention-deficit2026-10-06 https://evidence-hub.com/study/62199-cluster-headache-with-perimenstrual-trigger-mimicking-chronic2026-10-06 https://evidence-hub.com/study/62200-po-25-antiepileptic-medication-in-prrt2-familial-hemiplegic-migraine2026-10-06 https://evidence-hub.com/study/62201-pediatric-abdominal-migraine-as-a-recurrent-emergency-department2026-10-06 https://evidence-hub.com/study/62202-unraveling-the-threads-a-case-report-on-confusional-migraine-and-the2026-10-06 https://evidence-hub.com/study/62203-familial-hemiplegic-migraine-type-2-with-cerebral-vasospasm-and-acute2026-10-06 https://evidence-hub.com/study/62204-vertebral-artery-dissection-in-a-patient-with-migraine-treated-with2026-10-06 https://evidence-hub.com/study/62205-chilblains-with-cgrp-monoclonal-antibody-treatment-of-chronic2026-10-06 https://evidence-hub.com/study/62206-a-potentially-lethal-interaction-migraine-human-immunodeficiency2026-10-06 https://evidence-hub.com/study/62207-hyperacusis-in-vestibular-migraine-successfully-treated-with2026-10-06 https://evidence-hub.com/study/62208-the-potential-link-between-abdominal-migraine-and-chronic-apical2026-10-06 https://evidence-hub.com/study/62209-hemiplegic-migraine-with-prolonged-aura-case-report2026-10-06 https://evidence-hub.com/study/62210-hyperandrogenism-insulin-resistance-acanthosis-nigricans-syndrome-in2026-10-06 https://evidence-hub.com/study/62211-post-traumatic-trigeminal-injury-leading-to-novel-onset-orofacial2026-10-06 https://evidence-hub.com/study/62212-complete-resolution-of-new-daily-persistent-headache-with-migraine2026-10-06 https://evidence-hub.com/study/62213-acute-hypersensitivity-reaction-with-maculopapular-exanthem-and-angio2026-10-06 https://evidence-hub.com/study/62214-chiropractic-management-of-a-migraine-with-aura-in-a-28-year-old2026-10-06 https://evidence-hub.com/study/62215-two-rare-coexisting-diseases-and-an-uncommon-presentation-migraine2026-10-06 https://evidence-hub.com/study/62216-cervical-osteomyelitis-with-epidural-abscess-overlooked-in-a-patient2026-10-06 https://evidence-hub.com/study/62217-ayurvedic-management-of-migraine-ardhavabhedaka-with-scintillating2026-10-06 https://evidence-hub.com/study/62218-adult-onset-acute-disseminated-encephalomyelitis-mimicking-complex2026-10-06 https://evidence-hub.com/study/62219-integrative-yoga-and-naturopathy-management-in-a-middle-aged-woman2026-10-06 https://evidence-hub.com/study/62220-triggered-migraine-attack-by-flickering-fluorescent-lights-in-an2026-10-06 https://evidence-hub.com/study/62223-intermittent-ureteropelvic-junction-obstruction-can-mimic-abdominal2026-10-06 https://evidence-hub.com/study/62224-unexpected-migraine-improvement-following-surgical-ligation-of-the2026-10-06 https://evidence-hub.com/study/62225-case-report-migraine2026-10-06 https://evidence-hub.com/study/62236-cerebral-artery-vasoconstriction-after-galcanezumab-loading-dose-for2026-10-08 https://evidence-hub.com/study/62237-familial-hemiplegic-migraine-type-2-a-case-report-of-an-adolescent2026-10-06 https://evidence-hub.com/study/62238-treatment-of-migraine-with-aura-with-osteopathic-manipulative2026-10-06 https://evidence-hub.com/study/62239-a-twice-closed-patent-foramen-ovale-a-case-report-of-percutaneous2026-10-06 https://evidence-hub.com/study/62240-a-small-frontal-lobe-cavernoma-presenting-with-headache-mimicking2026-10-06 https://evidence-hub.com/study/62241-resolution-of-migraine-with-aura-post-pfo-closure-in-a-young-female-a2026-10-06 https://evidence-hub.com/study/62242-superficial-temporal-artery-aneurysm-misdiagnosed-in-a-patient-with2026-10-06 https://evidence-hub.com/study/62243-case-report-tadpole-pupil-and-concurrent-migraine-in-an-adolescent2026-10-06 https://evidence-hub.com/study/62245-eyebrow-bleeding-as-a-rare-migraine-symptom-a-case-report2026-10-06 https://evidence-hub.com/study/62246-effect-of-hijama-bi-l-shart-wet-cupping-along-with-unani-formulation2026-10-06 https://evidence-hub.com/study/62247-early-onset-stroke-like-migraine-attacks-after-radiation-therapy2026-10-06 https://evidence-hub.com/study/62248-brain-imaging-modalities-for-cavernous-sinus-pathology-with-migraine2026-10-06 https://evidence-hub.com/study/62249-paracentral-acute-middle-maculopathy-and-cotton-wool-spots-in-a2026-10-06 https://evidence-hub.com/study/62250-rimegepant-as-an-acute-treatment-in-a-refractory-migraine-patient-non2026-10-06 https://evidence-hub.com/study/62251-an-immediate-pain-relief-with-agnikarma-therapy-for-acute-episode-of2026-10-06 https://evidence-hub.com/study/62252-a-clinical-case-report-of-migraine-aura-without-headache2026-10-06 https://evidence-hub.com/study/62253-migraine-with-aura-and-paradoxical-embolism-case-report2026-10-06 https://evidence-hub.com/study/62254-could-cgrp-mabs-for-migraine-trigger-rheumatoid-arthritis-insights2026-10-08 https://evidence-hub.com/study/62255-monoclonal-antibody-therapy-for-refractory-chronic-migraine-like2026-10-06 https://evidence-hub.com/study/62256-a-novel-mutation-in-the-atp1a2-gene-associated-with-a-sporadic2026-10-06 https://evidence-hub.com/study/62257-chronic-pelvic-inflammatory-context-leading-to-migraine-exacerbation2026-10-06 https://evidence-hub.com/study/62258-migraine-with-aura-accompanied-by-myoclonus-a-case-report2026-10-06 https://evidence-hub.com/study/62259-successful-treatment-with-traditional-japanese-medicine-kampo2026-10-06 https://evidence-hub.com/study/62265-audited-large-language-model-triage-for-systematic-review-screening2026-10-06 https://evidence-hub.com/study/62266-2026-taiwan-guidelines-for-the-acute-pharmacologic-treatment-of2026-10-06 https://evidence-hub.com/study/62267-cost-trends-of-new-to-market-neurologic-medications2026-10-06 https://evidence-hub.com/study/62269-abstract-number-esoc2026a1166-persistence-with-botulinum-toxin-a-and2026-10-06 https://evidence-hub.com/study/62270-advances-in-primary-headache-disorder-management-a-review-of2026-10-06 https://evidence-hub.com/study/62272-pharmacogenetic-considerations-in-beta-blocker-therapy2026-10-06 https://evidence-hub.com/study/62273-cervicogenic-headache-how-to-recognize-and-treat2026-10-06 https://evidence-hub.com/study/62275-an-update-on-pharmacotherapy-for-trigeminal-neuralgia2026-10-06 https://evidence-hub.com/study/62276-cgrp-monoclonal-antibodies-and-cgrp-receptor-antagonists-gepants-in2026-10-08 https://evidence-hub.com/study/62277-acute-migraine-headache-treatment-strategies2026-10-06 https://evidence-hub.com/study/62278-the-evidence-for-diet-as-a-treatment-in-migraine-a-review2026-10-06 https://evidence-hub.com/study/62279-candesartan-for-treatment-of-migraine-headache-a-scoping-review2026-10-06 https://evidence-hub.com/study/62280-dizziness-when-is-it-migraine-and-when-is-it-not2026-10-06 https://evidence-hub.com/study/62281-interventional-treatments2026-10-06 https://evidence-hub.com/study/62282-posttraumatic-headache2026-10-06 https://evidence-hub.com/study/62283-spreading-depolarization-as-a-therapeutic-target-in-migraine2026-10-04 https://evidence-hub.com/study/62284-migraine-treatment-consensus-document-of-the-spanish-society-of2026-10-06 https://evidence-hub.com/study/62285-comparative-efficacy-quality-of-life-safety-and-tolerability-of2026-10-08 https://evidence-hub.com/study/62286-menstrually-associated-migraine2026-10-06 https://evidence-hub.com/study/62287-medication-underuse-headache2026-10-06 https://evidence-hub.com/study/62288-persistent-postural-perceptual-dizziness-versus-vestibular-migraine-a2026-10-06 https://evidence-hub.com/study/62289-migraine-headaches-what-is-new-in-treatment2026-10-06 https://evidence-hub.com/study/62290-vestibular-migraine-revisited-a-narrative-review-of-diagnostic2026-10-06 https://evidence-hub.com/study/62291-neural-plasticity-in-migraine-chronification2026-10-06 https://evidence-hub.com/study/62292-physical-treatment-of-migraine2026-10-06 https://evidence-hub.com/study/62293-neuron-glia-crosstalk-and-inflammatory-mediators-in-migraine2026-10-08 https://evidence-hub.com/study/62294-biobehavioral-treatments-of-migraine2026-10-06 https://evidence-hub.com/study/62295-the-role-of-caffeine-in-headache-disorders2026-10-06 https://evidence-hub.com/study/62296-interplay-between-vestibular-dysfunction-and-sleep-disorders2026-10-06 https://evidence-hub.com/study/62297-update-of-french-migraine-epidemiology-a-narrative-review2026-10-04 https://evidence-hub.com/study/62298-comorbidities-of-migraine-sleep-disorders2026-10-06 https://evidence-hub.com/study/62299-headache-in-multiple-sclerosis-a-narrative-review2026-10-06 https://evidence-hub.com/study/62300-centrally-mediated-disorders-of-gastrointestinal-pain2026-10-06 https://evidence-hub.com/study/62301-treatment-in-the-emergency-department2026-10-06 https://evidence-hub.com/study/62302-vestibular-neurology-for-the-generalist2026-10-06 https://evidence-hub.com/study/62303-non-neuronal-targets-for-migraine-therapy2026-10-04 https://evidence-hub.com/study/62304-digitalization-in-migraine-therapy2026-10-06 https://evidence-hub.com/study/62305-sexual-dysfunction-is-underrecognized-in-patients-with-migraine-a2026-10-06 https://evidence-hub.com/study/62306-a-narrative-review-of-autophagy-in-migraine2026-10-04 https://evidence-hub.com/study/62308-migraine-in-pregnancy-a-narrative-review2026-10-04 https://evidence-hub.com/study/62309-autism-and-migraine-a-narrative-review2026-10-04 https://evidence-hub.com/study/62310-perimenopausal-migraine-a-narrative-review2026-10-04 https://evidence-hub.com/study/62312-interictal-burden-of-migraine-a-narrative-review2026-10-04 https://evidence-hub.com/study/62314-quality-of-life-in-women-with-migraine-a-systematic-review2026-10-04 https://evidence-hub.com/study/62315-migraine-and-dementia-a-narrative-review-of-current-evidence2026-10-04 https://evidence-hub.com/study/62316-art-as-a-diagnostic-tool-for-migraine-a-narrative-review2026-10-04 https://evidence-hub.com/study/62317-prevalence-of-migraine-headache-in-pakistan-a-systematic-review2026-10-04 https://evidence-hub.com/study/62318-psychiatric-rehabilitation-in-prophylaxis-of-migraine-a-systematic2026-10-04 https://evidence-hub.com/study/62319-exploring-social-cognition-in-migraine-a-narrative-review2026-10-04 https://evidence-hub.com/study/62320-practical-supplements-for-prevention-and-management-of-migraine2026-10-08 https://evidence-hub.com/study/62321-orofacial-migraine-a-narrative-review2026-10-04 https://evidence-hub.com/study/62322-medicinal-plants-in-migraine-management-a-narrative-review2026-10-04 https://evidence-hub.com/study/62323-unraveling-the-connections-between-migraine-and-psychiatric2026-10-04 https://evidence-hub.com/study/62324-osmophobia-in-patients-with-migraine-a-systematic-review-and-meta2026-10-04 https://evidence-hub.com/study/62325-migraine-and-atrial-fibrillation-a-systematic-review-and-meta-analysis2026-10-04 https://evidence-hub.com/study/62326-association-between-personality-disorders-and-migraine-a-narrative2026-10-04 https://evidence-hub.com/study/62329-non-pharmacological-approaches-for-migraine-management-a-mini-review2026-10-04 https://evidence-hub.com/study/62330-the-role-of-the-autonomic-nervous-system-in-epilepsy-and-migraine-a2026-10-04 https://evidence-hub.com/study/62331-association-between-migraine-and-mood-disorders-a-systematic-review2026-10-04 https://evidence-hub.com/study/62332-migraine-in-pregnancy-a-mini-review2026-10-04 https://evidence-hub.com/study/62333-effectiveness-of-yoga-as-an-adjunctive-therapy-in-migraine-a2026-10-04 https://evidence-hub.com/study/62334-rimegepant-for-the-acute-and-preventive-treatment-of-migraine-a2026-10-04 https://evidence-hub.com/study/62335-migraine-across-the-menopausal-transition-and-beyond-a-narrative2026-10-04 https://evidence-hub.com/study/62336-zinc-as-an-emerging-therapy-in-the-management-of-migraine-a2026-10-04 https://evidence-hub.com/study/62337-cgrp-as-a-biochemical-biomarker-in-migraine-diagnosis-a-systematic2026-10-04 https://evidence-hub.com/study/62338-cellular-senescence-in-migraine-a-hypothesis-driven-narrative-review2026-10-04 https://evidence-hub.com/study/62339-microneedles-for-the-treatment-of-migraine-and-orofacial-pain-a2026-10-04 https://evidence-hub.com/study/62340-a-systematic-review-of-the-therapeutic-effect-of-acupuncture-on2026-10-04 https://evidence-hub.com/study/62341-migraine-and-brain-tumors-a-bibliometric-analysis-and-narrative-review2026-10-04 https://evidence-hub.com/study/62342-what-is-the-link-between-migraine-and-hypothyroidism-a-systematic2026-10-04 https://evidence-hub.com/study/62343-the-interplay-between-gut-microbiota-adipose-tissue-and-migraine-a2026-10-04 https://evidence-hub.com/study/62344-evaluating-the-role-of-coenzyme-q10-in-migraine-therapy-a-narrative2026-10-08 https://evidence-hub.com/study/62345-evaluating-modern-therapeutic-interventions-for-migraine-management-a2026-10-04 https://evidence-hub.com/study/62346-the-relationship-between-migraine-and-cognition-a-narrative-review-in2026-10-04 https://evidence-hub.com/study/62347-neck-pain-in-migraine-a-narrative-review-and-steps-to-correct2026-10-04 https://evidence-hub.com/study/62348-migraine-and-the-risk-of-glaucoma-a-systematic-review-and-meta2026-10-04 https://evidence-hub.com/study/62349-the-integration-of-migraine-and-sleep-disturbance-in-perimenopause-a2026-10-04 https://evidence-hub.com/study/62351-genetics-of-migraine-a-systematic-review-and-meta-analysis-of-21-genes2026-10-04 https://evidence-hub.com/study/62352-association-of-migraine-and-atrial-fibrillation-a-ten-years2026-10-04 https://evidence-hub.com/study/62353-are-we-closer-to-achieving-precision-medicine-for-migraine-treatment2026-10-04 https://evidence-hub.com/study/62354-neuropsychological-functioning-in-pediatric-primary-headache2026-10-06 https://evidence-hub.com/study/62355-systematic-review-for-vns-vs-pharmaceutical-modulations-for2026-10-06 https://evidence-hub.com/study/62356-machine-learning-for-functional-outcome-prediction-after-vestibular2026-10-06 https://evidence-hub.com/study/62357-mitochondrial-mutation-status-symptom-prevalence-and-neuroimaging2026-10-06 https://evidence-hub.com/study/62358-identifying-key-risk-factors-for-the-recurrence-of-benign-paroxysmal2026-10-06 https://evidence-hub.com/study/62359-risk-of-cardiovascular-disease-and-mortality-among-women-with2026-10-06 https://evidence-hub.com/study/62360-optimal-types-and-doses-of-exercise-for-improving-sleep-quality-in2026-10-06 https://evidence-hub.com/study/62361-facial-expression-deep-learning-algorithms-in-the-detection-of2026-10-08 https://evidence-hub.com/study/62362-health-utility-values-associated-with-pharmaceutical-treatment2026-10-06 https://evidence-hub.com/study/62363-the-effectiveness-of-vitamin-b6-in-reducing-mastalgia-a-systematic2026-10-06 https://evidence-hub.com/study/62364-differential-placebo-effect-of-sham-acupuncture-for-chronic-pain-a2026-10-06 https://evidence-hub.com/study/62365-does-the-ketogenic-diet-mediate-inflammation-markers-in-obese-and2026-10-06 https://evidence-hub.com/study/62366-long-term-risk-of-progression-from-unilateral-to-bilateral-meniere-s2026-10-06 https://evidence-hub.com/study/62367-effect-of-multistrain-probiotics-on-symptom-severity-in-irritable2026-10-06 https://evidence-hub.com/study/62368-is-manual-therapy-effective-for-cervical-dizziness-a-systematic2026-10-06 https://evidence-hub.com/study/62369-blood-biomarkers-for-the-diagnosis-of-peripheral-causes-of-vestibular2026-10-06 https://evidence-hub.com/study/62370-the-blinding-status-and-characteristics-in-acupuncture-clinical2026-10-06 https://evidence-hub.com/study/62371-assessment-of-central-sensitivity-syndrome-and-sensory-processing2026-10-06 https://evidence-hub.com/study/62372-gonadotropin-releasing-hormone-gnrh-analogues-for-premenstrual2026-10-06 https://evidence-hub.com/study/62373-a-systematic-review-and-meta-analysis-of-longitudinal-studies2026-10-06 https://evidence-hub.com/study/62374-corneal-confocal-microscopy-to-diagnose-peripheral-neuropathy-a2026-10-06 https://evidence-hub.com/study/62375-the-role-of-throat-packs-in-orthognathic-surgery-a-systematic-review2026-10-06 https://evidence-hub.com/study/62376-acupuncture-for-hypoxic-ischemic-encephalopathy-in-neonates2026-10-08 https://evidence-hub.com/study/62377-association-between-adrenoreceptor-agonists-and-antagonists-and2026-10-06 https://evidence-hub.com/study/62378-repetitive-peripheral-magnetic-stimulation-for-pain-disability-and2026-10-06 https://evidence-hub.com/study/62379-role-of-vitamins-in-the-pathogenesis-and-treatment-of-restless-leg2026-10-06 https://evidence-hub.com/study/62380-comparative-efficacy-of-ibuprofen-and-low-level-laser-therapy-on-pain2026-10-06 https://evidence-hub.com/study/62381-carbetocin-versus-oxytocin-in-prevention-of-postpartum-hemorrhage2026-10-06 https://evidence-hub.com/study/62382-water-pipe-smoking-and-stroke-a-systematic-review-and-meta-analysis2026-10-06 https://evidence-hub.com/study/62383-placebo-effect-of-sham-acupuncture-for-primary-insomnia-a-meta2026-10-06 https://evidence-hub.com/study/62384-telerehabilitation-for-neck-pain2026-10-06 https://evidence-hub.com/study/62385-the-relationship-between-psychological-factors-and-temporomandibular2026-10-06 https://evidence-hub.com/study/62386-the-effect-of-cinnamon-supplementation-on-cardiovascular-risk-factors2026-10-06 https://evidence-hub.com/study/62387-gut-dysbiosis-in-patients-with-chronic-pain-a-systematic-review-and2026-10-06 https://evidence-hub.com/study/62388-perioperative-interventions-in-pelvic-organ-prolapse-surgery2026-10-08 https://evidence-hub.com/study/62389-effects-of-human-papillomavirus-hpv-vaccination-programmes-on2026-10-06 https://evidence-hub.com/study/62390-effectiveness-of-topiramate-versus-acetazolamide-in-the-management-of2026-10-06 https://evidence-hub.com/study/62391-comparative-study-for-fatigue-prevalence-in-subjects-with-diseases-a2026-10-06 https://evidence-hub.com/study/62392-efficacy-and-safety-of-botulinum-neurotoxin-in-the-treatment-of2026-10-06 https://evidence-hub.com/study/62393-vasodilators-for-women-undergoing-fertility-treatment2026-10-10 https://evidence-hub.com/study/62394-optokinetic-stimulation-for-the-treatment-of-vestibular-and-balance2026-10-06 https://evidence-hub.com/study/62395-occlusal-interventions-for-managing-temporomandibular-disorders2026-10-06 https://evidence-hub.com/study/62396-drug-treatment-for-myotonia2026-10-06 https://evidence-hub.com/study/62397-nutritional-therapy-for-reducing-disability-and-improving-activities2026-10-08 https://evidence-hub.com/study/62398-efficacy-and-safety-of-repetitive-transcranial-magnetic-stimulation2026-10-06 https://evidence-hub.com/study/62399-the-effect-of-oral-synbiotics-on-the-gut-microbiota-and-inflammatory2026-10-06 https://evidence-hub.com/study/62400-effects-of-ambient-temperature-on-mental-and-neurological-conditions2026-10-06 https://evidence-hub.com/study/62401-human-papillomavirus-hpv-vaccination-for-the-prevention-of-cervical2026-10-06 https://evidence-hub.com/study/62402-adverse-events-of-anti-il-5-drugs-in-patients-with-eosinophilic2026-10-06 https://evidence-hub.com/study/62403-stem-cell-injections-for-osteoarthritis-of-the-knee2026-10-06 https://evidence-hub.com/study/62404-repetitive-transcranial-magnetic-stimulation-for-post-traumatic2026-10-06 https://evidence-hub.com/study/62405-prevalence-and-associated-factors-of-self-medication-in-worldwide2026-10-06 https://evidence-hub.com/study/62406-selective-serotonin-reuptake-inhibitors-for-premenstrual-syndrome-and2026-10-06 https://evidence-hub.com/study/62407-controlled-ovarian-stimulation-protocols-for-assisted-reproduction-a2026-10-06 https://evidence-hub.com/study/62408-interventions-for-central-serous-chorioretinopathy-a-network-meta2026-10-08 https://evidence-hub.com/study/62409-global-prevalence-and-mental-health-outcomes-of-intimate-partner2026-10-06 https://evidence-hub.com/study/62417-a-preliminary-meta-analysis-of-regulatory-t-cell-reduction-in2026-10-06 https://evidence-hub.com/study/62419-safety-and-efficacy-of-topiramate-in-migraine-prophylaxis-in-younger2026-10-06 https://evidence-hub.com/study/62420-safety-and-efficacy-of-galcanezumab-in-chronic-and-episodic-migraine2026-10-06 https://evidence-hub.com/study/62422-a-comparative-systematic-review-and-meta-analysis-of-amitriptyline2026-10-06 https://evidence-hub.com/study/62423-effectiveness-and-safety-of-pharmacologic-therapies-for-migraine-in2026-10-06 https://evidence-hub.com/study/62425-efficacy-and-safety-of-atogepant-for-migraine-prevention-a-systematic2026-10-06 https://evidence-hub.com/study/62426-traditional-chinese-medicine-for-acute-migraine-a-systematic-review2026-10-06 https://evidence-hub.com/study/62427-comparative-effectiveness-of-pharmacological-versus-non2026-10-06 https://evidence-hub.com/study/62428-efficacy-and-safety-of-botulinum-toxin-type-a-bont-a-use-in-the2026-10-06 https://evidence-hub.com/study/62429-basilar-artery-fenestration-in-migraine-patient2026-10-04 https://evidence-hub.com/study/62430-self-compassion-and-pain-experience-in-migraine-patients2026-10-04 https://evidence-hub.com/study/62431-theory-of-mind-and-metacognition-in-migraine-patients2026-10-04 https://evidence-hub.com/study/62432-the-role-of-oxidative-and-nitrosative-stress-in-migraine-patients2026-10-04 https://evidence-hub.com/study/62433-an-evaluation-of-magnesium-levels-in-pediatric-migraine-patients2026-10-04 https://evidence-hub.com/study/62434-evaluation-of-autonomic-dysfunction-in-pediatric-migraine-patients2026-10-04 https://evidence-hub.com/study/62436-volumetric-analysis-of-pain-centers-in-migraine-patients2026-10-04 https://evidence-hub.com/study/62437-cervical-musculoskeletal-comorbidities-in-migraine-patients2026-10-04 https://evidence-hub.com/study/62438-prevalence-of-improper-practice-of-aharavidhividhanam-in-migraine2026-10-04 https://evidence-hub.com/study/62440-assessing-the-role-of-antioxidants-in-migraine-patients-in-erbil-city2026-10-04 https://evidence-hub.com/study/62441-association-of-cognitive-impairment-with-clinical-variables-in2026-10-04 https://evidence-hub.com/study/62442-pattern-of-interleukin-17a-and-interleukin-1-in-migraine-patients2026-10-04 https://evidence-hub.com/study/62443-saccadometry-findings-in-migraine-patients-without-aura2026-10-04 https://evidence-hub.com/study/62444-the-perception-gap-on-migraine-a-survey-study-of-the-migraine2026-10-04 https://evidence-hub.com/study/62445-hyperacusis-questionnaire-and-event-related-potential-correlation-in2026-10-04 https://evidence-hub.com/study/62446-subclinical-cochlear-dysfunctions-in-migraine-patients-assessed-by2026-10-04 https://evidence-hub.com/study/62447-ultrasound-assessment-of-endothelial-dysfunction-in-egyptian-migraine2026-10-04 https://evidence-hub.com/study/62448-assessment-of-some-biometrics-and-biochemical-parameters-in-migraine2026-10-04 https://evidence-hub.com/study/62449-conjunctival-impression-cytology-and-dry-eye-parameters-in-migraine2026-10-04 https://evidence-hub.com/study/62450-lipid-profile-abnormalities-in-migraine-patients-a-cross-sectional2026-10-04 https://evidence-hub.com/study/62451-evaluation-of-oral-dental-health-in-headache-migraine-patients2026-10-04 https://evidence-hub.com/study/62452-cefaly-neurostimulation-therapy-for-intractable-migraine-patients2026-10-04 https://evidence-hub.com/study/62454-factors-associated-with-developing-chronic-daily-headache-in-migraine2026-10-04 https://evidence-hub.com/study/62455-function-of-the-stomatognathic-system-in-migraine-patients2026-10-04 https://evidence-hub.com/study/62457-characterising-aural-symptoms-in-vestibular-migraine-patients2026-10-04 https://evidence-hub.com/study/62458-botulinum-toxin-treatment-on-migraine-patients-its-effect-on2026-10-04 https://evidence-hub.com/study/62459-changes-in-cardiac-electrophysiology-and-predisposition-to-arrhythmia2026-10-04 https://evidence-hub.com/study/62460-conjunctival-impression-cytology-and-dry-eye-parameters-in-migraine2026-10-04 https://evidence-hub.com/study/62461-eeg-microstate-responses-of-migraine-patients-to-transcutaneous2026-10-04 https://evidence-hub.com/study/62462-eating-attitudes-of-migraine-patients-in-turkey-a-prospective-multi2026-10-04 https://evidence-hub.com/study/62463-polysomnographic-characteristics-of-migraine-patients-a-comparative2026-10-04 https://evidence-hub.com/study/62464-relationship-between-contingent-negative-variation-and-afterimage2026-10-04 https://evidence-hub.com/study/62465-frequency-of-patent-foramen-ovale-in-migraine-patient-with-aura2026-10-04 https://evidence-hub.com/study/62467-identifying-hidden-disability-in-migraine-patients-using-the-migraine2026-10-04 https://evidence-hub.com/study/62468-cardiovascular-responses-to-tilting-in-female-migraine-patients-with2026-10-04 https://evidence-hub.com/study/62471-evaluation-of-serum-uric-acid-levels-in-pediatric-migraine-patients2026-10-04 https://evidence-hub.com/study/62472-skin-ecchymosis-in-migraine-patients-a-retrospective-and-exploratory2026-10-04 https://evidence-hub.com/study/62473-exploring-pge2-and-lxa4-levels-in-migraine-patients-the-potential-of2026-10-04 https://evidence-hub.com/study/62474-a-systematic-review-and-meta-analysis-of-the-prevalence-of-celiac2026-10-04 https://evidence-hub.com/study/62475-a-comparative-study-of-cognitive-distortion-among-mild-and-severe2026-10-04 https://evidence-hub.com/study/62476-the-impact-of-limbic-sensitization-on-the-efficacy-of-fremanezumab2026-10-04 https://evidence-hub.com/study/62477-volumetric-mri-analysis-of-the-pineal-gland-and-brain-ventricles-in2026-10-04 https://evidence-hub.com/study/62478-metabolomics-reveals-reasons-for-the-efficacy-of-acupuncture-in2026-10-04 https://evidence-hub.com/study/62479-prevalence-of-anxiety-and-depression-among-migraine-patients-in-al2026-10-04 https://evidence-hub.com/study/62480-assessment-of-serum-oxidative-stress-parameters-in-migraine-patients2026-10-04 https://evidence-hub.com/study/62482-current-findings-in-functional-mri-for-migraine-patients2026-10-04 https://evidence-hub.com/study/62483-arabic-validation-of-mig-scog-questionnaire-in-migraine-patients2026-10-04 https://evidence-hub.com/study/62484-microbiota-alterations-are-related-to-migraine-food-triggers-and2026-10-04 https://evidence-hub.com/study/62485-increased-t1w-mri-based-brain-age-in-chronic-migraine-patients2026-10-04 https://evidence-hub.com/study/62486-profile-of-sensory-integration-disorders-in-migraine-patients-new2026-10-04 https://evidence-hub.com/study/62487-increased-cardio-ankle-vascular-index-values-in-migraine-patients2026-10-04 https://evidence-hub.com/study/62488-clinical-epidemiological-profile-of-vestibular-migraine-patients2026-10-04 https://evidence-hub.com/study/62489-risk-factors-for-white-matter-lesions-in-migraine-patients-insights2026-10-04 https://evidence-hub.com/study/62490-hemogram-and-inflammatory-indices-in-pain-free-periods-in-migraine2026-10-04 https://evidence-hub.com/study/62491-alterations-of-white-matter-microstructure-in-migraine-patients-vary2026-10-04 https://evidence-hub.com/study/62492-computerized-axiographic-findings-in-a-cohort-of-migraine-patients-a2026-10-04 https://evidence-hub.com/study/62493-new-migraine-drugs-a-critical-appraisal-of-the-reason-why-the2026-10-04 https://evidence-hub.com/study/62494-functional-evaluation-of-the-auditory-brainstem-in-migraine-patients2026-10-04 https://evidence-hub.com/study/62495-frequency-of-visual-snow-syndrome-in-migraine-patients-at-tertiary2026-10-04 https://evidence-hub.com/study/62496-efficacy-of-mindfulness-based-intervention-on-migraine-patients-a2026-10-04 https://evidence-hub.com/study/62497-efficacy-safety-and-tolerability-of-atogepant-in-migraine-patients2026-10-04 https://evidence-hub.com/study/62498-comparison-of-pentraxin-3-in-migraine-patients-without-auraand2026-10-04 https://evidence-hub.com/study/62499-detection-of-possible-trigger-nutrition-factors-in-migraine-patients2026-10-04 https://evidence-hub.com/study/62500-mri-radiomics-based-machine-learning-model-of-the-periaqueductal-gray2026-10-04 https://evidence-hub.com/study/62501-evaluation-of-the-efficacy-of-tinted-lenses-for-photophobia-in2026-10-04 https://evidence-hub.com/study/62502-evaluation-of-leptin-hormone-and-magnesium-levels-in-recently2026-10-04 https://evidence-hub.com/study/62503-auditory-evoked-brainstem-responses-and-medial-olivocochlear-efferent2026-10-04 https://evidence-hub.com/study/62504-the-role-of-emotion-regulation-strategies-in-predicting-pain2026-10-04 https://evidence-hub.com/study/62505-comparison-of-echocardiographic-and-clinical-characteristics-in2026-10-04 https://evidence-hub.com/study/62506-association-of-white-matter-hyperintensities-with-serum-lipid-profile2026-10-04 https://evidence-hub.com/study/62508-the-second-exteroceptive-suppression-period-of-the-temporalis-muscle2026-10-04 https://evidence-hub.com/study/62509-evaluation-of-the-optic-nerve-in-migraine-patients-by-magnetic2026-10-04 https://evidence-hub.com/study/62510-comparison-of-pentraxin-3-in-migraine-patients-without-aura-and2026-10-04 https://evidence-hub.com/study/62511-instrumental-occlusal-analysis-in-migraine-patients-a-quantitative2026-10-04 https://evidence-hub.com/study/62512-impact-of-visual-stimulus-complexity-on-associative-learning-and2026-10-04 https://evidence-hub.com/study/62513-to-study-the-effectiveness-of-yoga-and-aerobics-in-migraine-patients2026-10-04 https://evidence-hub.com/study/62515-orofacial-pain-models-induce-impairment-in-spatial-learning-and2026-10-06 https://evidence-hub.com/study/62516-safety-and-efficacy-of-calcitonin-gene-related-peptide-receptor2026-10-06 https://evidence-hub.com/study/62517-a-risk-difference-meta-analysis-for-the-prophylactic-treatments-of2026-10-06 https://evidence-hub.com/study/62518-efficacy-and-safety-of-melatonin-for-migraine-prevention-in-children2026-10-08 https://evidence-hub.com/study/62519-mitochondrial-dysfunction-in-trigeminal-ganglion-contributes-to2026-10-04 https://evidence-hub.com/study/62520-a-comprehensive-exploration-of-astrocytes-in-migraine-a-bibliometric2026-10-04 https://evidence-hub.com/study/62521-experimental-animal-models-in-neurological-diseases2026-10-04 https://evidence-hub.com/study/62522-effects-of-warm-needle-acupuncture-on-behavioral-pain-threshold-in-a2026-10-04 https://evidence-hub.com/study/62523-sensitization-of-meningeal-afferents-to-locomotion-related-meningeal2026-10-04 https://evidence-hub.com/study/62525-demonstration-of-ovarian-and-brain-tissue-interactions-as-a-result-of2026-10-04 https://evidence-hub.com/study/62526-efficacy-of-medi0618-a-ph-dependent-monoclonal-antibody-targeting2026-10-08 https://evidence-hub.com/study/62528-synergistic-effect-of-combining-dual-enkephalinase-inhibitor-pl37-and2026-10-04 https://evidence-hub.com/study/62529-the-research-progress-of-cacna1a-in-the-pathogenesis-of-vestibular2026-10-04 https://evidence-hub.com/study/62530-gut-microbiota-and-metabolite-variations-in-a-migraine-mouse-model2026-10-04 https://evidence-hub.com/study/62531-exploring-of-the-analgesic-effect-of-emodin-on-migraine-rat-model-via2026-10-04 https://evidence-hub.com/study/62532-author-response-sensitization-of-meningeal-afferents-to-locomotion2026-10-04 https://evidence-hub.com/study/62534-mechanisms-of-gtn-induced-migraine-role-of-nos-isoforms-sgc-and2026-10-04 https://evidence-hub.com/study/62535-behavioral-correlates-of-migraine-oxidative-stress-and-cgrp-levels-in2026-10-04 https://evidence-hub.com/study/62536-elife-assessment-sensitization-of-meningeal-afferents-to-locomotion2026-10-04 https://evidence-hub.com/study/62537-macrophages-and-inos-contribute-to-the-effects-of-dural-prolactin-and2026-10-06 https://evidence-hub.com/study/62539-differences-in-neuropathology-between-nitroglycerin-induced-mouse2026-10-04 https://evidence-hub.com/study/62540-overlapping-pathways-of-migraine-and-the-endocannabinoid-system2026-10-04 https://evidence-hub.com/study/62541-the-effects-of-topiramate-and-flunarizine-on-serum-glutamine-and2026-10-04 https://evidence-hub.com/study/62543-neuroinflammatory-and-redox-responses-in-a-rat-model-of-ntg-induced2026-10-04 https://evidence-hub.com/study/62544-studies-on-mechanisms-of-development-and-electrostimulation2026-10-04 https://evidence-hub.com/study/62545-cerebrovascular-and-behavioral-changes-in-the-nitroglycerin-mouse2026-10-04 https://evidence-hub.com/study/62546-reviewer-3-public-review-sensitization-of-meningeal-afferents-to2026-10-04 https://evidence-hub.com/study/62547-reviewer-1-public-review-sensitization-of-meningeal-afferents-to2026-10-04 https://evidence-hub.com/study/62548-reviewer-2-public-review-sensitization-of-meningeal-afferents-to2026-10-04 https://evidence-hub.com/study/62549-is-canonical-sd-a-clinically-relevant-model-of-migraine-argument-con2026-10-04 https://evidence-hub.com/study/62550-human-brain-organoids-in-the-preclinical-phase-of-drug-development2026-10-04 https://evidence-hub.com/study/62551-mechanisms-underlying-csd-initiation-implicated-by-genetic-mouse2026-10-04 https://evidence-hub.com/study/62552-trpa1-modulates-urocortin-1-turnover-in-the-centrally-projecting2026-10-04 https://evidence-hub.com/study/62553-provocation-of-attacks-to-discover-migraine-signaling-mechanisms-and2026-10-08 https://evidence-hub.com/study/62554-transcutaneous-auricular-vagus-nerve-stimulation-alleviates-headache2026-10-04 https://evidence-hub.com/study/62555-nop-receptor-activation-counteracts-stress-induced-migraine-like2026-10-04 https://evidence-hub.com/study/62556-the-restless-universe-of-migraine2026-10-04 https://evidence-hub.com/study/62557-altered-immunity-in-migraine-a-comprehensive-scoping-review2026-10-04 https://evidence-hub.com/study/62559-nrb-1a-in-silico-design-for-five-minute-migraine-intervention2026-10-04 https://evidence-hub.com/study/62561-in-vitro-propagation-of-stephania-pierrei-diels-and-exploration-of2026-10-06 https://evidence-hub.com/study/62563-targeting-serpine1-with-esculetin-for-migraine-management2026-10-04 https://evidence-hub.com/study/62564-mechanistic-investigation-of-hmgb1-in-an-in-vitro-model-of-the2026-10-04 https://evidence-hub.com/study/62566-in-vitro-characterization-and-in-vivo-pharmacokinetic-study-of2026-10-04 https://evidence-hub.com/study/62567-neuroprotective-and-anti-migraine-potential-of-piper-betel-a-multi2026-10-04 https://evidence-hub.com/study/62568-formulation-and-in-vitro-characterisation-of-nasal-in-situ-gel-for2026-10-04 https://evidence-hub.com/study/62569-transnasal-zolmitriptan-ginkgolide-b-loaded-liposomes-for-migraine2026-10-04 https://evidence-hub.com/study/62570-formulation-development-of-rizatriptan-cannabidiol-loaded2026-10-04 https://evidence-hub.com/study/62572-pharmacokinetic-and-pharmacodynamic-considerations-with-psychiatric2026-10-04 https://evidence-hub.com/study/62573-formulation-and-evaluation-of-trachyspermum-ammi-oil-roll-on-for2026-10-04 https://evidence-hub.com/study/62574-migraine-in-women-undergoing-fertility-treatment-a-prospective-study2026-10-04 https://evidence-hub.com/study/62575-formulation-and-evaluation-of-migrarelief-herbal-nasal-gel-for2026-10-08 https://evidence-hub.com/study/62576-formulation-and-evaluation-of-a-new-combined-dosage-form-for-migraine2026-10-04 https://evidence-hub.com/study/62577-herbal-medicines-in-the-management-of-migraine-ethnobotanical2026-10-04 https://evidence-hub.com/study/62578-prolactin-induced-sensitization-of-trigeminal-nociceptors-promotes2026-10-04 https://evidence-hub.com/study/62579-autotaxin-as-a-novel-biomarker-of-migraine2026-10-04 https://evidence-hub.com/study/62580-zolmitriptan-niosomal-transdermal-patches-combating-migraine-via2026-10-04 https://evidence-hub.com/study/62581-a-comprehensive-review-on-solid-lipid-nanoparticles-as-a-new-frontier2026-10-04 https://evidence-hub.com/study/62582-epilepsy-and-migraine-a-diagnostic-and-therapeutic-challenge2026-10-04 https://evidence-hub.com/study/62583-interplay-between-cannabinoids-and-the-neuroimmune-system-in-migraine2026-10-04 https://evidence-hub.com/study/62584-intranasal-application-of-ubrogepant-nanoparticles-improve-the-brain2026-10-04 https://evidence-hub.com/study/62585-par-2-monoclonal-antibody-as-a-treatment-for-migraine-a-systematic2026-10-04 https://evidence-hub.com/study/62586-migraine-and-alcohol-is-it-really-that-harmful2026-10-08 https://evidence-hub.com/study/62587-navigating-the-neurobiology-of-migraine-from-pathways-to-potential2026-10-04 https://evidence-hub.com/study/62588-from-tradition-to-innovation-a-polyherbal-nasal-oil-for-rapid2026-10-04 https://evidence-hub.com/study/62589-formulation-optimization-and-in-vivo-evaluation-of-orodispersible2026-10-04 https://evidence-hub.com/study/62590-extracellular-vesicles-in-migraine-biomarkers-and-therapeutics2026-10-04 https://evidence-hub.com/study/62591-formulation-and-characterization-of-transdermal-patches-for2026-10-04 https://evidence-hub.com/study/62592-design-and-evaluation-of-mouth-dissolving-tablets-of-eletriptan2026-10-04 https://evidence-hub.com/study/62593-a-review-of-triptan-formulations-for-the-treatment-of-migraine2026-10-04 https://evidence-hub.com/study/62594-sirtuins-contribute-to-the-migraine-stroke-connection2026-10-04 https://evidence-hub.com/study/62595-migraine-induced-cochlear-injury-triggers-zbp1-mediated-panoptosis2026-10-04 https://evidence-hub.com/study/62596-development-and-characterization-of-orodispersible-tablets-containing2026-10-04 https://evidence-hub.com/study/62597-regulation-of-na-k-atpase-by-cardiotonic-steroids-participation-in2026-10-04 https://evidence-hub.com/study/62598-evaluation-of-physical-activity-and-knowledge-related-to-the-impact2026-10-04 https://evidence-hub.com/study/62599-formulation-optimization-and-evaluation-of-rimegepant-pulsatile2026-10-04 https://evidence-hub.com/study/62600-formulation-and-characterization-of-fast-dissolving-oral-films-of2026-10-04 https://evidence-hub.com/study/62601-cgrp-antagonism-and-ketogenic-diet-in-the-treatment-of-migraine2026-10-08 https://evidence-hub.com/study/62602-meningeal-neuropeptide-and-neuroimmune-interactions-in-the-context-of2026-10-04 https://evidence-hub.com/study/62603-a-nasal-gel-formulation-of-ubrogepant-nanoparticles-for-enhanced-and2026-10-04 https://evidence-hub.com/study/62604-nanoformulation-innovations-revolutionizing-precision-in-migraine2026-10-04 https://evidence-hub.com/study/62606-migraine-and-neurovascular-health-inthe-general-population2026-10-04 https://evidence-hub.com/study/62607-advancements-in-valproate-therapy-for-seizures-migraines-and-bipolar2026-10-08 https://evidence-hub.com/study/62608-proinflammatory-cytokine-profiles-in-meniere-s-disease-and-vestibular2026-10-04 https://evidence-hub.com/study/62609-regulation-of-na-k-atpase-by-ouabain-like-compounds-phytocannabinoids2026-10-04 https://evidence-hub.com/study/62611-possible-role-of-novel-mitochondrial-subsets-in-migraine2026-10-04 https://evidence-hub.com/study/62612-development-of-a-novel-herbal-balm-using-mimosa-pudica-leaf-extract2026-10-04 https://evidence-hub.com/study/62613-the-prodrome-of-migraine-mechanistic-insights-and-emerging2026-10-04 https://evidence-hub.com/study/62614-development-of-a-fast-acting-nanosuspension-nasal-drop-using-a-novel2026-10-04 https://evidence-hub.com/study/62615-rizatriptan-as-an-over-the-counter-triptan-in-the-treatment-of2026-10-04 https://evidence-hub.com/study/62616-migraine-and-its-treatment-from-the-medicinal-chemistry-perspective2026-10-08 https://evidence-hub.com/study/62617-influence-of-metabolic-state-and-body-composition-on-the-action-of2026-10-04 https://evidence-hub.com/study/62618-role-of-tnf-in-the-pathogenesis-of-migraine2026-10-04 https://evidence-hub.com/study/62619-the-therapeutic-pipeline-in-migraine-what-does-the-future-hold2026-10-04 https://evidence-hub.com/study/62620-preparation-and-evaluation-of-gastrodin-ferulic-acid-co-loaded2026-10-04 https://evidence-hub.com/study/62621-senkyunolides-a-promising-natural-compounds-for-the-treatment-of2026-10-04 https://evidence-hub.com/study/62622-kcng4-genetic-variant-linked-to-migraine-prevents-expression-of-kcnb12026-10-04 https://evidence-hub.com/study/62624-exploring-the-potential-of-fargesin-from-chrysanthemum-indicum-for2026-10-08 https://evidence-hub.com/study/62626-in-silico-screening-of-lavandula-angustifolia-l-to-relieve-migraine-a2026-10-04 https://evidence-hub.com/study/62627-in-silico-evolutionary-and-structural-analysis-of-rab2b-protein-in2026-10-06 https://evidence-hub.com/study/62628-protease-resilient-intranasal-biologics-nrb-1a-in-silico-framework2026-10-04 https://evidence-hub.com/study/62629-in-silico-rational-design-and-immunoinformatic-analysis-of-a-multi2026-10-04 https://evidence-hub.com/study/62632-pharmacological-investigation-of-genistein-for-its-therapeutic2026-10-04 https://evidence-hub.com/study/62633-multiform-structure-based-identification-of-natural-phytochemical2026-10-04 https://evidence-hub.com/study/62634-in-silico-receptor-binding-and-ex-vivo-nasal-epithelial-membrane2026-10-04 https://evidence-hub.com/study/62635-polydatin-as-a-potential-therapeutic-agent-for-migraine-mechanistic2026-10-04 https://evidence-hub.com/study/62636-exploring-the-association-between-familial-hemiplegic-migraine-genes2026-10-04 https://evidence-hub.com/study/62637-unlocking-the-potential-of-luteolin-a-natural-migraine-management2026-10-04 https://evidence-hub.com/study/62638-gepants-cgpr-antagonist-a-new-clinical-approach-to-treat-migraine-and2026-10-04 https://evidence-hub.com/study/62639-elucidation-of-potential-inhibitor-compounds-from-zingiber-officinale2026-10-04 https://evidence-hub.com/study/62640-molecular-study-of-cacna1a-atp1a2-and-scn1a-genes-and-its-association2026-10-04 https://evidence-hub.com/study/62641-identification-of-polymorphisms-in-eaat1-glutamate-transporter-gene2026-10-04 https://evidence-hub.com/study/62642-uncovering-common-genetic-risk-factors-in-migraine-and-epilepsy2026-10-04 https://evidence-hub.com/study/62643-ginkgo-seed-as-medicine-food-homology-for-migraine-network2026-10-08 https://evidence-hub.com/study/62644-bridging-gaps-in-migraine-management-a-comprehensive-review-of2026-10-08 https://evidence-hub.com/study/62645-association-of-migraine-treatments-with-reduced-ischemic-stroke-risk2026-10-04 https://evidence-hub.com/study/62646-stroke-risk-reduction-in-migraine-patients-using-propranolol-evidence2026-10-08 https://evidence-hub.com/study/62647-calcitonin-gene-related-peptide-targeted-therapies-in-migraine-a2026-10-04 https://evidence-hub.com/study/62648-molecular-docking-analysis-of-mentha-x-piperita-derived-ligands-for2026-10-04 https://evidence-hub.com/study/62649-incidental-depdc5-variant-in-a-child-with-sporadic-hemiplegic2026-10-04 https://evidence-hub.com/study/62650-genetic-insights-into-hemiplegic-migraine-whole-exome-sequencing2026-10-04 https://evidence-hub.com/study/62651-allergic-sinusitis-allergic-migraine-and-sinus-headaches2026-10-04 https://evidence-hub.com/study/62653-potential-of-focal-cortical-dysplasia-in-migraine-pathogenesis2026-10-04 https://evidence-hub.com/study/62654-from-herb-to-headache-relief-a-network-based-study-on-origanum2026-10-04 https://evidence-hub.com/study/62656-targeting-serotonin-receptors-with-phytochemicals-an-in-silico-study2026-10-04 https://evidence-hub.com/study/62657-elicited-repetitive-daily-blindness-associated-with-gain-of-function2026-10-04 https://evidence-hub.com/study/62658-hemiplegic-migraines-exacerbated-using-an-injectable-glp-1-agonist2026-10-04 https://evidence-hub.com/study/62660-an-in-silico-analysis-of-ogt-gene-association-with-diabetes-mellitus2026-10-04 https://evidence-hub.com/study/62661-elucidating-the-cytogenotoxic-potential-of-gabapentin-in-vitro-and-in2026-10-04 https://evidence-hub.com/study/62662-in-silico-evaluation-of-the-pharmacokinetics-and-toxicity-of-novel2026-10-04 https://evidence-hub.com/study/62663-expanding-the-genetic-and-clinical-spectrum-of-scn1a-related2026-10-04 https://evidence-hub.com/study/62664-comprehensive-list-of-preventative-migraine-headache-medications2026-10-04 https://evidence-hub.com/study/62665-pathvar-a-customisable-ngs-variant-calling-algorithm-implicates-novel2026-10-04 https://evidence-hub.com/study/62666-antimigraine-activity-of-asarinin-by-oprm1-pathway-with-multifaceted2026-10-08 https://evidence-hub.com/study/62667-dnajc12-p-asp44gly-associated-with-mild-hyperphenylalaninemia-and2026-10-04 https://evidence-hub.com/study/62668-unlocking-adamts-5-in-silico-insights-into-tmj-proteomics-and-docking2026-10-04 https://evidence-hub.com/study/62669-pregpred-an-in-silico-alternative-to-animal-testing-for-predicting2026-10-04 https://evidence-hub.com/study/62670-serum-microrna-qpcr-profiling-and-validation-indicate-upregulation-of2026-10-04 https://evidence-hub.com/study/62671-nrv-an-open-framework-for-in-silico-evaluation-of-peripheral-nerve2026-10-04 https://evidence-hub.com/study/62672-integrated-in-silico-identification-of-cholinesterase-inhibitors-from2026-10-04 https://evidence-hub.com/study/62673-the-quaternary-structure-of-the-sodium-pump-regulatory-complex-is2026-10-04 https://evidence-hub.com/study/62674-investigation-of-cholinergic-inhibition-by-donepezil-rimegepant2026-10-04 https://evidence-hub.com/study/62675-thymol-as-a-potential-natural-antiemetic-insights-from-in-vivo-and-in2026-10-04 https://evidence-hub.com/study/62676-in-silico-exploration-of-anti-prostate-cancer-compounds-from2026-10-04 https://evidence-hub.com/study/62677-the-study-on-timolol-and-its-potential-phototoxicity-using-chemical2026-10-04 https://evidence-hub.com/study/62678-enhancing-acute-migraine-treatment-exploring-solid-lipid2026-10-04 https://evidence-hub.com/study/62679-identification-and-in-silico-study-of-non-synonymous-functional-snps2026-10-04 https://evidence-hub.com/study/62680-novel-properties-of-old-propranololassessment-of-antiglycation2026-10-04 https://evidence-hub.com/study/62681-in-silico-efforts-to-screen-potential-natural-compounds-against2026-10-04 https://evidence-hub.com/study/62682-in-silico-drug-repurposing-pipeline-using-deep-learning-and-structure2026-10-04 https://evidence-hub.com/study/62683-a-comprehensive-review-of-lavandula-stoechas-l-ustukhuddus-plant2026-10-04 https://evidence-hub.com/study/62684-in-silico-functional-structural-and-pathogenicity-analysis-of2026-10-04 https://evidence-hub.com/study/62685-ai-powered-in-silico-twins-redefining-precision-medicine-through2026-10-04 https://evidence-hub.com/study/62686-feverfew-tanacetum-parthenium-gc-ms-analysis-and-therapeutic-insights2026-10-04 https://evidence-hub.com/study/62688-mrgprx2-as-a-novel-therapeutic-target-in-headache2026-10-04 https://evidence-hub.com/study/62689-secondary-metabolites-of-euphorbia-pulcherrima-as-carbonic-anhydrases2026-10-04 https://evidence-hub.com/study/62690-calcium-ions-in-the-physiology-and-pathology-of-the-central-nervous2026-10-04 https://evidence-hub.com/study/62691-proposing-a-framework-to-quantify-the-potential-impact-of2026-10-04 https://evidence-hub.com/study/62693-in-silico-functional-structural-and-pathogenicity-assessment-of2026-10-04 https://evidence-hub.com/study/62694-genome-wide-association-analysis-of-treatment-response-to2026-10-04 https://evidence-hub.com/study/62695-in-silico-evaluation-of-tryptamine-derived-schiff-bases-as-modulators2026-10-04 https://evidence-hub.com/study/62696-unraveling-riboflavin-mediated-mitochondrial-modulation-as-a2026-10-04 https://evidence-hub.com/study/62697-marker-assisted-selection-an-approach-for-precision-plant-breeding-in2026-10-06 https://evidence-hub.com/study/62698-synthesis-crystal-structure-and-characterization-of-energetic-salts2026-10-06 https://evidence-hub.com/study/62699-platinum-iv-nitroxyl-complexes-as-possible-candidates-to-circumvent2026-10-06 https://evidence-hub.com/study/62700-transcriptomics-view-over-the-germination-landscape-in-biofortified2026-10-06 https://evidence-hub.com/study/62701-genomic-breeding-of-green-super-rice-varieties-and-their-deployment2026-10-06 https://evidence-hub.com/study/62702-realized-genetic-gain-in-rice-achievements-from-breeding-programs2026-10-06 https://evidence-hub.com/study/62703-green-revolution-the-way-forward2026-10-06 https://evidence-hub.com/study/62704-prevalence-and-predictors-of-driving-after-prescription-opioid-use-in2026-10-06 https://evidence-hub.com/study/62705-not-just-a-grain-of-rice-the-quest-for-quality2026-10-06 https://evidence-hub.com/study/62706-prospects-of-breeding-high-quality-rice-using-post-genomic-tools2026-10-06 https://evidence-hub.com/study/62707-sugar-flux-and-signaling-in-plant-microbe-interactions2026-10-06 https://evidence-hub.com/study/62709-the-social-and-economic-impact-of-biofortification-through-genetic2026-10-06 https://evidence-hub.com/study/62710-designing-climate-resilient-rice-with-ideal-grain-quality-suited-for2026-10-06 https://evidence-hub.com/study/62711-advances-in-the-uptake-and-transport-mechanisms-and-qtls-mapping-of2026-10-06 https://evidence-hub.com/study/62712-efficacy-and-cost-effectiveness-of-phenotyping-for-rice-resistance2026-10-06 https://evidence-hub.com/study/62713-meta-analysis-of-rice-phosphoproteomics-data-to-understand-variation2026-10-06 https://evidence-hub.com/study/62714-rice-responses-to-rising-temperatures-challenges-perspectives-and2026-10-06 https://evidence-hub.com/study/62715-ratoon-rice-research-review-and-prospect-for-the-tropics2026-10-06 https://evidence-hub.com/study/62716-genomics-based-precision-breeding-approaches-to-improve-drought2026-10-06 https://evidence-hub.com/study/62717-stomatal-development-and-gene-expression-in-rice-florets2026-10-06 https://evidence-hub.com/study/62718-multi-environment-genomic-selection-in-rice-elite-breeding-lines2026-10-06 https://evidence-hub.com/study/62719-crispr-from-prokaryotic-immune-systems-to-plant-genome-editing-tools2026-10-06 https://evidence-hub.com/study/62720-varietal-dependent-flavor-dynamics-in-piper-nigrum-l-under-thermal2026-10-06 https://evidence-hub.com/study/62721-advances-in-breeding-for-high-grain-zinc-in-rice2026-10-06 https://evidence-hub.com/study/62722-abscisic-acid-and-its-role-in-the-modulation-of-plant-growth2026-10-06 https://evidence-hub.com/study/62723-development-and-characterization-of-gr2e-golden-rice-introgression2026-10-06 https://evidence-hub.com/study/62724-lncphedb-a-genome-wide-lncrnas-regulated-phenotypes-database-in-plants2026-10-06 https://evidence-hub.com/study/62725-design-synthesis-and-evaluation-of-111in-labeled-dota-conjugated2026-10-06 https://evidence-hub.com/study/62726-the-knowns-and-unknowns-of-phosphorus-loading-into-grains-and2026-10-06 https://evidence-hub.com/study/62727-systems-based-rice-improvement-approaches-for-sustainable-food-and2026-10-06 https://evidence-hub.com/study/62728-intensifying-rice-production-to-reduce-imports-and-land-conversion-in2026-10-06 https://evidence-hub.com/study/62729-harmonizing-technological-advances-in-phenomics-and-genomics-for2026-10-06 https://evidence-hub.com/study/62730-combined-population-transcriptomic-and-genomic-analysis-reveals-cis2026-10-06 https://evidence-hub.com/study/62731-deep-learning-enables-instant-and-versatile-estimation-of-rice-yield2026-10-06 https://evidence-hub.com/study/62732-impact-of-climate-change-on-altered-fruit-quality-with-organoleptic2026-10-06 https://evidence-hub.com/study/62733-lost-genome-segments-associate-with-trait-diversity-during-rice2026-10-06 https://evidence-hub.com/study/62734-systems-biology-of-seeds-deciphering-the-molecular-mechanisms-of-seed2026-10-06 https://evidence-hub.com/study/62735-binding-of-platinum-diaminonitroxyl-complexes-to-animal-dna2026-10-06 https://evidence-hub.com/study/62736-response-of-hidden-architects-to-salt-stress2026-10-06 https://evidence-hub.com/study/62737-ulcerative-colitis-symptom-questionnaire-valid-for-use-in-adults-with2026-10-06 https://evidence-hub.com/study/62738-from-green-super-rice-to-green-agriculture-reaping-the-promise-of2026-10-06 https://evidence-hub.com/study/62739-synthesis-and-antitumor-activity-of-platinum-ii-complexes-with-trans2026-10-06 https://evidence-hub.com/study/62740-sustainable-intensification-for-a-larger-global-rice-bowl2026-10-06 https://evidence-hub.com/study/62741-synthesis-and-comparison-of-the-flame-retardant-properties-of2026-10-06 https://evidence-hub.com/study/62742-root-proteases-reinforced-links-between-nitrogen-uptake-and2026-10-06 https://evidence-hub.com/study/62743-effect-of-nitrogen-fertilizer-on-the-resistance-of-rice-near-isogenic2026-10-06 https://evidence-hub.com/study/62744-identification-of-reliable-qtls-and-designed-qtl-breeding-for-grain2026-10-06 https://evidence-hub.com/study/62745-progress-in-breeding-for-trace-minerals-in-staple-crops2026-10-06 https://evidence-hub.com/study/62746-inorganic-fertilizer-use-and-its-association-with-rice-yield-gaps-in2026-10-06 https://evidence-hub.com/study/62747-upadacitinib-induction-and-maintenance-therapy-improves-abdominal2026-10-06 https://evidence-hub.com/study/62748-genome-wide-selection-and-introgression-of-chinese-rice-varieties2026-10-06 https://evidence-hub.com/study/62749-meta-analysis-of-grain-yield-qtl-identified-during-agricultural2026-10-06 https://evidence-hub.com/study/62750-population-cycles-and-outbreaks-of-small-rodents-ten-essential2026-10-06 https://evidence-hub.com/study/62751-taking-transgenic-rice-drought-screening-to-the-field2026-10-06 https://evidence-hub.com/study/62752-mesocotyl-elongation-an-essential-trait-for-dry-seeded-rice-oryza2026-10-06 https://evidence-hub.com/study/62753-comprehensive-analysis-of-the-impact-of-extraction-methods-on-the2026-10-06 https://evidence-hub.com/study/62754-reciprocal-adaptation-of-rice-and-xanthomonas-oryzae-pv-oryzae-cross2026-10-06 https://evidence-hub.com/study/62755-cytokinin-increases-vegetative-growth-period-by-suppressing-florigen2026-10-06 https://evidence-hub.com/study/62756-progress-in-single-access-information-systems-for-wheat-and-rice-crop2026-10-06 https://evidence-hub.com/study/62757-rice-galaxy-an-open-resource-for-plant-science2026-10-06 https://evidence-hub.com/study/62758-phenoxazine-based-covalent-organic-frameworks-as-a-turn-off2026-10-06 https://evidence-hub.com/study/62759-effects-of-tadalafil-treatment-after-bilateral-nerve-sparing-radical2026-10-19 https://evidence-hub.com/study/62760-improving-rice-blast-resistance-of-feng39s-through-molecular-marker2026-10-06 https://evidence-hub.com/study/62761-molecular-analyses-of-transgenic-plants2026-10-06 https://evidence-hub.com/study/62762-genome-wide-and-gene-based-association-mapping-for-rice-eating-and2026-10-06 https://evidence-hub.com/study/62763-traces-of-introgression-from-caus-into-tropical-japonica-observed-in2026-10-06 https://evidence-hub.com/study/62764-deciphering-the-genetic-basis-of-agronomic-yield-and-nutritional2026-10-06 https://evidence-hub.com/study/62765-agronomic-economic-and-environmental-performance-of-nitrogen-rates2026-10-06 https://evidence-hub.com/study/62766-stressed-genomics-bringing-relief-to-rice-fields2026-10-06 https://evidence-hub.com/study/62767-introgression-of-tsv1-improves-tungro-disease-resistance-of-a-rice2026-10-06 https://evidence-hub.com/study/62768-plant-genetic-resources-for-food-and-agriculture-opportunities-and2026-10-06 https://evidence-hub.com/study/62769-convergent-evolution-of-perenniality-in-rice-and-sorghum2026-10-06 https://evidence-hub.com/study/62770-effects-of-nitrogen-on-egg-laying-inhibition-and-ovicidal-response-in2026-10-06 https://evidence-hub.com/study/62771-platinum-ii-platinum-iv-and-palladium-ii-complexes-of-amino2026-10-06 https://evidence-hub.com/study/62772-genome-wide-association-study-of-outcrossing-in-cytoplasmic-male2026-10-06 https://evidence-hub.com/study/62773-heterotic-groups-of-tropical-indica-rice-germplasm2026-10-06 https://evidence-hub.com/study/62774-the-evolutionary-basis-of-naturally-diverse-rice-leaves-anatomy2026-10-06 https://evidence-hub.com/study/62775-the-effect-of-climate-variability-in-the-efficacy-of-the2026-10-06 https://evidence-hub.com/study/62776-chlorophyll-fluorescence-and-reflectance-based-non-invasive2026-10-06 https://evidence-hub.com/study/62777-analysis-of-differential-gene-expression-and-alternative-splicing-is2026-10-06 https://evidence-hub.com/study/62778-genomics-assisted-breeding-for-successful-development-of-multiple2026-10-06 https://evidence-hub.com/study/62779-development-of-in-vitro-anther-culture-for-doubled-haploid-plant2026-10-06 https://evidence-hub.com/study/62780-accumulating-candidate-genes-for-broad-spectrum-resistance-to-rice2026-10-06 https://evidence-hub.com/study/62781-effect-of-carbohydrates-and-night-temperature-on-night-respiration-in2026-10-06 https://evidence-hub.com/study/62782-genome-wide-association-mapping-for-phenotypic-plasticity-in-rice2026-10-06 https://evidence-hub.com/study/62783-advances-in-sensing-response-and-regulation-mechanism-of-salt2026-10-06 https://evidence-hub.com/study/62784-qtl-mapping-for-resistance-to-and-tolerance-for-the-rice-root-knot2026-10-06 https://evidence-hub.com/study/62785-stomatal-conductance-responses-to-evaporative-demand-conferred-by2026-10-06 https://evidence-hub.com/study/62786-heat-stress-during-gametogenesis-irreversibly-damages-female2026-10-06 https://evidence-hub.com/study/62787-adaptation-measures-of-the-potential-double-cropping-region-in2026-10-06 https://evidence-hub.com/study/62788-development-and-evaluation-of-pyramiding-lines-carrying-early-or-late2026-10-06 https://evidence-hub.com/study/62789-genome-wide-association-study-of-grain-appearance-and-milling-quality2026-10-06 https://evidence-hub.com/study/62790-comparative-analysis-of-anther-transcriptome-profiles-of-two2026-10-06 https://evidence-hub.com/study/62791-genetic-dissection-of-epistatic-interactions-contributing-grain-yield2026-10-06 https://evidence-hub.com/study/62792-the-metabolic-signature-of-biomass-formation-in-barley2026-10-06 https://evidence-hub.com/study/62793-potential-of-conservation-agriculture-modules-for-energy-conservation2026-10-06 https://evidence-hub.com/study/62794-genomic-prediction-and-qtl-analysis-for-grain-zn-content-and-yield-in2026-10-06 https://evidence-hub.com/study/62795-from-data-to-innovation-how-digital-leadership-cultivates-employees2026-10-06 https://evidence-hub.com/study/62796-radiation-resistant-c-type-dipole-dump-magnet-for-mir-thz-fel2026-10-06 https://evidence-hub.com/study/62797-prevalence-of-protein-energy-wasting-among-non-dialytic-and-dialytic2026-10-06 https://evidence-hub.com/study/62798-climate-change-mitigation-in-rice-fields-a-global-synthesis-of2026-10-06 https://evidence-hub.com/study/62799-asymmetric-prompt-weighting-for-reinforcement-learning-with2026-10-06 https://evidence-hub.com/study/62800-water-balance-components-in-a-dry-seeded-rice-wheat-system-untangling2026-10-06 https://evidence-hub.com/study/62801-mesenteric-cyst-an-unusual-cause-of-recurrent-abdominal-pain-in-a2026-10-06 https://evidence-hub.com/study/62802-occult-hepatitis-b-and-the-detection-of-other-hbv-genes-in-hbs-gene2026-10-06 https://evidence-hub.com/study/62803-application-driven-pedagogical-knowledge-optimization-of-open-source2026-10-06 https://evidence-hub.com/study/62804-prevalence-of-schistosoma-haematobium-and-schistosoma-mansoni-co2026-10-06 https://evidence-hub.com/study/62805-antimicrobial-activities-of-bio-oil-and-bio-tar-obtained-from2026-10-06 https://evidence-hub.com/study/62806-exploiting-tree-structure-for-credit-assignment-in-reinforcement2026-10-06 https://evidence-hub.com/study/62807-mapping-the-structural-heterogeneity-of-pup-ligase-pafa-using-h-d2026-10-06 https://evidence-hub.com/study/62808-repurposed-medicines-a-scan-of-the-non-commercial-clinical-research2026-10-06 https://evidence-hub.com/study/62809-incidence-of-acute-kidney-injury-and-associated-mortality-in-nigeria2026-10-06 https://evidence-hub.com/study/62810-global-prevalence-of-depression-in-chronic-kidney-disease-a2026-10-06 https://evidence-hub.com/study/62811-perspectives-of-relatives-of-patients-with-end-stage-kidney-disease2026-10-06 https://evidence-hub.com/study/62812-integration-of-routine-immunization-and-covid-19-vaccination-in-ekiti2026-10-06 https://evidence-hub.com/study/62813-clinicopathological-determinants-of-suicidal-thoughts-and-behavior-in2026-10-06 https://evidence-hub.com/study/62814-a-twist-of-fate-the-helix-turn-helix-motif-in-pseudomonas-aeruginosa2026-10-06 https://evidence-hub.com/study/62815-global-prevalence-of-depression-in-chronic-kidney-disease-a2026-10-06 https://evidence-hub.com/study/62816-more-than-an-attachment-module-covalent-inhibitor-warheads-influence2026-10-06 https://evidence-hub.com/study/62817-repurposed-medicines-a-scan-of-the-non-commercial-clinical-research2026-10-06 https://evidence-hub.com/study/62818-horizon-scan-of-the-clinical-development-landscape-of-biosimilar2026-10-06 https://evidence-hub.com/study/62819-new-or-repurposed-a-novel-classification-system-for-the-horizon2026-10-06 https://evidence-hub.com/study/62820-piperine-from-green-extraction-to-clinical-translation-a-review2026-10-06 https://evidence-hub.com/study/62821-synthetic-peptides-elicit-humoral-response-against-porcine2026-10-06 https://evidence-hub.com/study/62822-suicidal-behaviour-among-patients-with-congestive-cardiac-failure-in2026-10-06 https://evidence-hub.com/study/62823-assessing-the-dimensional-structure-and-measurement-invariance-of2026-10-06 https://evidence-hub.com/study/62824-efficacy-and-safety-of-upadacitinib-for-16-week-extended-induction2026-10-06 https://evidence-hub.com/study/62825-activeinspect-grpo-optimized-multi-sensor-evidence-selection-for2026-10-06 https://evidence-hub.com/study/62826-examining-kidney-donation-in-nigeria-a-mixed-methods-study-of-family2026-10-06 https://evidence-hub.com/study/62827-a-probabilistic-decision-support-tool-for-prediction-and-management2026-10-06 https://evidence-hub.com/study/62828-efficacy-and-safety-of-upadacitinib-maintenance-therapy-for2026-10-06 https://evidence-hub.com/study/62829-ni-catalyzed-benzylic-c-sp3-h-bond-activation-of-formamides2026-10-06 https://evidence-hub.com/study/62830-facilitators-and-barriers-to-use-of-clinical-practice-guidelines2026-10-06 https://evidence-hub.com/study/62831-upadacitinib-therapy-reduces-ulcerative-colitis-symptoms-as-early-as2026-10-06 https://evidence-hub.com/study/62832-phosphine-oxide-promoted-rh-i-catalyzed-c-h-cyclization-of2026-10-06 https://evidence-hub.com/study/62833-the-prevalence-and-risk-of-mortality-associated-with-intradialytic2026-10-06 https://evidence-hub.com/study/62834-spray-flash-evaporation-a-promising-path-to-fundamental-research-and2026-10-06 https://evidence-hub.com/study/62835-roles-of-mobile-teams-in-tracing-lost-to-follow-up-clients-evidence2026-10-06 https://evidence-hub.com/study/62836-distribution-prediction-of-the-habitat-of-jingmen-tick-virus-in-china2026-10-06 https://evidence-hub.com/study/62837-predicted-conformations-of-5-ht3-receptor-ion-channels-are-modified2026-10-06 https://evidence-hub.com/study/62838-closing-the-loop-between-horizon-scanning-and-health-technology2026-10-06 https://evidence-hub.com/study/62839-functional-iron-status-of-chronic-kidney-disease-patients-at-the2026-10-06 https://evidence-hub.com/study/62840-analysis-of-risk-factors-treatment-patterns-and-survival-outcomes2026-10-06 https://evidence-hub.com/study/62841-anaerobic-oxidation-of-ammonium-and-short-chain-gaseous-alkanes2026-10-06 https://evidence-hub.com/study/62842-amplitude-response-melnikov-s-criteria-and-chaos-occurrence-in-a2026-10-06 https://evidence-hub.com/study/62843-revisiting-the-pneumocystis-host-specificity-paradigm-and2026-10-06 https://evidence-hub.com/study/62844-epidemiology-of-depression-in-primary-care-findings-from-the-mental2026-10-06 https://evidence-hub.com/study/62845-the-relationship-between-protective-factors-and-a-measure-of2026-10-06 https://evidence-hub.com/study/62846-evaluating-responses-by-chatgpt-to-farmers-questions-on-irrigated2026-10-06 https://evidence-hub.com/study/62847-taking-international-law-seriously-interpretation-of-the-1998-belfast2026-10-06 https://evidence-hub.com/study/62848-data-of-selected-set-of-rice-accessions-at-the-germination-stage2026-10-06 https://evidence-hub.com/study/62849-a-meta-analysis-of-rice-phosphoproteomics-data-to-understand2026-10-06 https://evidence-hub.com/study/62850-physicians-perception-of-task-sharing-with-non-physician-health-care2026-10-06 https://evidence-hub.com/study/62851-effects-of-monetary-policy-announcements-on-term-premia-in-the-euro2026-10-06 https://evidence-hub.com/study/62853-induction-and-maintenance-treatment-with-upadacitinib-improves-health2026-10-06 https://evidence-hub.com/study/62854-large-language-models-as-medical-code-selectors-a-benchmark-using-the2026-10-06 https://evidence-hub.com/study/62855-collective-escape-and-supratransmission-phenomena-in-a-nonlinear2026-10-06 https://evidence-hub.com/study/62856-forward-and-backward-propagating-breathers-in-a-dna-model-with-dipole2026-10-06 https://evidence-hub.com/study/62857-understanding-biological-control-with-entomopathogenic-fungi-insights2026-10-06 https://evidence-hub.com/study/62858-assessment-of-hypertension-service-availability-in-some-primary2026-10-06 https://evidence-hub.com/study/62859-the-impact-of-the-use-of-biological-weapons-in-warfare-covid-19-as-a2026-10-06 https://evidence-hub.com/study/62860-three-new-species-of-the-primitively-segmented-spider-genus-songthela2026-10-06 https://evidence-hub.com/study/62861-emergency-dental-care-triage-during-the-covid-19-pandemic2026-10-06 https://evidence-hub.com/study/62862-combination-therapies-for-covid-19-an-overview-of-the-clinical-trials2026-10-06 https://evidence-hub.com/study/62866-structure-narrative-context-and-function-of-healing-mantras-in-biaro2026-10-06 https://evidence-hub.com/study/62867-robust-summarization-of-doctor-patient-conversations-taltech-systems2026-10-06 https://evidence-hub.com/study/62872-entomopathogenic-efficacy-and-cuticle-degrading-enzyme-production-in2026-10-06 https://evidence-hub.com/study/62873-organizational-culture-as-a-predictor-of-climate-action2026-10-06 https://evidence-hub.com/study/62874-association-between-depression-severity-functional-impairment-and2026-10-06 https://evidence-hub.com/study/62876-evaluating-the-effect-of-hepatitis-b-vaccination-on-serological2026-10-06 https://evidence-hub.com/study/62878-dependency-and-vulnerability-argument-in-care-ethics-and-the-moral2026-10-06 https://evidence-hub.com/study/62879-study-of-the-distribution-range-of-species-f-the-genus-adonis-l2026-10-06 https://evidence-hub.com/study/62880-effectiveness-of-a-school-based-group-psychotherapy-program-for-war2026-10-06 https://evidence-hub.com/study/62882-nutritional-phytochemical-and-mineral-profiling-of-uvaria-chamae2026-10-06 https://evidence-hub.com/study/62885-herbal-interventions-in-the-management-of-diabetes-mellitus-a2026-10-06 https://evidence-hub.com/study/62887-optimisation-of-cultivation-conditions-for-enhanced-biomass-and-lipid2026-10-06 https://evidence-hub.com/study/62888-the-desirability-bias-in-personality-related-syllogistic-reasoning2026-10-06 https://evidence-hub.com/study/62890-comprehensive-evaluation-of-the-proximate-phytochemical-mineral-and2026-10-06 https://evidence-hub.com/study/62891-systematic-determination-of-the-reproductive-growth-stage-most2026-10-06 https://evidence-hub.com/study/62892-working-memory-span-tasks-group-administration-and-omitting-accuracy2026-10-06 https://evidence-hub.com/study/62893-determinants-of-covid-19-treatment-outcomes-among-patients-admitted2026-10-06 https://evidence-hub.com/study/62897-racial-differences-in-knowledge-and-beliefs-about-alzheimer-disease2026-10-06 https://evidence-hub.com/study/62899-determinants-of-changes-in-cognitive-functioning-in-the-elderly2026-10-06 https://evidence-hub.com/study/62900-correlation-of-mucosal-healing-endpoints-with-long-term-clinical-and2026-10-06 https://evidence-hub.com/study/62901-three-new-species-of-the-subterranean-genus-guiodytes-from-guangxi2026-10-06 https://evidence-hub.com/study/62902-qualitative-assessment-of-the-enablers-and-barriers-of-covid-192026-10-06 https://evidence-hub.com/study/62903-development-and-feasibility-assessment-of-a-collaborative-stepped2026-10-06 https://evidence-hub.com/study/62904-op55-classification-system-for-innovative-medicines-in-the-pipeline2026-10-06 https://evidence-hub.com/study/62907-p546-comparative-efficacy-and-safety-of-upadacitinib-versus2026-10-06 https://evidence-hub.com/study/62908-hormonal-contraceptives-use-and-clinical-changes-in-women-attending-a2026-10-06 https://evidence-hub.com/study/62910-p011-prevalence-of-hypertension-and-association-with-red-meat-and2026-10-06 https://evidence-hub.com/study/62912-pp18-horizon-scanning-for-clinical-biosimilar-medicines-informing-the2026-10-06 https://evidence-hub.com/study/62917-efficacy-safety-and-tolerability-of-vortioxetine-for-the-treatment-of2026-10-06 https://evidence-hub.com/study/62921-patient-perspective-of-cognitive-symptoms-in-major-depressive2026-10-06 https://evidence-hub.com/study/62923-dop40-impact-of-corticosteroid-usage-on-efficacy-and-safety-outcomes2026-10-06 https://evidence-hub.com/study/62924-s1028-symptoms-and-laboratory-values-as-proxies-for-endoscopic-and2026-10-06 https://evidence-hub.com/study/62927-femoral-preincisional-block-in-acute-postoperative-pain-management-of2026-10-04 https://evidence-hub.com/study/62928-oxycodone-extended-release-in-the-treatment-of-perioperative-pain-in2026-10-04 https://evidence-hub.com/study/62930-dapo-effect-in-fe23b62026-10-04 https://evidence-hub.com/study/62931-a-new-dapo-algorithm-for-stock-trading2026-10-04 https://evidence-hub.com/study/62933-characterization-of-nbcma-a-dapo-precursor2026-10-04 https://evidence-hub.com/study/62935-the-development-and-testing-of-the-depression-anxiety-and-positive2026-10-04 https://evidence-hub.com/study/62936-dapo-fe23b62026-10-04 https://evidence-hub.com/study/62937-dapo-llm-105-improving-the-particle-morphology-and-thermal-stability2026-10-04 https://evidence-hub.com/study/62938-peranan-bumdes-karang-dapo-sebagai-penggerak-ekonomi-pemerintahan2026-10-04 https://evidence-hub.com/study/62939-on-dapo-adelugba-and-theater-studies-in-nigeria2026-10-04 https://evidence-hub.com/study/62940-improving-dapo-from-a-mixed-policy-perspective2026-10-04 https://evidence-hub.com/study/62942-responsiveness-and-construct-validity-of-the-depression-anxiety-and2026-10-04 https://evidence-hub.com/study/62944-evocation-of-the-tides-dapo-adelugba-s-production-of-ozidi2026-10-04 https://evidence-hub.com/study/62945-the-director-as-a-theatre-critic-the-case-of-dapo-adelugba2026-10-04 https://evidence-hub.com/study/62946-dapo-kak-az-amirul-affiq-amran-et-al2026-10-04 https://evidence-hub.com/study/62948-comparative-analysis-and-parametric-tuning-of-ppo-grpo-and-dapo-for2026-10-04 https://evidence-hub.com/study/62949-evaluasi-layanan-perpustakaan-di-smp-negeri-karang-dapo2026-10-04 https://evidence-hub.com/study/62950-unsym-fac-exo-oh-co-dien-dapo-n3-zncl42026-10-04 https://evidence-hub.com/study/62951-a-study-on-the-present-situation-and-the-development-strategies-of2026-10-04 https://evidence-hub.com/study/62952-implementasi-sistem-informasi-inventaris-barang-pada-upt-bp-karang2026-10-04 https://evidence-hub.com/study/62954-the-development-process-of-the-plane-proportion-method-on-the-dapo2026-10-04 https://evidence-hub.com/study/62955-species-composition-and-distribution-of-set-net-catches-on-the-coast2026-10-04 https://evidence-hub.com/study/62956-the-depression-anxiety-and-positive-outlook-scale-dapos2026-10-04 https://evidence-hub.com/study/62957-sistem-informasi-pelayanan-administrasi-desa-karang-dapo-berbasis-web2026-10-04 https://evidence-hub.com/study/62958-cross-validation-of-the-depression-anxiety-and-positive-outlook-scale2026-10-04 https://evidence-hub.com/study/62959-dynamic-adaptive-prompt-optimization-dapo-a-smarter-approach-to2026-10-04 https://evidence-hub.com/study/62960-dapo-mobility-aware-joint-optimization-of-model-partitioning-and-task2026-10-04 https://evidence-hub.com/study/62961-dapo-an-open-source-llm-reinforcement-learning-system-at-scale2026-10-06 https://evidence-hub.com/study/62963-a-hybrid-approach-for-fmcw-radar-signal-augmentation-dapo-and-gspo2026-10-04 https://evidence-hub.com/study/62964-tinjauan-ulang-perhitungan-tikungan-proyek-perencanaan-jalan-karang2026-10-04 https://evidence-hub.com/study/62965-wa-0853-1102-5193-daftar-harga-jual-tempat-pemandian-jenazah2026-10-04 https://evidence-hub.com/study/62966-dapo-qaoa-an-algorithm-for-solving-combinatorial-optimization2026-10-04 https://evidence-hub.com/study/62967-grpo-dr-grpo-and-dapo-are-three-operations-on-one-number-the-group2026-10-04 https://evidence-hub.com/study/62968-dapo-design-structure-aware-pass-ordering-for-hls-via-contrastive-and2026-10-04 https://evidence-hub.com/study/62969-dapos-une-ile-a-lapos-autre-enjeux-de-la-creolite-au-feminin2026-10-04 https://evidence-hub.com/study/62970-automatic-paper-analysis-and-categorisation-for-systematic-reviews2026-10-04 https://evidence-hub.com/study/62972-characteristics-and-onsite-costs-of-the-sediment-lost-by-runoff-from2026-10-04 https://evidence-hub.com/study/62973-fundamentals-of-entrepreneurship-ent300-case-study-kafe-dapo-emak2026-10-04 https://evidence-hub.com/study/62974-penerapan-metode-moora-dalam-evaluasi-kinerja-penyuluh-pertanian-di2026-10-04 https://evidence-hub.com/study/62975-faktor-faktor-yang-berhubungan-dengan-kepatuhan-penderita-hipertensi2026-10-04 https://evidence-hub.com/study/62977-reinterpretasi-kisah-abigail-dari-perspektif-pairan-dapo-di-mamasa2026-10-04 https://evidence-hub.com/study/62978-personal-fund-of-professor-cherevan-in-state-archives-of-poltava2026-10-04 https://evidence-hub.com/study/62980-base-hydrolysis-of-pentaaminecobalt-iii-complexes-the-cox-dien-dapo-n2026-10-04 https://evidence-hub.com/study/62981-sistem-pengendalian-intern-atas-penggajian-karyawan-perusahaan-studi2026-10-04 https://evidence-hub.com/study/62982-principles-of-entrepreneurship-ent530-business-model-canvas-dapo-kak2026-10-04 https://evidence-hub.com/study/62983-base-hydrolysis-of-pentaaminecobalt-iii-complexes-the-cox-dien-dapo-n2026-10-04 https://evidence-hub.com/study/62984-transitivity-patterns-in-selected-excerpts-from-amma-darko-s-beyond2026-10-04 https://evidence-hub.com/study/62985-dapo-design-structure-aware-pass-ordering-in-high-level-synthesis2026-10-04 https://evidence-hub.com/study/62986-a-study-on-the-erection-system-of-the-dapo-style-buddhist-halls-based2026-10-04 https://evidence-hub.com/study/62987-immunities-of-state-officials-international-crimes-and-foreign2026-10-04 https://evidence-hub.com/study/62988-hubungan-dukungan-keluarga-dengan-tingkat-kesepian-lonlinnes-pada2026-10-04 https://evidence-hub.com/study/62990-two-performances-two-worlds-dapo-adelugba-s-directorial-intervention2026-10-04 https://evidence-hub.com/study/62991-reactions-of-mer-exo-and-mer-endo-co-dien-dapo-x-2-isomers-x-oh-cl2026-10-04 https://evidence-hub.com/study/62993-the-character-and-development-of-dapo-type-double-layered-interior2026-10-04 https://evidence-hub.com/study/62994-sosialisasi-dampak-penggunaan-smartphone-terhadap-siswa-siswi-mts2026-10-04 https://evidence-hub.com/study/62995-ben-saul-dapo-akande-the-oxford-guide-to-international-humanitarian2026-10-04 https://evidence-hub.com/study/62998-pengaruh-kepemimpinan-dan-motivasi-kerja-terhadap-kinerja-pegawai-di2026-10-04 https://evidence-hub.com/study/62999-base-hydrolysis-of-pentaaminecobalt-iii-complexes-the-cox-dien-dapo-n2026-10-04 https://evidence-hub.com/study/63000-workshop-penggunaan-canva-untuk-media-sosial-bagi-siswa-siswi-mts2026-10-04 https://evidence-hub.com/study/63002-analisis-faktor-faktor-yang-mempengaruhi-produksi-tanaman-karet2026-10-04 https://evidence-hub.com/study/63003-pengaruh-pengembangan-karier-dan-disiplin-kerja-terhadap-kepuasan2026-10-04 https://evidence-hub.com/study/63007-analisis-permintaan-tenaga-kerja-pada-usahatani-padi-sawah-di-desa2026-10-04 https://evidence-hub.com/study/63008-analisis-penyelesaian-tindak-kriminal-melalui-hukum-adat-studi-kasus2026-10-04 https://evidence-hub.com/study/63009-tradisi-pernikahan-melangkahi-saudara-kandung-di-desa-karang-dapo2026-10-04 https://evidence-hub.com/study/63010-revitalisasi-nilai-nilai-pendidikan-karakter-melalui-permainan-rakyat2026-10-04 https://evidence-hub.com/study/63012-growth-and-survival-of-catfish-clarias-gariepinus-with-addition-of2026-10-04 https://evidence-hub.com/study/63013-a-study-on-the-transition-of-salmi-in-dapo-type-kong-po-focused-on2026-10-04 https://evidence-hub.com/study/63015-ademola-o-dasylva-dapo-adelugba-on-theatre-practice-in-nigeria-bode2026-10-04 https://evidence-hub.com/study/63016-pola-internalisasi-nilai-nilai-agama-islam-pada-suku-anak-dalam-di2026-10-04 https://evidence-hub.com/study/63017-peranan-kepala-desa-dalam-memberdayakan-masyarakat-di-bidang2026-10-04 https://evidence-hub.com/study/63018-kemampuan-motorik-peserta-didik-kelas-iv-v-sdn-1-karang-dapo2026-10-04 https://evidence-hub.com/study/63019-austin-ovigue-asagba-ed-sam-ukala-his-work-at-sixty-and-duro-oni-sola2026-10-04 https://evidence-hub.com/study/63020-penalized-regression-models-for-the-nba2026-10-04 https://evidence-hub.com/study/63021-high-dimensional-subset-recovery-in-noise-sparsified-measurements2026-10-04 https://evidence-hub.com/study/63022-photonuclear-reactions-with-zinc-a-case-for-clinical-linacs2026-10-06 https://evidence-hub.com/study/63023-systematic-study-of-led-stimulated-recovery-of-radiation-damage-in2026-10-06 https://evidence-hub.com/study/63024-improving-multi-step-reasoning-abilities-of-large-language-models2026-10-04 https://evidence-hub.com/study/63025-rewards-as-labels-revisiting-rlvr-from-a-classification-perspective2026-10-04 https://evidence-hub.com/study/63026-learning-from-hard-prompts-difficulty-aware-advantage-amplification2026-10-04 https://evidence-hub.com/study/63027-dcpo-dynamic-clipping-policy-optimization2026-10-04 https://evidence-hub.com/study/63028-defect-aware-hybrid-prompt-optimization-via-progressive-tuning-for2026-10-06 https://evidence-hub.com/study/63029-dual-approximation-policy-optimization2026-10-04 https://evidence-hub.com/study/63030-rlharness-co-evolving-procedural-skills-with-reinforcement-learning2026-10-04 https://evidence-hub.com/study/63031-reinforcement-learning-for-large-language-model-selective-evidence2026-10-04 https://evidence-hub.com/study/63032-taming-the-thinker-conditional-entropy-shaping-for-adaptive-llm2026-10-04 https://evidence-hub.com/study/63033-guidance-contrastive-token-credit-assignment-for-discrete-policy2026-10-04 https://evidence-hub.com/study/63034-learning-when-to-think-while-listening-in-large-audio-language-models2026-10-04 https://evidence-hub.com/study/63035-mitigating-distribution-sharpening-in-math-rlvr-via-distribution2026-10-04 https://evidence-hub.com/study/63036-improving-sampling-efficiency-in-rlvr-through-adaptive-rollout-and2026-10-04 https://evidence-hub.com/study/63037-vl-norm-rethink-loss-aggregation-in-rlvr2026-10-04 https://evidence-hub.com/study/63038-cure-critical-token-guided-re-concatenation-for-entropy-collapse2026-10-04 https://evidence-hub.com/study/63039-prune-as-you-generate-online-rollout-pruning-for-faster-and-better2026-10-04 https://evidence-hub.com/study/63040-grpo-unifying-the-grpo-frameworks-with-learnable-token-preferences2026-10-04 https://evidence-hub.com/study/63041-htpo-towards-exploration-exploitation-balanced-policy-optimization2026-10-04 https://evidence-hub.com/study/63042-learning-to-use-tools-reinforcement-learning-for-tool-integrated2026-10-04 https://evidence-hub.com/study/63043-mg-thinker-bi-axial-self-reflection-for-multi-image-reasoning2026-10-04 https://evidence-hub.com/study/63044-ktae-a-model-free-algorithm-to-key-tokens-advantage-estimation-in2026-10-04 https://evidence-hub.com/study/63045-visual-sensitivity-is-not-claim-retractability-persistence-aware2026-10-04 https://evidence-hub.com/study/63046-dialogue-adaptive-language-model-pre-training-from-quality-estimation2026-10-04 https://evidence-hub.com/study/63047-disco-reinforcing-large-reasoning-models-with-discriminative2026-10-04 https://evidence-hub.com/study/63048-learning-zone-energy-online-data-selection-for-efficient-rl-post2026-10-04 https://evidence-hub.com/study/63049-adaturn-budget-aware-test-time-scaling-for-active-visual-perception2026-10-04 https://evidence-hub.com/study/63050-dualkv-shared-prompt-flash-attention-for-efficient-rl-training-with2026-10-04 https://evidence-hub.com/study/63051-f-grpo-don-t-let-your-policy-learn-the-obvious-and-forget-the-rare2026-10-04 https://evidence-hub.com/study/63052-siva-rl-sensitivity-invariance-visual-alignment-for-multimodal2026-10-04 https://evidence-hub.com/study/63053-multimodal-reward-hacking-in-reinforcement-learning2026-10-04 https://evidence-hub.com/study/63054-constrainedsql-training-llms-for-text2sql-via-constrained2026-10-04 https://evidence-hub.com/study/63055-memagent-reshaping-long-context-llm-with-multi-conv-rl-based-memory2026-10-04 https://evidence-hub.com/study/63056-rence-learning-to-reason-by-noise-contrastive-estimation2026-10-04 https://evidence-hub.com/study/63057-overconfident-errors-need-stronger-correction-asymmetric-confidence2026-10-04 https://evidence-hub.com/study/63058-vcrl-variance-based-curriculum-reinforcement-learning-for-large2026-10-04 https://evidence-hub.com/study/63059-gtpo-and-grpo-s-token-and-sequence-level-reward-shaping-with-policy2026-10-04 https://evidence-hub.com/study/63060-instruction-conditioned-exploration-for-reinforcement-learning-with2026-10-04 https://evidence-hub.com/study/63061-longr-unleashing-long-context-reasoning-via-reinforcement-learning2026-10-04 https://evidence-hub.com/study/63062-beyond-uniform-credit-causal-credit-assignment-for-policy-optimization2026-10-04 https://evidence-hub.com/study/63063-meta-learned-reward-shaping-for-reinforcement-learning-from-human2026-10-04 https://evidence-hub.com/study/63064-entropy-ratio-clipping-as-a-soft-global-constraint-for-stable2026-10-04 https://evidence-hub.com/study/63065-scrpo-from-errors-to-insights2026-10-04 https://evidence-hub.com/study/63066-qurl-efficient-reinforcement-learning-with-quantized-rollout2026-10-04 https://evidence-hub.com/study/63067-unipo-unified-interactive-visual-explanation-for-rl-fine-tuning2026-10-04 https://evidence-hub.com/study/63068-learning-to-solve-forgetting-to-retain-correct-set-turnover-in-rlvr2026-10-04 https://evidence-hub.com/study/63069-learning-generative-selection-for-best-of-n2026-10-04 https://evidence-hub.com/study/63070-rethinking-the-sampling-criteria-in-reinforcement-learning-for-llm2026-10-04 https://evidence-hub.com/study/63071-longact-harnessing-intrinsic-activation-patterns-for-long-context2026-10-04 https://evidence-hub.com/study/63072-rethinking-token-level-policy-optimization-for-multimodal-chain-of2026-10-04 https://evidence-hub.com/study/63073-attend-to-evidence-evidence-anchored-spatial-attention-supervision2026-10-04 https://evidence-hub.com/study/63074-prag-po-prompt-augmented-policy-optimization-for-robust-and-diverse2026-10-04 https://evidence-hub.com/study/63075-cfpo-counterfactual-policy-optimization-for-multimodal-reasoning2026-10-04 https://evidence-hub.com/study/63076-difficulty-estimated-policy-optimization2026-10-04 https://evidence-hub.com/study/63077-lora-scaffolded-policy-optimization-lspo-a-sampling-time-low-rank2026-10-04 https://evidence-hub.com/study/63078-execution-verified-reinforcement-learning-for-optimization-modeling2026-10-04 https://evidence-hub.com/study/63079-nes-an-instruction-free-low-latency-next-edit-suggestion-framework2026-10-06 https://evidence-hub.com/study/63080-gift-group-relative-implicit-fine-tuning-integrates-grpo-with-dpo-and2026-10-04 https://evidence-hub.com/study/63081-acpo-adaptive-curriculum-policy-optimization-for-aligning-vision2026-10-04 https://evidence-hub.com/study/63082-rpo-reinforcement-fine-tuning-with-partial-reasoning-optimization2026-10-04 https://evidence-hub.com/study/63083-diversifying-rlvr-rollouts-via-first-token-exploration2026-10-04 https://evidence-hub.com/study/63084-arbor-online-process-rewards-via-a-reusable-rubric-buffer-for-search2026-10-04 https://evidence-hub.com/study/63085-acpo-asymmetric-credit-policy-optimization-via-mode-local-entropy2026-10-04 https://evidence-hub.com/study/63086-future-policy-approximation-for-offline-reinforcement-learning-in-llm2026-10-04 https://evidence-hub.com/study/63087-redippo-reference-guided-value-calibration-and-discrepancy-aware2026-10-04 https://evidence-hub.com/study/63088-spend-your-rollouts-where-it-counts-rollout-allocation-for-group2026-10-04 https://evidence-hub.com/study/63089-faster-synchronous-on-policy-rl-via-straggler-aware-group-sizing2026-10-04 https://evidence-hub.com/study/63090-environments-as-scaffold-enriching-feedback-to-bootstrap-self2026-10-04 https://evidence-hub.com/study/63091-gcpo-diagnosing-and-constraining-subspace-geometry-in-rollout-rl-for2026-10-04 https://evidence-hub.com/study/63092-what-are-key-factors-for-updates-in-rl-for-llm-reasoning2026-10-04 https://evidence-hub.com/study/63093-gapo-robust-advantage-estimation-for-real-world-code-llms2026-10-04 https://evidence-hub.com/study/63094-one-way-policy-optimization-for-self-evolving-llms2026-10-04 https://evidence-hub.com/study/63095-towards-full-pipeline-fp8-reinforcement-learning-for-llms2026-10-04 https://evidence-hub.com/study/63096-appo-attention-guided-perception-policy-optimization-for-video2026-10-04 https://evidence-hub.com/study/63097-heterogeneous-adaptive-policy-optimization-tailoring-optimization-to2026-10-04 https://evidence-hub.com/study/63098-clore-content-level-optimization-for-reasoning-efficiency2026-10-04 https://evidence-hub.com/study/63099-right-makes-might-aligning-verified-hidden-states-empowers-rl2026-10-04 https://evidence-hub.com/study/63100-leveraging-error-diversity-in-group-rollouts-for-reinforcement2026-10-04 https://evidence-hub.com/study/63101-learning-from-own-solutions-self-conditioned-credit-assignment-for2026-10-04 https://evidence-hub.com/study/63102-failure-makes-the-agent-stronger-enhancing-accuracy-through2026-10-04 https://evidence-hub.com/study/63103-clipping-bottleneck-stabilizing-rlvr-via-stochastic-recovery-of-near2026-10-04 https://evidence-hub.com/study/63104-learn-from-the-gap-differential-aware-advantage-pruning-with-adaptive2026-10-04 https://evidence-hub.com/study/63105-does-seeing-more-mean-knowing-more-mono-anchored-advantage2026-10-04 https://evidence-hub.com/study/63106-learn-hard-problems-during-rl-with-reference-guided-fine-tuning2026-10-04 https://evidence-hub.com/study/63107-v-0-5-generalist-value-model-as-a-prior-for-sparse-rl-rollouts2026-10-04 https://evidence-hub.com/study/63108-vapo-efficient-and-reliable-reinforcement-learning-for-advanced2026-10-04 https://evidence-hub.com/study/63109-multi-task-grpo-reliable-llm-reasoning-across-tasks2026-10-04 https://evidence-hub.com/study/63110-training-long-context-multi-turn-software-engineering-agents-with2026-10-04 https://evidence-hub.com/study/63111-adjuvant-lactam-therapy-combined-with-vancomycin-or-daptomycin-for2026-10-06 https://evidence-hub.com/study/63112-op34-efficacy-and-safety-of-advanced-induction-and-maintenance2026-10-06 https://evidence-hub.com/study/63114-how-drowsiness-and-distraction-can-interfere-with-take-over2026-10-20 https://evidence-hub.com/study/63115-safety-improvements-by-intelligent-connected-vehicle-technologies-a2026-10-20 https://evidence-hub.com/study/63116-meta-analysis-and-the-science-of-research-synthesis2026-10-20 https://evidence-hub.com/study/63117-global-prevalence-and-case-fatality-rate-of-enterovirus-d682026-10-20 https://evidence-hub.com/study/63119-the-effectiveness-of-psychological-interventions-for-fatigue-in2026-10-19 https://evidence-hub.com/study/63120-diabetes-drugs-for-nonalcoholic-fatty-liver-disease-a-systematic2026-10-19 https://evidence-hub.com/study/63121-maternal-inflammatory-markers-for-chorioamnionitis-in-preterm2026-10-19 https://evidence-hub.com/study/63122-a-systematic-review-of-the-perceptions-of-adolescents-on-graphic2026-10-19 https://evidence-hub.com/study/63123-gender-based-violence-among-female-youths-in-educational-institutions2026-10-19 https://evidence-hub.com/study/63124-exercise-or-exercise-and-diet-for-the-management-of-polycystic-ovary2026-10-19 https://evidence-hub.com/study/63125-strategies-for-increasing-participation-in-mail-out-colorectal-cancer2026-10-19 https://evidence-hub.com/study/63126-synthesis-of-dapoxetine2026-10-04 https://evidence-hub.com/study/63127-study-on-the-resolution-of-racemic-dapoxetine2026-10-12 https://evidence-hub.com/study/63129-synthesis-of-s-dapoxetine2026-10-12 https://evidence-hub.com/study/63131-synthesis-of-dapoxetine-hydrochloride2026-10-12 https://evidence-hub.com/study/63134-dapoxetine-in-the-treatment-of-premature-ejaculation2026-10-12 https://evidence-hub.com/study/63135-the-progress-in-the-synthetic-methods-of-dapoxetine2026-10-12 https://evidence-hub.com/study/63136-dapoxetine-premature-ejaculation-not-worth-the-risk2026-10-12 https://evidence-hub.com/study/63138-synthesis-of-dapoxetine-hydrochloride2026-10-12 https://evidence-hub.com/study/63141-dapoxetine-licensed-treatment-for-premature-ejaculation2026-10-12 https://evidence-hub.com/study/63143-dapoxetine-a-pharmacological-therapy-for-the-treatment-of-premature2026-10-12 https://evidence-hub.com/study/63145-improved-synthesis-of-dapoxetine-hydrochloride2026-10-12 https://evidence-hub.com/study/63147-validated-uv-spectrophotometric-method-for-estimation-of-dapoxetine2026-10-12 https://evidence-hub.com/study/63151-efficacy-and-safety-of-switching-to-ixekizumab-in-etanercept-non2026-10-06 https://evidence-hub.com/study/63152-impact-of-the-population-medicine-multimorbidity-intervention-in2026-10-06 https://evidence-hub.com/study/63153-impact-of-the-population-medicine-multimorbidity-intervention-in2026-10-06 https://evidence-hub.com/study/63154-impact-of-baseline-corticosteroid-use-on-the-efficacy-and-safety-of2026-10-06 https://evidence-hub.com/study/63155-understanding-the-performance-of-a-pan-african-intervention-to-reduce2026-10-06 https://evidence-hub.com/study/63156-effect-of-convalescent-plasma-on-organ-support-free-days-in2026-10-06 https://evidence-hub.com/study/63157-shared-decision-making-and-the-use-of-decision-aids2026-10-06 https://evidence-hub.com/study/63158-impact-of-an-intervention-to-improve-treatment-seeking-behavior-and2026-10-06 https://evidence-hub.com/study/63159-convalescent-plasma-in-patients-admitted-to-hospital-with-covid-192026-10-06 https://evidence-hub.com/study/63161-rapid-and-sustained-symptom-reduction-following-psilocybin-treatment2026-10-06 https://evidence-hub.com/study/63162-a-5-year-multicentre-randomized-controlled-trial-comparing2026-10-06 https://evidence-hub.com/study/63163-role-of-vitamin-e-for-nonalcoholic-steatohepatitis-in-patients-with2026-10-19 https://evidence-hub.com/study/63164-disease-free-survival-and-local-recurrence-for-laparoscopic-resection2026-10-06 https://evidence-hub.com/study/63165-operative-versus-non-operative-treatment-for-2-part-proximal-humerus2026-10-06 https://evidence-hub.com/study/63166-effects-of-intermittent-and-continuous-calorie-restriction-on-body2026-10-12 https://evidence-hub.com/study/63168-a-randomized-controlled-trial-of-kundalini-yoga-in-mild-cognitive2026-10-19 https://evidence-hub.com/study/63169-continuous-glucose-monitoring-during-diabetic-pregnancy-glucomoms-a2026-10-06 https://evidence-hub.com/study/63170-condoliase-for-the-treatment-of-lumbar-disc-herniation-a-randomized2026-10-06 https://evidence-hub.com/study/63173-tiotropium-add-on-therapy-in-adolescents-with-moderate-asthma-a-12026-10-06 https://evidence-hub.com/study/63174-cluster-randomized-controlled-trial2026-10-19 https://evidence-hub.com/study/63175-intracoronary-infusion-of-wharton-s-jelly-derived-mesenchymal-stem2026-10-06 https://evidence-hub.com/study/63176-the-effects-of-a-course-of-intranasal-oxytocin-on-social-behaviors-in2026-10-06 https://evidence-hub.com/study/63177-efficacy-of-transoral-fundoplication-vs-omeprazole-for-treatment-of2026-10-09 https://evidence-hub.com/study/63179-significant-effects-of-oral-phenylbutyrate-and-vitamin-d3-adjunctive2026-10-06 https://evidence-hub.com/study/63181-symplicity-htn-japan-first-randomized-controlled-trial-of-catheter2026-10-06 https://evidence-hub.com/study/63183-examining-adherence-to-american-urological-association-aua-guidelines2026-10-08 https://evidence-hub.com/study/63184-evaluating-a-non-pharmacological-treatment-for-primary-premature2026-10-08 https://evidence-hub.com/study/63185-a-quantitative-analysis-of-street-level-drugs-seized-in-new-south2026-10-08 https://evidence-hub.com/study/63186-exploring-potential-drug-drug-interactions-a-cross-sectional-study-of2026-10-08 https://evidence-hub.com/study/63187-influence-of-low-level-laser-irradiation-of-the-red-and-infrared2026-10-08 https://evidence-hub.com/study/63188-clinical-evaluation-of-compound-jinji-granules-in-the-treatment-of2026-10-19 https://evidence-hub.com/study/63189-416-management-and-treatment-variations-in-premature-ejaculation-a2026-10-08 https://evidence-hub.com/study/63190-validity-and-reliability-of-the-turkish-version-of-the-premature2026-10-08 https://evidence-hub.com/study/63191-the-effects-of-selective-serotonin-reuptake-inhibitors-on-motility-of2026-10-08 https://evidence-hub.com/study/63194-long-term-sildenafil-dapoxetine-administration-exerts-anxiolytic-like2026-10-08 https://evidence-hub.com/study/63196-unraveling-the-anticancer-potential-of-ssris-in-prostate-cancer-by2026-10-08 https://evidence-hub.com/study/63197-the-pharmaceutical-treatment-of-premature-ejaculation2026-10-08 https://evidence-hub.com/study/63198-enantiodivergent-rh-catalyzed-reductive-hydroformylation-of-alkenyl2026-10-08 https://evidence-hub.com/study/63199-are-we-ready-to-explore-administration-of-botulinum-toxin-in-the2026-10-08 https://evidence-hub.com/study/63200-letter-to-the-editor-on-efficacy-and-safety-of-pharmacological2026-10-08 https://evidence-hub.com/study/63202-response-to-letter-to-the-editor-on-efficacy-and-safety-of2026-10-08 https://evidence-hub.com/study/63203-clinical-significance-of-serum-nesfatin-1-as-a-novel-biomarker-in2026-10-08 https://evidence-hub.com/study/63204-effectiveness-of-mobile-health-intervention-in-medication-adherence-a2026-10-13 https://evidence-hub.com/study/63205-efficacy-and-safety-of-biologics-for-chronic-rhinosinusitis-with2026-10-06 https://evidence-hub.com/study/63207-classification-of-animal-species-via-deep-neural-networks-and-species2026-10-08 https://evidence-hub.com/study/63208-multiple-breath-washout-in-primary-ciliary-dyskinesia-a-systematic2026-10-06 https://evidence-hub.com/study/63209-efficacy-of-yijinjing-for-soft-tissue-improvement-in-patients-with2026-10-08 https://evidence-hub.com/study/63210-effectiveness-of-two-supportive-periodontal-care-protocols-and2026-10-13 https://evidence-hub.com/study/63211-ai-driven-cognitive-telerehabilitation-for-stroke-a-randomized2026-10-08 https://evidence-hub.com/study/63212-the-effects-of-melatonin-on-follicular-oxidative-stress-and-art2026-10-13 https://evidence-hub.com/study/63214-the-rehand-bci-trial-a-randomized-controlled-trial-of-a-brain2026-10-08 https://evidence-hub.com/study/63215-natural-cycle-versus-hormone-replacement-therapy-as-endometrial2026-10-13 https://evidence-hub.com/study/63216-extended-continuous-positive-airway-pressure-in-preterm-infants2026-10-13 https://evidence-hub.com/study/63217-evaluating-a-mobile-digital-therapeutic-for-vasomotor-and-behavioral2026-10-06 https://evidence-hub.com/study/63218-assessment-of-the-efficacy-of-on-demand-tegoprazan-therapy-in2026-10-20 https://evidence-hub.com/study/63219-cord-red-blood-cell-transfusions-for-severe-retinopathy-in-preterm2026-10-13 https://evidence-hub.com/study/63220-ferric-carboxymaltose-for-anemia-in-late-pregnancy-a-randomized2026-10-13 https://evidence-hub.com/study/63222-effect-of-combination-of-multiple-anti-inflammatory-drugs-strategy-on2026-10-06 https://evidence-hub.com/study/63224-rehabilitation-therapy-for-children-with-autism-based-on-interactive2026-10-08 https://evidence-hub.com/study/63225-effects-of-probiotic-supplementation-on-depressive-symptoms-sleep2026-10-06 https://evidence-hub.com/study/63226-the-effects-of-a-web-based-need-supportive-intervention-for-physical2026-10-06 https://evidence-hub.com/study/63228-a-randomized-controlled-trial-of-telerehabilitation-intervention-for2026-10-08 https://evidence-hub.com/study/63229-outcomes-of-a-randomized-controlled-trial-of-neuromuscular-training2026-10-08 https://evidence-hub.com/study/63230-intervention-with-concentrated-albumin-for-undifferentiated-sepsis-in2026-10-06 https://evidence-hub.com/study/63231-effectiveness-of-virtual-and-augmented-reality-for-emergency2026-10-06 https://evidence-hub.com/study/63232-efficacy-of-opioid-free-anesthesia-in-reducing-postoperative-nausea2026-10-06 https://evidence-hub.com/study/63233-prebiotics-as-an-adjunct-therapy-for-posttraumatic-stress-disorder-a2026-10-08 https://evidence-hub.com/study/63234-chatgpt-as-a-learning-tool-for-medical-students-results-from-a2026-10-08 https://evidence-hub.com/study/63235-efficacy-of-delivery-of-care-with-tele-continuous-eeg-in-critically2026-10-06 https://evidence-hub.com/study/63236-patient-navigation-to-improve-colonoscopy-completion-following-an2026-10-06 https://evidence-hub.com/study/63237-randomized-controlled-trial-of-cognitive-behavioural-therapy-versus2026-10-06 https://evidence-hub.com/study/63238-videoconference-delivered-acceptance-and-commitment-therapy-for2026-10-06 https://evidence-hub.com/study/63239-efficacy-of-wearable-exoskeleton-for-gait-recovery-in-patients-with2026-10-06 https://evidence-hub.com/study/63240-circadian-and-gut-brain-axis-modulation-is-associated-with2026-10-06 https://evidence-hub.com/study/63241-does-propranolol-have-a-role-in-cancer-treatment-a-systematic-review2026-10-13 https://evidence-hub.com/study/63242-triple-switch-swog-cctg-pr26-a-randomized-phase-iii-clinical-trial2026-10-09 https://evidence-hub.com/study/63243-rapid-initiation-of-antiretroviral-therapy-with-coformulated2026-10-09 https://evidence-hub.com/study/63244-effectiveness-of-photobiomodulation-to-treat-motor-and-non-motor2026-10-08 https://evidence-hub.com/study/63245-artificial-intelligence-for-breast-cancer-screening-in-mammography-ai2026-10-13 https://evidence-hub.com/study/63246-comparison-of-triglyceride-glucose-index-and-modified-triglyceride2026-10-13 https://evidence-hub.com/study/63247-bleeding-and-new-malignancy-diagnoses-after-anticoagulation-for2026-10-13 https://evidence-hub.com/study/63248-association-of-respiratory-drive-and-effort-with-mortality-and-time2026-10-13 https://evidence-hub.com/study/63249-radiofrequency-ablation-of-low-risk-papillary-thyroid-microcarcinoma2026-10-13 https://evidence-hub.com/study/63250-the-interplay-between-birth-weight-and-intraventricular-hemorrhage-in2026-10-08 https://evidence-hub.com/study/63251-antihypertensive-drug-classes-and-risk-of-incident-dementia-a2026-10-13 https://evidence-hub.com/study/63252-early-and-long-term-effects-of-prophylactic-and-post-excision-human2026-10-06 https://evidence-hub.com/study/63253-severity-of-respiratory-syncytial-virus-versus-sars-cov-2-omicron-and2026-10-13 https://evidence-hub.com/study/63254-deep-cervical-lymphovenous-anastomosis-lva-for-alzheimer-s-disease2026-10-06 https://evidence-hub.com/study/63255-insulin-resistance-assessed-by-estimated-glucose-disposal-rate2026-10-08 https://evidence-hub.com/study/63256-life-s-essential-8-cardiovascular-health-cardiovascular-kidney2026-10-08 https://evidence-hub.com/study/63257-the-association-between-the-cally-index-and-all-cause-mortality-in2026-10-08 https://evidence-hub.com/study/63258-prognostic-nutritional-index-as-a-potential-predictor-of-prognosis-in2026-10-08 https://evidence-hub.com/study/63259-metabolic-dysfunction-associated-steatotic-liver-disease-metabolic2026-10-06 https://evidence-hub.com/study/63260-the-presence-and-prognosis-of-nerve-pathology-following-whiplash2026-10-08 https://evidence-hub.com/study/63261-revision-anterior-cruciate-ligament-reconstruction-using-rectus2026-10-08 https://evidence-hub.com/study/63262-mortality-hepatic-decompensation-and-cardiovascular-outcomes-in-lean2026-10-06 https://evidence-hub.com/study/63263-herpes-zoster-as-risk-factor-for-dementia-a-matched-cohort-study-over2026-10-08 https://evidence-hub.com/study/63264-risk-factors-for-dementia-and-cognitive-impairment-within-5-years2026-10-06 https://evidence-hub.com/study/63265-the-impact-of-the-triglyceride-glucose-index-on-the-deterioration-of2026-10-06 https://evidence-hub.com/study/63266-statin-use-and-the-risk-of-graves-orbitopathy-a-nationwide-population2026-10-08 https://evidence-hub.com/study/63267-effects-of-vaccination-on-acute-exacerbation-of-chronic-obstructive2026-10-06 https://evidence-hub.com/study/63268-the-effectiveness-of-nirsevimab-in-reducing-the-burden-of-disease-due2026-10-06 https://evidence-hub.com/study/63269-a-retrospective-cohort-study-of-valproate-and-infertility-in-men-with2026-10-06 https://evidence-hub.com/study/63270-specific-cardiovascular-mortality-in-cancer-survivors-a-nationwide2026-10-06 https://evidence-hub.com/study/63271-effect-of-qishen-yiqi-dripping-pills-on-the-classification-of2026-10-06 https://evidence-hub.com/study/63272-incarcerated-obturator-hernia-complicated-by-lower-limb-venous2026-10-08 https://evidence-hub.com/study/63273-a-successful-initial-management-of-a-penetrating-head-trauma-in-a2026-10-08 https://evidence-hub.com/study/63276-association-between-the-systemic-immune-inflammation-index-and2026-10-08 https://evidence-hub.com/study/63277-prevalence-and-risk-factors-of-gestational-diabetes-mellitus-among2026-10-08 https://evidence-hub.com/study/63278-war-related-continuous-traumatic-stress-as-a-potential-mediator-of2026-10-06 https://evidence-hub.com/study/63279-nurses-self-efficacy-job-embeddedness-and-psychological-empowerment-a2026-10-08 https://evidence-hub.com/study/63280-april-15th-war-and-hemodialysis-patients-in-sudan-a-cross-sectional2026-10-08 https://evidence-hub.com/study/63281-epidemiology-of-injuries-in-racket-sports-a-cross-sectional-study-of2026-10-08 https://evidence-hub.com/study/63282-effectiveness-of-multisport-play-based-practice-on-motor-coordination2026-10-06 https://evidence-hub.com/study/63283-factors-influencing-the-quality-of-life-and-mental-health-of2026-10-06 https://evidence-hub.com/study/63284-intuitive-stent-simulation-with-internal-cavity-airway-models-created2026-10-08 https://evidence-hub.com/study/63285-clinical-efficacy-of-elexacaftor-tezacaftor-ivacaftor-in-two-siblings2026-10-08 https://evidence-hub.com/study/63286-the-deceptive-cysts-of-echinococcus-granulosus-in-the-thigh-a-case2026-10-08 https://evidence-hub.com/study/63287-ocular-massage-in-central-retinal-artery-occlusion-monitoring2026-10-08 https://evidence-hub.com/study/63288-at-home-use-of-collagen-manuka-honey-hydroxyapatite-dressing-for2026-10-08 https://evidence-hub.com/study/63289-sheathless-delivery-of-a-transfemoral-pulsatile-left-ventricular2026-10-08 https://evidence-hub.com/study/63291-first-time-use-of-trans-anal-endorectal-pull-through-soave-procedure2026-10-08 https://evidence-hub.com/study/63292-the-use-of-platelet-rich-fibrin-prepared-with-titanium-tubes-t-prf-in2026-10-08 https://evidence-hub.com/study/63293-pulmonary-function-outcomes-in-children-undergoing-diaphragmatic2026-10-08 https://evidence-hub.com/study/63294-guided-bone-regeneration-gbr-for-reconstructing-alveolar-bone-defects2026-10-08 https://evidence-hub.com/study/63295-reverse-aqua-pump-vacuum-assisted-closure-alternative-and-affordable2026-10-08 https://evidence-hub.com/study/63296-a-case-series-of-functional-and-radiological-outcome-of-comminuted2026-10-12 https://evidence-hub.com/study/63297-gastroesophageal-junction-pancreatic-heterotopia-metaplasia-a-case2026-10-06 https://evidence-hub.com/study/63298-esophageal-cancer-secondary-to-achalasia-a-case-series-study2026-10-06 https://evidence-hub.com/study/63300-successful-treatment-of-pediatric-patient-with-dravet-syndrome-with2026-10-08 https://evidence-hub.com/study/63301-case-report-demonstrating-novel-approaches-for-leadless-pacemaker2026-10-08 https://evidence-hub.com/study/63302-post-traumatic-unilateral-elephantiasis-a-case-report2026-10-08 https://evidence-hub.com/study/63303-successful-replantation-of-a-completely-severed-hand-a-case-report2026-10-08 https://evidence-hub.com/study/63304-case-report-management-of-post-operative-infected-non-union-with2026-10-08 https://evidence-hub.com/study/63305-ozone-therapy-associated-pneumoperitoneum-in-a-patient-with-low-back2026-10-08 https://evidence-hub.com/study/63306-uterine-rupture-during-second-trimester-abortion-with-misoprostol-a2026-10-08 https://evidence-hub.com/study/63307-intraperitoneal-migration-of-an-intrauterine-device-a-case-report2026-10-08 https://evidence-hub.com/study/63308-zinner-syndrome-unveiled-ectopic-ureter-and-seminal-vesicle-cyst2026-10-08 https://evidence-hub.com/study/63309-appendicular-band-syndrome-leading-to-small-bowel-obstruction-a-case2026-10-08 https://evidence-hub.com/study/63310-successful-management-of-aluminum-phosphide-celphos-poisoning-with2026-10-08 https://evidence-hub.com/study/63311-hypertrichosis-associated-with-the-use-of-c-type-natriuretic-peptide2026-10-06 https://evidence-hub.com/study/63312-rare-metastasis-of-renal-cell-carcinoma-to-the-breast-a-case-report2026-10-08 https://evidence-hub.com/study/63313-necrotizing-fasciitis-caused-by-gas-producing-methicillin-sensitive2026-10-08 https://evidence-hub.com/study/63314-steroid-induced-cardiomyopathy-insights-from-a-systematic-literature2026-10-08 https://evidence-hub.com/study/63315-a-case-report-on-the-open-surgical-repair-of-thoracoabdominal-aortic2026-10-08 https://evidence-hub.com/study/63316-treatment-of-discoid-lupus-erythematosus-scarring-alopecia-with2026-10-08 https://evidence-hub.com/study/63317-pott-s-disease-presenting-with-bilateral-psoas-abscesses-in-a2026-10-08 https://evidence-hub.com/study/63318-treatment-refractory-immune-checkpoint-inhibitor-induced2026-10-08 https://evidence-hub.com/study/63319-a-case-of-aneurysmal-sah-and-stanford-type-a-acute-aortic-dissection2026-10-08 https://evidence-hub.com/study/63320-therapeutic-plasma-exchange-in-myelin-oligodendrocyte-glycoprotein2026-10-08 https://evidence-hub.com/study/63321-acute-psoriatic-flare-during-covid-19-infection-and-response-to2026-10-08 https://evidence-hub.com/study/63322-inverted-meckel-s-diverticulm-causing-intussecepsetion-case-report2026-10-08 https://evidence-hub.com/study/63323-polymyxin-b-therapy-induced-respiratory-arrest-in-a-liver-donor-a2026-10-08 https://evidence-hub.com/study/63324-early-onset-gitelman-syndrome-presenting-with-recurrent-hypokalaemia2026-10-08 https://evidence-hub.com/study/63325-unboxing-the-dilemma-of-a-fibro-osseous-lesion-of-maxilla-a-case2026-10-08 https://evidence-hub.com/study/63326-rituximab-for-thrombotic-thrombocytopenic-purpura-a-case-report2026-10-08 https://evidence-hub.com/study/63327-sclerosing-encapsulating-peritonitis-in-an-extensively-drug-resistant2026-10-08 https://evidence-hub.com/study/63328-uncommon-unilateral-congenital-knee-dislocation-a-case-report2026-10-06 https://evidence-hub.com/study/63329-coronary-spasm-as-a-manifestation-of-allergic-reaction-to-contrast2026-10-08 https://evidence-hub.com/study/63330-a-rare-presentation-of-adult-colonic-intussusception-secondary-to-a2026-10-08 https://evidence-hub.com/study/63331-pregnancy-and-lactation-related-osteoporosis-associating-multiple2026-10-08 https://evidence-hub.com/study/63332-a-case-of-a-metal-foreign-object-remaining-in-the-maxillary-bone-for2026-10-08 https://evidence-hub.com/study/63333-inflammatory-fibrous-hyperplasia-between-surgery-and-tissue2026-10-08 https://evidence-hub.com/study/63334-diagnosis-and-surgical-management-of-mesenteric-cysts-in-a-10-year2026-10-08 https://evidence-hub.com/study/63335-colo-ovarian-fistula-masquerading-as-tubo-ovarian-abscess-a-case2026-10-08 https://evidence-hub.com/study/63336-caseous-calcification-of-the-mitral-annulus-associated-with-a2026-10-08 https://evidence-hub.com/study/63337-inflammatory-optic-neuritis-and-scleritis-following-commencement-of2026-10-08 https://evidence-hub.com/study/63338-fecaloma-causing-small-bowel-obstruction-in-the-absence-of-risk2026-10-08 https://evidence-hub.com/study/63340-breakthrough-herpes-zoster-following-recombinant-zoster-vaccinations2026-10-08 https://evidence-hub.com/study/63341-malignant-anomalous-aortic-origin-of-the-left-main-coronary-artery2026-10-08 https://evidence-hub.com/study/63342-dupilumab-induced-psoriasis-in-a-patient-with-atopic-dermatitis2026-10-08 https://evidence-hub.com/study/63343-endobronchial-tuberculosis-mimicking-malignancy-lessons-from-a-case2026-10-08 https://evidence-hub.com/study/63344-immediate-autotransplantation-of-mature-third-molars-to-bilateral2026-10-08 https://evidence-hub.com/study/63345-interstitial-lung-disease-due-to-tepotinib-after-durvalumab-in-a2026-10-08 https://evidence-hub.com/study/63346-a-rare-clinical-presentation-of-metronidazole-induced-dysarthria-a2026-10-08 https://evidence-hub.com/study/63347-ruptured-heterotopic-pregnancy-with-successful-term-intrauterine2026-10-08 https://evidence-hub.com/study/63348-atypical-development-and-swift-resolution-of-an-ulcerated-hemangioma2026-10-08 https://evidence-hub.com/study/63350-early-pseudoprogression-after-tarlatamab-in-small-cell-lung-cancer-a2026-10-08 https://evidence-hub.com/study/63351-a-case-report-of-iga-type-multiple-myeloma-complicated-with2026-10-06 https://evidence-hub.com/study/63352-mri-findings-in-human-rabies-a-case-report-on-the-importance-of2026-10-08 https://evidence-hub.com/study/63353-hypothyroidism-and-hyperthyroidism-in-an-adolescent-with-complex2026-10-08 https://evidence-hub.com/study/63354-adult-wilms-tumor-with-inferior-vena-cava-thrombus-on-an-incomplete2026-10-08 https://evidence-hub.com/study/63355-concurrent-tp53-mutations-facilitate-resistance-evolution-in-egfr2026-10-08 https://evidence-hub.com/study/63356-robot-assisted-gastrectomy-and-sigmoid-colectomy-with-situs-inversus2026-10-08 https://evidence-hub.com/study/63357-metastatic-clear-renal-cell-carcinoma-in-urinary-bladder-at2026-10-08 https://evidence-hub.com/study/63358-zinner-syndrome-incidentally-diagnosed-in-a-man-with-ureteropelvic2026-10-08 https://evidence-hub.com/study/63359-bullous-lichen-planus-treated-with-adalimumab-a-case-report2026-10-08 https://evidence-hub.com/study/63360-the-importance-of-histopathology-in-the-diagnosis-of-annular2026-10-08 https://evidence-hub.com/study/63361-spontaneous-second-trimester-uterine-rupture-in-an-unscarred-uterus-a2026-10-08 https://evidence-hub.com/study/63362-a-case-report-supporting-the-use-of-teclistamab-in-multiple-myeloma2026-10-06 https://evidence-hub.com/study/63363-subacute-sclerosing-encephalitis-in-an-adult-with-congenital-hiv2026-10-08 https://evidence-hub.com/study/63364-partial-annular-pancreas-causing-obstruction-of-the-first-part-of-the2026-10-08 https://evidence-hub.com/study/63365-primary-renal-parenchymal-squamous-cell-carcinoma-involving-the-renal2026-10-08 https://evidence-hub.com/study/63366-successful-treatment-of-refractory-dermatomyositis-with2026-10-08 https://evidence-hub.com/study/63367-an-infective-endocarditis-case-report-involving-both-native-aortic2026-10-08 https://evidence-hub.com/study/63368-bilateral-choanal-atresia-in-a-65-year-old-female-a-case-report-and2026-10-06 https://evidence-hub.com/study/63369-recurrent-cavernous-sinus-syndrome-a-case-report-of-a-rare-clinical2026-10-06 https://evidence-hub.com/study/63370-pharmacotherapy-for-obesity-management-in-adults-2025-clinical2026-10-08 https://evidence-hub.com/study/63372-2025-canadian-guideline-for-physical-activity-sedentary-behaviour-and2026-10-08 https://evidence-hub.com/study/63373-reporting-guideline-for-the-use-of-generative-artificial-intelligence2026-10-08 https://evidence-hub.com/study/63374-therapy-for-stage-iv-non-small-cell-lung-cancer-with-driver2026-10-08 https://evidence-hub.com/study/63375-enhancing-intraoral-scanning-accuracy-from-the-influencing-factors-to2026-10-08 https://evidence-hub.com/study/63376-a-focused-update-to-the-clinical-practice-guidelines-for-the2026-10-08 https://evidence-hub.com/study/63377-nerandomilast-in-patients-with-idiopathic-pulmonary-fibrosis2026-10-08 https://evidence-hub.com/study/63378-design-and-rationale-of-lp-a-horizon-trial-assessing-the-effect-of2026-10-08 https://evidence-hub.com/study/63379-long-term-5-year-remission-and-survival-after-treatment-with2026-10-08 https://evidence-hub.com/study/63380-nerandomilast-in-patients-with-progressive-pulmonary-fibrosis2026-10-08 https://evidence-hub.com/study/63381-sotatercept-in-patients-with-pulmonary-arterial-hypertension-at-high2026-10-08 https://evidence-hub.com/study/63382-effects-of-semaglutide-on-chronic-kidney-disease-in-patients-with2026-10-08 https://evidence-hub.com/study/63383-global-prevalence-and-determinant-factors-of-pain-depression-and2026-10-08 https://evidence-hub.com/study/63385-prognostic-significance-of-the-cachexia-index-cxi-in-patients-with2026-10-08 https://evidence-hub.com/study/63386-5-year-outcomes-after-transcatheter-or-surgical-aortic-valve2026-10-08 https://evidence-hub.com/study/63387-multinational-attitudes-toward-ai-in-health-care-and-diagnostics2026-10-08 https://evidence-hub.com/study/63388-semaglutide-in-patients-with-obesity-related-heart-failure-and-type-22026-10-08 https://evidence-hub.com/study/63389-safety-of-pulsed-field-ablation-in-more-than-17-000-patients-with2026-10-08 https://evidence-hub.com/study/63390-lorlatinib-versus-crizotinib-in-patients-with-advanced-alk-positive2026-10-08 https://evidence-hub.com/study/63391-vutrisiran-in-patients-with-transthyretin-amyloidosis-with2026-10-08 https://evidence-hub.com/study/63392-the-global-epidemiology-of-non-alcoholic-fatty-liver-disease-and-non2026-10-08 https://evidence-hub.com/study/63393-recommendations-for-the-use-of-next-generation-sequencing-ngs-for2026-10-08 https://evidence-hub.com/study/63394-perioperative-toripalimab-plus-chemotherapy-for-patients-with2026-10-08 https://evidence-hub.com/study/63395-aga-clinical-practice-update-on-diet-and-nutritional-therapies-in2026-10-08 https://evidence-hub.com/study/63396-risk-of-nonarteritic-anterior-ischemic-optic-neuropathy-in-patients2026-10-08 https://evidence-hub.com/study/63397-trastuzumab-deruxtecan-in-patients-with-metastatic-non-small-cell2026-10-08 https://evidence-hub.com/study/63398-semaglutide-versus-placebo-in-patients-with-heart-failure-and-mildly2026-10-08 https://evidence-hub.com/study/63399-semaglutide-and-cardiovascular-outcomes-in-patients-with-obesity-and2026-10-08 https://evidence-hub.com/study/63400-allogeneic-cd19-targeted-car-t-therapy-in-patients-with-severe2026-10-08 https://evidence-hub.com/study/63401-interleukin-15-armored-gpc3-car-t-cells-for-patients-with-solid2026-10-08 https://evidence-hub.com/study/63402-anthracycline-cardiotoxicity-in-adult-cancer-patients2026-10-08 https://evidence-hub.com/study/63403-self-expanding-or-balloon-expandable-tavr-in-patients-with-a-small2026-10-08 https://evidence-hub.com/study/63404-acute-kidney-injury-in-patients-with-cirrhosis-acute-disease-quality2026-10-08 https://evidence-hub.com/study/63405-a-randomised-controlled-phase-3-trial-of-lutetium-177-psma-617-in2026-10-08 https://evidence-hub.com/study/63406-total-neoadjuvant-therapy-with-mfolfirinox-versus-preoperative2026-10-08 https://evidence-hub.com/study/63407-lowering-systolic-blood-pressure-to-less-than-120-mm-hg-versus-less2026-10-08 https://evidence-hub.com/study/63408-combined-jak-inhibition-and-pd-1-immunotherapy-for-non-small-cell2026-10-08 https://evidence-hub.com/study/63409-apixaban-to-prevent-recurrence-after-cryptogenic-stroke-in-patients2026-10-08 https://evidence-hub.com/study/63410-a-biomarker-stratified-comparison-of-top-down-versus-accelerated-step2026-10-08 https://evidence-hub.com/study/63411-invasive-fungal-diseases-in-adult-patients-in-intensive-care-unit2026-10-08 https://evidence-hub.com/study/63412-niraparib-first-line-maintenance-therapy-in-patients-with-newly2026-10-08 https://evidence-hub.com/study/63413-jak-inhibition-enhances-checkpoint-blockade-immunotherapy-in-patients2026-10-08 https://evidence-hub.com/study/63414-immune-related-adverse-events-and-survival-among-patients-with2026-10-08 https://evidence-hub.com/study/63415-intensive-blood-pressure-control-in-patients-with-type-2-diabetes2026-10-08 https://evidence-hub.com/study/63416-association-of-non-alcoholic-fatty-liver-disease-with-cardiovascular2026-10-08 https://evidence-hub.com/study/63417-restrictive-vs-liberal-transfusion-strategy-in-patients-with-acute2026-10-08 https://evidence-hub.com/study/63418-neoadjuvant-pembrolizumab-plus-chemotherapy-followed-by-adjuvant2026-10-08 https://evidence-hub.com/study/63419-lung-cancer-in-patients-who-have-never-smoked-an-emerging-disease2026-10-08 https://evidence-hub.com/study/63421-consensus-definitions-of-cytomegalovirus-cmv-infection-and-disease-in2026-10-08 https://evidence-hub.com/study/63422-cd19-targeted-chimeric-antigen-receptor-t-cell-therapy-in-two2026-10-08 https://evidence-hub.com/study/63423-pembrolizumab-plus-concurrent-chemoradiotherapy-versus-placebo-plus2026-10-08 https://evidence-hub.com/study/63424-induction-concurrent-chemoradiotherapy-with-or-without-sintilimab-in2026-10-06 https://evidence-hub.com/study/63425-liver-transplantation-plus-chemotherapy-versus-chemotherapy-alone-in2026-10-08 https://evidence-hub.com/study/63426-dynamic-changes-of-intrinsic-brain-activity-and-neurotransmitter2026-10-08 https://evidence-hub.com/study/63427-analysis-of-the-positive-influence-of-qianlie-shutong-capsule2026-10-08 https://evidence-hub.com/study/63428-gut-microbiota-characteristics-and-targeted-tryptophan-metabolomics2026-10-08 https://evidence-hub.com/study/63429-altered-glutamate-and-gamma-aminobutyric-acid-metabolism-in-the2026-10-08 https://evidence-hub.com/study/63430-predicting-pharmacokinetics-of-drugs-in-patients-with-heart-failure2026-10-08 https://evidence-hub.com/study/63431-effect-of-standardized-aronia-melanocarpa-extract-on-oxidative-stress2026-10-08 https://evidence-hub.com/study/63432-abstracts-for-free-papers2026-10-08 https://evidence-hub.com/study/63433-mp47-11-pharmacological-management-of-premature-ejaculation-a2026-10-08 https://evidence-hub.com/study/63434-abstracts-for-free-papers2026-10-08 https://evidence-hub.com/study/63435-shukragata-vata-premature-ejeculation2026-10-08 https://evidence-hub.com/study/63436-effectiveness-of-treatment-of-sexual-dysfunction-in-men-with2026-10-08 https://evidence-hub.com/study/63437-comparison-of-pain-control-between-lidocaine-and-prilocaine-spray2026-10-08 https://evidence-hub.com/study/63438-mastering-ejaculation-challenges-through-comprehensive-strategies-a2026-10-08 https://evidence-hub.com/study/63441-a-retrospective-study-of-selective-dorsal-neurectomy-for-lifelong2026-10-08 https://evidence-hub.com/study/63442-an-animal-model-of-severe-acute-respiratory-distress-syndrome-for2026-10-08 https://evidence-hub.com/study/63443-adropin-modulates-pancreatic-cell-proliferation-and-glutathione2026-10-08 https://evidence-hub.com/study/63444-octodon-degus-a-natural-animal-model-of-aging-and-alzheimer-s-disease2026-10-08 https://evidence-hub.com/study/63445-establishment-of-a-patient-derived-drug-resistant-oral-squamous-cell2026-10-08 https://evidence-hub.com/study/63446-development-and-validation-of-bcg-vaccine-induced-novel-granulomatous2026-10-08 https://evidence-hub.com/study/63447-deciphering-autosomal-and-x-linked-genetic-effects-of-early-growth2026-10-08 https://evidence-hub.com/study/63448-avicenna-s-canon-of-medicine-and-tuberculosis-a-review-on-herbal2026-10-08 https://evidence-hub.com/study/63449-effects-of-volume-management-on-free-flap-perfusion-and-metabolism-in2026-10-08 https://evidence-hub.com/study/63451-the-rhesus-macaque-as-an-animal-model-for-human-nutrition-an2026-10-08 https://evidence-hub.com/study/63452-reaction-norm-animal-model-analysis-of-average-daily-gain-heat2026-10-08 https://evidence-hub.com/study/63453-the-effect-of-pomegranate-juice-consumption-on-bone-histomorphometric2026-10-08 https://evidence-hub.com/study/63454-investigating-the-synergistic-potential-of-combination-of-natural2026-10-08 https://evidence-hub.com/study/63455-the-effect-of-cranberry-juice-on-bone-growth-and-development-using-an2026-10-08 https://evidence-hub.com/study/63456-elevated-levels-of-butyric-acid-in-the-jejunum-of-an-animal-model-of2026-10-08 https://evidence-hub.com/study/63457-development-of-an-animal-model-of-hypothyroxinemia-during-pregnancy2026-10-08 https://evidence-hub.com/study/63458-ultra-high-performance-liquid-chromatography-quadrupole-time-of2026-10-08 https://evidence-hub.com/study/63459-intracerebroventricular-streptozotocin-induced-animal-model-of2026-10-08 https://evidence-hub.com/study/63460-construction-and-evaluation-of-a-chronic-arthritis-animal-model2026-10-08 https://evidence-hub.com/study/63461-evaluating-perfusion-and-metabolic-responses-of-microvascular-free2026-10-08 https://evidence-hub.com/study/63462-characterization-of-inflammatory-pseudotumors-in-a-large-animal-model2026-10-08 https://evidence-hub.com/study/63463-identifying-co-expressed-lncrnas-correlated-with-traits-of-interest2026-10-08 https://evidence-hub.com/study/63465-an-animal-model-of-radiological-medical-image-reading-detection-of2026-10-08 https://evidence-hub.com/study/63466-refining-the-adriamycin-induced-focal-segmental-glomerulosclerosis2026-10-08 https://evidence-hub.com/study/63467-induction-of-endometriosis-in-a-menstruating-mouse-model-mus-musculus2026-10-06 https://evidence-hub.com/study/63468-application-of-animal-resources-into-the-maillard-reaction-model2026-10-08 https://evidence-hub.com/study/63469-asas-nanp-symposium-mathematical-modeling-in-animal-nutrition2026-10-08 https://evidence-hub.com/study/63470-the-role-of-extracellular-vesicles-in-murine-asthma-model-insights2026-10-08 https://evidence-hub.com/study/63471-understanding-animal-building-management-interactions-in-response-to2026-10-08 https://evidence-hub.com/study/63472-dp-dtmax-an-underestimated-prognostic-factor-in-large-animal2026-10-08 https://evidence-hub.com/study/63473-semantic-modelling-of-animal-welfare-explained-part-1-calculating2026-10-08 https://evidence-hub.com/study/63474-animal-models-of-cisplatin-induced-neuropathic-pain2026-10-08 https://evidence-hub.com/study/63475-advancing-animal-welfare-a-natural-mating-protocol-for-xenopus-laevis2026-10-08 https://evidence-hub.com/study/63476-strengthening-animal-welfare-monitoring-humane-endpoints-in-a-rat2026-10-06 https://evidence-hub.com/study/63477-horses-are-worthy-of-care-horse-sector-participants-attitudes-towards2026-10-08 https://evidence-hub.com/study/63478-animal-models-of-hypertension-and-concurrent-organs-injury2026-10-08 https://evidence-hub.com/study/63479-asas-nanp-symposium-mathematical-modeling-in-animal-nutrition2026-10-08 https://evidence-hub.com/study/63480-investigating-the-behavioral-implications-of-microplastic-exposure-in2026-10-08 https://evidence-hub.com/study/63481-multimorbidity-and-animal-models2026-10-08 https://evidence-hub.com/study/63482-asas-nanp-symposium-mathematical-modeling-in-animal-nutrition2026-10-08 https://evidence-hub.com/study/63483-assessment-of-postoperative-analgesic-efficacy-and-animal-well-being2026-10-08 https://evidence-hub.com/study/63484-the-fecal-metabolomic-signature-of-a-plant-based-vegan-diet-compared2026-10-08 https://evidence-hub.com/study/63485-small-mammal-owners-experiences-of-housing-challenges-and-animal2026-10-08 https://evidence-hub.com/study/63487-impact-of-environmental-endocrine-disruptors-in-the-development-of2026-10-08 https://evidence-hub.com/study/63488-asas-nanp-symposium-mathematical-modeling-in-animal-nutrition-the2026-10-08 https://evidence-hub.com/study/63489-effects-of-partial-cage-dividers-on-animal-welfare-and-social2026-10-08 https://evidence-hub.com/study/63490-rodent-research-of-attention-deficit-hyperactivity-disorder-insights2026-10-08 https://evidence-hub.com/study/63491-impact-of-animal-causing-air-and-water-pollution-on-the-incidence-of2026-10-08 https://evidence-hub.com/study/63492-animal-models-of-postpartum-hemorrhage2026-10-19 https://evidence-hub.com/study/63493-environmental-trade-offs-of-meeting-nutritional-requirements-with-a2026-10-08 https://evidence-hub.com/study/63494-experimental-animal-models-for-polycystic-ovarian-syndrome-methods2026-10-08 https://evidence-hub.com/study/63495-aortic-valve-disease-novel-animal-models-for-advancing-our2026-10-08 https://evidence-hub.com/study/63496-heterogeneity-of-animal-experiments-and-how-to-deal-with-it2026-10-08 https://evidence-hub.com/study/63497-animal-models-in-molecular-biology-research-challenges-ethical2026-10-08 https://evidence-hub.com/study/63498-practical-guidelines-for-validation-of-supervised-machine-learning2026-10-08 https://evidence-hub.com/study/63499-modelling-ruminant-grazing-systems-based-on-native-grasslands-22026-10-08 https://evidence-hub.com/study/63500-semantic-modelling-of-animal-welfare-explained-part-2-the-basis-of2026-10-08 https://evidence-hub.com/study/63501-exploring-new-animal-models-of-ulcerative-colitis-evaluating-chemical2026-10-08 https://evidence-hub.com/study/63502-review-multiobject-tracking-in-livestock-from-farm-animal-management2026-10-08 https://evidence-hub.com/study/63503-what-characteristics-of-dogs-help-them-stay-shorter-in-shelters2026-10-08 https://evidence-hub.com/study/63504-ethical-perspectives-influence-the-formation-of-researchers2026-10-06 https://evidence-hub.com/study/63505-male-reproductive-phenotype-in-cystic-fibrosis-comparison-of-existing2026-10-08 https://evidence-hub.com/study/63506-advances-and-perspectives-in-animal-models-of-human-hepatitis-a-virus2026-10-08 https://evidence-hub.com/study/63507-humanized-immune-system-animal-models-and-their-recent-applications2026-10-08 https://evidence-hub.com/study/63508-asas-nanp-symposium-mathematical-modeling-in-animal-nutrition-data2026-10-08 https://evidence-hub.com/study/63509-asas-nanp-symposium-mathematical-modeling-in-animal-nutrition-the2026-10-08 https://evidence-hub.com/study/63510-role-of-pentoxifylline-in-neonatal-hypoxic-ischaemic-encephalopathy-a2026-10-10 https://evidence-hub.com/study/63511-34-the-influence-and-interaction-of-nutrition-with-the-immune-system2026-10-08 https://evidence-hub.com/study/63513-advances-in-crispr-cas9-in-lineage-tracing-of-model-animals2026-10-08 https://evidence-hub.com/study/63514-refined-protocol-for-newly-onset-identification-in-non-obese-diabetic2026-10-08 https://evidence-hub.com/study/63515-animal-models-of-hemorrhage-parameters-and-development-of-hemostatic2026-10-08 https://evidence-hub.com/study/63516-use-of-hsalr-female-mice-as-a-model-for-the-study-of-myotonic2026-10-08 https://evidence-hub.com/study/63517-a-mouse-coccygeal-intervertebral-disc-degeneration-model-with-tail2026-10-08 https://evidence-hub.com/study/63518-development-of-an-innovative-intravaginal-model-of-probiotic2026-10-08 https://evidence-hub.com/study/63519-reducing-dextran-sodium-sulfate-interference-with-gene-expression2026-10-08 https://evidence-hub.com/study/63520-establishment-of-a-novel-alloxan-induced-rabbit-model-exhibiting2026-10-08 https://evidence-hub.com/study/63521-derivation-of-economic-values-for-breeding-objective-traits-of2026-10-08 https://evidence-hub.com/study/63522-comprehensive-review-of-animal-models-in-diabetes-research-using2026-10-08 https://evidence-hub.com/study/63523-drug-screening-for-ischemic-stroke-using-larvae-and-adult-zebrafish2026-10-08 https://evidence-hub.com/study/63524-multiple-low-dose-streptozotocin-induced-diabetes-as-a-model-for2026-10-08 https://evidence-hub.com/study/63525-streamlining-model-organisms-facilities-operation-the-benefits-of-a2026-10-08 https://evidence-hub.com/study/63526-the-vietnamese-swine-as-a-translational-model-of-invasive-ductal2026-10-06 https://evidence-hub.com/study/63527-tembleque-sdtq-rat-a-new-model-of-leukodystrophy-associated-with2026-10-08 https://evidence-hub.com/study/63528-a-novel-model-of-central-precocious-puberty-disease-paternal-mkrn32026-10-08 https://evidence-hub.com/study/63529-developing-a-greenhouse-gas-emission-model-for-sport-horses-case2026-10-08 https://evidence-hub.com/study/63530-glaucoma-animal-models-in-rabbits-state-of-the-art-and-perspectives-a2026-10-08 https://evidence-hub.com/study/63531-asas-nanp-symposium-mathematical-modeling-in-animal-nutrition2026-10-08 https://evidence-hub.com/study/63532-asas-nanp-symposium-mathematical-modeling-in-animal-nutrition2026-10-08 https://evidence-hub.com/study/63533-genotype-by-environment-interaction-for-yearling-weight-of-nellore2026-10-08 https://evidence-hub.com/study/63534-effectively-simplified-adriamycin-induced-chronic-kidney-disease2026-10-08 https://evidence-hub.com/study/63535-botanical-breakthroughs-in-depression-insights-from-the-cums-animal2026-10-08 https://evidence-hub.com/study/63536-kh-001-delays-para-chloroamphetamine-induced-ejaculation-in2026-10-08 https://evidence-hub.com/study/63537-ai-transforming-data-networking-and-cybersecurity-through-advanced2026-10-08 https://evidence-hub.com/study/63538-the-moving-mind-meets-the-beating-heart-in-the-age-of-ai-healthcare2026-10-08 https://evidence-hub.com/study/63539-clinical-application-study-of-neuromuscular-electrical-stimulation2026-10-08 https://evidence-hub.com/study/63540-intelligent-defense-redefining-os-security-with-ai2026-10-08 https://evidence-hub.com/study/63542-a-novel-topical-gel-of-the-fresh-young-coconut-husk-ethanolic-extract2026-10-08 https://evidence-hub.com/study/63543-analysis-of-real-time-video-for-the-detection-of-fire-using-opencv2026-10-08 https://evidence-hub.com/study/63544-predictive-algorithms-in-crypto-investment-platforms-rethinking-the2026-10-08 https://evidence-hub.com/study/63545-leveraging-artificial-intelligence-for-data-networking-and2026-10-08 https://evidence-hub.com/study/63546-unveiling-niaprazine-s-potential-behavioral-insights-into-a-re2026-10-08 https://evidence-hub.com/study/63547-nanomedicinas-una-alternativa-terapeutica-en-desarrollo-para-el2026-10-08 https://evidence-hub.com/study/63548-assessment-of-cytotoxicity-and-growth-inhibitory-effects-of-methanol2026-10-08 https://evidence-hub.com/study/63549-wu-zi-yan-zong-wan-enhances-sperm-quality-in-boars-by-regulating2026-10-08 https://evidence-hub.com/study/63550-nucleotide-contribution-to-the-functioning-of-sert-na-k-atpase-and2026-10-08 https://evidence-hub.com/study/63551-determination-of-25-hydroxyvitamin-d3-in-rat-brain-by-derivatization2026-10-08 https://evidence-hub.com/study/63552-integration-of-analytical-quality-by-design-green-and-white2026-10-08 https://evidence-hub.com/study/63553-aging-testosterone-and-male-fertility-therapy-a-review2026-10-08 https://evidence-hub.com/study/63554-a-novel-method-for-development-and-validation-of-the-degradation2026-10-08 https://evidence-hub.com/study/63555-an-examination-of-the-effectiveness-of-the-expired-drug-isoprinosine2026-10-08 https://evidence-hub.com/study/63556-duration-dependent-post-trauma-sleep-deprivation-differentially2026-10-08 https://evidence-hub.com/study/63557-the-role-of-nutrition-in-psychedelics-clinical-trials-key2026-10-08 https://evidence-hub.com/study/63558-greenness-blueness-and-whiteness-profiles-of-hptlc-method-for-the2026-10-08 https://evidence-hub.com/study/63559-mitochondrial-inflammation-crosstalk-in-major-depressive-disorder2026-10-08 https://evidence-hub.com/study/63560-oral-thin-films-a-modern-frontier-in-drug-delivery-systems2026-10-08 https://evidence-hub.com/study/63561-next-generation-nanocarriers-for-skin-cancer-therapy-via-transdermal2026-10-08 https://evidence-hub.com/study/63562-micelle-loaded-oral-dissolvable-strips-a-novel-strategy-to-enhance2026-10-08 https://evidence-hub.com/study/63563-size-control-of-lipid-nanoparticles-via-simulation-based-design-of-a2026-10-08 https://evidence-hub.com/study/63564-tuning-up-in-vitro-growth-and-development-of-cannabis-sativa-recent2026-10-08 https://evidence-hub.com/study/63565-comparative-in-vitro-study-of-sol-gel-derived-bioactive-glasses2026-10-08 https://evidence-hub.com/study/63566-optical-coherence-tomography-for-assessing-the-severity-of-dental2026-10-09 https://evidence-hub.com/study/63567-corticosterone-induced-neuronal-dysfunction-in-hippocampal-cultures-a2026-10-08 https://evidence-hub.com/study/63568-alcohol-alters-blood-testis-barrier-function-in-an-in-vitro-model2026-10-08 https://evidence-hub.com/study/63569-investigating-the-anticancer-effects-of-sulforaphane-in-an-in-vitro2026-10-08 https://evidence-hub.com/study/63571-benchmarking-deep-learning-designed-inlay-restorations-across2026-10-08 https://evidence-hub.com/study/63572-in-vitro-hepatocyte-differentiation-of-human-adipose-derived-stem2026-10-08 https://evidence-hub.com/study/63573-atrazine-induces-reproductive-toxicity-in-an-in-vitro-spermatogenesis2026-10-08 https://evidence-hub.com/study/63574-in-vitro-biomimetic-development-of-artificial-dental-calculus-a-proof2026-10-08 https://evidence-hub.com/study/63575-tau-repeats-disassemble-amyloid-fibrils-in-vitro-by-interacting-with2026-10-08 https://evidence-hub.com/study/63576-endotoxin-pretreatment-mitigates-myocardial-ischemia-reperfusion2026-10-08 https://evidence-hub.com/study/63577-thermal-processing-effects-on-phytochemical-profiles-antioxidant2026-10-08 https://evidence-hub.com/study/63578-effects-of-the-5-hydroxytryptamine-3-receptor-antagonist-palonosetron2026-10-08 https://evidence-hub.com/study/63579-antiviral-effects-of-heme-oxygenase-1-against-canine-coronavirus-and2026-10-08 https://evidence-hub.com/study/63580-immortalization-of-epidural-fat-derived-mesenchymal-stem-cells-in2026-10-08 https://evidence-hub.com/study/63581-in-vitro-characterization-of-phicd111-20024-ead-as-an-engineered2026-10-08 https://evidence-hub.com/study/63582-in-vitro-and-in-vivo-anti-inflammatory-and-antinociceptive-activities2026-10-08 https://evidence-hub.com/study/63584-human-bone-scaffolds-support-clonal-persistence-and-functional2026-10-08 https://evidence-hub.com/study/63587-strategic-acyl-carrier-protein-engineering-enables-functional-type-ii2026-10-08 https://evidence-hub.com/study/63588-rat-pharmacokinetics-and-in-vitro-metabolite-identification-of-km-8192026-10-08 https://evidence-hub.com/study/63589-amplified-response-of-drug-induced-liver-fibrosis-via-immune-cell-co2026-10-08 https://evidence-hub.com/study/63590-anti-cancer-effects-of-dhp107-on-canine-mammary-gland-cancer-examined2026-10-08 https://evidence-hub.com/study/63591-effects-of-herbal-medicine-on-ovulation-in-premature-ovarian2026-10-08 https://evidence-hub.com/study/63592-in-vitro-anti-inflammatory-and-skin-protective-effects-of-codium2026-10-08 https://evidence-hub.com/study/63593-evaluation-of-the-anti-aging-effects-of-zinc-2-glycoprotein-peptide2026-10-08 https://evidence-hub.com/study/63594-jeju-citrus-citrus-unshiu-leaf-extract-and-hesperidin-inhibit-small2026-10-08 https://evidence-hub.com/study/63595-anti-obesity-effects-of-ethanol-extract-of-green-citrus-junos-peel2026-10-10 https://evidence-hub.com/study/63596-in-vitro-evaluation-of-speed-sintering-and-glazing-effects-on-the2026-10-08 https://evidence-hub.com/study/63597-in-vitro-immune-enhancing-effects-of-platycodon-grandiflorum-combined2026-10-08 https://evidence-hub.com/study/63598-biocompatibility-and-dimensional-stability-through-the-use-of-3d2026-10-08 https://evidence-hub.com/study/63599-anti-osteoporotic-effects-of-boswellia-serrata-gum-resin-extract-in2026-10-08 https://evidence-hub.com/study/63600-distinguishing-discolored-caries-lesions-using-biofluorescence-and2026-10-08 https://evidence-hub.com/study/63601-accuracy-of-complete-arch-scans-obtained-by-intraoral-scanner-and2026-10-08 https://evidence-hub.com/study/63602-the-effect-of-nerve-growth-factor-on-cartilage-fibrosis-and2026-10-08 https://evidence-hub.com/study/63606-in-vitro-assays-for-the-assessment-of-safety-and-toxicity-in2026-10-08 https://evidence-hub.com/study/63608-translational-evaluation-of-a-disodium-adenosine-monophosphate-amp2na2026-10-09 https://evidence-hub.com/study/63610-in-vitro-study-on-the-effects-of-rhododendron-mucronulatum-branch2026-10-08 https://evidence-hub.com/study/63611-naproxen-and-ibuprofen-exposure-alter-the-blood-testis-barrier-in-a2026-10-08 https://evidence-hub.com/study/63612-solvent-free-glucan-coated-vd3-nanoliposomes-physicochemical2026-10-08 https://evidence-hub.com/study/63613-sparassis-crispa-and-a-bioactive-compound-therein-ergosterol-were2026-10-08 https://evidence-hub.com/study/63614-role-of-glutathione-and-cysteine-in-acrylamide-metabolism-during-in2026-10-08 https://evidence-hub.com/study/63615-dynamic-cellular-heterogeneity-revealed-through-a-time-resolved2026-10-08 https://evidence-hub.com/study/63616-development-of-in-vitro-and-in-planta-strategies-for-efficient2026-10-08 https://evidence-hub.com/study/63617-in-vitro-and-in-vivo-evaluation-of-yttria-niobia-stabilized-zirconia2026-10-08 https://evidence-hub.com/study/63618-microbiome-in-women-with-endometriosis-and-the-in-vitro-effects-of2026-10-08 https://evidence-hub.com/study/63619-a-preliminary-evaluation-on-poly-3-hydroxypropionic-acid-as-a-novel2026-10-08 https://evidence-hub.com/study/63620-effects-of-composition-finishing-and-salivary-ph-on-physicomechanical2026-10-08 https://evidence-hub.com/study/63622-preliminary-in-vitro-study-on-an-rfid-tagged-gauze-detection-system2026-10-09 https://evidence-hub.com/study/63626-two-and-three-dimensional-accuracy-of-tooth-reduction-depths-in2026-10-08 https://evidence-hub.com/study/63627-bridging-in-vitro-buoyancy-to-clinical-performance-a-pbpk-driven2026-10-08 https://evidence-hub.com/study/63628-exogenous-rna-surveillance-by-proton-sensing-trim252026-10-08 https://evidence-hub.com/study/63629-dual-mode-action-of-scalable-high-quality-engineered-stem-cell2026-10-06 https://evidence-hub.com/study/63630-formulation-and-statistical-optimization-of-cubosome-containing-raft2026-10-08 https://evidence-hub.com/study/63631-formulation-and-evaluation-of-oral-thin-film-of-esomeprazole-and2026-10-08 https://evidence-hub.com/study/63632-evaluation-of-orally-disintegrating-films-containing-ferulic-acid2026-10-08 https://evidence-hub.com/study/63633-doe-based-formulation-and-characterization-of-nifedipine-loaded2026-10-08 https://evidence-hub.com/study/63634-transethosome-technology-revolutionizing-transdermal-drug-delivery2026-10-08 https://evidence-hub.com/study/63635-quaternary-hexadeca-substituted-manganese-iii-phthalocyanine-as-a-dna2026-10-08 https://evidence-hub.com/study/63637-development-and-validation-of-a-gradient-program-rp-hplc-method-for2026-10-08 https://evidence-hub.com/study/63638-auxiliary-substances-for-enhancement-of-complexation-efficiency-and2026-10-08 https://evidence-hub.com/study/63639-dna-binding-mode-of-fluorine-containing-cobalt-ii-phthalocyanine2026-10-08 https://evidence-hub.com/study/63640-box-behnken-design-based-optimized-uhplc-method-for-the-analysis-of2026-10-08 https://evidence-hub.com/study/63641-a-comprehensive-rp-hplc-technique-for-analyzing-disodium-edetate-and2026-10-08 https://evidence-hub.com/study/63642-simultaneous-analysis-of-fenofibrate-and-rosuvastatin-in-commercial2026-10-08 https://evidence-hub.com/study/63644-stability-indicating-reversed-phase-high-performance-liquid2026-10-08 https://evidence-hub.com/study/63645-application-of-simultaneous-and-coupled-thermal-analysis-techniques2026-10-08 https://evidence-hub.com/study/63646-novel-combinational-nanomedicines-liposomes-to-tackle-breast-cancer2026-10-08 https://evidence-hub.com/study/63647-et-c-best-paper-of-20232026-10-06 https://evidence-hub.com/study/63648-an-integrated-transcriptomic-approach-for-identifying-enhancers-in2026-10-06 https://evidence-hub.com/study/63649-modulating-metabolic-signatures-to-mitigate-cabozantinib-resistance2026-10-06 https://evidence-hub.com/study/63650-evaluation-of-a-newly-developed-hybrid-brace-for-scoliosis-usability2026-10-06 https://evidence-hub.com/study/63651-first-report-of-novel-single-nucleotide-polymorphisms-snps-and2026-10-06 https://evidence-hub.com/study/63652-orexinergic-modulation-by-uwhangchungsimwon-restores-homeostasis-of2026-10-06 https://evidence-hub.com/study/63654-genome-wide-analysis-expression-profiling-and-molecular-docking-of2026-10-06 https://evidence-hub.com/study/63655-novel-single-nucleotide-polymorphisms-snps-and-genetic-studies-of-the2026-10-06 https://evidence-hub.com/study/63656-powerai-cvd-chinese-specific-artificial-intelligence-powered2026-10-06 https://evidence-hub.com/study/63657-novel-polymorphisms-and-genetic-studies-of-the-shadow-of-prion2026-10-06 https://evidence-hub.com/study/63658-exploring-the-role-of-selective-anti-depressants-on-the-energetics2026-10-08 https://evidence-hub.com/study/63659-environmental-factors2026-10-06 https://evidence-hub.com/study/63661-the-effects-of-nicotine-on-development2026-10-06 https://evidence-hub.com/study/63662-tobacco-e-cigarettes-and-child-health2026-10-06 https://evidence-hub.com/study/63664-an-update-on-controversies-in-e-cigarettes2026-10-06 https://evidence-hub.com/study/63665-the-epidemiology-of-lung-cancer2026-10-06 https://evidence-hub.com/study/63666-mri-shows-lung-perfusion-changes-after-vaping-and-smoking2026-10-06 https://evidence-hub.com/study/63667-tobacco-nicotine-and-health2026-10-06 https://evidence-hub.com/study/63668-current-and-emerging-issues-in-tobacco-prevention-and-control2026-10-06 https://evidence-hub.com/study/63669-update-on-thirdhand-smoke-a-comprehensive-systematic-review2026-10-06 https://evidence-hub.com/study/63670-tobacco-control-and-treatment-for-the-pediatric-clinician-practice2026-10-06 https://evidence-hub.com/study/63671-tobacco-use-and-smoke-exposure-in-children-new-trends-harm-and2026-10-06 https://evidence-hub.com/study/63672-systematic-analysis-of-the-scientific-literature-on-heated-tobacco2026-10-06 https://evidence-hub.com/study/63673-passive-exposure-to-pollutants-from-a-new-generation-of-cigarettes-in2026-10-06 https://evidence-hub.com/study/63674-electronic-cigarettes-exposure-and-use-among-pediatric-populations2026-10-06 https://evidence-hub.com/study/63675-student-attitudes-toward-tobacco-use-and-tobacco-policies-on-college2026-10-06 https://evidence-hub.com/study/63676-a-biomonitoring-assessment-of-secondhand-exposures-to-electronic2026-10-06 https://evidence-hub.com/study/63677-the-effects-of-hookah-waterpipe-smoking-on-general-health-and-the2026-10-06 https://evidence-hub.com/study/63678-electronic-cigarettes-in-the-indoor-environment2026-10-06 https://evidence-hub.com/study/63679-smoking-cessation-and-pregnancy2026-10-06 https://evidence-hub.com/study/63680-immunological-and-pathological-effects-of-electronic-cigarettes2026-10-06 https://evidence-hub.com/study/63681-passive-exposure-to-e-cigarette-emissions-is-associated-with-worsened2026-10-06 https://evidence-hub.com/study/63682-tobacco-smoke-and-endothelial-dysfunction-role-of-aldehydes2026-10-06 https://evidence-hub.com/study/63683-effective-message-elements-for-disclosures-about-chemicals-in2026-10-06 https://evidence-hub.com/study/63684-impairment-of-endothelial-function-by-cigarette-smoke-is-not-caused2026-10-06 https://evidence-hub.com/study/63685-effects-of-electronic-cigarettes-on-health-a-systematic-review-of-the2026-10-06 https://evidence-hub.com/study/63686-effects-of-electronic-cigarettes-on-indoor-air-quality-and-health2026-10-06 https://evidence-hub.com/study/63687-changes-in-eustachian-tube-mucosa-in-mice-after-short-term-tobacco2026-10-06 https://evidence-hub.com/study/63688-particulate-matter-from-electronic-cigarettes-and-conventional2026-10-06 https://evidence-hub.com/study/63689-quality-improvement-approach-to-increase-inpatient-pediatric2026-10-06 https://evidence-hub.com/study/63690-e-cigarettes-prevention-pulmonary-health-and-addiction2026-10-06 https://evidence-hub.com/study/63691-health-effects-of-electronic-cigarette-e-cigarette-use-on-organ2026-10-06 https://evidence-hub.com/study/63692-use-of-electronic-cigarettes-in-smoke-free-environments2026-10-06 https://evidence-hub.com/study/63693-potential-effects-of-e-cigarettes-and-vaping-on-pediatric-asthma2026-10-06 https://evidence-hub.com/study/63694-secondhand-exposure-to-vapors-from-electronic-cigarettes2026-10-06 https://evidence-hub.com/study/63695-the-toxicity-of-e-cigarettes-and-children-s-respiratory-health2026-10-06 https://evidence-hub.com/study/63696-early-life-exposure-to-electronic-cigarettes-cause-for-concern2026-10-06 https://evidence-hub.com/study/63697-assessment-of-the-exposure-to-polycyclic-aromatic-hydrocarbons-in2026-10-06 https://evidence-hub.com/study/63698-dna-damage-dna-repair-and-carcinogenicity-tobacco-smoke-versus2026-10-06 https://evidence-hub.com/study/63699-effect-of-second-hand-smoke-exposure-on-establishing-urinary-cotinine2026-10-06 https://evidence-hub.com/study/63700-patient-perspectives-on-discussions-of-electronic-cigarettes-in2026-10-06 https://evidence-hub.com/study/63701-national-institutes-of-health-funding-for-tobacco-control-2006-and2026-10-06 https://evidence-hub.com/study/63702-retinal-tissue-develops-an-inflammatory-reaction-to-tobacco-smoke-and2026-10-06 https://evidence-hub.com/study/63703-electronic-cigarettes-effects-on-health-previous-reports2026-10-06 https://evidence-hub.com/study/63704-e-cigarettes-and-atherosclerotic-cardiovascular-disease-what2026-10-06 https://evidence-hub.com/study/63705-smoking-cessation-in-asthmatic-patients-and-its-impact2026-10-06 https://evidence-hub.com/study/63706-e-cigarettes-methodological-and-ideological-issues-and-research2026-10-06 https://evidence-hub.com/study/63707-electronic-cigarettes-a-task-force-report-from-the-european2026-10-06 https://evidence-hub.com/study/63708-state-of-the-art-office-based-interventions-to-eliminate-youth2026-10-06 https://evidence-hub.com/study/63709-regulation-of-electronic-cigarette-use-in-public-and-private-areas-in2026-10-06 https://evidence-hub.com/study/63710-impact-of-secondhand-smoke-and-e-cigarette-aerosol-on-overweight-or2026-10-06 https://evidence-hub.com/study/63711-innovative-approaches-to-support-smoking-cessation-for-individuals2026-10-06 https://evidence-hub.com/study/63712-electronic-cigarettes-are-as-toxic-to-skin-flap-survival-as-tobacco2026-10-06 https://evidence-hub.com/study/63713-effects-on-health-of-passive-smoking-and-vape-on-terraces-in-the2026-10-04 https://evidence-hub.com/study/63714-impact-of-prenatal-exposure-to-smoking-on-child-health2026-10-06 https://evidence-hub.com/study/63715-prevalence-and-characteristics-of-secondhand-smoke-and-secondhand2026-10-06 https://evidence-hub.com/study/63716-should-electronic-cigarette-use-be-covered-by-clean-indoor-air-laws2026-10-06 https://evidence-hub.com/study/63717-a-qualitative-examination-of-smoke-free-policies-and-electronic2026-10-06 https://evidence-hub.com/study/63718-the-effect-of-e-cigarette-aerosol-emissions-on-respiratory-health-a2026-10-06 https://evidence-hub.com/study/63719-e-cigarettes-a-review-of-new-trends-in-cannabis-use2026-10-06 https://evidence-hub.com/study/63720-predicted-deposition-of-e-cigarette-aerosol-in-the-human-lungs2026-10-06 https://evidence-hub.com/study/63721-ethics-of-tobacco-harm-reduction-from-a-liberal-perspective2026-10-06 https://evidence-hub.com/study/63722-secondhand-nicotine-absorption-from-e-cigarette-vapor-vs-tobacco2026-10-06 https://evidence-hub.com/study/63723-fourteen-years-of-tobacco-control-law-in-spain-current-situation-and2026-10-06 https://evidence-hub.com/study/63724-inclusion-of-electronic-nicotine-delivery-systems-in-indoor-smoke2026-10-06 https://evidence-hub.com/study/63725-policy-support-for-smoke-free-and-e-cigarette-free-multiunit-housing2026-10-06 https://evidence-hub.com/study/63726-alterations-of-mitochondrial-network-by-cigarette-smoking-and-e2026-10-06 https://evidence-hub.com/study/63727-smoke-free-spaces-a-decade-of-progress-a-need-for-more2026-10-06 https://evidence-hub.com/study/63728-particle-doses-in-the-pulmonary-lobes-of-electronic-and-conventional2026-10-06 https://evidence-hub.com/study/63729-disparities-in-rural-tobacco-use-smoke-free-policies-and-tobacco-taxes2026-10-06 https://evidence-hub.com/study/63730-are-electronic-cigarettes-a-healthier-alternative-to-conventional2026-10-06 https://evidence-hub.com/study/63731-the-case-in-favor-of-e-cigarettes-for-tobacco-harm-reduction2026-10-06 https://evidence-hub.com/study/63732-emissions-from-electronic-cigarettes-assessing-vapers-intake-of-toxic2026-10-06 https://evidence-hub.com/study/63733-how-widespread-is-electronic-cigarette-use-in-outdoor-settings-a2026-10-06 https://evidence-hub.com/study/63734-influence-of-inhaled-nicotine-source-on-arterial-stiffness2026-10-06 https://evidence-hub.com/study/63735-poor-smoke-free-status-of-airports-in-a-country-with-a-smoke-free2026-10-06 https://evidence-hub.com/study/63736-a-filter-based-system-mimicking-the-particle-deposition-and2026-10-06 https://evidence-hub.com/study/63737-health-effects-from-secondhand-exposure-to-e-cigarettes-a-systematic2026-10-04 https://evidence-hub.com/study/63738-concentrations-of-serum-cotinine-across-stages-of-glomerular-function2026-10-06 https://evidence-hub.com/study/63739-recent-developments-in-the-determination-of-biomarkers-of-tobacco2026-10-06 https://evidence-hub.com/study/63740-tobacco-tracker-a-new-tool-to-support-college-smoke-and-tobacco-free2026-10-06 https://evidence-hub.com/study/63741-thirdhand-smoke-from-tobacco-e-cigarettes-cannabis-methamphetamine2026-10-06 https://evidence-hub.com/study/63742-heated-tobacco-products-volatile-emissions-and-their-predicted-impact2026-10-06 https://evidence-hub.com/study/63743-electronic-cigarette-aerosol-increases-the-risk-of-organ-dysfunction2026-10-06 https://evidence-hub.com/study/63744-a-systematic-review-of-the-health-risks-from-passive-exposure-to2026-10-06 https://evidence-hub.com/study/63745-exposure-to-secondhand-aerosol-from-electronic-cigarettes-among-us2026-10-06 https://evidence-hub.com/study/63746-the-impact-of-secondhand-vape-exposure-on-adolescents-willingness-to2026-10-04 https://evidence-hub.com/study/63747-secondhand-exposure-to-aerosols-from-electronic-nicotine-delivery2026-10-06 https://evidence-hub.com/study/63748-aerosol-vapor-or-chemicals-college-student-perceptions-of-harm-from2026-10-06 https://evidence-hub.com/study/63749-what-influences-adolescents-to-continuously-use-e-cigarettes2026-10-06 https://evidence-hub.com/study/63750-the-association-of-tobacco-smoking-second-hand-smoke-and-novel2026-10-06 https://evidence-hub.com/study/63751-secondhand-vape-exposure-regulation-of-cftr-and-immune-function-in2026-10-04 https://evidence-hub.com/study/63752-u-s-adult-attitudes-about-electronic-vapor-product-use-in-indoor2026-10-06 https://evidence-hub.com/study/63753-protecting-children-from-tobacco-nicotine-and-tobacco-smoke2026-10-06 https://evidence-hub.com/study/63754-attitudes-towards-smokefree-high-streets-a-survey-of-local-shoppers2026-10-06 https://evidence-hub.com/study/63755-impact-of-secondhand-smoke-and-e-cigarette-exposure-on-placental2026-10-06 https://evidence-hub.com/study/63756-impact-of-electronic-cigarette-use-on-cardiovascular-health-current2026-10-06 https://evidence-hub.com/study/63757-estimating-county-level-tobacco-use-and-exposure-in-south-carolina-a2026-10-06 https://evidence-hub.com/study/63758-breathe-easy-gippsland-community-attitudes-towards-expanding-smoke2026-10-06 https://evidence-hub.com/study/63759-smoking-and-vaping-profiles-of-healthcare-workers-and-their-knowledge2026-10-04 https://evidence-hub.com/study/63760-factors-associated-with-victorian-adolescents-harm-perceptions-and2026-10-06 https://evidence-hub.com/study/63761-australian-women-s-perspectives-on-preventing-postpartum-relapse-or2026-10-04 https://evidence-hub.com/study/63762-study-protocol-for-a-quasi-experimental-investigation-of-the2026-10-06 https://evidence-hub.com/study/63763-effectiveness-of-vaping-prevention-campaign-messages-on-cognitive-and2026-10-04 https://evidence-hub.com/study/63764-factors-influencing-vaping-behaviors-based-on-social-cognitive-theory2026-10-06 https://evidence-hub.com/study/63765-exploring-vaping-cessation-app-use-among-youth-qualitative2026-10-06 https://evidence-hub.com/study/63766-tobacco-and-vaping-exposure-among-spanish-adolescents-an-analysis-of2026-10-04 https://evidence-hub.com/study/63767-friends-gui-a-graphical-user-interface-for-data-collection-and2026-10-04 https://evidence-hub.com/study/63768-smoking-cessation-in-adolescents-and-effective-strategies-a-position2026-10-06 https://evidence-hub.com/study/63769-scrolling-into-substance-use-social-media-use-frequency-and-substance2026-10-06 https://evidence-hub.com/study/63770-what-is-the-addictive-potential-from-vaping2026-10-04 https://evidence-hub.com/study/63771-a-qualitative-study-of-same-session-co-use-of-nicotine-and-cannabis2026-10-06 https://evidence-hub.com/study/63772-utility-and-usability-testing-of-the-fresh-free-from-e-cigarettes-and2026-10-06 https://evidence-hub.com/study/63773-association-of-active-and-passive-smoking-with-adolescent-asthma-a2026-10-06 https://evidence-hub.com/study/63774-nicotine-pouch-advertising-and-sales-in-australia-a-qualitative-study2026-10-06 https://evidence-hub.com/study/63775-association-between-nicotine-and-cannabis-use-and-ocular-inflammatory2026-10-06 https://evidence-hub.com/study/63776-cigarette-e-cigarette-and-dual-use-among-malaysian-adolescents-a2026-10-06 https://evidence-hub.com/study/63777-smart-vape-detection-in-schools-for-mitigating-student-e-cigarette-use2026-10-06 https://evidence-hub.com/study/63778-synthetic-cooling-agents-enhance-nicotine-reinforcement-and2026-10-06 https://evidence-hub.com/study/63779-effects-of-smoking-on-the-sleep-wakefulness-cycle-actigraphic2026-10-06 https://evidence-hub.com/study/63780-examining-electronic-nicotine-delivery-system-ends-cue-reactivity2026-10-06 https://evidence-hub.com/study/63781-vaping-during-pregnancy-and-maternal-fetal-and-infant-health-outcomes2026-10-04 https://evidence-hub.com/study/63782-exploring-patients-perspectives-and-experiences-of-asthma-self2026-10-06 https://evidence-hub.com/study/63783-vape-flavoring-chemicals-and-oral-fibroblast-viability2026-10-04 https://evidence-hub.com/study/63784-periodontal-and-peri-implant-status-among-users-of-different-inhaled2026-10-04 https://evidence-hub.com/study/63785-secondhand-smoke-and-e-cigarette-aerosol-exposure-in-dogs-and-cats-a2026-10-04 https://evidence-hub.com/study/63786-study-protocol-for-the-breathe-easy-all-together-e-cigarette2026-10-06 https://evidence-hub.com/study/63787-playful-consumption-serious-concerns-navigating-risks-and2026-10-06 https://evidence-hub.com/study/63788-trends-in-daily-nicotine-vaping-and-unsuccessful-quit-attempts-in2026-10-04 https://evidence-hub.com/study/63789-novel-nicotine-and-tobacco-products-in-pediatric-age-a-joint-position2026-10-06 https://evidence-hub.com/study/63790-social-media-exposure-school-prevention-and-adolescent-vaping-a2026-10-06 https://evidence-hub.com/study/63791-e-cigarette-exposure-impairs-skeletal-muscle-mitochondrial-function2026-10-06 https://evidence-hub.com/study/63792-exposure-to-tobacco-smoke-concurrent-short-term-symptoms-of2026-10-06 https://evidence-hub.com/study/63793-beliefs-and-perceptions-of-negative-and-positive-aspects-associated2026-10-06 https://evidence-hub.com/study/63794-trends-in-u-s-adolescent-use-of-vaping-and-flavored-solutions-for2026-10-06 https://evidence-hub.com/study/63795-breaking-the-myths-around-e-cigarettes-a-narrative-review-exploring2026-10-04 https://evidence-hub.com/study/63796-tobacco-withdrawal-system-recovery-time-assessed-during-smoking2026-10-06 https://evidence-hub.com/study/63797-awareness-and-intended-behavioral-responses-to-oral-potentially2026-10-06 https://evidence-hub.com/study/63798-prevalence-of-use-impact-on-oral-health-and-knowledge-regarding2026-10-06 https://evidence-hub.com/study/63799-nicotine-mediated-redox-and-nitrosative-stress-in-cardiorenal-health2026-10-06 https://evidence-hub.com/study/63800-exploring-youth-vaping-in-new-zealand-intermediate-and-high-schools-a2026-10-04 https://evidence-hub.com/study/63801-exploration-of-digital-interventions-for-vaping-cessation-scoping2026-10-06 https://evidence-hub.com/study/63802-the-association-between-race-based-bullying-and-nicotine-vaping-in2026-10-06 https://evidence-hub.com/study/63803-adolescent-vaping-revisiting-developmental-perspectives-on-adolescent2026-10-06 https://evidence-hub.com/study/63804-vaping-education-a-two-year-study-examining-health-literacy-and2026-10-04 https://evidence-hub.com/study/63805-vaping-9-tetrahydrocannabinol-9-thc-in-liquid-forms-pharmacokinetics2026-10-06 https://evidence-hub.com/study/63806-effectiveness-of-a-one-year-smoking-cessation-intervention-for-people2026-10-06 https://evidence-hub.com/study/63807-effect-of-chronic-vapor-nicotine-exposure-on-affective-and-cognitive2026-10-04 https://evidence-hub.com/study/63808-nicotine-or-marijuana-vaping-exposure-during-pregnancy-and-altered2026-10-04 https://evidence-hub.com/study/63809-influence-of-social-media-channels-on-tobacco-product-consumption2026-10-06 https://evidence-hub.com/study/63810-prevalence-and-determinants-of-tobacco-smoking-among-university2026-10-06 https://evidence-hub.com/study/63811-attentional-bias-in-tobacco-use-disorder-using-eye-tracking-a2026-10-04 https://evidence-hub.com/study/63812-clinical-impact-of-vaping2026-10-04 https://evidence-hub.com/study/63813-indoor-air-nicotine-nitrogen-dioxide-exposure-and-covid-19-outcomes2026-10-06 https://evidence-hub.com/study/63814-perspectives-motivations-and-experiences-of-adolescents-and-young2026-10-04 https://evidence-hub.com/study/63815-electronic-cigarette-use-vaping-among-adolescents-a-narrative-review2026-10-04 https://evidence-hub.com/study/63816-the-impact-of-maternal-in-utero-exposure-of-novel-tobacco-products-on2026-10-04 https://evidence-hub.com/study/63817-associations-between-secondhand-smoke-exposure-during-pregnancy-and2026-10-06 https://evidence-hub.com/study/63818-association-between-household-secondhand-tobacco-smoke-exposure-and2026-10-06 https://evidence-hub.com/study/63819-metal-in-biological-samples-from-electronic-cigarette-users-and-those2026-10-04 https://evidence-hub.com/study/63820-sweeteners-in-e-cigarettes-a-minireview-of-flavoring-and-biological2026-10-04 https://evidence-hub.com/study/63821-outcomes-of-a-comprehensive-mobile-vaping-cessation-program-in-adults2026-10-06 https://evidence-hub.com/study/63822-vaping-leads-tobacco-consumption-among-university-students-in-arab2026-10-06 https://evidence-hub.com/study/63823-increasing-lung-screening-uptake-exploring-people-who-smoke-and-their2026-10-06 https://evidence-hub.com/study/63824-exploring-e-vape-aerosol-penetration-into-paranasal-sinuses-insights2026-10-04 https://evidence-hub.com/study/63825-sharing-antivaping-social-media-messages2026-10-06 https://evidence-hub.com/study/63826-knowledge-attitude-and-practices-regarding-e-cigarette-use-among2026-10-06 https://evidence-hub.com/study/63827-e-cigarette-narratives-of-user-generated-posts-on-xiaohongshu-in2026-10-06 https://evidence-hub.com/study/63828-association-between-household-food-security-and-socioeconomic-status2026-10-06 https://evidence-hub.com/study/63829-student-perspectives-on-smoking-and-second-hand-smoke-in-qatar-a2026-10-06 https://evidence-hub.com/study/63830-the-impact-of-the-catch-my-breath-vaping-prevention-curriculum-among2026-10-06 https://evidence-hub.com/study/63831-urinary-tobacco-and-nicotine-exposure-biomarkers-as-predictors-of2026-10-06 https://evidence-hub.com/study/63832-the-folk-sociological-imagination-manufacturing-agency-through2026-10-06 https://evidence-hub.com/study/63833-assessing-the-pragmatic-effectiveness-and-implementation-of-click2026-10-06 https://evidence-hub.com/study/63834-co-design-of-the-ourfutures-vaping-programme-a-school-based-ehealth2026-10-06 https://evidence-hub.com/study/63835-building-the-mountain-mama-baby-cohort-study-design-protocol-and2026-10-06 https://evidence-hub.com/study/63836-bidirectional-associations-between-engagement-with-tobacco2026-10-06 https://evidence-hub.com/study/63837-knowledge-and-perceptions-of-dentists-regarding-e-cigarettes2026-10-06 https://evidence-hub.com/study/63838-a-new-aerosol-respiratory-deposition-approach-health-risks-of-metals2026-10-06 https://evidence-hub.com/study/63839-satisfaction-behavior-paradox-in-lifestyle-choices-a-cross-sectional2026-10-06 https://evidence-hub.com/study/63840-intrinsic-dysregulation-and-environmental-modifiers-in-hidradenitis2026-10-06 https://evidence-hub.com/study/63841-smoking-and-liver-diseases-an-updated-review-of-pathogenesis2026-10-04 https://evidence-hub.com/study/63842-assessing-awareness-ever-use-of-e-cigarettes-and-effect-of-a-health2026-10-06 https://evidence-hub.com/study/63843-harnessing-machine-learning-in-contemporary-tobacco-research2026-10-06 https://evidence-hub.com/study/63844-importance-of-various-e-cigarette-device-and-e-liquid-characteristics2026-10-04 https://evidence-hub.com/study/63845-what-strategies-do-healthcare-providers-use-to-promote-adolescents2026-10-04 https://evidence-hub.com/study/63846-interpersonal-communication-and-perceived-norms-as-social-influence2026-10-04 https://evidence-hub.com/study/63847-cue-reactivity-effects-of-heated-tobacco-product-use-in-current2026-10-06 https://evidence-hub.com/study/63848-knowledge-perception-and-associated-factors-of-electronic-cigarette2026-10-06 https://evidence-hub.com/study/63849-media-reports-and-knowledge-of-e-cigarette-or-vaping-use-associated2026-10-06 https://evidence-hub.com/study/63850-supporting-health-literacy-in-youth-an-insight-from-academics-and2026-10-06 https://evidence-hub.com/study/63851-selected-population-based-oral-health-assessment-following-usage-of-e2026-10-06 https://evidence-hub.com/study/63852-exploring-the-cross-sectional-association-between-the-strength-of2026-10-06 https://evidence-hub.com/study/63853-a-randomized-controlled-trial-examining-the-effects-of-human-models2026-10-06 https://evidence-hub.com/study/63854-decoding-e-cigarette-secrets-unveiling-saliva-and-e-liquid2026-10-06 https://evidence-hub.com/study/63855-an-rct-of-acute-health-effects-in-copd-patients-after-passive-vape2026-10-04 https://evidence-hub.com/study/63856-alpha-emitters-concentration-of-natural-radionuclides-and-lung-cancer2026-10-06 https://evidence-hub.com/study/63857-passive-exposure-of-copd-patients-to-e-cigarette-vape-a-double2026-10-06 https://evidence-hub.com/study/63858-the-juul-e-cigarette-elevates-the-risk-of-thrombosis-and-potentiates2026-10-06 https://evidence-hub.com/study/63860-cue-salience-of-the-use-of-an-electronic-nicotine-delivery-system2026-10-06 https://evidence-hub.com/study/63861-awareness-and-behavioral-determinants-of-passive-smoking-and-vaping2026-10-04 https://evidence-hub.com/study/63862-secondary-indoor-air-pollution-and-passive-smoking-associated-with2026-10-04 https://evidence-hub.com/study/63863-indoor-air-quality-and-passive-e-cigarette-aerosol-exposures-in-vape2026-10-04 https://evidence-hub.com/study/63864-passive-exposure-to-pollutants-from-conventional-cigarettes-and-new2026-10-04 https://evidence-hub.com/study/63865-second-generation-electronic-nicotine-delivery-system-vape-pen2026-10-04 https://evidence-hub.com/study/63866-feasibility-of-using-stopwatch-smartwatch-system-for-passive2026-10-06 https://evidence-hub.com/study/63867-active-and-passive-smoking-and-fecundability-in-danish-pregnancy2026-10-06 https://evidence-hub.com/study/63868-decreased-cigarette-smoking-may-partially-explain-the-increased2026-10-04 https://evidence-hub.com/study/63869-how-does-a-smoke-free-campus-initiative-generates-changes-in-smoking2026-10-04 https://evidence-hub.com/study/63870-a-comparison-of-the-characteristics-of-aboriginal-and-torres-strait2026-10-06 https://evidence-hub.com/study/63872-the-problem-of-the-prevalence-of-smoking-habit-among-adolescent-girls2026-10-04 https://evidence-hub.com/study/63873-the-effects-of-smoking-and-vaping-on-multiple-sclerosis-onset-and2026-10-04 https://evidence-hub.com/study/63875-preliminary-impact-of-the-covid-19-pandemic-on-smoking-and-vaping-in2026-10-06 https://evidence-hub.com/study/63876-characterisation-of-mainstream-and-passive-vapours-emitted-by2026-10-04 https://evidence-hub.com/study/63877-an-exploration-of-smoking-to-vaping-transition-attempts-using-a-smart2026-10-04 https://evidence-hub.com/study/63878-a-diverse-paper-sensor-for-the-rapid-determination-of-nicotine-and2026-10-04 https://evidence-hub.com/study/63880-does-e-cigarette-consumption-cause-passive-vaping2026-10-04 https://evidence-hub.com/study/63882-the-role-of-exogenous-factors-in-the-development-and-clinical-course2026-10-06 https://evidence-hub.com/study/63883-effects-of-visual-exposure-to-iqos-use-on-smoking-urge-and-behavior2026-10-06 https://evidence-hub.com/study/63884-developing-e-cigarette-friendly-smoking-cessation-services-in-england2026-10-06 https://evidence-hub.com/study/63885-should-e-cigarette-use-be-included-in-indoor-smoking-bans2026-10-04 https://evidence-hub.com/study/63886-types-and-devices-for-smoking-and-their-harmful-effects-on-the-human2026-10-04 https://evidence-hub.com/study/63887-examination-of-the-impacts-of-e-cigarettes-smoking-on-the-tobacco-non2026-10-06 https://evidence-hub.com/study/63888-hygienic-approaches-to-assessing-lifestyle-factors-contributing-to2026-10-06 https://evidence-hub.com/study/63889-exposure-to-electronic-nicotine-delivery-systems-ends-visual-imagery2026-10-06 https://evidence-hub.com/study/63890-chronic-pod-mod-e-cigarette-aerosol-exposure-induces-aortic2026-10-06 https://evidence-hub.com/study/63891-prevalence-and-characteristics-of-smoking-among-school-going2026-10-06 https://evidence-hub.com/study/63892-factors-influencing-juul-e-cigarette-nicotine-vapour-induced-reward2026-10-06 https://evidence-hub.com/study/63894-multimodal-diagnostics-of-changes-in-rat-lungs-after-vaping2026-10-06 https://evidence-hub.com/study/63896-what-are-the-effects-of-smoke-free-and-tobacco-free-university-campus2026-10-04 https://evidence-hub.com/study/63897-chronic-pod-mod-e-cigarette-aerosol-exposure-induces-aortic2026-10-06 https://evidence-hub.com/study/63898-comparison-of-particle-size-distributions-and-volatile-organic2026-10-06 https://evidence-hub.com/study/63899-real-time-assessment-of-e-cigarettes-and-conventional-cigarettes2026-10-06 https://evidence-hub.com/study/63902-why-do-people-use-electronic-nicotine-delivery-systems-electronic2026-10-06 https://evidence-hub.com/study/63903-cognitive-stimulation-in-the-workplace-plasma-proteins-and-risk-of2026-10-06 https://evidence-hub.com/study/63904-a-summary-of-in-vitro-and-in-vivo-studies-evaluating-the-impact-of-e2026-10-06 https://evidence-hub.com/study/63909-effects-of-electronic-cigarettes-and-hookah-water-pipe-use-on-home2026-10-06 https://evidence-hub.com/study/63911-state-laws-prohibiting-sales-to-minors-and-indoor-use-of-electronic2026-10-06 https://evidence-hub.com/study/63916-the-psychobiological-problems-of-continued-nicotine-dependency-in-e2026-10-06 https://evidence-hub.com/study/63917-who-does-use-ends-in-russia-results-from-russian-tobacco-control2026-10-06 https://evidence-hub.com/study/63918-e-cigarettes-risk-mitigation-for-smokers-or-a-public-health-disaster2026-10-06 https://evidence-hub.com/study/63920-abstract-a095-enhancing-minority-patient-participation-in-tobacco2026-10-06 https://evidence-hub.com/study/63921-comment-on-flavoring-chemicals-in-e-cigarettes-diacetyl-2-32026-10-06 https://evidence-hub.com/study/63924-application-of-a-brief-digital-screening-tool-to-address-parental-and2026-10-04 https://evidence-hub.com/study/63925-feasibility-of-a-multi-level-school-intervention-for-lgbtq-youth2026-10-06 https://evidence-hub.com/study/63926-a-single-center-evaluation-of-environmental-emissions-from-electronic2026-10-04 https://evidence-hub.com/study/63927-a-pilot-rct-on-the-feasibility-of-an-online-quiz-game-to-promote2026-10-04 https://evidence-hub.com/study/63928-expanding-the-click-city-tobacco-prevention-program-to-include-e2026-10-04 https://evidence-hub.com/study/63929-acute-health-effects-of-passive-exposure-to-particles-from-electronic2026-10-04 https://evidence-hub.com/study/63930-novel-methods-to-reduce-children-s-secondhand-smoke-exposure-i2026-10-04 https://evidence-hub.com/study/63931-bystanders-exposure-to-electronic-cigarette-aerosol-in-confined2026-10-04 https://evidence-hub.com/study/63932-investigation-of-the-effects-of-passive-smoking-on-vital-signs-motor2026-10-04 https://evidence-hub.com/study/63933-cardiovascular-assessment-of-the-effects-of-tobacco-and-nicotine2026-10-04 https://evidence-hub.com/study/63934-digital-tools-for-improved-awareness-and-self-management-of-asthma-in2026-10-04 https://evidence-hub.com/study/63935-current-developments-of-smoking-and-vaping-is-vaping-safer2026-10-04 https://evidence-hub.com/study/63936-effects-of-involuntary-smoking-and-vaping-on-the-cardiovascular-system2026-10-04 https://evidence-hub.com/study/63937-us-nicotine-vaping-product-simsmoke-simulation-model-the-effect-of2026-10-04 https://evidence-hub.com/study/63938-is-vaping-better-than-smoking-for-cardiorespiratory-and-muscle2026-10-04 https://evidence-hub.com/study/63939-sars-cov-2-covid-19-susceptibility-and-lung-inflammatory-storm-by2026-10-04 https://evidence-hub.com/study/63940-a-qualitative-exploration-of-the-role-of-vape-shop-environments-in2026-10-04 https://evidence-hub.com/study/63941-vaping-and-lung-inflammation-and-injury2026-10-04 https://evidence-hub.com/study/63942-influence-of-smoking-and-vaping-on-bone-muscle-crosstalk2026-10-04 https://evidence-hub.com/study/63943-associations-among-smoking-vaping-psychopathology-and-identity2026-10-04 https://evidence-hub.com/study/63944-respiratory-infections-and-pneumonia-potential-benefits-of-switching2026-10-04 https://evidence-hub.com/study/63945-visible-vaping-e-cigarettes-and-the-further-de-normalization-of2026-10-04 https://evidence-hub.com/study/63946-youth-perspectives-on-concurrent-smoking-and-vaping-implications-for2026-10-04 https://evidence-hub.com/study/63949-impact-of-covid-19-lockdown-on-smoking-and-vaping-systematic-review2026-10-04 https://evidence-hub.com/study/63950-impact-of-vaping-on-respiratory-health2026-10-04 https://evidence-hub.com/study/63952-the-impact-of-tobacco-cigarettes-vaping-products-and-tobacco-heating2026-10-04 https://evidence-hub.com/study/63953-smoking-and-vaping-patterns-during-pregnancy-and-the-postpartum-a2026-10-04 https://evidence-hub.com/study/63954-passive-vaping-from-sub-ohm-electronic-cigarette-devices2026-10-04 https://evidence-hub.com/study/63955-vaping-and-vaping-associated-lung-injury-a-review2026-10-04 https://evidence-hub.com/study/63956-effects-of-e-cigarettes-and-vaping-devices-on-cardiac-and-pulmonary2026-10-04 https://evidence-hub.com/study/63957-the-healthy-schools-stop-smoking-and-vaping-service-provides-catch2026-10-04 https://evidence-hub.com/study/63958-tobacco-and-electronic-cigarette-cues-for-smoking-and-vaping-an2026-10-04 https://evidence-hub.com/study/63960-tobacco-and-electronic-cigarette-cues-for-smoking-and-vaping-an2026-10-04 https://evidence-hub.com/study/63961-vaping-and-anesthesia2026-10-04 https://evidence-hub.com/study/63962-deconstructing-disruptive-industry-technological-models-concord2026-10-04 https://evidence-hub.com/study/63963-vaping-as-a-smoking-cessation-tool-attitudes-of-pharmacy-students-a2026-10-04 https://evidence-hub.com/study/63964-no-to-nicotine-developing-and-evaluating-a-smoking-and-vaping2026-10-04 https://evidence-hub.com/study/63965-a-visual-interpretation-of-the-haram-prohibition-on-smoking-and2026-10-04 https://evidence-hub.com/study/63966-inhalation-toxicology-of-vaping-products-and-implications-for2026-10-04 https://evidence-hub.com/study/63967-vaping-environmental-toxicants-exposure-and-lung-cancer-risk2026-10-04 https://evidence-hub.com/study/63968-health-professionals-in-flanders-perceive-the-potential-health-risks2026-10-04 https://evidence-hub.com/study/63969-patterns-of-tobacco-smoking-and-nicotine-vaping-among-university2026-10-04 https://evidence-hub.com/study/63970-vaping-smoking-and-risk-of-early-onset-lung-cancer2026-10-04 https://evidence-hub.com/study/63972-p62-patient-reported-effects-of-vaping-on-asthma-control-in-severe2026-10-04 https://evidence-hub.com/study/63973-the-effects-of-tobacco-21-laws-on-smoking-and-vaping-evidence-from2026-10-04 https://evidence-hub.com/study/63974-electronic-cigarettes-and-vaping-a-new-challenge-in-clinical-medicine2026-10-04 https://evidence-hub.com/study/63976-are-electronic-cigarettes-and-vaping-effective-tools-for-smoking2026-10-04 https://evidence-hub.com/study/63977-public-health-concerns-and-unsubstantiated-claims-at-the-intersection2026-10-04 https://evidence-hub.com/study/63978-perioperative-implications-of-vaping2026-10-04 https://evidence-hub.com/study/63979-offsetting-the-impact-of-smoking-and-e-cigarette-vaping-on-the2026-10-04 https://evidence-hub.com/study/63980-vaping-and-adolescents-results-of-a-survey-in-two-pediatric2026-10-04 https://evidence-hub.com/study/63981-tobacco-smoking-and-vaping-in-pregnancy-and-neonatal-outcomes-results2026-10-04 https://evidence-hub.com/study/63982-the-effect-of-dpp10-in-smoking-and-vaping-induced-apoptosis-and2026-10-04 https://evidence-hub.com/study/63984-new-threats-for-pediatric-respiratory-health-beware-of-vaping2026-10-04 https://evidence-hub.com/study/63985-acute-health-effects-after-passive-e-vape-among-patients-with-copd-an2026-10-04 https://evidence-hub.com/study/63986-comparison-of-smoking-prevalence-in-canada-before-and-after-nicotine2026-10-04 https://evidence-hub.com/study/63987-external-hair-contamination-from-cannabis-and-light-cannabis2026-10-04 https://evidence-hub.com/study/63988-smoking-and-vaping-in-prevocational-schools-qualitative-insights-to2026-10-04 https://evidence-hub.com/study/63989-e-liquid-autofluorescence-can-be-used-as-a-marker-of-vaping2026-10-04 https://evidence-hub.com/study/63990-drug-vaping-applied-to-cannabis-is-cannavaping-a-therapeutic2026-10-04 https://evidence-hub.com/study/63991-vaping-as-a-new-threat-for-respiratory-health-a-position-statement2026-10-04 https://evidence-hub.com/study/63992-are-people-more-likely-to-vape-or-smoke-indoors-a-population-survey2026-10-04 https://evidence-hub.com/study/63994-assessment-of-indoor-air-quality-at-an-electronic-cigarette-vaping2026-10-04 https://evidence-hub.com/study/63995-cardiopulmonary-impact-of-electronic-cigarettes-and-vaping-products-a2026-10-04 https://evidence-hub.com/study/63996-the-phenomenon-of-vaping-in-female-students2026-10-04 https://evidence-hub.com/study/63997-don-t-go-vaping-my-heart-a-case-of-vaping-associated-cardiomyopathy2026-10-04 https://evidence-hub.com/study/63998-cost-of-passive-smoking-in-children-in-spain2026-10-04 https://evidence-hub.com/study/63999-alarming-rise-in-vape-smoking-among-teenagers-in-pakistan-a-call-for2026-10-04 https://evidence-hub.com/study/64000-drug-vaping-from-the-dangers-of-misuse-to-new-therapeutic-devices2026-10-04 https://evidence-hub.com/study/64001-smoking-and-vaping-in-children-associations-with-pulmonary-function2026-10-04 https://evidence-hub.com/study/64002-how-does-media-literacy-affect-smoking-and-vaping-behaviors-among2026-10-04 https://evidence-hub.com/study/64003-the-impact-of-vaping-on-the-health-of-children-and-adolescents2026-10-04 https://evidence-hub.com/study/64004-don-t-vape-nobody-uses-these-poisonous-sticks-a-content-analysis-of2026-10-04 https://evidence-hub.com/study/64005-commentary-on-staff-et-al-should-smoke-free-areas-be-made-vape-free2026-10-04 https://evidence-hub.com/study/64006-the-impact-of-exposure-to-tobacco-smoke-and-e-cigarettes-on-asthma2026-10-04 https://evidence-hub.com/study/64007-gastroesophageal-disease-risk-and-inhalational-exposure-a-systematic2026-10-09 https://evidence-hub.com/study/64008-culturally-sensitive-prevention-programs-for-substance-use-among2026-10-06 https://evidence-hub.com/study/64009-comparison-of-the-total-mortality-risk-for-nuclear-workers-uranium2026-10-06 https://evidence-hub.com/study/64010-passive-smoking-exposure-and-incidence-and-disease-outcomes-of2026-10-06 https://evidence-hub.com/study/64011-antibiotics-passive-smoking-high-socioeconomic-status-and-sweetened2026-10-06 https://evidence-hub.com/study/64012-passive-smoking-and-risk-of-head-and-neck-cancer-a-systematic-review2026-10-06 https://evidence-hub.com/study/64013-passive-smoking-and-risk-of-pancreatic-cancer-an-updated-systematic2026-10-06 https://evidence-hub.com/study/64014-passive-smoking-and-the-risk-of-hypertension-in-nonsmoking-adults-a2026-10-06 https://evidence-hub.com/study/64015-postnatal-passive-smoking-and-risk-of-myopia-in-children-and2026-10-06 https://evidence-hub.com/study/64017-passive-smoking-and-risk-of-gestational-diabetes-mellitus-a2026-10-06 https://evidence-hub.com/study/64018-effect-of-passive-smoking-exposure-on-risk-of-type-2-diabetes-a2026-10-06 https://evidence-hub.com/study/64020-active-and-passive-smoking-and-breast-cancer-in-japan-a-pooled2026-10-06 https://evidence-hub.com/study/64021-lung-cancer-occurrence-attributable-to-passive-smoking-among-never2026-10-06 https://evidence-hub.com/study/64025-influence-of-passive-smoking-on-the-onset-of-legg-calve-perthes2026-10-06 https://evidence-hub.com/study/64027-the-association-between-smoking-exposure-and-endothelial-function2026-10-06 https://evidence-hub.com/study/64029-maternal-smoking-consumption-of-alcohol-and-caffeinated-beverages2026-10-06 https://evidence-hub.com/study/64030-smoking-related-tear-film-abnormalities-and-dry-eye-disease-a-meta2026-10-06 https://evidence-hub.com/study/64031-an-intercontinental-comparison-of-the-influence-of-smoking-on-the2026-10-06 https://evidence-hub.com/study/64032-does-tobacco-smoking-affect-vaccine-induced-immune-response-a2026-10-06 https://evidence-hub.com/study/64035-prevalence-of-passive-smoking-in-the-community-population-aged-152026-10-06 https://evidence-hub.com/study/64036-exposure-to-tobacco-specific-nitrosamines-among-people-who-vape-smoke2026-10-06 https://evidence-hub.com/study/64037-passive-smoking-in-the-etiology-of-non-syndromic-orofacial-clefts-a2026-10-06 https://evidence-hub.com/study/64039-parental-smoking-and-risk-of-hypospadias-an-updated-meta-analysis-of2026-10-06 https://evidence-hub.com/study/64041-the-effects-of-electronic-smoking-on-dental-caries-and2026-10-06 https://evidence-hub.com/study/64042-association-between-prenatal-environmental-tobacco-smoke-exposure-and2026-10-06 https://evidence-hub.com/study/64043-tobacco-exposure-and-risk-of-spontaneous-abortion-a-dose-dependent2026-10-06 https://evidence-hub.com/study/64044-influencing-factors-of-neural-tube-malformation-a-systematic-review2026-10-06 https://evidence-hub.com/study/64045-vaping-and-smoking-in-pregnancy-a-meta-analysis-of-neurobehavioural2026-10-06 https://evidence-hub.com/study/64046-risk-assessment-of-congenital-heart-defects-based-on-maternal-factors2026-10-06 https://evidence-hub.com/study/64047-the-association-of-environmental-exposure-in-the-etiology-of2026-10-06 https://evidence-hub.com/study/64048-the-relationship-between-tobacco-and-non-alcoholic-fatty-liver2026-10-06 https://evidence-hub.com/study/64050-associations-between-passive-maternal-smoking-during-pregnancy-and2026-10-06 https://evidence-hub.com/study/64051-active-and-passive-smoking-with-breast-cancer-risk-for-chinese2026-10-06 https://evidence-hub.com/study/64052-response-to-comments-on-smoking-and-risk-of-uveitis-a-systematic2026-10-06 https://evidence-hub.com/study/64053-the-impact-of-cigarette-smoking-waterpipe-smoking-and-e-cigarette2026-10-06 https://evidence-hub.com/study/64054-association-between-preterm-birth-and-cigarette-smoking-among2026-10-06 https://evidence-hub.com/study/64055-the-effect-of-smoking-and-vaping-on-oral-health-a-meta-analysis2026-10-06 https://evidence-hub.com/study/64059-relation-of-active-passive-and-quitting-smoking-with-incident2026-10-06 https://evidence-hub.com/study/64060-maternal-tobacco-exposure-during-pregnancy-and-atopic-dermatitis-in2026-10-06 https://evidence-hub.com/study/64062-passive-smoking-and-risk-of-type-2-diabetes-a-meta-analysis-of2026-10-06 https://evidence-hub.com/study/64063-electronic-cigarettes-ends-or-ennds-smoking-in-asian-countries-after2026-10-06 https://evidence-hub.com/study/64064-effects-of-electronic-cigarettes-on-periodontal-health-a-systematic2026-10-06 https://evidence-hub.com/study/64065-smoking-and-vaping-alter-genes-related-to-mechanisms-of-sars-cov-22026-10-04 https://evidence-hub.com/study/64066-passive-smoking-and-cervical-cancer-risk-a-meta-analysis-based-on-32026-10-06 https://evidence-hub.com/study/64067-parental-smoking-and-the-risk-of-congenital-heart-defects-in2026-10-06 https://evidence-hub.com/study/64072-smoking-cessation-intervention-in-puerperium-a-systematic-review-and2026-10-06 https://evidence-hub.com/study/64074-tobacco-smoking-and-meningococcal-disease-in-adolescents-and-young2026-10-06 https://evidence-hub.com/study/64075-passive-smoking-and-inflammatory-bowel-disease-a-meta-analysis2026-10-06 https://evidence-hub.com/study/64076-assessing-the-impact-of-electronic-nicotine-delivery-systems-on2026-10-06 https://evidence-hub.com/study/64078-vaping-cessation-interventions-a-systematic-review-and-meta-analysis2026-10-06 https://evidence-hub.com/study/64080-maternal-exposure-to-second-hand-smoke-during-pregnancy-and-risk-of2026-10-06 https://evidence-hub.com/study/64081-evolution-of-mortality-attributable-to-passive-smoking-in-the-272026-10-06 https://evidence-hub.com/study/64082-impact-of-tobacco-smoking-upon-disease-risk-activity-and-therapeutic2026-10-06 https://evidence-hub.com/study/64084-risk-factors-associated-with-incidence-of-lung-cancer-in-never2026-10-06 https://evidence-hub.com/study/64088-smoke-exposure-and-childhood-atopic-eczema-and-food-allergy-a2026-10-06 https://evidence-hub.com/study/64090-effect-of-passive-exposure-to-cigarette-smoke-on-blood-pressure-in2026-10-06 https://evidence-hub.com/study/64091-active-or-passive-exposure-to-tobacco-smoking-and-allergic-rhinitis2026-10-06 https://evidence-hub.com/study/64092-effects-of-stress-and-emotional-distress-on-smoking-and-vaping-a2026-10-06 https://evidence-hub.com/study/64093-quantifying-the-evidence-and-burden-of-smoking-behaviour-on2026-10-06 https://evidence-hub.com/study/64096-exercise-based-interventions-for-smoking-cessation-a-systematic2026-10-06 https://evidence-hub.com/study/64099-meta-analysis-of-the-effect-of-exposure-to-indoor-cigarette-smoke-in2026-10-06 https://evidence-hub.com/study/64102-associations-of-occupational-and-leisure-time-physical-activity-with2026-10-06 https://evidence-hub.com/study/64103-inaccurate-and-misleading-meta-analysis-of-e-cigarettes-and2026-10-06 https://evidence-hub.com/study/64106-comparison-of-the-effects-of-active-and-passive-smoking-of-tobacco2026-10-04 https://evidence-hub.com/study/64107-health-impacts-of-passive-exposure-to-alternative-tobacco-products-a2026-10-04 https://evidence-hub.com/study/64108-the-effects-of-thirdhand-vape-residue-from-nicotine-and-non-nicotine2026-10-06 https://evidence-hub.com/study/64109-passive-electronic-cigarette-vapor-exposure-in-children-a-systematic2026-10-04 https://evidence-hub.com/study/64110-analysis-of-assessment-methods-for-detecting-nicotine-residue-and-its2026-10-04 https://evidence-hub.com/study/64111-health-hazards-of-e-cigarettes-and-heated-tobacco-products-a2026-10-06 https://evidence-hub.com/study/64112-virtual-reality-in-prevention-and-treatment-of-substance-related2026-10-06 https://evidence-hub.com/study/64113-smoking-cessation-and-harm-reduction-a-systematic-overview-of-ongoing2026-10-06 https://evidence-hub.com/study/64114-direct-health-implications-of-e-cigarette-use-a-systematic-scoping2026-10-04 https://evidence-hub.com/study/64115-lung-damage-caused-by-heated-tobacco-products-and-electronic-nicotine2026-10-06 https://evidence-hub.com/study/64116-a-systematic-literature-review-of-e-cigarette-related-illness-and2026-10-06 https://evidence-hub.com/study/64117-overview-of-electronic-nicotine-delivery-systems-a-systematic-review2026-10-06 https://evidence-hub.com/study/64118-active-and-passive-smoking-and-the-risk-of-breast-cancer-an-umbrella2026-10-06 https://evidence-hub.com/study/64120-passive-smoking-and-oral-health-of-infants-preschoolers-and-children2026-10-06 https://evidence-hub.com/study/64121-passive-smoking-and-lung-disease-in-children-systematic-review2026-10-06 https://evidence-hub.com/study/64122-effects-of-passive-smoking-on-the-health-of-children-and-ad-olescents2026-10-06 https://evidence-hub.com/study/64123-passive-smoking-and-allergic-diseases-in-childhood-a-systematic-review2026-10-06 https://evidence-hub.com/study/64125-the-relationship-between-smoking-and-the-cardiovascular-health-of2026-10-06 https://evidence-hub.com/study/64126-the-toxic-and-pathophysiological-aspects-of-smoking-related-to-the2026-10-04 https://evidence-hub.com/study/64127-vape-use-among-generation-z-students-a-systematic-literature-review2026-10-06 https://evidence-hub.com/study/64128-lung-and-airway-disease-caused-by-e-cigarette-vape-a-systematic-review2026-10-06 https://evidence-hub.com/study/64129-unveiling-atopic-dermatitis-exploring-smoking-obesity-and-fast-food2026-10-06 https://evidence-hub.com/study/64130-electronic-cigarettes-and-subsequent-cigarette-smoking-in-young2026-10-06 https://evidence-hub.com/study/64131-passive-smoking-as-a-risk-factor-for-dementia-and-cognitive2026-10-06 https://evidence-hub.com/study/64132-interventions-to-change-vaping-harm-perceptions-and-associations2026-10-06 https://evidence-hub.com/study/64134-the-impact-of-cigarette-smoking-and-vaping-use-on-the-development-and2026-10-06 https://evidence-hub.com/study/64135-toxic-metal-content-in-deciduous-teeth-a-systematic-review2026-10-06 https://evidence-hub.com/study/64136-pengaruh-kecanduan-merokok-dan-vape-pada-remaja-literatur-review2026-10-06 https://evidence-hub.com/study/64137-use-of-mobile-technologies-for-smoking-cessation-among-smokers-and2026-10-06 https://evidence-hub.com/study/64138-adverse-effects-of-e-cigarettes-or-vapes-in-otherwise-healthy-young2026-10-06 https://evidence-hub.com/study/64139-systematic-review-and-development-of-recommended-code-lists-to2026-10-04 https://evidence-hub.com/study/64141-protecting-young-lives-a-systematic-review-of-the-impact-of2026-10-06 https://evidence-hub.com/study/64142-inhaling-hazards-exhaling-insights-a-systematic-review-unveiling-the2026-10-06 https://evidence-hub.com/study/64143-what-is-the-contribution-of-smoking-to-the-increased-risk-of-suicide2026-10-06 https://evidence-hub.com/study/64144-correlation-of-exposure-to-environmental-tobacco-smoke-and2026-10-06 https://evidence-hub.com/study/64145-does-smoking-cessation-affect-postoperative-healing-following-oral2026-10-06 https://evidence-hub.com/study/64146-interactive-conversational-agents-for-cigarette-smoking-and-vaping2026-10-04 https://evidence-hub.com/study/64147-exploring-associations-of-population-characteristics-and-tobacco-and2026-10-06 https://evidence-hub.com/study/64148-sudden-deaths-in-infancy-and-pesticide-exposure-a-systematic-review2026-10-06 https://evidence-hub.com/study/64149-the-association-between-passive-smoke-exposure-and-the-incidence-of2026-10-06 https://evidence-hub.com/study/64150-lung-cancer-among-patients-with-secondhand-smoke-exposure-a2026-10-06 https://evidence-hub.com/study/64151-the-association-between-smoking-status-and-breast-cancer-recurrence-a2026-10-06 https://evidence-hub.com/study/64152-an-update-of-a-systematic-review-and-meta-analyses-exploring-flavours2026-10-06 https://evidence-hub.com/study/64154-the-implications-of-vaping-on-surgical-wound-healing-a-systematic2026-10-06 https://evidence-hub.com/study/64155-the-relationship-between-environmental-tobacco-smoke-exposure-and2026-10-06 https://evidence-hub.com/study/64156-smoking-cessation-intervention-for-indigenous-pregnant-women-a2026-10-06 https://evidence-hub.com/study/64157-a-systematic-review-of-ehealth-interventions-among-adolescents-of-low2026-10-06 https://evidence-hub.com/study/64158-parental-dual-use-of-e-cigarettes-and-traditional-cigarettes2026-10-06 https://evidence-hub.com/study/64159-an-integrated-digital-clinical-approach-to-smoking-cessation-in-lung2026-10-06 https://evidence-hub.com/study/64160-current-and-future-trends-in-electronic-cigarette-use2026-10-06 https://evidence-hub.com/study/64161-parental-smoking-and-e-cigarette-use-in-homes-and-cars2026-10-06 https://evidence-hub.com/study/64162-randomised-controlled-trial-of-real-time-feedback-and-brief-coaching2026-10-06 https://evidence-hub.com/study/64163-antioxidant-responses-following-active-and-passive-smoking-of-tobacco2026-10-06 https://evidence-hub.com/study/64164-passive-exposure-to-electronic-cigarette-e-cigarette-use-increases2026-10-06 https://evidence-hub.com/study/64165-comparative-indoor-pollution-from-glo-iqos-and-juul-using-traditional2026-10-06 https://evidence-hub.com/study/64166-digital-screening-tool-to-help-parents-and-adolescents-quit-smoking2026-10-06 https://evidence-hub.com/study/64167-feasibility-and-preliminary-efficacy-of-an-online-cardiovascular2026-10-06 https://evidence-hub.com/study/64168-framing-effects-in-youth-e-cigarette-use-prevention-individual-text2026-10-06 https://evidence-hub.com/study/64169-characteristics-of-covid-19-in-homeless-shelters-a-community-based2026-10-06 https://evidence-hub.com/study/64170-a-novel-online-vaping-intervention-and-smoking-prevention-program-for2026-10-06 https://evidence-hub.com/study/64172-e-liquid-flavors-and-nicotine-concentration-choices-over-6-months2026-10-06 https://evidence-hub.com/study/64173-58-a-digital-screening-and-brief-intervention-tool-to-help-parents2026-10-06 https://evidence-hub.com/study/64174-monthly-motivational-interview-counseling-and-nicotine-replacement2026-10-06 https://evidence-hub.com/study/64175-adverse-symptoms-attributed-to-e-cigarettes-over-6-months-among2026-10-06 https://evidence-hub.com/study/64176-development-of-a-school-program-for-vaping-and-smoking-prevention-and2026-10-04 https://evidence-hub.com/study/64177-passive-mobilization-with-place-and-hold-versus-active-mobilization2026-10-06 https://evidence-hub.com/study/64179-mutational-profile-of-oropharyngeal-squamous-cell-carcinoma-in2026-10-06 https://evidence-hub.com/study/64182-quitnic-a-pilot-randomized-controlled-trial-comparing-nicotine-vaping2026-10-06 https://evidence-hub.com/study/64183-effect-of-a-smoking-cessation-intervention-for-women-in-subsidized2026-10-06 https://evidence-hub.com/study/64184-low-dose-computed-tomography-for-lung-cancer-screening-in-anhui-china2026-10-06 https://evidence-hub.com/study/64185-brief-advice-and-active-referral-for-smoking-cessation-services-among2026-10-06 https://evidence-hub.com/study/64186-varenicline-and-counseling-for-vaping-cessation-a-double-blind2026-10-06 https://evidence-hub.com/study/64187-a-brief-digital-screening-tool-to-address-parental-and-adolescent2026-10-06 https://evidence-hub.com/study/64188-effect-of-a-peer-led-prevention-program-p2p-on-smoking-in-vocational2026-10-06 https://evidence-hub.com/study/64189-smokers-likelihood-to-engage-with-information-and-misinformation-on2026-10-06 https://evidence-hub.com/study/64190-geriatric-prehabilitation-prior-to-surgery-for-kidney-tumors-study2026-10-06 https://evidence-hub.com/study/64192-clinical-and-immunological-peri-implant-parameters-among-cigarette2026-10-06 https://evidence-hub.com/study/64193-a-brief-digital-screening-and-intervention-tool-for-parental-and2026-10-06 https://evidence-hub.com/study/64194-effect-of-intraoperative-active-warming-initiated-at-anesthesia2026-10-06 https://evidence-hub.com/study/64195-effectiveness-of-a-telephone-counseling-intervention-in-reducing2026-10-06 https://evidence-hub.com/study/64196-selenium-and-coenzyme-q10-supplementation-and-sex-differences-in2026-10-06 https://evidence-hub.com/study/64197-a-telegram-based-behavioral-intervention-for-smoking-cessation-after2026-10-06 https://evidence-hub.com/study/64198-the-effect-of-evening-technology-use-on-objective-sleep-in-older2026-10-08 https://evidence-hub.com/study/64199-the-effect-of-a-very-brief-smoking-reduction-intervention-in-smokers2026-10-06 https://evidence-hub.com/study/64200-delivering-vaping-cessation-interventions-to-adolescents-and-young2026-10-06 https://evidence-hub.com/study/64202-the-context-of-the-emergency-department-as-a-location-for-a-smoking2026-10-06 https://evidence-hub.com/study/64203-comparison-of-four-active-sars-cov-2-surveillance-strategies-in2026-10-06 https://evidence-hub.com/study/64204-study-protocol-for-active-study-safety-and-feasibility-evaluation-of2026-10-06 https://evidence-hub.com/study/64205-evaluation-after-delayed-and-repeated-intervention-in-the-vipviza2026-10-06 https://evidence-hub.com/study/64206-community-driven-grassroots-intervention-on-adolescent-vaping2026-10-06 https://evidence-hub.com/study/64207-social-and-behavioral-predictors-of-two-doses-4cmenb-vaccine-series2026-10-06 https://evidence-hub.com/study/64208-efficacy-and-safety-of-varenicline-for-vaping-cessation-a-systematic2026-10-06 https://evidence-hub.com/study/64209-nicotine-patches-in-patients-on-mechanical-ventilation-for-severe2026-10-06 https://evidence-hub.com/study/64210-effectiveness-and-cost-effectiveness-of-four-different-strategies-for2026-10-06 https://evidence-hub.com/study/64211-brief-interactive-lifestyle-preventive-education-in-the-primary-care2026-10-06 https://evidence-hub.com/study/64212-tobacco-control-messages-for-individuals-who-use-both-cigarettes-and2026-10-06 https://evidence-hub.com/study/64213-does-aerobic-exercise-facilitate-vaping-and-smoking-cessation-a2026-10-06 https://evidence-hub.com/study/64214-varenicline-for-smoking-cessation-in-individuals-who-smoke-cigarettes2026-10-06 https://evidence-hub.com/study/64215-a-systematic-review-of-randomized-controlled-trials-and-network-meta2026-10-06 https://evidence-hub.com/study/64216-targeted-smoking-cessation-for-dual-users-of-combustible-and2026-10-06 https://evidence-hub.com/study/64217-risk-perception-and-knowledge-following-a-social-game-based-tobacco2026-10-06 https://evidence-hub.com/study/64218-effect-of-vitamin-c-ingestion-on-the-vascular-endothelial-function2026-10-06 https://evidence-hub.com/study/64219-a-randomised-trial-to-stop-passive-smoking-in-children-with-a-high2026-10-06 https://evidence-hub.com/study/64222-a-randomized-clinical-trial-to-assess-the-effect-of-zinc-and-vitamin2026-10-06 https://evidence-hub.com/study/64225-effect-on-attendance-by-including-focused-information-on-spirometry2026-10-06 https://evidence-hub.com/study/64226-an-evaluation-of-cytisinicline-for-smoking-cessation-in-adult-smokers2026-10-06 https://evidence-hub.com/study/64227-psychosocial-interventions-for-supporting-women-to-stop-smoking-in2026-10-06 https://evidence-hub.com/study/64229-uptake-and-effectiveness-of-a-tailor-made-online-lifestyle-programme2026-10-06 https://evidence-hub.com/study/64233-effectiveness-and-cost-effectiveness-of-four-different-strategies-for2026-10-06 https://evidence-hub.com/study/64234-electronic-cigarettes-for-smoking-cessation2026-10-06 https://evidence-hub.com/study/64236-results-of-the-lung-and-colorectal-cancer-screening-study-in-china-a2026-10-06 https://evidence-hub.com/study/64238-heart-rehabilitation-for-all-herta-protocol-for-a-feasibility-study2026-10-06 https://evidence-hub.com/study/64240-electronic-cigarettes-for-smoking-cessation2026-10-06 https://evidence-hub.com/study/64242-prevalence-and-impact-of-active-and-passive-cigarette-smoking-in2026-10-06 https://evidence-hub.com/study/64245-transitions-between-smoking-and-vaping-evidence-or-lack-thereof-on2026-10-06 https://evidence-hub.com/study/64246-promoting-smoke-free-homes-through-biomarker-feedback-documenting2026-10-06 https://evidence-hub.com/study/64247-an-informal-school-based-peer-led-intervention-for-prevention-of2026-10-06 https://evidence-hub.com/study/64248-effect-of-e-cigarette-flavors-on-nicotine-delivery-and-puffing2026-10-06 https://evidence-hub.com/study/64249-cannabis-containing-thc-impairs-20-minute-cycling-time-trial2026-10-06 https://evidence-hub.com/study/64250-the-feasibility-and-acceptability-of-liffe-a-web-based-vaping2026-10-06 https://evidence-hub.com/study/64251-passive-smoking-in-babies-the-bibe-study-brief-intervention-in-babies2026-10-06 https://evidence-hub.com/study/64252-promoting-smoke-free-homes-through-biomarker-feedback-documenting2026-10-06 https://evidence-hub.com/study/64253-use-of-vaping-as-a-smoking-cessation-aid-a-review-of-clinical-trials2026-10-06 https://evidence-hub.com/study/64254-topical-fluorouracil-after-surgery-for-ocular-surface-squamous2026-10-06 https://evidence-hub.com/study/64256-examining-smoking-and-vaping-behaviors-expectancies-and-cessation2026-10-06 https://evidence-hub.com/study/64258-study-protocol-of-the-our-futures-vaping-trial-a-cluster-randomised2026-10-06 https://evidence-hub.com/study/64259-the-initiate-trial-protocol-a-randomized-controlled-trial-testing-the2026-10-06 https://evidence-hub.com/study/64260-rationale-design-and-methods-for-the-development-of-a-youth-adapted2026-10-06 https://evidence-hub.com/study/64261-high-school-students-use-of-juul-pod-flavors-before-and-after-juul2026-10-06 https://evidence-hub.com/study/64262-brief-interactive-lifestyle-preventive-medicine-video-education-in2026-10-06 https://evidence-hub.com/study/64263-c102-25-cytisinicline-for-cigarette-and-e-cigarette-smoking-cessation2026-10-06 https://evidence-hub.com/study/64264-effect-of-a-smoking-and-alcohol-cessation-intervention-initiated2026-10-06 https://evidence-hub.com/study/64265-active-subperiosteal-vs-passive-subdural-24-h-drainage-following2026-10-06 https://evidence-hub.com/study/64267-selecting-an-e-cigarette-for-use-in-smoking-cessation-interventions2026-10-06 https://evidence-hub.com/study/64268-the-cortisol-awakening-response-in-a-3-month-clinical-trial-of2026-10-06 https://evidence-hub.com/study/64269-does-varenicline-promote-abstinence-in-youths-who-vape2026-10-06 https://evidence-hub.com/study/64270-does-semaglutide-reduce-alcohol-intake-in-danish-patients-with2026-10-06 https://evidence-hub.com/study/64271-integrating-smoking-cessation-support-during-lung-cancer-diagnostic2026-10-06 https://evidence-hub.com/study/64273-is-passive-smoking-associated-with-acute-stress-response-an2026-10-06 https://evidence-hub.com/study/64274-implications-of-switching-from-conventional-to-electronic-cigarettes2026-10-06 https://evidence-hub.com/study/64276-vitamin-c-supplementation-for-pregnant-smoking-women-and-pulmonary2026-10-06 https://evidence-hub.com/study/64277-effects-of-transfer-point-glucan-300-supplementation-on-children2026-10-06 https://evidence-hub.com/study/64278-urinary-profiles-of-methoxyphenamine-and-its-metabolite-after2026-10-06 https://evidence-hub.com/study/64280-optimising-a-digital-intervention-to-support-parents-experiencing2026-10-06 https://evidence-hub.com/study/64281-acute-effects-of-heat-not-burn-electronic-vaping-and-traditional2026-10-06 https://evidence-hub.com/study/64282-a-qualitative-study-of-using-nicotine-products-for-smoking-cessation2026-10-06 https://evidence-hub.com/study/64284-tct-147-high-wattage-electronic-cigarette-vaping-after-coronary2026-10-06 https://evidence-hub.com/study/64287-smoking-and-cardiovascular-health-with-herbal-treatment2026-10-06 https://evidence-hub.com/study/64289-does-glucagon-like-peptide-1-glp-1-receptor-agonist-stimulation2026-10-06 https://evidence-hub.com/study/64290-using-the-very-brief-advice-method-for-referral-to-smoking-cessation2026-10-06 https://evidence-hub.com/study/64291-increasing-the-capacity-of-community-managed-organisations-to-provide2026-10-06 https://evidence-hub.com/study/64293-screening-and-diagnosis-of-combustion-smoking-with-exhaled-breath2026-10-06 https://evidence-hub.com/study/64294-quitline-counsellors-experiences-with-vaping-and-nicotine-replacement2026-10-06 https://evidence-hub.com/study/64297-current-therapeutic-cannabis-controversies-and-clinical-trial-design2026-10-06 https://evidence-hub.com/study/64298-design-and-rationale-of-the-my-heart-counts-cardiovascular-health2026-10-06 https://evidence-hub.com/study/64302-theme-09-clinical-trials-and-trial-design2026-10-06 https://evidence-hub.com/study/64304-the-importance-of-lay-navigators-in-lung-cancer-screening-among-asian2026-10-06 https://evidence-hub.com/study/64305-a-systematic-review-of-couple-or-household-targeted-interventions-for2026-10-04 https://evidence-hub.com/study/64307-cardiovascular-risk-factors-and-health-related-social-needs-among2026-10-06 https://evidence-hub.com/study/64310-how-do-electronic-cigarettes-affect-cravings-to-smoke-or-vape-parsing2026-10-06 https://evidence-hub.com/study/64311-interventions-for-quitting-vaping2026-10-06 https://evidence-hub.com/study/64313-effect-of-periodontal-therapy-on-the-oral-microbiome-and-lung2026-10-06 https://evidence-hub.com/study/64316-study-finds-varenicline-can-help-young-adults-quit-vaping2026-10-06 https://evidence-hub.com/study/64317-the-influence-of-various-nicotine-and-tobacco-delivery-methods-on-the2026-10-06 https://evidence-hub.com/study/64319-high-dose-steroids-in-high-pain-responders-undergoing-total-knee2026-10-06 https://evidence-hub.com/study/64323-smoking-cessation-in-individuals-who-use-vaping-as-compared-with2026-10-06 https://evidence-hub.com/study/64324-molecular-imaging-of-pulmonary-inflammation-claiming-that-vaping-is2026-10-06 https://evidence-hub.com/study/64325-electronic-cigarettes-for-smoking-cessation2026-10-06 https://evidence-hub.com/study/64326-prevalence-of-underreported-nicotine-exposure-among-us-nonsmoking2026-10-06 https://evidence-hub.com/study/64327-the-application-of-a-self-designed-microfluidic-lung-chip-in-the2026-10-06 https://evidence-hub.com/study/64328-susceptibility-to-e-cigarette-adoption-among-tobacco-naive-youths-a2026-10-06 https://evidence-hub.com/study/64329-coverage-of-indoor-smoking-and-vaping-restrictions-in-the-u-s-19902026-10-06 https://evidence-hub.com/study/64330-secondhand-e-cigarette-and-tobacco-smoke-exposure-and-stages-of-e2026-10-06 https://evidence-hub.com/study/64331-prevalence-of-electronic-smoking-exposure-and-tonsillectomy-surgery2026-10-06 https://evidence-hub.com/study/64332-tobacco-and-asthma-presenting-the-world-health-organization-who2026-10-06 https://evidence-hub.com/study/64333-different-lengths-of-gestational-exposure-to-secondhand-smoke-or-e2026-10-06 https://evidence-hub.com/study/64334-gender-trends-in-youth-tobacco-and-nicotine-use-in-georgia-across2026-10-06 https://evidence-hub.com/study/64335-low-levels-of-nicotine-and-cotinine-but-not-benzo-a-pyrene-induce2026-10-06 https://evidence-hub.com/study/64336-secondhand-exposure-to-cigarettes-smoke-and-e-cigarettes-aerosols-on2026-10-06 https://evidence-hub.com/study/64337-global-study-on-tobacco-use-among-youth-13-15-years-old-in-the2026-10-06 https://evidence-hub.com/study/64338-evaluating-the-toxicity-of-electronic-cigarette-aerosols-for2026-10-06 https://evidence-hub.com/study/64339-attitudes-toward-tobacco-and-nicotine-control-policies-in-italy2026-10-06 https://evidence-hub.com/study/64340-impact-of-smoking-from-childhood-associated-with-greater-risk-of2026-10-06 https://evidence-hub.com/study/64341-evaluation-and-comparison-of-dna-alkylation-and-oxidative-damage-in-e2026-10-06 https://evidence-hub.com/study/64342-from-biomarkers-to-the-risk-index-a-novel-integrated-model-using2026-10-06 https://evidence-hub.com/study/64343-biomarkers-of-secondhand-smoke-and-vaping-exposure-among-u-s2026-10-06 https://evidence-hub.com/study/64344-on-the-detection-and-scope-of-third-hand-vaping-a-critical-review-of2026-10-06 https://evidence-hub.com/study/64345-first-tobacco-free-generation-in-europe-a-lost-cause-latest-global2026-10-06 https://evidence-hub.com/study/64346-the-respiratory-impacts-of-primary-and-secondhand-exposure-to2026-10-06 https://evidence-hub.com/study/64347-linking-environmental-concentrations-to-cytotoxic-mechanisms-in2026-10-06 https://evidence-hub.com/study/64348-estimating-the-health-impact-of-nicotine-exposure-by-dissecting-the2026-10-06 https://evidence-hub.com/study/64349-exploratory-untargeted-metabolomics-analysis-reveals-differences-in2026-10-06 https://evidence-hub.com/study/64350-changes-in-tobacco-use-and-associated-factors-among-brazilian2026-10-06 https://evidence-hub.com/study/64351-a-study-on-the-dual-use-of-e-cigarettes-and-cigarettes-among2026-10-06 https://evidence-hub.com/study/64352-impact-of-secondhand-smoke-from-conventional-cigarettes-iqos-and-e2026-10-06 https://evidence-hub.com/study/64353-state-ends-taxes-and-cigarette-smoking-in-two-parent-households2026-10-06 https://evidence-hub.com/study/64354-medical-trainees-knowledge-and-attitudes-towards-electronic2026-10-06 https://evidence-hub.com/study/64355-characteristics-of-nicotine-product-use-perceptions-of-dependence-and2026-10-04 https://evidence-hub.com/study/64356-maternal-lung-inflammation-and-apoptosis-following-gestational2026-10-06 https://evidence-hub.com/study/64357-smokefree-home-rules-and-susceptibility-to-cigarette-and-e-cigarette2026-10-06 https://evidence-hub.com/study/64358-european-code-against-cancer-5th-edition-tobacco-and-nicotine2026-10-06 https://evidence-hub.com/study/64359-do-youth-e-cigarette-users-perceive-smoking-as-attractive-the2026-10-06 https://evidence-hub.com/study/64360-smoking-habits-ets-exposure-and-knowledge-of-tobacco-and-e-cigarettes2026-10-04 https://evidence-hub.com/study/64361-pathological-findings-of-respiratory-and-reproductive-organs-in-male2026-10-06 https://evidence-hub.com/study/64362-polycyclic-aromatic-hydrocarbons-and-cannabinoids-in-secondhand2026-10-06 https://evidence-hub.com/study/64363-unpacking-the-transformations-activated-by-smoke-free-campuses-a2026-10-06 https://evidence-hub.com/study/64364-mitochondrial-antioxidant-therapy-fails-to-improve-obese-asthma2026-10-06 https://evidence-hub.com/study/64365-emergency-psychiatric-effects-of-nicotine-vaping-cessation-a2026-10-06 https://evidence-hub.com/study/64366-assessing-home-environmental-hazards-for-older-adults-receiving-in2026-10-06 https://evidence-hub.com/study/64367-online-social-platform-engagement-by-young-treatment-seekers-in-a2026-10-04 https://evidence-hub.com/study/64368-to-vape-or-not-to-vape-oral-health-in-the-age-of-electronic-nicotine2026-10-04 https://evidence-hub.com/study/64369-change-in-vaping-smoking-and-dual-use-identities-predicts-quit2026-10-04 https://evidence-hub.com/study/64370-what-about-vaping-exploring-the-facilitators-and-barriers-experienced2026-10-04 https://evidence-hub.com/study/64371-public-health-and-legislative-strategies-in-tobacco-control2026-10-04 https://evidence-hub.com/study/64372-youths-awareness-and-attitudes-towards-raising-the-minimum-legal-age2026-10-04 https://evidence-hub.com/study/64373-perception-of-the-oral-health-risks-of-passive-smoking-from2026-10-04 https://evidence-hub.com/study/64374-pharmacists-perspectives-on-nicotine-vaping-products-nvps-for-smoking2026-10-04 https://evidence-hub.com/study/64375-perception-of-safety-a-survey-on-the-risks-of-vaping-hookah-and2026-10-04 https://evidence-hub.com/study/64376-a-global-health-survey-of-people-who-vape-but-never-smoked-protocol2026-10-04 https://evidence-hub.com/study/64377-preliminary-study-using-sensor-measurements-in-selected-homes-in2026-10-04 https://evidence-hub.com/study/64378-the-impact-of-vaping-on-the-ocular-surface-a-systematic-review-of-the2026-10-04 https://evidence-hub.com/study/64379-peningkatan-pengetahuan-siswa-sekolah-dasar-tentang-bahaya-rokok-dan2026-10-04 https://evidence-hub.com/study/64380-exploring-smoking-vaping-and-alcohol-behaviours-of-bond-university2026-10-04 https://evidence-hub.com/study/64381-school-vaping-bans-and-youth-e-cigarette-use2026-10-06 https://evidence-hub.com/study/64382-factors-associated-with-vaping-frequency-among-university-students2026-10-04 https://evidence-hub.com/study/64383-the-impact-of-vaping-behavior-on-functional-changes-within-the2026-10-04 https://evidence-hub.com/study/64384-nutritional-factors-for-preventing-the-impact-of-passive-smoking-on2026-10-04 https://evidence-hub.com/study/64385-effect-of-active-and-passive-smoking-on-certain-parameters-in-females2026-10-04 https://evidence-hub.com/study/64387-moderators-of-peer-influence-effects-for-adolescents-smoking-and2026-10-04 https://evidence-hub.com/study/64388-a-review-of-popular-vaping-misconceptions-redefining-ends-safety-and2026-10-04 https://evidence-hub.com/study/64389-applied-statistical-methods-for-identifying-features-of-heart-rate2026-10-04 https://evidence-hub.com/study/64391-smoking-legal-but-deadly-the-epidemic-of-the-century2026-10-04 https://evidence-hub.com/study/64392-respiratory-health-consequences-of-vaping-in-healthy-adults-a2026-10-04 https://evidence-hub.com/study/64393-transdisciplinary-research-to-address-youth-vaping-in-aotearoa-new2026-10-04 https://evidence-hub.com/study/64394-the-dependence-level-among-adolescent-vape-users-a-cross-sectional2026-10-04 https://evidence-hub.com/study/64395-the-role-of-puff-volume-in-vaping-emissions-inhalation-risks-and2026-10-04 https://evidence-hub.com/study/64396-the-impact-of-smoking-on-nasal-mucociliary-clearance-time2026-10-04 https://evidence-hub.com/study/64397-vaping-and-e-cigarette-s-as-a-danger-of-21st-century-overview-of-the2026-10-04 https://evidence-hub.com/study/64398-tourism-and-irresponsible-leisure-policing-the-vaping-landscape-in2026-10-04 https://evidence-hub.com/study/64399-smoking-and-cardio-renal-metabolic-health2026-10-04 https://evidence-hub.com/study/64400-exploring-the-influence-of-socialization-agents-0n-vaping-use-among2026-10-04 https://evidence-hub.com/study/64401-prenatal-exposure-to-tobacco-smoke-and-vaping-aerosols-mechanisms2026-10-04 https://evidence-hub.com/study/64402-adverse-effects-of-vaping-on-human-health-a-brief-review-of2026-10-04 https://evidence-hub.com/study/64403-unveiling-oral-health-impacts-of-vaping-in-african-americans-through2026-10-04 https://evidence-hub.com/study/64404-increased-risk-of-heart-rhythm-abnormalities-in-adolescents-and-young2026-10-04 https://evidence-hub.com/study/64405-an-eit-based-assessment-of-regional-ventilation-delay-under2026-10-04 https://evidence-hub.com/study/64406-on-the-role-of-monitoring-biomarkers-of-tobacco-consumption-and2026-10-04 https://evidence-hub.com/study/64407-the-association-of-vaping-and-electronic-cigarette-use-with2026-10-04 https://evidence-hub.com/study/64408-assessing-the-consequences-of-smoking-tobacco-products-with2026-10-04 https://evidence-hub.com/study/64409-myocardial-infarction-injury-is-exacerbated-by-nicotine-in-vape2026-10-04 https://evidence-hub.com/study/64411-the-social-nature-of-vaping-a-qualitative-review-of-substance-use2026-10-04 https://evidence-hub.com/study/64412-substance-general-and-substance-specific-influences-on-adolescent2026-10-04 https://evidence-hub.com/study/64413-increased-risk-of-heart-rhythm-abnormalities-in-adolescents-and-young2026-10-04 https://evidence-hub.com/study/64414-vaping-heated-tobacco-and-periodontal-health-a-systematic-review-of2026-10-04 https://evidence-hub.com/study/64415-the-school-community-s-role-in-addressing-vaping-findings-from2026-10-04 https://evidence-hub.com/study/64416-e-cigarettes-e-liquids-and-drug-vaping-forensic-perspectives-on2026-10-04 https://evidence-hub.com/study/64417-adolescents-experiences-and-perceptions-of-e-cigarettes-and-nicotine2026-10-06 https://evidence-hub.com/study/64418-multidimensional-analysis-of-conventional-and-electronic-cigarette2026-10-06 https://evidence-hub.com/study/64419-adult-consequences-of-repeated-nicotine-vapor-inhalation-in2026-10-06 https://evidence-hub.com/study/64420-adipo-myokine-irisin-a-promising-antioxidant-against-nicotine-induced2026-10-06 https://evidence-hub.com/study/64421-a-high-fat-diet-has-sex-specific-effects-on-nicotine-vapor-self2026-10-06 https://evidence-hub.com/study/64422-the-effects-of-electronic-nicotine-vapor-on-voluntary-alcohol2026-10-06 https://evidence-hub.com/study/64423-morphine-exposure-reduces-nicotine-induced-upregulation-of-nicotinic2026-10-06 https://evidence-hub.com/study/64424-5-facilitating-positive-health-behaviors-and-well-being-to-improve2026-10-06 https://evidence-hub.com/study/64425-association-between-friends-use-of-nicotine-and-cannabis-and-intake2026-10-06 https://evidence-hub.com/study/64426-urinary-cotinine-and-nicotine-dependence-levels-in-regular-male2026-10-06 https://evidence-hub.com/study/64427-characterization-of-a-novel-oronasal-restricted-nicotine-vaping-self2026-10-06 https://evidence-hub.com/study/64428-analysis-of-common-methodological-flaws-in-the-highest-cited-e2026-10-06 https://evidence-hub.com/study/64429-hispanic-latinx-individuals-attributions-for-abstinence-and-smoking-a2026-10-06 https://evidence-hub.com/study/64430-prevalence-and-correlates-of-generalized-anxiety-disorder-and2026-10-06 https://evidence-hub.com/study/64431-exposure-to-nicotine-vapor-produced-by-an-electronic-nicotine2026-10-06 https://evidence-hub.com/study/64432-chemical-flavorants-in-vaping-products-alter-neurobiology-in-a-sex2026-10-06 https://evidence-hub.com/study/64433-2025-heart-disease-and-stroke-statistics-a-report-of-us-and-global2026-10-08 https://evidence-hub.com/study/64434-in-vitro-consequences-of-electronic-cigarette-flavoring-exposure-on2026-10-06 https://evidence-hub.com/study/64435-2024-heart-disease-and-stroke-statistics-a-report-of-us-and-global2026-10-08 https://evidence-hub.com/study/64436-heart-disease-and-stroke-statistics-2023-update-a-report-from-the2026-10-18 https://evidence-hub.com/study/64437-using-polytomous-latent-class-analysis-to-compare-patterns-of2026-10-06 https://evidence-hub.com/study/64438-burden-and-mortality-of-breast-cancer-attributed-to-diabetes-and2026-10-06 https://evidence-hub.com/study/64439-the-association-between-cigarette-smoking-exposure-and-sarcopenia2026-10-06 https://evidence-hub.com/study/64440-continuing-use-of-e-cigarettes-after-stopping-smoking-and-relapse2026-10-06 https://evidence-hub.com/study/64441-biomarkers-of-potential-harm-in-people-switching-from-smoking-tobacco2026-10-06 https://evidence-hub.com/study/64442-barriers-to-implementation-of-smoking-cessation-support-among2026-10-06 https://evidence-hub.com/study/64443-smoking-alcohol-consumption-and-atrial-fibrillation-mendelian2026-10-06 https://evidence-hub.com/study/64444-do-people-who-smoke-and-vape-experience-different-cravings-for-each2026-10-06 https://evidence-hub.com/study/64445-mediation-analysis-investigating-the-mechanisms-of-two-school-based2026-10-06 https://evidence-hub.com/study/64446-cbd-containing-liquids-for-e-cigarettes-formation-of-psychotropic-and2026-10-06 https://evidence-hub.com/study/64448-smoking-and-e-cigarette-use-in-smoke-free-schools-among-secondary2026-10-06 https://evidence-hub.com/study/64449-smoking-nicotine-and-pregnancy-3-snap3-trial-protocol-for-a2026-10-06 https://evidence-hub.com/study/64450-validation-of-effective-dose-as-a-better-predictor-of-radiation2026-10-06 https://evidence-hub.com/study/64451-histological-and-histomorphometric-evaluation-of-anterior-part-of2026-10-06 https://evidence-hub.com/study/64452-tobacco-control-policies-to-promote-awareness-and-smoke-free2026-10-06 https://evidence-hub.com/study/64454-experiences-of-nicotine-users-motivated-to-quit-during-the-covid-192026-10-06 https://evidence-hub.com/study/64455-influence-of-the-sars-cov-2-outbreak-on-the-uptake-of-a-popular2026-10-06 https://evidence-hub.com/study/64456-unveiling-smoking-behavior-amid-the-covid-19-pandemic-a-cross2026-10-06 https://evidence-hub.com/study/64458-passive-smoking-at-home-is-a-risk-factor-for-community-acquired2026-10-06 https://evidence-hub.com/study/64459-influence-of-the-sars-cov-2-outbreak-on-the-uptake-of-a-popular2026-10-06 https://evidence-hub.com/study/64460-cigarette-smoking-e-cigarette-use-and-hypertension-a-population-based2026-10-06 https://evidence-hub.com/study/64461-influence-of-socioeconomics-and-social-marketing-on-smoking-in2026-10-06 https://evidence-hub.com/study/64463-impact-of-vaping-introduction-on-cigarette-smoking-in-six2026-10-06 https://evidence-hub.com/study/64465-prevalence-of-bronchial-asthma-among-secondary-school-students2026-10-06 https://evidence-hub.com/study/64466-the-perceived-risk-of-smoking-cannabis-method-of-use-by-age2026-10-06 https://evidence-hub.com/study/64467-prospective-association-between-e-cigarette-use-frequency-patterns2026-10-06 https://evidence-hub.com/study/64469-can-statistic-adjustment-of-or-minimize-the-potential-confounding2026-10-06 https://evidence-hub.com/study/64471-brief-report-the-prevalence-of-smoking-and-vaping-among-adolescents2026-10-06 https://evidence-hub.com/study/64472-dependence-motives-and-use-contexts-that-predicted-smoking-cessation2026-10-06 https://evidence-hub.com/study/64474-a-stop-smoking-in-schools-trial-in-three-culturally-different-middle2026-10-06 https://evidence-hub.com/study/64477-a-survey-exploring-the-practices-of-smoking-cessation-support-among2026-10-06 https://evidence-hub.com/study/64478-e-cigarette-adverts-and-children-s-perceptions-of-tobacco-smoking2026-10-06 https://evidence-hub.com/study/64479-time-since-cigarette-smoking-cessation-and-self-rated-health-among2026-10-06 https://evidence-hub.com/study/64480-analysis-of-modifiable-non-modifiable-and-physiological-risk-factors2026-10-06 https://evidence-hub.com/study/64481-vaping-characteristics-and-expectancies-are-associated-with-smoking2026-10-06 https://evidence-hub.com/study/64482-active-subperiosteal-versus-passive-subdural-24-hour-drainage2026-10-06 https://evidence-hub.com/study/64483-air-pollution-neighbourhood-and-maternal-level-factors-modify-the2026-10-06 https://evidence-hub.com/study/64484-sources-of-electronic-cigarette-acquisition-among-school-going2026-10-06 https://evidence-hub.com/study/64485-op63-i-don-t-do-it-in-front-of-the-children-it-s-the-worst-kept2026-10-06 https://evidence-hub.com/study/64486-e-cigarette-use-as-a-predictor-of-cigarette-smoking-results-from-a2026-10-06 https://evidence-hub.com/study/64487-electronic-cigarette-use-vaping-and-patterns-of-tobacco-cigarette2026-10-06 https://evidence-hub.com/study/64488-lung-cancer-disease-prediction-model-with-multiple-linear-regression2026-10-06 https://evidence-hub.com/study/64489-computational-mathematical-modeling-for-lung-cancer-disease2026-10-06 https://evidence-hub.com/study/64490-influence-of-preoperative-smoking-status-on-clinical-outcomes-of2026-10-06 https://evidence-hub.com/study/64492-skittles-red-bull-is-my-favourite-flavour-e-cigarettes-smoking-vaping2026-10-06 https://evidence-hub.com/study/64494-communication-about-adolescent-and-caregiver-smoking-and-vaping2026-10-06 https://evidence-hub.com/study/64495-prevalence-and-burden-of-possible-refractory-chronic-cough-in-four2026-10-06 https://evidence-hub.com/study/64496-vaping-smoking-and-the-physical-fitness-of-active-young-men2026-10-06 https://evidence-hub.com/study/64497-synthesis-using-prospective-meta-analysis-to-reduce-youths-e2026-10-06 https://evidence-hub.com/study/64498-modes-of-cannabis-use-among-canadian-youth-in-the-compass-study-using2026-10-06 https://evidence-hub.com/study/64499-pulmonary-nodule-prevalence-at-ct-in-middle-aged-participants-from2026-10-06 https://evidence-hub.com/study/64503-ranking-of-modifiable-lifestyle-risk-factors-for-breast-cancer-in2026-10-06 https://evidence-hub.com/study/64504-prevalence-and-risk-factors-of-small-airway-dysfunction-and2026-10-06 https://evidence-hub.com/study/64505-tobacco-quitlines-may-help-exclusive-vapers-quit-an-analysis-of-data2026-10-06 https://evidence-hub.com/study/64506-efficacy-of-yoga-on-tobacco-cessation-a-systematic-review-and-meta2026-10-06 https://evidence-hub.com/study/64507-the-associations-between-tobacco-exposure-and-diarrhea-within-the2026-10-06 https://evidence-hub.com/study/64508-prevalence-and-risk-factors-of-asthma-among-the-population-of-saudi2026-10-06 https://evidence-hub.com/study/64509-prevalence-of-myocardial-infarction-with-obstructive-and-non2026-10-06 https://evidence-hub.com/study/64510-targeted-analysis-of-placental-steroid-hormones-in-relation-to2026-10-06 https://evidence-hub.com/study/64512-analisis-peningkatan-resiko-penyakit-paru-obstruktif-kronis-ppok-pada2026-10-06 https://evidence-hub.com/study/64513-prevalence-and-factors-associated-with-e-cigarettes-consumption-among2026-10-06 https://evidence-hub.com/study/64514-tobacco-related-toxicant-exposure-among-people-with-and-without2026-10-06 https://evidence-hub.com/study/64516-nicotine-vaping-among-uk-adolescents-a-systematic-review-and-meta2026-10-06 https://evidence-hub.com/study/64517-maternal-factors-increase-risk-of-orofacial-cleft-a-meta-analysis2026-10-06 https://evidence-hub.com/study/64518-cardiovascular-health-effects-of-vaping-e-cigarettes-a-systematic2026-10-06 https://evidence-hub.com/study/64519-acute-cardiovascular-effects-of-electronic-cigarettes-a-systematic2026-10-06 https://evidence-hub.com/study/64520-effectiveness-of-non-instrumental-early-mobilization-to-reduce-the2026-10-06 https://evidence-hub.com/study/64521-the-effect-of-air-pollution-on-morbidity-and-mortality-among-children2026-10-06 https://evidence-hub.com/study/64522-association-between-passive-smoking-and-hypertension-a-panel-study2026-10-06 https://evidence-hub.com/study/64524-b26-11-how-vaping-shapes-pulmonary-function-and-feno-a-meta-analysis2026-10-06 https://evidence-hub.com/study/64525-birth-outcomes-following-intrauterine-exposure-to-electronic-nicotine2026-10-06 https://evidence-hub.com/study/64526-risk-factors-for-respiratory-syncytial-virus-associated-acute-lower2026-10-06 https://evidence-hub.com/study/64527-air-pollution-exposure-and-prevalence-of-non-alcoholic-fatty-liver2026-10-06 https://evidence-hub.com/study/64528-risk-factors-for-type-2-diabetes-mellitus-in-adolescents-a-systematic2026-10-06 https://evidence-hub.com/study/64530-prevalence-and-risk-factors-of-perinatal-depression-among-mothers-and2026-10-06 https://evidence-hub.com/study/64531-systematic-review-and-meta-analysis-of-lifestyle-and-reproductive2026-10-06 https://evidence-hub.com/study/64532-prevalence-and-risk-factors-of-atopic-dermatitis-in-chinese-children2026-10-06 https://evidence-hub.com/study/64533-factors-influencing-the-lung-cancer-incidence-in-china-a-meta-analysis2026-10-06 https://evidence-hub.com/study/64534-ldct-uptake-and-determinants-of-lung-cancer-screening-in-asia-a2026-10-06 https://evidence-hub.com/study/64535-ecg-and-echocardiographic-findings-in-adults-with-chronic-pulmonary2026-10-06 https://evidence-hub.com/study/64536-comparing-smoking-related-disease-rates-from-e-cigarette-use-with2026-10-06 https://evidence-hub.com/study/64538-blood-and-brain-based-genome-wide-association-studies-of-smoking2026-10-06 https://evidence-hub.com/study/64539-genome-wide-association-study-of-varenicline-aided-smoking-cessation2026-10-06 https://evidence-hub.com/study/64540-genome-wide-association-study-of-varenicline-aided-smoking-cessation2026-10-06 https://evidence-hub.com/study/64541-association-between-e-cigarette-use-physical-activity-and2026-10-06 https://evidence-hub.com/study/64542-maternal-factors-for-neural-tube-defects-in-offspring-an-umbrella2026-10-06 https://evidence-hub.com/study/64543-dop099-tobacco-smoke-exposure-from-prenatal-to-adolescent-periods2026-10-06 https://evidence-hub.com/study/64544-safety-efficacy-and-health-impact-of-electronic-nicotine-delivery2026-10-06 https://evidence-hub.com/study/64545-vaping-during-pregnancy-a-systematic-review-of-health-outcomes2026-10-06 https://evidence-hub.com/study/64546-scoping-review-of-e-cigarette-use-in-the-perioperative-setting-a2026-10-06 https://evidence-hub.com/study/64547-relationship-between-the-use-of-vapes-and-their-impact-on-oral-health2026-10-06 https://evidence-hub.com/study/64548-still-we-rise-research-on-bias-and-discrimination-will-endure2026-10-06 https://evidence-hub.com/study/64550-obstructive-sleep-apnoea-and-lung-function-and-their-association-with2026-10-06 https://evidence-hub.com/study/64551-genetic-liability-to-psoriasis-predicts-severe-disease-outcomes2026-10-06 https://evidence-hub.com/study/64552-prevalence-of-chronic-cough-its-risk-factors-and-population2026-10-06 https://evidence-hub.com/study/64553-health-effects-associated-with-exposure-to-secondhand-smoke-a-burden2026-10-06 https://evidence-hub.com/study/64554-oral-nicotine-pouches-for-cessation-or-reduction-of-use-of-other2026-10-06 https://evidence-hub.com/study/64555-desires-and-needs-for-quitting-both-e-cigarettes-and-cigarettes-among2026-10-06 https://evidence-hub.com/study/64556-tobacco-abuse-exposure-in-women-and-its-outcomes-to-perinatal-and2026-10-06 https://evidence-hub.com/study/64557-vaping-and-e-cigarettes-in-orthopaedic-surgery-outcomes-a-systematic2026-10-06 https://evidence-hub.com/study/64558-e-cigarette-smoking-and-depressive-disorders-a-systematic-review-of2026-10-06 https://evidence-hub.com/study/64559-behavioral-and-environmental-factors-of-carbon-monoxide-poisoning-and2026-10-06 https://evidence-hub.com/study/64560-effects-of-switching-from-smoking-to-vaping-on-clozapine2026-10-06 https://evidence-hub.com/study/64561-the-risk-of-lung-cancer-from-vaping-or-e-cigarette-usage-a-systematic2026-10-06 https://evidence-hub.com/study/64562-vaping-associated-pneumothorax-a-systematic-review-of-case-reports2026-10-06 https://evidence-hub.com/study/64563-the-impacts-of-vaping-on-the-cardiovascular-system-a-systematic2026-10-06 https://evidence-hub.com/study/64564-cannabis-use-among-cancer-patients-and-survivors-in-the-united-states2026-10-06 https://evidence-hub.com/study/64565-from-vape-to-disease-evaluating-the-oral-health-threat-of-electronic2026-10-06 https://evidence-hub.com/study/64566-the-role-of-passive-smoking-in-global-climate-change-and-the-negative2026-10-06 https://evidence-hub.com/study/64567-cannabis-use-variations-and-myocardial-infarction-a-systematic-review2026-10-06 https://evidence-hub.com/study/64568-exploring-vaping-patterns-and-weight-management-related-concerns2026-10-06 https://evidence-hub.com/study/64569-assessment-of-respiratory-health-implications-of-vaping-a-systematic2026-10-06 https://evidence-hub.com/study/64570-electronic-cigarettes-in-dermatology-a-systematic-review-of-the2026-10-06 https://evidence-hub.com/study/64571-prevalence-and-risk-factors-of-allergic-rhinitis-a-systematic-review2026-10-06 https://evidence-hub.com/study/64572-health-effects-of-cigarette-smoking-and-e-cigarette-vaping-on2026-10-06 https://evidence-hub.com/study/64573-e-cigarettes-use-and-respiratory-symptoms-in-asthmatic-and-non2026-10-06 https://evidence-hub.com/study/64574-impacts-of-vaping-on-children-and-young-people-a-systematic-review2026-10-06 https://evidence-hub.com/study/64575-factors-influencing-the-relationship-between-influenza-vaccination2026-10-06 https://evidence-hub.com/study/64576-electronic-nicotine-delivery-systems-and-clinical-outcomes-in-adults2026-10-06 https://evidence-hub.com/study/64577-srs317-the-impact-of-electronic-cigarettes-on-plastic-and2026-10-06 https://evidence-hub.com/study/64578-artificial-intelligence-in-tobacco-control-a-systematic-scoping2026-10-06 https://evidence-hub.com/study/64579-electronic-cigarettes-for-smoking-cessation2026-10-06 https://evidence-hub.com/study/64580-whatsapp-based-coaching-program-to-support-smoking-and-vaping2026-10-06 https://evidence-hub.com/study/64581-beyond-driving-after-cannabis-use-administration-method-and-using2026-10-06 https://evidence-hub.com/study/64582-cannabis-use-and-risk-of-periodontitis-and-adverse-oral-health2026-10-06 https://evidence-hub.com/study/64583-item-level-reanalysis-of-dash-outcomes-after-flexor-tendon-repair2026-10-06 https://evidence-hub.com/study/64584-the-beginning-of-ends-electronic-nicotine-delivery-systems-origins2026-10-06 https://evidence-hub.com/study/64585-effects-of-trunk-exercises-on-balance-in-hemiplegic-stroke-patients2026-10-06 https://evidence-hub.com/study/64586-educational-attainment-and-employment-status-in-lung-cancer-patients2026-10-06 https://evidence-hub.com/study/64587-puff-or-pass-the-truth-about-vaping-marijuana-and-tobacco-safety2026-10-06 https://evidence-hub.com/study/64588-mal-a-vista-consequencias-associadas-ao-uso-do-tabaco-para-a-saude2026-10-06 https://evidence-hub.com/study/64589-abstract-ss03-01-unraveling-the-genetic-and-environmental-risk2026-10-06 https://evidence-hub.com/study/64590-thoracic-society-of-australia-and-new-zealand-tsanz-guidance-for-the2026-10-06 https://evidence-hub.com/study/64591-characterisation-of-chronic-obstructive-pulmonary-disease-copd-in2026-10-06 https://evidence-hub.com/study/64592-accurate-verification-of-nicotine-and-tobacco-product-use-or2026-10-06 https://evidence-hub.com/study/64593-anticancer-activity-of-a-poly-herbal-formulation-tulsi-licorice2026-10-06 https://evidence-hub.com/study/64594-abstract-lb231-the-mutagenic-forces-shaping-the-genomic-landscape-of2026-10-06 https://evidence-hub.com/study/64595-guidelines-for-antenatal-and-preoperative-care-in-cesarean-delivery2026-10-06 https://evidence-hub.com/study/64596-protocol-for-the-magnitude-of-cigarette-substitution-after-initiation2026-10-06 https://evidence-hub.com/study/64597-using-smartphone-data-to-frequently-measure-atopic-dermatitis2026-10-06 https://evidence-hub.com/study/64598-should-household-air-quality-monitoring-be-considered-in-selected2026-10-06 https://evidence-hub.com/study/64599-e-cigarette-puff-topography-instruction-to-enhance-switching-among2026-10-06 https://evidence-hub.com/study/64600-effect-of-vaping-on-the-development-and-progression-of-periodontitis2026-10-06 https://evidence-hub.com/study/64601-salivary-cotinine-and-s100a8-a9-levels-in-children-exposed-to2026-10-06 https://evidence-hub.com/study/64602-consumption-of-hookahs-e-cigarettes-and-classic-cigarettes-and-the2026-10-04 https://evidence-hub.com/study/64603-prevalence-of-autonomic-dysreflexia-during-spinal-cord-stimulation2026-10-06 https://evidence-hub.com/study/64604-c35-17-prevalence-of-type-2-high-inflammatory-phenotype-copd-in-an2026-10-06 https://evidence-hub.com/study/64605-abstract-lb315-expression-of-notch3-and-dlk1-genes-in-tumor-and2026-10-06 https://evidence-hub.com/study/64606-similar-limited-protection-against-severe-acute-respiratory-syndrome2026-10-06 https://evidence-hub.com/study/64607-modifiable-factors-of-development-and-recurrence-of-adenomatous2026-10-06 https://evidence-hub.com/study/64608-microfibrillar-associated-protein-4-as-a-predictive-biomarker-of2026-10-06 https://evidence-hub.com/study/64609-evaluating-the-quality-of-technology-integration-across-seven2026-10-06 https://evidence-hub.com/study/64610-forensic-analysis-of-lung-cancer-from-secondhand-smoke-exposure-of-a2026-10-06 https://evidence-hub.com/study/64611-unraveling-lifestyle-disease-vulnerabilities-among-adolescents-a2026-10-06 https://evidence-hub.com/study/64612-duration-of-current-statin-use-and-amyotrophic-lateral-sclerosis-risk2026-10-06 https://evidence-hub.com/study/64613-cannabis-use-and-cannabis-use-disorder-among-older-adults-in-the-usa2026-10-06 https://evidence-hub.com/study/64614-b30-10-recurrent-spontaneous-pneumothorax-in-u-s-military-veterans-an2026-10-06 https://evidence-hub.com/study/64615-interventions-delivered-in-healthcare-settings-to-promote-vaping2026-10-06 https://evidence-hub.com/study/64616-comparison-of-the-vessel-loop-technique-versus-traditional-skin2026-10-06 https://evidence-hub.com/study/64617-behavioural-risk-factors-for-adolescent-injuries-findings-from-the2026-10-06 https://evidence-hub.com/study/64618-risk-factors-associated-with-suspected-tuberculosis-in-a-densely2026-10-06 https://evidence-hub.com/study/64619-956-leveraging-community-health-needs-assessment-chna-data-to-inform2026-10-06 https://evidence-hub.com/study/64620-understanding-healthcare-professionals-perspectives-on-the-management2026-10-06 https://evidence-hub.com/study/64621-d104-01-when-vaping-meets-vulnerability-necrotizing-pneumonia-and-e2026-10-06 https://evidence-hub.com/study/64622-socioeconomics-of-e-cigarette-use-in-colombia-2019-national-substance2026-10-06 https://evidence-hub.com/study/64623-pediatric-pilonidal-sinus-disease-a-single-center-cohort-study-of2026-10-06 https://evidence-hub.com/study/64624-clinical-profile-and-surgical-outcomes-of-pediatric-umbilical2026-10-06 https://evidence-hub.com/study/64625-statins-enhance-the-efficacy-of-pegylated-interferon-alpha2-in2026-10-06 https://evidence-hub.com/study/64627-coexisting-granulomatous-mastitis-and-breast-cancer-a-systematic2026-10-06 https://evidence-hub.com/study/64628-the-effect-of-active-and-passive-smoking-during-pregnancy-on-birth2026-10-06 https://evidence-hub.com/study/64629-impact-of-passive-smoking-on-vital-signs-motor-activity-and-agitation2026-10-06 https://evidence-hub.com/study/64631-the-role-of-active-and-passive-smoking-in-chronic-obstructive2026-10-06 https://evidence-hub.com/study/64632-perceived-harm-of-vaping-relative-to-smoking-and-associations-with2026-10-06 https://evidence-hub.com/study/64633-awareness-and-attitudes-toward-passive-smoking-sociodemographic2026-10-06 https://evidence-hub.com/study/64634-effect-of-passive-tobacco-smoke-on-the-incidence-of-respiratory2026-10-06 https://evidence-hub.com/study/64635-smoking-exposures-and-mortality-risk-in-individuals-with-idiopathic2026-10-06 https://evidence-hub.com/study/64636-impact-of-smoking-status-on-sjogren-s-disease-diagnosis-and-phenotype2026-10-06 https://evidence-hub.com/study/64637-association-between-active-and-passive-smoking-and-the-clinical2026-10-06 https://evidence-hub.com/study/64638-associations-between-long-term-pm2-5-exposure-and-metabolomic2026-10-06 https://evidence-hub.com/study/64639-association-between-smoking-status-and-complete-blood-cell-parameters2026-10-06 https://evidence-hub.com/study/64640-first-second-trimester-dietary-inflammatory-index-and-anemia-risk-in2026-10-06 https://evidence-hub.com/study/64641-association-of-secondhand-smoke-exposure-during-pregnancy-with-left2026-10-06 https://evidence-hub.com/study/64642-social-media-use-and-child-cigarette-smoking-and-e-cigarette-use-a2026-10-06 https://evidence-hub.com/study/64643-the-association-between-vaping-and-subsequent-initiation-of-cigarette2026-10-06 https://evidence-hub.com/study/64644-low-smoking-exposure-and-development-and-prognosis-of-copd-over-four2026-10-06 https://evidence-hub.com/study/64645-effects-of-smoking-on-clinical-treatment-outcomes-amongst-patients2026-10-06 https://evidence-hub.com/study/64646-secondhand-smoke-exposure-can-increase-the-risk-of-first-ischemic2026-10-06 https://evidence-hub.com/study/64647-potential-for-primary-prevention-of-low-birth-weight-in-pregnancies2026-10-06 https://evidence-hub.com/study/64648-urinary-biomarkers-and-respiratory-responses-to-indoor-and-traffic2026-10-06 https://evidence-hub.com/study/64649-water-pipe-tobacco-and-cigarette-smoking-on-preeclampsia-adverse-or2026-10-06 https://evidence-hub.com/study/64650-joint-association-of-cumulative-workplace-environmental-exposures-and2026-10-06 https://evidence-hub.com/study/64651-vitamin-d-status-in-an-italian-pediatric-cohort-is-there-a-role-for2026-10-06 https://evidence-hub.com/study/64652-prognostic-value-of-ros1-rearrangement-in-lung-adenocarcinoma2026-10-06 https://evidence-hub.com/study/64653-increased-incidence-of-chronic-obstructive-pulmonary-disease-in-women2026-10-06 https://evidence-hub.com/study/64654-urinary-cotinine-levels-versus-self-reported-smoking-status-for2026-10-06 https://evidence-hub.com/study/64655-passive-smoking-induced-mutagenesis-as-a-promoter-of-lung2026-10-06 https://evidence-hub.com/study/64656-longitudinal-study-of-the-influence-of-obesity-c-reactive-protein-and2026-10-06 https://evidence-hub.com/study/64657-a-preconception-cohort-study-of-nicotine-vaping-and-incidence-of2026-10-06 https://evidence-hub.com/study/64658-lung-cancer-in-non-smokers-prospective-descriptive-study-of-a-cohort2026-10-06 https://evidence-hub.com/study/64659-association-between-lipid-profiles-and-cigarette-smoke-among-adults2026-10-06 https://evidence-hub.com/study/64660-viremia-does-not-independently-predict-cardiovascular-disease-in2026-10-06 https://evidence-hub.com/study/64661-b-cell-immune-repertoire-sequencing-in-tobacco-cigarette-smoking2026-10-06 https://evidence-hub.com/study/64662-the-effect-of-heated-tobacco-products-on-metabolic-syndrome-a-cohort2026-10-06 https://evidence-hub.com/study/64663-cross-sectional-associations-of-gender-identity-and-sexual2026-10-06 https://evidence-hub.com/study/64664-o-065-occupational-particle-exposure-is-associated-with-chronic2026-10-06 https://evidence-hub.com/study/64665-trends-in-copd-mortality-from-1983-to-2018-protocol-for-a-population2026-10-06 https://evidence-hub.com/study/64666-mp13-12-a-preconception-cohort-study-of-alcohol-use-and-incidence-of2026-10-06 https://evidence-hub.com/study/64667-mp13-11-a-preconception-cohort-study-of-nicotine-vaping-and-incidence2026-10-06 https://evidence-hub.com/study/64668-71223-risk-factors-for-severe-complications-and-mortality-in-elderly2026-10-06 https://evidence-hub.com/study/64669-the-effects-of-electronic-cigarette-use-patterns-on-health-related2026-10-06 https://evidence-hub.com/study/64670-educational-impact-of-an-animated-video-on-medical-students-knowledge2026-10-06 https://evidence-hub.com/study/64671-dual-use-of-cigarettes-and-e-cigarettes-is-associated-with-higher2026-10-04 https://evidence-hub.com/study/64672-associations-between-modifiable-lifestyle-choices-and-academic2026-10-06 https://evidence-hub.com/study/64673-a-prospective-cohort-study-testing-whether-oral-cavity-mucosal-tissue2026-10-06 https://evidence-hub.com/study/64674-b-cell-immune-repertoire-sequencing-in-tobacco-cigarette-smoking2026-10-06 https://evidence-hub.com/study/64675-comorbidities-and-mortality-in-subgroups-of-adults-with-diabetes-with2026-10-06 https://evidence-hub.com/study/64676-sids-bed-sharing-and-passive-smoking-the-leading-causes-in-pakistan2026-10-06 https://evidence-hub.com/study/64677-association-between-the-fatty-liver-index-fli-and-incident-coronary2026-10-06 https://evidence-hub.com/study/64678-the-impact-of-electronic-cigarettes-on-pregnancy-and-childhood-health2026-10-06 https://evidence-hub.com/study/64679-a-nation-wide-study-on-snus-and-smoked-tobacco-the-swedish-tobacco2026-10-06 https://evidence-hub.com/study/64680-development-and-validation-of-a-perinatal-risk-prediction-model-for2026-10-06 https://evidence-hub.com/study/64681-preconception-hypoglycemia-and-adverse-pregnancy-outcomes-in-chinese2026-10-06 https://evidence-hub.com/study/64682-long-term-disease-course-of-crohn-s-disease-in-a-prospective-european2026-10-06 https://evidence-hub.com/study/64683-abstract-4366025-association-of-education-inequalities-with-premature2026-10-06 https://evidence-hub.com/study/64684-factors-associated-with-unsuccessful-treatment-outcome-among-new2026-10-06 https://evidence-hub.com/study/64685-validity-and-accuracy-of-swespine-data-on-surgery-for-central-lumbar2026-10-06 https://evidence-hub.com/study/64687-antenatal-depression-and-its-associated-factors-findings-from-kuwait2026-10-06 https://evidence-hub.com/study/64688-co-designing-a-smoking-cessation-chatbot-focus-group-study-of-end2026-10-06 https://evidence-hub.com/study/64689-early-onset-asthma-but-not-aeroallergen-sensitization-is-associated2026-10-06 https://evidence-hub.com/study/64690-systolic-inter-arm-blood-pressure-difference-and-subclinical2026-10-06 https://evidence-hub.com/study/64691-trends-in-lower-extremity-artery-disease-repair-incidence-comorbidity2026-10-06 https://evidence-hub.com/study/64692-effect-of-homemade-peanut-oil-consumption-during-pregnancy-on-low2026-10-06 https://evidence-hub.com/study/64693-the-challenges-of-recruiting-never-smokers-with-chronic-obstructive2026-10-06 https://evidence-hub.com/study/64694-maternal-occupational-exposures-during-early-stages-of-pregnancy-and2026-10-06 https://evidence-hub.com/study/64695-association-of-endothelial-dysfunction-with-chronic-marijuana-smoking2026-10-06 https://evidence-hub.com/study/64696-functional-respiratory-abnormalities-in-adults-who-vape-daily2026-10-06 https://evidence-hub.com/study/64697-does-e-cigarette-use-predict-short-term-smoking-cessation-behaviors2026-10-06 https://evidence-hub.com/study/64698-clinical-outcomes-after-first-line-anti-tnf-treatment-of-patients2026-10-06 https://evidence-hub.com/study/64699-correlation-of-maternal-vitamin-d-status-in-early-pregnancy-and2026-10-06 https://evidence-hub.com/study/64700-loneliness-emotional-support-and-the-mental-health-of-young-adults2026-10-06 https://evidence-hub.com/study/64701-a-clinicopathological-and-molecular-profiling-study-of-egfr-mutations2026-10-06 https://evidence-hub.com/study/64703-association-between-birth-weight-and-chronic-obstructive-pulmonary2026-10-06 https://evidence-hub.com/study/64704-dental-health-readiness-among-united-states-military-service-members2026-10-06 https://evidence-hub.com/study/64705-c16-08-association-of-nicotine-and-cannabis-vaping-and-respiratory2026-10-06 https://evidence-hub.com/study/64706-pulmonary-function-in-school-aged-preterm-children-with-a-history-of2026-10-06 https://evidence-hub.com/study/64707-parental-factors-prenatal-air-exposures-and-adolescent-trauma-are2026-10-06 https://evidence-hub.com/study/64708-relationship-between-autism-spectrum-disorder-and-maternal-exposure2026-10-06 https://evidence-hub.com/study/64709-a-study-on-association-between-passive-smoking-and-childhood2026-10-06 https://evidence-hub.com/study/64710-the-interaction-between-pax9-rs2073244-and-passive-smoking-during2026-10-06 https://evidence-hub.com/study/64711-effect-of-passive-smoking-on-birth-weight-in-pregnant-women-with2026-10-06 https://evidence-hub.com/study/64713-assessment-of-smoking-exposure-by-urine-cotinine-levels-in-severe2026-10-06 https://evidence-hub.com/study/64714-environmental-tobacco-smoking-ets-and-esophageal-cancer-a-population2026-10-06 https://evidence-hub.com/study/64716-the-relationship-between-oral-health-status-and-passive-smoking-and2026-10-06 https://evidence-hub.com/study/64717-passive-smoking-and-risk-of-leukemia-among-children-a-casecontrol2026-10-06 https://evidence-hub.com/study/64718-association-of-lifestyle-psychological-and-biological-risk-factors2026-10-06 https://evidence-hub.com/study/64720-impact-of-passive-smoking-on-low-birth-weight-among-pregnant-women-in2026-10-06 https://evidence-hub.com/study/64721-mediating-effect-of-tobacco-dependence-on-the-association-between2026-10-06 https://evidence-hub.com/study/64722-abstract-2213-vaping-smoking-and-lung-cancer-a-case-control-study2026-10-06 https://evidence-hub.com/study/64723-lifestyle-factors-associated-with-age-related-macular-degeneration2026-10-06 https://evidence-hub.com/study/64724-association-between-indoor-environmental-risk-factors-and-pneumonia2026-10-06 https://evidence-hub.com/study/64725-early-life-exposures-and-risk-of-inflammatory-bowel-disease-a-nested2026-10-06 https://evidence-hub.com/study/64726-prenatal-perinatal-and-postnatal-risk-factors-associated-with-autism2026-10-06 https://evidence-hub.com/study/64727-association-between-different-type-of-addictions-and-oral-cancer-a2026-10-06 https://evidence-hub.com/study/64728-factors-influencing-mode-of-delivery-a-case-control-study2026-10-06 https://evidence-hub.com/study/64729-serum-zinc-level-in-children-with-acute-lower-respiratory-tract2026-10-06 https://evidence-hub.com/study/64730-a58-21-clinical-outcomes-of-vaping-versus-cigarette-smoking-in2026-10-06 https://evidence-hub.com/study/64731-airway-extracellular-copper-concentrations-increase-with-age-and-are2026-10-06 https://evidence-hub.com/study/64733-blood-pressure-and-salivary-cotinine-levels-in-young-adults-using2026-10-06 https://evidence-hub.com/study/64734-association-between-indoor-air-pollution-and-risk-of-oesophageal2026-10-06 https://evidence-hub.com/study/64735-health-education-of-no-smoking-behavior-in-adolescents-with-a-social2026-10-04 https://evidence-hub.com/study/64736-vitamin-d-levels-lung-function-and-risk-factors-in-paediatric-asthma2026-10-06 https://evidence-hub.com/study/64737-folate-deficiency-in-pregnancy-and-the-risk-of-preterm-birth-a-nested2026-10-06 https://evidence-hub.com/study/64738-red-meat-consumption-and-risk-factors-of-lung-cancer-among-never2026-10-06 https://evidence-hub.com/study/64739-association-of-cigarette-smoking-exposure-in-pregnant-patients-and2026-10-06 https://evidence-hub.com/study/64740-risk-factors-for-lung-cancer-in-non-smoking-women-north-sumatera2026-10-06 https://evidence-hub.com/study/64741-the-influence-of-environmental-pollution-on-the-incidence-of-allergic2026-10-06 https://evidence-hub.com/study/64742-environmental-lifestyle-and-medical-risk-factors-associated-with2026-10-06 https://evidence-hub.com/study/64744-environmental-nutritional-and-socio-demographic-factors-associated2026-10-06 https://evidence-hub.com/study/64745-predictive-factors-and-adverse-perinatal-outcomes-associated-with2026-10-06 https://evidence-hub.com/study/64746-no-smoking-approach-in-the-educational-institute-cafeteria-to2026-10-06 https://evidence-hub.com/study/64747-cigarette-smoking-as-a-risk-factor-for-tuberculosis-in-adults2026-10-04 https://evidence-hub.com/study/64748-vaping-smoking-and-lung-cancer-risk2026-10-06 https://evidence-hub.com/study/64749-health-impact-of-tobacco-smoking-cardiovascular-respiratory-and2026-10-06 https://evidence-hub.com/study/64750-effect-of-electronic-smoking-vaping-on-thyroid-hormones-level-and2026-10-06 https://evidence-hub.com/study/64751-relationship-between-smoking-and-pulmonary-tuberculosis-based-on2026-10-06 https://evidence-hub.com/study/64752-vaping-and-smoking-in-adolescents-14-and-under-in-aotearoa-new2026-10-06 https://evidence-hub.com/study/64753-warning-and-informative-messages-on-e-cigarette-package-leaflets-a2026-10-06 https://evidence-hub.com/study/64754-impact-of-lifestyle-factors-post-infectious-mononucleosis-on-multiple2026-10-06 https://evidence-hub.com/study/64755-impact-of-electronic-cigarette-use-on-quality-of-life-and-autonomic2026-10-06 https://evidence-hub.com/study/64756-risk-assessment-of-metals-measured-in-regulated-canadian-dried2026-10-06 https://evidence-hub.com/study/64757-the-association-of-parental-use-of-new-tobacco-products-and2026-10-06 https://evidence-hub.com/study/64758-maternal-and-environmental-risk-factors-for-congenital-heart-diseases2026-10-06 https://evidence-hub.com/study/64759-maternal-folic-acid-supplementation-and-neural-tube-defects-in2026-10-06 https://evidence-hub.com/study/64760-impact-of-traditional-and-e-cigarette-smoking-metabolites-on-acute2026-10-06 https://evidence-hub.com/study/64761-characterize-oral-to-blood-microbial-dna-translocation-in-individuals2026-10-06 https://evidence-hub.com/study/64762-a70-30-the-low-burden-blind-spot-cavitary-tb-in-a-repeatedly-igra2026-10-06 https://evidence-hub.com/study/64763-assessment-of-some-biochemical-markers-in-electronic-nicotine-device2026-10-06 https://evidence-hub.com/study/64764-estimation-of-level-of-serum-cotinine-a-simple-rapid-and-sensitive2026-10-06 https://evidence-hub.com/study/64765-women-with-abdominal-aortic-aneurysms-have-a-different-pattern-of2026-10-06 https://evidence-hub.com/study/64766-implementation-of-tobacco-and-nicotine-control-health-policy-in-the2026-10-06 https://evidence-hub.com/study/64767-risk-factors-and-characteristics-of-active-and-latent-tuberculosis-in2026-10-06 https://evidence-hub.com/study/64768-hemoptysis-following-e-cigarette-inhalation-a-toxicological-concern2026-10-06 https://evidence-hub.com/study/64769-new-image-same-tactics-global-tobacco-and-vaping-industry-strategies2026-10-06 https://evidence-hub.com/study/64770-recurrent-laryngeal-leukoplakia-in-a-cook-occupationally-exposed-to2026-10-06 https://evidence-hub.com/study/64771-automated-detection-of-lung-cancer-levels-based-on-patient-s2026-10-06 https://evidence-hub.com/study/64772-factors-associated-with-attention-deficit-hyperactivity-disorder2026-10-06 https://evidence-hub.com/study/64773-early-trilogy-spontaneous-abortion-risk-from-caffeine-intake2026-10-06 https://evidence-hub.com/study/64774-environmental-risk-factors-associated-with-behavioral-problems-among2026-10-06 https://evidence-hub.com/study/64775-dietary-choline-intake-during-pregnancy-and-congenital-heart-defects2026-10-06 https://evidence-hub.com/study/64776-the-periogene-north-study-reveals-that-periodontal-inflammation-and2026-10-06 https://evidence-hub.com/study/64778-contributing-factors-for-low-birth-weight-among-newborns-in-a2026-10-06 https://evidence-hub.com/study/64779-pregnancy-log-records-and-management-of-risk-factors-for-gestational2026-10-06 https://evidence-hub.com/study/64780-non-habit-associated-oral-squamous-cell-carcinoma-a-systematic-review2026-10-06 https://evidence-hub.com/study/64782-c67-26-post-covid-paraseptal-lucencies-mimicking-emphysema-in-a-young2026-10-06 https://evidence-hub.com/study/64783-c34-29-il-18-and-neutrophils-stand-out-a-comparative-analysis-of2026-10-06 https://evidence-hub.com/study/64785-passive-smoking-is-associated-with-poor-carious-status-in-adults-a2026-10-06 https://evidence-hub.com/study/64786-the-association-between-passive-smoking-and-sleep-quality-in-a2026-10-06 https://evidence-hub.com/study/64787-tobacco-use-body-mass-index-potentially-malignant-disorder-and2026-10-06 https://evidence-hub.com/study/64788-students-knowledge-regarding-passive-smoking-a-cross-sectional-study2026-10-06 https://evidence-hub.com/study/64789-association-between-passive-smoking-and-dental-caries-status-in2026-10-06 https://evidence-hub.com/study/64790-association-of-active-and-passive-smoking-with-noncommunicable2026-10-06 https://evidence-hub.com/study/64791-the-quality-and-reliability-of-short-videos-about-passive-smoking-on2026-10-06 https://evidence-hub.com/study/64792-awareness-regarding-the-effect-of-passive-smoking-among-adults-a2026-10-06 https://evidence-hub.com/study/64793-knowledge-and-perception-of-health-implications-of-passive-smoking2026-10-06 https://evidence-hub.com/study/64794-association-between-smoking-status-and-vitamin-b12-levels-in2026-10-06 https://evidence-hub.com/study/64795-impact-of-passive-and-active-smoking-on-primary-dysmenorrhea-among2026-10-06 https://evidence-hub.com/study/64797-prevalence-of-tobacco-use-and-passive-exposure-among-adolescent2026-10-06 https://evidence-hub.com/study/64798-exploring-the-relationship-between-secondhand-smoke-exposure-in2026-10-04 https://evidence-hub.com/study/64799-prevalence-of-smoking-and-use-of-nicotine-containing-products-among2026-10-06 https://evidence-hub.com/study/64800-the-effect-of-smoking-on-dry-eye-disease-and-corneal-thickness-in-the2026-10-06 https://evidence-hub.com/study/64801-sociodemographic-determinants-of-smoking-behavior-among-adults-in-the2026-10-06 https://evidence-hub.com/study/64802-young-people-s-smoking-and-vaping-behaviour-and-comparative2026-10-06 https://evidence-hub.com/study/64803-the-effect-of-standardised-packaging-and-limited-flavour-descriptors2026-10-06 https://evidence-hub.com/study/64804-smoking-habits-and-osteoporosis-in-community-dwelling-men-subjected2026-10-06 https://evidence-hub.com/study/64805-interaction-between-parental-preconception-and-prenatal-smoking-and2026-10-06 https://evidence-hub.com/study/64806-evaluating-smoking-related-systemic-inflammation-through2026-10-06 https://evidence-hub.com/study/64807-investigating-the-spatial-and-temporal-variation-of-vape-retailer2026-10-06 https://evidence-hub.com/study/64808-trends-in-vaping-and-smoking-following-the-rise-of-disposable-e2026-10-06 https://evidence-hub.com/study/64809-prevalence-and-predictors-of-active-and-passive-smoking-in-saudi2026-10-06 https://evidence-hub.com/study/64810-knowledge-and-smoking-behavior-among-high-school-students-a-cross2026-10-06 https://evidence-hub.com/study/64811-association-between-smoking-behavior-and-oral-health-problems-a2026-10-06 https://evidence-hub.com/study/64812-article-9-smoking-behaviours-nicotine-dependence-and-use-of-nicotine2026-10-06 https://evidence-hub.com/study/64814-inhale-the-truth-knowledge-attitude-and-usage-patterns-of-cigarette2026-10-06 https://evidence-hub.com/study/64815-effect-of-ramadan-fasting-on-changes-in-smoking-and-vaping-behaviors2026-10-06 https://evidence-hub.com/study/64817-prevalence-and-risk-factors-of-elevated-blood-lead-levels-in-0-6-year2026-10-06 https://evidence-hub.com/study/64818-factors-associated-with-hospitalization-among-asthma-patients-in-a2026-10-06 https://evidence-hub.com/study/64819-household-exposure-to-secondhand-cigarette-smoke-during-pregnancy-and2026-10-06 https://evidence-hub.com/study/64820-awareness-of-lung-cancer-and-associated-factors-among-public-health2026-10-06 https://evidence-hub.com/study/64821-prevalence-and-risk-factors-of-antinuclear-antibodies-among-pregnant2026-10-06 https://evidence-hub.com/study/64822-social-acceptability-and-health-concerns-of-smoking-and-vaping-among2026-10-06 https://evidence-hub.com/study/64823-association-of-sleep-quality-and-general-mental-and-oral-health-with2026-10-06 https://evidence-hub.com/study/64824-smoking-status-and-factors-influencing-smoking-cessation-among2026-10-06 https://evidence-hub.com/study/64825-household-fuel-use-smoking-and-prevalence-of-self-reported-allergic2026-10-06 https://evidence-hub.com/study/64826-e-cigarette-use-vaping-and-cigarette-smoking-are-associated-with2026-10-06 https://evidence-hub.com/study/64827-knowledge-attitude-and-practice-of-lung-cancer-screening-and2026-10-06 https://evidence-hub.com/study/64828-prevalence-of-adverse-respiratory-symptoms-among-e-cigarette-users-in2026-10-06 https://evidence-hub.com/study/64829-electronic-cigarettes-use-and-parental-factors-among-children-and2026-10-06 https://evidence-hub.com/study/64830-comparative-effects-of-cigarette-smoking-e-cigarette-use-and-dual-use2026-10-06 https://evidence-hub.com/study/64831-structural-pathway-of-use-of-electronic-cigarettes-among-adult2026-10-06 https://evidence-hub.com/study/64832-harm-perceptions-across-vaping-product-features-an-on-line-cross2026-10-06 https://evidence-hub.com/study/64833-cross-sectional-study-of-partners-tobacco-consumption-during-their2026-10-06 https://evidence-hub.com/study/64834-limited-associations-between-passive-range-of-motion-and-gross-motor2026-10-06 https://evidence-hub.com/study/64835-a-cross-sectional-study-on-the-levels-of-knowledge-about-the-health2026-10-06 https://evidence-hub.com/study/64836-knowledge-attitude-and-perception-of-passive-smoking-among-medical2026-10-06 https://evidence-hub.com/study/64837-the-study-of-vape-smoking-among-al-iraqia-colleges-of-medicine-and2026-10-06 https://evidence-hub.com/study/64838-health-effects-of-passive-smoking-and-socio-demographic-factors-among2026-10-06 https://evidence-hub.com/study/64839-the-health-effects-of-passive-smoking-and-socio-demographic-factors2026-10-06 https://evidence-hub.com/study/64840-passive-smoking-as-a-significant-risk-factor-of-cervical-dysplasia-a2026-10-06 https://evidence-hub.com/study/64841-oral-nicotine-pouch-use-in-great-britain-a-repeat-cross-sectional2026-10-06 https://evidence-hub.com/study/64842-knowledge-and-attitude-of-the-general-population-toward-e-cigarette2026-10-06 https://evidence-hub.com/study/64843-the-rise-of-vaping-culture-in-students-exploring-the-trends-and2026-10-04 https://evidence-hub.com/study/64844-patterns-of-vaping-behavior-and-perceived-health-risks-among-young2026-10-06 https://evidence-hub.com/study/64845-patterns-and-factors-associated-with-e-cigarette-initiation-and2026-10-06 https://evidence-hub.com/study/64846-impact-of-household-environmental-conditions-on-residents-health-in2026-10-06 https://evidence-hub.com/study/64847-association-between-vigorous-intensity-work-activities-and-cough-or2026-10-06 https://evidence-hub.com/study/64848-identification-of-sociodemographic-and-risk-factors-contributing-to2026-10-06 https://evidence-hub.com/study/64849-prevalence-of-chronic-obstructive-pulmonary-disease-copd-in-sri2026-10-06 https://evidence-hub.com/study/64850-nonlinear-association-between-body-roundness-index-and-asthma-in-u-s2026-10-06 https://evidence-hub.com/study/64851-prevalence-of-passive-smoking-in-patients-with-stroke2026-10-06 https://evidence-hub.com/study/64852-the-relationship-between-passive-smoking-and-hypertension-in-adults2026-10-06 https://evidence-hub.com/study/64853-determinants-of-passive-smoking-behavior-in-state-elementary-school2026-10-06 https://evidence-hub.com/study/64855-awareness-of-passive-smoking-among-the-adult-population-in-northern2026-10-06 https://evidence-hub.com/study/64857-comparative-assessment-of-oral-health-findings-among-e-cigarette2026-10-06 https://evidence-hub.com/study/64858-the-prevalence-and-severity-of-dyspnea-in-young-saudi-female-adults-a2026-10-06 https://evidence-hub.com/study/64859-relationship-between-behavioral-related-variables-and-dental-caries2026-10-06 https://evidence-hub.com/study/64860-community-support-for-the-generational-end-game-policy-on-tobacco2026-10-06 https://evidence-hub.com/study/64861-awareness-of-obstructive-and-restrictive-lung-diseases-in-punjab-a2026-10-06 https://evidence-hub.com/study/64862-assessing-the-perceptions-usage-patterns-and-health-outcomes-of2026-10-06 https://evidence-hub.com/study/64863-impact-of-a-self-instructional-module-on-passive-smoking-awareness2026-10-06 https://evidence-hub.com/study/64864-covid-19-symptoms-associated-with-smoking-and-vaping-tobacco-and2026-10-06 https://evidence-hub.com/study/64865-association-between-electronic-cigarette-use-and-risk-of-obstructive2026-10-06 https://evidence-hub.com/study/64866-use-of-elf-bar-among-youth-and-young-adults-who-currently-vape-in2026-10-06 https://evidence-hub.com/study/64867-correlation-between-e-cigarette-use-and-salivary-flow-rate-ph-and2026-10-06 https://evidence-hub.com/study/64868-impact-of-alcohol-consumption-frequency-and-tobacco-use-on-blood2026-10-06 https://evidence-hub.com/study/64869-passive-smoking-and-respiratory-symptoms-among-children-in-tertiary2026-10-06 https://evidence-hub.com/study/64870-case-series-of-vaping-associated-lung-illness-related-to-use-of2026-10-06 https://evidence-hub.com/study/64872-d107-08-mediastinal-granuloma-and-fibrosing-mediastinitis-a-case2026-10-06 https://evidence-hub.com/study/64873-histopathological-and-microbiological-changes-in-chronic-tonsillitis2026-10-06 https://evidence-hub.com/study/64874-c77-45-beyond-tobacco-lung-cancer-in-young-non-smokers-and-the-role2026-10-06 https://evidence-hub.com/study/64875-prevalence-of-spine-pain-among-tunisian-children-and-adolescents-and2026-10-06 https://evidence-hub.com/study/64876-risk-factors-of-early-menopause-a-descriptive-study2026-10-06 https://evidence-hub.com/study/64877-multifocal-fibrosing-thyroiditis-a-high-volume-center-experience2026-10-06 https://evidence-hub.com/study/64878-non-small-cell-lung-cancer-in-women-experience-from-the-national2026-10-06 https://evidence-hub.com/study/64879-hexahydrocannabinol-poisoning-reported-to-french-poison-centres2026-10-06 https://evidence-hub.com/study/64880-idiopathic-nodular-glomerulosclerosis-in-a-long-term-passive-smoker2026-10-06 https://evidence-hub.com/study/64881-vaping-a-safe-alternative-to-counteract-smoking-case-report2026-10-06 https://evidence-hub.com/study/64882-smoking-hazard-education-as-an-effort-to-improve-adolescent-knowledge2026-10-06 https://evidence-hub.com/study/64883-feline-pulmonary-histiocytic-sarcoma-associated-with-passive-smoking2026-10-06 https://evidence-hub.com/study/64884-smoking-cessation-by-integrating-behavioral-support-pharmacotherapy2026-10-06 https://evidence-hub.com/study/64885-a-case-of-colonic-vasculitis-mimicking-ibd-in-a-45-year-old-female-a2026-10-06 https://evidence-hub.com/study/64886-pulmonary-langerhans-cell-histiocytosis-in-a-young-adult-with-a2026-10-06 https://evidence-hub.com/study/64887-vaping-use-associated-lung-injury-in-a-teenager-case-report2026-10-06 https://evidence-hub.com/study/64888-spontaneous-left-pneumothorax-revealing-an-atypical-carcinoid-tumor-a2026-10-06 https://evidence-hub.com/study/64889-rituximab-therapy-in-pulmonary-alveolar-proteinosis-a-case-report2026-10-06 https://evidence-hub.com/study/64890-aggressive-squamous-cell-lung-carcinoma-in-a-long-term-e-cigarette2026-10-06 https://evidence-hub.com/study/64891-spontaneous-pneumothorax-after-physical-exertion-on-adolescets-with2026-10-06 https://evidence-hub.com/study/64892-acute-nicotine-poisoning-in-a-2-year-old-child-a-case-report-of-a2026-10-06 https://evidence-hub.com/study/64893-aquafilling-filler-for-buttock-augmentation-cause-severe-long-term2026-10-06 https://evidence-hub.com/study/64894-potential-link-between-vaping-and-hypothyroidism-a-case-report2026-10-06 https://evidence-hub.com/study/64895-a-case-report-on-vaping-associated-spontaneous-pneumothorax2026-10-06 https://evidence-hub.com/study/64896-b26-18-acute-respiratory-distress-syndrome-secondary-to-suspected-e2026-10-06 https://evidence-hub.com/study/64897-vaping-associated-acute-respiratory-distress-syndrome-managed-with-vv2026-10-06 https://evidence-hub.com/study/64898-e-cigarette-or-vaping-product-use-associated-lung-injury-evali2026-10-06 https://evidence-hub.com/study/64899-the-influence-of-biologic-width-on-altered-passive-eruption-treatment2026-10-06 https://evidence-hub.com/study/64900-prevalence-and-correlates-of-e-cigarette-source-and-use-of-e2026-10-06 https://evidence-hub.com/study/64901-a-case-of-vaping-associated-candida-and-herpes-simplex-virus-hsv-co2026-10-06 https://evidence-hub.com/study/64902-b26-19-recurrent-diffuse-alveolar-hemorrhage-associated-with-smoking2026-10-06 https://evidence-hub.com/study/64903-chronic-airflow-limitation-emphysema-and-impaired-diffusing-capacity2026-10-06 https://evidence-hub.com/study/64904-smoking-among-healthcare-workers-prevalence-knowledge-and-attitudes2026-10-06 https://evidence-hub.com/study/64905-the-impact-of-electronic-cigarettes-smoking-on-the-health-of2026-10-06 https://evidence-hub.com/study/64906-the-case-for-a-pregnancy-specific-nicotine-policy2026-10-06 https://evidence-hub.com/study/64907-chronic-cough-with-reduced-diffusing-capacity-and-preserved-ratio2026-10-06 https://evidence-hub.com/study/64908-c42-35-infliximab-induced-eosinophilic-pneumonia-presenting-with2026-10-06 https://evidence-hub.com/study/64909-the-carcinogenicity-of-e-cigarettes-a-qualitative-risk-assessment2026-10-06 https://evidence-hub.com/study/64910-lung-cancer-epidemiology-evolution-over-the-last-twenty-years2026-10-06 https://evidence-hub.com/study/64911-c62-22-a-clouded-diagnosis-sarcoidosis-in-a-teen-vaper2026-10-06 https://evidence-hub.com/study/64912-bridging-innovation-prevention-and-holistic-practice-in-primary2026-10-06 https://evidence-hub.com/study/64913-e-cigarette-or-vaping-use-associated-lung-injury2026-10-06 https://evidence-hub.com/study/64914-d103-07-exogenous-lipoid-pneumonia-managed-with-whole-lung-lavage2026-10-06 https://evidence-hub.com/study/64915-how-do-clinicians-address-vaping-in-an-illegal-context-a-qualitative2026-10-06 https://evidence-hub.com/study/64916-vaping-culture-and-cutaneous-health-a-trend-with-skin-deep2026-10-06 https://evidence-hub.com/study/64917-machine-learning-approaches-for-asthma-disease-prediction-among2026-10-06 https://evidence-hub.com/study/64918-hexahydrocannabinol-and-hexahydrocannabiphorol-poisonings-data-from2026-10-06 https://evidence-hub.com/study/64919-the-impact-of-health-warnings-in-e-cigarette-content-on-instagram-on2026-10-06 https://evidence-hub.com/study/64920-clinical-and-socio-demographic-profile-of-pneumonia-in-children-aged2026-10-06 https://evidence-hub.com/study/64921-peripheral-ischemia-and-necrosis-revealing-buerger-s-disease-in-an2026-10-06 https://evidence-hub.com/study/64922-evali-and-beyond-an-update-on-the-spectrum-of-vaping-associated-lung2026-10-06 https://evidence-hub.com/study/64923-impact-of-cigarette-hookah-and-e-cigarette-use-on-seminal-fluid2026-10-06 https://evidence-hub.com/study/64924-public-health-interventions-to-minimize-the-impact-of-vaping2026-10-06 https://evidence-hub.com/study/64925-cardiovascular-and-respiratory-effects-of-cannabis-use-by-route-of2026-10-06 https://evidence-hub.com/study/64926-a-review-of-the-effect-of-vaping-on-the-plasma-levels-of-clozapine2026-10-06 https://evidence-hub.com/study/64927-an-unusual-cause-of-diffuse-alveolar-haemorrhage-post-streptococcal2026-10-06 https://evidence-hub.com/study/64928-perceptions-of-nicotine-vaping-products-among-australians-living-with2026-10-06 https://evidence-hub.com/study/64929-evali-syndrome-in-a-patient-with-hypersensitivity-pneumonitis2026-10-06 https://evidence-hub.com/study/64930-environmental-exposures-and-oxidative-stress-in-retinal-and-optic2026-10-04 https://evidence-hub.com/study/64931-heated-tobacco-products-emerging-health-outcomes-and-insights-into2026-10-06 https://evidence-hub.com/study/64932-components-and-harm-perceptions-of-e-cigarettes-health-risks-and2026-10-06 https://evidence-hub.com/study/64933-e-cigarette-use-among-university-students-a-structured-literature2026-10-06 https://evidence-hub.com/study/64934-memory-under-siege-the-cognitive-costs-of-smoking-and-vaping2026-10-06 https://evidence-hub.com/study/64935-understanding-the-cardiovascular-fallout-of-e-cigarettes-a2026-10-04 https://evidence-hub.com/study/64936-relationship-between-e-cigarette-media-content-and-product-use-a2026-10-06 https://evidence-hub.com/study/64937-world-no-tobacco-effects-of-second-hand-smoke-shs-and-vapors-on-the2026-10-06 https://evidence-hub.com/study/64938-the-preparticipation-evaluation-of-the-young-athlete-an-update-to2026-10-06 https://evidence-hub.com/study/64939-drosophila-melanogaster-as-an-alternative-model-to-higher-organisms2026-10-04 https://evidence-hub.com/study/64940-ers-international-congress-2023-highlights-from-the-epidemiology-and2026-10-06 https://evidence-hub.com/study/64941-smoking-among-healthcare-professionals-in-australia-a-scoping-review2026-10-06 https://evidence-hub.com/study/64942-better-life-guidelines-for-chronic-disease-preventive-care-for-people2026-10-06 https://evidence-hub.com/study/64943-national-and-subnational-plans-for-primary-prevention-and-early2026-10-06 https://evidence-hub.com/study/64944-arterial-stiffness-and-vascular-aging-mechanisms-prevention-and2026-10-06 https://evidence-hub.com/study/64945-flavored-tobacco-sales-restrictions-and-youth-e-cigarette-behavior2026-10-06 https://evidence-hub.com/study/64946-global-initiative-for-chronic-obstructive-lung-disease-gold-20232026-10-06 https://evidence-hub.com/study/64947-enhancing-translation-a-need-to-leverage-complex-preclinical-models2026-10-04 https://evidence-hub.com/study/64948-maternal-cannabis-use-during-lactation-and-potential-effects-on-human2026-10-06 https://evidence-hub.com/study/64949-unveiling-the-antioxidant-role-of-hemp-oils-in-cancer-prevention-and2026-10-06 https://evidence-hub.com/study/64950-asthma-inception-epidemiologic-risk-factors-and-natural-history2026-10-06 https://evidence-hub.com/study/64951-young-adults-exposure-to-and-engagement-with-tobacco-related-social2026-10-06 https://evidence-hub.com/study/64952-premalignant-progression-in-the-lung-knowledge-gaps-and-novel2026-10-06 https://evidence-hub.com/study/64953-up-in-smoke-cigarette-smoking-as-an-underrecognized-driver-of2026-10-04 https://evidence-hub.com/study/64954-smoking-prevalence-and-emerging-tobacco-product-use-among-saudi2026-10-04 https://evidence-hub.com/study/64955-a-systematic-review-on-the-impact-of-digital-interventions-for2026-10-04 https://evidence-hub.com/study/64956-can-smoking-alter-salivary-homeostasis-a-systematic-review-on-the2026-10-04 https://evidence-hub.com/study/64957-smoking-and-endometriosis-a-narrative-review2026-10-04 https://evidence-hub.com/study/64958-effects-of-maternal-electronic-cigarette-smoking-vs-tobacco-cigarette2026-10-04 https://evidence-hub.com/study/64959-impact-of-smoking-on-the-complement-system-a-narrative-review2026-10-04 https://evidence-hub.com/study/64960-smoking-and-risk-of-uveitis-a-systematic-review-and-meta-analysis2026-10-04 https://evidence-hub.com/study/64961-are-emergency-departments-useful-for-quitting-smoking-a-narrative2026-10-04 https://evidence-hub.com/study/64962-smoking-on-the-risk-of-acute-respiratory-distress-syndrome-a2026-10-04 https://evidence-hub.com/study/64963-a-systematic-review-and-network-meta-analysis-of-population-level2026-10-04 https://evidence-hub.com/study/64964-the-effect-of-tobacco-smoking-on-tooth-loss-a-systematic-review-and2026-10-04 https://evidence-hub.com/study/64965-the-effects-of-smoking-on-respiratory-microbiota-diversity-and2026-10-04 https://evidence-hub.com/study/64966-the-relationship-between-paternal-smoking-and-overweight-obesity-with2026-10-04 https://evidence-hub.com/study/64967-long-term-effectiveness-of-tobacco-smoking-cessation-interventions-in2026-10-04 https://evidence-hub.com/study/64968-the-hidden-dangers-e-cigarettes-heated-tobacco-and-their-impact-on2026-10-04 https://evidence-hub.com/study/64969-systematic-review-e-cigarettes-vs-conventional-cigarettes2026-10-04 https://evidence-hub.com/study/64970-prevalence-of-dual-use-of-combustible-tobacco-and-e-cigarettes-among2026-10-04 https://evidence-hub.com/study/64971-cardiovascular-effects-of-electronic-cigarettes-and-heated-tobacco2026-10-04 https://evidence-hub.com/study/64972-changes-in-concentration-of-selected-biomarkers-of-exposure-in-users2026-10-04 https://evidence-hub.com/study/64973-impact-of-maternal-smoking-on-obstetric-and-neonatal-outcomes-in-twin2026-10-04 https://evidence-hub.com/study/64974-emerging-cardiovascular-risk-factors-in-childhood-and-adolescence-a2026-10-04 https://evidence-hub.com/study/64975-inflammatory-and-carcinogenic-biomarker-signatures-in-e-cigarette2026-10-04 https://evidence-hub.com/study/64976-impact-of-smoke-free-legislation-on-stroke-risk-a-systematic-review2026-10-04 https://evidence-hub.com/study/64977-impact-of-electronic-nicotine-delivery-systems-ends-on-fetal-outcomes2026-10-04 https://evidence-hub.com/study/64978-association-between-electronic-cigarette-use-and-prediabetes-diabetes2026-10-04 https://evidence-hub.com/study/64979-health-impacts-of-electronic-nicotine-delivery-systems-an-umbrella2026-10-04 https://evidence-hub.com/study/64980-the-impact-of-electronic-cigarettes-on-the-respiratory-system-a2026-10-04 https://evidence-hub.com/study/64981-comparing-the-effects-of-e-cigarettes-and-traditional-cigarettes-on2026-10-04 https://evidence-hub.com/study/64982-a-systematic-review-on-health-impact-of-electronic-cigarettes-in2026-10-04 https://evidence-hub.com/study/64983-assessing-the-impact-of-e-cigarettes-on-human-barrier-systems-a2026-10-04 https://evidence-hub.com/study/64984-does-electronic-cigarette-use-increase-the-risk-of-early-onset2026-10-04 https://evidence-hub.com/study/64985-comparative-effects-of-electronic-cigarettes-and-dual-use-of2026-10-04 https://evidence-hub.com/study/64986-comparison-of-the-health-related-outcomes-for-traditional-cigarettes2026-10-04 https://evidence-hub.com/study/64987-narrative-review-of-novel-nicotine-delivery-systems-and-emerging2026-10-04 https://evidence-hub.com/study/64988-exercise-interventions-for-reducing-nicotine-dependence-and-craving2026-10-04 https://evidence-hub.com/study/64989-tobacco-free-university-campus-policies-a-systematic-review2026-10-04 https://evidence-hub.com/study/64990-impact-of-smoke-exposure-on-kidney-stone-formation-a-systematic-review2026-10-04 https://evidence-hub.com/study/64991-post-policy-evaluation-lags-of-tobacco-and-nicotine-product-policies2026-10-04 https://evidence-hub.com/study/64992-quantitative-reference-levels-for-thirdhand-smoke-residue-from2026-10-04 https://evidence-hub.com/study/64993-effects-of-nonsurgical-periodontal-therapy-nspt-on-periodontitis-in2026-10-04 https://evidence-hub.com/study/64994-sociodemographic-disparities-in-thirdhand-smoke-exposure-among2026-10-04 https://evidence-hub.com/study/64995-the-hidden-threat-of-microplastics-in-traditional-cigarettes-a2026-10-04 https://evidence-hub.com/study/64996-preoperative-management-in-patients-undergoing-hepatobiliary-surgery2026-10-04 https://evidence-hub.com/study/64997-from-copd-to-smoke-related-arteriopathy-the-mechanical-and-immune2026-10-04 https://evidence-hub.com/study/64998-nicotine-exposure-during-pregnancy-and-postnatal-cognitive-outcomes-a2026-10-04 https://evidence-hub.com/study/64999-school-connectedness-and-suicide-among-high-school-youth-a-systematic2026-10-04 https://evidence-hub.com/study/65000-risk-prediction-models-for-lung-cancer-in-people-who-have-never2026-10-04 https://evidence-hub.com/study/65001-tuberculosis-associated-respiratory-impairment-and-disability-in2026-10-04 https://evidence-hub.com/study/65002-the-millennium-challenge-of-young-adults-health-promotion-a-narrative2026-10-04 https://evidence-hub.com/study/65003-the-impact-of-social-media-on-health-behaviors-a-systematic-review2026-10-04 https://evidence-hub.com/study/65004-exploring-the-influence-of-user-generated-content-on-alcohol-related2026-10-04 https://evidence-hub.com/study/65005-the-role-of-environmental-exposures-in-pediatric-asthma-pathogenesis2026-10-04 https://evidence-hub.com/study/65007-a-systematic-review-and-narrative-synthesis-of-barriers-and2026-10-04 https://evidence-hub.com/study/65008-lifestyle-interventions-for-multiple-behavioral-risk-factors-among2026-10-04 https://evidence-hub.com/study/65009-risk-factors-for-severe-bronchiolitis-in-australian-and-aotearoa-new2026-10-04 https://evidence-hub.com/study/65010-the-impact-of-advanced-technology-and-social-media-platforms-on2026-10-04 https://evidence-hub.com/study/65011-substance-use-disorders-in-adults-a-narrative-review2026-10-04 https://evidence-hub.com/study/65012-use-of-big-data-artificial-intelligence-and-other-emerging2026-10-04 https://evidence-hub.com/study/65013-chronic-respiratory-morbidity-and-wheeze-after-preterm-birth-a2026-10-04 https://evidence-hub.com/study/65014-normative-reference-values-and-determinants-of-pulmonary-function-in2026-10-04 https://evidence-hub.com/study/65015-deciphering-the-impact-of-high-fat-diet-and-tobacco-exposure-on2026-10-04 https://evidence-hub.com/study/65016-exploring-the-perceived-socio-cultural-factors-in-the-initiation-of2026-10-04 https://evidence-hub.com/study/65017-gut-microbiota-heterogeneity-in-non-alcoholic-fatty-liver-disease-a2026-10-04 https://evidence-hub.com/study/65018-environmental-drivers-of-dry-eye-disease-a-narrative-review-of2026-10-04 https://evidence-hub.com/study/65019-disrupted-circadian-rhythms-and-substance-use-disorders-a-narrative2026-10-04 https://evidence-hub.com/study/65020-digital-interventions-for-recreational-cannabis-use-among-young2026-10-04 https://evidence-hub.com/study/65021-the-limbic-system-in-co-occurring-substance-use-and-anxiety-disorders2026-10-04 https://evidence-hub.com/study/65022-respiratory-syncytial-contagion-a-narrative-review-on-its-history2026-10-04 https://evidence-hub.com/study/65023-the-impact-of-social-media-interventions-on-eating-behaviours-and2026-10-04 https://evidence-hub.com/study/65024-state-impulsivity-and-substance-use-a-systematic-review-and-meta2026-10-04 https://evidence-hub.com/study/65025-patterns-of-use-of-e-cigarettes-and-their-respiratory-effects2026-10-06 https://evidence-hub.com/study/65026-addressing-the-dual-challenge-managing-smoking-cessation-in-patients2026-10-04 https://evidence-hub.com/study/65027-cardiovascular-effects-of-smoking-and-smoking-cessation-a-2024-update2026-10-04 https://evidence-hub.com/study/65028-analysis-of-copd-distinguishing-characteristics-and-management-of2026-10-04 https://evidence-hub.com/study/65029-third-hand-smoking-beliefs-in-patients-with-cancer2026-10-04 https://evidence-hub.com/study/65030-parent-perspectives-on-the-design-implementation-and-use-of-the2026-10-04 https://evidence-hub.com/study/65031-peer-smoking-status-as-factor-related-to-electronic-smoking-status-in2026-10-04 https://evidence-hub.com/study/65032-examining-the-impact-of-social-media-on-youth-vaping-behavior-in2026-10-04 https://evidence-hub.com/study/65033-awareness-of-vaping-health-risks-among-high-school-students-in-medina2026-10-04 https://evidence-hub.com/study/65034-oxidative-stress-and-inflammation-elucidating-mechanisms-of-smoking2026-10-04 https://evidence-hub.com/study/65035-chemical-analysis-of-exhaled-vape-emissions-unraveling-the2026-10-04 https://evidence-hub.com/study/65036-how-is-vaping-promoted-in-an-illegal-market-a-qualitative-study-of2026-10-04 https://evidence-hub.com/study/65037-cigarette-smoking-and-alcohol-related-liver-disease2026-10-04 https://evidence-hub.com/study/65039-trends-in-search-patterns-and-public-interest-in-vaping-cigarette2026-10-04 https://evidence-hub.com/study/65040-e-cigarette-or-vaping-product-use-associated-lung-injury-evali-and2026-10-04 https://evidence-hub.com/study/65041-comparing-the-effect-of-ascorbic-acid-and-conventional-vape-mod2026-10-04 https://evidence-hub.com/study/65042-the-relationship-between-smoking-habits-among-pneumonia-patients-and2026-10-04 https://evidence-hub.com/study/65043-smoking-prevalence-and-patterns-among-resident-doctors-at-aleppo2026-10-04 https://evidence-hub.com/study/65045-the-effect-of-smoking-on-the-course-of-the-disease-and-lipid2026-10-04 https://evidence-hub.com/study/65046-adolescent-nicotine-vaping-produced-sex-specific-alterations-in-mood2026-10-04 https://evidence-hub.com/study/65047-from-airways-to-alveoli-a-review-of-smoking-related-respiratory2026-10-04 https://evidence-hub.com/study/65048-a-phenomenological-study-of-barriers-to-smoking-cessation-among2026-10-04 https://evidence-hub.com/study/65049-the-effect-of-educational-videos-depicting-the-impact-of-smoking-on2026-10-04 https://evidence-hub.com/study/65050-health-effects-of-using-popular-alternatives-to-smoking-a-review-of2026-10-04 https://evidence-hub.com/study/65051-association-of-smoking-and-crohn-s-disease-an-update2026-10-04 https://evidence-hub.com/study/65052-socioeconomic-and-healthcare-cost-of-smoking2026-10-04 https://evidence-hub.com/study/65053-the-impact-of-electronic-cigarette-smoking-on-periodontal-status-and2026-10-04 https://evidence-hub.com/study/65054-prevalence-and-determine-knowledge-and-attitude-of-tobacco-smoking2026-10-04 https://evidence-hub.com/study/65055-the-impact-of-passive-tobacco-smoke-exposure-on-the-disease-course2026-10-04 https://evidence-hub.com/study/65056-smoking-intention-and-social-support-toward-smoking-behavior-among2026-10-04 https://evidence-hub.com/study/65057-small-cell-lung-cancer-in-a-never-smoking-patient-a-case-highlighting2026-10-04 https://evidence-hub.com/study/65058-parental-smoking-habits-and-children-s-exposure-to-household2026-10-04 https://evidence-hub.com/study/65059-effects-of-passive-smoking-on-cortical-spreading-depolarization-in2026-10-06 https://evidence-hub.com/study/65060-the-effect-of-vaping-and-smoking-on-colonic-anastomosis-healing-in-an2026-10-06 https://evidence-hub.com/study/65061-the-effect-of-pharmaceutical-composition-based-on-l-carnitine-on2026-10-06 https://evidence-hub.com/study/65062-aromatized-nicotine-containing-smoking-mixtures-as-a-factor-in2026-10-06 https://evidence-hub.com/study/65063-effect-of-tetrapeptides-kk1-and-kk5-on-the-immunological-parameters2026-10-06 https://evidence-hub.com/study/65064-effect-of-flavored-nicotine-containing-smoking-mixtures-on-changes-in2026-10-06 https://evidence-hub.com/study/65065-altered-uterine-artery-protein-signature-and-function-following-e2026-10-06 https://evidence-hub.com/study/65066-relationship-between-cigarette-smoke-exposure-and-laryngeal2026-10-06 https://evidence-hub.com/study/65067-prenatal-cigarette-smoke-exposure-increases-vulnerability-to-chronic2026-10-06 https://evidence-hub.com/study/65068-the-respiratory-epithelium-in-the-era-of-vaping-insights-from-in2026-10-06 https://evidence-hub.com/study/65069-analysis-of-kk1-compound-effects-on-immunological-and-biochemical2026-10-06 https://evidence-hub.com/study/65070-nicotine-and-neurocognition-in-hiv-translational-challenges-and2026-10-06 https://evidence-hub.com/study/65071-ultrasonographic-and-elastographic-findings-of-the-liver-of-dogs2026-10-06 https://evidence-hub.com/study/65073-continuous-nicotine-monitors-for-personal-nicotine-pharmacokinetics-a2026-10-06 https://evidence-hub.com/study/65074-abstract-fri006-epigenetic-impacts-of-e-cigarette-nicotine-vaping-and2026-10-06 https://evidence-hub.com/study/65075-a-deep-learning-based-efficientnetb0-smoker-surveillance-system-for2026-10-06 https://evidence-hub.com/study/65076-abstract-3005-transgenerational-impact-of-e-cigarette-nicotine-vaping2026-10-06 https://evidence-hub.com/study/65077-the-effects-of-e-cigarette-aerosol-components-on-the-morphology-and2026-10-06 https://evidence-hub.com/study/65078-impact-of-marijuana-use-on-lung-health2026-10-06 https://evidence-hub.com/study/65079-exposure-to-ambient-fine-particulate-matter-components-during2026-10-06 https://evidence-hub.com/study/65080-assessment-of-oxidative-stress-markers-and-cellular-damage-in-rat2026-10-04 https://evidence-hub.com/study/65083-impact-of-electronic-cigarette-vaping-on-the-cardiovascular-function2026-10-04 https://evidence-hub.com/study/65084-passive-nicotine-vapor-exposure-model-in-mice-reveals-translationally2026-10-04 https://evidence-hub.com/study/65085-the-effects-of-kretek-cigarettes-and-ascorbic-acid-based-vape-on-il-62026-10-04 https://evidence-hub.com/study/65086-higher-exposure-to-secondhand-smoking-among-adolescents-living-in2026-10-04 https://evidence-hub.com/study/65087-the-prevalence-and-habits-of-smoking-conventional-and-electronic2026-10-04 https://evidence-hub.com/study/65088-smoking-and-maternal-health-during-pregnancy2026-10-04 https://evidence-hub.com/study/65089-impact-of-traditional-cigarette-smoking-on-liver-structure-and2026-10-04 https://evidence-hub.com/study/65090-differential-associations-between-smoking-e-cigarette-use-and2026-10-04 https://evidence-hub.com/study/65091-what-is-the-real-impact-of-smoking-on-diseases-alleged-to-benefit2026-10-04 https://evidence-hub.com/study/65093-clinical-characteristics-of-chronic-obstructive-pulmonary-disease2026-10-04 https://evidence-hub.com/study/65094-impact-of-cigarette-smoking-on-gut-microbial-dysbiosis-a-structured2026-10-04 https://evidence-hub.com/study/65095-gc-hrms-analysis-of-e-liquids-complements-in-vivo-modeling-methods2026-10-04 https://evidence-hub.com/study/65096-metabolomic-insights-into-smoking-induced-metabolic-dysfunctions-a2026-10-04 https://evidence-hub.com/study/65097-association-of-tobacco-exposure-patterns-with-periodontal-health-a2026-10-04 https://evidence-hub.com/study/65098-electronic-cigarettes-increase-blood-brain-and-blood-tumor-barrier2026-10-04 https://evidence-hub.com/study/650992026-10-04 https://evidence-hub.com/study/65100-inflammatory-response-to-chronic-nicotine-containing-electronic2026-10-04 https://evidence-hub.com/study/65101-evaluation-of-acute-exposure-to-combustible-and-novel-tobacco2026-10-04 https://evidence-hub.com/study/65102-the-impact-of-e-cigarettes-on-endothelial-function-and-cardiovascular2026-10-04 https://evidence-hub.com/study/65103-nicotine-exposure-during-gestation-from-placental-dysfunction-to-long2026-10-04 https://evidence-hub.com/study/65104-multi-omics-assessment-of-puff-volume-mediated-salivary-biomarkers-of2026-10-04 https://evidence-hub.com/study/65105-analysis-of-awareness-of-the-effects-of-electronic-cigarettes-on2026-10-04 https://evidence-hub.com/study/65106-the-impact-of-cigarette-smoking-and-vaping-on-acute-chest-syndrome-in2026-10-04 https://evidence-hub.com/study/65107-electronic-cigarettes-wolves-in-sheep-s-clothing2026-10-04 https://evidence-hub.com/study/65109-plasma-nicotine-and-its-metabolite-as-biomarkers-of-tobacco-exposure2026-10-04 https://evidence-hub.com/study/65110-a-noninvasive-approach-to-modeling-cocaine-self-administration-in-mice2026-10-04 https://evidence-hub.com/study/65111-health-outcomes-associated-with-the-use-of-e-cigarettes-heated2026-10-04 https://evidence-hub.com/study/65112-nicotine-and-the-cardiovascular-system-unmasking-a-global-public2026-10-04 https://evidence-hub.com/study/65113-article-review-effect-of-electronic-cigarette-on-fertility-in-male2026-10-04 https://evidence-hub.com/study/65115-comprehensive-validation-enhancing-the-modified-nerah-model-via2026-10-04 https://evidence-hub.com/study/65116-correlation-of-serum-cotinine-with-fatty-liver-index-in-adults-data2026-10-04 https://evidence-hub.com/study/65117-nicotine-inhalant-via-e-cigarette-facilitates-sensorimotor-function2026-10-04 https://evidence-hub.com/study/65118-uso-de-cigarrillos-electronicos-y-su-relacion-con-la-lesion-pulmonar2026-10-04 https://evidence-hub.com/study/65119-rising-trend-of-e-cigarettes-among-adolescents-of-pakistan-and2026-10-04 https://evidence-hub.com/study/65120-addressing-cardiovascular-toxicity-risk-of-electronic-nicotine2026-10-04 https://evidence-hub.com/study/65121-electronic-nicotine-delivery-systems-ends-implications-for-the2026-10-04 https://evidence-hub.com/study/65122-metabolic-and-morphological-changes-in-rat-tissues-under-the-effect2026-10-04 https://evidence-hub.com/study/65123-smoking-electronic-cigarettes-is-a-global-danger-to-modern-health2026-10-04 https://evidence-hub.com/study/65124-cardiac-autonomic-dysfunction-and-increased-oxidative-stress-in2026-10-04 https://evidence-hub.com/study/65125-nicotinism-vs-glomerulopathies-smoking-as-a-risk-factor-for-primary2026-10-04 https://evidence-hub.com/study/65126-influence-of-gestational-window-on-offspring-vascular-health-in2026-10-04 https://evidence-hub.com/study/65127-evaluation-of-scientific-studies-on-electronic-cigarettes-in-the-last2026-10-04 https://evidence-hub.com/study/65128-prenatal-tobacco-smoke-exposure-and-neurological-impairment-at-102026-10-04 https://evidence-hub.com/study/65129-impacts-of-mislabeled-ecig-liquids-on-primary-particulate-matter2026-10-06 https://evidence-hub.com/study/65130-chemical-transformation-of-vaping-emissions-under-indoor-atmospheric2026-10-04 https://evidence-hub.com/study/65131-flavoring-compound-chemical-class-and-vaping-conditions-determine2026-10-04 https://evidence-hub.com/study/65132-metabolic-disruption-associated-with-e-cigarette-vaping-and2026-10-04 https://evidence-hub.com/study/65133-smoking-as-a-persistent-global-health-challenge-perspectives-on2026-10-04 https://evidence-hub.com/study/65134-effect-of-smoking-on-cbc-exposure-of-pah-and-oxidative-stress2026-10-04 https://evidence-hub.com/study/65135-effects-of-smoking-on-women-s-health-a-review-of-reviews2026-10-04 https://evidence-hub.com/study/65136-comparative-effects-of-e-cigarette-smoking-on-periodontal-status2026-10-04 https://evidence-hub.com/study/65137-health-impact-of-e-cigarettes-a-literature-review2026-10-04 https://evidence-hub.com/study/65138-alerte-aux-puffs-addiction-aux-produits-nicotiniques-chez-les-jeunes2026-10-04 https://evidence-hub.com/study/65139-emerging-emergency-of-e-cigarette-an-overview2026-10-04 https://evidence-hub.com/study/65140-e-cigarettes-and-associated-medical-burden-for-better-and-for-worse2026-10-04 https://evidence-hub.com/study/65141-association-between-use-of-heated-tobacco-products-and-long-term2026-10-04 https://evidence-hub.com/study/65142-association-between-use-of-heated-tobacco-products-and-long-term2026-10-04 https://evidence-hub.com/study/65143-acute-exposure-to-electronic-cigarette-components-alters-mrna2026-10-04 https://evidence-hub.com/study/65144-a-scoping-review-of-behavioural-studies-on-heated-tobacco-products2026-10-04 https://evidence-hub.com/study/65145-exploring-safer-smoke-free-alternatives-to-conventional-cigarettes2026-10-04 https://evidence-hub.com/study/65146-health-effects-of-nicotine-products-on-oral-tissues-prevention2026-10-04 https://evidence-hub.com/study/65147-e-sigaralar-ve-zarar-azalt-m-miti-kan-tlara-dayal-elestirel-bir2026-10-04 https://evidence-hub.com/study/65148-methods-for-a-non-targeted-qualitative-analysis-and-quantification-of2026-10-04 https://evidence-hub.com/study/65149-toxicological-profile-of-electronic-cigarette-use-a-literature-based2026-10-04 https://evidence-hub.com/study/65150-public-health-impact-of-disposable-electronic-cigarettes-since-2021-a2026-10-04 https://evidence-hub.com/study/65151-o-uso-de-cigarro-eletronico-e-seus-efeitos-prejudiciais-sistemicos2026-10-04 https://evidence-hub.com/study/65152-differential-cytotoxicity-of-flavored-e-liquids-with-and-without2026-10-04 https://evidence-hub.com/study/65153-nicotine-in-electronic-cigarettes2026-10-04 https://evidence-hub.com/study/65154-association-between-exposure-to-environmental-pollutants-and2026-10-04 https://evidence-hub.com/study/65155-molecular-health-effects-of-electronic-cigarettes2026-10-04 https://evidence-hub.com/study/65156-awareness-towards-the-thirdhand-smoke-and-new-generation-tobacco2026-10-04 https://evidence-hub.com/study/65157-association-between-children-s-secondhand-co-exposure-to-tobacco-and2026-10-04 https://evidence-hub.com/study/65158-tendencias-e-desafios-acerca-do-uso-de-cigarros-eletronicos-entre2026-10-04 https://evidence-hub.com/study/65159-method-for-simultaneous-determination-of-three-cooling-agents-in2026-10-04 https://evidence-hub.com/study/65160-tobacco-and-copd-presenting-the-world-health-organization-who-tobacco2026-10-04 https://evidence-hub.com/study/65161-analysis-of-the-nicotine-addiction-stage-and-secondhand-smoke2026-10-04 https://evidence-hub.com/study/65162-probability-of-nicotine-addiction-development-in-smoking-female2026-10-04 https://evidence-hub.com/study/65163-in-unit-particulate-matter-pm2-5-in-a-public-housing-complex-and-the2026-10-04 https://evidence-hub.com/study/65164-wearable-sweat-nicotine-biosensor-based-on-a-nicotine-oxidoreductase2026-10-04 https://evidence-hub.com/study/65165-from-copd-to-smoke-related-arteriopathy-the-mechanic-and-immune2026-10-04 https://evidence-hub.com/study/65166-a-review-on-development-of-eco-friendly-filters-in-nepal-for-use-in2026-10-04 https://evidence-hub.com/study/65167-chemopreventive-potential-of-alcoholic-extract-of-a-polyherbal2026-10-04 https://evidence-hub.com/study/65168-research-trends-in-microrna-profiling-as-a-biomarker-for-lung2026-10-04 https://evidence-hub.com/study/65169-formulation-and-characterization-of-albumin-nanoparticles-for-nsclc2026-10-04 https://evidence-hub.com/study/65170-development-and-characterisation-of-air-liquid-interface-exposure2026-10-04 https://evidence-hub.com/study/65172-natural-products-as-kinase-inhibitors-in-lung-cancer-molecular2026-10-04 https://evidence-hub.com/study/65174-immunoregulatory-role-of-extracellular-vesicles-in-advanced-non-small2026-10-04 https://evidence-hub.com/study/65176-second-multidisciplinary-international-scientific-conference-for2026-10-04 https://evidence-hub.com/study/65177-cryopreservation-of-human-lung-tissue-for-3d-ex-vivo-analysis2026-10-04 https://evidence-hub.com/study/65178-the-cost-effectiveness-of-oral-semaglutide-versus-empagliflozin-in2026-10-06 https://evidence-hub.com/study/65179-impact-of-empagliflozin-as-add-on-to-metformin-vs-metformin2026-10-04 https://evidence-hub.com/study/65180-empagliflozin-metformin-fixed-dose-combination-a-review-in-patients2026-10-04 https://evidence-hub.com/study/65181-pharmacokinetics-of-fixed-dose-combinations-of-empagliflozin2026-10-04 https://evidence-hub.com/study/65182-empagliflozin-metformin-combination-has-antioxidative-and-anti2026-10-04 https://evidence-hub.com/study/65183-effects-of-a-combination-of-empagliflozin-plus-metformin-vs-metformin2026-10-04 https://evidence-hub.com/study/65184-cost-effectiveness-analysis-of-empagliflozin-compared-with2026-10-06 https://evidence-hub.com/study/65185-role-of-oral-hypoglycaemic-drugs-in-preventing-complication-in-non2026-10-06 https://evidence-hub.com/study/65186-antidiabetic-medicines-utilisation-during-pre-pandemic-pandemic-and2026-10-06 https://evidence-hub.com/study/65187-a-survey-of-the-fda-s-adverse-event-reporting-system-database2026-10-06 https://evidence-hub.com/study/65188-silica-coated-magnetic-iron-oxide-functionalized-with-hydrophobic2026-10-06 https://evidence-hub.com/study/65189-longitudinal-changes-in-corneal-epithelial-and-central-corneal2026-10-06 https://evidence-hub.com/study/65190-effectiveness-and-safety-of-fixed-dose-combination-metformin-and2026-10-06 https://evidence-hub.com/study/65191-the-role-of-sglt2-inhibitors-in-the-prevention-of-type-2-diabetes-a2026-10-08 https://evidence-hub.com/study/65192-cardioprotective-effects-of-metformin-and-empagliflozin-in-stz2026-10-06 https://evidence-hub.com/study/65193-adverse-event-reporting-signals-for-sglt-2-inhibitor-metformin2026-10-06 https://evidence-hub.com/study/65194-drug-associated-ketoacidosis-a-comprehensive-disproportionality2026-10-06 https://evidence-hub.com/study/65195-dapagliflozin-beyond-glucose-lowering-mechanisms-of-renal-and2026-10-06 https://evidence-hub.com/study/65196-antihyperglycemic-treatment-of-type-2-diabetes-mellitus-update-20262026-10-06 https://evidence-hub.com/study/65197-targeting-metabolism-to-protect-fertility-and-healthy-pregnancy-with2026-10-06 https://evidence-hub.com/study/65198-balancing-performance-and-sustainability-a-white-differential-pulse2026-10-06 https://evidence-hub.com/study/65199-prioritizing-antidiabetic-drugs-for-inflammatory-bowel-disease2026-10-06 https://evidence-hub.com/study/65200-computational-discovery-of-fenugreek-paitan-turmeric-fpt-bioactive2026-10-06 https://evidence-hub.com/study/65201-projected-budget-impact-of-pharmacotherapy-scenarios-for-obesity-and2026-10-06 https://evidence-hub.com/study/65202-glp-1-receptor-agonists-sglt-2-inhibitors-and-their-combination2026-10-06 https://evidence-hub.com/study/65203-empagliflozin-metformin-benefit-assessment-according-to-35a-social2026-10-06 https://evidence-hub.com/study/65204-model-informed-approaches-for-pediatric-type-2-diabetes-evidence2026-10-06 https://evidence-hub.com/study/65205-diagnostic-and-management-pitfalls-of-sglt2-inhibitor-associated2026-10-06 https://evidence-hub.com/study/65206-enantioselective-analysis-of-metoprolol-in-plasma-of-hypertensive2026-10-06 https://evidence-hub.com/study/65207-green-evaluation-of-human-plasma-levels-of-metformin-linagliptin-and2026-10-06 https://evidence-hub.com/study/65208-antidiabetes-agents-and-risk-of-incident-depression-in-686-522-people2026-10-06 https://evidence-hub.com/study/65209-pharmacokinetic-comparison-and-bioequivalence-evaluation-of-two2026-10-04 https://evidence-hub.com/study/65210-comparison-of-empagliflozin-linagliptin-with-empagliflozin-metformin2026-10-04 https://evidence-hub.com/study/65211-a-repurposed-duo-empagliflozin-metformin-triggers-a-metabolic-crisis2026-10-04 https://evidence-hub.com/study/65212-empagliflozin-metformin-in-hypertension-therapy-synergistically2026-10-04 https://evidence-hub.com/study/65213-a-bioequivalence-study-of-empagliflozin-metformin-fixed-dose2026-10-04 https://evidence-hub.com/study/65215-effect-of-empagliflozin-metformin-with-clomiphene-citrate-versus2026-10-04 https://evidence-hub.com/study/65219-role-of-combination-therapy-with-sglt2-inhibitor-with-metformin-as2026-10-04 https://evidence-hub.com/study/65222-comparison-of-the-effects-of-metformin-and-empagliflozin-on-cardiac2026-10-06 https://evidence-hub.com/study/65224-comparative-analysis-of-metformin-and-empagliflozin-in-male-wistar2026-10-04 https://evidence-hub.com/study/65225-to-compare-the-efficacy-and-safety-profile-of-empagliflozin-and2026-10-04 https://evidence-hub.com/study/65226-development-of-a-sustainable-high-performance-liquid-chromatography2026-10-06 https://evidence-hub.com/study/65227-bioanalytical-method-development-and-validation-for-the-estimation-of2026-10-06 https://evidence-hub.com/study/65228-a-validated-ion-pair-reversed-phase-high-performance-liquid2026-10-04 https://evidence-hub.com/study/65229-an-analytical-of-an-experimental-method-for-evaluation-and-validation2026-10-06 https://evidence-hub.com/study/65230-comparison-of-empagliflozin-versus-vildagliptin-in-combination-with2026-10-06 https://evidence-hub.com/study/65232-comparative-study-of-efficacy-and-adverse-effects-of-metformin-plus2026-10-04 https://evidence-hub.com/study/65233-review-on-simultaneous-estimation-of-metformin-hydrochloride2026-10-04 https://evidence-hub.com/study/65234-comparison-of-efficacy-of-empagliflozin-versus-dapagliflozin-in-type2026-10-06 https://evidence-hub.com/study/65236-two-year-therapeutic-efficacy-and-safety-of-initial-triple2026-10-04 https://evidence-hub.com/study/65238-quantitative-determination-of-potential-genotoxic-impurities-in2026-10-06 https://evidence-hub.com/study/65239-formulation-and-evaluation-of-extended-release-bilayer-tablets2026-10-04 https://evidence-hub.com/study/65240-the-influence-of-metformin-and-empagliflozin-administration-on-gut2026-10-06 https://evidence-hub.com/study/65241-917-p-sotagliflozin-vs-empagliflozin-or-placebo-in-type-2-diabetes-on2026-10-06 https://evidence-hub.com/study/65242-effectiveness-of-a-fixed-combination-of-empagliflozin-with-metformin2026-10-04 https://evidence-hub.com/study/65243-effects-of-the-sodium-glucose-cotransporter-2-sglt2-inhibitor2026-10-06 https://evidence-hub.com/study/65244-comparative-studies-on-simultaneous-estimation-of-metformin2026-10-04 https://evidence-hub.com/study/65245-review-on-method-development-and-validation-of-metformin2026-10-06 https://evidence-hub.com/study/65246-evaluation-of-pharmacokinetic-interactions-between-lobeglitazone2026-10-04 https://evidence-hub.com/study/65247-a-comparison-of-the-effects-of-empagliflozin-and-sitagliptin-when2026-10-04 https://evidence-hub.com/study/65248-a-review-on-method-development-and-validation-of-stability-indicating2026-10-06 https://evidence-hub.com/study/65249-the-efficacy-of-combitation-of-empagliflozin-and-metformin-in2026-10-04 https://evidence-hub.com/study/65250-a-stability-indicating-assay-method-development-and-validation-for2026-10-06 https://evidence-hub.com/study/65251-empagliflozin-alone-and-in-combination-with-metformin-ameliorate2026-10-04 https://evidence-hub.com/study/65252-efficacy-and-safety-of-combination-of-empagliflozin-and-metformin2026-10-04 https://evidence-hub.com/study/65253-analytical-quality-by-design-based-on-design-space-in-reversed-phase2026-10-06 https://evidence-hub.com/study/65254-blunting-p38-mapk-and-erk1-2-activities-by-empagliflozin-enhances-the2026-10-06 https://evidence-hub.com/study/65255-the-cost-effectiveness-of-subcutaneous-semaglutide-versus2026-10-04 https://evidence-hub.com/study/65256-green-spectrophotometric-methods-for-simultaneous-quantification-of2026-10-04 https://evidence-hub.com/study/65258-new-validated-stability-indicating-rp-hplc-method-for-the2026-10-06 https://evidence-hub.com/study/65260-first-line-treatment-with-empagliflozin-and-metformin-combination2026-10-04 https://evidence-hub.com/study/65261-effects-of-liraglutide-empagliflozin-and-linagliptin-on-mild2026-10-04 https://evidence-hub.com/study/65262-a-phase-iii-randomised-double-blind-active-controlled-parallel-group2026-10-04 https://evidence-hub.com/study/65263-an-open-label-balanced-randomized-single-dose-two-treatment-two2026-10-04 https://evidence-hub.com/study/65264-the-role-of-cyp8b1-polymorphisms-in-modulating-the-biochemical2026-10-04 https://evidence-hub.com/study/65265-bioequivalence-of-empagliflozin-metformin-850-mg-fixed-dose2026-10-04 https://evidence-hub.com/study/65266-a-long-term-randomized-study-to-evaluate-the-effects-of-empagliflozin2026-10-04 https://evidence-hub.com/study/65267-a-randomized-double-blind-parallel-group-2-treatment-multiple-dose2026-10-04 https://evidence-hub.com/study/65268-bioequivalence-of-empagliflozin-metformin-12-5mg-500mg-fixed-dose2026-10-04 https://evidence-hub.com/study/65269-a-randomized-open-label-single-oral-dosing-two-sequence-and-two2026-10-08 https://evidence-hub.com/study/65270-a-comparative-study-of-the-effect-of-dapagliflozin-versus2026-10-04 https://evidence-hub.com/study/65271-a-randomized-comparator-controlled-cross-over-intervention-study-to2026-10-04 https://evidence-hub.com/study/65272-a-multicenter-randomized-placebo-controlled-parallel-group-double2026-10-04 https://evidence-hub.com/study/65273-a-randomised-double-blind-placebo-controlled-parallel-group-efficacy2026-10-04 https://evidence-hub.com/study/65274-comparison-of-mean-blood-pressure-in-patients-with-type-2-diabetes2026-10-04 https://evidence-hub.com/study/65275-an-open-label-randomised-single-dose-two-way-crossover-study-in2026-10-04 https://evidence-hub.com/study/65276-an-open-label-balanced-randomized-single-dose-two-treatment-two2026-10-04 https://evidence-hub.com/study/65277-a-24-week-phase-iii-randomized-double-blind-parallel-group-study-to2026-10-04 https://evidence-hub.com/study/65278-comparing-the-effects-of-empagliflozin-and-metformin-on-metabolic2026-10-04 https://evidence-hub.com/study/65279-comparison-of-empagliflozin-linagliptin-with-empagliflozin-metformin2026-10-04 https://evidence-hub.com/study/65280-a-phase-iii-randomised-double-blind-placebo-controlled-parallel-group2026-10-04 https://evidence-hub.com/study/65281-clinical-study-to-determine-bioequivalence-between-two-oral2026-10-08 https://evidence-hub.com/study/65282-bioequivalence-of-empagliflozin-metformin-500-mg-fixed-dose2026-10-04 https://evidence-hub.com/study/65283-comparative-study-of-dpp-4-inhibitors-and-sglt-2-inhibitors-in2026-10-04 https://evidence-hub.com/study/65284-an-open-label-randomized-two-period-two-treatment-two-sequence2026-10-04 https://evidence-hub.com/study/65285-is-the-stepping-down-approach-a-better-option-than-multiple-daily2026-10-04 https://evidence-hub.com/study/65286-bioequivalence-of-a-low-strength-fixed-dose-combination-tablet-of2026-10-04 https://evidence-hub.com/study/65287-relative-bioavailability-of-empagliflozin-metformin-fixed-dose2026-10-04 https://evidence-hub.com/study/65288-a-phase-iii-randomized-double-blind-placebo-controlled-parallel-group2026-10-04 https://evidence-hub.com/study/65289-a-26-week-randomized-double-blind-controlled-parallel-group2026-10-04 https://evidence-hub.com/study/65290-a-phase-iii-randomised-double-blind-parallel-group-24-week-study-to2026-10-04 https://evidence-hub.com/study/65291-comparative-randomized-single-dose-two-way-crossover-bioequivalence2026-10-04 https://evidence-hub.com/study/65292-relative-bioavailability-of-both-bi-10773-and-metformin-after2026-10-04 https://evidence-hub.com/study/65293-a-78-week-open-label-extension-to-trials-assessing-the-safety-and2026-10-04 https://evidence-hub.com/study/65294-relative-bioavailability-of-empagliflozin-12-5-or-5-mg-metformin-8502026-10-04 https://evidence-hub.com/study/65295-clinical-study-evaluating-the-efficacy-and-safety-of-metformin-versus2026-10-04 https://evidence-hub.com/study/65296-a-52-week-randomised-multi-centre-parallel-group-study-to-investigate2026-10-04 https://evidence-hub.com/study/65297-clinical-study-to-determine-bioequivalence-between-two-oral2026-10-04 https://evidence-hub.com/study/65298-first-time-usage-of-sglt2-inhibitors-in-type-2-diabetic-patients-who2026-10-04 https://evidence-hub.com/study/65299-clinical-efficacy-and-safety-of-glimepiride-empagliflozin-and2026-10-04 https://evidence-hub.com/study/65300-open-label-randomized-two-period-comparative-pharmacokinetics-and2026-10-04 https://evidence-hub.com/study/65301-randomized-two-way-two-period-single-oral-dose-open-label-crossover2026-10-04 https://evidence-hub.com/study/65302-relative-bioavailability-of-two-newly-developed-fdc-tablet-strengths2026-10-04 https://evidence-hub.com/study/65303-a-randomized-double-blind-multi-center-placebo-controlled-phase-iii2026-10-04 https://evidence-hub.com/study/65304-a-double-blind-randomised-placebo-controlled-parallel-group-trial-to2026-10-04 https://evidence-hub.com/study/65305-effectivity-of-empagliflozin-addition-to-insulin-and-oral2026-10-04 https://evidence-hub.com/study/65306-a-multicentre-randomized-double-blind-placebo-controlled-phase-iii2026-10-04 https://evidence-hub.com/study/65307-a-phase-3b-randomized-active-comparator-open-label-multicenter-study2026-10-04 https://evidence-hub.com/study/65332-glucometabolic-efficacy-of-the-empagliflozin-metformin-combination-in2026-10-04 https://evidence-hub.com/study/65335-lc-ms-ms-determination-of-empagliflozin-and-metformin2026-10-04 https://evidence-hub.com/study/65336-mean-centering-method-for-determination-of-empagliflozin-and-metformin2026-10-04 https://evidence-hub.com/study/65339-empagliflozin-and-metformin-combination-therapy-in-type-2-diabetes2026-10-04 https://evidence-hub.com/study/65340-comparison-of-glycemic-control-using-combination-of-empagliflozin2026-10-04 https://evidence-hub.com/study/65342-quality-by-design-approach-for-chromatographic-analysis-of-metformin2026-10-04 https://evidence-hub.com/study/65344-rp-hplc-method-development-for-simultaneous-estimation-of2026-10-04 https://evidence-hub.com/study/65345-efficacy-and-safety-of-empagliflozin-a-sodium-glucose-cotransporter-22026-10-04 https://evidence-hub.com/study/65346-validated-rp-hplc-method-for-simultaneousdetermination-of2026-10-04 https://evidence-hub.com/study/65347-effects-of-empagliflozin-sitagliptin-and-metformin-on-omentin-1-and2026-10-04 https://evidence-hub.com/study/65349-therapy-of-empagliflozin-plus-metformin-on-t2dm-mice-shows-no-higher2026-10-04 https://evidence-hub.com/study/65350-referat-keine-veranderung-der-empagliflozin-wirkung-mit-metformin2026-10-04 https://evidence-hub.com/study/65351-validated-liquid-chromatographic-method-for-the-determination-of2026-10-04 https://evidence-hub.com/study/65352-development-and-validation-of-rp-hplc-method-for-empagliflozin-and2026-10-04 https://evidence-hub.com/study/65353-combining-empagliflozin-and-linagliptin-with-metformin-reduces-hba1c2026-10-04 https://evidence-hub.com/study/65354-development-and-validation-of-uv-spectrophotometric-method-for2026-10-04 https://evidence-hub.com/study/65355-novel-uv-spectroscopic-methods-for-simultaneous-assessment-of2026-10-04 https://evidence-hub.com/study/65356-efficacy-and-safety-of-ertugliflozin-compared-to-placebo-in-patients2026-10-06 https://evidence-hub.com/study/65357-sodium-glucose-co-transporter-2-sglt2-inhibitors-versus-dipeptidyl2026-10-06 https://evidence-hub.com/study/65358-effectiveness-and-safety-of-the-combination-of-sodium-glucose2026-10-06 https://evidence-hub.com/study/65359-comparative-efficacy-of-pharmacological-interventions-on-metabolic2026-10-06 https://evidence-hub.com/study/65360-sglt2-inhibitors-and-nephrolithiasis-risk-a-meta-analysis2026-10-06 https://evidence-hub.com/study/65361-a-systematic-review-and-meta-analysis-of-semaglutide-effects-on2026-10-06 https://evidence-hub.com/study/65362-clinical-characteristics-and-outcomes-of-diabetes-related2026-10-06 https://evidence-hub.com/study/65363-impact-of-sodium-glucose-co-transporter-2-inhibitors-on-atrial2026-10-06 https://evidence-hub.com/study/65364-impact-of-different-anti-hyperglycaemic-treatments-on-bone-turnover2026-10-06 https://evidence-hub.com/study/65365-efficacy-of-sodium-glucose-cotransporter-2-inhibitors-on-hepatic2026-10-08 https://evidence-hub.com/study/65366-neutral-effects-of-sglt2-inhibitors-in-acute-coronary-syndromes2026-10-06 https://evidence-hub.com/study/65367-glucagon-like-peptide-1-receptor-agonists-and-risk-of-venous2026-10-06 https://evidence-hub.com/study/65368-relationship-between-sodium-glucose-cotransporter-2-inhibitors-and2026-10-06 https://evidence-hub.com/study/65369-meta-analysis-of-sotagliflozin-a-dual-sodium-glucose-cotransporter-12026-10-06 https://evidence-hub.com/study/65370-effect-of-different-hypoglycemic-drugs-and-insulin-on-the-risk-of-new2026-10-06 https://evidence-hub.com/study/65371-sodium-glucose-cotransporter-2-inhibitors-sglt2-in-frail-or-older2026-10-06 https://evidence-hub.com/study/65372-genetic-variations-in-anti-diabetic-drug-targets-and-copd-risk2026-10-06 https://evidence-hub.com/study/65373-comparative-effect-of-glucose-lowering-drugs-for-type-2-diabetes2026-10-06 https://evidence-hub.com/study/65374-impact-of-sglt2-inhibitors-on-atrial-fibrillation-recurrence-after2026-10-06 https://evidence-hub.com/study/65375-effects-of-sglt2-inhibitors-on-hepatic-fibrosis-and-steatosis-a2026-10-06 https://evidence-hub.com/study/65376-the-effects-of-sodium-glucose-cotransporter-2-inhibitors-on-adipose2026-10-06 https://evidence-hub.com/study/65377-effects-of-sglt2-inhibitors-on-cardiac-function-and-health-status-in2026-10-06 https://evidence-hub.com/study/65378-effects-of-sodium-glucose-cotransporter-2-inhibitors-on-bone2026-10-06 https://evidence-hub.com/study/65379-glucagon-like-peptide-1-glp-1-receptor-agonists-for-people-with2026-10-06 https://evidence-hub.com/study/65380-effect-of-dpp-4i-inhibitors-on-renal-function-in-patients-with-type-22026-10-06 https://evidence-hub.com/study/65381-effect-of-sglt-2-inhibitors-on-body-composition-in-patients-with-type2026-10-06 https://evidence-hub.com/study/65382-comparative-effects-of-glucagon-like-peptide-1-receptor-agonists-and2026-10-06 https://evidence-hub.com/study/65383-comparative-effectiveness-of-multiple-different-treatment-regimens2026-10-06 https://evidence-hub.com/study/65384-a-critical-view-over-the-newest-antidiabetic-molecules-in-light-of2026-10-06 https://evidence-hub.com/study/65385-metformin-versus-sodium-glucose-co-transporters-inhibitors-as-first2026-10-04 https://evidence-hub.com/study/65386-2185-pub-once-weekly-semaglutide-1mg-vs-empagliflozin-25mg-as-add-on2026-10-04 https://evidence-hub.com/study/65387-1233-p-systematic-literature-review-slr-and-network-meta-analysis-nma2026-10-04 https://evidence-hub.com/study/65388-type-2-diabetes-mellitus-t2dm-patients-with-inadequate-a1c-control-on2026-10-06 https://evidence-hub.com/study/65389-sglt2i-dual-therapy-with-metformin-met-for-type-2-diabetes-mellitus2026-10-04 https://evidence-hub.com/study/65390-148-lb-efficacy-and-safety-of-adding-an-oral-hypoglycemic-agent-or-a2026-10-06 https://evidence-hub.com/study/65392-sglt2-inhibitors-risks-and-benefits2026-10-06 https://evidence-hub.com/study/65394-cost-of-glycemic-target-achievement-with-sodium-glucose-co2026-10-06 https://evidence-hub.com/study/65395-pharmacological-treatment-options-for-metabolic-dysfunction2026-10-06 https://evidence-hub.com/study/65396-sodium-glucose-co-transporter-2-inhibitor-associated-euglycaemic2026-10-06 https://evidence-hub.com/study/65397-glucagon-like-peptide-1-receptor-agonists-and-sodium-glucose-co2026-10-06 https://evidence-hub.com/study/65398-association-between-glucagon-like-peptide-1-receptor-agonists-and2026-10-06 https://evidence-hub.com/study/65399-sodium-glucose-cotransporter-2-inhibitors-in-liver-cirrhosis-a2026-10-06 https://evidence-hub.com/study/65400-potential-use-of-sodium-glucose-co-transporter-2-inhibitors-during2026-10-06 https://evidence-hub.com/study/65401-clinical-efficacy-of-probiotics-in-the-treatment-of-diabetes-kidney2026-10-06 https://evidence-hub.com/study/65402-risk-of-diabetic-ketoacidosis-of-sglt2-inhibitors-in-patients-with2026-10-06 https://evidence-hub.com/study/65403-long-term-effects-of-adding-an-sglt-2-inhibitor-to-insulin-therapy-in2026-10-06 https://evidence-hub.com/study/65404-interactions-between-gut-microbiota-and-oral-antihyperglycemic-drugs2026-10-06 https://evidence-hub.com/study/65405-impact-of-diabetes-mellitus-type-two-on-incidence-and-progression-of2026-10-06 https://evidence-hub.com/study/65406-effects-of-glp-1-agonists-and-sglt2-inhibitors-during-pregnancy-and2026-10-04 https://evidence-hub.com/study/65407-glp-1-receptor-agonists-in-eye-disease-a-comprehensive-review-of2026-10-06 https://evidence-hub.com/study/65408-cost-effectiveness-of-newer-antidiabetic-drugs-as-second-line2026-10-06 https://evidence-hub.com/study/65409-comparison-of-safety-profile-of-dpp4-inhibitors-with-sglt2-inhibitors2026-10-04 https://evidence-hub.com/study/65410-sglt2-inhibitors-as-add-on-therapy-to-metformin-for-people-with-type2026-10-06 https://evidence-hub.com/study/65412-supar-identifies-treatment-resistant-inflammatory-risk-beyond-hs-crp2026-10-06 https://evidence-hub.com/study/65413-pharmacokinetics-and-safety-of-fixed-dose-versus-separate2026-10-06 https://evidence-hub.com/study/65414-dapagliflozin-reduces-ambulatory-arterial-stiffness-index-in-ckd2026-10-06 https://evidence-hub.com/study/65415-efficacy-and-safety-of-enavogliflozin-as-add-on-in-adults-with-type-22026-10-06 https://evidence-hub.com/study/65416-impact-of-gpt-4-generated-discharge-letters-on-patients-medical2026-10-06 https://evidence-hub.com/study/65417-randomized-study-of-the-effects-of-empagliflozin-and-topiramate-dual2026-10-06 https://evidence-hub.com/study/65418-effects-of-semaglutide-treatment-on-psoriatic-lesions-in-obese2026-10-06 https://evidence-hub.com/study/65419-contemporary-oral-medication-use-and-frequency-in-patients-with2026-10-06 https://evidence-hub.com/study/65420-dapagliflozin-restores-odour-induced-functional-integration-of2026-10-06 https://evidence-hub.com/study/65421-comparative-efficacy-and-safety-of-sitagliptin-or-gliclazide-combined2026-10-06 https://evidence-hub.com/study/65422-once-weekly-semaglutide-versus-placebo-for-the-treatment-of-type-22026-10-06 https://evidence-hub.com/study/65423-fixed-dose-combination-of-dapagliflozin-glimepiride-and-extended2026-10-06 https://evidence-hub.com/study/65424-curcumin-supplementation-reduces-inflammation-neutrophil-to2026-10-06 https://evidence-hub.com/study/65425-effects-of-the-sglt2-inhibitor-dapagliflozin-in-early-alzheimer-s2026-10-12 https://evidence-hub.com/study/65426-semaglutide-promotes-bone-marrow-derived-progenitor-cell-flux-towards2026-10-06 https://evidence-hub.com/study/65427-efficacy-of-dapagliflozin-sitagliptin-metformin-versus-sitagliptin2026-10-06 https://evidence-hub.com/study/65428-a-multicenter-randomized-open-label-study-to-compare-the-effects-of2026-10-06 https://evidence-hub.com/study/65429-effects-of-sodium-glucose-cotransporter-2-inhibitor-on-atrial-high2026-10-06 https://evidence-hub.com/study/65430-efficacy-and-safety-of-dapagliflozin-in-patients-hospitalized-with2026-10-06 https://evidence-hub.com/study/65431-impact-of-diabetes-duration-on-left-ventricular-mass-regression-with2026-10-06 https://evidence-hub.com/study/65432-pharmacokinetic-and-pharmacodynamic-drug-drug-interactions-between2026-10-06 https://evidence-hub.com/study/65433-cardiovascular-benefits-of-empagliflozin-are-associated-with-gut2026-10-06 https://evidence-hub.com/study/65434-curcumin-supplementation-improves-the-clinical-outcomes-of-patients2026-10-06 https://evidence-hub.com/study/65436-ameliorating-metabolic-profiles-after-kidney-transplantation-a2026-10-06 https://evidence-hub.com/study/65437-is-basal-nitric-oxide-activity-of-the-renal-vasculature-altered2026-10-06 https://evidence-hub.com/study/65438-angiotensin-profiles-in-patients-with-hypertension-and-type-22026-10-04 https://evidence-hub.com/study/65439-12-month-effects-of-incretins-versus-sglt2-inhibitors-on-cognitive2026-10-10 https://evidence-hub.com/study/65440-400-p-more-pronounced-effect-of-empagliflozin-losartan-combination2026-10-06 https://evidence-hub.com/study/65442-a-long-term-cost-effectiveness-analysis-of-treatments-for-type-22026-10-06 https://evidence-hub.com/study/65443-empagliflozin-may-attenuate-adipose-tissue-inflammation-and-arterial2026-10-06 https://evidence-hub.com/study/65445-starting-triple-oral-hypoglycemic-agent-therapy-in-poorly-controlled2026-10-06 https://evidence-hub.com/study/65446-combination-therapy-in-type-2-diabetes-mellitus-adding-empagliflozin2026-10-06 https://evidence-hub.com/study/65447-sodium-glucose-cotransporter-2-sglt-2-attenuates-serum-uric-acid-sua2026-10-06 https://evidence-hub.com/study/65448-metformin-and-physical-performance-in-older-people-with-probable2026-10-06 https://evidence-hub.com/study/65449-safety-overview-and-management-of-inavolisib-alone-and-in-combination2026-10-06 https://evidence-hub.com/study/65450-effect-of-heat-therapy-compared-with-strength-training-on-metabolic2026-10-06 https://evidence-hub.com/study/65451-progressive-weight-loss-induced-remission-of-insulin-resistance2026-10-06 https://evidence-hub.com/study/65452-dapagliflozin-as-an-oral-antihyperglycemic-agent-in-the-management-of2026-10-06 https://evidence-hub.com/study/65453-efficacy-and-safety-of-bexagliflozin-compared-with-dapagliflozin-as2026-10-06 https://evidence-hub.com/study/65454-rationale-and-study-design-of-a-randomized-controlled-trial-to2026-10-06 https://evidence-hub.com/study/65455-effect-of-sy009-a-novel-sglt1-inhibitor-on-the-plasma-metabolome-and2026-10-06 https://evidence-hub.com/study/65456-efficacy-and-safety-of-luseogliflozin-in-caucasian-patients-with-type2026-10-06 https://evidence-hub.com/study/65457-efficacy-and-safety-of-nefecon-in-patients-with-iga-nephropathy-from2026-10-06 https://evidence-hub.com/study/65458-rationale-and-design-of-the-randomised-controlled-cross-over-trial2026-10-06 https://evidence-hub.com/study/65459-effectiveness-of-a-digitally-delivered-continuous-care-intervention2026-10-06 https://evidence-hub.com/study/65460-an-analysis-of-dpv-and-dive-registry-patients-with-chronic-kidney2026-10-06 https://evidence-hub.com/study/65461-effects-and-mechanisms-of-dapagliflozin-treatment-on-ambulatory-blood2026-10-06 https://evidence-hub.com/study/65462-safety-and-efficacy-of-the-sglt2-inhibitor-dapagliflozin-in-patients2026-10-06 https://evidence-hub.com/study/65463-phase-i-ib-trial-of-inavolisib-plus-palbociclib-and-endocrine-therapy2026-10-06 https://evidence-hub.com/study/65464-efficacy-of-the-treatment-with-dapagliflozin-and-metformin-compared2026-10-06 https://evidence-hub.com/study/65465-feasibility-of-simplification-from-a-basal-bolus-insulin-regimen-to-a2026-10-06 https://evidence-hub.com/study/65466-efficacy-and-safety-of-dapagliflozin-in-children-and-young-adults2026-10-06 https://evidence-hub.com/study/65467-protocol-of-beyond-trial-clinical-benefit-of-sodium-glucose2026-10-06 https://evidence-hub.com/study/65468-effect-of-dapagliflozin-on-urine-metabolome-in-patients-with-type-22026-10-06 https://evidence-hub.com/study/65469-exogenous-ketosis-in-patients-with-type-2-diabetes-safety2026-10-06 https://evidence-hub.com/study/65470-efficacy-and-safety-of-remogliflozin-etabonate-a-new-sodium-glucose2026-10-06 https://evidence-hub.com/study/65471-efficacy-and-safety-of-metabolic-interventions-for-the-treatment-of2026-10-06 https://evidence-hub.com/study/65472-efficacy-and-safety-of-ertugliflozin-in-patients-with-overweight-and2026-10-06 https://evidence-hub.com/study/65473-licogliflozin-for-nonalcoholic-steatohepatitis-a-randomized-double2026-10-06 https://evidence-hub.com/study/65474-large-scale-evidence-generation-and-evaluation-across-a-network-of2026-10-06 https://evidence-hub.com/study/65475-hemoglobin-a1c-threshold-for-reduction-in-bone-turnover-in-men-with2026-10-06 https://evidence-hub.com/study/65476-effects-of-canagliflozin-on-body-composition-and-hepatic-fat-content2026-10-06 https://evidence-hub.com/study/65477-long-term-treatment-with-empagliflozin-as-add-on-to-oral-antidiabetes2026-10-06 https://evidence-hub.com/study/65478-effects-of-dapagliflozin-on-cardiac-substrate-uptake-myocardial2026-10-06 https://evidence-hub.com/study/65479-pharmacokinetics-of-empagliflozin-a-sodium-glucose-cotransporter-22026-10-06 https://evidence-hub.com/study/65480-a-comparison-of-renal-effects-between-empagliflozin-and-linagliptin2026-10-06 https://evidence-hub.com/study/65481-efficacy-and-safety-of-once-weekly-semaglutide-versus-tirzepatide-in2026-10-06 https://evidence-hub.com/study/65482-1292-p-projected-long-term-clinical-benefit-and-cost-effectiveness-of2026-10-06 https://evidence-hub.com/study/65483-diabetes-medications-with-cardiovascular-protection-what-now-after2026-10-06 https://evidence-hub.com/study/65484-effect-of-empagliflozin-on-liver-enzymes-of-patients-in-non-alcoholic2026-10-06 https://evidence-hub.com/study/65485-evaluating-the-cost-effectiveness-of-once-weekly-semaglutide-1-mg2026-10-06 https://evidence-hub.com/study/65486-evaluating-impact-of-empagliflozin-on-lipid-profile-of-patients-of2026-10-06 https://evidence-hub.com/study/65487-machine-learning-to-identify-predictors-of-glycemic-control-in-type-22026-10-06 https://evidence-hub.com/study/65488-options-for-empagliflozin-in-combination-therapy-in-type-2-diabetes2026-10-06 https://evidence-hub.com/study/65491-treatment-satisfaction-in-type-2-diabetes-patients-taking2026-10-06 https://evidence-hub.com/study/65492-comparison-of-metformin-and-myoinositol-on-clinical-hormonal-and2026-10-06 https://evidence-hub.com/study/65493-expression-of-concern-comparison-of-myo-inositol-and-metformin-on2026-10-06 https://evidence-hub.com/study/65494-effectiveness-of-carbohydrate-counting-and-dietary-approach-to-stop2026-10-06 https://evidence-hub.com/study/65495-phase-ii-propensity-matched-controlled-trial-evaluating-metformin-as2026-10-06 https://evidence-hub.com/study/65497-comparative-evaluation-of-subgingivally-delivered-1-metformin-and2026-10-06 https://evidence-hub.com/study/65498-effects-of-combination-treatment-on-renal-endothelial-function-in2026-10-06 https://evidence-hub.com/study/65499-pharmacokinetic-landscape-and-interaction-potential-of-sglt22026-10-06 https://evidence-hub.com/study/65500-current-treatment-for-diabetes-a-holistic-approach2026-10-06 https://evidence-hub.com/study/65501-use-of-glucagon-like-peptide-1-receptor-agonists-and-the-associated2026-10-06 https://evidence-hub.com/study/65502-cardiovascular-disease-and-diabetes-a-new-challenge-in-the-treatment2026-10-06 https://evidence-hub.com/study/65503-combining-sglt2is-glp1-ras-and-nsmras-in-diabetes-a-scoping-review-of2026-10-06 https://evidence-hub.com/study/65504-effects-of-antidiabetic-drugs-on-the-level-of-serum-uric-acid-in2026-10-06 https://evidence-hub.com/study/65505-optimal-medical-therapy-targeting-metabolic-status-for-secondary2026-10-06 https://evidence-hub.com/study/65506-metabolic-associated-steatotic-liver-disease-from-molecular2026-10-06 https://evidence-hub.com/study/65507-bexagliflozin-on-renal-outcomes-in-type-2-diabetes-mellitus-a2026-10-06 https://evidence-hub.com/study/65508-beyond-the-cardio-renal-metabolic-axis-emerging-therapeutic-targets2026-10-06 https://evidence-hub.com/study/65509-glucagon-like-peptide-1-receptor-agonists-for-major-neurocognitive2026-10-06 https://evidence-hub.com/study/65510-effects-of-canagliflozin-on-kidney-resistive-index-and-oxygenation-in2026-10-06 https://evidence-hub.com/study/65511-safety-considerations-of-semaglutide-in-the-potential-treatment-of2026-10-06 https://evidence-hub.com/study/65512-effect-of-sodium-glucose-cotransporter-2-inhibitors-on-uric-acid-in2026-10-06 https://evidence-hub.com/study/65513-evaluating-cardio-protective-molecules-by-efficacy-based-on-weight2026-10-06 https://evidence-hub.com/study/65514-myoprotective-fat-loss-phenotypes-in-obesity-associated-type-22026-10-06 https://evidence-hub.com/study/65515-11-chronic-kidney-disease-and-risk-management-standards-of-care-in2026-10-06 https://evidence-hub.com/study/65516-finerenone-as-an-add-on-treatment-to-conventional-therapies-for-the2026-10-06 https://evidence-hub.com/study/65517-effects-of-sodium-glucose-co-transporter-2-inhibitors-on-body2026-10-06 https://evidence-hub.com/study/65518-the-landscape-of-novel-antidiabetic-drugs-in-diabetic-hfpef-relevant2026-10-06 https://evidence-hub.com/study/65519-pillar-risk-based-treatment-for-chronic-kidney-disease-in-people-with2026-10-06 https://evidence-hub.com/study/65520-efficacy-and-safety-of-fixed-dose-dapagliflozin-pioglitazone-in2026-10-06 https://evidence-hub.com/study/65521-semaglutide-in-diabetic-kidney-disease-integrating-clinical-evidence2026-10-06 https://evidence-hub.com/study/65522-a-multicentre-prospective-non-interventional-single-arm-study2026-10-06 https://evidence-hub.com/study/65523-comparative-efficacy-of-sodium-glucose-transporter-2-inhibitors-on2026-10-06 https://evidence-hub.com/study/65524-sglt2-inhibitors-and-their-effect-on-urolithiasis-current-evidence2026-10-06 https://evidence-hub.com/study/65526-comparative-analysis-of-sitagliptan-vs-empagliflozin-as-an-add-on2026-10-04 https://evidence-hub.com/study/65527-comparative-study-of-different-derivative-spectrophotometric2026-10-06 https://evidence-hub.com/study/65528-real-world-safety-and-effectiveness-of-empagliflozin-diampa-alone-or2026-10-06 https://evidence-hub.com/study/65529-to-compare-the-effects-of-empagliflozin-and-metformin-on-serum2026-10-04 https://evidence-hub.com/study/65531-long-term-cost-effectiveness-of-oral-semaglutide-versus-empagliflozin2026-10-06 https://evidence-hub.com/study/65532-1152-p-effect-of-initiating-empagliflozin-vs-glucagon-like-peptide-12026-10-06 https://evidence-hub.com/study/65533-abstract-232-initiating-empagliflozin-vs-glucagon-like-peptide-12026-10-06 https://evidence-hub.com/study/65534-impact-of-sglt2-inhibitors-on-preventing-heart-failure2026-10-06 https://evidence-hub.com/study/65535-5699-is-gfr-decline-induced-by-sglt-2-inhibitor-of-clinical-importance2026-10-06 https://evidence-hub.com/study/65537-validation-of-a-novel-uplc-ms-ms-method-for-estimation-of-metformin2026-10-06 https://evidence-hub.com/study/65538-cardioprotective-effects-of-dipeptidyl-peptidase-4-inhibitors-versus2026-10-06 https://evidence-hub.com/study/65539-glucagonoma-a-diagnostic-challenge2026-10-06 https://evidence-hub.com/study/65540-sun-176-euglycemic-diabetic-ketoacidosis-withsglt2-inhibitor2026-10-06 https://evidence-hub.com/study/65541-metformin-associated-lactic-acidosis-during-docetaxel-therapy-for2026-10-06 https://evidence-hub.com/study/65542-metformin-dolutegravir-interaction-leads-to-metformin-associated2026-10-06 https://evidence-hub.com/study/65543-unintentional-weight-loss-from-metformin-despite-good-glycaemic2026-10-06 https://evidence-hub.com/study/65544-immunomodulatory-effects-of-anti-diabetic-therapies-cytokine-and2026-10-06 https://evidence-hub.com/study/65545-initial-combination-of-metformin-sitagliptin-and-empagliflozin-in2026-10-04 https://evidence-hub.com/study/65546-prevalence-of-vitamin-b12-deficiency-among-patients-with-type-22026-10-06 https://evidence-hub.com/study/65547-perioperative-management-of-hyperglycemic-patients-undergoing-surgery2026-10-06 https://evidence-hub.com/study/65548-efficacy-and-safety-of-semaglutide-for-obesity-and-hyperphagia-in2026-10-06 https://evidence-hub.com/study/65549-urogenital-infection-risk-associated-with-sglt2-inhibitors-versus-dpp2026-10-06 https://evidence-hub.com/study/65550-diabetes-mellitus-in-short-syndrome-managed-with-multi-agent-oral2026-10-06 https://evidence-hub.com/study/65551-new-treatment-options-for-masld-patients-with-type-2-diabetes2026-10-06 https://evidence-hub.com/study/65552-case-report-metformin-induced-hemolytic-anemia-in-a-glucose-62026-10-06 https://evidence-hub.com/study/65553-candida-glabrata-prostatitis-a-rare-case-in-a-patient-with-type-22026-10-06 https://evidence-hub.com/study/65554-pharmacological-management-of-type-2-diabetes-mellitus-in-children2026-10-06 https://evidence-hub.com/study/65555-novel-use-of-glucagon-like-peptide-1-glp-1-and-dual-glucose-dependent2026-10-06 https://evidence-hub.com/study/65556-pregnancy-outcomes-following-first-trimester-exposure-to-semaglutide2026-10-06 https://evidence-hub.com/study/65557-glycemic-derangements-with-capivasertib-from-hyperglycemia-to2026-10-06 https://evidence-hub.com/study/65558-advancing-type-1-diabetes-management-integrating-novel-therapies2026-10-06 https://evidence-hub.com/study/65559-continuous-glucose-monitoring-guides-glucagon-like-peptide-1-based2026-10-06 https://evidence-hub.com/study/65560-clinical-outcomes-and-complications-of-basal-bolus-and-combination2026-10-06 https://evidence-hub.com/study/65561-therapies-in-autosomal-dominant-polycystic-kidney-disease-beyond2026-10-06 https://evidence-hub.com/study/65562-postoperative-outcomes-among-sodium-glucose-cotransporter-2-inhibitor2026-10-06 https://evidence-hub.com/study/65563-gestational-diabetes-from-pathogenesis-to-therapeutic-intervention2026-10-08 https://evidence-hub.com/study/65564-hidden-in-the-mediastinum-a-grade-1-neuroendocrine-tumor-revealed-by2026-10-06 https://evidence-hub.com/study/65565-robotic-hormonal-and-autonomic-modulation-for-type-2-diabetes-ileal2026-10-06 https://evidence-hub.com/study/65566-coincidence-of-autoimmune-diabetes-mellitus-and-familial-partial2026-10-06 https://evidence-hub.com/study/65567-feasibility-and-tolerability-of-controllable-pulse-parameter2026-10-08 https://evidence-hub.com/study/65568-macrophage-immunometabolism-in-epicardial-adipose-tissue-and-obesity2026-10-06 https://evidence-hub.com/study/65569-non-insulin-diabetes-medicines-a-narrative-review-for-anaesthetists2026-10-06 https://evidence-hub.com/study/65570-repurposed-systemic-pharmacologic-agents-in-chronic-pain-emerging2026-10-06 https://evidence-hub.com/study/65571-sglt2-inhibitors-in-diabetic-and-non-diabetic-kidney-transplant2026-10-06 https://evidence-hub.com/study/65572-cutaneous-adverse-drug-reactions-associated-with-sglt2-inhibitors2026-10-06 https://evidence-hub.com/study/65573-case-report-severe-hypertriglyceridaemia-and-multivessel-coronary2026-10-06 https://evidence-hub.com/study/65574-our-experiences-and-learnings-in-diagnosing-mody-from-non2026-10-06 https://evidence-hub.com/study/65575-glp-1ra-and-the-risk-of-non-arteritic-anterior-ischaemic-optic2026-10-06 https://evidence-hub.com/study/65576-severe-occupational-hypersensitivity-pneumonitis-a-case-series-of2026-10-06 https://evidence-hub.com/study/65577-9-pharmacologic-approaches-to-glycemic-treatment-standards-of-care-in2026-10-06 https://evidence-hub.com/study/65578-ibero-american-position-statement-on-therapeutic-recommendations-for2026-10-06 https://evidence-hub.com/study/65579-case-report-misdiagnosis-of-maturity-onset-diabetes-of-the-young-as2026-10-06 https://evidence-hub.com/study/65580-real-world-evidence-on-the-association-of-novel-antidiabetic2026-10-06 https://evidence-hub.com/study/65581-managing-post-bariatric-hypoglycemia-a-systematic-review-of2026-10-19 https://evidence-hub.com/study/65582-the-evolving-understanding-of-cystic-fibrosis-related-diabetes-in-the2026-10-06 https://evidence-hub.com/study/65583-recurrent-sigmoid-volvulus-after-robotic-assisted-laparoscopic2026-10-06 https://evidence-hub.com/study/65584-bariatric-surgery-in-patients-with-prader-willi-syndrome2026-10-06 https://evidence-hub.com/study/65585-sglt2-inhibitors-as-a-strategy-for-volume-management-in-peritoneal2026-10-06 https://evidence-hub.com/study/65587-effect-of-changbudodam-tang-with-acupuncture-in-treatment-of-poly2026-10-06 https://evidence-hub.com/study/65588-approach-to-poisoned-patients-with-high-anion-gap-metabolic-acidosis2026-10-06 https://evidence-hub.com/study/65589-sono-case-series-a-65-year-old-man-with-right-eye-vision-loss2026-10-06 https://evidence-hub.com/study/65590-fri657-case-series-on-glp-1-receptor-agonist-related-acute2026-10-06 https://evidence-hub.com/study/65591-adjusting-background-insulin-therapy-in-type-2-diabetes-when2026-10-06 https://evidence-hub.com/study/65592-type-2-diabetes-mellitus-or-maturity-onset-diabetes-in-the-young-due2026-10-06 https://evidence-hub.com/study/65593-two-cases-of-diabetes-remission-through-temporary-tirzepatide2026-10-06 https://evidence-hub.com/study/65594-mitochondrial-myopathy-lactic-acidosis-and-stroke-like-episodes2026-10-06 https://evidence-hub.com/study/65595-an-unusual-combination-of-latent-autoimmune-diabetes-in-young-and2026-10-06 https://evidence-hub.com/study/65596-unmasking-latent-autoimmune-diabetes-a-case-that-challenges-type-22026-10-06 https://evidence-hub.com/study/65597-tirzepatide-reduced-alcohol-use-in-three-patients-with-alcohol2026-10-06 https://evidence-hub.com/study/65598-metformin-associated-lactic-acidosis-induced-by-even-modest-amounts2026-10-06 https://evidence-hub.com/study/65599-pathophysiological-mechanisms-and-benefits-of-sglt-2-inhibitors-in-a2026-10-06 https://evidence-hub.com/study/65600-unusual-painless-upper-limb-ischemia-in-a-patient-with-diabetes-a2026-10-06 https://evidence-hub.com/study/65601-community-acquired-hypervirulent-klebsiella-pneumoniae-meningitis-in2026-10-06 https://evidence-hub.com/study/65602-breaking-the-cycle-of-polypharmacy-a-case-report-of-renal-denervation2026-10-06 https://evidence-hub.com/study/65603-postinfluenza-organizing-pneumonia-in-an-older-adult-successfully2026-10-06 https://evidence-hub.com/study/65604-dabigatran-induced-acute-hepatitis-in-a-patient-with-atrial2026-10-06 https://evidence-hub.com/study/65605-candida-parapsilosis-fungemia-in-a-patient-with-spinal-cord-injury-on2026-10-06 https://evidence-hub.com/study/65606-sglt2-inhibitor-associated-euglycemic-ketoacidosis-after-percutaneous2026-10-06 https://evidence-hub.com/study/65607-relapse-of-euglycemic-diabetic-ketoacidosis-with-prolonged-glucosuria2026-10-06 https://evidence-hub.com/study/65608-giant-left-ventricular-intracavitary-mass-diagnostic-challenges-in2026-10-06 https://evidence-hub.com/study/65609-unveiling-an-uncommon-complication-pleural-effusion-secondary-to2026-10-06 https://evidence-hub.com/study/65610-recurrent-euglycemic-diabetic-ketoacidosis-precipitated-by-diabetic2026-10-06 https://evidence-hub.com/study/65611-when-falls-reveal-acidosis-unmasking-sodium-glucose-co-transporter-22026-10-06 https://evidence-hub.com/study/65612-erythrodermic-crusted-scabies-a-diagnostic-pitfall-and-mini-review-a2026-10-06 https://evidence-hub.com/study/65613-cystic-fibrosis-and-hemochromatosis-carriers-may-be-prone-to-glucagon2026-10-06 https://evidence-hub.com/study/65614-severe-euglycemic-ketoacidosis-following-combined-therapy-with-glp-12026-10-06 https://evidence-hub.com/study/65615-a-rare-case-of-euglycemic-diabetic-ketoacidosis-triad-of-influenza-a2026-10-06 https://evidence-hub.com/study/65616-autonomic-seizures-and-hyperhidrosis-due-to-glioblastoma-in-a-middle2026-10-06 https://evidence-hub.com/study/65617-sglt2-inhibitor-in-a-type-2-diabetes-mellitus-patient-coexisted-with2026-10-06 https://evidence-hub.com/study/65618-recurrent-endometrial-carcinoma-with-immune-mediated-thrombocytopenia2026-10-06 https://evidence-hub.com/study/65619-bilateral-acquired-chorea-a-unique-presentation-of-diabetic2026-10-06 https://evidence-hub.com/study/65620-case-report-generalized-lipodystrophy-following-immune-checkpoint2026-10-06 https://evidence-hub.com/study/65621-critical-care-management-of-diabetic-ketoacidosis-caused-by-sodium2026-10-06 https://evidence-hub.com/study/65626-fixed-drug-eruption-secondary-to-four-anti-diabetic-medications-an2026-10-06 https://evidence-hub.com/study/65627-mon-546-euglycemic-diabetic-ketoacidosis-with-recent-initiation-of-a2026-10-06 https://evidence-hub.com/study/65629-necrotizing-pancreatitis-secondary-to-dulaglutide-use2026-10-06 https://evidence-hub.com/study/65630-successful-management-of-patient-presenting-with-metformin-and2026-10-06 https://evidence-hub.com/study/65631-metformin-toxicity-in-chronic-kidney-disease-a-case-report-of-severe2026-10-06 https://evidence-hub.com/study/65632-p-29-metformin-poisoning-without-lactic-acidosis-case-report2026-10-06 https://evidence-hub.com/study/65633-nine-year-recurrence-free-survival-in-gastric-signet-ring-cell2026-10-06 https://evidence-hub.com/study/65634-atypical-presentation-of-metformin-induced-lactic-acidosis-in-a2026-10-06 https://evidence-hub.com/study/65635-severe-metformin-associated-lactic-acidosis-a-case-report2026-10-06 https://evidence-hub.com/study/65636-a-case-report-of-phenotypic-discrepancy-in-sex-determination-and2026-10-06 https://evidence-hub.com/study/65637-comparison-of-decaffeinated-green-tea-and-green-coffee-with-metformin2026-10-04 https://evidence-hub.com/study/65638-the-role-of-green-tea-and-green-coffee-extract-empagliflozin-and2026-10-04 https://evidence-hub.com/study/65639-from-diabetes-to-tumor-growth-unravelling-the-impact-of-glucose2026-10-06 https://evidence-hub.com/study/65640-breaking-barriers-in-pulmonary-health-of-patients-with-metabolic2026-10-06 https://evidence-hub.com/study/65641-the-heart-gut-axis-in-heart-failure-the-role-of-next-generation2026-10-06 https://evidence-hub.com/study/65642-mitohormesis-linking-metabolic-dysfunction-and-neurodegeneration2026-10-06 https://evidence-hub.com/study/65643-obesity-in-adults-with-type-1-diabetes-mellitus2026-10-06 https://evidence-hub.com/study/65644-repurposing-antidiabetic-medications-for-parkinson-s-disease-focus-on2026-10-06 https://evidence-hub.com/study/65645-from-glucose-transport-to-microbial-modulation-the-impact-of-sodium2026-10-06 https://evidence-hub.com/study/65646-molecular-mechanisms-and-clinical-evidence-supporting-the-four2026-10-06 https://evidence-hub.com/study/65647-diabetes-and-cancer-therapeutic-implications2026-10-06 https://evidence-hub.com/study/65648-established-and-emerging-non-cellular-therapies-in-inherited-bone2026-10-06 https://evidence-hub.com/study/65649-metabolic-concepts-of-sodium-glucose-cotransporter-2-inhibitors-based2026-10-06 https://evidence-hub.com/study/65650-pharmacological-modulation-of-the-diabetic-gut-microbiome-with2026-10-06 https://evidence-hub.com/study/65651-cardiovascular-diseases-and-heart-failure-in-diabetes-diagnostics-and2026-10-06 https://evidence-hub.com/study/65652-metabolic-dysfunction-and-the-use-of-adjunct-medications-in-type-12026-10-06 https://evidence-hub.com/study/65653-role-and-mechanisms-of-vascular-smooth-muscle-cell-phenotypic2026-10-06 https://evidence-hub.com/study/65654-preconditioning-strategies-for-stem-cells-and-exosomes-transformative2026-10-06 https://evidence-hub.com/study/65655-type-1-diabetes-in-the-era-of-obesity-pathophysiology-and-therapeutic2026-10-06 https://evidence-hub.com/study/65656-antidiabetic-agents-and-male-fertility-unraveling-the-impact-of2026-10-06 https://evidence-hub.com/study/65657-cardiometabolic-therapies-shape-non-coding-rna-landscapes-in2026-10-04 https://evidence-hub.com/study/65658-heart-matters-how-glucose-and-lipid-modulating-drugs-remodel2026-10-06 https://evidence-hub.com/study/65659-prediabetes-in-children-and-adolescents-what-do-we-need-to-know2026-10-06 https://evidence-hub.com/study/65660-preventing-type-2-diabetes-in-at-risk-cardiorenal-populations2026-10-06 https://evidence-hub.com/study/65661-antidiabetic-agents-as-antioxidant-and-anti-inflammatory-therapies-in2026-10-06 https://evidence-hub.com/study/65662-the-gut-microbiome-cardiometabolic-axis-insights-into-obesity-type-22026-10-06 https://evidence-hub.com/study/65663-comparative-analysis-of-clinical-outcomes-in-patients-with-type-22026-10-06 https://evidence-hub.com/study/65664-ceramides-as-biomarkers-and-pharmacological-targets-in-heart-failure2026-10-06 https://evidence-hub.com/study/65665-non-coding-rna-in-type-2-diabetes-cardio-renal-complications-and2026-10-06 https://evidence-hub.com/study/65666-oxidative-stress-in-diabetic-cardiomyopathy-molecular-mechanisms2026-10-06 https://evidence-hub.com/study/65667-metabolic-reprogramming-in-diabetic-panvascular-disease-molecular2026-10-06 https://evidence-hub.com/study/65668-patient-adherence-for-oral-combination-therapies-in-diabetes2026-10-06 https://evidence-hub.com/study/65669-toxicological-profile-of-anti-diabetic-drugs-and-emerging-measures-to2026-10-06 https://evidence-hub.com/study/65671-network-meta-analysis-of-responses-to-dpp-4-and-sglt2-inhibitors-what2026-10-04 https://evidence-hub.com/study/65673-on-the-wake-of-metformin-do-anti-diabetic-sglt2-inhibitors-exert-anti2026-10-04 https://evidence-hub.com/study/65674-a-narrative-review-repurposing-metformin-as-a-potential-therapeutic2026-10-04 https://evidence-hub.com/study/65675-effect-of-empagliflozin-on-liver-function-in-type-2-diabetes-a2026-10-04 https://evidence-hub.com/study/65676-hypomagnesemia-with-metformin-use-in-diabetes-mellitus-a-case-and2026-10-04 https://evidence-hub.com/study/65677-role-of-metformin-and-other-metabolic-drugs-in-the-prevention-and2026-10-04 https://evidence-hub.com/study/65678-immunomodulatory-effects-of-sglt2-inhibitors-and-metformin-in2026-10-04 https://evidence-hub.com/study/65679-metformin-and-type-2-diabetes-in-the-era-of-cardiovascular-outcome2026-10-04 https://evidence-hub.com/study/65681-a-systematic-review-cost-effectiveness-of-sglt2-inhibitors-versus-dpp2026-10-04 https://evidence-hub.com/study/65682-efficacy-and-safety-of-sodium-glucose-cotransporter-2-inhibitors-as2026-10-04 https://evidence-hub.com/study/65683-efficacy-and-safety-of-sodium-glucose-cotransporter-2-inhibitors-in2026-10-04 https://evidence-hub.com/study/65684-cardioprotective-effects-of-antidiabetic-medications-in-type-22026-10-04 https://evidence-hub.com/study/65685-choice-of-glucose-lowering-drugs-as-initial-monotherapy-for-type-22026-10-04 https://evidence-hub.com/study/65686-efficacy-of-ertugliflozin-compared-with-metformin-or-placebo-in2026-10-04 https://evidence-hub.com/study/65687-effects-of-sitagliptin-as-monotherapy-and-add-on-to-metformin-on2026-10-04 https://evidence-hub.com/study/65688-comparison-of-efficacy-of-dipeptidyl-peptidase-4-inhibitor-versus2026-10-04 https://evidence-hub.com/study/65689-sodium-glucose-cotransporter-2-inhibitor-combination-therapy-to2026-10-04 https://evidence-hub.com/study/65690-comparative-efficacy-of-dual-and-single-initiation-of-add-on-oral2026-10-04 https://evidence-hub.com/study/65691-effect-of-antidiabetic-drugs-on-gut-endocrine-function-after2026-10-04 https://evidence-hub.com/study/65692-anorectic-drugs-an-experimental-and-clinical-perspective-a-review2026-10-04 https://evidence-hub.com/study/65693-histological-analysis-of-hypoglycemic-agents-on-liver-fibrosis-in2026-10-04 https://evidence-hub.com/study/65694-exploring-the-evidence-for-personalized-pharmacotherapy-in-type-22026-10-04 https://evidence-hub.com/study/65695-comparing-the-efficacy-and-safety-of-glucagon-like-peptide-1-receptor2026-10-04 https://evidence-hub.com/study/65696-sodium-glucose-co-transporter-2-inhibitors-for-the-treatment-of-type2026-10-04 https://evidence-hub.com/study/65697-sodium-glucose-cotransporter-2-inhibitors-for-the-treatment-of2026-10-04 https://evidence-hub.com/study/65698-expanding-therapeutic-horizons-glucagon-like-peptide-1-receptor2026-10-04 https://evidence-hub.com/study/65699-efficacy-and-safety-of-initial-combination-therapy-in-treatment-naive2026-10-04 https://evidence-hub.com/study/65700-combination-therapy-with-an-sglt2-inhibitor-as-initial-treatment-for2026-10-04 https://evidence-hub.com/study/65701-diabetes-mellitus-and-stroke-pathophysiological-connections-and2026-10-06 https://evidence-hub.com/study/65702-dapagliflozin-preserves-peripheral-nerve-structure-and-reduces2026-10-06 https://evidence-hub.com/study/65703-metabolic-dysfunction-associated-steatotic-liver-disease-a-silent2026-10-06 https://evidence-hub.com/study/65704-the-role-of-oxidative-stress-in-diabetes-mellitus-induced-vascular2026-10-06 https://evidence-hub.com/study/65705-potentials-of-natural-antioxidants-in-reducing-inflammation-and2026-10-06 https://evidence-hub.com/study/65706-a-structured-narrative-review-of-the-osa-t2dm-axis2026-10-06 https://evidence-hub.com/study/65707-a-review-on-herbal-interventions-and-nanotechnological-advancements2026-10-06 https://evidence-hub.com/study/65708-distinct-roles-of-common-genetic-variants-and-their-contributions-to2026-10-06 https://evidence-hub.com/study/65709-analysis-of-reports-sent-to-the-portuguese-pharmacovigilance-system2026-10-06 https://evidence-hub.com/study/65710-present-and-future-perspectives-in-the-treatment-of-liver-fibrosis2026-10-06 https://evidence-hub.com/study/65711-comparative-effectiveness-of-acupuncture-and-pharmacological2026-10-06 https://evidence-hub.com/study/65712-new-onset-diabetes-mellitus-in-post-renal-transplant-patients-on2026-10-06 https://evidence-hub.com/study/65713-cardiorenal-syndrome-molecular-pathways-linking-cardiovascular2026-10-06 https://evidence-hub.com/study/65714-is-time-restricted-eating-safe-in-the-treatment-of-type-2-diabetes-a2026-10-06 https://evidence-hub.com/study/65715-an-integrated-approach-for-representing-knowledge-on-the-potential-of2026-10-09 https://evidence-hub.com/study/65716-systemic-impacts-of-diabetes-on-spermatogenesis-and-intervention2026-10-06 https://evidence-hub.com/study/65717-developing-pharmacological-therapies-for-atrial-fibrillation2026-10-06 https://evidence-hub.com/study/65718-cost-effectiveness-of-empagliflozin-and-metformin-combination-versus2026-10-04 https://evidence-hub.com/study/65719-the-effect-of-empagliflozin-on-fractalkine-levels-in-patients-with2026-10-06 https://evidence-hub.com/study/65720-effect-of-a-12-month-treatment-with-liraglutide-empagliflozin-and2026-10-06 https://evidence-hub.com/study/65722-1148-p-antioxidative-effects-of-empagliflozin-and-metformin-in-type-12026-10-04 https://evidence-hub.com/study/65723-linagliptin-as-add-on-to-empagliflozin-and-metformin-in-patients-with2026-10-04 https://evidence-hub.com/study/65725-influence-of-adding-empagliflozin-to-conventional-anti-diabetic2026-10-06 https://evidence-hub.com/study/65726-mon-645-association-of-baseline-cardio-metabolic-parameters-on-the2026-10-04 https://evidence-hub.com/study/65728-observational-study-to-evaluate-effectiveness-of-adding-empagliflozin2026-10-04 https://evidence-hub.com/study/65729-sat-lb031-empagliflozin-as-an-add-on-medication-to-subjects2026-10-04 https://evidence-hub.com/study/65730-1223-p-empagliflozin-vs-dapagliflozin-in-patients-with-type-22026-10-06 https://evidence-hub.com/study/65733-long-term-effectiveness-of-quadruple-combination-therapy-with2026-10-06 https://evidence-hub.com/study/65734-empagliflozin-as-add-on-to-metformin-plus-sulfonylurea-in-patients2026-10-04 https://evidence-hub.com/study/65735-efficacy-and-safety-of-addition-of-empagliflozin-in-diabetic-patients2026-10-04 https://evidence-hub.com/study/65737-comparative-study-between-combination-therapy-empagliflozin2026-10-04 https://evidence-hub.com/study/65738-lipid-metabolism-features-in-patients-with-type-2-diabetes-on2026-10-04 https://evidence-hub.com/study/65740-combination-of-metformin-and-empagliflozin-can-changes-gut-microbiota2026-10-04 https://evidence-hub.com/study/65741-once-weekly-semaglutide-1-mg-vs-empagliflozin-25-mg-as-add-on-to2026-10-04 https://evidence-hub.com/study/65743-4-6-effects-of-combined-therapy-of-empagliflozin-and-linagliptin2026-10-04 https://evidence-hub.com/study/65744-abstract-p162-comparison-of-the-clinical-effect-of-empagliflozin-on2026-10-04 https://evidence-hub.com/study/65747-multiple-benefits-of-empagliflozin-in-pcos-evidence-from-a2026-10-06 https://evidence-hub.com/study/65748-mito-metformin-protects-against-mitochondrial-dysfunction-and2026-10-08 https://evidence-hub.com/study/65751-long-term-cost-effectiveness-analyses-of-empagliflozin-versus-oral2026-10-04 https://evidence-hub.com/study/65752-drug-testing-for-residual-progression-of-diabetic-kidney-disease-in2026-10-06 https://evidence-hub.com/study/65754-red-green-and-blue-model-assessment-and-aqbd-approach-to-hptlc-method2026-10-06 https://evidence-hub.com/study/65755-hepatic-restorative-potential-of-portulaca-oleracea-ethanolic-extract2026-10-06 https://evidence-hub.com/study/65757-evaluating-spironolactone-monotherapy-against-combined-treatment-with2026-10-06 https://evidence-hub.com/study/65759-the-impact-of-metformin-on-dust-induced-histopathological-changes-and2026-10-08 https://evidence-hub.com/study/65761-initiation-of-metformin-in-early-pregnancy-results-in-fetal2026-10-06 https://evidence-hub.com/study/65762-the-role-of-the-cholinergic-system-in-the-memory-protecting-effects2026-10-06 https://evidence-hub.com/study/65764-simultaneous-estimation-of-empagliflozin-and-metformin-by-high2026-10-06 https://evidence-hub.com/study/65765-enhanced-anticancer-effect-of-lysozyme-functionalized-metformin2026-10-06 https://evidence-hub.com/study/65766-fo051glycogen-synthase-kinases-3-inhibition-attenuates-progression-of2026-10-04 https://evidence-hub.com/study/65768-preventive-effect-of-empagliflozin-and-ezetimibe-on-hepatic-steatosis2026-10-04 https://evidence-hub.com/study/65769-use-of-animal-models-for-investigating-cardioprotective-roles-of2026-10-04 https://evidence-hub.com/study/65770-economic-spectrofluorometric-bioanalysis-of-empagliflozin-in-rats2026-10-04 https://evidence-hub.com/study/65771-empagliflozin-a-wonder-drug-for-the-treatment-of-siad2026-10-04 https://evidence-hub.com/study/65772-fp410an-optimized-animal-model-of-progressive-ckd-in-type-2-diabetes2026-10-04 https://evidence-hub.com/study/65773-the-sglt2-inhibitor-empagliflozin-for-the-treatment-of-type-22026-10-04 https://evidence-hub.com/study/65774-metabolic-effects-of-metformin-in-the-failing-heart2026-10-04 https://evidence-hub.com/study/65775-dulaglutide-alone-and-in-combination-with-empagliflozin-attenuate2026-10-04 https://evidence-hub.com/study/65776-translation-animal-models-of-diabetic-kidney-disease-biochemical-and2026-10-04 https://evidence-hub.com/study/65777-growth-differentiation-factor-15-and-the-effect-of-empagliflozin-in2026-10-04 https://evidence-hub.com/study/65778-the-impact-of-combined-decaffeinated-green-coffee-and-green-tea2026-10-04 https://evidence-hub.com/study/65779-genomic-proteomic-and-metabolic-comparisons-of-small-animal-models-of2026-10-04 https://evidence-hub.com/study/65780-metabolic-and-hepatic-effects-of-empagliflozin-on-nonalcoholic-fatty2026-10-04 https://evidence-hub.com/study/65781-insights-in-animal-models-for-translational-cardiovascular-research-a2026-10-04 https://evidence-hub.com/study/65782-effect-of-high-fat-diet-and-empagliflozin-on-cardiac-proteins-in-mice2026-10-04 https://evidence-hub.com/study/65783-empagliflozin-in-type-2-diabetes-mellitus-patients-with-high2026-10-04 https://evidence-hub.com/study/65784-animal-models-for-the-evaluation-of-the-cardiometabolic-therapeutic2026-10-04 https://evidence-hub.com/study/65785-a-review-of-animal-models-for-studying-bone-health-in-type-2-diabetes2026-10-04 https://evidence-hub.com/study/65786-the-dual-role-of-empagliflozin-cardio-renal-protection-in-t2dm2026-10-04 https://evidence-hub.com/study/65787-elucidating-carfilzomib-s-induced-cardiotoxicity-in-an-in-vivo-model2026-10-04 https://evidence-hub.com/study/65788-metformin-new-insights-into-an-archetypal-cardiometabolic-drug2026-10-04 https://evidence-hub.com/study/65789-empagliflozin-ameliorates-preeclampsia-and-reduces-postpartum2026-10-04 https://evidence-hub.com/study/65790-effects-of-metformin-on-knee-joint-capsule-fibrosis-in-a-diabetic2026-10-04 https://evidence-hub.com/study/65791-empagliflozin-reduces-brain-pathology-in-alzheimer-s-disease-and-type2026-10-04 https://evidence-hub.com/study/65792-gut-microbiota-directed-interventions-in-type-2-diabetes-a-systematic2026-10-06 https://evidence-hub.com/study/65793-the-effect-of-semaglutide-on-pancreatic-cell-function-in-adults-with2026-10-06 https://evidence-hub.com/study/65794-a-scoping-review-of-the-effect-of-intermittent-fasting-on-diabetes2026-10-06 https://evidence-hub.com/study/65795-animal-studies-of-sodium-glucose-co-transporter-2-inhibitors-in2026-10-06 https://evidence-hub.com/study/65796-glucagon-like-peptide-1-receptor-agonists-in-total-joint-arthroplasty2026-10-06 https://evidence-hub.com/study/65797-efficacy-and-safety-of-luseogliflozin-in-patients-with-type-22026-10-06 https://evidence-hub.com/study/65798-semaglutide-alleviates-osteoarthritis-independent-of-weight-loss-via2026-10-06 https://evidence-hub.com/study/65799-validation-of-an-algorithm-for-selection-of-sglt2-and-dpp4-inhibitor2026-10-06 https://evidence-hub.com/study/65800-cardio-renal-metabolic-syndrome-an-integrated-approach-to-prevention2026-10-06 https://evidence-hub.com/study/65801-efficacy-and-safety-of-antidiabetic-agents-for-major-depressive2026-10-06 https://evidence-hub.com/study/65802-association-between-sodium-glucose-co-transporter-2-inhibitors-and2026-10-06 https://evidence-hub.com/study/65803-risk-of-fracture-with-sodium-glucose-cotransporter-2-inhibitors-in2026-10-06 https://evidence-hub.com/study/65804-comparing-the-efficacy-and-long-term-outcomes-of-sodium-glucose2026-10-06 https://evidence-hub.com/study/65805-comparative-safety-of-sglt2-versus-dpp4-inhibitors-in-patients-with2026-10-06 https://evidence-hub.com/study/65806-comparative-efficacy-and-safety-of-antidiabetic-agents-for-post2026-10-06 https://evidence-hub.com/study/65807-methicillin-sensitive-staphylococcus-aureus-associated2026-10-06 https://evidence-hub.com/study/65808-frailty-stratified-effectiveness-of-sglt2-inhibitors-versus-dpp-42026-10-06 https://evidence-hub.com/study/65809-personalised-approach-to-the-management-of-older-people-with-type-22026-10-06 https://evidence-hub.com/study/65810-bridging-innovation-and-practice-in-type-2-diabetes-mellitus-novel2026-10-06 https://evidence-hub.com/study/65811-dual-gip-glp1-ra-gcgr-glp-1-ra-and-glp1-ra-for-the-treatment-of2026-10-06 https://evidence-hub.com/study/65812-addressing-meta-inflammation-in-the-comprehensive-management-of2026-10-06 https://evidence-hub.com/study/65813-pathogenesis-and-therapeutic-perspectives-of-tubular-injury-in2026-10-06 https://evidence-hub.com/study/65814-treatment-of-hyperglycemia-with-empagliflozin-with-or-without2026-10-04 https://evidence-hub.com/study/65815-design-and-optimization-of-pulsatile-and-extended-release-bilayer2026-10-06 https://evidence-hub.com/study/65816-hd-6277-a-novel-gpr40-agonist-improves-glucose-homeostasis-and2026-10-06 https://evidence-hub.com/study/65817-sustainable-hplc-technique-for-measurement-of-antidiabetic-drugs2026-10-06 https://evidence-hub.com/study/65818-18-association-of-tumor-pathological-complete-response-with-the-use2026-10-06 https://evidence-hub.com/study/65819-functional-characterization-of-mate2-k-genetic-variants-and-their2026-10-06 https://evidence-hub.com/study/65820-fabrication-of-a-redox-reversible-near-infrared-fluorogenic-probe-for2026-10-06 https://evidence-hub.com/study/65822-mo640-treatment-with-sodium-glucose-cotransporter-2-inhibitors2026-10-06 https://evidence-hub.com/study/65823-synthesis-of-tmpa-derivatives-through-sequential-ir-iii-catalyzed-c-h2026-10-06 https://evidence-hub.com/study/65824-p1008therapy-with-sodium-glucose-cotransporter-type-2-inhibitors2026-10-06 https://evidence-hub.com/study/65825-1011-p-therapeutic-potential-of-novel-combination-of-a-long-acting2026-10-06 https://evidence-hub.com/study/65827-p0967enhancing-podocyte-regeneration-with-bromoindirubin-3-oxime-bio2026-10-06 https://evidence-hub.com/study/65828-formulation-and-evaluation-of-bilayer-fixed-dose-combination-tablets2026-10-04 https://evidence-hub.com/study/65830-empagliflozin-a-new-strategy-for-nephroprotection-in-diabetes2026-10-04 https://evidence-hub.com/study/65831-exorbitant-drug-loading-of-metformin-and-sitagliptin-in-mucoadhesive2026-10-04 https://evidence-hub.com/study/65832-cardiovascular-effects-of-metformin2026-10-04 https://evidence-hub.com/study/65833-metformin-a-dual-role-player-in-cancer-treatment-and-prevention2026-10-04 https://evidence-hub.com/study/65834-effect-of-empagliflozin-on-candida-glabrata-adhesion-to-vaginal2026-10-04 https://evidence-hub.com/study/65835-empagliflozin-as-a-new-management-strategy-on-outcomes-in-patients2026-10-04 https://evidence-hub.com/study/65836-advantages-of-metformin-for-a-diversity-of-diseases2026-10-04 https://evidence-hub.com/study/65838-effects-of-metformin-in-heart-failure-from-pathophysiological2026-10-04 https://evidence-hub.com/study/65839-drug-delivery-system-for-controlled-release-of-empagliflozin-from2026-10-04 https://evidence-hub.com/study/65840-a-pharmaceutical-study-on-quality-surveillance-of-six-empagliflozin2026-10-04 https://evidence-hub.com/study/65841-the-future-of-metformin-in-the-prevention-of-diabetes-related2026-10-04 https://evidence-hub.com/study/65842-liver-transcriptomic-reveals-novel-pathways-of-empagliflozin2026-10-04 https://evidence-hub.com/study/65843-empagliflozin-restores-cardiac-metabolic-flexibility-in-diet-induced2026-10-04 https://evidence-hub.com/study/65844-metformin-attenuates-postinfarction-myocardial-fibrosis-and2026-10-04 https://evidence-hub.com/study/65845-empagliflozin-in-acute-myocardial-infarction-reduces-no-reflow-and2026-10-04 https://evidence-hub.com/study/65846-metformin-from-diabetes-to-cancer-to-prolongation-of-life2026-10-04 https://evidence-hub.com/study/65847-a-review-on-pharmacology-and-therapeutic-effects-of-empagliflozin-in2026-10-04 https://evidence-hub.com/study/65849-early-treatment-with-empagliflozin-and-gaba-improves-cell-mass-and2026-10-04 https://evidence-hub.com/study/65850-guideline-directed-medical-therapy-for-diabetic-kidney-disease2026-10-06 https://evidence-hub.com/study/65851-multi-omics-and-artificial-intelligence-for-precision-drug-discovery2026-10-06 https://evidence-hub.com/study/65852-comparative-admet-profiling-and-pharmacokinetic-assessment-of2026-10-04 https://evidence-hub.com/study/65853-potensi-kombinasi-senyawa-bioaktif-kumis-kucing-dan-daun-yakon2026-10-04 https://evidence-hub.com/study/65854-antiproliferative-effects-of-empagliflozin-on-human-pancreatic-cancer2026-10-04 https://evidence-hub.com/study/65855-analytical-method-development-and-validation-of-empagliflozin-via-rp2026-10-04 https://evidence-hub.com/study/65856-investigating-and-comparing-the-lethal-effect-of-nanoempagliflozin2026-10-04 https://evidence-hub.com/study/65857-use-of-a-sodium-glucose-cotransporter-2-inhibitor-empagliflozin-in-a2026-10-04 https://evidence-hub.com/study/65858-pharmacokinetic-evaluation-of-antidiabetic-fdcs-an-in-silico-approach2026-10-04 https://evidence-hub.com/study/65859-stability-indicating-hplc-method-development-and-validation-for2026-10-04 https://evidence-hub.com/study/65860-in-silico-screening-of-some-old-drugs-for-new-approaches-in-heart2026-10-08 https://evidence-hub.com/study/65861-facile-hplc-uv-method-for-determination-of-metformin-and-12026-10-04 https://evidence-hub.com/study/65862-valuation-of-environmental-influence-of-recently-invented-high2026-10-04 https://evidence-hub.com/study/65863-combination-therapy-including-metformin-hydrochloride-for-the2026-10-04 https://evidence-hub.com/study/65864-neurobehavioural-biochemical-and-histological-effects-of-metformin-in2026-10-04 https://evidence-hub.com/study/65865-stability-indicating-hplc-method-development-and-validation-for-the2026-10-04 https://evidence-hub.com/study/65866-metabolic-effects-of-mangosteen-supplementation-as-an-adjuvant-to2026-10-04 https://evidence-hub.com/study/65867-pendekatan-in-silico-dalam-penemuan-senyawa-bioaktif-tanaman-sebagai2026-10-04 https://evidence-hub.com/study/65868-the-ability-to-inhibit-amylase-and-glucosidase-by-aromatic-compounds2026-10-04 https://evidence-hub.com/study/65869-in-silico-evaluation-of-phytochemicals-from-mangifera-indica-against2026-10-04 https://evidence-hub.com/study/65870-in-silico-molecular-docking-approach-to-investigate-the-anti-diabetic2026-10-04 https://evidence-hub.com/study/65871-effects-of-catha-edulis-khat-on-the-pharmacokinetics-of-metformin-in2026-10-04 https://evidence-hub.com/study/65872-telmisartan-induced-alteration-of-voltage-gated-na-currents2026-10-04 https://evidence-hub.com/study/65873-in-silico-drug-likeness-adme-t-studies-and-molecular-docking-of2026-10-04 https://evidence-hub.com/study/65874-studi-in-silico-senyawa-bioaktif-pada-daun-yakon-smallanthus2026-10-04 https://evidence-hub.com/study/65875-biochemical-evaluation-of-indus-viva-i-pulse-natural-ayurvedic-syrup2026-10-04 https://evidence-hub.com/study/65876-in-silico-evaluation-of-n-methyl-1-adamantaneacetamide-and-3-4-di-o2026-10-04 https://evidence-hub.com/study/65877-exploratory-ai-assisted-in-silico-evidence-that-bacterial-signaling2026-10-04 https://evidence-hub.com/study/65879-empaglifozin-in-type-2-diabetes-from-mechanisms-to-clinical-practice2026-10-04 https://evidence-hub.com/study/65880-mechanistic-evaluation-of-the-inhibitory-effect-of-four-sglt-22026-10-04 https://evidence-hub.com/study/65881-drugs-repurposing-for-heart-failure-computational-approaches2026-10-08 https://evidence-hub.com/study/65882-hypoglycemic-medicines-in-the-treatment-of-alzheimer-s-disease2026-10-04 https://evidence-hub.com/study/65883-repurposing-the-hypoglycaemic-agents-for-neuroinflammation-a2026-10-04 https://evidence-hub.com/study/65885-the-potential-off-target-neuroprotective-effect-of-sister-gliflozins2026-10-04 https://evidence-hub.com/study/65886-adenosine-monophosphate-activated-protein-kinase-as-a-potential2026-10-04 https://evidence-hub.com/study/65887-the-role-of-ampk-activation-for-cardioprotection-in-doxorubicin2026-10-04 https://evidence-hub.com/study/65888-drug-likeness-screening-and-evaluation-of-physicochemical-properties2026-10-04 https://evidence-hub.com/study/65889-qualitative-and-quantitative-determination-of-dapagliflozin2026-10-04 https://evidence-hub.com/study/65890-comparative-effects-of-selective-and-non-selective-sodium-glucose2026-10-04 https://evidence-hub.com/study/65891-safety-and-efficacy-of-protracted-usage-of-oral-antidiabetic-drugs-in2026-10-04 https://evidence-hub.com/study/65892-isorhamnetin-reduces-glucose-level-inflammation-and-oxidative-stress2026-10-04 https://evidence-hub.com/study/65893-flozins-inhibitors-of-type-2-renal-sodium-glucose-co-transporter-not2026-10-04 https://evidence-hub.com/study/65894-phytochemicals-with-sodium-glucose-co-transporter-inhibitory-effects2026-10-04 https://evidence-hub.com/study/65895-association-between-prescription-drugs-and-all-cause-mortality-risk2026-10-04 https://evidence-hub.com/study/65896-phytochemical-and-in-silicoanalysis-of-the-potentantidiabetic2026-10-04 https://evidence-hub.com/study/65897-the-optimal-medical-therapy-for-glycemic-control-in-covid-192026-10-04 https://evidence-hub.com/study/65898-modulating-sirtuin-biology-and-nicotinamide-adenine-diphosphate2026-10-04 https://evidence-hub.com/study/65899-a-novel-mutation-in-the-insr-causes-severe-insulin-resistance-and2026-10-04 https://evidence-hub.com/study/65900-proteomic-analysis-of-the-effects-of-shenzhu-tiaopi-granules-on-model2026-10-04 https://evidence-hub.com/study/65901-a-novel-mutation-in-the-insr-gene-causes-severe-insulin-resistance2026-10-04 https://evidence-hub.com/study/65902-characterization-of-the-sglt2-interaction-network-and-its-regulation2026-10-04 https://evidence-hub.com/study/65903-persistent-multidrug-resistant-salmonella-enterica-serovar-paratyphi2026-10-08 https://evidence-hub.com/study/65906-levofloxacin-induced-acute-psychosis2026-10-08 https://evidence-hub.com/study/65907-levaquin-levofloxacin2026-10-08 https://evidence-hub.com/study/65908-clinical-verification-of-levofloxacin-mesylate-vs-levofloxacin2026-10-08 https://evidence-hub.com/study/65909-anaphylactoid-reaction-to-levofloxacin2026-10-08 https://evidence-hub.com/study/65911-levofloxacin-and-warfarin-interaction2026-10-08 https://evidence-hub.com/study/65912-hplc-determination-of-levofloxacin-in-levofloxacin-ophthalmic-gel2026-10-08 https://evidence-hub.com/study/65914-determination-of-levofloxacin-in-levofloxacin-lactate-injection-by2026-10-08 https://evidence-hub.com/study/65915-preformulation-study-of-levofloxacin2026-10-08 https://evidence-hub.com/study/65916-levofloxacin-treatment-failure-inhaemophilus-influenzaepneumonia2026-10-08 https://evidence-hub.com/study/65918-levofloxacin-associated-neurotoxicity-in-a-patient-with-a-high2026-10-08 https://evidence-hub.com/study/65919-effect-of-dehydration-on-the-formation-of-levofloxacin2026-10-08 https://evidence-hub.com/study/65921-a-review-of-levofloxacin-for-the-treatment-of-bacterial-infections2026-10-13 https://evidence-hub.com/study/65922-photodegradation-products-of-levofloxacin-in-aqueous-solution2026-10-08 https://evidence-hub.com/study/65925-synthesis-of-levofloxacin2026-10-04 https://evidence-hub.com/study/65932-a-sticker-reminder-intervention-to-promote-intravenous-to-oral2026-10-13 https://evidence-hub.com/study/65933-fibroblast-inhibition-by-tocilizumab-enabled-gemcitabine-nab2026-10-06 https://evidence-hub.com/study/65934-medical-management-of-multifocal-immune-mediated-punctate-keratitis2026-10-08 https://evidence-hub.com/study/65935-efgartigimod-for-guillain-barre-syndrome-rationale-clinical-evidence2026-10-08 https://evidence-hub.com/study/65936-delayed-methotrexate-elimination-in-a-patient-with-primary-central2026-10-08 https://evidence-hub.com/study/65938-a-randomized-controlled-trial-of-repeated-ketamine-administration-for2026-10-12 https://evidence-hub.com/study/65939-effects-of-four-hour-and-six-hour-time-restricted-feeding-on-weight2026-10-19 https://evidence-hub.com/study/65940-hydroxychloroquine-for-early-treatment-of-adults-with-mild-covid-19-a2026-10-19 https://evidence-hub.com/study/65941-efficacy-of-the-mindfulness-meditation-mobile-app-calm-to-reduce2026-10-06 https://evidence-hub.com/study/65942-ten-year-results-of-fast-a-randomized-controlled-trial-of-5-fraction2026-10-08 https://evidence-hub.com/study/65943-a-randomized-controlled-trial-of-dapagliflozin-on-left-ventricular2026-10-12 https://evidence-hub.com/study/65947-mindfulness-based-stress-reduction-for-residents-a-randomized2026-10-06 https://evidence-hub.com/study/65951-modernizing-clinical-trial-eligibility-criteria-recommendations-of2026-10-19 https://evidence-hub.com/study/65953-high-risk-of-thrombosis-in-patients-with-severe-sars-cov-2-infection2026-10-13 https://evidence-hub.com/study/65954-development-and-internal-external-validation-of-statistical-and2026-10-06 https://evidence-hub.com/study/65955-1-year-outcomes-in-hospital-survivors-with-covid-19-a-longitudinal2026-10-13 https://evidence-hub.com/study/65956-long-term-cardiovascular-outcomes-in-covid-19-survivors-among-non2026-10-06 https://evidence-hub.com/study/65957-sars-cov-2-vaccination-and-myocarditis-in-a-nordic-cohort-study-of-232026-10-13 https://evidence-hub.com/study/65958-risk-of-hospitalisation-associated-with-infection-with-sars-cov-22026-10-06 https://evidence-hub.com/study/65959-long-covid-in-adults-discharged-from-uk-hospitals-after-covid-19-a2026-10-08 https://evidence-hub.com/study/65960-novel-antihyperglycaemic-drugs-and-prevention-of-chronic-obstructive2026-10-06 https://evidence-hub.com/study/65961-long-term-exposure-to-wildfires-and-cancer-incidence-in-canada-a2026-10-13 https://evidence-hub.com/study/65962-clinical-characteristics-and-outcomes-of-covid-19-in-haematopoietic2026-10-08 https://evidence-hub.com/study/65963-association-of-ischemic-stroke-incidence-severity-and-recurrence-with2026-10-06 https://evidence-hub.com/study/65964-association-between-long-term-exposure-to-air-pollution-and-immune2026-10-06 https://evidence-hub.com/study/65965-primary-cns-vasculitis-pcnsv-a-cohort-study2026-10-13 https://evidence-hub.com/study/65966-a-national-cohort-study-2000-2018-of-long-term-air-pollution-exposure2026-10-13 https://evidence-hub.com/study/65967-incidence-of-co-infections-and-superinfections-in-hospitalized2026-10-08 https://evidence-hub.com/study/65968-meat-intake-is-associated-with-a-higher-risk-of-ulcerative-colitis-in2026-10-06 https://evidence-hub.com/study/65969-colorectal-cancer-in-ulcerative-colitis-a-scandinavian-population2026-10-08 https://evidence-hub.com/study/65970-adverse-outcomes-in-covid-19-and-diabetes-a-retrospective-cohort2026-10-06 https://evidence-hub.com/study/65971-time-to-antibiotics-and-clinical-outcomes-in-patients-with-sepsis-and2026-10-06 https://evidence-hub.com/study/65972-autoimmune-inflammatory-rheumatic-diseases-and-covid-19-outcomes-in2026-10-06 https://evidence-hub.com/study/65973-famotidine-use-is-associated-with-improved-clinical-outcomes-in2026-10-13 https://evidence-hub.com/study/65974-effects-of-tocilizumab-on-mortality-in-hospitalized-patients-with2026-10-06 https://evidence-hub.com/study/65975-the-relationship-between-aki-and-ckd-in-patients-with-type-2-diabetes2026-10-06 https://evidence-hub.com/study/65976-associations-between-macrolide-antibiotics-prescribing-during2026-10-06 https://evidence-hub.com/study/65977-the-prevalence-and-impact-of-depression-and-anxiety-in-cardiac2026-10-13 https://evidence-hub.com/study/65978-nature-and-prevalence-of-combinations-of-mental-disorders-and-their2026-10-06 https://evidence-hub.com/study/65979-prorepair-b-a-prospective-cohort-study-of-the-impact-of-germline-dna2026-10-13 https://evidence-hub.com/study/65981-non-alcoholic-fatty-liver-disease-and-risk-of-incident-acute2026-10-13 https://evidence-hub.com/study/65982-ultra-processed-food-consumption-and-risk-of-obesity-a-prospective2026-10-13 https://evidence-hub.com/study/65983-study-design-and-participants-profile-in-the-sub-cohort-study-in-the2026-10-06 https://evidence-hub.com/study/65984-qatar-biobank-cohort-study-study-design-and-first-results2026-10-08 https://evidence-hub.com/study/65985-phenotypic-variability-and-disparities-in-treatment-and-outcomes-of2026-10-06 https://evidence-hub.com/study/65986-risk-of-radiation-associated-intracranial-malignancy-after2026-10-13 https://evidence-hub.com/study/65987-serum-neurofilament-light-chain-in-genetic-frontotemporal-dementia-a2026-10-13 https://evidence-hub.com/study/65989-discovery-and-validation-of-a-prognostic-proteomic-signature-for2026-10-12 https://evidence-hub.com/study/65990-sleep-and-the-risk-of-chronic-kidney-disease-a-cohort-study2026-10-06 https://evidence-hub.com/study/65991-total-cholesterol-and-all-cause-mortality-by-sex-and-age-a2026-10-06 https://evidence-hub.com/study/65992-long-term-dietary-fiber-intake-and-risk-of-chronic-obstructive2026-10-12 https://evidence-hub.com/study/65993-physical-activity-and-the-prevention-of-depression-a-cohort-study2026-10-08 https://evidence-hub.com/study/65994-association-between-systolic-blood-pressure-and-dementia-in-the2026-10-06 https://evidence-hub.com/study/65995-alcohol-consumption-and-risk-of-dementia-23-year-follow-up-of2026-10-12 https://evidence-hub.com/study/65996-risk-of-spread-in-adult-onset-isolated-focal-dystonia-a-prospective2026-10-06 https://evidence-hub.com/study/65998-how-women-are-treated-during-facility-based-childbirth-in-four2026-10-19 https://evidence-hub.com/study/65999-reasons-for-cannabidiol-use-a-cross-sectional-study-of-cbd-users2026-10-19 https://evidence-hub.com/study/66000-gastric-cancer-for-young-adults-case-series-of-three-cases2026-10-19 https://evidence-hub.com/study/66001-effect-of-dapoxetine-on-intravaginal-ejaculatory-latency-time-ielt-in2026-10-12 https://evidence-hub.com/study/66002-current-and-future-pharmacotherapies-of-premature-ejaculation2026-10-06 https://evidence-hub.com/study/66003-273-efficacy-of-dapoxetine-in-the-treatment-of-premature-ejaculation2026-10-04 https://evidence-hub.com/study/66004-123-possible-factors-affecting-efficacy-of-dapoxetine-30mg-treatment2026-10-04 https://evidence-hub.com/study/66007-ab087-discontinuation-of-dapoxetine-treatment-in-patients-with2026-10-04 https://evidence-hub.com/study/66010-140-comparison-of-the-effects-and-side-effects-between-pde-52026-10-04 https://evidence-hub.com/study/66011-patient-reported-outcomes-and-improvements-in-intravaginal2026-10-04 https://evidence-hub.com/study/66013-simple-evaluation-of-listeria-monocytogenes-pathogenesis-using2026-10-06 https://evidence-hub.com/study/66014-review-the-prevailing-mathematical-modeling-classifications-and2026-10-19 https://evidence-hub.com/study/66015-implementing-a-course-based-undergraduate-research-experience-to-grow2026-10-19 https://evidence-hub.com/study/66016-impacts-of-prenatal-nutrition-on-animal-production-and-performance-a2026-10-09 https://evidence-hub.com/study/66017-pharmacology-of-drugs-used-in-premature-ejaculation2026-10-04 https://evidence-hub.com/study/66019-effect-of-hesperetin-on-the-antidepressant-activity-of2026-10-04 https://evidence-hub.com/study/66020-functional-and-molecular-investigation-of-alpha-1-adrenoceptors-in-an2026-10-04 https://evidence-hub.com/study/66021-eco-friendly-stability-indicating-rp-hptlc-method-for-sildenafil2026-10-04 https://evidence-hub.com/study/66024-mp47-02-dapoxetine-inhibits-erectile-responses-to-stimulation-of-the2026-10-04 https://evidence-hub.com/study/66025-the-investigation-of-anti-proliferative-effects-of-ag2-sac-2-dap-22026-10-04 https://evidence-hub.com/study/66026-what-s-new-in-the-other-journals2026-10-04 https://evidence-hub.com/study/66027-formulation-and-evaluation-of-prednisolone-retention-enema-as2026-10-04 https://evidence-hub.com/study/66028-advances-in-the-management-of-refractory-helicobacter-pylori2026-10-08 https://evidence-hub.com/study/66029-a-brief-review-of-adverse-drug-reactions-of-levofloxacin2026-10-08 https://evidence-hub.com/study/66030-meta-analysis-of-the-efficacy-and-safety-of-gatifloxacin-and2026-10-08 https://evidence-hub.com/study/66031-formulation-and-evaluation-of-floating-microspheres-of-levofloxacin2026-10-13 https://evidence-hub.com/study/66032-bacterial-profile-and-antimicrobial-resistance-of-infections-among2026-10-13 https://evidence-hub.com/study/66033-meta-analysis-of-antibiotic-therapies-for-helicobacter-pylori2026-10-13 https://evidence-hub.com/study/66034-gastroenteritis-in-japanese-females-caused-by-shigella-flexneri2026-10-08 https://evidence-hub.com/study/66035-endophthalmitis-isolates-and-antibiotic-sensitivities-a-8-year-review2026-10-08 https://evidence-hub.com/study/66036-prevalence-and-common-microbial-isolates-of-urinary-tract-infection2026-10-13 https://evidence-hub.com/study/66037-safety-and-efficacy-of-nitazoxanide-based-regimen-for-the-eradication2026-10-13 https://evidence-hub.com/study/66038-association-between-fluoroquinolones-and-achilles-tendon-injuries-a2026-10-08 https://evidence-hub.com/study/66039-role-of-levofloxacin-in-the-treatment-of-urinary-tract-infections2026-10-20 https://evidence-hub.com/study/66040-post-marketing-surveillance-of-levofloxacin-0-5-ophthalmic-solution2026-10-06 https://evidence-hub.com/study/66041-induced-membrane-reconstruction-of-a-6-cm-ulnar-defect-with2026-10-08 https://evidence-hub.com/study/66044-levofloxacin-induced-rhabdomyolysis-in-a-hemodialysis-patient2026-10-08 https://evidence-hub.com/study/66047-pharmacokinetics-of-levofloxacin-in-hemodialyzed-patients2026-10-08 https://evidence-hub.com/study/66048-acute-hepatitis-associated-with-levofloxacin-in-a-patient-with-renal2026-10-08 https://evidence-hub.com/study/66050-levofloxacin-in-treating-infective-disease-in-60-patients2026-10-08 https://evidence-hub.com/study/66051-levofloxacin-induced-hypoglycemia-in-a-non-diabetic-patient2026-10-08 https://evidence-hub.com/study/66054-clinical-pharmacology-and-efficacy-of-levofloxacin-in-elderly-patients2026-10-20 https://evidence-hub.com/study/66055-effect-of-levofloxacin-on-renal-function-in-elderly-patients2026-10-08 https://evidence-hub.com/study/66056-levofloxacin-in-treatment-of-70-patients-with-bacterial-infections2026-10-13 https://evidence-hub.com/study/66057-ceftriaxone-versus-levofloxacin-for-antibiotic-therapy-in-patients2026-10-08 https://evidence-hub.com/study/66058-cerebrospinal-fluid-concentration-of-levofloxacin-in-patients-with2026-10-08 https://evidence-hub.com/study/66061-a-clinical-observation-on-levofloxacin-in-treatment-of-cap-in-elderly2026-10-08 https://evidence-hub.com/study/66062-a-study-on-the-concentrations-of-levofloxacin-in-the-gallbladder2026-10-08 https://evidence-hub.com/study/66063-levofloxacin-weight-adjusted-dosing-and-pharmacokinetic-disposition2026-10-08 https://evidence-hub.com/study/66065-efficacy-of-a-new-quinolone-levofloxacin-in-patients-with-surgical2026-10-08 https://evidence-hub.com/study/66068-pharmacokinetic-and-pharmacodynamic-evaluations-of-levofloxacin-in2026-10-08 https://evidence-hub.com/study/66069-effect-of-terazosin-on-the-pharmacokinetics-of-levofloxacin-in-the2026-10-08 https://evidence-hub.com/study/66070-on-the-pharmocodynamic-of-major-components-of-compound-levofloxacin2026-10-08 https://evidence-hub.com/study/66071-effect-of-porosity-micropipe-carrying-levofloxacin-pulvis-in-the2026-10-08 https://evidence-hub.com/study/66073-severe-legionnaires-disease-successfully-treated-with-levofloxacin2026-10-08 https://evidence-hub.com/study/66074-specific-antibodies-levofloxacin-and-modulation-of-capsule-associated2026-10-08 https://evidence-hub.com/study/66075-prophylactic-efficacy-of-linezolid-alone-or-combined-with2026-10-08 https://evidence-hub.com/study/66076-the-effect-of-levofloxacin-ointment-against-imiquimod-induced2026-10-08 https://evidence-hub.com/study/66077-the-nephroprotective-effect-of-clove-oil-oleum-caryophylli-against2026-10-08 https://evidence-hub.com/study/66078-adsorption-of-levofloxacin-on-microplastics-in-aqueous-solution2026-10-08 https://evidence-hub.com/study/66079-effects-of-levofloxacin-moxifloxacin-and-prulifloxacin-on-murine-gut2026-10-08 https://evidence-hub.com/study/66080-polymer-coated-ovalbumin-nanoparticles-loaded-levofloxacin2026-10-08 https://evidence-hub.com/study/66081-population-pharmacokinetics-modeling-of-levofloxacin-in-rabbit-by2026-10-05 https://evidence-hub.com/study/66082-intraocular-penetration-of-sequentially-instilled-topical2026-10-05 https://evidence-hub.com/study/66083-study-on-pharmacokinetics-of-syndrome-differentiation-after-a-single2026-10-05 https://evidence-hub.com/study/66084-in-vitro-activities-of-several-antimicrobial-agents-against-recently2026-10-06 https://evidence-hub.com/study/66085-rapid-succession-of-multidrug-resistant-bacteremia-and-candidemia-in2026-10-13 https://evidence-hub.com/study/66086-tadalafil-5-mg-once-daily-improves-lower-urinary-tract-symptoms-and2026-10-13 https://evidence-hub.com/study/66087-efficacy-and-safety-of-long-term-tadalafil-5-mg-once-daily-combined2026-10-06 https://evidence-hub.com/study/66089-tadalafil-associated-priapism2026-10-04 https://evidence-hub.com/study/66090-cardiovascular-effects-of-tadalafil2026-10-10 https://evidence-hub.com/study/66091-tadalafil-for-the-treatment-of-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/66092-potential-beneficial-impacts-of-tadalafil-on-cardiovascular-diseases2026-10-19 https://evidence-hub.com/study/66093-effects-of-sildenafil-and-tadalafil-on-skin-flap-viability2026-10-04 https://evidence-hub.com/study/66094-tadalafil-and-steroid-hormones-interactions-in-adipose-bone-and2026-10-19 https://evidence-hub.com/study/66095-tadalafil-in-pulmonary-arterial-hypertension2026-10-04 https://evidence-hub.com/study/66096-combination-of-tadalafil-and-finasteride-for-the-treatment-of-urinary2026-10-06 https://evidence-hub.com/study/66097-oral-drugs-used-to-treat-persistent-pulmonary-hypertension-of-the2026-10-08 https://evidence-hub.com/study/66098-bioequivalence-study-of-tadalafil-oral-soluble-film-and-tadalafil2026-10-08 https://evidence-hub.com/study/66099-tadalafil-in-the-treatment-of-erectile-dysfunction-an-overview-of-the2026-10-19 https://evidence-hub.com/study/66100-intranasal-tadalafil-nanoemulsions-formulation-characterization-and2026-10-06 https://evidence-hub.com/study/66101-solubilization-of-tadalafil-using-a-tartaric-acid-and-chitosan-based2026-10-06 https://evidence-hub.com/study/66102-efficacy-and-tolerability-of-tadalafil-a-novel-phosphodiesterase-52026-10-04 https://evidence-hub.com/study/66103-safety-trial-of-tadalafil-administered-for-the-treatment-of2026-10-06 https://evidence-hub.com/study/66104-recent-advances-in-the-management-of-pulmonary-arterial-hypertension2026-10-06 https://evidence-hub.com/study/66105-tadalafil-for-the-treatment-of-pulmonary-arterial-hypertension2026-10-04 https://evidence-hub.com/study/66106-tadalafil-once-daily-narrative-review-of-a-treatment-option-for2026-10-04 https://evidence-hub.com/study/66107-single-and-combined-toxicity-of-tadalafil-cilais-and-microplastic-in2026-10-05 https://evidence-hub.com/study/66108-tadalafil-a-phosphodiesterase-5-inhibitor-for-benign-prostatic2026-10-19 https://evidence-hub.com/study/66109-tadalafil-a-long-acting-phosphodiesterase-inhibitor-promotes-bone2026-10-06 https://evidence-hub.com/study/66110-review-of-tadalafil-in-the-treatment-of-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/66111-the-efficacy-of-tadalafil-in-clinical-populations2026-10-19 https://evidence-hub.com/study/66112-tadalafil-in-the-treatment-of-signs-and-symptoms-of-benign-prostatic2026-10-04 https://evidence-hub.com/study/66113-risk-benefit-considerations-when-prescribing-phosphodiesterase-52026-10-08 https://evidence-hub.com/study/66114-inhibition-of-phosphodiesterase-5a-by-tadalafil-improves-sirt12026-10-06 https://evidence-hub.com/study/66115-cardiovascular-effects-of-tadalafil-in-patients-on-common2026-10-04 https://evidence-hub.com/study/66116-protective-effects-of-tadalafil-against-cisplatin-induced2026-10-06 https://evidence-hub.com/study/66117-prospective-randomized-placebo-controlled-two-arm-study-to-evaluate2026-10-05 https://evidence-hub.com/study/66118-treatment-of-benign-prostatic-hyperplasia-and-abnormal-ejaculation2026-10-06 https://evidence-hub.com/study/66119-tadalafil-protects-against-renal-fibrosis-after-ischemia-reperfusion2026-10-06 https://evidence-hub.com/study/66120-update-on-clinical-trials-of-tadalafil-demonstrates-no-increased-risk2026-10-06 https://evidence-hub.com/study/66121-the-cardiovascular-safety-of-tadalafil2026-10-04 https://evidence-hub.com/study/66122-changes-in-posterior-ocular-structures-in-individuals-using2026-10-06 https://evidence-hub.com/study/66123-efficacy-and-safety-of-tadalafil-once-daily-considerations-for-the2026-10-06 https://evidence-hub.com/study/66124-the-configuration-of-tadalafil-and-tadalafil-analogues-found-in2026-10-04 https://evidence-hub.com/study/66125-tadalafil-treatment-of-mice-with-fetal-growth-restriction-and2026-10-06 https://evidence-hub.com/study/66126-drug-repositioning-identification-of-potent-inhibitors-of-ns32026-10-05 https://evidence-hub.com/study/66127-insights-on-protective-effect-of-platelet-rich-plasma-and-tadalafil2026-10-05 https://evidence-hub.com/study/66129-characterization-and-stability-of-amorphous-tadalafil-and-four2026-10-06 https://evidence-hub.com/study/66130-safety-and-dose-finding-trial-of-tadalafil-administered-for-fetal2026-10-06 https://evidence-hub.com/study/66131-tadalafil-loaded-nanostructured-lipid-carriers-using-permeation2026-10-04 https://evidence-hub.com/study/66132-comparison-of-the-efficacy-of-the-early-li-swt-plus-daily-tadalafil2026-10-04 https://evidence-hub.com/study/66133-isolation-and-characterization-of-a-novel-tadalafil-analogue2026-10-06 https://evidence-hub.com/study/66134-effect-and-mechanism-of-prophylactic-use-of-tadalafil-during2026-10-06 https://evidence-hub.com/study/66135-the-effect-of-grapefruit-juice-on-the-pharmacokinetics-of-tadalafil2026-10-06 https://evidence-hub.com/study/66136-efficacy-and-safety-of-tadalafil-monotherapy-for-lower-urinary-tract2026-10-19 https://evidence-hub.com/study/66137-efficacy-and-safety-of-once-daily-tadalafil-in-men-with-erectile2026-10-06 https://evidence-hub.com/study/66138-fetal-biometric-assessment-and-infant-developmental-prognosis-of-the2026-10-10 https://evidence-hub.com/study/66139-maternal-blood-concentration-of-tadalafil-and-uterine-blood-flow-in2026-10-06 https://evidence-hub.com/study/66140-tadalafil-alleviates-preeclampsia-and-fetal-growth-restriction-in2026-10-04 https://evidence-hub.com/study/66141-isolation-and-characterisation-of-n-benzyl-tadalafil-as-a-novel2026-10-06 https://evidence-hub.com/study/66142-breast-cancer-resistance-protein-limits-fetal-transfer-of-tadalafil2026-10-06 https://evidence-hub.com/study/66143-nebivolol-and-tadalafil-synergistically-ameliorate-insulin-resistance2026-10-19 https://evidence-hub.com/study/66144-tadalafil-for-the-treatment-of-pulmonary-arterial-hypertension2026-10-04 https://evidence-hub.com/study/66145-improvement-of-cognitive-dysfunction-by-a-novel-phosphodiesterase2026-10-06 https://evidence-hub.com/study/66146-isolation-and-characterization-of-new-tadalafil-analogues-in-male2026-10-06 https://evidence-hub.com/study/66147-tadalafil-against-hyperoxia-induced-oxidative-stress-an-experimental2026-10-06 https://evidence-hub.com/study/66148-efficacy-of-tadalafil-de-escalation-in-the-treatment-of-psychogenic2026-10-06 https://evidence-hub.com/study/66149-bioequivalence-of-macitentan-and-tadalafil-given-as-fixed-dose2026-10-06 https://evidence-hub.com/study/66150-efficacy-of-pentoxifylline-and-tadalafil-in-rat-model-of-ischemic2026-10-06 https://evidence-hub.com/study/66151-vasodilatory-effects-of-tadalafil-in-an-animal-model-of-cerebral2026-10-04 https://evidence-hub.com/study/66152-effect-of-tadalafil-and-nitric-oxide-agonist-sodium-nitroprusside-on2026-10-06 https://evidence-hub.com/study/66153-safety-and-dose-finding-trial-of-tadalafil-administered-for-fetus-in2026-10-19 https://evidence-hub.com/study/66154-evaluation-of-tadalafil-supplementation-on-the-neutrophil-lymphocyte2026-10-05 https://evidence-hub.com/study/66155-retrospective-study-of-tadalafil-for-fetal-growth-restriction-impact2026-10-06 https://evidence-hub.com/study/66156-tadalafil-protective-action-against-the-development-of-multiple-organ2026-10-04 https://evidence-hub.com/study/66157-tadalafil-enhances-working-memory-and-reduces-hippocampal-oxidative2026-10-06 https://evidence-hub.com/study/66158-a-three-part-study-to-investigate-the-incidence-and-potential2026-10-06 https://evidence-hub.com/study/66159-pulmonary-embolism-after-tadalafil-ingestion2026-10-06 https://evidence-hub.com/study/66160-oral-tadalafil-in-children-with-pulmonary-arterial-hypertension2026-10-06 https://evidence-hub.com/study/66161-chinese-herbal-medicine-combined-with-tadalafil-for-erectile2026-10-19 https://evidence-hub.com/study/66162-the-phosphodiesterase-inhibitor-tadalafil-promotes-splenic-retention2026-10-04 https://evidence-hub.com/study/66163-evaluation-of-efficacy-and-safety-profile-of-tadalafil-5-mg-daily2026-10-10 https://evidence-hub.com/study/66164-transdermal-delivery-of-tadalafil-using-a-novel-formulation2026-10-04 https://evidence-hub.com/study/66165-the-efficacy-and-safety-of-tadalafil-in-the-management-of-erectile2026-10-06 https://evidence-hub.com/study/66166-tadalafil-in-increasing-doses-the-influence-on-coronary-blood-flow2026-10-06 https://evidence-hub.com/study/66167-the-potential-effect-of-ambrisentan-as-monotherapy-and-combined-with2026-10-06 https://evidence-hub.com/study/66168-association-of-nos3-vegf-ace-and-ace2-polymorphisms-with-erectile2026-10-06 https://evidence-hub.com/study/66169-preparation-of-deuterium-labeled-tadalafil-and-omeprazole-by-carbon2026-10-06 https://evidence-hub.com/study/66170-effect-of-daily-tadalafil-on-pudendal-nerve-entrapment-symptoms-in2026-10-06 https://evidence-hub.com/study/66171-the-role-of-the-atherogenic-index-of-plasma-in-response-to-once-daily2026-10-06 https://evidence-hub.com/study/66172-comparative-efficacy-of-low-intensity-extracorporeal-shockwave2026-10-06 https://evidence-hub.com/study/66173-assessing-the-therapeutic-potential-of-pde-5-inhibitors-in-adults2026-10-10 https://evidence-hub.com/study/66174-design-of-experiments-assisted-development-and-validation-of-an-hptlc2026-10-06 https://evidence-hub.com/study/66175-qbd-consideration-for-developing-and-validating-the-dissolution-test2026-10-06 https://evidence-hub.com/study/66176-quantification-of-tadalafil-in-hlms-using-an-ultrafast-uplc-ms-ms2026-10-05 https://evidence-hub.com/study/66177-improved-cardiac-function-and-quality-of-life-with-initial-macitentan2026-10-04 https://evidence-hub.com/study/66178-apparent-non-response-to-phosphodiesterase-type-5-inhibitors-in2026-10-19 https://evidence-hub.com/study/66179-improving-erectile-function-and-quality-of-life-in-hypogonadal2026-10-06 https://evidence-hub.com/study/66180-retrospective-comparative-analysis-of-the-efficacy-of-treatment2026-10-06 https://evidence-hub.com/study/66181-multimodal-rehabilitation-improves-erectile-function-and-quality-of2026-10-06 https://evidence-hub.com/study/66182-development-of-a-population-pharmacokinetic-model-using-combined2026-10-08 https://evidence-hub.com/study/66183-phosphodiesterase-type-5-inhibitors-as-chemical-hazards-in-honey-and2026-10-19 https://evidence-hub.com/study/66184-camp-and-cgmp-pathways-modulate-spontaneous-contractile-activity-in2026-10-06 https://evidence-hub.com/study/66185-balancing-analytical-performance-and-sustainability-agsa-and-ma-tools2026-10-19 https://evidence-hub.com/study/66186-the-efficacy-and-safety-of-adrenergic-alpha-antagonists-combined-with2026-10-06 https://evidence-hub.com/study/66187-efficacy-of-medical-interventions-for-erectile-dysfunction-after2026-10-19 https://evidence-hub.com/study/66188-pharmacokinetic-and-dissolution-profiling-of-tadalafil-formulated2026-10-06 https://evidence-hub.com/study/66189-evaluation-the-reno-protective-effect-of-tadalafil-alone-and-in2026-10-06 https://evidence-hub.com/study/66190-identification-of-ring-finger-protein-related-biomarkers-in-sepsis2026-10-06 https://evidence-hub.com/study/66191-comparative-efficacy-of-tadalafil-and-amitriptyline-in-female2026-10-06 https://evidence-hub.com/study/66192-pretreatment-factors-associated-with-pain-improvement-after-cernitin2026-10-06 https://evidence-hub.com/study/66193-reduction-in-wearable-derived-maximal-oxygen-consumption-vo2max2026-10-19 https://evidence-hub.com/study/66194-targeting-canonical-tgf-smad3-and-erk1-2-signaling-in-human-valve2026-10-06 https://evidence-hub.com/study/66195-design-of-experiments-assisted-micellar-electrokinetic-chromatography2026-10-08 https://evidence-hub.com/study/66196-fetal-tadalafil-exposure-increases-pulmonary-blood-flow-and-reduces2026-10-04 https://evidence-hub.com/study/66197-association-of-phosphodiesterase-type-5-inhibitor-use-with2026-10-19 https://evidence-hub.com/study/66198-pharmacologic-and-clinical-considerations-of-phosphodiesterase-type-52026-10-19 https://evidence-hub.com/study/66199-effect-of-mirabegron-tamsulosin-and-tadalafil-on-quality-of-life-in2026-10-08 https://evidence-hub.com/study/66200-clinical-study-on-the-combined-use-of-tadalafil-and-epalrestat-in-the2026-10-06 https://evidence-hub.com/study/66201-comparison-of-metrics-for-investigating-bioequivalence-in-onset-of2026-10-06 https://evidence-hub.com/study/66202-pulmonary-veno-occlusive-disease-presenting-as-congenital-heart2026-10-06 https://evidence-hub.com/study/66203-planer-chromatographic-method-development-and-validation-of-tadalafil2026-10-06 https://evidence-hub.com/study/66204-safety-profile-and-signal-detection-of-tadalafil-a-real-world2026-10-06 https://evidence-hub.com/study/66205-inhalable-porous-plga-microspheres-enable-lung-targeted-dual-drug2026-10-04 https://evidence-hub.com/study/66206-a-qbd-based-method-for-the-simultaneous-determination-of-tadalafil2026-10-19 https://evidence-hub.com/study/66207-association-of-pericardial-tamponade-with-initiation-of-sotatercept2026-10-08 https://evidence-hub.com/study/66208-tadalafil-and-tamsulosin-in-the-management-of-lower-urinary-tract2026-10-19 https://evidence-hub.com/study/66209-patient-derived-prostate-organoids-identify-maoa-as-a-disease2026-10-06 https://evidence-hub.com/study/66210-evaluation-of-the-efficacy-of-pharmacological-interventions-in-the2026-10-10 https://evidence-hub.com/study/66211-comparison-of-safety-and-efficacy-of-avanafil-and-tadalafil-in-the2026-10-04 https://evidence-hub.com/study/66212-hypotensive-events-associated-with-pde-5-inhibitors-in-pulmonary2026-10-08 https://evidence-hub.com/study/66213-long-term-treatment-with-single-tablet-combination-of-macitentan-and2026-10-06 https://evidence-hub.com/study/66214-phosphodiesterase-inhibitors-for-the-management-of-lower-urinary2026-10-19 https://evidence-hub.com/study/66215-evidence-for-the-additional-health-benefits-associated-with2026-10-19 https://evidence-hub.com/study/66216-combined-therapy-with-dutasteride-and-tadalafil-vs-dutasteride-or2026-10-19 https://evidence-hub.com/study/66217-selective-targeting-phosphodiesterase-5-pde5-clinical-progress-design2026-10-08 https://evidence-hub.com/study/66218-from-fibrosis-to-restoration-the-multimodal-3-ts-protocol-for2026-10-06 https://evidence-hub.com/study/66219-evaluation-of-vardenafil-s-metabolic-stability-in-human-liver2026-10-06 https://evidence-hub.com/study/66220-effect-of-stereochemistry-on-the-antiplasmodial-activity-and2026-10-05 https://evidence-hub.com/study/66221-enhanced-antiproliferative-and-anti-inflammatory-effects-of-combined2026-10-06 https://evidence-hub.com/study/66222-an-in-silico-and-in-vitro-approach-identified-potential-trypanothione2026-10-05 https://evidence-hub.com/study/66223-radiodensity-as-a-predictor-can-penile-and-splenic-hounsfield-units2026-10-06 https://evidence-hub.com/study/66224-analytical-strategies-for-identifying-pde5-inhibitors-in-damiana2026-10-06 https://evidence-hub.com/study/66225-a-single-centre-clinical-audit-of-erectile-dysfunction-assessment-and2026-10-06 https://evidence-hub.com/study/66226-phytotherapies-and-complementary-therapies-for-erectile-dysfunction-a2026-10-06 https://evidence-hub.com/study/66227-eisenmenger-syndrome-hidden-by-unrepaired-patent-ductus-arteriosus2026-10-06 https://evidence-hub.com/study/66228-phosphodiesterase-5-inhibitor-use-masking-a-necrotizing-syphilitic2026-10-06 https://evidence-hub.com/study/66229-modulating-phosphodiesterase-5-activity-to-suppress-the2026-10-05 https://evidence-hub.com/study/66230-vardenafil-in-the-multidisciplinary-management-of-erectile2026-10-04 https://evidence-hub.com/study/66231-synthesis-and-pharmacological-evaluation-of-6-7-dihydro-3h-oxazolo-32026-10-19 https://evidence-hub.com/study/66232-drug-drug-coamorphous-system-of-tadalafil-and-finasteride-for2026-10-05 https://evidence-hub.com/study/66233-pulmonary-hypertension-workup-unraveling-a-rare-anomaly-in-turner2026-10-06 https://evidence-hub.com/study/66234-cognitive-outcomes-after-tadalafil-treatment-in-patients-with2026-10-10 https://evidence-hub.com/study/66235-chlorpromazine-tadalafil-interaction-leading-to-refractory-ischemic2026-10-06 https://evidence-hub.com/study/66236-integrating-machine-learning-with-lateral-flow-immunoassay-for2026-10-06 https://evidence-hub.com/study/66237-high-altitude-pulmonary-edema-management-in-a-special-operator2026-10-06 https://evidence-hub.com/study/66238-environmentally-benign-first-derivative-synchronous2026-10-06 https://evidence-hub.com/study/66239-phosphodiesterase-type-5-inhibitor-tadalafil-reduces-prostatic2026-10-19 https://evidence-hub.com/study/66240-neuronal-nitric-oxide-synthase-activation-by-tadalafil-protects2026-10-06 https://evidence-hub.com/study/66241-application-of-box-behnken-design-in-the-preparation-optimization-and2026-10-19 https://evidence-hub.com/study/66242-proniosomal-gel-loaded-phosphodiesterase-inhibitors-sildenafil2026-10-04 https://evidence-hub.com/study/66243-synchronous-fluorescence-as-a-green-and-selective-method-for-the2026-10-06 https://evidence-hub.com/study/66244-effects-of-tadalafil-on-sexual-behavior-of-male-rats-induced-by2026-10-04 https://evidence-hub.com/study/66245-the-pastis-trial-testing-tadalafil-for-possible-use-in-vascular2026-10-10 https://evidence-hub.com/study/66246-initial-use-of-ambrisentan-plus-tadalafil-in-pulmonary-arterial2026-10-04 https://evidence-hub.com/study/66247-supramolecular-tadalafil-nanovaccine-for-cancer-immunotherapy-by2026-10-06 https://evidence-hub.com/study/66248-effects-of-furosemide-and-tadalafil-in-both-conventional-and2026-10-06 https://evidence-hub.com/study/66249-the-wound-healing-effect-of-nanoclay-collagen-and-tadalafil-in2026-10-06 https://evidence-hub.com/study/66250-tadalafil-enhances-immune-signatures-in-response-to-neoadjuvant2026-10-19 https://evidence-hub.com/study/66251-role-of-adma-ddah-1-and-inos-enos-signaling-in-the-gastroprotective2026-10-06 https://evidence-hub.com/study/66252-prospective-comparison-of-tadalafil-5-mg-alone-silodosin-8-mg-alone2026-10-19 https://evidence-hub.com/study/66253-cytochrome-p450-3a4-mediated-pharmacokinetic-interaction-study2026-10-06 https://evidence-hub.com/study/66255-is-tadalafil-associated-with-decreased-risk-of-major-adverse-cardiac2026-10-06 https://evidence-hub.com/study/66257-analysis-of-integrated-clinical-safety-data-of-tadalafil-in-patients2026-10-19 https://evidence-hub.com/study/66258-integration-of-transcriptomics-and-metabolomics-reveals-the-antitumor2026-10-19 https://evidence-hub.com/study/66259-initial-combination-therapy-of-macitentan-and-tadalafil-in-pulmonary2026-10-06 https://evidence-hub.com/study/66260-initial-combination-therapy-of-ambrisentan-and-tadalafil-in2026-10-06 https://evidence-hub.com/study/66261-novel-hptlc-densitometric-methods-for-determination-of-tamsulosin-hcl2026-10-06 https://evidence-hub.com/study/66262-improved-molecular-softness-of-tadalafil-hapten-enhancing-antibody2026-10-06 https://evidence-hub.com/study/66263-stability-assessment-of-tamsulosin-and-tadalafil-co-formulated-in2026-10-06 https://evidence-hub.com/study/66264-implementing-analytical-quality-by-design-aqbd-approach-for2026-10-06 https://evidence-hub.com/study/66265-tadalafil-ameliorates-bladder-overactivity-by-restoring-insulin2026-10-06 https://evidence-hub.com/study/66266-digital-real-world-data-suggest-patient-preference-for-tadalafil-over2026-10-04 https://evidence-hub.com/study/66267-tadalafil-enhances-the-therapeutic-efficacy-of-bet-inhibitors-in2026-10-06 https://evidence-hub.com/study/66268-hemodynamics-and-risk-assessment-2-years-after-the-initiation-of2026-10-06 https://evidence-hub.com/study/66269-aliskiren-tadalafil-and-cinnamaldehyde-alleviate-joint-destruction2026-10-06 https://evidence-hub.com/study/66270-repurposing-erectile-dysfunction-drugs-tadalafil-and-vardenafil-to2026-10-06 https://evidence-hub.com/study/66271-falsified-tadalafil-tablets-distributed-in-japan-via-the-internet2026-10-06 https://evidence-hub.com/study/66272-surgical-suture-assembled-with-tadalafil-polycaprolactone-drug2026-10-04 https://evidence-hub.com/study/66273-whether-adding-vitamin-d-to-tadalafil-5-mg-treatment-is-useful-in2026-10-06 https://evidence-hub.com/study/66274-tamsulosin-and-placebo-vs-tamsulosin-and-tadalafil-in-male-lower2026-10-06 https://evidence-hub.com/study/66275-tadalafil-may-improve-cerebral-perfusion-in-small-vessel-occlusion2026-10-06 https://evidence-hub.com/study/66276-tadalafil-loaded-limonene-based-orodispersible-tablets-formulation-in2026-10-19 https://evidence-hub.com/study/66277-protective-and-therapeutic-effects-of-sildenafil-and-tadalafil-on2026-10-06 https://evidence-hub.com/study/66278-d-optimal-design-as-a-useful-tool-response-surface-methodology-for2026-10-06 https://evidence-hub.com/study/66279-tadalafil-ameliorates-memory-deficits-oxidative-stress-endothelial2026-10-19 https://evidence-hub.com/study/66280-a-novel-multifaceted-approach-for-wound-healing-optimization-and-in2026-10-06 https://evidence-hub.com/study/66281-the-daily-therapy-with-l-arginine-2-500-mg-and-tadalafil-5-mg-in2026-10-06 https://evidence-hub.com/study/66283-chronic-inhibition-of-phosphodiesterase-5-with-tadalafil-affords2026-10-06 https://evidence-hub.com/study/66284-effect-of-supersaturation-on-absorption-of-indomethacin-and-tadalafil2026-10-06 https://evidence-hub.com/study/66285-evaluation-of-combined-therapeutic-effects-of-hydrogen-sulfide-donor2026-10-06 https://evidence-hub.com/study/66287-simultaneous-determination-of-citalopram-and-tadalafil-by-the-second2026-10-06 https://evidence-hub.com/study/66288-a-novel-analytical-method-for-simultaneous-quantification-of2026-10-06 https://evidence-hub.com/study/66289-tadalafil-treatment-improves-cardiac-renal-and-lower-urinary-tract2026-10-04 https://evidence-hub.com/study/66290-tadalafil-restores-long-term-memory-and-synaptic-plasticity-in-mice2026-10-04 https://evidence-hub.com/study/66291-smart-spectrophotometric-assessment-of-tamsulosin-hydrochloride-and2026-10-06 https://evidence-hub.com/study/66292-a-novel-drug-drug-coamorphous-system-without-molecular-interactions2026-10-06 https://evidence-hub.com/study/66293-enhancement-of-the-apparent-solubility-and-bioavailability-of2026-10-06 https://evidence-hub.com/study/66294-sildenafil-and-tadalafil-reduce-the-risk-of-contrast-induced2026-10-10 https://evidence-hub.com/study/66295-investigation-of-dissolution-mechanism-and-release-kinetics-of-poorly2026-10-06 https://evidence-hub.com/study/66296-development-of-an-analytical-method-based-on-citric-acid-coated2026-10-06 https://evidence-hub.com/study/66297-effects-of-macitentan-and-tadalafil-monotherapy-or-their-combination2026-10-06 https://evidence-hub.com/study/66298-the-phosphodiesterase-5-inhibitor-tadalafil-has-renoprotective2026-10-06 https://evidence-hub.com/study/66299-protective-effects-of-tadalafil-on-prostatic-hyperplasia-in2026-10-06 https://evidence-hub.com/study/66300-efficacy-and-safety-of-low-intensity-shockwave-therapy-plus-tadalafil2026-10-06 https://evidence-hub.com/study/66301-tadalafil-treatment-in-mice-for-preeclampsia-with-fetal-growth2026-10-06 https://evidence-hub.com/study/66302-inhibitory-effects-of-sildenafil-and-tadalafil-on-inflammation2026-10-10 https://evidence-hub.com/study/66303-a-post-marketing-clinical-study-of-ly450190-combined-with-alpha12026-10-19 https://evidence-hub.com/study/66304-switching-from-sildenafil-citrate-to-tadalafil-in-treatment-of2026-10-04 https://evidence-hub.com/study/66305-a-randomised-double-blind-placebo-controlled-study-to-evaluate-the2026-10-04 https://evidence-hub.com/study/66306-non-ablative-erbium-yag-laser-transurethral-treatment-for-chronic2026-10-04 https://evidence-hub.com/study/66307-a-phase-1-study-to-demonstrate-the-relative-bioavailability-of-fixed2026-10-04 https://evidence-hub.com/study/66308-a-randomized-double-blind-parallel-group-placebo-controlled-study2026-10-04 https://evidence-hub.com/study/66309-define-in-preclinical-diastolic-dysfunction-pdd-with-renal2026-10-04 https://evidence-hub.com/study/66310-a-randomized-double-blind-parallel-design-placebo-controlled-study-to2026-10-04 https://evidence-hub.com/study/66311-a-randomized-controlled-double-blind-trial-for-prevention-of2026-10-04 https://evidence-hub.com/study/66312-a-randomized-double-blind-placebo-controlled-study-of-the-efficacy2026-10-04 https://evidence-hub.com/study/66313-prospective-multicenter-open-label-study-evaluating-the-effects-of2026-10-04 https://evidence-hub.com/study/66314-comparison-of-mirabegron-tamsulosin-and-solifenacinin-relieving2026-10-04 https://evidence-hub.com/study/66315-effect-of-tadalafil-on-exercise-capacity-in-pediatric-fontan-patients2026-10-04 https://evidence-hub.com/study/66316-a-randomized-open-label-crossover-multicenter-single-dose-comparator2026-10-10 https://evidence-hub.com/study/66317-a-randomized-controlled-trial-of-the-effects-of-tadalafil-and2026-10-04 https://evidence-hub.com/study/66318-a-single-center-open-label-single-dose-randomized-2-way-crossover2026-10-04 https://evidence-hub.com/study/66319-tadalafil-combined-with-low-energy-pulsed-ultrasound-lipus-for-the2026-10-04 https://evidence-hub.com/study/66320-a-randomized-open-label-multiple-dosing-2-way-crossover-study-to2026-10-04 https://evidence-hub.com/study/66321-a-phase-2-study-of-the-safety-efficacy-and-immune-response-of-crs-2072026-10-04 https://evidence-hub.com/study/66322-effect-of-tadalafil-on-insulin-secretion-and-insulin-sensitivity-in2026-10-04 https://evidence-hub.com/study/66323-a-randomized-placebo-controlled-trial-of-tadalafil-for-erectile2026-10-04 https://evidence-hub.com/study/66324-a-randomized-double-blind-parallel-design-placebo-controlled-study-to2026-10-04 https://evidence-hub.com/study/66325-an-open-label-multicenter-study-of-ambrisentan-and-a2026-10-10 https://evidence-hub.com/study/66326-effect-of-tadalafil-on-the-quality-of-life-and-sexual-life-in2026-10-04 https://evidence-hub.com/study/66327-o-a-prospective-randomized-open-label-phase-ii-study-evaluating-the2026-10-04 https://evidence-hub.com/study/66328-phosphodiesterase-5-inhibitor-tadalafil-two-weeks-administration2026-10-04 https://evidence-hub.com/study/66329-a-randomized-double-blind-placebo-controlled-parallel-design2026-10-04 https://evidence-hub.com/study/66330-the-effect-of-tadalafil-on-cerebral-large-arteries-in-stroke-patients2026-10-04 https://evidence-hub.com/study/66331-does-presence-of-distress-due-to-erectile-dysfunction-affect-the2026-10-04 https://evidence-hub.com/study/66332-phosphodiesterase-type-5-inhibition-with-tadalafil-changes-outcomes2026-10-04 https://evidence-hub.com/study/66333-a-randomized-double-blind-placebo-controlled-phase-3-trial-of2026-10-04 https://evidence-hub.com/study/66334-clinical-trial-to-evaluate-the-efficacy-and-safety-of-ckd-397-in2026-10-19 https://evidence-hub.com/study/66335-a-phase-2-randomized-double-blind-placebo-controlled-parallel-design2026-10-19 https://evidence-hub.com/study/66336-a-randomized-trial-of-pharmacological-penile-rehabilitation-in-the2026-10-10 https://evidence-hub.com/study/66337-tadalafil-once-daily-following-as-needed-phosphodiesterase-type-52026-10-04 https://evidence-hub.com/study/66338-a-randomized-double-blind-placebo-controlled-parallel-design2026-10-19 https://evidence-hub.com/study/66339-low-intensity-shockwave-therapy-list-for-the-treatment-of-mild-and2026-10-04 https://evidence-hub.com/study/66340-efficacy-and-safety-of-once-daily-administration-tadalafil-in2026-10-19 https://evidence-hub.com/study/66341-phase-3-randomized-trial-of-tadalafil-and-glycemic-traits2026-10-04 https://evidence-hub.com/study/66342-a-study-to-evaluate-the-pharmacokinetics-of-tadalafil-administered2026-10-04 https://evidence-hub.com/study/66343-functional-muscle-ischemia-and-pde5a-inhibition-in-becker-muscular2026-10-04 https://evidence-hub.com/study/66344-a-single-center-open-label-single-dose-randomized-3-way-crossover2026-10-04 https://evidence-hub.com/study/66345-an-extension-study-to-evaluate-the-long-term-safety-and-efficacy-of2026-10-04 https://evidence-hub.com/study/66346-efficacy-of-transcutaneous-electrical-neural-stimulation-and2026-10-04 https://evidence-hub.com/study/66347-a-randomized-open-label-single-dose-2-treatment-2-way-2-period2026-10-04 https://evidence-hub.com/study/66348-a-phase-3-randomized-double-blind-placebo-controlled-parallel-design2026-10-19 https://evidence-hub.com/study/66349-ly2452473-formulation-exploratory-bioavailability-study2026-10-04 https://evidence-hub.com/study/66350-efficacy-of-intracavernosal-injection-of-platelet-rich-plasma-alone2026-10-04 https://evidence-hub.com/study/66351-a-randomized-double-blind-parallel-placebo-controlled-study-to2026-10-04 https://evidence-hub.com/study/66352-multi-center-randomized-placebo-and-positive-controlled-clinical2026-10-04 https://evidence-hub.com/study/66353-early-postoperative-triple-targeted-therapy-in-patients-with-chd-pah2026-10-04 https://evidence-hub.com/study/66354-a-multicenter-open-label-study-to-determine-treatment-preference-of2026-10-10 https://evidence-hub.com/study/66355-a-phase-3-randomized-double-blind-placebo-controlled-parallel-design2026-10-19 https://evidence-hub.com/study/66356-tadalafil-for-pulmonary-hypertension-associated-with-chronic-lung2026-10-04 https://evidence-hub.com/study/66357-a-randomized-placebo-controlled-double-blinded-parallel-phase-2a2026-10-04 https://evidence-hub.com/study/66358-a-randomized-double-blind-placebo-controlled-phase-iii-trial-to2026-10-04 https://evidence-hub.com/study/66359-a-phase-3-randomized-double-blind-placebo-controlled-parallel-design2026-10-19 https://evidence-hub.com/study/66360-pilot-study-of-phosphodiesterase-5-inhibitor-tadalafil-cialis-as-an2026-10-04 https://evidence-hub.com/study/66361-randomized-placebo-controlled-double-blind-cross-over-trial-of-the2026-10-04 https://evidence-hub.com/study/66362-skeletal-muscle-blood-flow-in-becker-muscular-dystrophy2026-10-04 https://evidence-hub.com/study/66363-a-multi-centre-randomised-open-label-home-use-parallel-group-clinical2026-10-04 https://evidence-hub.com/study/66364-a-multicenter-parallel-arm-placebo-controlled-double-blind-study-to2026-10-19 https://evidence-hub.com/study/66365-effect-of-different-dosing-regimens-of-tadalafil-or-tamsulosin2026-10-19 https://evidence-hub.com/study/66366-investigational-and-comparative-study-to-assess-safety-and2026-10-04 https://evidence-hub.com/study/66367-a-comparison-of-psychosocial-outcomes-following-tadalafil-once-a-day2026-10-10 https://evidence-hub.com/study/66368-a-phase-3-randomized-double-blind-placebo-and-tamsulosin-controlled2026-10-19 https://evidence-hub.com/study/66369-daily-oral-l-arginine-plus-tadalafil-in-diabetic-patients-with2026-10-04 https://evidence-hub.com/study/66370-low-dose-tadalafil-5mg-for-treatment-of-female-overactive-bladder2026-10-04 https://evidence-hub.com/study/66371-a-phase-i-study-of-ranolazine-acute-administration-and-short-term2026-10-08 https://evidence-hub.com/study/66372-prospective-case-crossover-study-to-assess-whether-pde5-inhibitor2026-10-04 https://evidence-hub.com/study/66373-a-phase-ii-trial-of-tadalafil-in-patients-with-squamous-cell2026-10-04 https://evidence-hub.com/study/66374-a-double-blind-efficacy-and-safety-study-of-the-phosphodiesterase2026-10-04 https://evidence-hub.com/study/66375-a-study-to-investigate-the-pharmacokinetic-drug-interactions-between2026-10-04 https://evidence-hub.com/study/66376-single-dose-oral-bioequivalence-study-of-macitentan-and-tadalafil2026-10-04 https://evidence-hub.com/study/66377-comparative-study-between-silodosin-tamsulosin-silodosin-plus2026-10-04 https://evidence-hub.com/study/66378-safety-and-pharmacokinetic-interaction-study-of-tadalafil-and2026-10-04 https://evidence-hub.com/study/66379-tadalafil-for-the-treatment-of-secondary-raynaud-s-phenomenon2026-10-04 https://evidence-hub.com/study/66380-assessment-of-single-dose-oral-tadalafil-pharmacokinetic2026-10-04 https://evidence-hub.com/study/66381-clinical-efficacy-of-phosphodiesterase-5-inhibitor-tadalafil-in2026-10-04 https://evidence-hub.com/study/66382-a-randomized-double-blind-placebo-controlled-study-to-evaluate-the2026-10-04 https://evidence-hub.com/study/66383-the-efficacy-of-phosphodiesterase-inhibitors-in-patients-with-group-22026-10-04 https://evidence-hub.com/study/66384-the-effect-of-combination-therapy-using-li-eswt-low-intensity2026-10-04 https://evidence-hub.com/study/66385-comparison-between-the-effect-of-intracavernosal-injection-of2026-10-04 https://evidence-hub.com/study/66386-an-evaluation-of-tadalafil-and-sildenafil-treatment-in-men-with2026-10-10 https://evidence-hub.com/study/66387-tadalafil-5-mg-once-a-day-compared-to-placebo-in-improving-erectile2026-10-04 https://evidence-hub.com/study/66388-phase-ii-study-of-nivolumab-anti-pd1-tadalafil-and-oral-vancomycin-in2026-10-04 https://evidence-hub.com/study/66389-single-center-open-label-single-dose-2-period-randomized-crossover2026-10-04 https://evidence-hub.com/study/66390-efficacy-and-safety-of-tadalafil-tamsulosin-and-their-combinations-in2026-10-19 https://evidence-hub.com/study/66391-a-randomised-double-blind-double-dummy-parallel-group-active2026-10-04 https://evidence-hub.com/study/66392-safety-and-efficacy-of-l-arginine-monotherapy-versus-tadalafil2026-10-04 https://evidence-hub.com/study/66393-a-multi-center-randomized-double-blinded-double-dummy-parallel-group2026-10-19 https://evidence-hub.com/study/66394-actual-use-trial-to-switch-tadalafil-5-mg-tablets-from-prescription2026-10-04 https://evidence-hub.com/study/66395-tadalafil-and-acetazolamide-versus-acetazolamide-in-acute-mountain2026-10-04 https://evidence-hub.com/study/66396-efficacy-and-tolerability-of-tadalafil-5mg-once-daily-versus2026-10-04 https://evidence-hub.com/study/66397-effect-of-pde5-inhibition-on-adipose-metabolism-in-humans2026-10-04 https://evidence-hub.com/study/66398-administration-of-an-oral-pde5-inhibitor-tadalafil-in-conjunction2026-10-04 https://evidence-hub.com/study/66399-a-randomized-open-label-oral-single-dosing-two-way-crossover-clinical2026-10-04 https://evidence-hub.com/study/66400-assessment-of-serum-ykl-40-level-and-platelets-indices-among-patients2026-10-04 https://evidence-hub.com/study/66401-double-blind-placebo-controlled-randomized-study-of-co-administering2026-10-04 https://evidence-hub.com/study/66402-the-effect-of-selective-pde-5-inhibition-on-capillary-recruitment2026-10-04 https://evidence-hub.com/study/66403-tadalafil-pharmacokinetics-in-healthy-subjects2026-10-04 https://evidence-hub.com/study/66404-tadalafil-therapy-for-pulmonary-arterial-hypertension2026-10-04 https://evidence-hub.com/study/66405-the-efficacy-and-safety-of-tadalafil-an-update2026-10-04 https://evidence-hub.com/study/66406-tadalafil-in-the-treatment-of-erectile-dysfunction2026-10-19 https://evidence-hub.com/study/66408-efficacy-and-safety-of-daily-tadalafil-in-men-with-erectile2026-10-04 https://evidence-hub.com/study/66410-comparison-of-efficacy-safety-and-tolerability-of-on-demand-tadalafil2026-10-04 https://evidence-hub.com/study/66411-overview-of-the-cardiovascular-effects-of-tadalafil2026-10-04 https://evidence-hub.com/study/66413-effects-of-tadalafil-on-erectile-dysfunction-in-men-with-diabetes2026-10-04 https://evidence-hub.com/study/66415-tadalafil-cialistm-for-men-with-erectile-dysfunction2026-10-04 https://evidence-hub.com/study/66418-efficacy-and-safety-of-tadalafil-for-the-treatment-of-erectile2026-10-04 https://evidence-hub.com/study/66423-initial-experience-with-tadalafil-in-pediatric-pulmonary-arterial2026-10-04 https://evidence-hub.com/study/66425-physicochemical-characterization-of-solid-dispersion-systems-of2026-10-04 https://evidence-hub.com/study/66426-tadalafil-has-no-detrimental-effect-on-human-spermatogenesis-or2026-10-04 https://evidence-hub.com/study/66427-tadalafil-relieves-lower-urinary-tract-symptoms-secondary-to-benign2026-10-19 https://evidence-hub.com/study/66428-pharmacokinetic-interaction-between-tadalafil-and-bosentan-in-healthy2026-10-04 https://evidence-hub.com/study/66430-both-tadalafil-and-dexamethasone-may-reduce-the-incidence-of-high2026-10-04 https://evidence-hub.com/study/66431-ic351-tadalafil-cialis-update-on-clinical-experience2026-10-04 https://evidence-hub.com/study/66432-efficacy-of-continuous-dosing-of-tadalafil-once-daily-vs-tadalafil-on2026-10-04 https://evidence-hub.com/study/66433-dissolution-enhancement-of-tadalafil-by-liquisolid-technique2026-10-04 https://evidence-hub.com/study/66434-tadalafil-for-treatment-of-erectile-dysfunction-in-men-on2026-10-04 https://evidence-hub.com/study/66436-tadalafil-a-clinical-update2026-10-04 https://evidence-hub.com/study/66438-conversion-from-sildenafil-to-tadalafil-results-from-the-sildenafil2026-10-04 https://evidence-hub.com/study/66447-tadalafil-in-primary-pulmonary-arterial-hypertension2026-10-04 https://evidence-hub.com/study/66458-tadalafil-in-the-treatment-of-erectile-dysfunction2026-10-04 https://evidence-hub.com/study/66469-tadalafil-a-novel-treatment-for-erectile-dysfunction2026-10-04 https://evidence-hub.com/study/66480-macitentan-and-tadalafil-opsynvi2026-10-04 https://evidence-hub.com/study/66486-erectile-function-recovery-in-men-treated-with-phosphodiesterase-type2026-10-04 https://evidence-hub.com/study/66487-the-effect-of-oral-phosphodiesterase-5-inhibitors-on-sperm-parameters2026-10-08 https://evidence-hub.com/study/66488-phosphodiesterase-5-inhibitors-use-and-the-risk-of-alzheimer-s2026-10-19 https://evidence-hub.com/study/66489-genome-wide-interaction-study-with-major-depression-identifies-novel2026-10-06 https://evidence-hub.com/study/66490-strategies-for-managing-sexual-dysfunction-induced-by-antidepressant2026-10-08 https://evidence-hub.com/study/66491-efficacy-and-safety-of-phosphodiesterase-type-5-pde5-inhibitors-in2026-10-08 https://evidence-hub.com/study/66492-combining-testosterone-and-pde5-inhibitors-in-erectile-dysfunction2026-10-08 https://evidence-hub.com/study/66493-time-from-dosing-to-sexual-intercourse-attempts-in-men-taking2026-10-08 https://evidence-hub.com/study/66494-an-evidence-based-approach-to-writing-reviews-as-illustrated-by2026-10-08 https://evidence-hub.com/study/66495-exon-skipping-for-duchenne-muscular-dystrophy-a-systematic-review-and2026-10-06 https://evidence-hub.com/study/66496-assessment-of-combination-therapies-vs-monotherapy-for-erectile2026-10-19 https://evidence-hub.com/study/66497-analysis-of-phosphodiesterase-5-pde5-inhibitors-in-modulating2026-10-19 https://evidence-hub.com/study/66498-vasodilators-for-persistent-pulmonary-hypertension-of-the-newborn-a2026-10-08 https://evidence-hub.com/study/66499-systematic-review-and-meta-analysis-of-phosphodiesterase-type-52026-10-08 https://evidence-hub.com/study/66500-comparisons-of-regular-and-on-demand-regimen-of-ped5-is-in-the2026-10-10 https://evidence-hub.com/study/66501-interventions-affecting-the-nitric-oxide-pathway-versus-placebo-or-no2026-10-10 https://evidence-hub.com/study/66502-safety-and-efficacy-of-phosphodiesterase-5-pde-5-inhibitors-in-fetal2026-10-19 https://evidence-hub.com/study/66503-phosphodiesterase-5-inhibitors-for-the-treatment-of-secondary-raynaud2026-10-19 https://evidence-hub.com/study/66504-postmicturition-dribble-in-men-with-no-previous-urogenital-surgery2026-10-04 https://evidence-hub.com/study/66505-phosphodiesterase-5-inhibitors-in-pregnancy-systematic-review-and2026-10-08 https://evidence-hub.com/study/66506-efficacy-of-pde-5-inhibitors-for-erectile-dysfunction-a-comparative2026-10-10 https://evidence-hub.com/study/66507-cardiovascular-safety-update-of-tadalafil-retrospective-analysis-of2026-10-06 https://evidence-hub.com/study/66508-comparative-effectiveness-and-safety-of-oral-phosphodiesterase-type-52026-10-04 https://evidence-hub.com/study/66509-comparative-safety-of-drugs-targeting-the-nitric-oxide-pathway-in2026-10-08 https://evidence-hub.com/study/66510-efficacy-and-safety-of-combination-comprising-tamsulosin-and-pde5-is2026-10-19 https://evidence-hub.com/study/66511-defining-the-efficacy-and-safety-of-phosphodiesterase-type-52026-10-19 https://evidence-hub.com/study/66512-the-effect-of-phosphodiesterase-5-inhibitors-on-uteroplacental-and2026-10-08 https://evidence-hub.com/study/66513-efficacy-and-safety-of-pde5-is-and-1-blockers-for-treating-lower2026-10-19 https://evidence-hub.com/study/66514-factors-associated-with-ejaculatory-and-orgasmic-dysfunction-in-men2026-10-06 https://evidence-hub.com/study/66515-comparison-of-efficacy-of-various-drugs-used-for-medical-expulsive2026-10-08 https://evidence-hub.com/study/66516-deflazacort-vs-prednisone-treatment-for-duchenne-muscular-dystrophy-a2026-10-06 https://evidence-hub.com/study/66517-which-pde5-inhibitor-is-the-most-effective-in-the-treatment-of2026-10-19 https://evidence-hub.com/study/66518-phosphodiesterase-inhibitors-for-erectile-dysfunction-in-patients2026-10-08 https://evidence-hub.com/study/66519-phosphodiesterase-type-5-inhibitor-plus-endothelin-receptor2026-10-10 https://evidence-hub.com/study/66520-efficacy-and-safety-of-novel-targeted-drugs-in-the-treatment-of2026-10-10 https://evidence-hub.com/study/66521-a-bayesian-network-meta-analysis-on-the-efficacy-and-safety-of2026-10-19 https://evidence-hub.com/study/66522-comparative-effectiveness-and-safety-of-monodrug-therapies-for-lower2026-10-19 https://evidence-hub.com/study/66523-the-safety-and-efficacy-of-phosphodiesterase-type-5-inhibitors-in-the2026-10-08 https://evidence-hub.com/study/66524-doxazosin-versus-tamsulosin-for-the-treatment-of-male-lower-urinary2026-10-19 https://evidence-hub.com/study/66525-the-influence-of-pre-stenting-and-drugs-on-the-outcomes-of2026-10-04 https://evidence-hub.com/study/66526-low-intensity-shockwave-therapy-for-erectile-dysfunction-due-to2026-10-06 https://evidence-hub.com/study/66527-comparative-efficacy-of-combination-therapy-including-regenerative2026-10-04 https://evidence-hub.com/study/66528-effects-of-pulmonary-arterial-hypertension-therapies-on-arterial2026-10-08 https://evidence-hub.com/study/66529-which-combination-of-medical-expulsive-therapy-is-more-effective-for2026-10-04 https://evidence-hub.com/study/66530-meta-analysis-of-targeted-drugs-for-pulmonary-hypertension-to-improve2026-10-08 https://evidence-hub.com/study/66531-sildenafil-and-risk-of-alzheimer-disease-a-systematic-review-and-meta2026-10-08 https://evidence-hub.com/study/66532-biomarkers-of-neoadjuvant-immunotherapy-for-locally-advanced-head-and2026-10-06 https://evidence-hub.com/study/66533-low-dose-versus-high-dose-intravenous-nitroglycerin-in-the-treatment2026-10-08 https://evidence-hub.com/study/66534-comparative-efficacy-of-solifenacin-and-tamsulosin-in-alleviating2026-10-19 https://evidence-hub.com/study/66535-high-prevalence-of-erectile-dysfunction-in-men-with-hyperthyroidism-a2026-10-08 https://evidence-hub.com/study/66536-the-effectiveness-of-vasodilators-on-chronic-obstructive-pulmonary2026-10-10 https://evidence-hub.com/study/66537-determining-the-minimum-important-differences-for-field-walking-tests2026-10-13 https://evidence-hub.com/study/66538-an-increased-risk-of-pulmonary-hypertension-in-patients-with-combined2026-10-08 https://evidence-hub.com/study/66539-pharmacology-management-in-improving-exercise-capacity-of-patients2026-10-10 https://evidence-hub.com/study/66540-low-intensity-shockwave-therapy-for-erectile-dysfunction2026-10-19 https://evidence-hub.com/study/66541-a-systematic-review-and-network-meta-analysis-of-pharmaceutical2026-10-06 https://evidence-hub.com/study/66542-phosphodiesterase-type-5-inhibitors-for-erectile-dysfunction2026-10-10 https://evidence-hub.com/study/66543-pulmonary-artery-denervation-versus-conventional-therapies-for-pah-a2026-10-10 https://evidence-hub.com/study/66544-phosphodiesterase-5-inhibitors-for-the-treatment-of-heart-failure-a2026-10-10 https://evidence-hub.com/study/66545-pulmonary-hypertension-survival-and-hospitalisations-in-people-living2026-10-08 https://evidence-hub.com/study/66546-pulmonary-arterial-hypertension-treatment-an-individual-participant2026-10-08 https://evidence-hub.com/study/66547-comparison-of-efficacy-of-three-commonly-used-alpha-blockers-as2026-10-10 https://evidence-hub.com/study/66548-evidence-synthesis-in-pulmonary-arterial-hypertension-a-systematic2026-10-08 https://evidence-hub.com/study/66549-bmi-and-treatment-response-in-patients-with-pulmonary-arterial2026-10-06 https://evidence-hub.com/study/66550-heterogeneity-of-treatment-effects-by-risk-in-pulmonary-arterial2026-10-06 https://evidence-hub.com/study/66551-erectile-dysfunction-and-penile-rehabilitation-after-pelvic-fracture2026-10-10 https://evidence-hub.com/study/66552-long-term-outcomes-in-patients-with-connective-tissue-disease2026-10-08 https://evidence-hub.com/study/66553-efficacy-and-safety-of-adrenergic-alpha-1-receptor-antagonists-in2026-10-19 https://evidence-hub.com/study/66554-vaccines-for-preventing-infections-in-adults-with-solid-tumours2026-10-10 https://evidence-hub.com/study/66555-is-low-risk-status-a-surrogate-outcome-in-pulmonary-arterial2026-10-06 https://evidence-hub.com/study/66556-phosphodiesterase-inhibitors-for-lower-urinary-tract-symptoms2026-10-19 https://evidence-hub.com/study/66557-placebo-responses-among-men-with-erectile-dysfunction-enrolled-in2026-10-06 https://evidence-hub.com/study/66558-efficacy-of-aspirin-for-vasculogenic-erectile-dysfunction-in-men-a2026-10-10 https://evidence-hub.com/study/66559-endothelin-receptor-antagonists-for-pulmonary-arterial-hypertension2026-10-10 https://evidence-hub.com/study/66560-medications-for-the-treatment-of-pulmonary-arterial-hypertension-a2026-10-06 https://evidence-hub.com/study/66561-therapeutic-options-for-patients-with-rare-rheumatic-diseases-a2026-10-10 https://evidence-hub.com/study/66562-efficacy-and-safety-of-phosphodiesterase-5-inhibitors-for-erectile2026-10-19 https://evidence-hub.com/study/66563-meta-analysis-of-the-long-term-efficacy-and-tolerance-of-tadalafil2026-10-19 https://evidence-hub.com/study/66564-a-letter-to-the-editor-concerning-the-meta-analysis-by-zhou-et-al2026-10-19 https://evidence-hub.com/study/66565-response-to-letter-to-the-editor-meta-analysis-of-the-long-term2026-10-19 https://evidence-hub.com/study/66567-a64-05-comparative-efficacy-of-pharmacologic-interventions-for2026-10-19 https://evidence-hub.com/study/66568-effect-of-phosphodiesterase-5-inhibitors-on-the-treatment-of-male2026-10-08 https://evidence-hub.com/study/66570-re-efficacy-and-safety-of-tadalafil-monotherapy-for-lower-urinary2026-10-19 https://evidence-hub.com/study/66571-acupuncture-for-treatment-of-erectile-dysfunction-a-systematic-review2026-10-04 https://evidence-hub.com/study/66576-combination-therapies-for-erectile-dysfunction-a-synergy-of2026-10-06 https://evidence-hub.com/study/66577-efficacy-and-tolerability-of-combination-therapy-with-alpha-blockers2026-10-19 https://evidence-hub.com/study/66578-are-phosphodiesterase-type-5-inhibitors-effective-for-the-management2026-10-19 https://evidence-hub.com/study/66579-to-evaluate-the-efficacy-and-safety-of-different-kinds-of-pde5-is2026-10-19 https://evidence-hub.com/study/66585-nutraceutical-interventions-for-erectile-dysfunction-a-systematic2026-10-19 https://evidence-hub.com/study/66586-silodosin-in-treating-men-with-bph-associated-lower-urinary-tract2026-10-19 https://evidence-hub.com/study/66587-long-term-effects-of-phosphodiesterase-5-inhibitors-on-cardiovascular2026-10-08 https://evidence-hub.com/study/66588-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/66589-comorbid-luts-and-erectile-dysfunction-optimizing-their-management2026-10-06 https://evidence-hub.com/study/66590-are-we-overstating-the-risk-of-priapism-with-oral-phosphodiesterase2026-10-06 https://evidence-hub.com/study/66591-negative-effects-on-sexual-function-of-medications-for-the-treatment2026-10-06 https://evidence-hub.com/study/66592-oral-phosphodiesterase-type-5-inhibitors-nonerectogenic-beneficial2026-10-19 https://evidence-hub.com/study/66593-unconsummated-marriage-a-systematic-review-of-etiological-factors-and2026-10-10 https://evidence-hub.com/study/66594-pharmacologic-treatment-of-idiopathic-chilblains-pernio-a-systematic2026-10-04 https://evidence-hub.com/study/66595-oral-therapy-for-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/66596-the-relationship-between-the-history-of-pde5-inhibitors-assumption2026-10-06 https://evidence-hub.com/study/66597-phosphodiesterases-5-inhibitors-and-erectile-dysfunction-recovery2026-10-06 https://evidence-hub.com/study/66598-a-systematic-review-of-regulatory-approved-drugs-and-pharmacological2026-10-08 https://evidence-hub.com/study/66599-strategies-for-managing-antidepressant-induced-sexual-dysfunction2026-10-04 https://evidence-hub.com/study/66600-cardiovascular-safety-of-the-recreational-use-of-cannabis-associated2026-10-08 https://evidence-hub.com/study/66601-indirect-comparison-of-interventions-using-published-randomised2026-10-10 https://evidence-hub.com/study/66602-appropriateness-of-oral-drugs-for-long-term-treatment-of-lower2026-10-06 https://evidence-hub.com/study/66603-efficacy-of-newer-medications-for-lower-urinary-tract-symptoms2026-10-19 https://evidence-hub.com/study/66604-management-of-pulmonary-arterial-hypertension-in-systemic-sclerosis2026-10-10 https://evidence-hub.com/study/66605-drugs-targeting-the-no-sgc-cgmp-pathway-in-the-treatment-of-patients2026-10-08 https://evidence-hub.com/study/66606-management-of-inflammatory-cardiopulmonary-manifestations-in-systemic2026-10-10 https://evidence-hub.com/study/66607-compound-xuanju-capsules-combined-with-phosphodiesterase-5-inhibitors2026-10-10 https://evidence-hub.com/study/66608-hard-flaccid-syndrome-a-systematic-review-of-aetiopathophysiology2026-10-10 https://evidence-hub.com/study/66609-inhaled-nitric-oxide-for-bronchopulmonary-dysplasia-associated2026-10-08 https://evidence-hub.com/study/66610-a-systematic-review-on-administration-of-botulinum-toxin-in-the2026-10-10 https://evidence-hub.com/study/66611-medical-therapies-for-pediatric-lymphatic-malformations-a-systematic2026-10-08 https://evidence-hub.com/study/66612-sexual-health-after-neurological-disorders-a-comprehensive-umbrella2026-10-08 https://evidence-hub.com/study/66613-the-specific-medications-for-pulmonary-arterial-hypertension-at2026-10-08 https://evidence-hub.com/study/66614-platelet-rich-plasma-prp-and-the-future-of-male-fertility-a-path2026-10-06 https://evidence-hub.com/study/66615-developing-treatments-for-cerebral-small-vessel-disease-a-scoping2026-10-19 https://evidence-hub.com/study/66616-global-hotspots-and-trends-in-pre-metastatic-niche-research-a2026-10-08 https://evidence-hub.com/study/66617-efficacy-evaluation-of-pulmonary-hypertension-therapy-in-patients2026-10-10 https://evidence-hub.com/study/66618-vasoactive-drugs-for-the-treatment-of-pulmonary-hypertension2026-10-08 https://evidence-hub.com/study/66619-beyond-urodynamics-non-invasive-approaches-to-diagnosing-detrusor2026-10-19 https://evidence-hub.com/study/66620-effects-of-oral-targeted-treatments-in-pulmonary-arterial2026-10-06 https://evidence-hub.com/study/66621-platelet-rich-plasma-therapy-in-erectile-dysfunction-and-peyronie-s2026-10-04 https://evidence-hub.com/study/66622-testosterone-replacement-in-men-with-sexual-dysfunction2026-10-19 https://evidence-hub.com/study/66623-penile-rehabilitation-and-treatment-options-for-erectile-dysfunction2026-10-10 https://evidence-hub.com/study/66624-exploring-the-economic-burden-of-pulmonary-arterial-hypertension-and2026-10-08 https://evidence-hub.com/study/66625-urinary-incontinence-rehabilitation-of-after-radical-prostatectomy-a2026-10-06 https://evidence-hub.com/study/66626-effect-of-phosphodiesterase-type-5-inhibitors-on-erectile-function-an2026-10-19 https://evidence-hub.com/study/66627-efficacy-and-safety-of-switching-from-bosentan-or-ambrisentan-to2026-10-06 https://evidence-hub.com/study/66628-systemic-pharmacological-treatment-of-digital-ulcers-in-systemic2026-10-10 https://evidence-hub.com/study/66629-new-progress-in-diagnosis-and-treatment-of-pulmonary-arterial2026-10-06 https://evidence-hub.com/study/66630-silodosin-versus-tamsulosin-for-medical-expulsive-therapy-of-ureteral2026-10-06 https://evidence-hub.com/study/66631-a-systematic-review-of-neoadjuvant-and-definitive-immunotherapy-in2026-10-06 https://evidence-hub.com/study/66632-pudendal-nerve-neurolysis-outcomes-for-urogenital-and-rectal2026-10-06 https://evidence-hub.com/study/66633-is-it-worth-starting-sexual-rehabilitation-before-radical2026-10-06 https://evidence-hub.com/study/66634-european-stroke-organisation-eso-guideline-on-cerebral-small-vessel2026-10-10 https://evidence-hub.com/study/66635-effects-of-diet-and-antihyperglycemic-drugs-on-erectile-dysfunction-a2026-10-19 https://evidence-hub.com/study/66637-a-systematic-review-of-medical-treatments-for-benign-prostatic2026-10-19 https://evidence-hub.com/study/66639-the-use-of-tadalafil-to-treat-lower-urinary-tract-symptoms-and2026-10-19 https://evidence-hub.com/study/66643-pde-5-inhibitors-implications-in-women-are-they-of-help2026-10-06 https://evidence-hub.com/study/66646-three-versus-two-drug-therapy-for-patients-with-newly-diagnosed2026-10-06 https://evidence-hub.com/study/66647-tadalafil-versus-tamsulosin-as-combination-therapy-with-5-alpha2026-10-19 https://evidence-hub.com/study/66648-comparison-of-three-different-tadalafil-regimens-for-erectile2026-10-06 https://evidence-hub.com/study/66649-multi-pharmacological-treatment-for-young-subfertile-males-with2026-10-13 https://evidence-hub.com/study/66650-erectile-dysfunction-after-therapy-with-metoprolol-the-hawthorne2026-10-06 https://evidence-hub.com/study/66651-phosphodiesterase-5-inhibition-improves-beta-cell-function-in2026-10-06 https://evidence-hub.com/study/66652-chronic-treatment-with-tadalafil-improves-endothelial-function-in-men2026-10-06 https://evidence-hub.com/study/66653-ultrastructural-study-of-clitoral-cavernous-tissue-and-clitoral-blood2026-10-06 https://evidence-hub.com/study/66654-population-pharmacokinetics-of-tadalafil-in-pediatric-patients-with2026-10-06 https://evidence-hub.com/study/66655-kangle-decoction-for-erectile-dysfunction-with-liver-qi-stagnation2026-10-06 https://evidence-hub.com/study/66656-dexamethasone-but-not-tadalafil-improves-exercise-capacity-in-adults2026-10-06 https://evidence-hub.com/study/66657-effects-of-acetazolamide-on-pulmonary-artery-pressure-and-prevention2026-10-06 https://evidence-hub.com/study/66658-cardiorenal-effects-of-long-term-phosphodiesterase-v-inhibition-in2026-10-10 https://evidence-hub.com/study/66659-low-dose-tadalafil-combined-with-shuganyiyang-capsules-for-mild-to2026-10-06 https://evidence-hub.com/study/66660-durability-of-response-following-cessation-of-tadalafil-taken-once2026-10-06 https://evidence-hub.com/study/66661-efficacy-of-levocarnitine-combined-with-tadalafil-in-treating2026-10-06 https://evidence-hub.com/study/66662-follow-up-functional-class-and-6-minute-walk-distance-identify-long2026-10-06 https://evidence-hub.com/study/66663-expression-of-the-pde5-enzyme-on-human-retinal-tissue-new-aspects-of2026-10-10 https://evidence-hub.com/study/66664-tamsulosin-versus-tadalafil-as-a-medical-expulsive-therapy-for-distal2026-10-19 https://evidence-hub.com/study/66665-pde5-inhibitors-blunt-inflammation-in-human-bph-a-potential-mechanism2026-10-19 https://evidence-hub.com/study/66666-clinical-outcomes-stratified-by-baseline-functional-class-after2026-10-06 https://evidence-hub.com/study/66667-the-effect-of-testosterone-therapy-on-erectile-dysfunction-in-type-22026-10-08 https://evidence-hub.com/study/66668-audiometry-results-and-teoae-and-dpoae-amplitudes-in-men-taking-a2026-10-06 https://evidence-hub.com/study/66669-risk-stratified-outcomes-with-initial-combination-therapy-in2026-10-06 https://evidence-hub.com/study/66670-the-phosphodiesterases-type-5-inhibitor-tadalafil-reduces-the2026-10-06 https://evidence-hub.com/study/66671-effects-of-different-medications-with-tadalafil-on-erectile2026-10-06 https://evidence-hub.com/study/66672-efficacy-of-adjusted-dose-tadalafil-for-treating-erectile-dysfunction2026-10-04 https://evidence-hub.com/study/66673-tadalafil-population-pharmacokinetics-in-patients-with-erectile2026-10-04 https://evidence-hub.com/study/66674-aspects-of-sexual-satisfaction-in-men-with-erectile-dysfunction-a2026-10-06 https://evidence-hub.com/study/66675-sex-differences-in-response-to-tadalafil-in-pulmonary-arterial2026-10-06 https://evidence-hub.com/study/66676-impact-of-baseline-total-testosterone-level-on-successful-treatment2026-10-19 https://evidence-hub.com/study/66677-through-the-eyes-of-women-the-partners-perspective-on-tadalafil2026-10-06 https://evidence-hub.com/study/66678-investigating-women-s-preference-for-sildenafil-or-tadalafil-use-by2026-10-06 https://evidence-hub.com/study/66679-low-dose-testosterone-undecanoate-capsules-combined-with-tadalafil2026-10-06 https://evidence-hub.com/study/66680-efficacy-and-safety-of-pde-5-inhibitor-tadalafil-in-pulmonary2026-10-06 https://evidence-hub.com/study/66681-tadalafil-dosed-once-a-day-in-men-with-erectile-dysfunction-a2026-10-06 https://evidence-hub.com/study/66682-dumai-moxibustion-combined-with-low-dose-tadalafil-for-erectile2026-10-06 https://evidence-hub.com/study/66683-positive-predictors-for-response-to-ambrisentan-combination-therapy2026-10-06 https://evidence-hub.com/study/66684-to-evaluate-the-efficacy-of-yishen-tongluo-decoction-combined-with2026-10-06 https://evidence-hub.com/study/66685-effect-of-phosphodiesterase-inhibition-on-insulin-resistance-in-obese2026-10-06 https://evidence-hub.com/study/66686-effects-of-tadalafil-on-erectile-dysfunction-on-demand-versus-once2026-10-06 https://evidence-hub.com/study/66687-tadalafil-reduces-myeloid-derived-suppressor-cells-and-regulatory-t2026-10-04 https://evidence-hub.com/study/66688-tadalafil-augments-tumor-specific-immunity-in-patients-with-head-and2026-10-04 https://evidence-hub.com/study/66689-the-effects-of-tadalafil-on-cold-induced-vasoconstriction-in-patients2026-10-04 https://evidence-hub.com/study/66690-tadalafil-improves-lean-mass-and-endothelial-function-in-nonobese-men2026-10-04 https://evidence-hub.com/study/66691-tadalafil-for-the-treatment-of-pulmonary-arterial-hypertension-a2026-10-04 https://evidence-hub.com/study/66692-tadalafil-monotherapy-and-as-add-on-to-background-bosentan-in2026-10-04 https://evidence-hub.com/study/66693-regional-cerebral-blood-flow-following-single-dose-and-continuous2026-10-06 https://evidence-hub.com/study/66694-effect-of-tadalafil-on-anaerobic-performance-indices-in-healthy2026-10-06 https://evidence-hub.com/study/66695-vardenafil-in-pulmonary-arterial-hypertension-a-randomized-double2026-10-06 https://evidence-hub.com/study/66696-population-dose-response-model-for-tadalafil-in-the-treatment-of-male2026-10-06 https://evidence-hub.com/study/66697-tadalafil-alleviates-muscle-ischemia-in-patients-with-becker-muscular2026-10-04 https://evidence-hub.com/study/66698-sexual-function-in-men-with-lower-urinary-tract-symptoms-and2026-10-06 https://evidence-hub.com/study/66699-effects-of-high-altitude-exposure-on-cerebral-hemodynamics-in-normal2026-10-06 https://evidence-hub.com/study/66700-treatment-satisfaction-and-clinically-meaningful-symptom-improvement2026-10-19 https://evidence-hub.com/study/66701-treatment-of-erectile-dysfunction-reduces-psychological-distress2026-10-06 https://evidence-hub.com/study/66702-tadalafil-5-mg-once-daily-for-the-treatment-of-asian-men-with-lower2026-10-19 https://evidence-hub.com/study/66703-sexual-asthenia-tradamixina-versus-tadalafil-5-mg-daily2026-10-04 https://evidence-hub.com/study/66704-randomized-placebo-controlled-crossover-trial-of-tadalafil-in-raynaud2026-10-06 https://evidence-hub.com/study/66705-efficacy-and-safety-of-tadalafil-20-mg-on-demand-vs-tadalafil-5-mg2026-10-06 https://evidence-hub.com/study/66706-effect-on-sexual-function-of-a-vacuum-erection-device-post2026-10-06 https://evidence-hub.com/study/66707-therapeutic-effect-of-tadalafil-on-lower-urinary-tract-symptoms-with2026-10-06 https://evidence-hub.com/study/66708-pharmaco-induced-erections-for-penile-color-duplex-ultrasound-oral2026-10-10 https://evidence-hub.com/study/66709-the-minimally-important-difference-in-the-six-minute-walk-test2026-10-06 https://evidence-hub.com/study/66710-l-arginine-role-for-stone-lower-ureter-a-randomized-controlled-trial2026-10-19 https://evidence-hub.com/study/66711-randomized-controlled-trial-of-vericiguat-in-patients-with-coronary2026-10-10 https://evidence-hub.com/study/66712-citrulline-supplementation-improves-microvascular-function-and-muscle2026-10-06 https://evidence-hub.com/study/66713-bioequivalence-and-the-food-effect-of-macitentan-tadalafil-10-202026-10-06 https://evidence-hub.com/study/66714-functional-outcomes-of-hypothermic-robot-assisted-radical2026-10-06 https://evidence-hub.com/study/66715-long-term-tadalafil-once-daily-in-chinese-men-with-erectile2026-10-19 https://evidence-hub.com/study/66716-shock-wave-therapy-in-the-treatment-of-erection-dysfunction-how-to2026-10-10 https://evidence-hub.com/study/66717-comparative-study-between-tamsulosin-silodosin-and-tadalafil-as-a2026-10-06 https://evidence-hub.com/study/66718-the-cardiorenal-effects-of-chronic-phosphodiesterase-v-inhibition-in2026-10-10 https://evidence-hub.com/study/66719-a-phase-2-randomized-placebo-controlled-study-on-the-efficacy-and2026-10-08 https://evidence-hub.com/study/66720-a-prospective-randomized-controlled-study-on-scheduled-pde5i-and2026-10-10 https://evidence-hub.com/study/66721-optimal-markers-of-treatment-response-to-vasodilatory-drugs-in-small2026-10-10 https://evidence-hub.com/study/66722-clinical-study-of-comprehensive-tcm-therapy-in-the-treatment-of-damp2026-10-06 https://evidence-hub.com/study/66723-extracellular-matrix-mycaf-signatures-correlate-with-resistance-to2026-10-06 https://evidence-hub.com/study/66724-pharmacokinetic-drug-interaction-between-amlodipine-and-tadalafil-an2026-10-06 https://evidence-hub.com/study/66725-pharmacokinetics-pharmacodynamics-and-safety-interaction-study-of2026-10-10 https://evidence-hub.com/study/66726-adjuvant-daily-therapy-with-l-arginine-2-500-mg-and-tadalafil-5-mg2026-10-10 https://evidence-hub.com/study/66727-impact-of-low-dose-tadalafil-on-adverse-events-after-low-dose-rate2026-10-19 https://evidence-hub.com/study/66728-efficacy-of-testosterone-replacement-therapy-plus-alternate-day2026-10-06 https://evidence-hub.com/study/66729-inhaled-treprostinil-in-pulmonary-hypertension-associated-with-copd2026-10-10 https://evidence-hub.com/study/66730-long-term-safety-and-tolerability-of-ambrisentan-treatment-for2026-10-10 https://evidence-hub.com/study/66731-the-effect-of-drug-holidays-on-sexual-dysfunction-in-men-treated-with2026-10-08 https://evidence-hub.com/study/66732-pharmacokinetic-and-bioequivalence-evaluation-of-2-tadalafil-tablets2026-10-06 https://evidence-hub.com/study/66733-effects-of-phosphodiesterase-v-inhibition-alone-and-in-combination2026-10-06 https://evidence-hub.com/study/66734-dihydrotestosterone-dht-rapidly-increase-after-maximal-aerobic2026-10-06 https://evidence-hub.com/study/66735-efficacy-and-safety-of-tadalafil-vs-tamsulosin-in-lower-urinary-tract2026-10-19 https://evidence-hub.com/study/66736-intrapartum-sildenafil-to-improve-perinatal-outcomes-a-randomized2026-10-08 https://evidence-hub.com/study/66737-a-sham-controlled-randomised-trial-of-pulmonary-artery-denervation2026-10-06 https://evidence-hub.com/study/66738-comparison-of-cernitin-pollen-extract-vs-tadalafil-therapy-for2026-10-06 https://evidence-hub.com/study/66739-a-randomized-double-blind-placebo-controlled-study-to-evaluate2026-10-06 https://evidence-hub.com/study/66740-riociguat-in-patients-with-sickle-cell-disease-and-hypertension-or2026-10-10 https://evidence-hub.com/study/66741-treatment-of-experimentally-induced-benign-prostatic-hyperplasia-with2026-10-06 https://evidence-hub.com/study/66742-intralesional-collagenase-clostridium-histolyticum-vs-verapamil2026-10-06 https://evidence-hub.com/study/66743-efficacy-and-safety-of-regular-use-of-sildenafil-in-the-treatment-of2026-10-10 https://evidence-hub.com/study/66744-adjuvant-administration-of-probiotic-effects-on-sexual-function-in2026-10-08 https://evidence-hub.com/study/66745-tadalafil-5-mg-once-daily-therapy-for-men-with-lower-urinary-tract2026-10-19 https://evidence-hub.com/study/66749-effect-of-tadalafil-on-blood-flow-pain-and-function-in-chronic-cold2026-10-06 https://evidence-hub.com/study/66750-platelet-count-and-function-at-high-altitude-and-in-high-altitude2026-10-06 https://evidence-hub.com/study/66751-the-efficacy-of-low-dose-tadalafil-in-patients-undergoing2026-10-10 https://evidence-hub.com/study/66752-phosphodiesterase-5-inhibitor-in-eisenmenger-syndrome-a-preliminary2026-10-06 https://evidence-hub.com/study/66753-long-term-results-of-autologous-venous-grafts-for-penile2026-10-06 https://evidence-hub.com/study/66754-evaluation-of-erectile-function-after-laparoscopic-radical2026-10-06 https://evidence-hub.com/study/66755-tadalafil-induced-improvement-in-left-ventricular-diastolic-function2026-10-06 https://evidence-hub.com/study/66756-effect-of-tadalafil-on-erectile-dysfunction-in-male-patients-with2026-10-04 https://evidence-hub.com/study/66757-perfusion-by-arterial-spin-labelling-following-single-dose-tadalafil2026-10-06 https://evidence-hub.com/study/66758-exercise-training-improves-erectile-dysfunction-ed-in-patients-with2026-10-06 https://evidence-hub.com/study/66759-vardenafil-rescue-rates-of-sildenafil-nonresponders-objective2026-10-10 https://evidence-hub.com/study/66760-treatment-satisfaction-with-tadalafil-or-tamsulosin-vs-placebo-in-men2026-10-19 https://evidence-hub.com/study/66761-effect-of-atorvastatin-on-erectile-functions-in-comparison-with2026-10-06 https://evidence-hub.com/study/66762-tadalafil-rehabilitation-therapy-preserves-penile-size-after2026-10-06 https://evidence-hub.com/study/66763-effects-of-iloprost-combined-with-low-dose-tadalafil-in-adult2026-10-06 https://evidence-hub.com/study/66764-randomized-study-of-adding-tadalafil-to-existing-ambrisentan-in2026-10-04 https://evidence-hub.com/study/66765-a-return-to-normal-erectile-function-with-tadalafil-once-daily-after2026-10-06 https://evidence-hub.com/study/66766-low-dose-tadalafil-improves-arterial-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/66767-impact-of-pretreatment-with-carnitine-and-tadalafil-on-contrast2026-10-04 https://evidence-hub.com/study/66768-response-to-treatment-with-tadalafil-in-men-with-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/66769-sexual-satisfaction-in-men-with-erectile-dysfunction-correlates-and2026-10-06 https://evidence-hub.com/study/66770-tadalafil-combined-with-behavioral-therapy-and-psychological2026-10-06 https://evidence-hub.com/study/66771-successful-transition-from-phosphodiesterase-5-inhibitors-to2026-10-10 https://evidence-hub.com/study/66772-effect-of-once-daily-macitentan-75-mg-on-the-pharmacokinetics-of2026-10-10 https://evidence-hub.com/study/66773-effects-of-riociguat-on-right-ventricular-size-and-function-in2026-10-08 https://evidence-hub.com/study/66774-fucoidan-from-undaria-pinnatifida-improves-benign-prostatic2026-10-19 https://evidence-hub.com/study/66775-cerebralcare-pills-on-cerebral-small-vessel-disease-cable-trial2026-10-06 https://evidence-hub.com/study/66776-new-horizons-in-systemic-sclerosis-treatment-advances-and-emerging2026-10-10 https://evidence-hub.com/study/66777-innovative-nitric-oxide-delivery-technology-for-postoperative2026-10-06 https://evidence-hub.com/study/66778-ventilatory-limitation-to-exercise-in-patients-with-hfpef-and-obesity2026-10-08 https://evidence-hub.com/study/66779-assessment-of-the-value-of-measuring-soluble-fms-like-tyrosine-kinase2026-10-06 https://evidence-hub.com/study/66780-relaxin-mimetic-in-pulmonary-hypertension-associated-with-left-heart2026-10-10 https://evidence-hub.com/study/66781-tadalafil-treatment-for-fetuses-with-early-onset-growth-restriction-a2026-10-19 https://evidence-hub.com/study/66782-perioperative-sildenafil-citrate-administration-in-hepatectomy-a2026-10-10 https://evidence-hub.com/study/66783-bioequivalence-and-food-effect-of-a-fixed-dose-combination-of2026-10-10 https://evidence-hub.com/study/66784-sildenafil-versus-placebo-for-early-pulmonary-vascular-disease-in2026-10-08 https://evidence-hub.com/study/66785-vericiguat-global-study-in-participants-with-chronic-heart-failure2026-10-10 https://evidence-hub.com/study/66786-the-isearch-randomised-controlled-trial-protocol-a-pragmatic2026-10-10 https://evidence-hub.com/study/66787-4-aminopyridine-treatment-for-nerve-injury-resulting-from-radical2026-10-08 https://evidence-hub.com/study/66788-the-efficacy-of-tadalafil-5mg-in-the-treatment-of-lower-urinary-tract2026-10-19 https://evidence-hub.com/study/66789-efficacy-of-tadalafil-therapy-and-changes-in-oxidative-stress-levels2026-10-19 https://evidence-hub.com/study/66790-a-phase-i-study-to-evaluate-the-safety-tolerability-and2026-10-10 https://evidence-hub.com/study/66791-effects-of-chaihu-shugan-san-capsule-for-psychogenic-erectile2026-10-06 https://evidence-hub.com/study/66792-pharmacokinetic-interaction-between-linagliptin-and-tadalafil-in2026-10-06 https://evidence-hub.com/study/66793-disease-progression-rates-in-ambulatory-duchenne-muscular-dystrophy2026-10-06 https://evidence-hub.com/study/66794-pharmacokinetics-and-safety-of-tadalafil-in-a-paediatric-population2026-10-06 https://evidence-hub.com/study/66795-clinical-efficacy-of-tadalafil-compared-to-sildenafil-in-treatment-of2026-10-19 https://evidence-hub.com/study/66796-prognostic-factors-for-changes-in-the-timed-4-stair-climb-in-patients2026-10-06 https://evidence-hub.com/study/66797-cardiac-function-and-tadalafil-used-for-treating-fetal-growth2026-10-06 https://evidence-hub.com/study/66798-outcomes-and-characteristics-of-cardiac-arrest-in-children-with2026-10-06 https://evidence-hub.com/study/66799-a-phase-i-study-to-show-the-relative-bioavailability-and2026-10-06 https://evidence-hub.com/study/66800-efficacy-and-safety-of-tadalafil-5-mg-once-daily-in-asian-men-with2026-10-19 https://evidence-hub.com/study/66801-tadafer-ii-tadalafil-treatment-for-fetal-growth-restriction-a-study2026-10-10 https://evidence-hub.com/study/66802-oral-treprostinil-improves-pulmonary-vascular-compliance-in-pulmonary2026-10-06 https://evidence-hub.com/study/66803-evaluation-of-the-long-term-safety-and-effectiveness-of-tadalafil2026-10-10 https://evidence-hub.com/study/66804-effects-of-tadalafil-on-storage-and-voiding-function-in-patients-with2026-10-06 https://evidence-hub.com/study/66805-evaluation-of-arterial-stiffness-and-cardiac-function-in-patients2026-10-06 https://evidence-hub.com/study/66806-antivirals-for-adult-patients-hospitalized-with-sars-cov-2-infection2026-10-10 https://evidence-hub.com/study/66807-effects-of-taking-tadalafil-5-mg-once-daily-on-erectile-function-and2026-10-06 https://evidence-hub.com/study/66808-effect-of-tadalafil-on-myocardial-and-endothelial-function-and2026-10-06 https://evidence-hub.com/study/66809-a-4-week-comparison-of-capillaroscopy-changes-healing-effect-and-cost2026-10-06 https://evidence-hub.com/study/66810-serenoa-repens-selenium-lycopene-vs-tadalafil-5-mg-for-the-treatment2026-10-19 https://evidence-hub.com/study/66811-chitosan-membranes-applied-on-the-prostatic-neurovascular-bundles2026-10-06 https://evidence-hub.com/study/66812-effects-of-tadalafil-treatment-combined-with-physical-activity-in2026-10-06 https://evidence-hub.com/study/66813-an-analysis-of-treatment-preferences-and-sexual-quality-of-life2026-10-10 https://evidence-hub.com/study/66814-effect-of-rilpivirine-on-the-pharmacokinetics-of-methadone-in-hiv2026-10-06 https://evidence-hub.com/study/66815-effects-of-phosphodiesterase-5-inhibitor-on-ischemic-kidney-injury2026-10-06 https://evidence-hub.com/study/66816-assessment-of-cyp-mediated-drug-interactions-for-evocalcet-a-new2026-10-06 https://evidence-hub.com/study/66817-treatment-with-rilpivirine-does-not-alter-plasma-concentrations-of2026-10-04 https://evidence-hub.com/study/66818-a-pilot-study-to-evaluate-the-safety-and-efficacy-of-treprostinil-in2026-10-10 https://evidence-hub.com/study/66819-rationale-and-study-design-of-respite-an-open-label-phase-3b-study-of2026-10-06 https://evidence-hub.com/study/66820-effect-of-surgical-approach-on-erectile-function-recovery-following2026-10-06 https://evidence-hub.com/study/66821-efficacy-and-safety-of-tetramethylpyrazine-phosphate-on-pulmonary2026-10-10 https://evidence-hub.com/study/66822-sexual-potency-preservation-and-quality-of-life-after-prostate2026-10-06 https://evidence-hub.com/study/66823-low-dose-tadalafil-for-erectile-dysfunction-following-pelvic-fracture2026-10-06 https://evidence-hub.com/study/66824-clinical-efficacy-of-daily-low-dose-tadalafil-on-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/66825-tadalafil-5-mg-daily-treatment-for-type-1-diabetic-premenopausal2026-10-06 https://evidence-hub.com/study/66826-tadalafil-combined-with-behavior-therapy-for-semen-collection-from2026-10-06 https://evidence-hub.com/study/66827-first-in-human-modified-atrial-septostomy-combining-radiofrequency2026-10-06 https://evidence-hub.com/study/66828-pde5-inhibition-alleviates-functional-muscle-ischemia-in-boys-with2026-10-06 https://evidence-hub.com/study/66829-tadalafil-for-treatment-of-fetal-growth-restriction-a-review-of2026-10-19 https://evidence-hub.com/study/66830-260-combination-tadalafil-and-tamsulosin-therapy-versus-monotherapy2026-10-19 https://evidence-hub.com/study/66831-efficacy-comparison-for-a-schizophrenia-and-a-dysuria-drug-among-east2026-10-19 https://evidence-hub.com/study/66832-monotherapy-with-tadalafil-or-tamsulosin-similarly-improved-lower2026-10-19 https://evidence-hub.com/study/66833-safety-evaluation-of-tadalafil-treatment-for-fetuses-with-early-onset2026-10-19 https://evidence-hub.com/study/66836-tadalafil-5-mg-alone-or-in-combination-with-tamsulosin-0-4-mg-for-the2026-10-06 https://evidence-hub.com/study/66838-initial-combination-therapy-with-ambrisentan-tadalafil-on-pulmonary2026-10-06 https://evidence-hub.com/study/66841-initial-combination-therapy-with-ambrisentan-and-tadalafil-in2026-10-06 https://evidence-hub.com/study/66842-clinical-utility-of-tadalafil-in-the-treatment-of-pulmonary-arterial2026-10-06 https://evidence-hub.com/study/66843-kids-mod-pah-trial-a-multicenter-trial-comparing-mono-versus-duo2026-10-06 https://evidence-hub.com/study/66844-o-30-bz371a-a-first-in-class-topical-peptide-for-erectile-dysfunction2026-10-08 https://evidence-hub.com/study/66845-latest-treatment-for-lower-urinary-tract-dysfunction-therapeutic2026-10-19 https://evidence-hub.com/study/66846-persistent-sexual-dysfunction-with-finasteride-1-mg-taken-for-hair2026-10-06 https://evidence-hub.com/study/66847-efficacy-of-tadalafil-in-men-with-erectile-dysfunction-naive-to2026-10-06 https://evidence-hub.com/study/66848-tadalafil-in-the-management-of-lower-urinary-tract-symptoms-a-review2026-10-19 https://evidence-hub.com/study/66849-onset-of-efficacy-of-tadalafil-once-daily-in-men-with-erectile2026-10-19 https://evidence-hub.com/study/66850-effects-of-dose-and-age-on-adverse-events-associated-with-tadalafil2026-10-06 https://evidence-hub.com/study/66851-tolerance-to-the-therapeutic-effect-of-tadalafil-does-not-occur2026-10-06 https://evidence-hub.com/study/66852-early-improvement-of-storage-or-voiding-symptoms-by-tadalafil2026-10-06 https://evidence-hub.com/study/66853-factors-associated-with-preference-for-sildenafil-citrate-and2026-10-10 https://evidence-hub.com/study/66854-the-influence-of-age-on-treatment-outcomes-in-men-with-erectile2026-10-06 https://evidence-hub.com/study/66855-macitentan-and-phosphodiesterase-5-inhibitor-alone-or-in-combination2026-10-10 https://evidence-hub.com/study/66856-the-efficacy-of-tadalafil-in-improving-sexual-satisfaction-and2026-10-06 https://evidence-hub.com/study/66857-the-role-of-initial-success-rates-and-other-factors-in-determining2026-10-06 https://evidence-hub.com/study/66858-effects-of-tadalafil-on-nighttime-voiding-nocturia-in-men-with-lower2026-10-19 https://evidence-hub.com/study/66859-determining-the-earliest-time-within-30-minutes-to-erectogenic-effect2026-10-06 https://evidence-hub.com/study/66860-changes-in-peak-urinary-flow-and-voiding-efficiency-in-men-with-signs2026-10-06 https://evidence-hub.com/study/66861-impact-of-cardiovascular-risk-factors-and-related-comorbid-conditions2026-10-19 https://evidence-hub.com/study/66862-a-comprehensive-review-of-the-clinical-evidence-on-the-efficacy2026-10-19 https://evidence-hub.com/study/66863-exploring-the-therapeutic-landscape-of-pulmonary-hypertension2026-10-08 https://evidence-hub.com/study/66864-selection-of-endothelin-receptor-antagonists-in-the-treatment-of2026-10-10 https://evidence-hub.com/study/66865-pharmacologically-increasing-cgmp-improves-proteostasis-and-reduces2026-10-10 https://evidence-hub.com/study/66866-update-on-pulmonary-hypertension2026-10-10 https://evidence-hub.com/study/66867-exploring-integrin-5-1-as-a-potential-therapeutic-target-for2026-10-19 https://evidence-hub.com/study/66868-priapism-as-an-initial-presentation-of-sickle-cell-disease-a-case2026-10-08 https://evidence-hub.com/study/66869-proof-of-concept-study-apoe4-brain-endothelial-cells-as-a-phenotypic2026-10-10 https://evidence-hub.com/study/66870-the-therapeutic-efficacy-of-drugs-targeting-the-no-sgc-cgmp-pathway2026-10-08 https://evidence-hub.com/study/66871-marked-clinical-and-haemodynamic-improvement-with-sotatercept-in2026-10-06 https://evidence-hub.com/study/66872-penile-rehabilitation-after-surgery-for-prostate-cancer-an-umbrella2026-10-10 https://evidence-hub.com/study/66873-pericardial-effusion-and-prostacyclin-analog-toxicity-after2026-10-06 https://evidence-hub.com/study/66874-upfront-triple-combination-therapy-with-selexipag-insights-from-a2026-10-06 https://evidence-hub.com/study/66875-arduous-management-in-treatment-of-elderly-patient-with-pulmonary2026-10-06 https://evidence-hub.com/study/66876-prevalence-pathogenesis-and-clinical-impact-of-pulmonary-hypertension2026-10-08 https://evidence-hub.com/study/66877-efficacy-and-safety-of-mirabegron-in-males-with-overactive-bladder2026-10-19 https://evidence-hub.com/study/66878-association-between-upper-airway-obstruction-and-pulmonary2026-10-08 https://evidence-hub.com/study/66879-antifibrotic-therapy-for-lower-urinary-tract-symptoms-secondary-to2026-10-19 https://evidence-hub.com/study/66880-interaction-of-sublingual-glyceryl-tri-nitrate-administration-on2026-10-08 https://evidence-hub.com/study/66881-global-stagnation-and-misaligned-priorities-in-bph-drug-development-a2026-10-19 https://evidence-hub.com/study/66882-the-impact-of-pde5-inhibitors-on-cardiovascular-outcomes2026-10-08 https://evidence-hub.com/study/66883-pulmonary-arterial-hypertension-and-left-heart-disease-phenotype-a2026-10-08 https://evidence-hub.com/study/66884-initial-body-weight-as-an-important-factor-for-improving-the2026-10-05 https://evidence-hub.com/study/66885-comparing-the-efficacy-of-tadalafil-and-tamsulosin-for-managing2026-10-19 https://evidence-hub.com/study/66886-updates-on-pulmonary-hypertension2026-10-06 https://evidence-hub.com/study/66887-the-potential-therapeutic-effects-of-tadalafil-on-the-endothelium-in2026-10-05 https://evidence-hub.com/study/66888-neutrophil-to-lymphocyte-ratio-as-a-prognostic-factor-of-survival2026-10-06 https://evidence-hub.com/study/66889-shenronggubenhuanshao-pill-ameliorates-hydrocortisone-induced2026-10-10 https://evidence-hub.com/study/66890-clinical-research-on-pulmonary-hypertension-from-a-2025-perspective-a2026-10-10 https://evidence-hub.com/study/66891-pulmonary-hypertension-associated-with-nonparenchymal-restrictive2026-10-06 https://evidence-hub.com/study/66892-influence-of-patient-characteristics-on-the-effectiveness-of-inhaled2026-10-06 https://evidence-hub.com/study/66893-addressing-unmet-needs-for-patients-with-erectile-dysfunction-a2026-10-10 https://evidence-hub.com/study/66894-stable-longitudinal-quality-of-life-in-the-serve-trial-among-adults2026-10-06 https://evidence-hub.com/study/66895-the-no-pathway-as-a-target-in-patients-with-stable-and-advanced-heart2026-10-10 https://evidence-hub.com/study/66896-non-invasive-assessment-of-endothelial-dysfunction-and-arterial2026-10-06 https://evidence-hub.com/study/66897-pulmonary-hypertension-associated-with-interstitial-lung-disease-ph2026-10-08 https://evidence-hub.com/study/66898-early-addition-of-selexipag-to-double-therapy-for-pulmonary-arterial2026-10-06 https://evidence-hub.com/study/66899-does-characterization-of-phenotypic-heterogeneity-provide-mechanistic2026-10-08 https://evidence-hub.com/study/66900-phenotypic-clustering-of-idiopathic-pulmonary-arterial-hypertension2026-10-06 https://evidence-hub.com/study/66901-use-of-soluble-guanylyl-cyclase-stimulators-in-heart-failure-therapy2026-10-10 https://evidence-hub.com/study/66902-safety-tolerability-and-efficacy-of-an-in-class-combination-therapy2026-10-08 https://evidence-hub.com/study/66903-winning-with-four-hemodynamic-and-symptomatic-improvement-of2026-10-10 https://evidence-hub.com/study/66904-the-nitric-oxide-soluble-guanylate-cyclase-cgmp-pathway-in-pulmonary2026-10-10 https://evidence-hub.com/study/66905-high-prevalence-of-erectile-dysfunction-in-male-patients-with-acute2026-10-06 https://evidence-hub.com/study/66906-unraveling-the-causal-association-between-circulating-copper-levels2026-10-08 https://evidence-hub.com/study/66907-clinical-application-of-inhaled-nitric-oxide-in-conditions-of2026-10-08 https://evidence-hub.com/study/66908-phenotypes-and-treatment-outcomes-in-idiopathic-pulmonary-arterial2026-10-06 https://evidence-hub.com/study/66909-ctd-pah-an-updated-practical-approach-to-screening-diagnosis-and2026-10-06 https://evidence-hub.com/study/66910-treatment-algorithm-for-pulmonary-arterial-hypertension2026-10-10 https://evidence-hub.com/study/66911-do-patients-with-low-risk-pulmonary-arterial-hypertension-really2026-10-06 https://evidence-hub.com/study/66912-efficacy-of-low-intensity-extracorporeal-shock-wave-therapy-for2026-10-06 https://evidence-hub.com/study/66913-pulmonary-hypertension-associated-with-interstitial-lung-diseases2026-10-06 https://evidence-hub.com/study/66914-maternal-obesogenic-diet-during-pregnancy-and-its-impact-on-fetal2026-10-10 https://evidence-hub.com/study/66915-genetically-proxied-inhibition-of-phosphodiesterase-5-and-cancer2026-10-08 https://evidence-hub.com/study/66916-therapeutic-approaches-for-pulmonary-hypertension-in-patients-with2026-10-06 https://evidence-hub.com/study/66917-research-advances-in-connective-tissue-disease-associated-pulmonary2026-10-06 https://evidence-hub.com/study/66918-efficacy-and-safety-of-oral-treprostinil-in-patients-with-pulmonary2026-10-06 https://evidence-hub.com/study/66919-the-effect-of-concomitant-drugs-on-oncological-outcomes-in-patients2026-10-13 https://evidence-hub.com/study/66920-a-case-report-lisdexamfetamine-induced-delusional-parasitosis2026-10-06 https://evidence-hub.com/study/66921-stem-cell-therapy-for-erectile-dysfunction-a-systematic-review-and2026-10-06 https://evidence-hub.com/study/66922-development-of-a-clinical-scoring-system-to-predict-response-to-low2026-10-06 https://evidence-hub.com/study/66923-new-pharmacological-agents-and-novel-cardiovascular-pharmacotherapy2026-10-10 https://evidence-hub.com/study/66924-therapeutic-challenges-and-new-therapeutic-targets-for-combined2026-10-06 https://evidence-hub.com/study/66926-effects-of-tadalafil-on-lower-urinary-tract-symptoms-secondary-to2026-10-19 https://evidence-hub.com/study/66927-pathways-implicated-in-tadalafil-amelioration-of-duchenne-muscular2026-10-19 https://evidence-hub.com/study/66928-evaluation-of-the-effectiveness-and-safety-of-a-daily-dose-of-5-mg-of2026-10-06 https://evidence-hub.com/study/66930-a-simple-protocol-for-the-characterization-of-fraudulent-erectile2026-10-08 https://evidence-hub.com/study/66933-an-eco-friendly-hplc-method-for-the-sustainable-analysis-of-the-newly2026-10-19 https://evidence-hub.com/study/66934-testing-the-cognitive-effects-of-tadalafil-neuropsychological2026-10-04 https://evidence-hub.com/study/66935-dutasteride-add-on-treatment-to-tadalafil-for-patients-with-benign2026-10-19 https://evidence-hub.com/study/66936-qualitative-secondary-analysis-a-case-exemplar2026-10-08 https://evidence-hub.com/study/66937-combining-tadalafil-and-hyperbaric-oxygen-therapy-protects-against2026-10-06 https://evidence-hub.com/study/66939-analysis-of-short-term-treatment-with-the-phosphodiesterase-type-52026-10-06 https://evidence-hub.com/study/66941-long-term-improvement-during-tadalafil-therapy-in-a-patient-with2026-10-06 https://evidence-hub.com/study/66942-implementing-reactive-secondary-electrospray-ionization-based-on-gas2026-10-06 https://evidence-hub.com/study/66943-tadalafil-for-lower-urinary-tract-symptoms-secondary-to-benign2026-10-19 https://evidence-hub.com/study/66944-secondary-analysis-of-existing-data-opportunities-and-implementation2026-10-06 https://evidence-hub.com/study/66945-mass-spectral-analysis-of-secondary-metabolites-from-zingiber2026-10-06 https://evidence-hub.com/study/66946-effect-of-tadalafil-on-male-lower-urinary-tract-symptoms-an2026-10-19 https://evidence-hub.com/study/66947-the-bioactivities-of-ecoenzymes-derived-from-fruit-peels-and-their2026-10-06 https://evidence-hub.com/study/66948-efficacy-and-safety-of-the-coadministration-of-tadalafil-once-daily2026-10-19 https://evidence-hub.com/study/66949-spatial-and-temporal-prediction-of-secondary-crashes-combining2026-10-06 https://evidence-hub.com/study/66950-increased-bleeding-risk-with-phosphodiesterase-5-inhibitors-after2026-10-06 https://evidence-hub.com/study/66951-enrichment-benefits-of-risk-algorithms-for-pulmonary-arterial2026-10-06 https://evidence-hub.com/study/66952-initial-dual-oral-combination-therapy-in-pulmonary-arterial2026-10-06 https://evidence-hub.com/study/66953-clinical-use-of-phosphodiesterase-5-inhibitors-in-cardiopulmonary2026-10-06 https://evidence-hub.com/study/66954-maternal-and-fetal-outcomes-in-pregnancy-complicated-with-eisenmenger2026-10-06 https://evidence-hub.com/study/66955-the-effects-of-tadalafil-on-optical-coherence-tomography-optical2026-10-05 https://evidence-hub.com/study/66956-prospective-evaluation-of-early-postoperative-male-and-female-sexual2026-10-06 https://evidence-hub.com/study/66957-real-world-switching-to-riociguat-management-and-practicalities-in2026-10-06 https://evidence-hub.com/study/66958-efficacy-of-a-preprostatectomy-multi-modal-penile-rehabilitation2026-10-06 https://evidence-hub.com/study/66959-comparison-of-silodosin-monotherapy-vs-silodosin-with-tadalafil-add2026-10-19 https://evidence-hub.com/study/66960-pde5-inhibitor-treatment-persistence-and-adherence-in-brazilian-men2026-10-06 https://evidence-hub.com/study/66961-oral-pulmonary-vasoactive-drugs-achieve-hemodynamic-eligibility-for2026-10-06 https://evidence-hub.com/study/66962-daily-use-of-phosphodiesterase-type-5-inhibitors-as-prevention-for2026-10-06 https://evidence-hub.com/study/66963-tadalafil-is-sufficiently-effective-for-severe-chronic-prostatitis2026-10-19 https://evidence-hub.com/study/66964-patterns-of-switching-phosphodiesterase-type-5-inhibitors-in-the2026-10-06 https://evidence-hub.com/study/66965-patient-characteristics-and-treatment-patterns-for-patients-with2026-10-06 https://evidence-hub.com/study/66966-therapeutic-augmentation-of-no-sgc-cgmp-signalling-lessons-learned2026-10-06 https://evidence-hub.com/study/66967-factors-that-predict-changing-the-type-of-phosphodiesterase-type-52026-10-06 https://evidence-hub.com/study/66968-penile-rehabilitation-protocol-after-robot-assisted-radical2026-10-06 https://evidence-hub.com/study/66969-prospective-drug-safety-monitoring-using-the-uk-primary-care-general2026-10-06 https://evidence-hub.com/study/66970-lower-urinary-tract-symptoms-and-sexual-dysfunction-a-common-approach2026-10-06 https://evidence-hub.com/study/66971-carotid-artery-intima-media-thickness-can-predict-the-response-of2026-10-06 https://evidence-hub.com/study/66972-psychotherapy-a-missing-piece-in-the-puzzle-of-post-radical2026-10-06 https://evidence-hub.com/study/66973-haemodynamic-changes-in-pulmonary-hypertension-in-patients-with2026-10-06 https://evidence-hub.com/study/66974-combination-therapy-with-topical-alprostadil-and-phosphodiesterase-52026-10-10 https://evidence-hub.com/study/66975-tadalafil-for-lower-urinary-tract-symptoms-secondary-to-benign2026-10-19 https://evidence-hub.com/study/66976-treatment-patterns-and-associated-health-care-costs-before-and-after2026-10-06 https://evidence-hub.com/study/66977-high-frequency-of-potential-phosphodiesterase-type-5-inhibitor-drug2026-10-06 https://evidence-hub.com/study/66978-contralateral-pulmonary-hypertension-following-resuscitation-of2026-10-06 https://evidence-hub.com/study/66979-predictive-capacity-of-immune-related-adverse-events-and-cytokine2026-10-06 https://evidence-hub.com/study/66980-oral-drug-treatments-in-patients-with-erectile-dysfunction-and2026-10-06 https://evidence-hub.com/study/66981-ambrisentan-and-tadalafil-up-front-combination-therapy-in-scleroderma2026-10-06 https://evidence-hub.com/study/66982-giving-patients-with-erectile-dysfunction-the-opportunity-to-try-all2026-10-06 https://evidence-hub.com/study/66983-effect-of-tadalafil-5mg-daily-treatment-on-penile-haemodynamics-in2026-10-06 https://evidence-hub.com/study/66984-prescribing-all-phosphodiesterase-5-inhibitors-to-a-patient-with2026-10-06 https://evidence-hub.com/study/66985-efficacy-of-tadalafil-on-symptom-specific-bother-in-men-with-lower2026-10-19 https://evidence-hub.com/study/66986-pharmacokinetics-of-drugs-for-pediatric-pulmonary-hypertension2026-10-06 https://evidence-hub.com/study/66987-tadalafil-a-new-agent-for-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/66988-persistence-rate-with-tadalafil-for-treatment-of-male-lower-urinary2026-10-06 https://evidence-hub.com/study/66989-successful-transition-from-treprostinil-to-selexipag-in-patient-with2026-10-06 https://evidence-hub.com/study/66990-daily-tadalafil-for-the-chronic-phase-of-stuttering-priapism-a-case2026-10-06 https://evidence-hub.com/study/66991-trimodal-mini-invasive-therapy-for-stable-phase-peyronie-s-disease-a2026-10-06 https://evidence-hub.com/study/66992-an-epidemiological-and-knowledge-attitudes-beliefs-and-practices2026-10-06 https://evidence-hub.com/study/66993-synergistic-effects-of-ace-insertion-deletion-and-gnb3-c825t2026-10-10 https://evidence-hub.com/study/66994-eeg-abnormalities-during-treatment-with-tadalafil-a-phosphodiesterase2026-10-06 https://evidence-hub.com/study/66995-evaluating-the-safety-profile-of-1-blockers-5-reductase-inhibitors2026-10-19 https://evidence-hub.com/study/66996-real-world-treatment-patterns-among-patients-with-connective-tissue2026-10-06 https://evidence-hub.com/study/66997-refractory-cutaneous-ulcers-in-anti-mda5-dermatomyositis-were-not2026-10-06 https://evidence-hub.com/study/66998-tadalafil-once-daily-in-men-with-erectile-dysfunction-an-integrated2026-10-06 https://evidence-hub.com/study/66999-redefining-the-role-of-long-acting-phosphodiesterase-inhibitor2026-10-06 https://evidence-hub.com/study/67000-effects-of-phosphodiesterase-type-5-inhibitors-on-raynaud-s-phenomenon2026-10-06 https://evidence-hub.com/study/67001-tadalafil-improves-symptoms-erectile-function-and-quality-of-life-in2026-10-06 https://evidence-hub.com/study/67002-sexual-dysfunctions-induced-by-stress-of-timed-intercourse-and2026-10-06 https://evidence-hub.com/study/67004-tadalafil-administered-once-daily-for-lower-urinary-tract-symptoms2026-10-19 https://evidence-hub.com/study/67005-increased-risk-of-non-fatal-myocardial-infarction-following2026-10-06 https://evidence-hub.com/study/67006-non-invasive-alternative-for-phosphodiesterase-inhibitor-refractory2026-10-06 https://evidence-hub.com/study/67007-sildenafil-use-in-children-with-pulmonary-hypertension2026-10-08 https://evidence-hub.com/study/67008-erectile-response-profiles-of-men-using-pde5-inhibitors-combined-with2026-10-06 https://evidence-hub.com/study/67009-a-clinical-comparison-of-an-endothelin-receptor-antagonist-and2026-10-19 https://evidence-hub.com/study/67010-application-of-the-complex-edelim-in-pathogenetic-management-of2026-10-06 https://evidence-hub.com/study/67012-choice-of-initial-oral-therapy-for-pulmonary-arterial-hypertension2026-10-06 https://evidence-hub.com/study/67013-role-of-phosphodiesterase-inhibitors-in-improving-urodynamic2026-10-06 https://evidence-hub.com/study/67018-the-economic-effect-of-switching-from-sildenafil-to-another2026-10-06 https://evidence-hub.com/study/67019-pih21-influence-of-concomitant-diseases-on-the-clinical-response-to2026-10-06 https://evidence-hub.com/study/67020-200-real-world-effectiveness-and-safety-of-treatment-for-testosterone2026-10-08 https://evidence-hub.com/study/67021-real-world-outcomes-and-safety-of-testosterone-therapy-a-longitudinal2026-10-06 https://evidence-hub.com/study/67022-phosphodiesterase-5-inhibitor-treatment-and-survival-in-interstitial2026-10-06 https://evidence-hub.com/study/67023-effect-of-tamsulosin-versus-tamsulosin-plus-tadalafil-on-renal2026-10-06 https://evidence-hub.com/study/67024-tadalafil-improves-nocturia-and-nocturia-related-quality-of-life-in2026-10-19 https://evidence-hub.com/study/67025-role-of-serum-high-sensitivity-c-reactive-protein-as-a-predictor-of2026-10-06 https://evidence-hub.com/study/67026-efficacy-of-tamsulosin-and-tadalafil-in-relieving-benign-prostatic2026-10-19 https://evidence-hub.com/study/67027-a-comparison-of-different-oral-therapies-versus-no-treatment-for2026-10-10 https://evidence-hub.com/study/67028-central-serous-chorioretinopathy-and-phosphodiesterase-5-inhibitors-a2026-10-06 https://evidence-hub.com/study/67029-the-vo-2-on-kinetics-in-constant-load-exercise-sub-anaerobic2026-10-06 https://evidence-hub.com/study/67030-dual-phosphodiesterase-type-5-inhibitor-therapy-for-refractory2026-10-06 https://evidence-hub.com/study/67031-erectile-function-after-cystectomy-with-neurovascular-preservation2026-10-06 https://evidence-hub.com/study/67032-sudden-hearing-loss-from-pde-5-inhibitors-a-possible-cellular-stress2026-10-06 https://evidence-hub.com/study/67033-plasma-drug-concentrations-in-patients-with-pulmonary-arterial2026-10-06 https://evidence-hub.com/study/67034-effects-of-tadalafil-5-mg-dosed-once-daily-in-men-with-premature2026-10-06 https://evidence-hub.com/study/67035-phosphodiesterase-type-5-inhibitor-prescription-patterns-in-the2026-10-06 https://evidence-hub.com/study/67036-an-evaluation-of-an-alternative-dosing-regimen-with-tadalafil-3-times2026-10-06 https://evidence-hub.com/study/67037-acute-effect-of-phosphodiesterase-type-5-inhibitor-on-serum-oxidative2026-10-06 https://evidence-hub.com/study/67038-undertreatment-of-overactive-bladder-among-men-with-lower-urinary2026-10-06 https://evidence-hub.com/study/67039-risk-reduction-and-right-heart-reverse-remodeling-by-upfront-triple2026-10-06 https://evidence-hub.com/study/67040-type-v-phosphodiesterase-inhibitor-treatments-for-erectile2026-10-06 https://evidence-hub.com/study/67041-retrospective-analysis-of-the-efficacy-and-safety-of-once-daily2026-10-06 https://evidence-hub.com/study/67042-therapeutic-potential-of-phosphodiesterase-type-5-inhibitors-in-heart2026-10-06 https://evidence-hub.com/study/67043-effects-on-sexual-function-in-japanese-patients-with-benign-prostatic2026-10-06 https://evidence-hub.com/study/67044-low-dose-daily-versus-on-demand-high-dose-tadalafil-in-diabetic2026-10-04 https://evidence-hub.com/study/67045-phosphodiesterase-inhibitors-in-the-treatment-of-erectile-dysfunction2026-10-10 https://evidence-hub.com/study/67046-treatment-of-erectile-dysfunction-in-patients-with-plastic-induration2026-10-06 https://evidence-hub.com/study/67047-retrospective-evaluation-of-the-efficacy-of-daily-paroxetine2026-10-06 https://evidence-hub.com/study/67048-phosphodiesterase-type-5-inhibitors-improve-microvascular-dysfunction2026-10-06 https://evidence-hub.com/study/67049-circulating-endothelial-progenitor-cells-and-endothelial2026-10-06 https://evidence-hub.com/study/67050-use-of-phosphodiesterase-type-5-inhibitors-for-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/67051-safety-and-tolerability-of-combination-therapy-with-ambrisentan-and2026-10-06 https://evidence-hub.com/study/67052-impact-of-postoperative-phosphodiesterase-type-5-inhibitor-treatment2026-10-06 https://evidence-hub.com/study/67053-use-of-phosphodiesterase-type-5-inhibitors-in-assistive-living-and2026-10-06 https://evidence-hub.com/study/67054-long-term-effects-of-combination-treatment-comprising-low-intensity2026-10-19 https://evidence-hub.com/study/67055-the-association-of-tadalafil-exposure-with-lower-rates-of-major2026-10-06 https://evidence-hub.com/study/67056-transition-of-ph-patients-from-sildenafil-to-tadalafil-feasibility2026-10-04 https://evidence-hub.com/study/67057-role-of-tadalafil-in-enhancing-visualization-of-posterior-urethra2026-10-06 https://evidence-hub.com/study/67058-evaluation-of-the-efficacy-of-once-daily-use-of-tadalafil-vs-on2026-10-19 https://evidence-hub.com/study/67059-impact-of-tadalafil-once-daily-in-men-with-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/67060-initial-tadalafil-and-ambrisentan-combination-therapy-in-pulmonary2026-10-06 https://evidence-hub.com/study/67064-ischemic-priapism-caused-by-self-intracavernous-injection-of-tadalafil2026-10-04 https://evidence-hub.com/study/67065-clinical-application-of-tadalafil-in-dogs-with-pulmonary-hypertension2026-10-19 https://evidence-hub.com/study/67066-clustering-of-tadalafil-api-samples-according-to-their-manufacturer2026-10-06 https://evidence-hub.com/study/67067-upadacitinib-as-a-potential-management-option-for-diffuse-cutaneous2026-10-06 https://evidence-hub.com/study/67068-multimodal-rehabilitation-for-hard-flaccid-syndrome-in-a2026-10-19 https://evidence-hub.com/study/67069-a-united-states-cross-sectional-analysis-of-annual-out-of-pocket-cost2026-10-10 https://evidence-hub.com/study/67070-community-pharmacy-detection-of-erectile-dysfunction-in-men-with-risk2026-10-06 https://evidence-hub.com/study/67071-importation-of-prescription-medicines-into-new-zealand-a-snapshot-of2026-10-06 https://evidence-hub.com/study/67072-the-global-online-sexuality-survey-goss-the-united-states-of-america2026-10-06 https://evidence-hub.com/study/67073-prescription-opioids-for-back-pain-and-use-of-medications-for2026-10-06 https://evidence-hub.com/study/67074-do-baseline-estrogen-and-testosterone-affect-lower-urinary-tract2026-10-06 https://evidence-hub.com/study/67075-recreational-use-of-erectile-dysfunction-medications-in-undergraduate2026-10-06 https://evidence-hub.com/study/67076-evaluating-the-management-trends-for-priapism-and-assessing-the-risk2026-10-06 https://evidence-hub.com/study/67077-pde5is-naive-versus-non-naive-patients-at-first-investigation-for2026-10-06 https://evidence-hub.com/study/67078-pulmonary-veno-occlusive-disease-a-focused-clinicopathologic-series2026-10-06 https://evidence-hub.com/study/67079-presentations-due-to-priapism-in-an-urban-hospital-in-switzerland2026-10-06 https://evidence-hub.com/study/67080-sexual-dysfunction-and-infertility-in-male-patients-with-spinal-cord2026-10-10 https://evidence-hub.com/study/67081-methamphetamine-associated-pulmonary-arterial-hypertension-in-a2026-10-06 https://evidence-hub.com/study/67082-surgical-management-of-autoimmune-associated-calcinosis-a2026-10-06 https://evidence-hub.com/study/67083-use-of-sotatercept-to-facilitate-transition-from-intravenous-to-oral2026-10-06 https://evidence-hub.com/study/67084-extracorporeal-life-support-ecls-for-pulmonary-vein-stenosis2026-10-06 https://evidence-hub.com/study/67085-an-early-single-center-case-series-experience-with-a-recently2026-10-06 https://evidence-hub.com/study/67086-low-intensity-extracorporeal-shock-wave-therapy-li-eswt-for-erectile2026-10-05 https://evidence-hub.com/study/67087-ophthalmoplegia-caused-by-non-aneurysm-neurovascular-conflict2026-10-06 https://evidence-hub.com/study/67088-right-ventricular-function-improves-with-pulmonary-vasodilator2026-10-06 https://evidence-hub.com/study/67089-a-case-series-pericardial-effusion-in-patients-treated-with2026-10-06 https://evidence-hub.com/study/67090-the-role-of-phosphodiesterase-5-enzyme-inhibitors-and-prostacyclin2026-10-04 https://evidence-hub.com/study/67091-late-onset-pulmonary-arterial-hypertension-associated-with-features2026-10-06 https://evidence-hub.com/study/67092-high-altitude-pulmonary-edema-a-case-series-of-four-patients-from2026-10-06 https://evidence-hub.com/study/67093-sotatercept-for-the-treatment-of-portopulmonary-hypertension-a-case2026-10-10 https://evidence-hub.com/study/67094-acute-postpartum-respiratory-distress-with-right-ventricular2026-10-06 https://evidence-hub.com/study/67095-parenteral-treprostinil-as-an-effective-bridge-to-lung-transplant-in2026-10-06 https://evidence-hub.com/study/67096-erectile-dysfunction-and-peyronie-s-disease-following-a-severe-case2026-10-06 https://evidence-hub.com/study/67097-progressive-pericardial-effusions-pef-in-patients-with-pulmonary2026-10-06 https://evidence-hub.com/study/67098-off-label-sildenafil-citrate-as-a-rescue-therapy-for-areolar-venous2026-10-10 https://evidence-hub.com/study/67099-dermatomyositis-with-necrotizing-vasculitis-pulmonary-arterial2026-10-06 https://evidence-hub.com/study/67100-the-multidisciplinary-management-of-pulmonary-arterial-hypertension2026-10-10 https://evidence-hub.com/study/67101-pubovesical-complex-sparing-under-hypothermia-during-robotic-assisted2026-10-06 https://evidence-hub.com/study/67102-safety-of-robotic-assisted-bronchoscopy-for-pulmonary-lesions-in2026-10-06 https://evidence-hub.com/study/67103-hyperbaric-oxygen-therapy-in-the-management-of-dermal-filler-induced2026-10-06 https://evidence-hub.com/study/67104-the-choroid-as-a-vascular-sensor-in-pulmonary-hypertension-an2026-10-06 https://evidence-hub.com/study/67105-pediatric-pulmonary-hypertension-associated-with-treatment-of2026-10-06 https://evidence-hub.com/study/67106-risk-stratification-and-multidisciplinary-management-strategies-for2026-10-10 https://evidence-hub.com/study/67107-dasatinib-associated-chylothorax-a-scoping-review-and2026-10-10 https://evidence-hub.com/study/67108-current-and-evolving-concepts-in-the-management-of-complex-regional2026-10-04 https://evidence-hub.com/study/67109-direct-prostacyclin-transition-in-pediatric-patients-with-pulmonary2026-10-10 https://evidence-hub.com/study/67110-diagnostic-and-management-dilemmas-in-pulmonary-hypertension2026-10-06 https://evidence-hub.com/study/67111-exploratory-disproportionality-analysis-of-potentially-drug-induced2026-10-06 https://evidence-hub.com/study/67112-replantation-following-complete-penile-amputation-summary-of2026-10-06 https://evidence-hub.com/study/67113-avanafil-use-in-patients-with-erectile-dysfunction-and-co-morbidities2026-10-10 https://evidence-hub.com/study/67114-jak-inhibitors-beyond-the-label-emerging-applications-in-dermatology2026-10-06 https://evidence-hub.com/study/67115-altitude-hypoxia-and-hypoxemia-pathogenesis-and-management2026-10-10 https://evidence-hub.com/study/67116-successful-interventional-closure-of-patent-ductus-arteriosus-in2026-10-06 https://evidence-hub.com/study/67117-pulmonary-arterial-hypertension-therapies-in-patients-with-obesity2026-10-06 https://evidence-hub.com/study/67118-anterior-ischemic-optic-neuropathy-in-patients-treated-with2026-10-06 https://evidence-hub.com/study/67119-sexual-dysfunction-in-movement-disorders-prevalence-clinical-features2026-10-10 https://evidence-hub.com/study/67120-from-pulmonary-hyperlucency-to-pulmonary-hypertension-a-case-report2026-10-06 https://evidence-hub.com/study/67121-himplant-subcutaneous-penile-implant-improves-penile-appearance-and2026-10-10 https://evidence-hub.com/study/67122-chronic-intestinal-pseudo-obstruction-in-the-course-of-systemic2026-10-06 https://evidence-hub.com/study/67123-pulmonary-tumor-embolism-due-to-oropharyngeal-carcinoma-diagnosed-by2026-10-06 https://evidence-hub.com/study/67124-phosphodiesterase-type-5-inhibitors-related-hearing-impairment-a-real2026-10-10 https://evidence-hub.com/study/67125-emergency-cesarean-section-in-pregnant-women-with-severe-pulmonary2026-10-10 https://evidence-hub.com/study/67126-resolution-of-severe-portopulmonary-hypertension-with-inhaled2026-10-10 https://evidence-hub.com/study/67127-contemporary-management-and-future-directions-of-adults-living-with-a2026-10-08 https://evidence-hub.com/study/67128-bridging-the-gap-in-psychogenic-erectile-dysfunction-a-narrative2026-10-06 https://evidence-hub.com/study/67129-penile-revascularization-for-erectile-dysfunction-secondary-to2026-10-06 https://evidence-hub.com/study/67130-haemodynamic-spectrum-in-heritable-pulmonary-arterial-hypertension-a2026-10-06 https://evidence-hub.com/study/67131-shone-s-syndrome-and-transplant-a-road-less-traveled2026-10-06 https://evidence-hub.com/study/67132-intracavernous-injection-therapy-as-second-line-treatment-for-ed2026-10-06 https://evidence-hub.com/study/67133-long-term-survival-of-heritable-pulmonary-arterial-hypertension2026-10-06 https://evidence-hub.com/study/67134-treatment-recommendations-for-the-systemic-pharmacological-treatment2026-10-06 https://evidence-hub.com/study/67135-case-report-selexipag-in-pediatric-pulmonary-hypertension-initiation2026-10-06 https://evidence-hub.com/study/67136-therapeutic-approaches-for-toxic-optic-neuropathies-insights-from2026-10-10 https://evidence-hub.com/study/67137-the-use-of-selexipag-a-prostacyclin-receptor-analog-for-treatment-of2026-10-06 https://evidence-hub.com/study/67138-development-of-a-predictive-model-for-visual-outcomes-and-risk2026-10-10 https://evidence-hub.com/study/67139-treatment-of-central-serous-chorioretinopathy-new-options-for-an-old2026-10-06 https://evidence-hub.com/study/67140-bosentan-as-adjunctive-therapy-in-neonates-with-congenital2026-10-10 https://evidence-hub.com/study/67141-dasatinib-induced-pulmonary-hypertension-and-third-space-effusion-a2026-10-10 https://evidence-hub.com/study/67142-type-i-brugada-pattern-in-a-febrile-patient-following-covid-192026-10-06 https://evidence-hub.com/study/67143-treatable-traits-in-pediatric-interstitial-lung-diseases-bridging-the2026-10-06 https://evidence-hub.com/study/67144-current-management-and-future-directions-for-pulmonary-arterial2026-10-06 https://evidence-hub.com/study/67145-phosphodiesterase-5-inhibitors-effects-on-adaptation-to-high-altitude2026-10-19 https://evidence-hub.com/study/67148-lower-lobe-predominant-pleuroparenchymal-fibroelastosis2026-10-06 https://evidence-hub.com/study/67149-liraglutide-associated-acute-pancreatitis2026-10-06 https://evidence-hub.com/study/67150-stuttering-priapism-in-a-dog-first-report2026-10-06 https://evidence-hub.com/study/67151-post-obstructive-diuresis-a-cautionary-tale2026-10-06 https://evidence-hub.com/study/67152-titration-of-pulmonary-arterial-hypertension-therapeutics-experience2026-10-06 https://evidence-hub.com/study/67153-peyronie-s-disease-a-triple-oxygenant-therapy2026-10-06 https://evidence-hub.com/study/67154-nocturnal-seizures-in-idiopathic-pulmonary-arterial-hypertension2026-10-06 https://evidence-hub.com/study/67155-hybrid-treat-and-repair-strategy-for-large-patent-ductus-arteriosus-a2026-10-06 https://evidence-hub.com/study/67156-safe-and-successful-transition-from-oral-selexipag-to-subcutaneous2026-10-06 https://evidence-hub.com/study/67157-analogues-of-erectile-dysfunction-drugs-an-under-recognised-threat2026-10-06 https://evidence-hub.com/study/67158-pdei-5-for-erectile-dysfunction-a-potential-role-in-seizure2026-10-06 https://evidence-hub.com/study/67159-central-serous-chorioretinopathy-following-the-use-of2026-10-06 https://evidence-hub.com/study/67160-targeting-immune-suppression-with-pde5-inhibition-in-end-stage2026-10-06 https://evidence-hub.com/study/67161-portopulmonary-hypertension-success-with-combined-medical-treatment2026-10-06 https://evidence-hub.com/study/67162-silica-associated-systemic-sclerosis-an-occupational-health-hazard2026-10-06 https://evidence-hub.com/study/67163-tadalafil-once-a-day-for-men-with-erectile-dysfunction-is-it-superior2026-10-06 https://evidence-hub.com/study/67164-2-4-dinitrophenol-overdose-everything-old-is-new-again2026-10-06 https://evidence-hub.com/study/67165-bilateral-sequential-non-arteritic-anterior-ischemic-optic-neuropathy2026-10-06 https://evidence-hub.com/study/67166-clinical-and-molecular-study-of-4-cases-of-pulmonary-hypertension2026-10-06 https://evidence-hub.com/study/67167-laparoscopic-rectopexy-in-a-patient-with-pulmonary-hypertension2026-10-06 https://evidence-hub.com/study/67168-hyperprolactinemia-presenting-with-encephalomalacia-associated2026-10-06 https://evidence-hub.com/study/67169-tadalafil-induced-generalized-bullous-fixed-drug-eruption-a-rare-side2026-10-19 https://evidence-hub.com/study/67170-successful-transition-from-intravenous-epoprostenol-to-oral-selexipag2026-10-06 https://evidence-hub.com/study/67171-a-case-of-interferon-induced-pulmonary-arterial-hypertension-after2026-10-06 https://evidence-hub.com/study/67172-a-successful-treatment-of-tadalafil-in-incontinentia-pigmenti-with2026-10-06 https://evidence-hub.com/study/67173-epistaxis-after-pde-5-inhibitors-misuse2026-10-06 https://evidence-hub.com/study/67174-a-case-of-suspected-portal-pulmonary-hypertension-due-to-hepatitis-c2026-10-06 https://evidence-hub.com/study/67175-right-ventricular-st-elevation-myocardial-infarction-as-a-cause-of2026-10-06 https://evidence-hub.com/study/67176-acute-serous-retinal-detachment-in-idiopathic-pulmonary-arterial2026-10-06 https://evidence-hub.com/study/67177-successful-delayed-treatment-of-acute-glans-penis-ischaemia-after2026-10-06 https://evidence-hub.com/study/67178-hemodynamic-effects-of-ambrisentan-tadalafil-combination-therapy-on2026-10-06 https://evidence-hub.com/study/67179-sudden-sensorineural-hearing-loss-associated-with-vardenafil2026-10-06 https://evidence-hub.com/study/67180-treatment-using-tadalafil-for-severe-pre-eclampsia-with-fetal-growth2026-10-06 https://evidence-hub.com/study/67181-optical-coherence-tomography-in-tadalafil-associated-retinal-toxicity2026-10-06 https://evidence-hub.com/study/67182-patient-diagnosed-with-chronic-erectile-dysfunction-refractory-to-pde2026-10-06 https://evidence-hub.com/study/67183-tadalafil-therapy-and-severe-chronic-foot-wound-resolution2026-10-04 https://evidence-hub.com/study/67184-reversible-pulmonary-arterial-hypertension-associated-with-interferon2026-10-06 https://evidence-hub.com/study/67185-myopathy-with-concurrent-tadalafil-and-simvastatin2026-10-04 https://evidence-hub.com/study/67186-hereditary-hemorrhagic-telangiectasia-with-pulmonary-hypertension-a2026-10-10 https://evidence-hub.com/study/67187-bilateral-knee-and-intermittent-elbow-pain-in-a-competitive-archer2026-10-06 https://evidence-hub.com/study/67188-prostacyclin-therapy-as-adjunctive-treatment-for-pulmonary2026-10-06 https://evidence-hub.com/study/67189-implantable-lenus-pro-pump-for-treprostinil-infusion-in-three2026-10-06 https://evidence-hub.com/study/67190-use-of-tadalafil-in-a-patient-with-a-secondary-raynaud-s-phenomenon2026-10-04 https://evidence-hub.com/study/67191-smoking-related-interstitial-fibrosis-srif-and-pulmonary-hypertension2026-10-06 https://evidence-hub.com/study/67192-pulmonary-arterial-hypertension-in-patient-treated-for-multiple2026-10-06 https://evidence-hub.com/study/67193-long-term-oral-phosphodiesterase-5-inhibitor-therapy-alleviates2026-10-06 https://evidence-hub.com/study/67194-possible-drug-nutraceutical-interaction-leading-to-unexpected2026-10-06 https://evidence-hub.com/study/67195-combination-therapy-with-prostacyclin-and-tadalafil-for-severe2026-10-06 https://evidence-hub.com/study/67196-leber-s-hereditary-optic-neuropathy-precipitated-by-tadalafil-use-for2026-10-06 https://evidence-hub.com/study/67197-tadalafil-reversal-of-sexual-dysfunction-caused-by-serotonin2026-10-06 https://evidence-hub.com/study/67198-correction-of-tricuspid-regurgitation-in-pulmonary-arterial2026-10-06 https://evidence-hub.com/study/67199-use-of-hyperbaric-oxygen-therapy-to-treat-glans-penis-necrosis-after2026-10-06 https://evidence-hub.com/study/67200-pulmonary-arterial-hypertension-in-an-80-year-old-man-with-long-term2026-10-06 https://evidence-hub.com/study/67201-cutaneous-reaction-to-drugs-used-for-erectile-dysfunction-case-report2026-10-06 https://evidence-hub.com/study/67202-transient-global-amnesia-after-intake-of-tadalafil-a-pde-5-inhibitor2026-10-06 https://evidence-hub.com/study/67203-initial-and-programmed-combination-therapy-with-oral-drugs-for-severe2026-10-06 https://evidence-hub.com/study/67204-pulmonary-hypertension-due-to-silicosis-and-right-upper-pulmonary2026-10-06 https://evidence-hub.com/study/67205-stiff-fingers-as-an-unwanted-side-effect-of-intravascular-tadalafil2026-10-06 https://evidence-hub.com/study/67206-use-of-tadalafil-for-treating-pulmonary-arterial-hypertension2026-10-06 https://evidence-hub.com/study/67207-pulmonary-arterial-hypertension-in-adult-onset-still-s-disease-a-case2026-10-06 https://evidence-hub.com/study/67208-recurrent-epistaxis-after-treatment-with-tadalafil-cialis2026-10-06 https://evidence-hub.com/study/67209-amelioration-of-right-ventricular-systolic-function-and-stiffness-in2026-10-06 https://evidence-hub.com/study/67210-good-response-to-pulmonary-arterial-hypertension-targeted-therapy-in2026-10-06 https://evidence-hub.com/study/67211-two-patients-with-mixed-connective-tissue-disease-complicated-by2026-10-06 https://evidence-hub.com/study/67212-efficacy-of-immunosuppressants-with-bridge-vasodilator-therapy-in2026-10-19 https://evidence-hub.com/study/67213-non-arteritic-anterior-ischemic-optic-neuropathy-associated-with2026-10-06 https://evidence-hub.com/study/67214-intracavernous-injection-a-treatment-modality-for-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/67215-leflunomide-induced-pulmonary-arterial-hypertension-in-a-young-man2026-10-06 https://evidence-hub.com/study/67216-clinical-and-functional-recovery-in-a-patient-with-pulmonary2026-10-06 https://evidence-hub.com/study/67217-central-serous-chorioretinopathy-due-to-tadalafil-use2026-10-06 https://evidence-hub.com/study/67218-characteristics-of-pulmonary-arterial-hypertension-in-patients-with2026-10-06 https://evidence-hub.com/study/67219-pulmonary-artery-denervation-for-refractory-sjogren-s-syndrome2026-10-06 https://evidence-hub.com/study/67220-reversible-dasatinib-associated-pulmonary-hypertension-managed-with2026-10-06 https://evidence-hub.com/study/67221-reversible-pre-capillary-pulmonary-hypertension-due-to-long-standing2026-10-06 https://evidence-hub.com/study/67222-exertional-rhabdomyolysis-following-concurrent-exercise-including2026-10-06 https://evidence-hub.com/study/67223-bleeding-without-fracture-unmasking-a-penile-arterial-leak-as-a-cause2026-10-06 https://evidence-hub.com/study/67224-from-sedation-to-stimulation-anecdotal-case-reports-of-enhanced2026-10-06 https://evidence-hub.com/study/67225-ai-assisted-identification-of-a-novel-vardenafil-analog-kd-0272026-10-06 https://evidence-hub.com/study/67226-nifedipine-and-mycophenolate-mofetil-induced-gingival-hyperplasia-in2026-10-06 https://evidence-hub.com/study/67227-pulmonary-hypertension-in-a-19-year-old-patient-due-to-a-mutation-in2026-10-06 https://evidence-hub.com/study/67228-online-sourced-retatrutide-complicating-impending-diabetic2026-10-06 https://evidence-hub.com/study/67229-epicardial-coronary-spasm-mimicking-right-coronary-artery-occlusion2026-10-06 https://evidence-hub.com/study/67230-case-report-pulmonary-artery-biopsy-findings-in-a-patient-with-a2026-10-06 https://evidence-hub.com/study/67231-cerebral-air-embolism-after-implantation-of-a-leadless-pacemaker-via2026-10-06 https://evidence-hub.com/study/67232-case-report-treatment-of-refractory-lung-disease-in-systemic-juvenile2026-10-06 https://evidence-hub.com/study/67233-unmasking-cancer-risk-in-heritable-pah-the-hidden-role-of-bmpr2-in2026-10-06 https://evidence-hub.com/study/67234-when-labiaplasty-is-not-enough-rejuvenation-of-the-labia-majora-using2026-10-06 https://evidence-hub.com/study/67235-multiple-trocar-site-hernias-following-robot-assisted-incisional2026-10-06 https://evidence-hub.com/study/67236-minimally-invasive-laser-enucleation-of-the-prostate-milep-in-a2026-10-19 https://evidence-hub.com/study/67237-autonomic-dysregulation-attributed-to-vertebral-artery-insufficiency2026-10-06 https://evidence-hub.com/study/67238-dynamic-left-main-coronary-artery-compression-by-a-dilated-pulmonary2026-10-06 https://evidence-hub.com/study/67239-catastrophic-antiphospholipid-syndrome-complicated-with-multiple2026-10-06 https://evidence-hub.com/study/67240-perioperative-management-of-emergency-non-cardiac-surgery-in-a2026-10-06 https://evidence-hub.com/study/67241-atrial-septal-defect-closure-with-persistently-elevated-pulmonary2026-10-06 https://evidence-hub.com/study/67242-left-main-coronary-artery-stenting-in-pulmonary-arterial-hypertension2026-10-06 https://evidence-hub.com/study/67243-the-silent-threat-unmasking-combined-post-and-pre-capillary-pulmonary2026-10-06 https://evidence-hub.com/study/67244-sotatercept-administration-in-a-young-infant-with-severe-pulmonary2026-10-06 https://evidence-hub.com/study/67245-clinical-spectrum-of-bosutinib-related-side-effects-in-a-patient-of2026-10-06 https://evidence-hub.com/study/67246-seminal-vesicle-atrophy-and-ejaculatory-dysfunction-secondary-to2026-10-06 https://evidence-hub.com/study/67247-recurrent-priapism-associated-with-occupational-cocaine-exposure-in-a2026-10-06 https://evidence-hub.com/study/67248-a-case-report-of-two-hit-digenic-mutations-in-pah-role-of-padn-in2026-10-06 https://evidence-hub.com/study/67249-management-of-ischemia-and-necrosis-following-nonsurgical-rhinoplasty2026-10-06 https://evidence-hub.com/study/67250-case-report-rethinking-pulmonary-arterial-hypertension-immune-and2026-10-06 https://evidence-hub.com/study/67251-igg-type-lymphoplasmacytic-lymphoma-with-light-chain-deposition2026-10-19 https://evidence-hub.com/study/67252-group-5-pulmonary-hypertension-associated-with-t-cell-large-granular2026-10-06 https://evidence-hub.com/study/67253-utilizing-apple-vision-pro-for-mindfulness-intervention-to-reduce2026-10-06 https://evidence-hub.com/study/67254-management-of-acute-cholecystitis-in-a-patient-with-eisenmenger2026-10-06 https://evidence-hub.com/study/67255-concomitant-recurrent-follicular-lymphoma-and-prostate-adenocarcinoma2026-10-06 https://evidence-hub.com/study/67256-conservative-management-of-iatrogenic-pulmonary-vein-obstruction2026-10-06 https://evidence-hub.com/study/67257-severe-penile-ischemia-after-metallic-ring-strangulation-a-rare-case2026-10-06 https://evidence-hub.com/study/67258-management-strategy-for-congenital-hyperinsulinism-with-atrial-septal2026-10-06 https://evidence-hub.com/study/67259-somatic-pik3ca-activating-mutation-in-a-plexiform-lesion-of-a-patient2026-10-06 https://evidence-hub.com/study/67260-indication-technical-considerations-and-outcome-of-remote-central2026-10-06 https://evidence-hub.com/study/67261-novel-utilization-of-circulating-tumor-dna-in-primary2026-10-06 https://evidence-hub.com/study/67262-lupus-associated-pulmonary-arterial-hypertension-a-success-story2026-10-06 https://evidence-hub.com/study/67263-acute-decompensated-heart-failure-in-a-woman-with-eisenmenger2026-10-06 https://evidence-hub.com/study/67264-treat-and-repair-strategy-for-a-giant-pulmonary-artery-aneurysm2026-10-06 https://evidence-hub.com/study/67265-two-case-reports-of-eosinophilic-fasciitis-with-onset-after-immune2026-10-06 https://evidence-hub.com/study/67266-case-report-pemetrexed-induced-pseudocellulitis-a-rare-adverse-effect2026-10-06 https://evidence-hub.com/study/67267-relapse-of-acute-myelogenous-leukemia-with-history-of2026-10-06 https://evidence-hub.com/study/67268-novel-kcnk3-variant-in-a-child-with-pulmonary-arterial-hypertension2026-10-06 https://evidence-hub.com/study/67269-a-case-report-ertapenem-induced-encephalopathy2026-10-06 https://evidence-hub.com/study/67270-dynamic-immunomodulation-by-hydrogen-capsule-therapy-in-sle2026-10-06 https://evidence-hub.com/study/67271-unusual-cutaneous-adverse-reaction-to-an-erectile-dysfunction-drug-a2026-10-06 https://evidence-hub.com/study/67272-stent-placement-and-coil-embolization-for-plastic-bronchitis-in-a2026-10-06 https://evidence-hub.com/study/67273-treatment-of-sexual-dysfunction-induced-by-hyperprolactinemia2026-10-06 https://evidence-hub.com/study/67274-bi-allelic-loss-of-function-variants-in-tmem63b-cause-syndromic2026-10-06 https://evidence-hub.com/study/67275-thyrotropin-tsh-binding-inhibiting-immunoglobulin-negative-thyroid2026-10-06 https://evidence-hub.com/study/67276-pulmonary-aspergilloma-in-a-non-adherent-systemic-lupus-erythematosus2026-10-06 https://evidence-hub.com/study/67277-development-of-severe-pre-capillary-pulmonary-hypertension-7-years2026-10-06 https://evidence-hub.com/study/67278-pulmonary-tumor-thrombotic-microangiopathy-associated-with2026-10-06 https://evidence-hub.com/study/67279-difficulty-controlling-sedation-level-using-processed2026-10-06 https://evidence-hub.com/study/67280-case-report-the-tale-of-an-extruding-inflatable-penile-prosthesis2026-10-06 https://evidence-hub.com/study/67281-dilemmas-in-the-management-of-digital-ulcers-in-systemic-sclerosis2026-10-06 https://evidence-hub.com/study/67283-a-case-of-tadalafil-induced-fixed-drug-eruption2026-10-04 https://evidence-hub.com/study/67287-combination-therapy-with-pulmonary-arterial-hypertension-targeted2026-10-06 https://evidence-hub.com/study/67288-a-case-report-of-cyanopsia-after-taking-sildenafil2026-10-06 https://evidence-hub.com/study/67290-fatal-cardiac-tamponade-in-newly-diagnosed-systemic-sclerosis-with2026-10-06 https://evidence-hub.com/study/67297-tadalafil-associated-recurrent-intracerebral-hemorrhage-54142026-10-06 https://evidence-hub.com/study/67298-a-case-of-pulmonary-arterial-hypertension-complicated-by-anti2026-10-06 https://evidence-hub.com/study/67299-acute-bilateral-concurrent-central-retinal-artery-occlusion-in-sickle2026-10-06 https://evidence-hub.com/study/67301-tadalafil-as-treatment-for-idiopathic-pulmonary-arterial-hypertension2026-10-06 https://evidence-hub.com/study/67304-association-between-sexual-activity-related-death-and-non2026-10-06 https://evidence-hub.com/study/67305-eau-guidelines-on-the-treatment-and-follow-up-of-non-neurogenic-male2026-10-19 https://evidence-hub.com/study/67306-wilderness-medical-society-consensus-guidelines-for-the-prevention2026-10-06 https://evidence-hub.com/study/67307-hormonal-testing-and-pharmacologic-treatment-of-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/67308-the-2024-british-society-for-rheumatology-guideline-for-management-of2026-10-06 https://evidence-hub.com/study/67309-international-liver-transplantation-society-practice-guideline-update2026-10-06 https://evidence-hub.com/study/67310-european-academy-of-neurology-ean-european-federation-of-autonomic2026-10-19 https://evidence-hub.com/study/67311-diagnosis-and-treatment-of-autonomic-failure-pain-and-sleep2026-10-10 https://evidence-hub.com/study/67312-guidelines-for-parkinson-s-disease-management-part-ii-consensus-from2026-10-13 https://evidence-hub.com/study/67313-2023-brazilian-society-of-rheumatology-guidelines-for-the-treatment2026-10-10 https://evidence-hub.com/study/67314-clinical-practice-guideline-for-transurethral-plasmakinetic-resection2026-10-19 https://evidence-hub.com/study/67315-singapore-urological-association-clinical-guidelines-for-male-lower2026-10-19 https://evidence-hub.com/study/67316-pediatric-cardiac-intensive-care-society-2014-consensus-statement2026-10-10 https://evidence-hub.com/study/67317-peyronie-s-disease-aua-guideline2026-10-06 https://evidence-hub.com/study/67318-standardized-data-structures-in-rare-diseases-cdisc-user-guides-for2026-10-06 https://evidence-hub.com/study/67319-korean-clinical-practice-guideline-for-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/67320-an-official-american-thoracic-society-clinical-practice-guideline2026-10-06 https://evidence-hub.com/study/67321-enhancing-insights-into-pulmonary-vascular-disease-through-a2026-10-06 https://evidence-hub.com/study/67322-canadian-cardiovascular-society-canadian-association-of-radiologists2026-10-06 https://evidence-hub.com/study/67323-guidelines-of-care-for-the-management-of-atopic-dermatitis-section-32026-10-06 https://evidence-hub.com/study/67324-diagnostic-evaluation-and-management-of-chronic-thromboembolic2026-10-10 https://evidence-hub.com/study/67325-evidence-based-guideline-summary-diagnosis-and-treatment-of-limb2026-10-06 https://evidence-hub.com/study/67326-assessment-of-right-ventricular-function-in-the-research-setting2026-10-10 https://evidence-hub.com/study/67327-stability-indicating-rp-hplc-dad-method-for-simultaneous-estimation2026-10-06 https://evidence-hub.com/study/67330-effect-of-aqueous-fruit-extract-of-ficus-polita-vahl-on-body-weight2026-10-06 https://evidence-hub.com/study/67331-discovery-of-highly-selective-and-orally-available-benzimidazole2026-10-04 https://evidence-hub.com/study/67333-management-of-lower-urinary-tract-symptoms-attributed-to-benign2026-10-06 https://evidence-hub.com/study/67334-deep-eutectic-liquids-as-a-topical-vehicle-for-tadalafil2026-10-06 https://evidence-hub.com/study/67335-t-cell-mediated-targeted-delivery-of-tadalafil-regulates2026-10-06 https://evidence-hub.com/study/67338-322-patient-out-of-pocket-costs-for-guideline-recommended-treatments2026-10-06 https://evidence-hub.com/study/67339-erectile-dysfunction-aua-guideline2026-10-06 https://evidence-hub.com/study/67340-tadalafil-nanoemulsion-mists-for-treatment-of-pediatric-pulmonary2026-10-19 https://evidence-hub.com/study/67344-tadalafil-loaded-self-nanoemulsifying-chewable-tablets-for-improved2026-10-04 https://evidence-hub.com/study/67346-therapy-for-pulmonary-arterial-hypertension-in-adults-update-of-the2026-10-06 https://evidence-hub.com/study/67347-phosphodiesterase-pde-5-inhibitors-sildenafil-tadalafil-and2026-10-06 https://evidence-hub.com/study/67348-tadalafil-alleviates-lps-induced-inflammation-and-oxidative-stress-of2026-10-06 https://evidence-hub.com/study/67349-diketopiperazine-based-flexible-tadalafil-analogues-synthesis-crystal2026-10-06 https://evidence-hub.com/study/67350-development-of-spray-dried-amorphous-solid-dispersions-of-tadalafil2026-10-06 https://evidence-hub.com/study/67351-effectiveness-and-efficiency-of-guideline-dissemination-and2026-10-08 https://evidence-hub.com/study/67352-drug-drug-interactions-in-the-management-of-patients-with-pulmonary2026-10-06 https://evidence-hub.com/study/67353-diagnosis-and-treatment-of-pulmonary-arterial-hypertension-a-review2026-10-06 https://evidence-hub.com/study/67354-acvim-consensus-statement-guidelines-for-the-diagnosis-classification2026-10-06 https://evidence-hub.com/study/67355-nitric-oxide-synthases-regulation-and-function2026-10-06 https://evidence-hub.com/study/67356-lower-urinary-tract-symptoms-in-men-a-review2026-10-06 https://evidence-hub.com/study/67357-erectile-dysfunction-in-adolescents-and-young-adults2026-10-06 https://evidence-hub.com/study/67359-beyond-erectile-dysfunction-cgmp-specific-phosphodiesterase-52026-10-04 https://evidence-hub.com/study/67360-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/67361-drug-induced-hearing-loss2026-10-06 https://evidence-hub.com/study/67362-pulmonary-arterial-hypertension2026-10-06 https://evidence-hub.com/study/67363-sildenafil-and-cardioprotection2026-10-08 https://evidence-hub.com/study/67365-new-and-emerging-therapeutic-drugs-for-the-treatment-of-pulmonary2026-10-10 https://evidence-hub.com/study/67366-chronic-pde-5-inhibition-in-patients-with-erectile-dysfunction-a2026-10-04 https://evidence-hub.com/study/67367-pharmacotherapy-for-pulmonary-arterial-hypertension2026-10-06 https://evidence-hub.com/study/67368-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/67369-pde-5-inhibitors-clinical-points2026-10-06 https://evidence-hub.com/study/67370-pulmonary-arterial-hypertension-in-pregnancy2026-10-06 https://evidence-hub.com/study/67371-tadalafil-and-vardenafil-vs-sildenafil-a-review-of-patient-preference2026-10-04 https://evidence-hub.com/study/67372-otorhinolaryngological-adverse-effects-of-urological-drugs2026-10-19 https://evidence-hub.com/study/67373-pharmacological-management-of-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/67374-phosphodiesterase-inhibition-in-cognitive-decline2026-10-06 https://evidence-hub.com/study/67375-pharmacology-of-phosphodiesterase-5-inhibitors2026-10-06 https://evidence-hub.com/study/67376-pharmacotherapeutic-management-of-pulmonary-arterial-hypertension2026-10-06 https://evidence-hub.com/study/67377-medication-and-dosage-considerations-in-the-prophylaxis-and-treatment2026-10-06 https://evidence-hub.com/study/67378-screening-of-synthetic-pde-5-inhibitors-and-their-analogues-as2026-10-06 https://evidence-hub.com/study/67379-pathological-function-of-ca2-sensing-receptor-in-pulmonary-arterial2026-10-06 https://evidence-hub.com/study/67380-management-of-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/67381-sexual-activity-in-patients-with-cardiac-diseases2026-10-06 https://evidence-hub.com/study/67382-update-on-pulmonary-arterial-hypertension-pharmacotherapy2026-10-06 https://evidence-hub.com/study/67383-phosphodiesterase-inhibitors-in-clinical-urology2026-10-19 https://evidence-hub.com/study/67384-gateways-to-clinical-trials2026-10-08 https://evidence-hub.com/study/67385-pharmacology-of-phosphodiesterase-5-inhibitors2026-10-06 https://evidence-hub.com/study/67386-pde5-inhibitors-in-non-urological-conditions2026-10-06 https://evidence-hub.com/study/67387-novel-insights-regarding-nitric-oxide-and-cardiovascular-diseases2026-10-06 https://evidence-hub.com/study/67388-phosphodiesterase-inhibitors-in-raynaud-s-phenomenon2026-10-06 https://evidence-hub.com/study/67389-evaluation-of-tadalafil-for-the-treatment-of-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/67390-erectile-dysfunction-key-role-of-cavernous-smooth-muscle-cells2026-10-06 https://evidence-hub.com/study/67391-cyclic-nucleotide-phosphodiesterases-molecular-regulation-to-clinical2026-10-06 https://evidence-hub.com/study/67392-pde-5-inhibition-and-sexual-response-pharmacological-mechanisms-and2026-10-06 https://evidence-hub.com/study/67393-current-diagnosis-and-management-of-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/67394-phosphodiesterase-type-5-inhibitors-and-visual-side-effects-a2026-10-10 https://evidence-hub.com/study/67395-prostaglandins-as-a-topical-therapy-for-erectile-dysfunction-a2026-10-06 https://evidence-hub.com/study/67396-phosphodiesterase-type-5-inhibitors-the-day-after2026-10-06 https://evidence-hub.com/study/67397-tadalafil-a-further-innovation-in-the-treatment-of-sexual-dysfunction2026-10-06 https://evidence-hub.com/study/67398-from-nature-to-drug-discovery-the-indole-scaffold-as-a-privileged2026-10-06 https://evidence-hub.com/study/67399-potency-selectivity-and-consequences-of-nonselectivity-of-pde2026-10-06 https://evidence-hub.com/study/67400-latest-pharmacotherapy-options-for-benign-prostatic-hyperplasia2026-10-06 https://evidence-hub.com/study/67401-opportunities-and-challenges-of-pharmacotherapy-for-pulmonary2026-10-06 https://evidence-hub.com/study/67403-therapeutic-potential-of-phosphodiesterase-inhibitors-against2026-10-06 https://evidence-hub.com/study/67404-modulating-no-gc-pathway-in-pulmonary-arterial-hypertension2026-10-06 https://evidence-hub.com/study/67405-the-phosphodiasterase-5-inhibitors-pde-5i-for-erectile-dysfunction-ed2026-10-06 https://evidence-hub.com/study/67406-pde5-inhibitors-breaking-new-grounds-in-the-treatment-of-covid-192026-10-19 https://evidence-hub.com/study/67407-novel-therapeutic-approaches-in-pulmonary-arterial-hypertension-focus2026-10-06 https://evidence-hub.com/study/67408-repositioning-of-drugs-in-cardiometabolic-disorders-importance-and2026-10-06 https://evidence-hub.com/study/67409-structure-activity-relationships-of-pde5-inhibitors2026-10-06 https://evidence-hub.com/study/67410-current-use-of-phosphodiesterase-inhibitors-in-urology2026-10-06 https://evidence-hub.com/study/67411-tadalafil-a-therapeutic-option-in-the-management-of-bph-luts2026-10-06 https://evidence-hub.com/study/67412-targeting-inflammation-oxidative-stress-crosstalk-advances-and2026-10-10 https://evidence-hub.com/study/67413-dopamine-receptors-potential-therapeutic-targets-for-ischemia2026-10-06 https://evidence-hub.com/study/67414-myeloid-derived-suppressor-cells-in-multiple-myeloma-mechanistic2026-10-06 https://evidence-hub.com/study/67415-phytochemical-based-nanomedicine-as-a-promising-therapeutic-strategy2026-10-19 https://evidence-hub.com/study/67416-direct-to-consumer-erectile-dysfunction-medications-is-the2026-10-06 https://evidence-hub.com/study/67417-clinical-updates-in-pulmonary-hypertension2026-10-06 https://evidence-hub.com/study/67418-erectile-dysfunction-a-comprehensive-review-of-pathophysiology2026-10-19 https://evidence-hub.com/study/67419-comparative-effectiveness-of-pharmacological-treatments-for-fetal2026-10-06 https://evidence-hub.com/study/67420-overcoming-mdsc-mediated-immunosuppression-in-hepatocellular2026-10-06 https://evidence-hub.com/study/67421-expert-viewpoint-on-endpoints-in-systemic-sclerosis-current-and2026-10-06 https://evidence-hub.com/study/67422-pitfalls-of-therapies-targeting-the-nitric-oxide-signaling-pathway-in2026-10-10 https://evidence-hub.com/study/67423-pde-5-inhibitors-in-complex-matrices-recent-updates-on-pretreatment2026-10-06 https://evidence-hub.com/study/67424-erectile-dysfunction-drugs-as-potential-therapy-for-cognitive-decline2026-10-19 https://evidence-hub.com/study/67425-contemporary-management-strategies-for-peyronie-s-disease-a2026-10-10 https://evidence-hub.com/study/67426-unconsummated-marriage-etiology-and-treatment-of-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/67427-2025-annual-review-of-pulmonary-arterial-hypertension-clinical2026-10-06 https://evidence-hub.com/study/67428-myeloid-derived-suppressor-cells-function-migration-and-therapeutic2026-10-06 https://evidence-hub.com/study/67429-worldwide-epidemiology-of-pulmonary-hypertension-associated-with-left2026-10-06 https://evidence-hub.com/study/67430-guideline-of-guidelines-a-scoping-review-on-comparison-of-major2026-10-19 https://evidence-hub.com/study/67431-the-interplay-between-neuroinflammation-and-endothelial-dysfunction2026-10-06 https://evidence-hub.com/study/67432-exploring-the-interconnectedness-of-multiple-sclerosis-and-erectile2026-10-10 https://evidence-hub.com/study/67434-congenital-heart-disease-and-pulmonary-arterial-hypertension-current2026-10-06 https://evidence-hub.com/study/67435-from-symptomatic-relief-to-restorative-medicine-a-comprehensive2026-10-06 https://evidence-hub.com/study/67436-the-pathophysiology-mechanism-diagnosis-and-management-of-pulmonary2026-10-06 https://evidence-hub.com/study/67437-pulmonary-hypertension-in-pregnancy-hemodynamic-challenges-maternal2026-10-06 https://evidence-hub.com/study/67438-management-and-treatment-of-benign-prostatic-hyperplasia-symptoms2026-10-19 https://evidence-hub.com/study/67439-the-il-12-family-cytokines-in-neurodegenerative-diseases-dual-roles2026-10-06 https://evidence-hub.com/study/67440-from-nanotechnology-to-immunomodulation-emerging-strategies-targeting2026-10-10 https://evidence-hub.com/study/67441-management-of-pulmonary-arterial-hypertension-current-strategies-and2026-10-10 https://evidence-hub.com/study/67442-fetal-heart-failure-exploring-diagnosis-and-treatment-strategies2026-10-04 https://evidence-hub.com/study/67443-pharmacological-treatment-of-bladder-stent-symptoms2026-10-06 https://evidence-hub.com/study/67444-an-overview-on-pharmaceutical-applications-of-phosphodiesterase2026-10-19 https://evidence-hub.com/study/67445-phosphodiesterase-inhibitors-as-emerging-therapeutics-for-skeletal2026-10-19 https://evidence-hub.com/study/67446-antenatal-sildenafil-for-congenital-diaphragmatic-hernia-a-systematic2026-10-10 https://evidence-hub.com/study/67447-diagnosis-and-treatment-of-benign-prostatic-hyperplasia-in-dogs-new2026-10-19 https://evidence-hub.com/study/67448-evaluation-and-management-of-sepsis-in-pulmonary-hypertension2026-10-06 https://evidence-hub.com/study/67449-advances-in-the-pathogenesis-and-clinical-management-of-pulmonary2026-10-06 https://evidence-hub.com/study/67453-the-association-between-phosphodiesterase-type-5-inhibitor-use-and2026-10-10 https://evidence-hub.com/study/67454-phosphodiesterase-type-5-inhibitors-pde-5i-as-a-potential-therapeutic2026-10-10 https://evidence-hub.com/study/67455-effective-therapy-for-the-management-of-erectile-dysfunction-in-men2026-10-04 https://evidence-hub.com/study/67456-phosphodiesterase-type-5-inhibitors-for-the-treatment-of-sexual2026-10-04 https://evidence-hub.com/study/67457-role-of-no-cgmp-pkg-axis-in-pulmonary-arterial-hypertension2026-10-06 https://evidence-hub.com/study/67458-placenta-anchored-tadalafil-liposomes-rescues-intrauterine-growth2026-10-06 https://evidence-hub.com/study/67459-protective-effects-of-tadalafil-on-damaged-podocytes-in-an-adriamycin2026-10-04 https://evidence-hub.com/study/67460-analgesia-additive-interaction-between-tadalafil-and-morphine-in-an2026-10-04 https://evidence-hub.com/study/67461-tadalafil-for-male-lower-urinary-tract-symptoms-improves-endothelial2026-10-06 https://evidence-hub.com/study/67462-cialis-tadalafil-a-new-treatment-for-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/67463-cytochrome-p450-mediated-metabolic-interactions-between-donepezil-and2026-10-06 https://evidence-hub.com/study/67464-tadalafil-for-the-treatment-of-lower-urinary-tract-symptoms-in-men2026-10-19 https://evidence-hub.com/study/67465-tadalafil-increases-muscle-capillary-recruitment-and-forearm-glucose2026-10-06 https://evidence-hub.com/study/67466-the-phosphodiesterase-5-inhibitor-tadalafil-regulates-lipidic2026-10-06 https://evidence-hub.com/study/67467-oral-appliance-combined-with-tadalafil-for-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/67468-phosphodiesterase-type-5-inhibitor-tadalafil-increases-rituximab2026-10-06 https://evidence-hub.com/study/67469-tadalafil-treatment-delays-the-onset-of-cardiomyopathy-in-dystrophin2026-10-06 https://evidence-hub.com/study/67470-experimental-rodent-models-of-chronic-prostatitis-effect-of2026-10-19 https://evidence-hub.com/study/67471-efficacy-of-tadalafil-for-erectile-dysfunction-an-updated-review2026-10-06 https://evidence-hub.com/study/67472-safety-of-tadalafil-in-patients-with-cardiovascular-comorbidities2026-10-19 https://evidence-hub.com/study/67473-effects-of-tadalafil-versus-silodosin-on-voiding-function-in-male2026-10-06 https://evidence-hub.com/study/67474-decreased-circulating-thrombomodulin-is-improved-by-tadalafil-therapy2026-10-06 https://evidence-hub.com/study/67475-phosphodiesterase-type-5-inhibition-as-a-therapeutic-strategy-in2026-10-06 https://evidence-hub.com/study/67476-tadalafil-promotes-the-recovery-of-peripheral-neuropathy-in-type-ii2026-10-06 https://evidence-hub.com/study/67477-novel-chemicals-derived-from-tadalafil-exhibit-prmt5-inhibition-and2026-10-06 https://evidence-hub.com/study/67478-alternate-day-tadalafil-in-the-management-of-honeymoon-impotence2026-10-06 https://evidence-hub.com/study/67479-comparative-clinical-evaluation-of-endothelin-receptor-antagonists-in2026-10-06 https://evidence-hub.com/study/67480-phosphodiesterase-5-inhibitors-for-erectile-function-rehabilitation2026-10-06 https://evidence-hub.com/study/67481-bedb-a-comprehensive-binding-energy-database-for-molecular-docking2026-10-05 https://evidence-hub.com/study/67482-synuclein-blocks-endoplasmic-reticulum-co-translational-protein2026-10-06 https://evidence-hub.com/study/67483-intralesional-and-topical-treatments-for-peyronie-s-disease-a2026-10-10 https://evidence-hub.com/study/67484-calcium-channel-blockers-in-critical-care-medicine-current-clinical2026-10-10 https://evidence-hub.com/study/67485-genetic-biomarkers-associated-with-risk-and-therapeutic-response-in2026-10-19 https://evidence-hub.com/study/67486-vascular-aging-driven-erectile-dysfunction-pathophysiological2026-10-06 https://evidence-hub.com/study/67487-soluble-guanylate-cyclase-deficiency-drives-retinal-ganglion-cell2026-10-06 https://evidence-hub.com/study/67488-dash-diet-dietary-nitrate-and-nitric-oxide-bioavailability2026-10-10 https://evidence-hub.com/study/67489-molecular-insights-and-admet-profiling-of-iridoids-as-candidate-leads2026-10-10 https://evidence-hub.com/study/67490-pretreatment-with-tadalafil-attenuates-cardiotoxicity-induced-by2026-10-10 https://evidence-hub.com/study/67491-plasmon-enhanced-fluorescence-determination-of-tamsulosin-using2026-10-06 https://evidence-hub.com/study/67492-a-narrative-review-of-the-roles-of-nursing-in-addressing-sexual2026-10-06 https://evidence-hub.com/study/67493-molecular-dynamics-assisted-discovery-of-novel-phosphodiesterase-52026-10-10 https://evidence-hub.com/study/67494-structural-basis-of-phosphodiesterase-5-conformational-organization2026-10-10 https://evidence-hub.com/study/67495-development-and-pharmacokinetic-evaluation-of-newly-formulated2026-10-06 https://evidence-hub.com/study/67496-unveiling-of-phosphodiesterase-5-hot-residues-binding-to-xanthine2026-10-10 https://evidence-hub.com/study/67497-analyzing-the-clinical-efficacy-of-a-type-5-phosphodiesterase2026-10-06 https://evidence-hub.com/study/67498-the-role-of-the-aging-bladder-in-lower-urinary-tract-symptoms2026-10-19 https://evidence-hub.com/study/67499-cerebral-small-vessel-disease-therapeutic-approaches-targeting2026-10-10 https://evidence-hub.com/study/67500-identification-of-potentially-causative-drugs-associated-with2026-10-06 https://evidence-hub.com/study/67501-epilepsy-therapy-beyond-neurons-unveiling-astrocytes-as-cellular2026-10-06 https://evidence-hub.com/study/67502-immune-mediated-skin-diseases-and-erectile-dysfunction-mechanisms-and2026-10-06 https://evidence-hub.com/study/67503-epidemiology-and-treatment-of-priapism-in-sickle-cell-disease2026-10-10 https://evidence-hub.com/study/67504-microbiological-and-clinical-assessments-of-suture-materials-and2026-10-06 https://evidence-hub.com/study/67505-structure-based-virtual-screening-identifies-vx-809-as-a-candidate2026-10-06 https://evidence-hub.com/study/67506-pharmacological-management-of-urinary-incontinence-current-and2026-10-19 https://evidence-hub.com/study/67507-the-assessment-and-aetiology-of-drug-induced-ischaemic-priapism2026-10-06 https://evidence-hub.com/study/67508-profiling-sars-cov-2-main-protease-mpro-binding-to-repurposed-drugs2026-10-06 https://evidence-hub.com/study/67509-virtual-screening-molecular-dynamics-and-structure-activity2026-10-06 https://evidence-hub.com/study/67510-low-intensity-extracorporeal-shockwave-therapy-for-erectile2026-10-06 https://evidence-hub.com/study/67511-piperonal-derived-schiff-base-molecules-as-potential-multi-target2026-10-06 https://evidence-hub.com/study/67512-inflammation-is-a-target-of-medical-treatment-for-lower-urinary-tract2026-10-19 https://evidence-hub.com/study/67513-identifying-phosphodiesterase-5-inhibitors-with-drug-repurposing2026-10-19 https://evidence-hub.com/study/67514-improving-sexual-dysfunction-with-cinnamon-leaf-extract-and2026-10-10 https://evidence-hub.com/study/67515-life-threatening-pphn-refractory-to-nitric-oxide-proposal-for-a2026-10-10 https://evidence-hub.com/study/67516-lipocalin-2-not-only-a-biomarker-a-study-of-current-literature-and2026-10-06 https://evidence-hub.com/study/67517-cyclic-nucleotide-phosphodiesterases-as-drug-targets2026-10-19 https://evidence-hub.com/study/67518-systemic-lupus-erythematosus-and-pulmonary-hypertension2026-10-10 https://evidence-hub.com/study/67519-pleiotropic-effects-of-influenza-vaccination2026-10-06 https://evidence-hub.com/study/67520-a-lifelike-guided-journey-through-the-pathophysiology-of-pulmonary2026-10-06 https://evidence-hub.com/study/67521-novel-tnip2-and-traf2-variants-are-implicated-in-the-pathogenesis-of2026-10-06 https://evidence-hub.com/study/67522-pulmonary-vasodilation-in-acute-pulmonary-embolism-a-systematic-review2026-10-06 https://evidence-hub.com/study/67523-gut-opportunistic-pathogens-contribute-to-high-altitude-pulmonary2026-10-06 https://evidence-hub.com/study/67524-structural-determination-biological-function-and-molecular-modelling2026-10-10 https://evidence-hub.com/study/67525-investigation-of-pde5-pde6-and-pde5-pde11-selective-potent-tadalafil2026-10-06 https://evidence-hub.com/study/67526-interventions-for-altering-blood-pressure-in-people-with-acute2026-10-10 https://evidence-hub.com/study/67527-detrusor-underactivity-in-men-with-bladder-outlet-obstruction2026-10-19 https://evidence-hub.com/study/67528-lopinavir-ritonavir-in-sars-cov-2-infection-and-drug-drug2026-10-06 https://evidence-hub.com/study/67529-interventions-for-treating-pain-and-disability-in-adults-with-complex2026-10-06 https://evidence-hub.com/study/67530-epidemiology-etiopathogenesis-diagnosis-and-treatment-of-male2026-10-19 https://evidence-hub.com/study/67531-physiologically-based-pharmacokinetic-modeling-in-neonates-current2026-10-06 https://evidence-hub.com/study/67532-trpa1-sensitization-during-diabetic-vascular-impairment-contributes2026-10-06 https://evidence-hub.com/study/67533-short-term-outcomes-of-phosphodiesterase-type-5-inhibitors-for-fetal2026-10-08 https://evidence-hub.com/study/67534-predictive-value-of-systemic-inflammatory-response-index-in-patients2026-10-05 https://evidence-hub.com/study/67535-comparative-study-of-tamsulosin-tadalafil-and-combination-of2026-10-05 https://evidence-hub.com/study/67536-comparative-study-of-tamsulosin-versus-tadalafil-in-benign-prostatic2026-10-19 https://evidence-hub.com/study/67537-the-effect-of-vitamin-d-replacement-in-patients-with-lower-urinary2026-10-06 https://evidence-hub.com/study/67538-does-treatment-of-erectile-dysfunction-with-pde-5-inhibitor-tadalafil2026-10-06 https://evidence-hub.com/study/67539-efficacy-and-safety-of-dutasteride-with-tadalafil-add-on-therapy-in2026-10-19 https://evidence-hub.com/study/67540-selecting-an-individualized-treatment-approach-the-predictive-value2026-10-06 https://evidence-hub.com/study/67541-the-role-of-tadalafil-in-treated-hypertensive-patients-with-erectile2026-10-04 https://evidence-hub.com/study/67542-efficacy-of-combination-treatment-with-tadalafil-and-mirabegron-in2026-10-19 https://evidence-hub.com/study/67543-new-possibilities-in-heart-failure-the-effects-of-tadalafil-on2026-10-06 https://evidence-hub.com/study/67544-effect-of-tadalafil-sz-on-endothelial-function-in-patients-with2026-10-19 https://evidence-hub.com/study/67545-efficacy-of-a-combination-of-dutasteride-tadalafil-and-solifenacin-in2026-10-19 https://evidence-hub.com/study/67546-tadalafil-5-mg-once-daily-improved-each-ipss-subscore-qol-and2026-10-06 https://evidence-hub.com/study/67547-simultaneous-lc-ms-analysis-of-plasma-concentrations-of-sildenafil2026-10-06 https://evidence-hub.com/study/67548-tadalafil-treatment-improves-inflammation-cognitive-function-and2026-10-19 https://evidence-hub.com/study/67549-the-effect-of-using-tadalafil-5-mg-day-on-neutrophil-lymphocyte-and2026-10-06 https://evidence-hub.com/study/67550-the-effect-of-daily-low-dose-tadalafil-on-cerebral-perfusion-and2026-10-04 https://evidence-hub.com/study/67551-can-subfoveal-choroidal-thickness-replace-subjective-tests-in2026-10-06 https://evidence-hub.com/study/67552-daily-low-dose-of-tadalafil-improves-pain-and-frequency-in-bladder2026-10-06 https://evidence-hub.com/study/67553-does-tadalafil-5-mg-day-affect-lymphocyte-to-monocyte-and-monocyte-to2026-10-06 https://evidence-hub.com/study/67554-real-world-safety-and-effectiveness-of-tadalafil-in-patients-with2026-10-06 https://evidence-hub.com/study/67555-administration-of-daily-5-mg-tadalafil-improves-endothelial-function2026-10-19 https://evidence-hub.com/study/67557-pre-treatment-serum-testosterone-level-can-be-a-useful-factor-to2026-10-19 https://evidence-hub.com/study/67558-treatment-persistence-with-a-fixed-dose-combination-of-tadalafil-5-mg2026-10-19 https://evidence-hub.com/study/67559-an-open-label-single-arm-pilot-study-to-evaluate-the-efficacy-of2026-10-06 https://evidence-hub.com/study/67560-the-impact-of-ambrisentan-and-tadalafil-upfront-combination-therapy2026-10-06 https://evidence-hub.com/study/67562-once-daily-5-mg-tadalafil-oral-treatment-for-patients-with-chronic2026-10-06 https://evidence-hub.com/study/67563-efficacy-of-tadalafil-treatment-on-erectile-dysfunction-in-patients2026-10-06 https://evidence-hub.com/study/67564-the-effect-of-tadalafil-on-functional-capacity-and-echocardiographic2026-10-04 https://evidence-hub.com/study/67565-penile-blood-pressure-is-useful-to-identify-candidates-for-tadalafil2026-10-06 https://evidence-hub.com/study/67566-effect-of-tadalafil-add-on-therapy-in-patients-with-persistant2026-10-19 https://evidence-hub.com/study/67567-comparison-of-silodosin-versus-tadalafil-in-patients-with-lower2026-10-19 https://evidence-hub.com/study/67571-chronic-administration-of-tadalafil-improves-the-symptoms-of-patients2026-10-04 https://evidence-hub.com/study/67572-tadalafil-ameliorates-symptoms-of-patients-with-benign-prostatic2026-10-19 https://evidence-hub.com/study/67573-outcomes-and-management-of-peyronie-s-disease-with-combined-treatment2026-10-06 https://evidence-hub.com/study/67574-erectile-dysfunction-patients-are-more-satisfied-with-penile2026-10-04 https://evidence-hub.com/study/67575-benefits-of-tadalafil-to-ed-patients2026-10-06 https://evidence-hub.com/study/67576-ed-patients-and-their-female-partners-prefer-tadalafil2026-10-04 https://evidence-hub.com/study/67577-haemodynamic-and-renal-effects-of-tadalafil-in-patients-with-cirrhosis2026-10-04 https://evidence-hub.com/study/67578-efficacy-and-safety-of-tadalafil-for-erectile-dysfunction-in-patients2026-10-04 https://evidence-hub.com/study/67580-the-use-of-tadalafil-on-demand-in-specific-categories-of-patients2026-10-19 https://evidence-hub.com/study/67582-standard-doses-of-tadalafil-for-different-ed-patients2026-10-04 https://evidence-hub.com/study/67583-prevention-of-tadalafil-induced-backache-in-erectile-dysfunction2026-10-04 https://evidence-hub.com/study/67584-tadalafil-and-patients-preference-in-the-treatment-of-erectile2026-10-04 https://evidence-hub.com/study/67585-the-efficacy-and-safety-of-tamsulosin-and-tadalafil-combination2026-10-19 https://evidence-hub.com/study/67586-a-comparative-study-of-tadalafil-versus-tadalafil-combined-with-alpha2026-10-04 https://evidence-hub.com/study/67587-tadalafil-in-patients-with-chronic-obstructive-pulmonary-disease-a2026-10-04 https://evidence-hub.com/study/67588-once-a-day-tadalafil-administration-improves-the-spermogram2026-10-04 https://evidence-hub.com/study/67589-patient-preference-for-erectile-dysfunction-sildenafil-vs-tadalafil2026-10-04 https://evidence-hub.com/study/67590-adherence-to-initial-pde5-inhibitor-treatment-randomized-openlabel2026-10-04 https://evidence-hub.com/study/67592-a-comparative-randomized-prospective-study-to-evaluate-efficacy-and2026-10-19 https://evidence-hub.com/study/67593-tadalafil-once-daily-in-the-management-of-erectile-dysfunction2026-10-04 https://evidence-hub.com/study/67594-tadalafil-in-patients-on-antihypertensive-medications-does-safety2026-10-19 https://evidence-hub.com/study/67595-tadalafil-and-modifications-in-peak-systolic-velocity-doppler2026-10-04 https://evidence-hub.com/study/67596-effect-of-tadalafil-on-penile-duplex-parameters-in-erectile2026-10-04 https://evidence-hub.com/study/67597-effects-of-tadalafil-on-myocardial-blood-flow-in-patients-with2026-10-04 https://evidence-hub.com/study/67602-efficacy-of-tadalafil-once-daily-versus-fesoterodine-in-the-treatment2026-10-04 https://evidence-hub.com/study/67603-effectiveness-and-safety-of-tadalafil-in-very-elderly-patients-with2026-10-04 https://evidence-hub.com/study/67608-combination-of-tadalafil-and-finasteride-for-improving-the-symptoms2026-10-19 https://evidence-hub.com/study/67609-a-comparative-study-of-efficacy-of-tadalafil-and-alfuzosin-regimens2026-10-19 https://evidence-hub.com/study/67610-comparison-of-the-first-intake-of-vardenafil-and-tadalafil-in2026-10-04 https://evidence-hub.com/study/67614-efficacy-and-safety-of-medium-and-long-term-tadalafil-use-in-spinal2026-10-04 https://evidence-hub.com/study/67616-effects-of-tadalafil-on-platelets-and-endothelium-in-patients-with2026-10-04 https://evidence-hub.com/study/67617-tadalafil-in-patients-with-benign-prostatic-hyperplasia-during2026-10-04 https://evidence-hub.com/study/67619-safety-tolerability-and-efficacy-of-overnight-switching-from2026-10-10 https://evidence-hub.com/study/67620-clinical-effect-on-tadalafil-combined-with-adult-movie-on-patients2026-10-04 https://evidence-hub.com/study/67621-abstract-10964-clinical-safety-of-tadalafil-in-patients-receiving2026-10-04 https://evidence-hub.com/study/67622-the-effect-of-cardiovascular-morbidity-on-clinical-response-provided2026-10-04 https://evidence-hub.com/study/67623-comparative-efficacy-and-safety-of-a-fixed-dose-combination-therapy2026-10-19 https://evidence-hub.com/study/67626-does-tadalafil-prevent-erectile-dysfunction-in-patients-undergoing2026-10-04 https://evidence-hub.com/study/67627-efficacy-and-safety-of-combined-oral-therapy-with-tadalafil-and2026-10-04 https://evidence-hub.com/study/67628-pkg-1-leucine-zipper-domain-defect-increases-pulmonary-vascular-tone2026-10-06 https://evidence-hub.com/study/67629-pathophysiological-changes-of-the-lower-urinary-tract-behind-voiding2026-10-06 https://evidence-hub.com/study/67630-tadalafil-analgesia-in-experimental-arthritis-involves-suppression-of2026-10-04 https://evidence-hub.com/study/67631-combination-therapy-improves-vascular-volume-in-female-rats-with2026-10-06 https://evidence-hub.com/study/67632-mechanisms-underlying-spontaneous-constrictions-of-postcapillary2026-10-06 https://evidence-hub.com/study/67633-a-p97-valosin-containing-protein-inhibitor-drug-cb-5083-has-a-potent2026-10-06 https://evidence-hub.com/study/67634-concomitant-phosphodiesterase-5-inhibition-enhances-myocardial2026-10-06 https://evidence-hub.com/study/67635-effects-of-the-pde5-inhibitor-vardenafil-in-a-mouse-stroke-model2026-10-06 https://evidence-hub.com/study/67636-modulation-of-sirt1-expression-improves-erectile-function-in-aged-rats2026-10-06 https://evidence-hub.com/study/67637-the-effect-of-long-term-oral-tadalafil-treatment-on-corpus-cavernosum2026-10-06 https://evidence-hub.com/study/67638-preserved-activity-of-soluble-guanylate-cyclase-sgc-in-iliac-artery2026-10-06 https://evidence-hub.com/study/67639-tadalafil-improves-oxygenation-in-a-model-of-newborn-pulmonary2026-10-04 https://evidence-hub.com/study/67640-the-effects-of-tadalafil-on-renal-ischemia-reperfusion-injury-an2026-10-06 https://evidence-hub.com/study/67641-mechanism-of-action-of-phosphodiesterase-type-5-inhibition-in2026-10-06 https://evidence-hub.com/study/67642-title-efficacy-of-phosphodiesterase-5-inhibitor-on-distant-burn2026-10-06 https://evidence-hub.com/study/67643-anti-inflammatory-and-cardioprotective-effects-of-tadalafil-in2026-10-04 https://evidence-hub.com/study/67644-tadalafil-integrates-nitric-oxide-hydrogen-sulfide-signaling-to2026-10-06 https://evidence-hub.com/study/67645-hydrogen-sulfide-mediates-the-cardioprotective-effects-of-gene2026-10-06 https://evidence-hub.com/study/67646-tadalafil-improves-l-ng-nitroarginine-methyl-ester-induced2026-10-06 https://evidence-hub.com/study/67647-tadalafil-reduces-visceral-adipose-tissue-accumulation-by-promoting2026-10-04 https://evidence-hub.com/study/67648-tadalafil-alters-energy-metabolism-in-c2c12-skeletal-muscle-cells2026-10-04 https://evidence-hub.com/study/67649-effect-of-leech-centipede-medicine-on-improving-erectile-function-in2026-10-06 https://evidence-hub.com/study/67650-the-discovery-of-tadalafil-a-novel-and-highly-selective-pde52026-10-06 https://evidence-hub.com/study/67651-research-progress-of-phosphodiesterase-inhibitors-in-inflammatory2026-10-06 https://evidence-hub.com/study/67652-increased-bioavailability-of-cyclic-guanylate-monophosphate-prevents2026-10-06 https://evidence-hub.com/study/67653-erectile-dysfunction-in-a-murine-model-of-sleep-apnea2026-10-06 https://evidence-hub.com/study/67654-protective-effect-of-endothelial-nitric-oxide-synthase-against2026-10-06 https://evidence-hub.com/study/67655-phosphodiesterase-4-inhibitor-and-phosphodiesterase-5-inhibitor2026-10-19 https://evidence-hub.com/study/67656-sildenafil-and-tadalafil-in-simulated-chlorination-conditions2026-10-06 https://evidence-hub.com/study/67657-inhibitors-of-phosphodiesterase-5-pde-5-inhibit-the-nerve-induced2026-10-06 https://evidence-hub.com/study/67658-chronic-treatment-with-long-acting-phosphodiesterase-5-inhibitor2026-10-06 https://evidence-hub.com/study/67659-the-association-of-phosphodiesterase-5-inhibitor-on-ischemia2026-10-06 https://evidence-hub.com/study/67660-methyl-11as-1-2-3-5-11-11a-hexahydro-3-3-dimethyl-1-oxo-6h-imidazo-32026-10-06 https://evidence-hub.com/study/67661-combination-phosphodiesterase-type-4-inhibitor-and-phosphodiesterase2026-10-19 https://evidence-hub.com/study/67662-adenoviral-short-hairpin-rna-therapy-targeting-phosphodiesterase-5a2026-10-06 https://evidence-hub.com/study/67663-increased-intra-abdominal-pressure-induces-acute-kidney-injury-in-an2026-10-06 https://evidence-hub.com/study/67664-conversion-of-phosphodiesterase-5-pde5-catalytic-site-to-higher2026-10-06 https://evidence-hub.com/study/67665-phosphodiesterase-5a-regulates-the-vomeronasal-pump-in-mice2026-10-08 https://evidence-hub.com/study/67666-effects-of-tadalafil-type-v-phosphodiesterase-enzyme-inhibitor-on2026-10-06 https://evidence-hub.com/study/67667-dynamic-erectile-responses-of-a-novel-penile-organ-model-utilizing2026-10-06 https://evidence-hub.com/study/67668-selective-class-i-histone-deacetylase-inhibition-suppresses-hypoxia2026-10-06 https://evidence-hub.com/study/67669-cgmp-catabolism-by-phosphodiesterase-5a-regulates-cardiac-adrenergic2026-10-10 https://evidence-hub.com/study/67670-cigarette-smoke-induced-emphysema-and-pulmonary-hypertension-can-be2026-10-06 https://evidence-hub.com/study/67671-vcsa1-acts-as-a-marker-of-erectile-function-recovery-after-gene2026-10-06 https://evidence-hub.com/study/67672-no-mediated-signal-transmission-in-bladder-vasculature-as-a2026-10-06 https://evidence-hub.com/study/67673-cardiopulmonary-protective-effects-of-the-selective-fxr-agonist2026-10-06 https://evidence-hub.com/study/67674-the-renoprotective-effect-of-oral-tadalafil-pretreatment-on-ischemia2026-10-06 https://evidence-hub.com/study/67675-chemopreventive-effect-of-tadalafil-in-cisplatin-induced2026-10-06 https://evidence-hub.com/study/67676-effects-of-phosphodiesterase-type-5-inhibitor-tadalafil-on-continence2026-10-06 https://evidence-hub.com/study/67677-improvement-of-exercise-capacity-in-monocrotaline-induced-pulmonary2026-10-06 https://evidence-hub.com/study/67678-effect-of-tadalafil-on-reduction-of-necrosis-in-the-ischemic-zone-in2026-10-04 https://evidence-hub.com/study/67679-forgotten-driving-forces-in-right-heart-failure-part-ii-experimental2026-10-06 https://evidence-hub.com/study/67680-effects-of-tadalafil-on-hemorrhagic-cystitis-and-testicular2026-10-06 https://evidence-hub.com/study/67681-male-enhancement-nutraceuticals-in-the-middle-east-market-claim2026-10-06 https://evidence-hub.com/study/67682-effects-of-tadalafil-on-ischemia-reperfusion-injury-in-rat-brain2026-10-06 https://evidence-hub.com/study/67683-pharmacokinetic-and-tissue-distribution-study-of-pectolinarigenin-in2026-10-06 https://evidence-hub.com/study/67684-cardioprotective-role-of-tadalafil-against-cisplatin-induced2026-10-06 https://evidence-hub.com/study/67685-protein-kinase-g1-overexpression-increases-stem-cell-survival-and2026-10-06 https://evidence-hub.com/study/67686-gender-differences-in-tail-skin-flushing-induced-by-nitrates-and2026-10-06 https://evidence-hub.com/study/67687-in-vitro-inhibition-of-phosphodiesterase-type-4-enhances-rat-corpus2026-10-19 https://evidence-hub.com/study/67688-tadalafil-reversed-h-89-and-scopolamine-induced-spatial-learning2026-10-06 https://evidence-hub.com/study/67689-the-effect-of-methamphetamine-on-an-animal-model-of-erectile-function2026-10-19 https://evidence-hub.com/study/67690-mechanisms-and-treatment-of-halogen-inhalation-induced-pulmonary-and2026-10-06 https://evidence-hub.com/study/67691-in-vitro-p-glycoprotein-mediated-transport-of-tadalafil-a-comparison2026-10-10 https://evidence-hub.com/study/67692-long-acting-pde5-inhibitor-tadalafil-prevents-early-doxorubicin2026-10-06 https://evidence-hub.com/study/67693-the-protective-effects-of-tadalafil-on-renal-damage-following2026-10-06 https://evidence-hub.com/study/67694-molecular-signalling-of-a-novel-curcumin-derivative-versus-tadalafil2026-10-06 https://evidence-hub.com/study/67695-discovery-of-evodiamine-derivatives-as-highly-selective-pde52026-10-06 https://evidence-hub.com/study/67696-beneficial-effects-of-tadalafil-on-left-ventricular-dysfunction-in2026-10-06 https://evidence-hub.com/study/67697-hot-melt-extrusion-of-heat-sensitive-and-high-melting-point-drug2026-10-06 https://evidence-hub.com/study/67698-stress-induced-impairment-of-parasympathetic-no-mediated-inhibition2026-10-06 https://evidence-hub.com/study/67699-the-effect-of-sorafenib-tadalafil-and-macitentan-treatments-on2026-10-04 https://evidence-hub.com/study/67700-positive-effect-of-tadalafil-a-phosphodiesterase-5-inhibitor-on2026-10-06 https://evidence-hub.com/study/67701-tadalafil-improves-short-term-memory-by-suppressing-ischemia-induced2026-10-06 https://evidence-hub.com/study/67702-melatonin-and-tadalafil-treatment-improves-erectile-dysfunction-after2026-10-06 https://evidence-hub.com/study/67703-tadalafil-prevents-acute-heart-failure-with-reduced-ejection-fraction2026-10-04 https://evidence-hub.com/study/67704-tadalafil-versus-linaclotide-in-gastrointestinal-dysfunction-and2026-10-06 https://evidence-hub.com/study/67705-effect-of-chronic-low-dose-tadalafil-on-penile-cavernous-tissues-in2026-10-06 https://evidence-hub.com/study/67706-nicotine-induced-hypoxia-in-rat-urothelium-deteriorates-bladder2026-10-06 https://evidence-hub.com/study/67707-tadalafil-increases-akt-and-extracellular-signal-regulated-kinase-1-22026-10-06 https://evidence-hub.com/study/67708-possible-protective-effect-of-tnf-inhibition-and-triad-no-cgmp-vegf2026-10-06 https://evidence-hub.com/study/67709-tadalafil-inhibits-the-camp-stimulated-glucose-output-in-the-rat-liver2026-10-06 https://evidence-hub.com/study/67710-ameliorative-effect-of-phosphodiesterase-5-inhibitor-in-rat-model-of2026-10-06 https://evidence-hub.com/study/67711-intrapulmonary-shear-stress-enhancement-a-new-therapeutic-approach-in2026-10-06 https://evidence-hub.com/study/67712-tadalafil-protector-effect-during-ischemia-reperfusion-in-rats2026-10-04 https://evidence-hub.com/study/67713-effect-of-chronic-tadalafil-administration-on-penile-hypoxia-induced2026-10-04 https://evidence-hub.com/study/67714-the-renoprotective-effects-of-tadalafil-on-ischemia-reperfusion2026-10-19 https://evidence-hub.com/study/67715-e-209-comparative-analysis-of-the-vasodilatory-effects-of-enteral2026-10-04 https://evidence-hub.com/study/67716-method-development-and-method-validation-of-phosphodiesterase-52026-10-05 https://evidence-hub.com/study/67717-the-long-term-protective-effect-of-tadalafil-on-spermatogenesis2026-10-04 https://evidence-hub.com/study/67718-maternal-administration-of-tadalafil-improves-fetal-ventricular2026-10-04 https://evidence-hub.com/study/67722-anti-allergic-effect-of-sildenafil-and-tadalafil-in-ovalbumin-induced2026-10-04 https://evidence-hub.com/study/67724-human-vascular-wall-microfluidic-model-for-preclinical-evaluation-of2026-10-19 https://evidence-hub.com/study/67726-tadalafil-attenuates-spinal-cord-injury-induced-oxidative-organ2026-10-04 https://evidence-hub.com/study/67727-tadalafil-for-prevention-of-renal-dysfunction-secondary-to-renal2026-10-04 https://evidence-hub.com/study/67728-additive-effect-of-tadalafil-and-simvastatin-on-monocrotaline-induced2026-10-04 https://evidence-hub.com/study/67729-tadalafil-in-pulmonary-hypertension-may-be-more-than-seen2026-10-04 https://evidence-hub.com/study/67730-kfc-determination-after-ischemia-reperfusion-in-lungs-treated-with2026-10-04 https://evidence-hub.com/study/67732-correcting-imbalance-of-sex-hormones-by-a-phosphodiesterase-52026-10-06 https://evidence-hub.com/study/67734-the-selectivity-and-potency-of-the-new-pde5-inhibitor-tpn729ma2026-10-19 https://evidence-hub.com/study/67735-2emf-the-sex-gap-a-multisite-mixed-method-study-exploring-sex2026-10-06 https://evidence-hub.com/study/67738-the-effects-of-prophylactic-tadalafil-use-on-vegf-expression-in-the2026-10-04 https://evidence-hub.com/study/67739-impact-of-tadalafil-on-cardiovascular-and-organ-dysfunction-induced2026-10-05 https://evidence-hub.com/study/67740-effect-of-tadalafil-on-chronic-pelvic-pain-and-prostatic-inflammation2026-10-04 https://evidence-hub.com/study/67741-effects-of-tadalafil-to-prevent-injury-on-corpus-cavernosum-after2026-10-06 https://evidence-hub.com/study/67742-intranasal-nanocrystals-of-tadalafil-in-vitro-characterisation-and-in2026-10-19 https://evidence-hub.com/study/67743-ab211-effect-of-early-chronic-low-dose-tadalafil-administration-on2026-10-04 https://evidence-hub.com/study/67744-ab0100-to-study-the-t-cell-and-cytokine-profile-in-ankylosing2026-10-04 https://evidence-hub.com/study/67745-tadalafil-effect-on-metabolic-syndrome-associated-bladder-alterations2026-10-04 https://evidence-hub.com/study/67746-synergy-between-oral-pde5-inhibitors-and-topically-applied-nitric2026-10-05 https://evidence-hub.com/study/67751-540-synergy-in-improving-the-erectile-responses-in-a-rat-model-of2026-10-19 https://evidence-hub.com/study/67752-the-effect-of-tadalafil-on-reepithelialization-and-scarring-of2026-10-04 https://evidence-hub.com/study/67756-phosphodiesterase-inhibition-with-tadalafil-provides-longer-and2026-10-04 https://evidence-hub.com/study/67757-differential-vasoactive-effects-of-sildenafil-and-tadalafil-on2026-10-04 https://evidence-hub.com/study/67758-effects-of-the-phosphodiesterase-5-inhibitor-tadalafil-on-bladder2026-10-04 https://evidence-hub.com/study/67759-potential-of-tadalafil-and-tadalafil-cellulose-nanocomposite-in2026-10-05 https://evidence-hub.com/study/67760-effects-of-sildenafil-and-tadalafil-on-intraocular-pressure-in-sheep2026-10-10 https://evidence-hub.com/study/67761-39-effect-of-tadalafil-on-reduction-of-necrosis-in-the-ischemic-zone2026-10-04 https://evidence-hub.com/study/67762-tadalafil-rehabilitation-therapy-for-erectile-dysfunction-following2026-10-19 https://evidence-hub.com/study/67763-protective-effect-of-tadalafil-on-the-functional-and-structural2026-10-04 https://evidence-hub.com/study/67764-protective-effect-of-tadalafil-and-verapamil-on-testicular-function2026-10-04 https://evidence-hub.com/study/67765-protective-effect-of-tadalafil-against-ischemia-reperfusion-injury-in2026-10-04 https://evidence-hub.com/study/67766-protective-effect-of-tadalafil-in-diabetic-nephropathy-induced-rat2026-10-04 https://evidence-hub.com/study/67767-tadalafil-as-an-agent-of-pharmacological-preconditioning-in-ischemic2026-10-19 https://evidence-hub.com/study/67768-oxidative-stress-assessment-in-intestine-of-newborn-rats-submitted-to2026-10-04 https://evidence-hub.com/study/67769-evaluation-of-sildenafil-and-tadalafil-for-reversing-constriction-of2026-10-10 https://evidence-hub.com/study/67771-effects-of-experimental-hyperlipidemia-on-the-pharmacokinetics-of2026-10-04 https://evidence-hub.com/study/67772-effect-of-tadalafil-on-neointimal-hyperplasia-in-a-rabbit-carotid2026-10-04 https://evidence-hub.com/study/67773-tadalafil-a-pde5-inhibitor-exhibits-renoprotective-effects-preventing2026-10-04 https://evidence-hub.com/study/67774-the-relationship-between-solubility-and-transdermal-absorption-of2026-10-04 https://evidence-hub.com/study/67775-the-use-of-a-single-daily-dose-of-tadalafil-to-treat-signs-and2026-10-19 https://evidence-hub.com/study/67776-combined-use-of-arginase-ii-inhibitors-and-tadalafil-for-the2026-10-04 https://evidence-hub.com/study/67777-a-once-daily-dose-of-tadalafil-for-erectile-dysfunction-compliance2026-10-19 https://evidence-hub.com/study/67778-tadalafil-preserves-penile-nitric-oxide-synthase-from-detrimental2026-10-04 https://evidence-hub.com/study/67779-39-oral-tadalafil-speeds-reepithelialization-and-reduces-erythema-of2026-10-04 https://evidence-hub.com/study/67780-tadalafil-treatment-improves-the-cardiovascular-dysfunction-and2026-10-04 https://evidence-hub.com/study/67781-evaluation-of-the-colo-protective-effects-of-tadalafil-in-an2026-10-04 https://evidence-hub.com/study/67782-the-effects-of-sildenafil-and-tadalafil-on-ischemia-reperfusion2026-10-10 https://evidence-hub.com/study/67783-effect-of-long-acting-phosphodiesterase-type-5-inhibitor-tadalafil-on2026-10-04 https://evidence-hub.com/study/67784-protective-effects-of-tadalafil-and-darbepoetin-against-ischemia2026-10-04 https://evidence-hub.com/study/67785-animal-models-of-preeclampsia2026-10-10 https://evidence-hub.com/study/67787-a-phosphodiesterase-5-inhibitor-tadalafil-suppresses-stromal2026-10-04 https://evidence-hub.com/study/67788-multi-therapeutic-action-of-chronic-treatment-with-tadalafil-in2026-10-04 https://evidence-hub.com/study/67789-oral-tadalafil-reduces-intra-abdominal-adhesion-reformation-in-rats2026-10-04 https://evidence-hub.com/study/67791-enhanced-bioavailability-of-tadalafil-after-intranasal-administration2026-10-19 https://evidence-hub.com/study/67792-tadalafil-significantly-reduces-ischemia-reperfusion-injury-in-skin2026-10-19 https://evidence-hub.com/study/67794-tadalafil-impacts-the-mechanical-properties-of-plasmodium-falciparum2026-10-04 https://evidence-hub.com/study/67795-boosting-tadalafil-bioavailability-via-sono-assisted-nano-emulsion2026-10-06 https://evidence-hub.com/study/67796-modulators-of-histone-demethylase-jmjd1c-selectively-target-leukemic2026-10-04 https://evidence-hub.com/study/67797-novel-pyrazolo-4-3-c-quinolin-3-one-derivatives-as-pde5a-inhibitors2026-10-06 https://evidence-hub.com/study/67798-pharmacological-treatment-of-chronic-pelvic-ischemia2026-10-06 https://evidence-hub.com/study/67799-effect-of-avanafil-on-rat-and-human-corpus-cavernosum2026-10-06 https://evidence-hub.com/study/67800-inhibition-of-phosphodiesterase-3a-by-cilostazol-dampens2026-10-06 https://evidence-hub.com/study/67801-mechanism-of-phosphodiesterase-5-inhibitor-relief-of-prostatitis2026-10-06 https://evidence-hub.com/study/67802-regulation-of-osu-03012-toxicity-by-er-stress-proteins-and-er-stress2026-10-06 https://evidence-hub.com/study/67803-effects-of-phosphodiesterase-5-inhibitors-on-sperm-parameters-and2026-10-06 https://evidence-hub.com/study/67804-sulindac-selectively-inhibits-colon-tumor-cell-growth-by-activating2026-10-06 https://evidence-hub.com/study/67805-inhibition-of-hyaluronan-export-reduces-collagen-degradation-in2026-10-06 https://evidence-hub.com/study/67806-decrease-apob-apoa-1-ratio-and-cardiovascular-risk-improvement-a2026-10-06 https://evidence-hub.com/study/67807-pde5-inhibitors-in-vitro-and-in-vivo-pharmacological-profile2026-10-06 https://evidence-hub.com/study/67808-inhibition-of-phosphodiesterase-5-reduces-bone-mass-by-suppression-of2026-10-06 https://evidence-hub.com/study/67809-grp78-bip-hspa5-dna-k-is-a-universal-therapeutic-target-for-human2026-10-06 https://evidence-hub.com/study/67810-identification-of-small-molecule-enzyme-inhibitors-as-broad-spectrum2026-10-04 https://evidence-hub.com/study/67811-development-of-dry-powder-inhaler-containing-tadalafil-loaded-plga2026-10-04 https://evidence-hub.com/study/67812-phosphodiesterase-isoenzymes-in-the-human-urethra-a-molecular-biology2026-10-06 https://evidence-hub.com/study/67813-synthesis-of-novel-tadalafil-analogues-and-their-evaluation-as2026-10-06 https://evidence-hub.com/study/67814-the-soluble-guanylyl-cyclase-activator-bay-60-2770-potently-relaxes2026-10-06 https://evidence-hub.com/study/67815-tadalafil-nanocomposites-as-a-dry-powder-formulation-for-inhalation-a2026-10-04 https://evidence-hub.com/study/67816-phosphodiesterase-5-inhibition-augments-endogenous-antitumor-immunity2026-10-06 https://evidence-hub.com/study/67817-interactions-between-grapefruit-juice-and-cardiovascular-drugs2026-10-06 https://evidence-hub.com/study/67818-review-of-phosphodiesterases-in-the-urogenital-system-new-directions2026-10-06 https://evidence-hub.com/study/67819-mirabegron-elicits-rat-corpus-cavernosum-relaxation-and-increases-in2026-10-06 https://evidence-hub.com/study/67820-tadalafil-a-phosphodiesterase-inhibitor-protects-stem-cells-over2026-10-06 https://evidence-hub.com/study/67821-design-of-pvp-va-s-630-based-tadalafil-solid-dispersion-to-enhance2026-10-04 https://evidence-hub.com/study/67822-phosphodiesterase-inhibitors-sildenafil-and-vardenafil-reduce2026-10-06 https://evidence-hub.com/study/67823-tadalafil-solid-dispersion-formulations-based-on-pvp-va-s-6302026-10-06 https://evidence-hub.com/study/67824-discovery-of-novel-pyrazolopyrimidinone-analogs-as-potent-inhibitors2026-10-06 https://evidence-hub.com/study/67825-comparative-dissolution-study-on-counterfeit-medicines-of-pde-52026-10-06 https://evidence-hub.com/study/67826-phosphodiesterase-type-5-inhibitors-for-erectile-dysfunction2026-10-06 https://evidence-hub.com/study/67827-drug-to-genome-to-drug-step-2-reversing-selectivity-in-a-series-of2026-10-06 https://evidence-hub.com/study/67828-attenuation-of-doxorubicin-induced-cardiotoxicity-by-tadalafil-a-long2026-10-04 https://evidence-hub.com/study/67829-phosphodiesterase-5-inhibitor-tadalafil-acts-on-endothelial2026-10-04 https://evidence-hub.com/study/67830-structured-solubility-behaviour-in-bioequivalent-fasted-simulated2026-10-06 https://evidence-hub.com/study/67831-long-acting-phosphodiesterase-5-inhibitor-tadalafil-attenuates2026-10-04 https://evidence-hub.com/study/67832-medication-of-the-month-vardenafil-levitra2026-10-06 https://evidence-hub.com/study/67833-characterization-and-functional-role-of-androgen-dependent-pde52026-10-06 https://evidence-hub.com/study/67834-solubility-and-dissolution-enhancement-of-tadalafil-using-self2026-10-04 https://evidence-hub.com/study/67835-effects-of-phosphodiesterase-inhibitors-on-contraction-induced-by2026-10-06 https://evidence-hub.com/study/67836-the-phosphodiesterase-5-inhibitor-vardenafil-is-a-potent-inhibitor-of2026-10-06 https://evidence-hub.com/study/67837-tadalafil-as-an-in-vitro-sperm-motility-stimulant2026-10-04 https://evidence-hub.com/study/67838-pde5-inhibitors-loaded-nanovesicles-physico-chemical-properties-and2026-10-06 https://evidence-hub.com/study/67839-tryptophan-hydroxylase-1-inhibition-impacts-pulmonary-vascular2026-10-06 https://evidence-hub.com/study/67840-borreliacidal-activity-of-borrelia-metal-transporter-a-bmta-binding2026-10-04 https://evidence-hub.com/study/67841-ciprofloxacin-induced-antibacterial-activity-is-attenuated-by2026-10-06 https://evidence-hub.com/study/67842-the-relationship-between-erectile-dysfunction-and-cardiovascular2026-10-06 https://evidence-hub.com/study/67843-phosphodiesterase-type-5-inhibitor-tadalafil-modulates-steroid2026-10-19 https://evidence-hub.com/study/67844-small-scale-in-vitro-method-to-determine-a-bioequivalent-equilibrium2026-10-06 https://evidence-hub.com/study/67845-c-c-motif-chemokine-receptor-2-blockade-ameliorates-pulmonary2026-10-05 https://evidence-hub.com/study/67846-transdermal-delivery-of-tadalafil-i-effect-of-vehicles-on-skin2026-10-06 https://evidence-hub.com/study/67847-avanafil-a-potent-and-highly-selective-phosphodiesterase-5-inhibitor2026-10-06 https://evidence-hub.com/study/67848-preparation-and-evaluation-of-tadalafil-loaded-nanoemulgel-for2026-10-19 https://evidence-hub.com/study/67849-pde5-inhibitors-sildenafil-and-vardenafil-reverse-multidrug2026-10-06 https://evidence-hub.com/study/67850-statistical-investigation-of-simulated-fed-intestinal-media2026-10-04 https://evidence-hub.com/study/67851-dose-dependent-effects-of-tadalafil-and-roflumilast-on-ovalbumin2026-10-04 https://evidence-hub.com/study/67852-olinciguat-an-oral-sgc-stimulator-exhibits-diverse-pharmacology2026-10-06 https://evidence-hub.com/study/67853-phosphodiesterase-type-5-is-not-upregulated-by-tadalafil-in-cultures2026-10-04 https://evidence-hub.com/study/67854-neuroprotective-effects-of-phosphodiesterase-inhibitors-on-sestrin-22026-10-05 https://evidence-hub.com/study/67855-tadalafil-reverses-the-effect-of-three-dimensional-cell-culture2026-10-06 https://evidence-hub.com/study/67856-aphrodisiac-drug-and-dental-health-a-systematic-review2026-10-08 https://evidence-hub.com/study/67857-from-regenerative-mechanisms-to-clinical-practice-current-status2026-10-06 https://evidence-hub.com/study/67858-stability-and-dissolution-behavior-changes-after-drug-compounding-for2026-10-06 https://evidence-hub.com/study/67859-membrane-mediated-action-of-phosphodiesterase-5-inhibitors2026-10-08 https://evidence-hub.com/study/67860-emerging-perspectives-in-the-formulation-of-lyophilized-orally2026-10-06 https://evidence-hub.com/study/67861-the-association-between-vitamin-d-levels-and-erectile-dysfunction-in2026-10-10 https://evidence-hub.com/study/67862-herbal-dietary-supplements-for-erectile-dysfunction-a-systematic2026-10-06 https://evidence-hub.com/study/67863-liver-transplantation-improves-erectile-function-in-patients-with-end2026-10-06 https://evidence-hub.com/study/67864-procyanidin-improves-erectile-function-in-rats-by-inhibiting-pde5a2026-10-10 https://evidence-hub.com/study/67865-a-resource-description-framework-rdf-model-of-named-entity-co2026-10-06 https://evidence-hub.com/study/67866-the-long-term-outcomes-of-pulmonary-hypertension-in-systemic-lupus2026-10-06 https://evidence-hub.com/study/67867-dysregulated-fibroblast-immune-crosstalk-drives-statin-associated2026-10-06 https://evidence-hub.com/study/67868-elucidation-of-bioinformatic-guided-high-prospect-drug-repositioning2026-10-06 https://evidence-hub.com/study/67869-systemic-sclerosis-and-rheumatoid-arthritis-overlap-syndrome2026-10-06 https://evidence-hub.com/study/67870-vascular-dysfunction-is-at-the-onset-of-oxaliplatin-induced2026-10-06 https://evidence-hub.com/study/67871-molecular-mechanics-simulations-and-experimental-investigation-of-the2026-10-04 https://evidence-hub.com/study/67872-fundamental-and-targeted-approaches-in-pulmonary-arterial2026-10-10 https://evidence-hub.com/study/67873-mechanical-thrombectomy-for-inferior-vena-cava-tumor-thrombus2026-10-06 https://evidence-hub.com/study/67874-a-narrative-review-of-independent-treatment-methods-for-ed-assessment2026-10-06 https://evidence-hub.com/study/67875-successful-treatment-of-pulmonary-hypertension-in-a-neonate-with2026-10-10 https://evidence-hub.com/study/67876-drug-interactions-associated-with-therapies-for-pulmonary-arterial2026-10-10 https://evidence-hub.com/study/67877-management-of-urinary-incontinence-following-radical-prostatectomy2026-10-06 https://evidence-hub.com/study/67878-a-narrative-review-on-sexual-wellbeing-and-dysfunctions-research-in2026-10-05 https://evidence-hub.com/study/67879-trigeminal-neuralgia-as-an-initial-presentation-of-systemic2026-10-06 https://evidence-hub.com/study/67880-genome-mining-of-albocandins-a-e-from-streptomyces-sp-yinm000302026-10-19 https://evidence-hub.com/study/67881-idiopathic-recurrent-ischemic-priapism-a-review-of-current-literature2026-10-19 https://evidence-hub.com/study/67882-erectile-dysfunction-following-surgical-repair-of-penile-fracture-a2026-10-06 https://evidence-hub.com/study/67883-ashwagandha-optimizing-the-extraction-and-electrospun-nanofiber2026-10-06 https://evidence-hub.com/study/67884-depression-in-pulmonary-hypertension-a-systematic-review-of-clinical2026-10-06 https://evidence-hub.com/study/67885-colorectal-cancer-therapeutic-approaches-and-their-complications2026-10-10 https://evidence-hub.com/study/67886-development-and-evaluation-of-febuxostat-solid-dispersion-through2026-10-06 https://evidence-hub.com/study/67887-free-energy-perturbation-fep-guided-scaffold-hopping2026-10-10 https://evidence-hub.com/study/67888-pulmonary-vasodilator-therapy-in-severe-pulmonary-hypertension-due-to2026-10-06 https://evidence-hub.com/study/67889-formulation-and-in-vitro-evaluation-of-tadalafil-oral-disintegrating2026-10-05 https://evidence-hub.com/study/67890-in-vitro-evaluation-and-in-vivo-pharmacokinetic-assessment-of2026-10-19 https://evidence-hub.com/study/67891-determination-of-the-serum-unbound-fraction-of-tadalafil-in-children2026-10-04 https://evidence-hub.com/study/67892-development-of-a-tadalafil-transdermal-formulation-and-evaluation-of2026-10-05 https://evidence-hub.com/study/67894-in-vitro-and-in-vivo-evaluation-of-novel-tadalafil-tcp-collagen2026-10-04 https://evidence-hub.com/study/67898-in-vitro-and-in-vivo-behavior-of-ground-tadalafil-hot-melt-extrudates2026-10-04 https://evidence-hub.com/study/67900-the-effect-of-phosphodiesterase-5-inhibitor-tadalafil-on-in-vitro2026-10-04 https://evidence-hub.com/study/67901-rp-hplc-pda-method-development-and-validation-for-the-analysis-of2026-10-04 https://evidence-hub.com/study/67902-degradable-hydrogel-microspheres-for-drug-delivery-in-vitro2026-10-19 https://evidence-hub.com/study/67903-po-01-012-tadalafil-modulates-aromatase-and-androgem-receptor2026-10-04 https://evidence-hub.com/study/67904-molecular-mechanisms-regulating-pde11a4-age-related-liquid-liquid2026-10-06 https://evidence-hub.com/study/67905-is-the-cyclic-amp-specific-phosphodiesterase-type-4-pde4-a-new2026-10-19 https://evidence-hub.com/study/67906-in-vitro-and-in-vivo-studies-of-titanium-dioxide-nanoparticles-with2026-10-05 https://evidence-hub.com/study/67907-oral-solid-self-emulsifying-system-containing-non-oncology-drug2026-10-05 https://evidence-hub.com/study/67908-2161-phosphodiesterase-v-inhibitor-attenuates-the-fibrotic-gene2026-10-05 https://evidence-hub.com/study/67909-mechanism-investigation-of-highly-selective-inhibitors-toward2026-10-05 https://evidence-hub.com/study/67910-effect-of-acute-tadalafil-on-sperm-motility-and-acrosome-reaction-in2026-10-10 https://evidence-hub.com/study/67911-effects-of-tadalafil-and-sildenafil-on-hiv-infection-in-vitro2026-10-04 https://evidence-hub.com/study/67912-forced-degradation-studies-quantification-and-in-vitro-dissolution2026-10-04 https://evidence-hub.com/study/67914-revealing-the-impact-of-tadalafil-loaded-proniosomal-gel-against2026-10-05 https://evidence-hub.com/study/67915-preparation-and-characterization-of-tadalafil-loaded-hydrogel-an-in2026-10-05 https://evidence-hub.com/study/67916-tailored-transethosomal-systems-for-tadalafil-transdermal-delivery2026-10-05 https://evidence-hub.com/study/67918-tadalafil-enhances-the-therapeutic-efficacy-of-mesenchymal-stem-cells2026-10-05 https://evidence-hub.com/study/67919-three-strikingly-different-crystal-habits-of-tadalafil-design2026-10-05 https://evidence-hub.com/study/67922-effect-of-tadalafil-on-cytochrome-p450-3a4-mediated-clearance-studies2026-10-04 https://evidence-hub.com/study/67923-formulation-and-evaluation-of-tadalafil-loaded-nano-ointment-and2026-10-05 https://evidence-hub.com/study/67925-combination-of-alfuzosin-and-tadalafil-exerts-in-vitro-an-additive2026-10-04 https://evidence-hub.com/study/67926-effect-of-phosphodiesterase-type-5-inhibitors-on-sperm-motility-and2026-10-10 https://evidence-hub.com/study/67931-tadalafil-rescues-the-p-m325t-mutant-of-best1-chloride-channel2026-10-04 https://evidence-hub.com/study/67932-42-treatment-of-acute-phase-of-peyronie-s-disease-with-tamoxifen-and2026-10-06 https://evidence-hub.com/study/67933-in-vitro-assessment-of-pharmacokinetic-drug-drug-interactions-of2026-10-10 https://evidence-hub.com/study/67934-tadalafil-attenuates-angiotensin-ii-induced-extracellular-matrix2026-10-06 https://evidence-hub.com/study/67936-co-administration-of-sodium-hydrosulfide-and-tadalafil-modulates2026-10-06 https://evidence-hub.com/study/67937-effect-of-surfactants-and-drug-load-on-physico-mechanical-and2026-10-06 https://evidence-hub.com/study/67938-design-and-evaluation-of-fast-dissolving-tablet-containing-tadalafil2026-10-04 https://evidence-hub.com/study/67939-bioenhanced-advanced-third-generation-solid-dispersion-of-tadalafil2026-10-06 https://evidence-hub.com/study/67940-three-dimensional-models-of-mycobacterium-tuberculosis-proteins2026-10-06 https://evidence-hub.com/study/67942-solubility-enhancement-formulation-development-and-evaluation-of2026-10-04 https://evidence-hub.com/study/67943-formulation-of-double-layer-tadalafil-and-amlodipine-complex-tablets2026-10-06 https://evidence-hub.com/study/67944-formulation-and-evaluation-of-nanosuspensions-of-tadalafil-using2026-10-04 https://evidence-hub.com/study/67945-formulation-and-evaluation-of-mouth-dissolving-film-of-tadalafil2026-10-04 https://evidence-hub.com/study/67947-formulation-development-and-evaluation-of-tadalafil-transdermal2026-10-06 https://evidence-hub.com/study/67948-inhaled-roflumilast-and-tadalafil-supress-airway-reactivity-and2026-10-04 https://evidence-hub.com/study/67949-differential-effects-of-selective-pde5-inhibitors-in-rat-cerebral2026-10-06 https://evidence-hub.com/study/67952-phosphodiesterase-type-5-expression-in-human-and-rat-lower-urinary2026-10-04 https://evidence-hub.com/study/67953-tadalafil-for-the-treatment-of-lower-urinary-tract-symptoms-secondary2026-10-04 https://evidence-hub.com/study/67954-plasma-concentrations-of-tadalafil-in-children-with-pulmonary2026-10-04 https://evidence-hub.com/study/67955-tadalafil-loaded-plga-microspheres-for-pulmonary-administration2026-10-04 https://evidence-hub.com/study/67958-formulation-optimization-and-evaluation-of-oral-dissolving-films-of2026-10-04 https://evidence-hub.com/study/67959-enhancement-of-solubility-of-tadalafil-by-cocrystal-approach2026-10-04 https://evidence-hub.com/study/67960-formulation-development-of-immediate-release-pellets-of-tadalafil2026-10-04 https://evidence-hub.com/study/67961-improvement-of-tadalafil-solubility-through-microwave-assisted2026-10-04 https://evidence-hub.com/study/67962-the-role-of-tadalafil-in-treatment-of-infertility2026-10-04 https://evidence-hub.com/study/67964-tadalafil-loaded-plga-microspheres-for-pulmonary-administration2026-10-04 https://evidence-hub.com/study/67965-differential-vasoactive-effects-of-sildenafil-and-tadalafil-on2026-10-04 https://evidence-hub.com/study/67966-formulation-and-evaluation-of-solid-dispersion-of-tadalafil2026-10-04 https://evidence-hub.com/study/67967-nanosphere-loaded-tadalafil-with-enhanced-oral-bioavailability2026-10-04 https://evidence-hub.com/study/67968-modification-tadalafil-and-macitentan-tablets-to-aerosol2026-10-04 https://evidence-hub.com/study/67969-effects-of-tadalafil-on-skeletal-muscle-tissue-exploring-interactions2026-10-04 https://evidence-hub.com/study/67970-fluorometric-detection-of-protein-ligand-engagement-the-case-of2026-10-10 https://evidence-hub.com/study/67971-in-silico-prediction-of-novel-phosphodiesterase-type-5-inhibitors2026-10-04 https://evidence-hub.com/study/67972-in-silico-design-of-novel-herg-neutral-sildenafil-like-pde5-inhibitors2026-10-10 https://evidence-hub.com/study/67973-searching-for-target-specific-and-multi-targeting-organics-for-covid2026-10-04 https://evidence-hub.com/study/67974-fluorescent-detection-of-tadalafil-based-on-competitive-host-guest2026-10-06 https://evidence-hub.com/study/67975-molecular-docking-analysis-of-anti-severe-acute-respiratory-syndrome2026-10-06 https://evidence-hub.com/study/67976-extending-the-use-of-tadalafil-scaffold-development-of-novel2026-10-06 https://evidence-hub.com/study/67977-the-molecular-basis-for-the-selectivity-of-tadalafil-toward2026-10-06 https://evidence-hub.com/study/67978-exploring-the-binding-mechanisms-of-pde5-with-chromeno-2-3-c-pyrrol-92026-10-06 https://evidence-hub.com/study/67979-in-silico-screening-of-anthraquinones-from-prismatomeris-memecyloides2026-10-04 https://evidence-hub.com/study/67980-q817g-mutation-in-phosphodiesterase-type-5-conformational-analysis2026-10-06 https://evidence-hub.com/study/67981-key-features-for-designing-phosphodiesterase-5-inhibitors2026-10-06 https://evidence-hub.com/study/67982-exploring-the-pde5-h-pocket-by-ensemble-docking-and-structure-based2026-10-06 https://evidence-hub.com/study/67983-ab-initio-qm-mm-study-shows-a-highly-dissociated-sn2-hydrolysis2026-10-06 https://evidence-hub.com/study/67984-a-comparison-study-of-macrocyclic-hosts-functionalized-reduced2026-10-06 https://evidence-hub.com/study/67985-toward-natural-products-based-drug-development-for-erectile2026-10-05 https://evidence-hub.com/study/67986-design-synthesis-and-biological-evaluation-of-orally-available-first2026-10-06 https://evidence-hub.com/study/67987-a-multi-reference-poly-conformational-method-for-in-silico-design2026-10-04 https://evidence-hub.com/study/67988-logic-based-modeling-and-drug-repurposing-for-the-prediction-of-novel2026-10-04 https://evidence-hub.com/study/67989-a-multi-modal-approach-to-investigate-desmodium-gangeticum-s2026-10-05 https://evidence-hub.com/study/67990-flunarizine-as-a-candidate-for-drug-repurposing-against-human2026-10-05 https://evidence-hub.com/study/67991-role-of-interaction-mode-of-phenanthrene-derivatives-as-selective2026-10-06 https://evidence-hub.com/study/67992-computational-drug-repurposing-reveals-alectinib-as-a-potential-lead2026-10-06 https://evidence-hub.com/study/67993-aphrodisiac-principles-and-other-constituents-from-the-roots-of-panax2026-10-10 https://evidence-hub.com/study/67994-a-review-on-in-silico-virtual-screening-methods-in-covid-19-using2026-10-04 https://evidence-hub.com/study/67995-the-anti-depressant-effects-of-a-novel-pde4-inhibitor-derived-from2026-10-06 https://evidence-hub.com/study/67996-covid-19-and-phosphodiesterase-enzyme-type-5-inhibitors2026-10-06 https://evidence-hub.com/study/67997-in-silico-admet-profiling-of-flavonoids-as-potential2026-10-05 https://evidence-hub.com/study/67998-phosphodiesterase-5-pde5-inhibitory-potential-of-major-phytochemicals2026-10-04 https://evidence-hub.com/study/67999-in-silico-mapping-of-essential-residues-in-the-catalytic-domain-of2026-10-19 https://evidence-hub.com/study/68000-comparison-of-tadalafil-pharmacokinetics-after-administration-of-a2026-10-06 https://evidence-hub.com/study/68003-effect-of-ticagrelor-a-cytochrome-p450-3a4-inhibitor-on-the2026-10-04 https://evidence-hub.com/study/68004-analises-histopatologicas-e-imunohistoquimicas-do-tadalafil-sobre2026-10-04 https://evidence-hub.com/study/68005-industry-patient-friendly-tadalafil-oral-spray-statistical2026-10-04 https://evidence-hub.com/study/68006-rp-hplc-based-stability-indicating-analytical-method-for-concurrent2026-10-04 https://evidence-hub.com/study/68007-male-mice-treated-with-combined-anti-fibrotic-therapeutics-ipw53712026-10-19 https://evidence-hub.com/study/68008-multi-reference-computational-method-for-de-novo-design-optimization2026-10-04 https://evidence-hub.com/study/68009-the-analysis-of-primer-gene-of-phosphodiesterase-type-5-pde5-on2026-10-04 https://evidence-hub.com/study/68010-flunarizine-as-a-candidate-for-drug-repurposing-against-human2026-10-04 https://evidence-hub.com/study/68011-real-world-clinical-perspective-on-pde5i-utility-in-dementia2026-10-04 https://evidence-hub.com/study/68012-innovative-methodologies-for-the-purification-of-polluted-water2026-10-10 https://evidence-hub.com/study/68013-devoloppement-of-new-in-silico-screening-methods-in-chemogenomics2026-10-04 https://evidence-hub.com/study/68015-a-focus-on-riociguat-in-the-treatment-of-pulmonary-arterial2026-10-04 https://evidence-hub.com/study/68016-a-contemporary-review-on-the-important-role-of-in-silico-approaches2026-10-04 https://evidence-hub.com/study/68017-pde5-inhibitor-drugs-for-use-in-dementia2026-10-10 https://evidence-hub.com/study/68018-computational-view-toward-the-inhibition-of-sars-cov-2-spike2026-10-04 https://evidence-hub.com/study/68019-identification-of-counterfeit-medicines-for-erectile-dysfunction-by2026-10-19 https://evidence-hub.com/study/68020-targeting-sars-cov-2-rna-dependent-rna-polymerase-an-in-silico-drug2026-10-04 https://evidence-hub.com/study/68021-in-silico-evaluation-of-fda-approved-drugs-as-pde5-inhibitors-for2026-10-10 https://evidence-hub.com/study/68023-in-vitro-in-silico-and-in-vivo-screening-of-non-oncology-drugs-for2026-10-04 https://evidence-hub.com/study/68024-development-of-in-silico-models-for-the-prediction-of-toxicity2026-10-13 https://evidence-hub.com/study/68025-developpement-de-nouvelles-methodes-de-criblage-in-silico-en2026-10-04 https://evidence-hub.com/study/68027-the-identification-of-certain-chemical-disruptors-of-the-estrogen2026-10-04 https://evidence-hub.com/study/68028-phytochemical-identification-and-in-silico-study-of-ethanolic-extract2026-10-04 https://evidence-hub.com/study/68029-in-silico-and-in-vivo-evaluation-of-the-aphrodisiac-effect-of-azanza2026-10-04 https://evidence-hub.com/study/68030-aphrodisiac-performance-of-bioactive-compounds-from-mimosa-pudica2026-10-04 https://evidence-hub.com/study/68031-effect-of-deep-eutectic-system-des-on-oral-bioavailability-of2026-10-04 https://evidence-hub.com/study/68033-in-silico-and-in-vitro-studies-unveil-the-protective-potential-of2026-10-04 https://evidence-hub.com/study/68034-insomnia-and-benzodiazepine-use-as-risk-factors-for-erectile2026-10-04 https://evidence-hub.com/study/68035-phytochemical-profiling-heavy-metals-composition-in-silico2026-10-10 https://evidence-hub.com/study/68036-in-silico-identification-of-approved-drugs-for-potential-prophylactic2026-10-08 https://evidence-hub.com/study/68037-comparative-analysis-of-phosphodiesterase-type-5-inhibitors-and-usnic2026-10-04 https://evidence-hub.com/study/68038-pulmonary-arterial-hypertension-rationale-for-using-multiple-vs2026-10-04 https://evidence-hub.com/study/68039-identification-of-antiparasitic-drug-targets-using-a-multi-omics2026-10-04 https://evidence-hub.com/study/68040-in-silico-identification-of-promising-pde5-inhibitors-against2026-10-04 https://evidence-hub.com/study/68041-small-scale-in-vitro-method-to-determine-a-potential-bioequivalent2026-10-04 https://evidence-hub.com/study/68042-an-in-silico-investigation-of-allosteric-inhibition-potential-of2026-10-04 https://evidence-hub.com/study/68043-senyawa-metabolit-sekunder-dan-aktifitas-afrodisiak-ekstrak-etanol2026-10-04 https://evidence-hub.com/study/68044-exploring-the-inhibitory-potential-of-phytosterols-sitosterol2026-10-19 https://evidence-hub.com/study/68045-unraveling-the-nephroprotective-potential-of-papaverine-against2026-10-04 https://evidence-hub.com/study/68046-scaffold-repurposing-reveals-new-nanomolar-phosphodiesterase-type-52026-10-04 https://evidence-hub.com/study/68047-infertil-erkeklerde-spermatogonial-kok-hucre-farkl-lasmas-nda-mirna2026-10-04 https://evidence-hub.com/study/68048-lansoprazole-identified-as-a-prophylactic-agent-for-oxaliplatin2026-10-08 https://evidence-hub.com/study/68049-dengue-virus-ns5-target-discovery-a-comprehensive-in-silico2026-10-04 https://evidence-hub.com/study/68050-therapeutic-potential-of-cucurbita-maxima-duch-seed-extract-in2026-10-10 https://evidence-hub.com/study/68051-a-multi-biochemical-and-in-silico-study-on-anti-enzymatic-actions-of2026-10-10 https://evidence-hub.com/study/68052-peer-review-report-for-targeting-sars-cov-2-rna-dependent-rna2026-10-04 https://evidence-hub.com/study/68053-structure-based-drug-metabolism-predictions-for-drug-design2026-10-04 https://evidence-hub.com/study/68054-molecular-docking-and-dynamics-simulation-of-fda-approved-drugs-to2026-10-04 https://evidence-hub.com/study/68055-solid-dosage-form-development-of-glibenclamide-aspartame-cocrystal2026-10-04 https://evidence-hub.com/study/68056-trivariate-linear-regression-and-machine-learning-prediction-of2026-10-04 https://evidence-hub.com/study/68057-discovery-of-novel-trypanosoma-brucei-phosphodiesterase-b1-inhibitors2026-10-04 https://evidence-hub.com/study/68058-rethinking-natural-product-discovery-a-complex-epistemological2026-10-04 https://evidence-hub.com/study/68060-molecular-docking-and-admet-analysis-of-metabolite-profiling-derived2026-10-06 https://evidence-hub.com/study/68061-a-study-of-3clpros-as-promising-targets-against-sars-cov-and-sars-cov2026-10-04 https://evidence-hub.com/study/68062-design-synthesis-and-biological-evaluation-of-highly-functionalized2026-10-04 https://evidence-hub.com/study/68063-characterisation-of-colloidal-structures-and-their-solubilising2026-10-05 https://evidence-hub.com/study/68064-estudos-computacionais-para-novas-possibilidades-de-sintese-de2026-10-04 https://evidence-hub.com/study/68065-therapeutic-efficacy-of-tadalafil-and-eriythropoietin-in-experimental2026-10-06 https://evidence-hub.com/study/68066-effect-of-tadalafil-on-prevention-of-urethral-stricture-after2026-10-06 https://evidence-hub.com/study/68067-protective-effects-of-diltiazem-and-tadalafil-on-shock-wave-induced2026-10-06 https://evidence-hub.com/study/68068-physician-rated-patient-preference-and-patient-and-partner-rated2026-10-06 https://evidence-hub.com/study/68069-efficacy-of-tadalafil-in-secondary-raynaud-s-phenomenon-resistant-to2026-10-06 https://evidence-hub.com/study/68070-antinociceptive-effect-of-tadalafil-in-various-pain-models2026-10-06 https://evidence-hub.com/study/68072-ginseng-for-erectile-dysfunction2026-10-19 https://evidence-hub.com/study/68073-penile-rehabilitation-for-postprostatectomy-erectile-dysfunction2026-10-10 https://evidence-hub.com/study/68074-vasodilators-for-women-undergoing-fertility-treatment2026-10-10 https://evidence-hub.com/study/68075-the-effect-of-exercise-training-on-clinical-outcomes-in-patients-with2026-10-06 https://evidence-hub.com/study/68076-identifying-complementary-and-alternative-medicine-usage-information2026-10-06 https://evidence-hub.com/study/68077-meta-analysis-of-blood-genome-wide-expression-profiling-studies-in2026-10-06 https://evidence-hub.com/study/68078-pharmacological-interventions-for-heart-failure-in-people-with2026-10-10 https://evidence-hub.com/study/68079-interventions-for-preventing-high-altitude-illness-part-2-less2026-10-10 https://evidence-hub.com/study/68080-comparative-effectiveness-of-oral-drug-therapies-for-lower-urinary2026-10-19 https://evidence-hub.com/study/68081-sildenafil-citrate-for-erectile-dysfunction-in-patients-with-multiple2026-10-10 https://evidence-hub.com/study/68082-oral-vasodilators-for-primary-raynaud-s-phenomenon2026-10-06 https://evidence-hub.com/study/68083-sildenafil-for-pulmonary-hypertension-in-neonates2026-10-10 https://evidence-hub.com/study/68084-interventions-for-treating-sexual-dysfunction-in-patients-with2026-10-10 https://evidence-hub.com/study/68085-interventions-for-treating-pain-and-disability-in-adults-with-complex2026-10-06 https://evidence-hub.com/study/68086-silodosin-for-the-treatment-of-lower-urinary-tract-symptoms-in-men2026-10-19 https://evidence-hub.com/study/68087-desmopressin-for-treating-nocturia-in-men2026-10-19 https://evidence-hub.com/study/68088-naftopidil-for-the-treatment-of-lower-urinary-tract-symptoms2026-10-19 https://evidence-hub.com/study/68089-hemodynamics-in-pulmonary-arterial-hypertension-pah-do-they-explain2026-10-10 https://evidence-hub.com/study/68090-alpha-blockers-as-medical-expulsive-therapy-for-ureteral-stones2026-10-06 https://evidence-hub.com/study/68091-nitric-oxide-for-preventing-pre-eclampsia-and-its-complications2026-10-06 https://evidence-hub.com/study/68092-antioxidant-supplementation-for-sickle-cell-disease2026-10-10 https://evidence-hub.com/study/68093-on-demand-ic351-cialis-enhances-erectile-function-in-patients-with2026-10-06 https://evidence-hub.com/study/68094-reliability-of-efficacy-in-men-with-erectile-dysfunction-treated-with2026-10-06 https://evidence-hub.com/study/68095-efficacy-and-treatment-satisfaction-with-on-demand-tadalafil-cialis2026-10-06 https://evidence-hub.com/study/68096-study-of-antithrombotic-treatment-after-intracerebral-haemorrhage2026-10-06 https://evidence-hub.com/study/68097-efficacy-of-combination-of-solifenacin-and-tadalafil-versus2026-10-04 https://evidence-hub.com/study/68098-single-dose-oral-bioequivalence-study-of-macitentan-and-tadalafil2026-10-04 https://evidence-hub.com/study/68099-a-case-study-of-a-patient-with-a-diabetic-foot-ulcer-dfu-with2026-10-08 https://evidence-hub.com/study/68114-development-of-liquisolid-systems-containing-tadalafil2026-10-04 https://evidence-hub.com/study/68115-tadalafil-monotherapy-versus-tadalafil-combined-pumpkin-seed-oil-in2026-10-04 https://evidence-hub.com/study/68123-advancements-in-tadalafil-formulation-and-transdermal-delivery-a2026-10-19 https://evidence-hub.com/study/68124-comparative-efficacy-of-on-demand-sildenafil-tadalafil-and-daily2026-10-10 https://evidence-hub.com/study/68126-voltammetric-determination-tadalafil-on-a-carbon-composite-electrode2026-10-04 https://evidence-hub.com/study/68127-histomorphological-effects-of-tadalafil-on-the-liver-of-adult-wistar2026-10-04 https://evidence-hub.com/study/68128-development-of-analytical-method-for-estimation-of-tadalafil-and2026-10-04 https://evidence-hub.com/study/68129-the-effects-of-tadalafil-on-the-liver-after-intraperitoneal-injury-in2026-10-04 https://evidence-hub.com/study/68130-tadalafil-review-on-analytical-methods-developed-for-pharmaceutical2026-10-04 https://evidence-hub.com/study/68131-correction-to-combined-therapy-with-dutasteride-and-tadalafil-vs2026-10-06 https://evidence-hub.com/study/68132-biochemical-role-of-tadalafil-in-experimental-brain-impairment2026-10-04 https://evidence-hub.com/study/68133-tadalafil-in-neonates-and-infants-with-pulmonary-hypertension2026-10-05 https://evidence-hub.com/study/68135-a-comprehensive-review-on-dapagliflozin-and-tadalafil-role-in2026-10-04 https://evidence-hub.com/study/68136-repurposed-tadalafil-rapamycin-combination-for-penile-tissue2026-10-04 https://evidence-hub.com/study/68137-a-sensitive-spectrophotometric-determination-of-tadalafil-in2026-10-04 https://evidence-hub.com/study/68138-no-nitric-oxide-to-priapism-with-hydroxyurea-and-tadalafil2026-10-04 https://evidence-hub.com/study/68141-effect-of-tadalafil-on-the-hippocampus-and-prefrontal-cortex-of-adult2026-10-04 https://evidence-hub.com/study/68143-application-of-hplc-for-detection-of-sildenafil-tadalafil-in-marketed2026-10-08 https://evidence-hub.com/study/68144-estimation-of-tadalafil-in-tablet-dosage-form-by-uv2026-10-04 https://evidence-hub.com/study/68145-bao-che-vien-nen-ra-nhanh-tadalafil-5-mg2026-10-04 https://evidence-hub.com/study/68146-effects-of-phenobarbital-and-dosing-time-on-the-plasma-concentration2026-10-04 https://evidence-hub.com/study/68147-paradoxical-post-tadalafil-cerebral-vasoconstriction-causing2026-10-04 https://evidence-hub.com/study/68148-cialis-20-mg-a-guide-to-tadalafil-effectiveness-and-safe-use2026-10-06 https://evidence-hub.com/study/68149-hplc-method-for-the-simultaneous-determination-of-tadalafil-and2026-10-04 https://evidence-hub.com/study/68150-effect-of-tadalafil-on-pulmonary-hypoplasia-in-congenital2026-10-04 https://evidence-hub.com/study/68151-qualitative-determination-of-sildenafil-and-tadalafil-adulterants-in2026-10-04 https://evidence-hub.com/study/68154-vitamin-c-deficiency-can-lead-to-pulmonary-hypertension-a-systematic2026-10-10 https://evidence-hub.com/study/68155-hemorheological-cardiorespiratory-and-cerebrovascular-effects-of2026-10-06 https://evidence-hub.com/study/68156-prevalence-and-predictors-of-erectile-dysfunction-among-men-in-the2026-10-10 https://evidence-hub.com/study/68157-ventriculo-arterial-coupling-parameters-by-cardiac-magnetic-imaging2026-10-08 https://evidence-hub.com/study/68158-from-tool-to-teammate-a-randomized-controlled-trial-of-clinician-ai2026-10-08 https://evidence-hub.com/study/68159-efficacy-of-time-restricted-eating-and-resistance-training-on-body2026-10-13 https://evidence-hub.com/study/68160-real-time-surveillance-system-for-patient-deterioration-a-pragmatic2026-10-13 https://evidence-hub.com/study/68161-effects-of-exercise-on-cognition-and-alzheimer-s-biomarkers-in-a2026-10-13 https://evidence-hub.com/study/68162-effectiveness-of-point-of-care-high-sensitivity-troponin-testing-in2026-10-06 https://evidence-hub.com/study/68163-delta-large-channel-endoscopy-versus-unilateral-biportal-endoscopy2026-10-13 https://evidence-hub.com/study/68164-whole-food-diet-induces-remission-in-children-and-young-adults-with2026-10-13 https://evidence-hub.com/study/68165-effect-of-an-intensive-care-unit-virtual-reality-intervention-on2026-10-13 https://evidence-hub.com/study/68166-treatment-of-adolescent-idiopathic-scoliosis-with-the-conservative2026-10-08 https://evidence-hub.com/study/68167-a-randomized-controlled-trial-of-mindfulness-effects-on-academic2026-10-13 https://evidence-hub.com/study/68168-mixed-reality-based-physical-therapy-in-older-adults-with-sarcopenia2026-10-08 https://evidence-hub.com/study/68169-comparative-clinical-performance-of-stainless-steel-zirconia-and2026-10-08 https://evidence-hub.com/study/68170-t1-mapping-predicts-outcome-in-patients-with-a-systemic-right2026-10-06 https://evidence-hub.com/study/68171-pulmonary-hypertension-associated-with-interstitial-lung-disease-a2026-10-08 https://evidence-hub.com/study/68172-evaluation-of-neoadjuvant-immunotherapy-regimens-for-head-and-neck2026-10-06 https://evidence-hub.com/study/68173-effect-of-colchicine-for-secondary-prevention-according-to-stroke2026-10-06 https://evidence-hub.com/study/68174-effectiveness-of-hyaluronic-acid-in-the-treatment-of-peyronie-s2026-10-06 https://evidence-hub.com/study/68175-trends-patterns-and-public-health-implications-of-dietary-supplement2026-10-06 https://evidence-hub.com/study/68176-comparison-of-the-effect-of-hyperbaric-oxygen-therapy-and-tadalafil2026-10-06 https://evidence-hub.com/study/68177-novel-drug-therapy-of-acute-hepatic-failure-induced-in-rats-by-a2026-10-19 https://evidence-hub.com/study/68178-long-term-prospective-evaluation-of-li-eswt-with-or-without-pde52026-10-06 https://evidence-hub.com/study/68179-a-new-alternative-approach-to-management-of-acute-phase-peyronie-s2026-10-06 https://evidence-hub.com/study/68180-temporal-trends-in-intracavernosal-injection-therapy-and-penile2026-10-08 https://evidence-hub.com/study/68181-insulin-resistance-related-indices-genetic-risk-and-the-risk-of2026-10-08 https://evidence-hub.com/study/68182-joint-association-of-the-triglyceride-glucose-index-and-stress2026-10-08 https://evidence-hub.com/study/68183-joint-association-of-estimated-glucose-disposal-rate-and-systemic2026-10-13 https://evidence-hub.com/study/68184-utilizing-explainable-machine-learning-for-progression-free-survival2026-10-08 https://evidence-hub.com/study/68185-association-between-hospital-frailty-risk-score-and-length-of2026-10-08 https://evidence-hub.com/study/68186-the-effects-of-vaginal-infections-on-pregnancy-outcomes-a2026-10-08 https://evidence-hub.com/study/68187-self-rated-health-as-a-predictor-of-mortality-and-healthcare-use-in2026-10-06 https://evidence-hub.com/study/68188-intestinal-ultrasound-findings-and-their-prognostic-value-in-early2026-10-06 https://evidence-hub.com/study/68189-macitentan-in-the-treatment-of-digital-ulcers-in-patients-with2026-10-10 https://evidence-hub.com/study/68190-pheochromocytoma-across-the-perioperative-course-current-concepts-and2026-10-10 https://evidence-hub.com/study/68191-sotatercept-in-children-with-pulmonary-hypertension-a-narrative-review2026-10-06 https://evidence-hub.com/study/68192-prognosis-and-treatment-with-phosphodiesterase-5-inhibitors-in2026-10-06 https://evidence-hub.com/study/68193-gastric-epithelial-neoplasms-in-patients-with-pulmonary-arterial2026-10-06 https://evidence-hub.com/study/68194-a-multifaceted-clinical-portrait-of-ebstein-s-anomaly-a-case-series2026-10-06 https://evidence-hub.com/study/68195-patent-foramen-ovale-closure-in-neuroendocrine-prostate-cancer2026-10-06 https://evidence-hub.com/study/68196-when-the-heart-becomes-suicidal-a-case-report-of-severe-left2026-10-08 https://evidence-hub.com/study/68197-possible-pathophysiologic-roles-of-neurotransmitter-systems-in-men2026-10-06 https://evidence-hub.com/study/68198-impacts-of-maternal-preeclampsia-exposure-on-offspring-neuronal2026-10-04 https://evidence-hub.com/study/68199-shining-a-spotlight-on-pulmonary-hypertension-associated-with2026-10-06 https://evidence-hub.com/study/68200-role-of-nutraceuticals-in-treating-erectile-dysfunction-via2026-10-06 https://evidence-hub.com/study/68201-a-review-of-combined-phosphodiesterase-5-inhibitors-and-blockers2026-10-19 https://evidence-hub.com/study/68202-the-potential-therapeutic-effect-of-phosphodiesterase-5-inhibitors-in2026-10-06 https://evidence-hub.com/study/68203-emerging-clinical-approaches-in-diabetic-cardiomyopathy-insights-from2026-10-06 https://evidence-hub.com/study/68204-multi-platform-metabolomics-for-fraud-detection-in-spices-and2026-10-06 https://evidence-hub.com/study/68205-understanding-physiological-adaptations-of-pregnancy-to-the-chronic2026-10-10 https://evidence-hub.com/study/68207-comparative-analysis-of-novel-modified-drug-delivery-systems-for2026-10-06 https://evidence-hub.com/study/68208-tadalafil-ameliorates-chronic-ischemia-associated-bladder2026-10-19 https://evidence-hub.com/study/68209-determination-of-the-presence-of-sildenafil-and-tadalafil-in-herbal2026-10-08 https://evidence-hub.com/study/68210-presence-of-sildenafil-and-tadalafil-in-herbal-medicinal-products2026-10-10 https://evidence-hub.com/study/68212-sildenafil-improves-radiation-induced-oral-mucositis-by-attenuating2026-10-08 https://evidence-hub.com/study/68213-outcomes-management-of-peyronie-s-disease-pd-with-combined-treatment2026-10-06 https://evidence-hub.com/study/68214-comprehensive-analytical-studies-on-the-solubility-and-dissolution2026-10-19 https://evidence-hub.com/study/68215-self-concocted-mixture-of-liquid-oral-tadalafil-resulting-in-ischemic2026-10-06 https://evidence-hub.com/study/68216-stability-indicating-rp-hplc-method-development-and-validation-for2026-10-06 https://evidence-hub.com/study/68217-analyzing-food-supplements-to-enhance-erectile-system-function-for2026-10-08 https://evidence-hub.com/study/68220-comparison-of-tamsulosin-with-tadalafil-versus-tamsulosin-alone-in2026-10-19 https://evidence-hub.com/study/68221-comparison-of-excitation-wavelengths-in-surface-enhanced-raman2026-10-06 https://evidence-hub.com/study/68222-stability-study-of-tadaflexe-tadalafil-10-mg-oral-gel-sachet-in2026-10-04 https://evidence-hub.com/study/68223-postoperative-tadalafil-for-recovery-of-continence-and-voiding2026-10-19 https://evidence-hub.com/study/68224-comparative-effectiveness-of-dalerpen-vs-branded-and-other-generic2026-10-06 https://evidence-hub.com/study/68225-tadalafil-inducedhis-to-morphological-and-biochemical-alterations-in2026-10-06 https://evidence-hub.com/study/68226-the-effectiveness-of-combined-oral-pentoxifylline-colchicine-and2026-10-05 https://evidence-hub.com/study/68227-cases-detected-with-sildenafil-tadalafil-vardenafil-in-autopsies2026-10-08 https://evidence-hub.com/study/68228-dissolution-enhancement-of-tadalafil-tablets-by-the-complex-method-of2026-10-19 https://evidence-hub.com/study/68229-detection-and-quantification-of-sildenafil-and-tadalafil-in-dietary2026-10-08 https://evidence-hub.com/study/68230-correction-comparison-of-excitation-wavelengths-in-surface-enhanced2026-10-06 https://evidence-hub.com/study/68231-validated-rp-hplc-method-for-simultaneous-estimation-of-tadalafil-and2026-10-06 https://evidence-hub.com/study/68232-the-role-of-5-phosphodiesterase-inhibitors-pde-5i-in-current-benign2026-10-19 https://evidence-hub.com/study/68233-results-from-the-international-collaborative-systematic-literature2026-10-04 https://evidence-hub.com/study/68234-systemic-effects-of-phosphodiesterase-type-5-inhibitors-beyond2026-10-19 https://evidence-hub.com/study/68235-efficacy-of-sexual-stimulation-in-the-treatment-of-distal-ureteral2026-10-04 https://evidence-hub.com/study/68236-phosphodiesterase-inhibitors-and-testicular-torsion-a-systematic2026-10-04 https://evidence-hub.com/study/68237-is-the-vacuum-erectile-device-suitable-for-treating-erectile2026-10-04 https://evidence-hub.com/study/68238-therapeutic-effect-of-micro-energy-treatment-for-erectile-dysfunction2026-10-04 https://evidence-hub.com/study/68239-updates-in-management-of-pulmonary-hypertension-in-pediatrics-a2026-10-04 https://evidence-hub.com/study/68240-the-relationship-between-testosterone-levels-and-the-severity-of2026-10-19 https://evidence-hub.com/study/68241-comparing-the-effects-of-different-diuretic-agents-on-renal-function2026-10-04 https://evidence-hub.com/study/68242-efficacy-and-safety-of-muscarinic-antagonists-combined-with2026-10-04 https://evidence-hub.com/study/68243-pulmonary-hypertension-in-underrepresented-minorities-a-narrative2026-10-04 https://evidence-hub.com/study/68244-new-drug-therapies-for-women-with-eclampsia-impact-on-prognosis-as2026-10-04 https://evidence-hub.com/study/68245-chemsex-as-a-diagnostic-challenge-toward-recognition-in-icd-12-and2026-10-04 https://evidence-hub.com/study/68246-smoking-and-flap-survival-a-comprehensive-systematic-review2026-10-04 https://evidence-hub.com/study/68247-management-of-persistent-storage-symptoms-and-overactive-bladder-in2026-10-19 https://evidence-hub.com/study/68248-pulmonary-vasodilators-in-copd-associated-pulmonary-hypertension-an2026-10-04 https://evidence-hub.com/study/68249-the-impact-of-hypertension-on-treatment-outcomes-in-benign-prostatic2026-10-19 https://evidence-hub.com/study/68250-dexamethasone-for-prevention-of-ams-hace-and-hape-and-for-limiting2026-10-04 https://evidence-hub.com/study/68251-effects-of-low-intensity-shock-wave-therapy-on-erectile-function-and2026-10-19 https://evidence-hub.com/study/68252-economic-burden-of-pulmonary-hypertension-systematic-review2026-10-04 https://evidence-hub.com/study/68253-evaluating-the-safety-and-effectiveness-of-blockers-versus-mirabegron2026-10-04 https://evidence-hub.com/study/68254-erectile-dysfunction-associated-with-prostate-cancer-treatment-and2026-10-19 https://evidence-hub.com/study/68255-low-intensity-shockwave-therapy-in-men-s-health-insights-from-a2026-10-04 https://evidence-hub.com/study/68256-associations-between-erectile-dysfunction-and-vascular-parameters-a2026-10-04 https://evidence-hub.com/study/68257-low-intensity-extracorporeal-shockwave-therapy-for-erectile2026-10-04 https://evidence-hub.com/study/68258-impact-of-preoperative-silodosin-on-ureteroscopy-outcomes-for2026-10-04 https://evidence-hub.com/study/68259-still-standing-strong-a-narrative-review-of-why-bcg-remains-central2026-10-19 https://evidence-hub.com/study/68260-sildenafil-citrate-oral-suspension-for-managing-erectile-dysfunction2026-10-19 https://evidence-hub.com/study/68261-functional-measures-in-non-copd-chronic-respiratory-diseases-a2026-10-04 https://evidence-hub.com/study/68262-palliative-care-in-pulmonary-hypertension-a-systematic-review-and2026-10-04 https://evidence-hub.com/study/68263-from-growth-factors-to-an-immune-centric-approach-a-systematic-review2026-10-04 https://evidence-hub.com/study/68264-an-updated-systematic-review-and-meta-analysis-of-pde-5-inhibitors2026-10-04 https://evidence-hub.com/study/68265-sotatercept-in-the-treatment-of-pulmonary-arterial-hypertension-a2026-10-04 https://evidence-hub.com/study/68266-early-detection-treatment-initiation-and-long-term-health-outcomes-in2026-10-04 https://evidence-hub.com/study/68267-what-are-the-risk-factors-for-erectile-dysfunction-following-penile2026-10-04 https://evidence-hub.com/study/68268-erectile-dysfunction-type-2-diabetes-and-cardiovascular-disease-a2026-10-05 https://evidence-hub.com/study/68269-the-relationship-between-vitamin-d-levels-and-erectile-dysfunction-a2026-10-04 https://evidence-hub.com/study/68270-testosterone-replacement-in-men-with-sexual-dysfunction-an-abridged2026-10-04 https://evidence-hub.com/study/68271-the-efficacy-of-resveratrol-supplementation-on-inflammation-and2026-10-08 https://evidence-hub.com/study/68272-role-of-the-triglyceride-glucose-index-as-a-predictor-of-therapeutic2026-10-05 https://evidence-hub.com/study/68273-op0336-modulation-of-genetic-markers-of-fibrosis-and-skin-score-in2026-10-05 https://evidence-hub.com/study/68274-biochemical-changes-in-overweight-and-obese-patients-after-taking-52026-10-05 https://evidence-hub.com/study/68276-efficacy-and-safety-of-tadalafil-when-used-in-monoand-initial2026-10-05 https://evidence-hub.com/study/68277-comparison-of-safety-and-efficacy-between-silodosin-monotherapy-and2026-10-19 https://evidence-hub.com/study/68281-the-impact-of-long-term-covid-19-infection-on-the-patients-erectile2026-10-05 https://evidence-hub.com/study/68282-cavernosal-uric-acid-level-in-vasculogenic-erectile-dysfunction2026-10-05 https://evidence-hub.com/study/68283-low-dose-tadalafil-and-cabergoline-versus-cabergoline-alone-in2026-10-05 https://evidence-hub.com/study/68295-tadalafil-as-an-adjunct-therapy-in-primary-end-to-end-urethroplasty2026-10-04 https://evidence-hub.com/study/68296-efficacy-of-combined-targeted-radionuclide-therapy-and-immune2026-10-08 https://evidence-hub.com/study/68297-african-animal-trypanosomosis-among-cattle-in-west-africa-a-meta2026-10-08 https://evidence-hub.com/study/68298-histological-study-on-the-effects-of-sildenafil-viagra-versus2026-10-04 https://evidence-hub.com/study/68299-anti-inflammatory-and-anti-oxidant-action-of-tadalafil-in-testicular2026-10-05 https://evidence-hub.com/study/68300-tadalafil-pretreatment-attenuates-doxorubicin-induced-hepatorenal2026-10-19 https://evidence-hub.com/study/68301-investigation-of-the-effects-of-tadalafil-on-the-myocardium-via2026-10-04 https://evidence-hub.com/study/68302-comparison-of-cilomilast-tadalafil-and-both-drug-combinations-in-the2026-10-05 https://evidence-hub.com/study/68303-maternal-tadalafil-treatment-does-not-increase-uterine-artery-blood2026-10-05 https://evidence-hub.com/study/68304-effects-of-tadalafil-and-sglt2-inhibitors-on-erectile-and-diastolic2026-10-04 https://evidence-hub.com/study/68305-response-surface-methodology-for-optimizing-adsorption-process2026-10-04 https://evidence-hub.com/study/68306-bio-analytical-method-development-and-validation-of-finasteride2026-10-04 https://evidence-hub.com/study/68307-mp44-06-renoprotective-effect-of-pde5i-in-a-partially-nephrectomized2026-10-04 https://evidence-hub.com/study/68308-green-stability-indicating-rp-hplc-method-for-simultaneous-estimation2026-10-04 https://evidence-hub.com/study/68309-pde5-inhibitor-tadalafil-attenuates-liver-sinusoid-endothelial-cell2026-10-04 https://evidence-hub.com/study/68311-histopathological-and-real-time-pcr-analysis-of-alterations-in-the2026-10-04 https://evidence-hub.com/study/68312-063-effect-of-phosphodiesterase-type-4-inhibitor-on-erectile-function2026-10-04 https://evidence-hub.com/study/68313-bs33-the-interplay-of-calcium-fluxes-and-calcium-buffering-in-heart2026-10-04 https://evidence-hub.com/study/68314-study-of-phosphodiesterase-5-inhibitor-pde5-i-and-anti-diabetic-in2026-10-04 https://evidence-hub.com/study/68315-pathophysiology-and-management-of-testicular-ischemia-reperfusion2026-10-04 https://evidence-hub.com/study/68316-animal-models-of-steroid-induced-osteonecrosis-of-the-femoral-head2026-10-04 https://evidence-hub.com/study/68317-mechanistic-insights-on-immune-activation-driven-erectile-dysfunction2026-10-04 https://evidence-hub.com/study/68318-targeting-trpc-5-channel-inhibition-to-improve-penile-vascular2026-10-19 https://evidence-hub.com/study/68319-tribulus-terrestris-l-confers-protection-against-hypoxia-induced2026-10-04 https://evidence-hub.com/study/68320-erectile-dysfunction-in-hypercholestermic-patients2026-10-19 https://evidence-hub.com/study/68321-benchtop-nmr-coupled-with-chemometrics-a-workflow-for-unveiling2026-10-04 https://evidence-hub.com/study/68322-phosphodiesterase-5-inhibition-collaborates-with-vaccine-based2026-10-05 https://evidence-hub.com/study/68323-pde5-inhibitor-potentially-improves-polyuria-and-bladder-storage-and2026-10-05 https://evidence-hub.com/study/68324-impacts-of-low-birthweight-on-kidney-development-and2026-10-04 https://evidence-hub.com/study/68325-vitamin-d-deficiency-and-erectile-dysfunction-emerging-mechanisms-and2026-10-04 https://evidence-hub.com/study/68326-long-term-pde5-inhibitors-and-glaucoma-risk-causal-inference-and2026-10-04 https://evidence-hub.com/study/68327-effects-of-fu-plus-tablets-on-intracavernosal-pressure-in-animal2026-10-04 https://evidence-hub.com/study/68328-the-effect-of-phosphodiesterase-type-5-inhibitors-on-the-hearing-of2026-10-04 https://evidence-hub.com/study/68329-vitamin-d-as-an-add-on-therapy-to-phosphodiesterase-5-inhibitor-in2026-10-05 https://evidence-hub.com/study/68330-evaluation-of-nicorandil-in-treatment-of-induced-pulmonary-arterial2026-10-04 https://evidence-hub.com/study/68331-preventing-a-public-health-issue-by-quantification-of-illegally-added2026-10-04 https://evidence-hub.com/study/68332-inhibition-of-pde-4-and-pde-5-differentially-modulates-isolated2026-10-08 https://evidence-hub.com/study/68333-inhibition-of-pde-4-isoenzyme-attenuates-frequency-and-overall2026-10-10 https://evidence-hub.com/study/68334-quality-characteristics-and-hplc-detection-of-phosphodiesterase2026-10-04 https://evidence-hub.com/study/68335-improving-sorafenib-efficacy-in-hcc-tumour-cores-via-pde5-inhibitor2026-10-05 https://evidence-hub.com/study/68336-age-related-increases-in-pde11a4-protein-expression-trigger-liquid2026-10-05 https://evidence-hub.com/study/68337-systemic-sclerosis-associated-pulmonary-arterial-hypertension-from2026-10-04 https://evidence-hub.com/study/68338-formulation-and-evaluation-of-tadalafil-sublingual-film-using-322026-10-04 https://evidence-hub.com/study/68339-tadalafil-less-known-effects-of-the-drug-and-potential-directions-for2026-10-04 https://evidence-hub.com/study/68340-treatment-of-acute-phase-of-peyronie-s-disease-with-tamoxifen-and2026-10-04 https://evidence-hub.com/study/68341-fabrication-and-characterization-of-bilayered-electrospun-nanofibrous2026-10-04 https://evidence-hub.com/study/68342-tadalafil-versus-tamsulosin-for-distal-ureteric-stone-expulsion-a2026-10-19 https://evidence-hub.com/study/68343-co-spray-dried-macitentan-tadalafil-with-leucine-microparticles-for2026-10-04 https://evidence-hub.com/study/68344-a-novel-stability-indicating-rp-hplc-method-development-and2026-10-19 https://evidence-hub.com/study/68345-utilization-of-absorbance-subtraction-and-ratio-difference-green2026-10-19 https://evidence-hub.com/study/68346-stability-indicating-hptlc-method-development-and-validation-for2026-10-19 https://evidence-hub.com/study/68347-effects-of-postprandial-factors-and-second-meal-intake-time-on2026-10-05 https://evidence-hub.com/study/68348-tadalafil-plus-endothelin-receptor-antagonists-in-connective-tissue2026-10-05 https://evidence-hub.com/study/68349-nghien-cuu-cai-thien-o-tan-va-o-hoa-tan-cua-tadalafil-bang-phuong2026-10-04 https://evidence-hub.com/study/68350-435-off-label-tamoxifen-with-phosphodiesterase-type-5-inhibition2026-10-05 https://evidence-hub.com/study/68351-adulterated-dietary-supplements-commercialized-in-brazil-development2026-10-05 https://evidence-hub.com/study/68352-favipiravir-s-surprising-role-as-a-pde5-inhibitor-a-new-therapeutic2026-10-05 https://evidence-hub.com/study/68353-exploring-pde5a-upregulation-in-bipolar-disorder-insights-from-single2026-10-05 https://evidence-hub.com/study/68354-in-vitro-aphrodisiac-potentials-of-some-nigerian-herbal-drinks2026-10-04 https://evidence-hub.com/study/68355-formulation-and-in-vitro-evaluation-of-immediate-release-tablets2026-10-04 https://evidence-hub.com/study/68356-polymer-stabilized-amorphous-dispersions-of-clonazepam2026-10-04 https://evidence-hub.com/study/68357-age-related-increases-in-pde11a4-protein-expression-trigger-liquid2026-10-04 https://evidence-hub.com/study/68358-effect-of-activated-platelet-rich-plasma-on-in-vitro-spermatogenesis2026-10-04 https://evidence-hub.com/study/68359-study-of-the-regulation-of-the-mechanical-properties-of-plasmodium2026-10-04 https://evidence-hub.com/study/68360-etude-de-la-regulation-des-proprietes-mecaniques-des-erythrocytes2026-10-04 https://evidence-hub.com/study/68361-design-of-colon-targeted-drug-delivery-of-dexamethasone-formulation2026-10-04 https://evidence-hub.com/study/68362-self-nanoemulsion-intrigues-the-gold-phytopharmaceutical-chrysin-in2026-10-04 https://evidence-hub.com/study/68363-a-novel-simulated-media-system-for-in-vitro-evaluation-of2026-10-04 https://evidence-hub.com/study/68364-acridocarpus-smeathmannii-root-extracts-inhibit-human-prostate-and2026-10-19 https://evidence-hub.com/study/68365-physiologically-based-pharmacokinetic-modeling-for-predicting-drug2026-10-04 https://evidence-hub.com/study/68366-identification-of-nucleotide-binding-sites-and-repurposing-of2026-10-04 https://evidence-hub.com/study/68367-aildenafil-citrate-with-superior-pde5-selectivity-ameliorates2026-10-10 https://evidence-hub.com/study/68368-common-dysregulated-pathways-and-genes-in-alzheimer-s-parkinson-s-and2026-10-04 https://evidence-hub.com/study/68369-assessment-of-toxicity-and-antiprostate-cancer-effect-of-annona2026-10-19 https://evidence-hub.com/study/68370-neurotherapeutics-across-blood-brain-barrier-screening-of-bbb2026-10-04 https://evidence-hub.com/study/68371-recent-advances-in-drug-repositioning-and-rediscovery-for-different2026-10-10 https://evidence-hub.com/study/68372-molecular-mechanisms-underlying-the-erectogenic-effects-of2026-10-04 https://evidence-hub.com/study/68373-phosphodiesterase-type-5-inhibitors-in-men-with-erectile-dysfunction2026-10-19 https://evidence-hub.com/study/68374-polypharmacological-potential-of-phosphodiesterase-5-inhibitors-for2026-10-04 https://evidence-hub.com/study/68375-virtual-screening-of-phytochemicals-from-medicinal-plants-as2026-10-04 https://evidence-hub.com/study/68376-reprogramming-biocatalytic-futile-cycles-through-computational2026-10-04 https://evidence-hub.com/study/68379-a-review-on-new-frontiers-in-drug-drug-interaction-predictions-and2026-10-04 https://evidence-hub.com/study/68380-pde-5-restore-cognitive-and-metabolic-function-in-patients-with2026-10-04 https://evidence-hub.com/study/68381-advanced-techniques-to-improve-amorphous-dispersion-performance-with2026-10-04 https://evidence-hub.com/study/68382-repurposing-of-phosphodiesterase-5-inhibitor-sildenafil-as-a2026-10-08 https://evidence-hub.com/study/68383-white-mugwort-artemisia-lactiflora-fraction-loaded-chitosan2026-10-04 https://evidence-hub.com/study/68384-cerebrovascular-effects-of-sildenafil-in-small-vessel-disease-the2026-10-10 https://evidence-hub.com/study/68385-non-surgical-management-of-bph-an-updated-review-of-current2026-10-19 https://evidence-hub.com/study/68386-the-role-of-genetics-in-congenital-heart-disease-associated-pulmonary2026-10-04 https://evidence-hub.com/study/68387-a-novel-phosphodiesterase-target-as-a-therapeutic-approach-inhibiting2026-10-19 https://evidence-hub.com/study/68388-a-review-of-the-reported-pharmacokinetic-interactions-of-sildenafil2026-10-08 https://evidence-hub.com/study/68389-rapid-screening-and-identification-of-illegally-adulterated-pde-52026-10-10 https://evidence-hub.com/study/68390-adulteration-in-herbal-aphrodisiacs-toxicological-risks-analytical2026-10-04 https://evidence-hub.com/study/68392-zincpharmer-based-identification-of-multi-target-inhibitors-for2026-10-08 https://evidence-hub.com/study/68393-advancements-and-applications-of-herbal-cocrystals2026-10-04 https://evidence-hub.com/study/68394-molecular-docking-study-of-boheco-desire-an-ayurvedic-proprietary2026-10-04 https://evidence-hub.com/study/68395-simulation-of-clinical-trials-of-oral-treprostinil-in-pulmonary2026-10-04 https://evidence-hub.com/study/68396-phosphodiesterase-5-inhibitors-and-alzheimer-s-disease-a-meta2026-10-19 https://evidence-hub.com/study/68397-a-novel-stability-indicating-rp-hplc-method-for-the-simultaneous2026-10-04 https://evidence-hub.com/study/68398-quantitative-analysis-of-dextromethorphan-hbr-guaifenesin-and2026-10-04 https://evidence-hub.com/study/68399-enhancement-of-solubility-profiles-of-azelnidipine-drug-likeliness2026-10-04 https://evidence-hub.com/study/68400-from-antipsychotic-to-neuroprotective-computational-repurposing-of2026-10-04 https://evidence-hub.com/study/68401-pka-estimation-of-ambrisentan-by-reversed-phase-high-performance2026-10-04 https://evidence-hub.com/study/68402-molecular-docking-of-silymarin-as-a-ligand-for-aromatase-enzyme-and2026-10-04 https://evidence-hub.com/study/68403-sildenafil-as-a-candidate-drug-for-alzheimer-s-disease-real-world2026-10-10 https://evidence-hub.com/study/68404-discovery-of-indole-based-pde5-inhibitors-synthesis-and2026-10-19 https://evidence-hub.com/study/68405-estimation-of-catha-edulis-anti-platelet-drugs-interaction-by-hplc2026-10-04 https://evidence-hub.com/study/68406-exploring-co-milling-of-poorly-water-soluble-drugs-with-swellable2026-10-04 https://evidence-hub.com/study/68407-indole-amide-derivatives-in-alzheimer-s-disease-advancing-from2026-10-04 https://evidence-hub.com/study/68408-ozone-modified-properties-of-pumpkin-seed-oil-as-anti-h-pylori2026-10-19 https://evidence-hub.com/study/68409-the-development-of-a-gc-fid-method-for-indirect-quantification-of2026-10-04 https://evidence-hub.com/study/68410-forced-degradation-study-of-vonoprazan-fumarate-by-hplc-and2026-10-04 https://evidence-hub.com/study/68411-dna-minor-groove-molecular-docking-and-molecular-dynamics-simulations2026-10-04 https://evidence-hub.com/study/68413-metabolic-gene-therapy-in-a-canine-with-pulmonary-hypertension2026-10-04 https://evidence-hub.com/study/68414-assessment-of-antibiotic-resistance-in-bacteriophage-insensitive2026-10-08 https://evidence-hub.com/study/68415-intravenous-to-oral-transition-therapy-in-community-acquired2026-10-08 https://evidence-hub.com/study/68416-does-critical-illness-change-levofloxacin-pharmacokinetics2026-10-08 https://evidence-hub.com/study/68417-host-cell-oxidative-stress-promotes-intracellular-fluoroquinolone2026-10-20 https://evidence-hub.com/study/68418-association-between-oral-fluoroquinolone-use-and-lateral-canthal2026-10-08 https://evidence-hub.com/study/68419-assessing-prescription-of-antibiotics-after-vaccination-against2026-10-08 https://evidence-hub.com/study/68420-comparative-antimicrobial-susceptibility-of-respiratory-tract2026-10-08 https://evidence-hub.com/study/68421-new-fluoroquinolones-levofloxacin-moxifloxacin-and-gatifloxacin2026-10-08 https://evidence-hub.com/study/68422-antibacterial-activity-of-a-dna-topoisomerase-i-inhibitor-versus2026-10-08 https://evidence-hub.com/study/68423-clinical-experience-in-the-management-of-community-acquired-pneumonia2026-10-08 https://evidence-hub.com/study/68424-activity-of-jnj-q2-a-new-fluoroquinolone-tested-against-contemporary2026-10-08 https://evidence-hub.com/study/68425-acinetobacter-baumannii-klebsiella-pneumoniae-and-elizabethkingia2026-10-08 https://evidence-hub.com/study/68428-adverse-drug-reactions-of-levofloxacin-in-the-management-of-pneumonia2026-10-08 https://evidence-hub.com/study/68429-comparison-of-different-dosages-in-treating-pneumonia-of-rat-model2026-10-20 https://evidence-hub.com/study/68433-sequential-levofloxacin-administration-in-the-treatment-of-community2026-10-20 https://evidence-hub.com/study/68434-role-and-place-of-levofloxacin-in-the-treatment-of-community-acquired2026-10-08 https://evidence-hub.com/study/68435-effectiveness-of-levofloxacin-in-community-acquired-pneumonia-in2026-10-08 https://evidence-hub.com/study/68436-clinical-observation-of-levofloxacin-in-treating-30-cases-with2026-10-08 https://evidence-hub.com/study/68437-clinical-investigation-on-levofloxacin-and-azithromycin-in-the2026-10-20 https://evidence-hub.com/study/68439-effect-of-levofloxacin-on-intestinal-microbiota-of-patients-with2026-10-08 https://evidence-hub.com/study/68441-effects-of-levofloxacin-injection-on-pneumonia-after-esophageal2026-10-08 https://evidence-hub.com/study/68442-comparative-pharmacokinetics-of-levofloxacin-in-the-saliva-and-blood2026-10-08 https://evidence-hub.com/study/68443-a-comparison-between-levofloxacin-and-cefuroxime-with-azithromycin-in2026-10-20 https://evidence-hub.com/study/68444-artificial-intelligence-models-for-pediatric-lung-sound-analysis2026-10-08 https://evidence-hub.com/study/68445-zinc-as-an-adjunct-therapy-in-the-management-of-severe-pneumonia2026-10-06 https://evidence-hub.com/study/68446-emergence-of-mcr-8-1-bearing-mdr-hypervirulent-klebsiella-pneumoniae2026-10-08 https://evidence-hub.com/study/68447-covid-19-associated-cognitive-biases-on-pneumonia-differential2026-10-08 https://evidence-hub.com/study/68448-unravelling-the-genomic-characteristics-of-a-klebsiella2026-10-08 https://evidence-hub.com/study/68449-effects-of-simulated-microgravity-on-acquired-antibiotic-resistance2026-10-08 https://evidence-hub.com/study/68450-drug-resistance-of-acinetobacter-ssp-in-patients-with-pneumonia-in-a2026-10-08 https://evidence-hub.com/study/68451-molecular-characterization-of-carbapenem-resistance-mechanisms-and2026-10-08 https://evidence-hub.com/study/68452-pathogenic-diversity-of-klebsiella-pneumoniae-strains-with-different2026-10-08 https://evidence-hub.com/study/68453-detection-of-delafloxacin-resistance-mechanisms-in-multidrug2026-10-08 https://evidence-hub.com/study/68454-the-evolution-of-the-antimicrobial-resistance-of-streptococcus2026-10-08 https://evidence-hub.com/study/68455-prevalence-of-antimicrobial-resistance-in-saurashtra-gujarat-and2026-10-08 https://evidence-hub.com/study/68456-dissemination-of-kpc-2-producing-carbapenem-resistant-klebsiella2026-10-08 https://evidence-hub.com/study/68457-risk-factors-and-clinical-characteristics-for-stenotrophomonas2026-10-08 https://evidence-hub.com/study/68458-a-rare-case-of-blastomycosis-in-a-psoriasis-patient-treated-with2026-10-08 https://evidence-hub.com/study/68459-occurrence-of-antimicrobial-resistant-bovine-mastitis-bacteria-in2026-10-08 https://evidence-hub.com/study/68460-nanowire-mediated-eradication-of-polymicrobial-biofilms2026-10-08 https://evidence-hub.com/study/68461-global-prediction-of-antimicrobial-resistance-trends-using2026-10-08 https://evidence-hub.com/study/68462-antibiotic-susceptibility-according-to-age-of-clinical-strains-from2026-10-08 https://evidence-hub.com/study/68463-antibiotic-resistance-profiles-of-extended-spectrum-lactamase-esbl2026-10-08 https://evidence-hub.com/study/68464-antibiotic-resistance-and-novel-sequence-types-of-klebsiella-spp-in2026-10-08 https://evidence-hub.com/study/68465-four-year-variation-in-pathogen-distribution-and-antimicrobial2026-10-08 https://evidence-hub.com/study/68466-antimicrobial-resistance-of-clinical-klebsiella-pneumoniae-isolates2026-10-08 https://evidence-hub.com/study/68467-increased-antibiotic-susceptibility-of-gram-positive-bacteria-in2026-10-08 https://evidence-hub.com/study/68468-antimicrobial-resistance-of-streptococcus-pneumoniae-clinical2026-10-08 https://evidence-hub.com/study/68471-chest-pain-as-a-diagnostic-dilemma-in-community-acquired-pneumonia-a2026-10-08 https://evidence-hub.com/study/68472-pharmacoeconomic-study-using-cost-effectiveness-analysis-to-examine2026-10-08 https://evidence-hub.com/study/68473-winter-onset-acute-q-fever-presenting-as-atypical-pneumonia-with2026-10-08 https://evidence-hub.com/study/68474-rapid-clinical-improvement-with-levofloxacin-in-drowning-associated2026-10-08 https://evidence-hub.com/study/68475-pneumonia-with-therapeutic-failure-attributed-to-impaired-absorption2026-10-08 https://evidence-hub.com/study/68476-levofloxacin-vs-ceftriaxone-pada-pasien-pneumonia-rawat-inap-di-rsud2026-10-08 https://evidence-hub.com/study/68478-analisis-efektivitas-antibiotik-levofloxacin-dan-ceftriaxon-pada2026-10-08 https://evidence-hub.com/study/68480-uji-resistensi-bakteri-basil-gram-negatif-pada-sputum-penderita2026-10-08 https://evidence-hub.com/study/68481-advancing-the-combine-pneumonia-model-pk-pd-evaluation-of-meropenem2026-10-08 https://evidence-hub.com/study/68482-perbandingan-efektivitas-pemberian-antibiotik-empiris-ceftriaxone-dan2026-10-08 https://evidence-hub.com/study/68484-not-your-typical-pneumonia-delftia-acidovorans-pneumonia-associated2026-10-08 https://evidence-hub.com/study/68485-transform-your-heart-failure-treatment-approach-conquering-svt-and2026-10-08 https://evidence-hub.com/study/68486-how-lung-tissue-damage-improves-by-moringa-oleifera-leaves-extract-in2026-10-08 https://evidence-hub.com/study/68488-pneumonia-komunitas-pada-leukimia-prolimfositik2026-10-08 https://evidence-hub.com/study/68489-evaluasi-rasionalitas-penggunaan-antibiotik-pasien-pneumonia-di-rs2026-10-08 https://evidence-hub.com/study/68490-a-case-of-legionella-pneumophila-with-hearing-loss-improved-by2026-10-08 https://evidence-hub.com/study/68491-evaluation-of-antibiotic-use-in-pneumonia-patients-at-bahteramas2026-10-08 https://evidence-hub.com/study/68492-karakteristik-penggunaan-antibiotik-pada-pasien-pneumonia-di-rsup-dr2026-10-08 https://evidence-hub.com/study/68493-effectiveness-of-cinnamomum-burmannii-bark-oil-in-pneumonia-time2026-10-08 https://evidence-hub.com/study/68494-pola-penggunaan-antibiotik-pada-pasien-pneumonia-di-rumah-sakit-p2026-10-08 https://evidence-hub.com/study/68495-beyond-walking-pneumonia-a-rare-case-of-mycoplasma-pneumonia-leading2026-10-08 https://evidence-hub.com/study/68496-pasteurella-multocida-pneumonia-diagnosed-5-months-after-a-cat-bite2026-10-08 https://evidence-hub.com/study/68497-a-rare-case-of-legionella-necrotizing-pneumonia-in-liver-cirrhosis2026-10-08 https://evidence-hub.com/study/68498-analysis-of-antibacterial-therapy-of-community-acquired-pneumonia-in2026-10-08 https://evidence-hub.com/study/68500-evaluasi-kualitatif-dan-kuantitatif-penggunaan-antibiotik-pada-pasien2026-10-08 https://evidence-hub.com/study/68501-evaluasi-penggunaan-antibiotik-pada-pasien-pneumonia-di-rumah-sakit2026-10-08 https://evidence-hub.com/study/68502-incidence-and-resistance-patterns-of-pathogens-from-lower-respiratory2026-10-08 https://evidence-hub.com/study/68503-modification-of-empirical-antimicrobial-regimen-during-the-first-722026-10-08 https://evidence-hub.com/study/68504-antimicrobial-susceptibility-among-gram-positive-organisms-collected2026-10-08 https://evidence-hub.com/study/68505-emergence-of-multidrug-resistant-streptococcus-pneumoniae-report-from2026-10-08 https://evidence-hub.com/study/68506-molecular-analysis-of-rising-fluoroquinolone-resistance-in-belgian2026-10-08 https://evidence-hub.com/study/68507-antimicrobial-resistance-among-isolates-of-respiratory-tract2026-10-08 https://evidence-hub.com/study/68508-characteristics-of-st11-kpc-2-producing-carbapenem-resistant2026-10-08 https://evidence-hub.com/study/68509-clinical-analysis-of-non-tuberculous-mycobacterial-pulmonary-diseases2026-10-08 https://evidence-hub.com/study/68510-clinical-characteristics-of-children-with-streptococcus-pneumoniae2026-10-08 https://evidence-hub.com/study/68511-clarithromycin-extended-release-tablet-a-review-of-its-use-in-the2026-10-08 https://evidence-hub.com/study/68512-antimicrobial-resistance-in-respiratory-pathogens-isolated-in-brazil2026-10-08 https://evidence-hub.com/study/68513-covid-19-management-in-heart-transplanted-recipients-registry-of2026-10-08 https://evidence-hub.com/study/68514-postoperative-respiratory-events-and-risk-factors-after-hip2026-10-08 https://evidence-hub.com/study/68515-zinc-as-an-adjuvant-therapy-in-acute-severe-pneumonia-in-children2026-10-08 https://evidence-hub.com/study/68516-clinical-efficacy-of-qingke-mixture-in-treating-mycoplasma-pneumonia2026-10-08 https://evidence-hub.com/study/68517-effects-of-oral-rehydration-solution-based-prophylactic-sodium2026-10-08 https://evidence-hub.com/study/68518-abstract-no-404-comparative-efficacy-of-tactile-stimulation-airway2026-10-08 https://evidence-hub.com/study/68519-low-dose-versus-high-dose-methylprednisolone-for-children-with-severe2026-10-08 https://evidence-hub.com/study/68520-adjunctive-effects-of-pediatric-tuina-on-symptoms-inflammation-and2026-10-08 https://evidence-hub.com/study/68521-toolcap-novel-tools-to-improve-management-of-paediatric-community2026-10-08 https://evidence-hub.com/study/68522-twenty-four-month-outcomes-of-extended-versus-standard-course2026-10-08 https://evidence-hub.com/study/68523-efficacy-of-zinc-as-an-adjuvant-therapy-in-acute-pneumonia-in2026-10-08 https://evidence-hub.com/study/68524-efficacy-and-safety-of-aerosol-inhalation-of-recombinant-human2026-10-08 https://evidence-hub.com/study/68525-efficacy-of-an-oral-intake-restoration-intervention-on-timely2026-10-08 https://evidence-hub.com/study/68526-effects-of-oral-care-combined-with-neuromuscular-electrical2026-10-08 https://evidence-hub.com/study/68528-pay-it-forward-23-valent-pneumococcal-polysaccharide-vaccination2026-10-08 https://evidence-hub.com/study/68529-mass-azithromycin-distribution-and-cause-specific-mortality-among2026-10-08 https://evidence-hub.com/study/68530-identification-of-hif1a-as-a-therapeutic-target-during-sars-cov-22026-10-08 https://evidence-hub.com/study/68531-antimicrobial-peptides-for-diabetic-foot-ulcers-and-infections2026-10-13 https://evidence-hub.com/study/68532-evaluation-of-bloodstream-infections-in-febrile-neutropenic-patients2026-10-13 https://evidence-hub.com/study/68533-293-challenges-and-outcomes-of-tuberculosis-exposure-investigations2026-10-08 https://evidence-hub.com/study/68534-back-stimulation-with-gaussian-frequency-biphasic-burst-stimulation2026-10-08 https://evidence-hub.com/study/68535-prevalence-of-community-acquired-pneumonia-among-egyptian-children2026-10-08 https://evidence-hub.com/study/68536-maternal-knowledge-and-practices-in-caring-for-children-under-five2026-10-08 https://evidence-hub.com/study/68537-prevalence-and-risk-factors-of-severe-pneumonia-among-children-aged-22026-10-08 https://evidence-hub.com/study/68538-burden-and-sociodemographic-determinants-of-pneumonia-and-diarrhoea2026-10-08 https://evidence-hub.com/study/68539-association-between-microplastic-exposure-and-macrolide-resistance-in2026-10-08 https://evidence-hub.com/study/68540-intensive-care-unit-nurses-knowledge-and-compliance-with-ventilator2026-10-08 https://evidence-hub.com/study/68541-multilevel-analysis-of-community-acquired-pneumonia-among-2-59-months2026-10-08 https://evidence-hub.com/study/68542-hospitalization-due-to-pneumonia-in-australia-england-and-wales-an2026-10-08 https://evidence-hub.com/study/68543-a-cross-sectional-study-comparing-ai-generated-educational-content-on2026-10-08 https://evidence-hub.com/study/68545-comparative-study-of-x-ray-and-sonographic-findings-in-pneumonia-in-a2026-10-08 https://evidence-hub.com/study/68546-prevalence-of-community-acquired-pneumonia-among-egyptian-children2026-10-08 https://evidence-hub.com/study/68547-can-serum-procalcitonin-be-used-for-severity-identification-and2026-10-08 https://evidence-hub.com/study/68548-pre-existing-renal-graft-dysfunction-as-a-major-risk-factor-for-sars2026-10-08 https://evidence-hub.com/study/68549-high-proportion-of-pneumonia-morbidity-and-risk-factors-in-sick-under2026-10-08 https://evidence-hub.com/study/68550-association-of-modifiable-risk-factors-with-severity-of-pneumonia-in2026-10-08 https://evidence-hub.com/study/68551-cross-sectional-study-of-calves-from-norwegian-dairy-herds-with2026-10-08 https://evidence-hub.com/study/68552-factors-associated-with-pneumonia-diagnosis-among-children-aged-1-602026-10-08 https://evidence-hub.com/study/68553-prevalence-of-vitamin-a-deficiency-in-children-aged-6-months-to-52026-10-08 https://evidence-hub.com/study/68554-multidimensional-assessment-of-nutritional-status-among-hospitalized2026-10-06 https://evidence-hub.com/study/68555-frequency-of-pneumonia-and-associated-breastfeeding-status-in-infants2026-10-08 https://evidence-hub.com/study/68556-characteristics-and-influencing-factors-of-bronchoalveolar-lavage2026-10-08 https://evidence-hub.com/study/68557-factors-associated-with-community-acquired-pneumonia-in-older-adults2026-10-08 https://evidence-hub.com/study/68558-factors-associated-with-severe-pneumonia-among-hospitalised-children2026-10-08 https://evidence-hub.com/study/68559-association-of-t-eat-10-and-nuffe-tr-scores-with-a-history-of2026-10-08 https://evidence-hub.com/study/68560-association-between-normalized-mycoplasma-pneumoniae-sequence-reads2026-10-08 https://evidence-hub.com/study/68561-assessment-of-knowledge-attitudes-and-practices-regarding-community2026-10-08 https://evidence-hub.com/study/68562-concurrent-klebsiella-pneumoniae-liver-abscess-and-infective2026-10-08 https://evidence-hub.com/study/68563-a-case-of-helicobacter-cinaedi-pleuritis-and-continuous-ambulatory2026-10-08 https://evidence-hub.com/study/68564-contarini-s-syndrome-in-a-covid-19-positive-patient-with-viral2026-10-08 https://evidence-hub.com/study/68565-positron-emission-tomography-computed-tomography-in-risk-factor2026-10-08 https://evidence-hub.com/study/68566-disseminated-nocardia-otitidiscaviarum-presenting-as-lung-brain-skin2026-10-08 https://evidence-hub.com/study/68567-mycoplasma-pneumonia-infection-complicated-with-haemolytic-anaemia2026-10-08 https://evidence-hub.com/study/68568-c63-52-intralobar-pulmonary-sequestration-presenting-as-recurrent2026-10-08 https://evidence-hub.com/study/68569-sequential-serratia-liquefaciens-and-serratia-odorifera-pneumonia-in2026-10-08 https://evidence-hub.com/study/68571-challenging-management-of-postoperative-empyema-a-case-report-with2026-10-08 https://evidence-hub.com/study/68572-critical-role-of-multiplex-pcr-in-diagnosing-legionella-sars-cov-2-co2026-10-08 https://evidence-hub.com/study/68573-legionnaires-disease-with-neurological-manifestations-case-report2026-10-08 https://evidence-hub.com/study/68574-the-role-of-therapeutic-plasma-exchange-using-membrane-plasma2026-10-08 https://evidence-hub.com/study/68575-suspected-triple-co-infection-with-sars-cov-2-legionella-pneumophila2026-10-08 https://evidence-hub.com/study/68576-c57-08-a-rare-case-of-legionella-longbeachae-pneumonia-linked-to2026-10-08 https://evidence-hub.com/study/68577-diagnosis-and-management-of-pneumocystis-carinii-pneumonia-pcp-in-hiv2026-10-08 https://evidence-hub.com/study/68578-c50-31-extracorporeal-life-support-for-severe-adenovirus-pneumonia2026-10-08 https://evidence-hub.com/study/68579-a49-18-atypical-presentation-of-legionella-pneumonia-masquerading-as2026-10-08 https://evidence-hub.com/study/68580-p18-a-case-of-rhabdomyolysis-induced-by-clarithromycin2026-10-08 https://evidence-hub.com/study/68581-b71-11-hot-tub-pneumonia2026-10-08 https://evidence-hub.com/study/68582-invasive-candida-infection-as-the-cause-of-seizure-in-a-patient-with2026-10-08 https://evidence-hub.com/study/68583-narrative-review-evaluasi-penggunaan-antibiotika-empiris-pada-pasien2026-10-08 https://evidence-hub.com/study/68584-short-course-versus-standard-course-antibiotic-therapy-for-pneumonia2026-10-08 https://evidence-hub.com/study/68585-doxycycline-for-macrolide-resistant-mycoplasma-pneumoniae-pneumonia2026-10-08 https://evidence-hub.com/study/68586-fatal-septic-shock-due-to-pvl-positive-staphylococcus-aureus2026-10-08 https://evidence-hub.com/study/68587-pentasystem-embolism-associated-with-transient-antiphospholipid2026-10-08 https://evidence-hub.com/study/68588-beyond-the-m-spike-immunoparesis-and-multiple-myeloma-a-narrative2026-10-08 https://evidence-hub.com/study/68589-stenotrophomonas-maltophilia-meningitis-in-the-children-age-group-a2026-10-08 https://evidence-hub.com/study/68590-fosfomycin-as-an-adjunctive-agent-against-carbapenem-resistant2026-10-08 https://evidence-hub.com/study/68591-mycoplasma-pneumoniae-infection-an-updated-narrative-review2026-10-08 https://evidence-hub.com/study/68592-the-comprehensive-systematic-review-of-association-of-qt-prolonging2026-10-08 https://evidence-hub.com/study/68593-legionelloses-caused-by-non-pneumophila-legionella-species-and-their2026-10-08 https://evidence-hub.com/study/68594-role-of-efflux-pump-genes-in-antibiotic-resistance-of-klebsiella2026-10-08 https://evidence-hub.com/study/68595-a-systematic-review-and-meta-analysis-of-the-efficacy-and-safety-of2026-10-13 https://evidence-hub.com/study/68596-antibiotic-resistance-in-saudi-arabia-a-systematic-review-of-the-past2026-10-08 https://evidence-hub.com/study/68597-safety-and-tolerability-of-moxifloxacin-in-pediatric-population-a2026-10-08 https://evidence-hub.com/study/68598-unraveling-the-global-landscape-of-elizabethkingia-antibiotic2026-10-08 https://evidence-hub.com/study/68599-the-prevalence-risk-factors-and-drug-resistance-profiles-of2026-10-08 https://evidence-hub.com/study/68600-h-pylori-treatment-in-a-resistant-world-regional-strategies-for2026-10-08 https://evidence-hub.com/study/68601-narrative-review-of-lactam-resistance-in-key-bacterial-pathogens2026-10-08 https://evidence-hub.com/study/68602-antimicrobial-resistance-pollution-in-waters-of-pakistan-a-narrative2026-10-08 https://evidence-hub.com/study/68603-a-systematic-review-and-network-meta-analysis-of-empirical2026-10-13 https://evidence-hub.com/study/68604-the-role-of-therapeutic-drug-monitoring-tdm-by-clinical-pharmacists2026-10-08 https://evidence-hub.com/study/68605-efficacy-and-mechanisms-of-andrographolide-derivative-in-acute2026-10-06 https://evidence-hub.com/study/68606-rapid-raman-spectroscopy-based-test-for-antimicrobial-resistance2026-10-06 https://evidence-hub.com/study/68607-results-from-the-survey-of-antibiotic-resistance-soar-2018-21-in2026-10-06 https://evidence-hub.com/study/68608-isolation-and-characterization-of-lytic-bacteriophage-vb-kpnp-23-a2026-10-06 https://evidence-hub.com/study/68609-trends-and-patterns-of-antibiotics-use-in-serbia-from-2006-to-20212026-10-06 https://evidence-hub.com/study/68610-potential-application-of-maldi-tof-ms-to-identify-streptococcus2026-10-06 https://evidence-hub.com/study/68611-overview-and-resistance-profiles-of-isolated-pathogens-in-women-with2026-10-20 https://evidence-hub.com/study/68612-antimicrobial-susceptibilities-of-clinical-bacterial-isolates-from2026-10-13 https://evidence-hub.com/study/68613-exploring-new-delhi-metallo-beta-lactamases-in-klebsiella-pneumoniae2026-10-06 https://evidence-hub.com/study/68614-prevalence-of-and-risk-factors-for-antimicrobial-resistance-in2026-10-06 https://evidence-hub.com/study/68615-double-blakpc-2-copies-quadrupled-minimum-inhibitory-concentration-of2026-10-06 https://evidence-hub.com/study/68616-emergence-and-regional-spread-of-extended-spectrum-lactamase2026-10-06 https://evidence-hub.com/study/68617-clinical-and-epidemiological-characteristics-of-multi-drug-resistant2026-10-06 https://evidence-hub.com/study/68618-ofatumumab-associated-legionella-pneumonia-in-a-young-multiple2026-10-08 https://evidence-hub.com/study/68619-intersecting-pathologies-a-unique-case-of-usual-interstitial2026-10-08 https://evidence-hub.com/study/68621-therapeutic-challenges-of-concurrent-pneumonia-and-disease-flare-in-a2026-10-08 https://evidence-hub.com/study/68622-adolescent-pneumococcal-pneumonia-with-pleural-effusion-in-developing2026-10-08 https://evidence-hub.com/study/68623-role-of-nemonoxacin-as-a-therapeutic-option-for-community-acquired2026-10-08 https://evidence-hub.com/study/68624-acquired-fanconi-syndrome-in-the-setting-of-legionella-pneumonia2026-10-08 https://evidence-hub.com/study/68625-study-of-delirium-type-symptoms-caused-by-levofloxacin-in-mice2026-10-08 https://evidence-hub.com/study/68626-determination-of-embryotoxic-effects-of-levofloxacin-exposure-by-the2026-10-08 https://evidence-hub.com/study/68627-evaluation-of-the-protective-effect-of-cannabidiol-against2026-10-08 https://evidence-hub.com/study/68628-fluoroquinolone-antimicrobial-agent-levofloxacin-in-veterinary2026-10-08 https://evidence-hub.com/study/68629-enhanced-antibacterial-efficacy-and-topical-performance-of-a2026-10-08 https://evidence-hub.com/study/68630-experimental-evaluation-of-levofloxacin-efficacy-against-multidrug2026-10-08 https://evidence-hub.com/study/68632-early-sitting-improves-the-accuracy-of-predicting-in-hospital2026-10-08 https://evidence-hub.com/study/68633-when-low-risk-pneumonia-is-not-low-risk-a-case-of-multisystem2026-10-08 https://evidence-hub.com/study/68634-antimicrobial-photodynamic-therapy-using-indocyanine-green-and2026-10-08 https://evidence-hub.com/study/68635-aspiration-pneumonia-patophysiology-diagnosis-and-treatment2026-10-08 https://evidence-hub.com/study/68637-the-effect-of-zingiber-officinale-var-rubrum-extract-on-il-6-cytokine2026-10-08 https://evidence-hub.com/study/68638-drug-resistance-and-pathogenicity-characteristics-of-escherichia-coli2026-10-08 https://evidence-hub.com/study/68639-role-of-antipseudomonal-antibiotics-in-older-patients-with-aspiration2026-10-08 https://evidence-hub.com/study/68640-aspiration-pneumonia-epidemiology-risk-factors-etiology-diagnosis2026-10-08 https://evidence-hub.com/study/68641-rapid-in-vitro-activity-of-telavancin-against-bacillus-anthracis-and2026-10-08 https://evidence-hub.com/study/68642-investigation-of-klebsiella-pneumonia-and-acinetobacter-baumannii2026-10-08 https://evidence-hub.com/study/68643-evaluation-of-inhaled-colistin-fosfomycin-as-an-adjunctive-treatment2026-10-08 https://evidence-hub.com/study/68644-a-case-report-of-integrated-traditional-chinese-and-western-medicine2026-10-08 https://evidence-hub.com/study/68645-coexisting-autoimmune-haemolysis-and-pneumocystis-jirovecii-pneumonia2026-10-08 https://evidence-hub.com/study/68646-the-difluoroboranyl-fluoroquinolone-derivative-7a-inhibits-bacterial2026-10-08 https://evidence-hub.com/study/68647-fatal-necrotising-pneumonia-by-exfolative-toxin-ete2-producing2026-10-04 https://evidence-hub.com/study/68648-anti-inflammatory-efficacy-of-nsaids-and-their-combinations-with2026-10-08 https://evidence-hub.com/study/68649-differential-modulation-of-macrophage-polarization-and-nf-b-signaling2026-10-08 https://evidence-hub.com/study/68650-case-report-fatal-necrotizing-pneumonia-by-exfoliative-toxin-ete22026-10-08 https://evidence-hub.com/study/68651-tryptophan-substituted-antimicrobial-peptide-temporin-1ceb-in-vitro2026-10-08 https://evidence-hub.com/study/68652-antimicrobial-resistance-and-comparative-genome-analysis-of-high-risk2026-10-08 https://evidence-hub.com/study/68653-nursing-management-and-clinical-outcomes-of-aspiration-pneumonia-in2026-10-08 https://evidence-hub.com/study/68654-treatment-of-infection-caused-by-animal-commensal-pathogen2026-10-08 https://evidence-hub.com/study/68655-in-vitro-antibacterial-effect-of-reduning-combined-with-polymyxin-on2026-10-06 https://evidence-hub.com/study/68656-bacterial-etiology-antimicrobial-susceptibility-and-clinical-outcomes2026-10-06 https://evidence-hub.com/study/68657-effects-of-clinically-achievable-pulmonary-antibiotic-concentrations2026-10-06 https://evidence-hub.com/study/68658-tazobactam-ceftolozane-taz-ctlz-and-relebactam-imipenem-rel-ipm2026-10-06 https://evidence-hub.com/study/68659-in-vitro-interaction-study-of-levofloxacin-with-metformin-hcl-and2026-10-08 https://evidence-hub.com/study/68660-levofloxacin-combined-with-azithromycin-shows-greater-efficacy-in2026-10-08 https://evidence-hub.com/study/68661-levofloxacin-adsorption-and-release-on-mesoporous-alumina2026-10-08 https://evidence-hub.com/study/68662-crystal-structure-and-hirshfeld-surface-analysis-of-anhydrous-salt-of2026-10-08 https://evidence-hub.com/study/68663-p-1182-in-vitro-activity-of-omadacycline-and-comparator-agents2026-10-08 https://evidence-hub.com/study/68664-p-1320-antimicrobial-susceptibility-of-s-maltophilia-and-b-cepacia2026-10-08 https://evidence-hub.com/study/68665-synthesis-and-characterization-of-cellulose-based-hydrogel-films-for2026-10-08 https://evidence-hub.com/study/68666-perbandingan-efektivitas-regimen-antibiotik-levofloxacin-based-dan2026-10-08 https://evidence-hub.com/study/68667-high-performance-liquid-chromatography-method-for-the-determination2026-10-08 https://evidence-hub.com/study/68669-current-treatment-options-for-pneumonia-caused-by-carbapenem2026-10-08 https://evidence-hub.com/study/68670-the-role-of-syndromic-testing-in-pneumonia-diagnosis-a-comparison2026-10-08 https://evidence-hub.com/study/68671-efficacy-and-safety-of-nemonoxacin-injection-in-the-treatment-of2026-10-08 https://evidence-hub.com/study/68672-in-vitro-activity-of-delafloxacin-against-corynebacterium-spp2026-10-08 https://evidence-hub.com/study/68673-clinical-trial-landscape-for-pneumonia-evolving-agents-against2026-10-08 https://evidence-hub.com/study/68674-analysis-of-anti-infective-therapy-in-a-challenging-case-of-brainstem2026-10-08 https://evidence-hub.com/study/68675-p-1100-activity-of-cefiderocol-and-comparator-agents-against-global2026-10-08 https://evidence-hub.com/study/68676-characterization-of-chitosan-and-cyclodextrin-modified-forms-of2026-10-08 https://evidence-hub.com/study/68677-p-1083-antimicrobial-activity-of-aztreonam-avibactam-and-comparator2026-10-08 https://evidence-hub.com/study/68678-an-in-silico-drug-repurposing-study-to-inhibit-the-spike-protein-of2026-10-08 https://evidence-hub.com/study/68679-insights-into-the-toxic-effects-of-moxifloxacin-in-allium-cepa2026-10-08 https://evidence-hub.com/study/68680-identification-of-resistance-modifying-agents-from-pteris-vittata-l2026-10-08 https://evidence-hub.com/study/68681-in-silico-screening-of-phenolic-compounds-as-potential-inhibitors-of2026-10-08 https://evidence-hub.com/study/68682-in-silico-identification-and-characterization-of-drug-targets-in2026-10-08 https://evidence-hub.com/study/68683-in-silico-mutational-analysis-of-two-component-system-genes2026-10-08 https://evidence-hub.com/study/68684-efficacy-and-influencing-factors-of-piperacillin-sodium-tazobactam2026-10-08 https://evidence-hub.com/study/68685-synthesis-and-in-silico-pharmacokinetics-of-some-sulfone2026-10-08 https://evidence-hub.com/study/68686-evaluation-of-the-anti-biofilm-activity-of-vitamins-against2026-10-08 https://evidence-hub.com/study/68687-pharmacokinetics-of-intravenous-ciprofloxacin-for-legionella2026-10-08 https://evidence-hub.com/study/68688-study-for-possible-synergism-of-bio-produced-silver-nanoparticles2026-10-08 https://evidence-hub.com/study/68689-molecular-biofilm-and-motility-characterization-of-acinetobacter2026-10-08 https://evidence-hub.com/study/68690-genomic-insights-into-st85-and-st158-belonging-to-recently-emerged2026-10-08 https://evidence-hub.com/study/68691-profil-terapi-dan-evaluasi-peresepan-pasien-covid-19-rawat-inap-di2026-10-08 https://evidence-hub.com/study/68692-dna-targeting-mononuclear-ni-ii-and-cu-ii-metallocarboxylates-of-2-32026-10-08 https://evidence-hub.com/study/68693-correlation-between-the-exou-exos-genotype-biofilm-formation-and2026-10-13 https://evidence-hub.com/study/68694-research-progress-of-houttuynia-cordata-on-drug-resistant-bacteria-in2026-10-08 https://evidence-hub.com/study/68695-characterization-of-genetic-context-of-blakpc-in-pseudomonas2026-10-08 https://evidence-hub.com/study/68696-genomic-epidemiology-of-carbapenem-resistant-acinetobacter-baumannii2026-10-04 https://evidence-hub.com/study/68697-ml-driven-in-vitro-remodeling-of-alveolar-macrophage-profiles-from2026-10-04 https://evidence-hub.com/study/68698-ai-driven-secondary-immunomodulatory-effects-of-conventional-drugs-on2026-10-08 https://evidence-hub.com/study/68699-a-importancia-das-quinolonas-perspetivas-futuras-e-os-desafios-da2026-10-08 https://evidence-hub.com/study/68700-analysis-of-composition-and-antimicrobial-activity-of-pomegranate2026-10-08 https://evidence-hub.com/study/68701-in-vitro-microbiological-evaluation-of-gemifloxacin-derivatives2026-10-08 https://evidence-hub.com/study/68702-regional-features-of-the-circulation-of-micro-organisms-of2026-10-08 https://evidence-hub.com/study/68703-genomic-characterization-of-multidrug-resistant-escherichia-coli2026-10-13 https://evidence-hub.com/study/68704-carbapenem-resistant-acinetobacter-baumannii-from-jordan-complicated2026-10-08 https://evidence-hub.com/study/68705-the-application-arbutin-in-elimination-resistance-of-antibiotics2026-10-08 https://evidence-hub.com/study/68706-evaluation-of-chitosan-activity-produced-via-biotransformation-of2026-10-08 https://evidence-hub.com/study/68707-novel-1-3-4-oxadiazolyltriazole-derived-phthalazine-scaffolds-design2026-10-08 https://evidence-hub.com/study/68708-prevalence-of-chlorquinolone-and-cephalosporin-resistant-escherichia2026-10-08 https://evidence-hub.com/study/68709-norfloxacin-derivative-with-carbazole-at-c-7-fqb-1-induces-cytotoxic2026-10-08 https://evidence-hub.com/study/68710-first-genomic-report-of-epidemic-super-lineage-clade-2-5-62026-10-08 https://evidence-hub.com/study/68711-bronchoscope-an-important-and-easily-overlooked-vector-of-clinical2026-10-08 https://evidence-hub.com/study/68712-emerging-pathogens-in-urinary-tract-infections-virulence-and2026-10-20 https://evidence-hub.com/study/68713-development-of-inhalable-extra-fine-particles-of-vancomycin-for-the2026-10-08 https://evidence-hub.com/study/68778-levofloxacin-determination-in-urine-by-photoluminescence2026-10-05 https://evidence-hub.com/study/68779-photocatalytic-degradation-of-levofloxacin-and-inactivation-of2026-10-05 https://evidence-hub.com/study/68793-antibiotic-exposure-and-drug-induced-intracranial-hypertension-a2026-10-06 https://evidence-hub.com/study/68795-comparison-of-keverprazan-based-versus-esomeprazole-based-dual2026-10-16 https://evidence-hub.com/study/68796-health-system-and-household-costs-of-preventive-treatment-delivery2026-10-06 https://evidence-hub.com/study/68797-ai-assisted-tailored-intervention-for-nurse-burnout-a-three-group2026-10-13 https://evidence-hub.com/study/68798-reflective-mindfulness-and-emotional-regulation-training-to-enhance2026-10-13 https://evidence-hub.com/study/68799-real-time-continuous-glucose-monitoring-in-pregnancies-with2026-10-13 https://evidence-hub.com/study/68800-safety-and-effectiveness-of-dual-therapy-for-helicobacter-pylori2026-10-06 https://evidence-hub.com/study/68801-trabeculectomy-versus-stepwise-treatment-for-breaking-the-attack-of2026-10-06 https://evidence-hub.com/study/68802-protocol-for-a-randomised-screen-and-treat-helicobacter-pylori2026-10-13 https://evidence-hub.com/study/68803-completion-of-tuberculosis-preventive-treatment-with-300-mg-vs-100-mg2026-10-06 https://evidence-hub.com/study/68804-non-inferiority-stepped-wedge-cluster-randomized-controlled-trial-on2026-10-06 https://evidence-hub.com/study/68805-fluoroquinolones-and-rifampin-combination-in-the-backdrop-of2026-10-06 https://evidence-hub.com/study/68806-antimicrobial-resistance-profiles-of-bacterial-pathogens-from-feline2026-10-13 https://evidence-hub.com/study/68807-eravacycline-cefiderocol-combination-therapy-for-carbapenem-resistant2026-10-06 https://evidence-hub.com/study/68808-management-of-acute-myeloid-leukemia-in-older-patients-an-updated2026-10-06 https://evidence-hub.com/study/68809-population-structure-of-helicobacter-pylori-and-antibiotic-resistance2026-10-06 https://evidence-hub.com/study/68810-hemorrhagic-risk-of-concomitant-direct-oral-anticoagulants-and2026-10-06 https://evidence-hub.com/study/68811-blood-culture-positive-sepsis-and-sensitivity-pattern-in-nicu-at-a2026-10-06 https://evidence-hub.com/study/68812-pregnant-women-with-multidrug-resistant-rifampicin-resistant2026-10-06 https://evidence-hub.com/study/68813-unveiling-the-association-between-fluoroquinolones-and-aortic2026-10-06 https://evidence-hub.com/study/68814-insulin-resistance-quantified-by-estimated-glucose-disposal-rate2026-10-06 https://evidence-hub.com/study/68815-semaglutide-therapy-and-accelerated-sarcopenia-in-older-adults-with2026-10-13 https://evidence-hub.com/study/68816-night-and-shift-work-and-incidence-of-physician-diagnosed-sleep2026-10-13 https://evidence-hub.com/study/68817-epidemiological-and-clinical-features-of-mpox-during-the-clade-ib2026-10-13 https://evidence-hub.com/study/68818-change-in-urine-albumin-creatinine-ratio-and-occurrence-of2026-10-13 https://evidence-hub.com/study/68819-long-covid-associated-with-sars-cov-2-reinfection-among-children-and2026-10-06 https://evidence-hub.com/study/68820-remnant-cholesterol-plasma-triglycerides-and-risk-of-cardiovascular2026-10-13 https://evidence-hub.com/study/68821-burden-of-rsv-infections-among-young-children-in-primary-care-a2026-10-08 https://evidence-hub.com/study/68822-impact-of-time-in-tight-range-on-all-cause-and-cardiovascular2026-10-08 https://evidence-hub.com/study/68823-association-between-cardiovascular-kidney-metabolic-syndrome2026-10-13 https://evidence-hub.com/study/68824-nationwide-cohort-study-of-primary-open-angle-glaucoma-risk-and2026-10-08 https://evidence-hub.com/study/68825-summary-of-the-clinical-characteristics-of-tuberculous-otitis-media2026-10-06 https://evidence-hub.com/study/68826-multidrug-resistant-acinetobacter-spp-bloodstream-infections-in2026-10-06 https://evidence-hub.com/study/68827-a25-14-acute-pulmonary-hemorrhage-in-a-neutropenic-patient2026-10-06 https://evidence-hub.com/study/68828-po-25-081-atypical-onset-of-anti-sae-1-positive-dermatomyositis2026-10-13 https://evidence-hub.com/study/68829-factors-associated-with-methicillin-resistance-in-staphylococcus2026-10-06 https://evidence-hub.com/study/68830-atypical-bulbar-myasthenia-gravis-in-an-elderly-male-unmasked-by2026-10-06 https://evidence-hub.com/study/68831-safeguarding-the-heart-nigella-sativa-black-seed-oil-mitigates2026-10-06 https://evidence-hub.com/study/68832-a-case-of-hepatic-splenic-abscess-in-a-non-endemic-area-of2026-10-06 https://evidence-hub.com/study/68833-ciprofloxacin-induced-encephalopathy2026-10-06 https://evidence-hub.com/study/68834-positive-murphy-s-sign-of-fitz-hugh-curtis-syndrome2026-10-06 https://evidence-hub.com/study/68835-ischemic-colitis-induced-by-a-platelet-raising-capsule-a-case-report2026-10-06 https://evidence-hub.com/study/68836-a-case-of-pott-s-disease-complicated-by-tuberculous-meningitis-and2026-10-13 https://evidence-hub.com/study/68837-a-late-onset-hyperammonemia-syndrome-caused-by-ureaplasma-parvum2026-10-06 https://evidence-hub.com/study/68838-isolation-and-identification-of-morganella-morganii-from-rhesus2026-10-06 https://evidence-hub.com/study/68839-mucosal-infection-with-tsukamurella-species-following-nasal-septum2026-10-06 https://evidence-hub.com/study/68840-infectious-costochondritis-with-sternal-osteomyelitis2026-10-06 https://evidence-hub.com/study/68841-role-of-follow-up-gallium-scintigraphy-in-the-evaluation-of-malignant2026-10-06 https://evidence-hub.com/study/68842-prostatic-abscess-by-morganella-morganii2026-10-06 https://evidence-hub.com/study/68843-clinical-management-of-herpes-zoster-complicated-by-mrsa-infection2026-10-06 https://evidence-hub.com/study/68844-psoas-abscess-from-spinal-tuberculosis-mimicking-appendicitis-a-case2026-10-06 https://evidence-hub.com/study/68845-infantile-bacterial-meningitis-combined-with-sepsis-caused-by2026-10-06 https://evidence-hub.com/study/68846-looking-beyond-the-surface-a-case-of-shigella-enterocolitis-in-a2026-10-06 https://evidence-hub.com/study/68847-chronic-post-operative-endophthalmitis-caused-by-acinetobacter2026-10-06 https://evidence-hub.com/study/68848-rhodococcus-equi-and-brucella-pulmonary-mass-in-immunocompetent-a2026-10-06 https://evidence-hub.com/study/68849-case-report-a-pharmacist-led-precision-therapy-framework-for-managing2026-10-06 https://evidence-hub.com/study/68850-a-case-of-persistent-pasteurella-multocida-cellulitis-complicated2026-10-06 https://evidence-hub.com/study/68851-a-case-of-problem-free-survival-five-years-after-abdominal-aortic2026-10-06 https://evidence-hub.com/study/68852-case-report-bilateral-adrenal-hemorrhage-and-hemophagocytosis-in-the2026-10-13 https://evidence-hub.com/study/68853-brucella-orchitis-a-case-report-on-a-rare-cause-of-scrotal-abscess2026-10-06 https://evidence-hub.com/study/68854-pseudomonas-keratitis-from-diagnosis-to-successful-deep-anterior2026-10-06 https://evidence-hub.com/study/68855-disseminated-bcg-infection-in-a-child-with-multifocal-osteomyelitis2026-10-06 https://evidence-hub.com/study/68856-recurrent-paradoxical-reactions-as-non-communicating-hydrocephalus2026-10-06 https://evidence-hub.com/study/68857-levofloxacin-induced-rupture-of-the-long-head-of-the-biceps-tendon-a2026-10-13 https://evidence-hub.com/study/68861-integrated-herbal-medicine-treatment-for-acute-pyelonephritis-a-case2026-10-06 https://evidence-hub.com/study/68862-iga-nephropathy-with-crescent-cell-lesions-in-a-human-brucellosis2026-10-06 https://evidence-hub.com/study/68863-a-novel-information-technology-in-management-of-neuro-infection-after2026-10-06 https://evidence-hub.com/study/68864-drug-eruption-and-hepatitis-induced-by-antituberculosis-therapy-a2026-10-06 https://evidence-hub.com/study/68865-prolonged-culture-negativity-in-infective-endocarditis-following2026-10-06 https://evidence-hub.com/study/68866-persistent-intestinal-myiasis-caused-by-oestrus-ovis-in-a-nigerian2026-10-06 https://evidence-hub.com/study/68867-refractory-granulomatous-lobular-mastitis-associated-with-subpectoral2026-10-06 https://evidence-hub.com/study/68868-deadly-diarrhea-caused-by-co-infection-of-clostridium-perfringens2026-10-06 https://evidence-hub.com/study/68869-solobacterium-moorei-sepsis-secondary-to-flexor-tenosynovitis-a-case2026-10-06 https://evidence-hub.com/study/68870-blue-ear-drum-as-an-unusual-adverse-effect-of-adalimumab-a-case-report2026-10-06 https://evidence-hub.com/study/68871-case-report-pediatric-pontine-abscess-and-ecthyma-gangrenosum-due-to2026-10-06 https://evidence-hub.com/study/68872-a-rare-and-complex-overlap-of-toxic-epidermal-necrolysis-ten-and-drug2026-10-06 https://evidence-hub.com/study/68873-delftia-acidovorans-isolated-from-pus-sample-in-hospitalized-patient2026-10-06 https://evidence-hub.com/study/68874-exploring-the-connection-between-hidradenitis-suppurativa-and2026-10-06 https://evidence-hub.com/study/68875-helicobacter-pylori-and-the-human-gastrointestinal-microbiota-a2026-10-06 https://evidence-hub.com/study/68876-preanalytical-stability-of-13-antibiotics-in-biological-samples-a2026-10-06 https://evidence-hub.com/study/68877-cerebrospinal-fluid-analysis-in-tuberculous-meningitis-a-literature2026-10-06 https://evidence-hub.com/study/68878-molecular-tools-of-antibiotic-resistance-for-helicobacter-pylori-an2026-10-06 https://evidence-hub.com/study/68879-schematic-portfolio-of-potent-anti-microbial-scaffolds-targeting-dna2026-10-06 https://evidence-hub.com/study/68880-quinoline-analogs-multifaceted-heterocyclic-compounds-with-varied2026-10-06 https://evidence-hub.com/study/68881-recommendations-and-adjuvant-therapies-to-mitigate-clarithromycin2026-10-06 https://evidence-hub.com/study/68882-topical-formulations-containing-mentha-piperita-for-wound-healing-a2026-10-06 https://evidence-hub.com/study/68883-lc-enantioseparation-of-active-pharmaceutical-ingredients-using2026-10-06 https://evidence-hub.com/study/68884-flavonoids-as-potential-therapeutic-agents-against-gastrointestinal2026-10-06 https://evidence-hub.com/study/68885-defects-rich-ru-doped-black-tio2-nanotube-arrays-for2026-10-06 https://evidence-hub.com/study/68886-waste-biomass-based-sodium-lignosulfonate-chitosan-polyvinyl-alcohol2026-10-06 https://evidence-hub.com/study/68887-synergistic-adsorption-mechanisms-of-self-n-doped-biochar-for2026-10-06 https://evidence-hub.com/study/68888-mechanically-improved-chitosan-graphene-oxide-nanocomposite-hydrogel2026-10-06 https://evidence-hub.com/study/68889-low-valent-cu-doping-optimizes-ruddlesden-popper-perovskite-for2026-10-06 https://evidence-hub.com/study/68891-levofloxacin-synergistic-capture-using-a-memory-effect-layered-double2026-10-06 https://evidence-hub.com/study/68892-electrochemical-sensor-using-zno-mwcnts-modified-carbon-paste2026-10-06 https://evidence-hub.com/study/68893-thermoresponsive-in-situ-forming-and-self-healing-double-network2026-10-06 https://evidence-hub.com/study/68895-cyclodextrin-carbon-dots-grafted-cellulose-nanofibrils-hydrogel-for2026-10-06 https://evidence-hub.com/study/68896-effect-of-mnfe2o4-loading-on-photocatalytic-performance-of-bivo4-for2026-10-06 https://evidence-hub.com/study/68897-synthesis-and-characterization-of-core-shell-mussel-inspired-magnetic2026-10-06 https://evidence-hub.com/study/68898-performance-and-mechanism-of-cufe2o4-2d-v-to-activate-persulfate-for2026-10-06 https://evidence-hub.com/study/68899-pharmacological-evaluation-of-levofloxacin-residue-depletion-and2026-10-06 https://evidence-hub.com/study/68900-comparative-safety-profile-of-levofloxacin-versus-moxifloxacin-in2026-10-06 https://evidence-hub.com/study/68901-yolk-shell-cofe2o4-hollow-mesoporous-carbon-spheres-for-levofloxacin2026-10-06 https://evidence-hub.com/study/68902-enhancing-treatment-performance-of-chlorella-pyrenoidosa-on2026-10-06 https://evidence-hub.com/study/68903-cu2o-wo3-s-scheme-heterojunctions-for-photocatalytic-degradation-of2026-10-05 https://evidence-hub.com/study/68904-ingenious-construction-of-a-magnetic-recyclable-photo-fenton-catalyst2026-10-06 https://evidence-hub.com/study/68905-citric-acid-modulated-strong-magnetic-cofe-ldh-cofe2o4-coupled2026-10-06 https://evidence-hub.com/study/68906-a-novel-molecularly-imprinted-electrochemical-sensor-from-poly-3-42026-10-06 https://evidence-hub.com/study/68907-ultra-sensitive-electrochemical-detection-of-levofloxacin-using-a2026-10-06 https://evidence-hub.com/study/68908-mallotus-philippensis-extract-infused-locust-bean-gum-based-ternary2026-10-06 https://evidence-hub.com/study/68909-waste-to-resource-utilization-of-carbon-dots-derived-from2026-10-06 https://evidence-hub.com/study/68910-comprehensive-toxicity-assessment-of-selected-pharmaceuticals2026-10-06 https://evidence-hub.com/study/68911-dual-emission-nitrogen-doped-carbon-dots-for-ratiometric-and2026-10-06 https://evidence-hub.com/study/68912-an-18-connected-wheel-shaped-molybdenum-v-nickel-phosphate-cluster2026-10-06 https://evidence-hub.com/study/68913-surgical-repair-of-bilateral-achilles-tendon-rupture-following2026-10-13 https://evidence-hub.com/study/68914-interfacial-engineering-mediated-s-scheme-heterojunction-with-dual2026-10-06 https://evidence-hub.com/study/68915-novel-europium-grafted-3d-covalent-organic-framework-for-selective2026-10-06 https://evidence-hub.com/study/68917-development-and-validation-of-an-lc-ms-ms-multiplex-assay-for-the2026-10-06 https://evidence-hub.com/study/68918-synthesis-characterization-and-optimization-of-cellulose-based2026-10-06 https://evidence-hub.com/study/68920-acceptability-of-a-250-mg-levofloxacin-formulation-in-children2026-10-06 https://evidence-hub.com/study/68921-preparation-of-fe-zn-mofs-by-microwave-assisted-ball-milling-and2026-10-06 https://evidence-hub.com/study/68922-development-of-a-mof-based-dual-channel-levofloxacin-probe-and-its2026-10-06 https://evidence-hub.com/study/68923-electrosprayed-co-crystals-of-levofloxacin-for-inhalation-a-strategy2026-10-06 https://evidence-hub.com/study/68924-fabrication-of-levofloxacin-loaded-ph-sensitive-eudragit-polymeric2026-10-06 https://evidence-hub.com/study/68925-metabolic-modulation-by-antibiotic-levofloxacin-alters-cis-bifenthrin2026-10-06 https://evidence-hub.com/study/68928-genetic-determinants-and-clonal-composition-of-levofloxacin-resistant2026-10-06 https://evidence-hub.com/study/68929-drought-exacerbates-levofloxacin-phytotoxicity-insights-from2026-10-06 https://evidence-hub.com/study/68931-vitamin-b6-cofactor-derived-aiee-active-luminogen-for-detecting2026-10-06 https://evidence-hub.com/study/68932-fluoroquinolone-resistance-in-campylobacter-isolates-from-broiler2026-10-04 https://evidence-hub.com/study/68933-examining-hypoglycemia-risk-with-systemic-fluoroquinolone-use-a2026-10-05 https://evidence-hub.com/study/68934-antibiotic-prophylaxis-in-metabolic-and-bariatric-surgery-a2026-10-05 https://evidence-hub.com/study/68935-a-review-on-prevalence-and-genetic-elements-associated-with2026-10-05 https://evidence-hub.com/study/68936-high-dose-dual-therapy-versus-bismuth-quadruple-therapy-for-rescue2026-10-16 https://evidence-hub.com/study/68937-antitubercular-treatment-induced-psychosis-a-systematic-review-and2026-10-05 https://evidence-hub.com/study/68938-a-systematic-review-on-helicobacter-pylori-antimicrobial-resistance2026-10-05 https://evidence-hub.com/study/68939-sample-preparation-approaches-for-determination-of-quinolones-in2026-10-08 https://evidence-hub.com/study/68941-burden-clinical-impact-and-primary-antimicrobial-resistance-profiles2026-10-08 https://evidence-hub.com/study/68942-diagnostic-yield-of-nine-user-friendly-bioinformatics-tools-for2026-10-05 https://evidence-hub.com/study/68943-antimicrobial-resistance-patterns-of-helicobacter-pylori-in-thailand2026-10-05 https://evidence-hub.com/study/68945-bloodstream-infections-in-the-neonatal-intensive-care-unit-a2026-10-05 https://evidence-hub.com/study/68946-systematic-review-and-meta-analysis-bismuth-enhances-the-efficacy-for2026-10-05 https://evidence-hub.com/study/68948-levofloxacin-ameliorates-atherosclerosis-by-regulating-lipid2026-10-05 https://evidence-hub.com/study/68949-formulation-in-vitro-evaluation-and-animal-study-of-levofloxacin2026-10-05 https://evidence-hub.com/study/68950-adsorption-of-levofloxacin-from-aqueous-solutions-using-barley-husks2026-10-04 https://evidence-hub.com/study/68951-magnesium-orotate-influence-on-thoracic-aorta-in-laboratory-rabbits2026-10-05 https://evidence-hub.com/study/68952-effect-of-cyclodextrin-complexes-with-chitosan-and-levofloxacin-on2026-10-05 https://evidence-hub.com/study/68953-linezolid-and-levofloxacin-an-uncommon-pairing-that-suppresses2026-10-08 https://evidence-hub.com/study/68954-bicarinalin-enhances-the-antibacterial-activity-of-levofloxacin-and2026-10-05 https://evidence-hub.com/study/68955-nano-extract-of-epimedium-alpinum-preserves-testicular-histology2026-10-08 https://evidence-hub.com/study/68956-microbiological-study-of-wounds-and-large-intestine-of-sturgeons2026-10-04 https://evidence-hub.com/study/68957-effect-of-combined-treatment-with-levofloxacin-and-metformin-on2026-10-04 https://evidence-hub.com/study/68959-decreased-collagen-xii-expression-and-increased-reactive-oxygen2026-10-08 https://evidence-hub.com/study/68960-in-vitro-efficacy-of-poly-gamma-glutamic-acid-loaded-nano-formulation2026-10-04 https://evidence-hub.com/study/68962-hepatoprotective-role-of-naringin-against-levofloxacin-toxicity2026-10-05 https://evidence-hub.com/study/68963-hyaluronic-acid-functionalized-thermoresponsive-in-situ-gel-embedded2026-10-05 https://evidence-hub.com/study/68964-carbon-dots-derived-from-waste-fish-scale-for-enhanced-removal-of2026-10-04 https://evidence-hub.com/study/68968-formulation-of-lecithin-based-nanocapsules-of-levofloxacin-and-in2026-10-05 https://evidence-hub.com/study/68969-predictive-potential-of-pharmacokinetic-pharmacodynamic-parameters-in2026-10-05 https://evidence-hub.com/study/68971-design-characterization-and-in-vitro-evaluation-of-a-novel2026-10-04 https://evidence-hub.com/study/68972-formulation-and-evaluation-of-gastroretentive-floating-microspheres2026-10-05 https://evidence-hub.com/study/68973-levofloxacin-reducing-the-risk-of-pseudomonas-aeruginosa-resistance2026-10-04 https://evidence-hub.com/study/68974-formulation-and-evaluation-of-levofloxacin-ophtalmic-insitu-gel2026-10-05 https://evidence-hub.com/study/68975-formulation-optimisation-and-characterisation-of-a-novel-nanoparticle2026-10-05 https://evidence-hub.com/study/68976-comparative-study-of-efficacy-of-fenugreek-oil-and-levofloxacin2026-10-05 https://evidence-hub.com/study/68977-formulation-and-evaluation-of-aloe-vera-based-levofloxacin-gel-for2026-10-04 https://evidence-hub.com/study/68978-formulation-and-evaluation-of-cuo-enhanced-levofloxacin-nanoparticles2026-10-04 https://evidence-hub.com/study/68979-a-novel-in-situ-gel-based-nanoparticle-system-for-controlled-release2026-10-05 https://evidence-hub.com/study/68980-study-the-efficacy-of-mono-and-combination-therapy-of-amoxicillin-and2026-10-08 https://evidence-hub.com/study/68981-preparation-and-evaluation-of-anti-bacterial-ocular-insert-containing2026-10-05 https://evidence-hub.com/study/68982-synthesis-and-characterization-of-mgo-loaded-levofloxacin2026-10-04 https://evidence-hub.com/study/68984-mucolytic-core-shell-particles-to-boost-levofloxacin-penetration2026-10-05 https://evidence-hub.com/study/68985-design-development-and-characterization-of-gastroretentive-floating2026-10-05 https://evidence-hub.com/study/68986-formulation-characterization-and-enhanced-antibacterial-activity-of2026-10-04 https://evidence-hub.com/study/68987-synthesis-identification-and-molecular-docking-evaluation-of-novel2026-10-13 https://evidence-hub.com/study/68988-in-silico-molecular-docking-of-gatifloxacin-analogues-as2026-10-13 https://evidence-hub.com/study/68990-quinolinequinone-based-sulfonamide-bioisosteres-as-promising2026-10-04 https://evidence-hub.com/study/68991-identification-of-novel-inha-inhibitors-using-in-silico-screening2026-10-04 https://evidence-hub.com/study/68992-in-silico-repurposing-of-fluoxetine-targeting-the-mvfr-protein-of2026-10-04 https://evidence-hub.com/study/68993-down-the-resistance-road-an-exploration-of-the-evolution-and2026-10-08 https://evidence-hub.com/study/68994-combined-use-of-broad-spectrum-antibiotics-in-phthisiology2026-10-05 https://evidence-hub.com/study/68995-priorizacao-in-silico-de-moleculas-com-acao-sobre-m-tuberculosis2026-10-05 https://evidence-hub.com/study/68996-development-and-oecd-guided-experimental-validation-of-eigenvalue2026-10-04 https://evidence-hub.com/study/68997-novel-aromatic-sulfonimides-with-antidyslipidemic-activity-facile2026-10-04 https://evidence-hub.com/study/68998-in-silico-and-in-vitro-characterization-of-bacillus-p45-screening-for2026-10-04 https://evidence-hub.com/study/68999-investigation-and-prediction-of-aquatic-toxicity-of-organic-compounds2026-10-04 https://evidence-hub.com/study/69000-comparative-evaluation-of-the-anticancer-efficacy-of-fluoroquinolone2026-10-04 https://evidence-hub.com/study/69002-precipitation-inhibition-by-small-molecule-analogues-to-sustain-drug2026-10-08 https://evidence-hub.com/study/69003-antibiotic-sensitivity-resistance-pattern-of-hospital-acquired-blood2026-10-06 https://evidence-hub.com/study/69004-an-evaluation-of-multidrug-resistant-mdr-bacteria-in-patients-with2026-10-13 https://evidence-hub.com/study/69005-antimicrobial-susceptibility-and-serotype-distribution-of-pneumococci2026-10-06 https://evidence-hub.com/study/69006-burkholderia-cepacia-infection-in-children-a-clinical-analysis-of-162026-10-06 https://evidence-hub.com/study/69007-in-vitro-susceptibilities-of-gram-negative-bacteria-isolated-from2026-10-06 https://evidence-hub.com/study/69008-streptococcus-pneumoniae-serotype-distribution-antimicrobial2026-10-06 https://evidence-hub.com/study/69009-respiratory-hyperinfection-with-strongyloides-stercoralis-in-a2026-10-06 https://evidence-hub.com/study/69010-histoplasmosis-an-unusual-african-souvenir2026-10-06 https://evidence-hub.com/study/69011-e-cigarette-or-vaping-product-use-associated-lung-injury-evali-a2026-10-06 https://evidence-hub.com/study/69012-invasive-infections-of-aggregatibacter-actinobacillus2026-10-06 https://evidence-hub.com/study/69013-bronchobiliary-fistula-following-radiofrequency-ablation-for-liver2026-10-06 https://evidence-hub.com/study/69014-cerebrospinal-fluid-penetration-of-high-dose-daptomycin-in-suspected2026-10-06 https://evidence-hub.com/study/69015-severe-and-resistant-hypoglycemia-associated-with-concomitant2026-10-06 https://evidence-hub.com/study/69017-community-acquired-pneumonia-in-the-elderly-a-practical-guide-to2026-10-06 https://evidence-hub.com/study/69018-nosocomial-pneumonia-diagnostic-and-therapeutic-considerations2026-10-06 https://evidence-hub.com/study/69019-comparative-pharmacokinetics-and-pharmacodynamics-of-the-newer2026-10-06 https://evidence-hub.com/study/69020-strategies-to-control-antibiotic-resistance2026-10-06 https://evidence-hub.com/study/69021-what-is-the-role-of-fluoroquinolones-in-intensive-care2026-10-13 https://evidence-hub.com/study/69022-therapeutic-options-for-pneumococcal-pneumonia-in-turkey2026-10-06 https://evidence-hub.com/study/69023-pseudomonal-infections-in-patients-with-copd-epidemiology-and2026-10-06 https://evidence-hub.com/study/69024-bacteriological-evidence-of-antibiotic-failure-in-pneumococcal-lower2026-10-06 https://evidence-hub.com/study/69025-bacterial-infections-in-liver-cirrhosis2026-10-19 https://evidence-hub.com/study/69026-choice-of-antimicrobial-drug-for-infections-caused-by-chlamydia2026-10-06 https://evidence-hub.com/study/69027-systematic-review-on-prescribing-trends-of-antibiotics-in-community2026-10-04 https://evidence-hub.com/study/69028-lemierre-s-syndrome-under-the-disguise-of-covid-19-pneumonia-a-case2026-10-04 https://evidence-hub.com/study/69029-fluoroquinolones-versus-lactams-plus-macrolides-for-community2026-10-08 https://evidence-hub.com/study/69030-anaphylaxis-due-to-intravenous-levofloxacin-with-tolerance-to2026-10-06 https://evidence-hub.com/study/69031-intrapulmonary-pharmacodynamics-of-high-dose-levofloxacin-in-subjects2026-10-06 https://evidence-hub.com/study/69032-fluoroquinolone-resistance-determining-region-mutation-in2026-10-06 https://evidence-hub.com/study/69033-a-little-education-goes-a-long-way-decreasing-antibiotics-for2026-10-06 https://evidence-hub.com/study/69034-tigecycline-versus-levofloxacin-in-hospitalized-patients-with2026-10-08 https://evidence-hub.com/study/69035-high-dose-levofloxacin-short-courses-for-the-treatment-of-patients2026-10-04 https://evidence-hub.com/study/69036-macrolide-resistant-streptococcus-pneumoniae-in-community-acquired2026-10-08 https://evidence-hub.com/study/69037-randomized-comparative-study-of-levofloxacin-and-amoxicillin2026-10-04 https://evidence-hub.com/study/69038-evaluation-of-the-efficacy-of-combination-of-biapenem-and2026-10-20 https://evidence-hub.com/study/69043-community-acquired-pneumonia-patients-treated-with-high-dose-oral2026-10-04 https://evidence-hub.com/study/69052-modeling-the-hiv-epidemic-in-africa2026-10-06 https://evidence-hub.com/study/69053-eosinophilic-pneumonia-and-covid-19-vaccination2026-10-04 https://evidence-hub.com/study/69054-comparison-of-levofloxacin-l-and-cefotaxime-c-combined-with-ofloxacin2026-10-08 https://evidence-hub.com/study/69055-corticosteroid-therapy-combined-with-antibiotics-for-severe2026-10-08 https://evidence-hub.com/study/69057-comparative-study-of-the-disposition-of-levofloxacin-netilmicin-and2026-10-08 https://evidence-hub.com/study/69059-corrugated-surface-microparticles-with-chitosan-and-levofloxacin-for2026-10-04 https://evidence-hub.com/study/69061-comparing-the-protective-effects-of-ciprofloxacin-moxifloxacin-and2026-10-04 https://evidence-hub.com/study/69062-lung-tissue-distribution-after-intravenous-administration-of2026-10-08 https://evidence-hub.com/study/69063-title-effect-of-curcumin-and-ginger-on-adverse-effects-of2026-10-08 https://evidence-hub.com/study/69064-pharmacokinetics-and-tissue-residue-study-of-levofloxacin-following2026-10-08 https://evidence-hub.com/study/69065-the-anti-virulence-effect-of-sub-minimal-inhibitory-concentrations-of2026-10-04 https://evidence-hub.com/study/69066-ciprofloxacin-and-levofloxacin-adversely-affect-male-infertility2026-10-04 https://evidence-hub.com/study/69067-a-retrospective-analysis-of-probability-of-target-attainment-in2026-10-08 https://evidence-hub.com/study/69069-identifying-mutator-phenotypes-among-fluoroquinolone-resistant2026-10-06 https://evidence-hub.com/study/69070-antibacterial-antifungal-and-antiviral-activities-of-some-flavonoids2026-10-06 https://evidence-hub.com/study/69071-in-vitro-activity-of-dalbavancin-and-five-comparator-agents-against2026-10-06 https://evidence-hub.com/study/69072-comparative-activities-of-beta-lactam-antibiotics-and-quinolones-for2026-10-06 https://evidence-hub.com/study/69073-purification-of-pneumococcal-type-ii-topoisomerases-and-inhibition-by2026-10-06 https://evidence-hub.com/study/69074-in-vitro-activity-of-levofloxacin-against-lower-respiratory-tract2026-10-06 https://evidence-hub.com/study/69075-antibiotic-resistance-in-outpatient-urinary-isolates-final-results2026-10-13 https://evidence-hub.com/study/69076-fluoroquinolone-resistance-in-streptococcus-pneumoniae-in-united2026-10-06 https://evidence-hub.com/study/69077-in-vitro-comparative-activity-of-moxifloxacin-and-other2026-10-06 https://evidence-hub.com/study/69078-selected-mutations-by-nemonoxacin-and-fluoroquinolone-exposure-among2026-10-06 https://evidence-hub.com/study/69079-in-vitro-activity-of-fosfomycin-trometamol-and-other-oral-antibiotics2026-10-13 https://evidence-hub.com/study/69080-antimicrobial-resistance-and-serotype-distribution-of-streptococcus2026-10-06 https://evidence-hub.com/study/69081-in-vitro-activity-of-moxifloxacin-and-other-fluoroquinolones-against2026-10-06 https://evidence-hub.com/study/69082-synergistic-antibiotic-combinations-for-colistin-resistant-klebsiella2026-10-06 https://evidence-hub.com/study/69083-synthesis-and-in-vitro-antibacterial-activity-of-7-4-alkoxyimino-32026-10-06 https://evidence-hub.com/study/69084-in-vitro-antibacterial-activity-of-prulifloxacin-a-new-oral-quinolone2026-10-06 https://evidence-hub.com/study/69085-in-vitro-activities-of-moxifloxacin-and-other-fluoroquinolones2026-10-06 https://evidence-hub.com/study/69086-comparative-antimicrobial-activity-of-trovafloxacin-tested-against2026-10-06 https://evidence-hub.com/study/69087-antimicrobial-activity-of-moxifloxacin-gatifloxacin-and-six2026-10-06 https://evidence-hub.com/study/69088-probing-the-chemical-constituents-of-cassia-javanica-and-its-in-vitro2026-10-06 https://evidence-hub.com/study/69089-in-vitro-antibacterial-activity-of-the-peptide-deformylase-inhibitor2026-10-06 https://evidence-hub.com/study/69090-in-vitro-activity-of-delafloxacin-against-highly-levofloxacin2026-10-06 https://evidence-hub.com/study/69091-s-thanatin-functionalized-liposome-potentially-targeting-on2026-10-06 https://evidence-hub.com/study/69092-fluoroquinolone-resistance-of-streptococcus-pneumoniae-isolates2026-10-06 https://evidence-hub.com/study/69093-comparative-in-vitro-activity-of-garenoxacin-against-chlamydia-spp2026-10-06 https://evidence-hub.com/study/69094-intracellular-targets-of-moxifloxacin-a-comparison-with-other2026-10-06 https://evidence-hub.com/study/69095-antibacterial-activity-of-cefditoren-against-major-community-acquired2026-10-06 https://evidence-hub.com/study/69096-in-vitro-activities-of-gepotidacin-gsk2140944-and-other-antimicrobial2026-10-06 https://evidence-hub.com/study/69097-in-vitro-activity-of-levofloxacin-against-bacterial-pathogens2026-10-04 https://evidence-hub.com/study/69098-antibiotic-sensitivity-of-common-bacterial-pathogens-against2026-10-08 https://evidence-hub.com/study/69099-comparative-in-vitro-evaluation-of-antibacterial-activity-of2026-10-04 https://evidence-hub.com/study/69100-economic-and-clinical-value-of-levofloxacin2026-10-08 https://evidence-hub.com/study/69101-in-vitro-activity-of-fluoroquinolones-gatifloxacin-levofloxacin-and2026-10-04 https://evidence-hub.com/study/69102-quality-evaluation-and-in-vitro-interaction-studies-between2026-10-13 https://evidence-hub.com/study/69103-levofloxacin-induced-tendon-rupture-a-case-report-and-review-of-the2026-10-04 https://evidence-hub.com/study/69104-an-integrated-strategy-designed-to-explore-the-common-and-diverging2026-10-08 https://evidence-hub.com/study/69106-pneumonia-caused-by-community-acquired-methicillin-resistant2026-10-04 https://evidence-hub.com/study/69107-determination-of-chemical-components-and-analysis-in-silico2026-10-04 https://evidence-hub.com/study/69108-from-genotype-to-phenotype-a-clinical-perspective-for-hospital2026-10-04 https://evidence-hub.com/study/69109-in-silico-study-of-various-compounds-from-essential-oil-of-cymbopogon2026-10-13 https://evidence-hub.com/study/69110-in-silico-and-microbiological-studies-for-reduction-of-pseudomonas2026-10-08 https://evidence-hub.com/study/69111-subtractive-genomics-based-analysis-for-in-silico-recognition-and2026-10-04 https://evidence-hub.com/study/69113-emergent-virus-reactivation-in-sars-cov-2-negative-community-acquired2026-10-04 https://evidence-hub.com/study/69114-comparison-study-of-ionic-gelation-and-snedds-method-in-the2026-10-04 https://evidence-hub.com/study/69118-comments-to-editorial-by-j-curtis-nickel-it-is-premature-to2026-10-06 https://evidence-hub.com/study/69120-retracted-article-utilizing-artificial-intelligence-to-enhance-social2026-10-06 https://evidence-hub.com/study/69121-towards-independence-the-development-of-children-s-capability-to-have2026-10-06 https://evidence-hub.com/study/69122-evaluating-the-performance-of-wearable-devices-for-contact-tracing-in2026-10-06 https://evidence-hub.com/study/69123-isolating-delayed-attentional-disengagement-from-biased-orienting-to2026-10-06 https://evidence-hub.com/study/69125-retracted-article-artificial-intelligence-as-an-assistive-technology2026-10-06 https://evidence-hub.com/study/69126-retracted-article-enhancing-communication-for-people-with-hearing2026-10-06 https://evidence-hub.com/study/69127-retracted-article-ketogenic-diets-are-associated-with-an-elevated2026-10-06 https://evidence-hub.com/study/69128-retracted-article-multimodal-deep-learning-methods-for-speech-and2026-10-06 https://evidence-hub.com/study/69129-retracted-article-willingness-to-communicate-with-ai-chatbots-in2026-10-06 https://evidence-hub.com/study/69130-retracted-article-disability-oriented-data-protection-in-ai-enabled2026-10-06 https://evidence-hub.com/study/69131-retracted-article-mri-feature-engineering-and-svm-framework-for2026-10-06 https://evidence-hub.com/study/69132-recent-progress-in-the-exploitation-of-anti-cancer-small-molecules2026-10-06 https://evidence-hub.com/study/69133-retracted-article-personalised-sports-rehabilitation-analysis-using-a2026-10-06 https://evidence-hub.com/study/69134-retracted-article-evaluating-ai-tutor-feedback-in-medical-education-a2026-10-06 https://evidence-hub.com/study/69135-retracted-article-ai-empowered-assistive-technology-for-optimizing2026-10-06 https://evidence-hub.com/study/69136-retracted-article-choral-harmony-the-role-of-collective-singing-in2026-10-06 https://evidence-hub.com/study/69137-retracted-article-impacts-of-virtual-reality-aided-physical-training2026-10-06 https://evidence-hub.com/study/69138-retracted-article-prevention-and-health-care-intervention-of-common2026-10-06 https://evidence-hub.com/study/69139-retracted-article-dual-channel-conduction-modulated-by-digital2026-10-06 https://evidence-hub.com/study/69140-retracted-article-artificial-intelligence-enabled-integration-of-fu2026-10-06 https://evidence-hub.com/study/69141-retracted-article-intelligent-sports-rehabilitation-integrating-deep2026-10-06 https://evidence-hub.com/study/69142-electrochemical-and-hot-corrosion-behaviour-of-steel-reinforced-with2026-10-06 https://evidence-hub.com/study/69143-retracted-article-from-cognitive-alignment-to-technological2026-10-06 https://evidence-hub.com/study/69145-retracted-article-virtual-classrooms-real-resilience-how-ai-tutors2026-10-06 https://evidence-hub.com/study/69146-retracted-article-between-intimacy-and-surveillance-elderly-users2026-10-06 https://evidence-hub.com/study/69147-retracted-article-good-intentions-may-be-wrong-evidence-from2026-10-06 https://evidence-hub.com/study/69148-retracted-article-the-relationship-between-job-competence-demographic2026-10-06 https://evidence-hub.com/study/69149-retracted-article-evaluating-the-role-of-social-support-systems-in2026-10-06 https://evidence-hub.com/study/69150-retracted-article-hierarchical-attention-mechanism-in-deep-learning2026-10-06 https://evidence-hub.com/study/69151-retracted-article-ai-enhanced-assistive-interventions-for-adolescent2026-10-06 https://evidence-hub.com/study/69152-retracted-article-configuration-analysis-of-mobile-phone-addiction2026-10-06 https://evidence-hub.com/study/69154-retracted-article-an-ai-integrated-spatial-auxiliary-decision-support2026-10-06 https://evidence-hub.com/study/69155-retracted-article-the-impact-of-social-media-on-adolescent-conformity2026-10-06 https://evidence-hub.com/study/69156-retracted-article-unveiling-the-mechanisms-influencing-service2026-10-06 https://evidence-hub.com/study/69158-bioengineering-of-anaerobic-digestion-for-volatile-fatty-acids2026-10-06 https://evidence-hub.com/study/69159-wet-bulb-globe-temperature-indicating-extreme-heat-risk-on-a-global2026-10-06 https://evidence-hub.com/study/69160-a-review-on-microalgae-cultivation-and-harvesting-and-their-biomass2026-10-06 https://evidence-hub.com/study/69162-rally-round-the-flag-the-covid-19-crisis-and-trust-in-the-national2026-10-06 https://evidence-hub.com/study/69163-a-systematic-review-of-secondary-traumatic-stress-and-compassion2026-10-06 https://evidence-hub.com/study/69164-a-review-of-plant-leaf-fungal-diseases-and-its-environment-speciation2026-10-06 https://evidence-hub.com/study/69165-seroprevalence-of-chikungunya-virus-jamaica-and-new-tools-for2026-10-06 https://evidence-hub.com/study/69166-microstructure-and-wear-behaviour-of-alcocrfeni-coated-ss316l-by2026-10-06 https://evidence-hub.com/study/69167-laser-versus-anti-vegf-a-paradigm-shift-for-treatment-warranted2026-10-06 https://evidence-hub.com/study/69168-pedagogical-approaches-to-health-related-physical-education-pe-in-the2026-10-06 https://evidence-hub.com/study/69169-retracted-article-prevalence-and-knowledge-of-polycystic-ovary2026-10-06 https://evidence-hub.com/study/69171-vat-gst-harmonisation-challenges-for-digital-assets-such-as-bitcoin2026-10-06 https://evidence-hub.com/study/69172-retracted-article-development-of-thermosensitive-liposome-containing2026-10-06 https://evidence-hub.com/study/69173-discovery-of-novel-benzohydroxamate-based-histone-deacetylase-6-hdac62026-10-06 https://evidence-hub.com/study/69174-high-throughput-micronucleus-assay-using-three-dimensional-heparg2026-10-06 https://evidence-hub.com/study/69176-longitudinal-associations-of-experiential-and-reflective-dimensions2026-10-06 https://evidence-hub.com/study/69178-risk-of-all-cause-and-cardiac-related-mortality-after-vaccination2026-10-06 https://evidence-hub.com/study/69179-retracted-article-green-synthesis-of-calcium-nanoferrites-using-leaf2026-10-06 https://evidence-hub.com/study/69180-retracted-article-human-vulnerability-assessment-based-on-bullet2026-10-06 https://evidence-hub.com/study/69181-retracted-article-finding-of-antibiotic-compounds-pyrrolo-1-2-a2026-10-06 https://evidence-hub.com/study/69182-factors-influencing-volatile-fatty-acids-production-from-food-wastes2026-10-06 https://evidence-hub.com/study/69183-bio-processing-of-algal-bio-refinery-a-review-on-current-advances-and2026-10-06 https://evidence-hub.com/study/69184-mathematical-models-of-cancer-when-to-predict-novel-therapies-and2026-10-06 https://evidence-hub.com/study/69185-retracted-article-men-s-perceptions-of-female-genitals2026-10-06 https://evidence-hub.com/study/69186-lncrna-snhg12-in-extracellular-vesicles-derived-from-carcinoma2026-10-06 https://evidence-hub.com/study/69187-personalized-medicine-empowered-patients-in-the-21st-century2026-10-06 https://evidence-hub.com/study/69188-self-managed-abortion-a-constellation-of-actors-a-cacophony-of-laws2026-10-06 https://evidence-hub.com/study/69189-mental-health-in-adolescence-the-role-of-schools-based-social2026-10-06 https://evidence-hub.com/study/69190-we-have-gifted-enough-indigenous-genomic-data-sovereignty-in2026-10-06 https://evidence-hub.com/study/69191-lipopolysaccharides-derived-from-gram-negative-bacterial-pool-of2026-10-06 https://evidence-hub.com/study/69192-the-regulation-of-cell-homeostasis-and-antiviral-innate-immunity-by2026-10-06 https://evidence-hub.com/study/69193-methyltransferase-like-3-silenced-inhibited-the-ferroptosis2026-10-06 https://evidence-hub.com/study/69194-biological-pretreatment-of-corn-straw-for-enhancing-degradation2026-10-06 https://evidence-hub.com/study/69195-neisseria-sicca-and-corynebacterium-matruchotii-inhibited-oral2026-10-06 https://evidence-hub.com/study/69196-identification-of-a-novel-circular-rna-circznf652-mir-486-5p-serpine12026-10-06 https://evidence-hub.com/study/69197-retracted-article-recent-progress-in-aptamer-functionalized-metal2026-10-06 https://evidence-hub.com/study/69198-nesfatin-1-protects-against-diabetic-cardiomyopathy-in-the2026-10-06 https://evidence-hub.com/study/69199-n-6-methyladenosine-mediated-mir-380-3p-maturation-and-upregulation2026-10-06 https://evidence-hub.com/study/69200-retracted-article-the-effects-of-autologous-platelet-rich-plasma-in2026-10-06 https://evidence-hub.com/study/69201-becoming-a-non-native-chinese-language-teacher-an-identity-triangle2026-10-06 https://evidence-hub.com/study/69202-defining-generic-skills-to-better-support-the-development-of-future2026-10-06 https://evidence-hub.com/study/69203-graphene-based-scaffolds-on-bone-tissue-engineering2026-10-06 https://evidence-hub.com/study/69205-enhancing-microalga-chlorella-sorokiniana-cy-1-biomass-and-lipid2026-10-06 https://evidence-hub.com/study/69206-treatment-of-granuloma-annulare-with-tofacitinib2026-10-06 https://evidence-hub.com/study/69207-a-comprehensive-review-on-fungal-endophytes-and-its-dynamics-on2026-10-06 https://evidence-hub.com/study/69208-measuring-age-differences-among-different-sex-couples-across2026-10-06 https://evidence-hub.com/study/69209-expert-clinician-certainty-in-diagnosing-autism-spectrum-disorder-in2026-10-06 https://evidence-hub.com/study/69210-biochar-based-compost-a-bibliometric-and-visualization-analysis2026-10-06 https://evidence-hub.com/study/69211-exosomes-derived-from-fibrinogen-like-protein-1-overexpressing-bone2026-10-06 https://evidence-hub.com/study/69212-retracted-article-a-bayesian-joint-model-for-multivariate2026-10-06 https://evidence-hub.com/study/69213-a-case-of-psoriasis-and-multiple-sclerosis-succesfully-treated-with2026-10-06 https://evidence-hub.com/study/69214-retracted-article-chitosan-tamarind-based-nanoparticles-as-a2026-10-06 https://evidence-hub.com/study/69215-occupational-stress-and-catholic-priests-a-scoping-review-of-the2026-10-06 https://evidence-hub.com/study/69216-enhancement-of-ph-values-stability-and-photo-fermentation-biohydrogen2026-10-06 https://evidence-hub.com/study/69217-retracted-article-silencing-of-long-noncoding-rna-h19-alleviates2026-10-06 https://evidence-hub.com/study/69219-relationship-between-grammar-and-schizophrenia-a-systematic-review2026-10-06 https://evidence-hub.com/study/69220-which-is-the-best-adhesive-system-for-primary-tooth-enamel-a2026-10-06 https://evidence-hub.com/study/69221-osteoporosis-and-fractures-in-systemic-vasculitides-a-systematic2026-10-06 https://evidence-hub.com/study/69222-burnout-increased-among-university-students-during-the-covid-192026-10-06 https://evidence-hub.com/study/69223-machine-learning-driven-radiomics-on-18-f-fdg-pet-for-glioma2026-10-06 https://evidence-hub.com/study/69224-diagnostic-accuracy-of-pulse-pressure-variation-stroke-volume2026-10-06 https://evidence-hub.com/study/69225-prevalence-of-oral-high-risk-hpv-and-hpv16-infection-among-people2026-10-06 https://evidence-hub.com/study/69226-effect-of-mussel-inspired-primers-on-resin-dentin-bonding-interface2026-10-06 https://evidence-hub.com/study/69227-global-prevalence-of-post-covid-19-condition-a-systematic-review-and2026-10-06 https://evidence-hub.com/study/69229-systematic-review-and-meta-analysis-of-exercise-interventions-for2026-10-06 https://evidence-hub.com/study/69230-activity-and-levels-of-tnf-il-6-and-il-8-in-saliva-of-children-and2026-10-06 https://evidence-hub.com/study/69231-increased-of-il-18-levels-are-associated-with-periodontitis-a2026-10-06 https://evidence-hub.com/study/69232-prevalence-and-correlates-of-manic-hypomanic-and-depressive2026-10-06 https://evidence-hub.com/study/69233-a-systematic-review-and-meta-analysis-of-measurement-properties-for2026-10-06 https://evidence-hub.com/study/69234-expression-of-il-33-in-subjects-with-periodontitis-a-systematic2026-10-06 https://evidence-hub.com/study/69235-the-effectiveness-of-unguided-self-help-psychological-interventions2026-10-06 https://evidence-hub.com/study/69236-salivary-8-hydroxy-2-deoxyguanosine-levels-in-patients-with-oral2026-10-06 https://evidence-hub.com/study/69238-addition-of-immune-checkpoint-inhibitor-to-standard-of-care2026-10-06 https://evidence-hub.com/study/69239-histological-and-immunohistochemical-features-of-the-placenta2026-10-06 https://evidence-hub.com/study/69240-complications-after-covid-19-review-of-scientific-reports-and-meta2026-10-06 https://evidence-hub.com/study/69241-retracted-article-pregnancy-outcomes-of-foetal-reduction-from-twin-to2026-10-06 https://evidence-hub.com/study/69242-values-and-the-dark-side-meta-analysis-of-links-between-dark-triad2026-10-06 https://evidence-hub.com/study/69243-unfinished-work-tasks-and-work-related-thoughts-during-off-job-time2026-10-06 https://evidence-hub.com/study/69244-peek-surface-treatments-for-resin-bonding-a-systematic-review-and2026-10-06 https://evidence-hub.com/study/69245-left-atrial-appendage-closure-in-patients-with-atrial-fibrillation2026-10-06 https://evidence-hub.com/study/69246-treatment-with-inhaled-argon-a-systematic-review-of-pre-clinical-and2026-10-06 https://evidence-hub.com/study/69247-retraction-notice-effect-of-chest-ultrasound-compared-with2026-10-06 https://evidence-hub.com/study/69248-vividness-of-imagery-and-affective-response-to-episodic-memories-and2026-10-06 https://evidence-hub.com/study/69250-evaluation-of-heterogeneity-in-meta-analysis2026-10-06 https://evidence-hub.com/study/69252-association-between-convalescent-plasma-treatment-and-mortality-in2026-10-06 https://evidence-hub.com/study/69256-effect-of-triple-inhaled-therapy-on-mace-and-cardiovascular-events-in2026-10-06 https://evidence-hub.com/study/69257-association-of-ambient-air-pollution-with-blood-pressure-in2026-10-06 https://evidence-hub.com/study/69258-parasitism-and-host-social-behaviour-a-meta-analysis-of-insights2026-10-06 https://evidence-hub.com/study/69259-retracted-article-the-effect-of-maternal-gestational-diabetes-on2026-10-06 https://evidence-hub.com/study/69260-maintenance-therapy-with-a-poly-adp-ribose-polymerase-inhibitor-in2026-10-06 https://evidence-hub.com/study/69262-the-association-between-concentrations-of-arginine-ornithine2026-10-06 https://evidence-hub.com/study/69263-assessing-patterns-of-eavesdropper-risk-on-sexual-signals-and-the-use2026-10-06 https://evidence-hub.com/study/69264-reduced-left-atrial-strain-can-predict-stroke-in-atrial-fibrillation2026-10-06 https://evidence-hub.com/study/69266-correction-mental-fatigue-might-be-not-so-bad-for-exercise2026-10-06 https://evidence-hub.com/study/69268-effectiveness-of-non-pharmacological-interventions-to-manage-anxiety2026-10-06 https://evidence-hub.com/study/69269-a-10-or-14-day-bismuth-containing-quadruple-therapy-as-a-first-line2026-10-06 https://evidence-hub.com/study/69273-proton-pump-inhibitors-and-the-risk-of-dementia-a-systematic-review2026-10-06 https://evidence-hub.com/study/69275-salvage-regimens-after-failure-of-previous-helicobacter-pylori2026-10-06 https://evidence-hub.com/study/69278-eradication-rates-of-clarithromycin-triple-therapy-in-korea-a2026-10-06 https://evidence-hub.com/study/69279-efficacy-of-finasteride-in-female-pattern-hair-loss-a-meta-analysis2026-10-06 https://evidence-hub.com/study/69281-impact-of-nurse-led-self-management-education-on-type-2-diabetes-a2026-10-06 https://evidence-hub.com/study/69287-few-concerns-about-evidence-feasibility-and-safety-of-performing2026-10-06 https://evidence-hub.com/study/69288-on-the-moments-of-cochran-s-q-statistic-under-the-null-hypothesis2026-10-06 https://evidence-hub.com/study/69289-indirect-effect-of-patient-outcome-expectation-on-improvement-through2026-10-06 https://evidence-hub.com/study/69290-effect-of-exercise-intervention-on-anxiety-among-college-students-a2026-10-06 https://evidence-hub.com/study/69291-the-effectiveness-of-spinal-manipulative-therapy-in-treating-spinal2026-10-06 https://evidence-hub.com/study/69295-group-therapy-for-schizophrenia-a-meta-analysis-correction-to2026-10-06 https://evidence-hub.com/study/69296-extracorporeal-shock-wave-therapy-versus-local-corticosteroid2026-10-06 https://evidence-hub.com/study/69298-circulating-long-noncoding-rnas-as-potential-biomarkers-for-stomach2026-10-06 https://evidence-hub.com/study/69300-fluid-resuscitation-in-adults-with-severe-infection-and-sepsis-a2026-10-06 https://evidence-hub.com/study/69301-the-epidemiology-of-unintentional-falls-among-older-people-in-the2026-10-06 https://evidence-hub.com/study/69302-efficacy-of-periodontal-treatment-modalities-in-down-syndrome2026-10-06 https://evidence-hub.com/study/69304-a-meta-analysis-of-executive-functions-among-survivors-of2026-10-06 https://evidence-hub.com/study/69305-factors-associated-with-burden-of-family-caregivers-of-home-dwelling2026-10-06 https://evidence-hub.com/study/69306-treatment-effects-on-neurometabolite-levels-in-schizophrenia-a-meta2026-10-06 https://evidence-hub.com/study/69307-the-effect-of-post-exercise-heat-exposure-passive-heat-acclimation-on2026-10-06 https://evidence-hub.com/study/69308-impact-of-virtual-avatar-appearance-realism-on-perceptual-interaction2026-10-06 https://evidence-hub.com/study/69309-vitamin-d-nutritional-status-in-the-middle-east-and-north-africa2026-10-06 https://evidence-hub.com/study/69310-platelet-parameters-as-potential-biomarkers-for-sepsis-a-systematic2026-10-06 https://evidence-hub.com/study/69311-pharmaco-toxicological-aspects-of-thymol-in-veterinary-medicine-a2026-10-06 https://evidence-hub.com/study/69312-identifying-subtypes-of-long-covid-a-systematic-review2026-10-06 https://evidence-hub.com/study/69313-understanding-the-burden-of-injuries-in-nepal-a-systematic-review-of2026-10-06 https://evidence-hub.com/study/69314-il-23-il-17-axis-levels-in-gingival-crevicular-fluid-of-subjects-with2026-10-06 https://evidence-hub.com/study/69315-clinical-pharmacy-key-performance-indicators-for-hospital-inpatient2026-10-06 https://evidence-hub.com/study/69316-effects-of-passive-or-active-recovery-regimes-applied-during-long2026-10-06 https://evidence-hub.com/study/69317-healthy-lifestyle-scales-to-assess-general-and-clinical-population-a2026-10-06 https://evidence-hub.com/study/69318-a-systematic-review-of-candidate-genes-and-their-relevant-pathways2026-10-06 https://evidence-hub.com/study/69319-a-systematic-review-of-parent-child-communication-in-pediatric-asthma2026-10-06 https://evidence-hub.com/study/69320-barriers-and-facilitators-for-the-use-of-telehealth-by-healthcare2026-10-06 https://evidence-hub.com/study/69321-nurses-perceptions-attitudes-and-perspectives-in-relation-to-climate2026-10-06 https://evidence-hub.com/study/69322-systematic-review-of-type-1-diabetes-biomarkers-reveals-regulation-in2026-10-06 https://evidence-hub.com/study/69323-impact-of-fasting-on-the-ampk-and-pgc-1-axis-in-rodent-and-human2026-10-06 https://evidence-hub.com/study/69324-influence-of-surface-treatment-by-laser-irradiation-on-bacterial2026-10-06 https://evidence-hub.com/study/69325-coxiella-burnetii-infections-from-animals-and-ticks-in-south-africa-a2026-10-06 https://evidence-hub.com/study/69326-biologic-therapy-for-refractory-pemphigoid-gestationis-an-evidence2026-10-06 https://evidence-hub.com/study/69327-concerns-about-a-systematic-review-of-mediators-of-ptsd-treatments-a2026-10-06 https://evidence-hub.com/study/69328-retracted-article-impact-tb-co-infections-on-immune-tolerance-among2026-10-06 https://evidence-hub.com/study/69329-systematic-review-on-diabetes-mellitus-and-dental-implants-an-update2026-10-06 https://evidence-hub.com/study/69330-topical-treatment-for-plantar-warts-a-systematic-review2026-10-06 https://evidence-hub.com/study/69331-the-reporting-standards-of-randomised-controlled-trials-in-leading2026-10-06 https://evidence-hub.com/study/69332-assessing-the-gaps-in-cardiovascular-disease-risk-assessment-and2026-10-06 https://evidence-hub.com/study/69333-distrust-within-protected-area-and-natural-resource-management-a2026-10-06 https://evidence-hub.com/study/69334-retracted-article-the-impact-of-aerosol-box-on-tracheal-intubation2026-10-06 https://evidence-hub.com/study/69335-taxonomic-discordance-of-immersive-realities-in-dentistry-a2026-10-06 https://evidence-hub.com/study/69336-barriers-to-and-facilitators-of-digital-health-technology-adoption2026-10-06 https://evidence-hub.com/study/69337-towards-a-description-of-the-elements-of-art-therapy-practice-for2026-10-06 https://evidence-hub.com/study/69338-gender-transformative-programming-with-men-and-boys-to-improve-sexual2026-10-06 https://evidence-hub.com/study/69339-association-between-active-use-of-urban-green-spaces-and-well-being2026-10-06 https://evidence-hub.com/study/69340-opportunities-challenges-and-requirements-for-artificial-intelligence2026-10-06 https://evidence-hub.com/study/69341-artificial-intelligence-in-the-management-of-malnutrition-in-cancer2026-10-06 https://evidence-hub.com/study/69343-the-impact-of-mobile-health-interventions-on-service-users-health2026-10-06 https://evidence-hub.com/study/69346-resilience-based-interventions-in-the-public-sector-workplace-a2026-10-06 https://evidence-hub.com/study/69347-a-systematic-review-of-portable-technologies-for-the-early-assessment2026-10-06 https://evidence-hub.com/study/69348-horizontal-violence-or-workplace-bullying-among-intensive-care-unit2026-10-06 https://evidence-hub.com/study/69349-factors-affecting-patient-safety-near-miss-reporting-a-systematic2026-10-06 https://evidence-hub.com/study/69350-a-cognitive-model-of-pathological-worry-in-children-and-adolescents-a2026-10-06 https://evidence-hub.com/study/69354-auditory-acclimatization-in-new-adult-hearing-aid-users-a-registered2026-10-06 https://evidence-hub.com/study/69355-impact-of-generative-ai-in-medical-education-in-india-a-systematic2026-10-06 https://evidence-hub.com/study/69356-immunosuppressive-therapy-and-nutritional-diseases-of-patients-after2026-10-06 https://evidence-hub.com/study/69357-analgesic-use-in-sports-results-of-a-systematic-literature-review2026-10-06 https://evidence-hub.com/study/69358-homicides-and-maltreatment-related-deaths-of-disabled-children-a2026-10-06 https://evidence-hub.com/study/69359-efficacy-of-pharmacological-interventions-for-adhd-protocol-for-an2026-10-06 https://evidence-hub.com/study/69360-the-relationship-between-running-biomechanics-and-running-economy-a2026-10-06 https://evidence-hub.com/study/69362-impact-of-social-distancing-on-curtailing-covid-2019-epidemic-in2026-10-06 https://evidence-hub.com/study/69363-effects-of-radiofrequency-electromagnetic-field-rf-emf-exposure-on2026-10-06 https://evidence-hub.com/study/69365-the-effectiveness-of-neuromuscular-electrical-stimulation-on-pain2026-10-06 https://evidence-hub.com/study/69366-systematic-review-on-sanitary-pads-and-female-health2026-10-06 https://evidence-hub.com/study/69367-heavy-metal-content-of-over-the-counter-toothpastes-a-systematic2026-10-06 https://evidence-hub.com/study/69368-the-application-of-ai-to-ecological-momentary-assessment-data-in2026-10-06 https://evidence-hub.com/study/69369-gut-microbiota-changes-in-patients-with-alzheimer-s-disease-spectrum2026-10-08 https://evidence-hub.com/study/69370-acceptability-of-digital-mental-health-interventions-for-depression2026-10-06 https://evidence-hub.com/study/69371-effect-of-physical-activity-on-physical-and-mental-health-in-young2026-10-06 https://evidence-hub.com/study/69373-the-effects-of-radiofrequency-electromagnetic-field-exposure-on2026-10-06 https://evidence-hub.com/study/69374-adaptive-designs-in-clinical-trials-a-systematic-review-part-i2026-10-06 https://evidence-hub.com/study/69376-cost-effectiveness-of-an-extended-role-general-practitioner-clinic2026-10-06 https://evidence-hub.com/study/69377-robotic-versus-open-ventral-hernia-repair-rovhr-a-randomized2026-10-06 https://evidence-hub.com/study/69378-an-individualized-ttm-based-intervention-promotes-child-safety-seat2026-10-06 https://evidence-hub.com/study/69379-updated-protocol-of-the-point-trial-a-multicenter-randomized2026-10-06 https://evidence-hub.com/study/69380-erratum-to-the-impact-of-vagal-nerve-stimulation-from-the-lateral2026-10-06 https://evidence-hub.com/study/69381-correction-detoxification-of-heterocyclic-aromatic-amines-from2026-10-06 https://evidence-hub.com/study/69382-regional-anesthesia-lower-body-warming-and-postoperative-temperature2026-10-06 https://evidence-hub.com/study/69383-proportional-assist-ventilation-for-minimizing-the-duration-of2026-10-06 https://evidence-hub.com/study/69384-correction-a-randomized-controlled-trial-to-examine-the-relationship2026-10-06 https://evidence-hub.com/study/69385-correction-theobromine-supplementation-in-combination-with-a-low2026-10-06 https://evidence-hub.com/study/69386-a-feasibility-randomized-controlled-trial-of-an-individually2026-10-06 https://evidence-hub.com/study/69387-authorship-correction-implementation-of-a-randomized-placebo2026-10-06 https://evidence-hub.com/study/69388-correction-to-costs-and-benefits-of-acting-extraverted-a-randomized2026-10-06 https://evidence-hub.com/study/69389-randomized-controlled-trial-of-smartphone-based-interpretation-bias2026-10-06 https://evidence-hub.com/study/69390-correction-clinical-and-lipid-metabolic-responses-to-diacylglycerol2026-10-06 https://evidence-hub.com/study/69391-oral-carnitine-supplementation-reduces-body-weight-and-insulin2026-10-06 https://evidence-hub.com/study/69392-correction-association-between-low-sodium-salt-intervention-and-long2026-10-06 https://evidence-hub.com/study/69395-durability-of-high-frequency-10-khz-spinal-cord-stimulation-for2026-10-06 https://evidence-hub.com/study/69397-the-effect-of-a-video-tutorial-to-improve-patients-keratoconus2026-10-06 https://evidence-hub.com/study/69398-expression-of-concern-metabolic-and-genetic-response-to-probiotics2026-10-06 https://evidence-hub.com/study/69399-ultra-processed-diets-cause-excess-calorie-intake-and-weight-gain-an2026-10-06 https://evidence-hub.com/study/69401-oral-language-enrichment-in-preschool-improves-children-s-language2026-10-06 https://evidence-hub.com/study/69402-effect-of-an-arsenic-mitigation-program-on-arsenic-exposure-in2026-10-06 https://evidence-hub.com/study/69404-effects-of-a-health-education-intervention-for-covid-19-prevention-in2026-10-06 https://evidence-hub.com/study/69405-pregnancy-vitamin-d-supplementation-and-offspring-bone-mineral2026-10-06 https://evidence-hub.com/study/69406-the-effect-of-mindfulness-based-cognitive-behavioral-sex-therapy-on2026-10-06 https://evidence-hub.com/study/69407-the-effects-of-yakson-or-gentle-human-touch-training-given-to-mothers2026-10-06 https://evidence-hub.com/study/69408-online-peer-led-intervention-to-improve-adolescent-wellbeing-during2026-10-06 https://evidence-hub.com/study/69413-the-effect-of-digital-health-interventions-on-postpartum-depression2026-10-06 https://evidence-hub.com/study/69415-remarkably-high-efficacy-of-cenobamate-in-adults-with-focal-onset2026-10-06 https://evidence-hub.com/study/69417-preexposure-prophylaxis-uptake-among-spanish-speaking-transgender2026-10-06 https://evidence-hub.com/study/69418-retracted-article-effect-of-empiric-intravenous-intralipid-therapy-on2026-10-06 https://evidence-hub.com/study/69423-retracted-article-the-value-of-amniopatch-in-pregnancies-associated2026-10-06 https://evidence-hub.com/study/69425-efficacy-and-acceptability-of-a-mobile-app-for-monitoring-the2026-10-06 https://evidence-hub.com/study/69430-effectiveness-of-a-multifaceted-intervention-temp-for-prevention-of2026-10-06 https://evidence-hub.com/study/69431-validating-a-digital-depression-prevention-program-for-adolescents-in2026-10-06 https://evidence-hub.com/study/69434-retracted-article-does-implementing-a-regime-of-dexamethasone-before2026-10-06 https://evidence-hub.com/study/69435-effectiveness-of-eye-movement-desensitization-and-reprocessing-emdr2026-10-06 https://evidence-hub.com/study/69436-smartphone-based-intervention-targeting-norms-and-risk-perception2026-10-06 https://evidence-hub.com/study/69438-a-phase-iii-randomized-controlled-trial-comparing-palliative2026-10-06 https://evidence-hub.com/study/69439-enhancing-maternal-and-newborn-outcomes-in-ghana-a-comprehensive2026-10-06 https://evidence-hub.com/study/69440-exploring-the-role-of-resilience-in-selective-prevention-intervention2026-10-06 https://evidence-hub.com/study/69441-a-cluster-randomized-controlled-trial-of-the-effectiveness-of-a2026-10-06 https://evidence-hub.com/study/69442-the-benefits-of-conversation-group-treatment-for-individuals-with2026-10-06 https://evidence-hub.com/study/69443-a-multisite-randomized-controlled-trial-comparing-the-effectiveness2026-10-06 https://evidence-hub.com/study/69444-multi-center-randomized-controlled-trial-on-advance-care-planning-for2026-10-06 https://evidence-hub.com/study/69445-digital-training-for-mental-health-promotion-in-young-people-with2026-10-06 https://evidence-hub.com/study/69447-engaging-rural-communities-in-bangladesh-to-address-antimicrobial2026-10-06 https://evidence-hub.com/study/69450-corrigendum-to-can-menstrual-health-apps-selected-based-on-users2026-10-06 https://evidence-hub.com/study/69453-efficacy-of-the-echomantra-online-intervention-to-support-recovery2026-10-06 https://evidence-hub.com/study/69454-interim-treatment-fidelity-for-a-randomized-controlled-comparative2026-10-06 https://evidence-hub.com/study/69455-retracted-article-subcuticular-interrupted-versus-continuous-skin2026-10-06 https://evidence-hub.com/study/69456-risk-expression-using-likelihood-ratios-and-natural-frequencies-in2026-10-06 https://evidence-hub.com/study/69457-corrigendum-provision-of-intrauterine-contraception-in-association2026-10-06 https://evidence-hub.com/study/69458-chosen-a-randomized-controlled-feasibility-trial2026-10-06 https://evidence-hub.com/study/69460-retracted-article-foley-s-catheter-balloon-for-induction-of-mid2026-10-06 https://evidence-hub.com/study/69461-evaluation-of-a-guided-chatbot-intervention-for-young-people-in2026-10-06 https://evidence-hub.com/study/69462-effects-of-heated-humidified-anesthetic-gas-in-the-elderly-patients2026-10-06 https://evidence-hub.com/study/69464-nudging-plant-based-alternatives-to-meat-and-dairy-in-a-real-life2026-10-06 https://evidence-hub.com/study/69471-the-importance-of-understanding-minimal-important-difference-for2026-10-06 https://evidence-hub.com/study/69473-letter-to-the-editor-of-the-british-journal-of-clinical-pharmacology2026-10-06 https://evidence-hub.com/study/69475-correction-to-maribavir-for-refractory-cytomegalovirus-infections2026-10-06 https://evidence-hub.com/study/69477-response-to-the-comments-of-onerup-et-al-and-lu-and-song-on-effects2026-10-06 https://evidence-hub.com/study/69481-serum-8-isoprostane-levels-in-patients-with-resistant-oral-lichen2026-10-06 https://evidence-hub.com/study/69482-continued-post-retraction-citation-of-a-fraudulent-clinical-trial2026-10-06 https://evidence-hub.com/study/69483-writing-up-your-clinical-trial-report-for-a-scientific-journal-the2026-10-06 https://evidence-hub.com/study/69484-retracted-article-vaginal-length-and-sexual-function-after-vertical2026-10-06 https://evidence-hub.com/study/69485-clinical-trial-participation-improves-survival-outcomes-by-increasing2026-10-06 https://evidence-hub.com/study/69486-photobiomodulation-preconditioning-for-oral-mucositis-prevention-and2026-10-06 https://evidence-hub.com/study/69488-a-clinical-trial-evaluating-feasibility-and-acceptability-of-a-brain2026-10-06 https://evidence-hub.com/study/69489-retracted-article-l-carnitine-plus-metformin-in-clomiphene-resistant2026-10-06 https://evidence-hub.com/study/69490-effects-of-intensive-intonation-training-in-transgender-and-gender2026-10-06 https://evidence-hub.com/study/69491-efficacy-and-safety-of-subserosal-versus-submucosal-carbon2026-10-06 https://evidence-hub.com/study/69493-retracted-article-efficacy-of-ferrous-bis-glycinate-versus-ferrous2026-10-06 https://evidence-hub.com/study/69494-pulse-wave-velocity-in-chronic-obstructive-pulmonary-disease-and-the2026-10-06 https://evidence-hub.com/study/69495-enamel-matrix-derivative-in-the-reconstructive-surgical-therapy-of2026-10-06 https://evidence-hub.com/study/69496-platelet-rich-plasma-and-its-application-in-clinical-trial2026-10-06 https://evidence-hub.com/study/69497-an-international-randomized-waitlist-controlled-trial-of-internet2026-10-06 https://evidence-hub.com/study/69498-assessing-the-efficacy-and-safety-of-stop-successful-treatment-for2026-10-06 https://evidence-hub.com/study/69500-working-on-mental-health-stigma-in-education-a-multicentre-community2026-10-06 https://evidence-hub.com/study/69502-effects-of-bacopa-monnieri-herbal-supplement-on-aging-and2026-10-06 https://evidence-hub.com/study/69503-effect-of-a-tea-tree-oil-mouthwash-on-plaque-induced-gingivitis-when2026-10-06 https://evidence-hub.com/study/69505-celecoxib-or-prednisolone-for-treatment-of-medication-overuse2026-10-06 https://evidence-hub.com/study/69507-randomized-double-blind-placebo-controlled-clinical-trial-for-the2026-10-06 https://evidence-hub.com/study/69508-treating-benign-paroxysmal-positional-vertigo-in-acute-traumatic2026-10-06 https://evidence-hub.com/study/69509-binimetinib-and-encorafenib-for-the-treatment-of-advanced-solid2026-10-06 https://evidence-hub.com/study/69510-clinical-decision-making-and-artificial-intelligence-the-role-of2026-10-06 https://evidence-hub.com/study/69512-a-first-in-human-phase-1-trial-of-dose-escalating-intrathecal-it2026-10-06 https://evidence-hub.com/study/69513-clinical-effectiveness-child-patient-and-parent-satisfaction-of-two2026-10-06 https://evidence-hub.com/study/69514-long-term-outcomes-of-intracarotid-arterial-transfusion-of2026-10-06 https://evidence-hub.com/study/69515-a-guided-chatbot-based-psychological-intervention-for-psychologically2026-10-06 https://evidence-hub.com/study/69516-what-a-negative-trial-does-not-tell-us-bayesian-reanalysis-of-the2026-10-06 https://evidence-hub.com/study/69517-cooled-radiofrequency-ablation-versus-cryoneurolysis-of-the-genicular2026-10-06 https://evidence-hub.com/study/69518-remote-multicomponent-rehabilitation-compared-to-standard-care-for2026-10-06 https://evidence-hub.com/study/69519-long-term-comparison-of-the-efficacy-of-manual-versus-powered-tooth2026-10-06 https://evidence-hub.com/study/69520-expanded-nursing-roles-to-promote-person-centred-care-for-people-with2026-10-06 https://evidence-hub.com/study/69521-the-vip-trial-a-randomised-controlled-trial-of-the-clinical2026-10-06 https://evidence-hub.com/study/69522-a-randomised-controlled-trial-of-treatments-of-childhood-anxiety2026-10-06 https://evidence-hub.com/study/69523-clinical-genetic-testing-in-parkinson-s-disease-should-become-part-of2026-10-06 https://evidence-hub.com/study/69524-impact-of-covid-19-pandemic-on-the-predimed-plus-randomized-clinical2026-10-06 https://evidence-hub.com/study/69525-remodeling-dental-anatomy-vs-sham-therapy-for-chronic2026-10-06 https://evidence-hub.com/study/69526-autologous-adipose-derived-mesenchymal-stem-cell-therapy-reverses2026-10-06 https://evidence-hub.com/study/69527-effectiveness-of-stuttering-modification-treatment-in-school-age2026-10-06 https://evidence-hub.com/study/69528-final-results-from-a-phase-2b-randomized-placebo-controlled-clinical2026-10-06 https://evidence-hub.com/study/69529-three-dimensional-task-specific-robot-therapy-of-the-arm-a2026-10-05 https://evidence-hub.com/study/69530-a-digital-twin-technique-using-external-observational-data-to-reduce2026-10-06 https://evidence-hub.com/study/69531-a-decade-after-the-surgical-treatment-for-ischemic-heart-failure2026-10-06 https://evidence-hub.com/study/69533-awake-prone-positioning-in-patients-with-hypoxemic-respiratory2026-10-06 https://evidence-hub.com/study/69534-correction-to-sulopenem-or-ciprofloxacin-for-the-treatment-of2026-10-08 https://evidence-hub.com/study/69536-covid-19-and-myeloma-clinical-research-experience-from-the-cardamon2026-10-06 https://evidence-hub.com/study/69537-updated-protocol-of-the-sano-trial-a-stepped-wedge-cluster-randomised2026-10-06 https://evidence-hub.com/study/69538-a-randomized-clinical-trial-using-coronavac-or-bnt162b2-vaccine-as-a2026-10-06 https://evidence-hub.com/study/69539-effects-of-mediterranean-diet-on-plasma-metabolites-and-their2026-10-06 https://evidence-hub.com/study/69540-the-quality-and-reporting-of-recommendation-documents-to-enhance-the2026-10-06 https://evidence-hub.com/study/69542-teaching-caregivers-to-support-social-communication-results-from-a2026-10-06 https://evidence-hub.com/study/69544-interleukin-31-serum-and-pruritus-dimension-after-acupuncture2026-10-06 https://evidence-hub.com/study/69545-the-reporting-of-social-determinants-of-health-in-pediatric2026-10-06 https://evidence-hub.com/study/69546-analysis-of-a-covid-19-clinical-trial-to-emphasize-experimental2026-10-06 https://evidence-hub.com/study/69547-clinical-effectiveness-of-vaginal-pessary-self-management-vs-clinic2026-10-06 https://evidence-hub.com/study/69548-enhanced-doubly-robust-estimation-with-concave-link-functions-for2026-10-06 https://evidence-hub.com/study/69549-chia-a-large-annotated-corpus-of-clinical-trial-eligibility-criteria2026-10-06 https://evidence-hub.com/study/69550-the-recline-and-head-lift-exercises-a-randomized-clinical-trial2026-10-06 https://evidence-hub.com/study/69551-cairo-consensus-statement-on-research-integrity-of-randomised2026-10-06 https://evidence-hub.com/study/69552-p-020-clinical-outcomes-of-583-treatment-cycles-with-fresh-and2026-10-06 https://evidence-hub.com/study/69553-effectiveness-of-microosteoperforations-in-accelerating-alignment-of2026-10-06 https://evidence-hub.com/study/69554-a-follow-up-clinical-trial-evaluating-the-consumer-decides-service2026-10-06 https://evidence-hub.com/study/69557-precious-prevention-of-complications-to-improve-outcome-in-elderly2026-10-06 https://evidence-hub.com/study/69558-comparison-of-the-incidence-of-post-operative-pain-after-low-level2026-10-06 https://evidence-hub.com/study/69559-a-pilot-clinical-trial-of-repetitive-transcranial-magnetic2026-10-06 https://evidence-hub.com/study/69561-j-shaped-association-between-serum-potassium-and-30-day-mortality-in2026-10-06 https://evidence-hub.com/study/69562-association-of-antibiotic-exposure-with-the-mortality-in-bevacizumab2026-10-06 https://evidence-hub.com/study/69565-a-spotlight-on-prey-induced-metabolite-dynamics-in-sundew-a2026-10-06 https://evidence-hub.com/study/69568-factors-associated-with-the-intention-to-continue-using-tobacco-among2026-10-06 https://evidence-hub.com/study/69569-auditory-function-and-brainstem-responses-in-allergic-rhinitis2026-10-06 https://evidence-hub.com/study/69571-ophthoevidence-report-comparative-effects-of-treatments-for2026-10-06 https://evidence-hub.com/study/69573-factors-related-to-asthma-in-korean-adults-a-secondary-data-analysis2026-10-06 https://evidence-hub.com/study/69575-expanding-communication-modalities-and-functions-for-preschoolers2026-10-06 https://evidence-hub.com/study/69576-depression-and-anxiety-symptoms-health-behavior-related-personal2026-10-06 https://evidence-hub.com/study/69577-analysis-of-cardiovascular-risk-factors-in-a-cohort-of-patients-with2026-10-06 https://evidence-hub.com/study/69579-the-association-between-pelvic-organ-prolapse-pelvic-pain-and-pelvic2026-10-06 https://evidence-hub.com/study/69580-secondary-school-randomized-controlled-interventions-with-a-minimum2026-10-06 https://evidence-hub.com/study/69581-case-of-secondary-milia-after-regressing-lesions-of-bullous-lichen2026-10-06 https://evidence-hub.com/study/69582-economic-burden-of-road-traffic-injuries-in-nepal2026-10-06 https://evidence-hub.com/study/69583-replicating-and-extending-the-reliability-criterion-validity-and2026-10-06 https://evidence-hub.com/study/69584-muscle-memory-not-mediated-by-myonuclear-number-secondary-analysis-of2026-10-06 https://evidence-hub.com/study/69585-accelerated-invasion-of-nypa-fruticans-during-2000-2024-in-degraded2026-10-06 https://evidence-hub.com/study/69586-chemometric-profiling-of-metabolites-in-avicennia-marina-leaves-from2026-10-06 https://evidence-hub.com/study/69587-comparative-analysis-of-the-effectiveness-of-bone-matrix-purification2026-10-06 https://evidence-hub.com/study/69589-evolution-trends-internal-fixation-materials-knowledge-mapping2026-10-06 https://evidence-hub.com/study/69590-interprofessional-collaboration-and-patient-reported-outcomes-a2026-10-06 https://evidence-hub.com/study/69591-draft-genome-assembly-of-piper-divaricatum-reveals-genomic-basis-of2026-10-06 https://evidence-hub.com/study/69592-percentile-based-diagnostic-thresholds-for-median-nerve-inlet-to2026-10-06 https://evidence-hub.com/study/69594-lamas-light-activity-meals-sleep-timings-burnout-anxiety-and2026-10-06 https://evidence-hub.com/study/69595-different-inflammatory-pathways-underlying-cardiovascular-risk-in2026-10-06 https://evidence-hub.com/study/69596-enhancing-athletic-performance-the-critical-role-of-oral-health-in2026-10-06 https://evidence-hub.com/study/69597-graphical-advance-organizers-and-their-impact-to-develop-higher-order2026-10-06 https://evidence-hub.com/study/69598-examining-trends-in-substance-use-behaviors-among-women-with-primary2026-10-06 https://evidence-hub.com/study/69599-native-t1-is-independently-associated-with-aerobic-exercise-capacity2026-10-06 https://evidence-hub.com/study/69600-the-use-of-colchicine-as-an-elicitor-increases-the-accumulation-of2026-10-06 https://evidence-hub.com/study/69601-flower-color-associated-variation-in-phenolic-content-and-antioxidant2026-10-06 https://evidence-hub.com/study/69602-correction-to-higher-plasma-viremia-in-the-febrile-phase-is2026-10-06 https://evidence-hub.com/study/69603-design-and-early-use-of-the-nationally-implemented-healthier-you2026-10-06 https://evidence-hub.com/study/69604-effects-of-temporarily-suspending-low-dose-methotrexate-treatment-for2026-10-06 https://evidence-hub.com/study/69605-in-reply-window-periods-for-secondary-bacterial-culture-of-platelets2026-10-06 https://evidence-hub.com/study/69606-development-research-on-an-ai-english-learning-support-system-to2026-10-06 https://evidence-hub.com/study/69607-soft-tissue-grafting-at-immediate-implants-does-it-protect-the-buccal2026-10-06 https://evidence-hub.com/study/69608-the-use-of-probiotics-for-pain-reduction-in-patients-with2026-10-06 https://evidence-hub.com/study/69609-ethnopharmacology-and-scientific-validation-of-antidiarrheal-plants2026-10-06 https://evidence-hub.com/study/69610-association-of-postpartum-temperature-exposure-with-postpartum2026-10-06 https://evidence-hub.com/study/69611-effect-of-long-term-beta-blocker-treatment-following-myocardial2026-10-06 https://evidence-hub.com/study/69612-n-nitrosodimethylamine-contaminated-ranitidine-and-risk-of-cancer-in2026-10-06 https://evidence-hub.com/study/69615-quality-of-patient-centred-recovery-trajectories-after-different2026-10-06 https://evidence-hub.com/study/69623-incidence-and-sociodemographic-characteristics-of-eczema-diagnosis-in2026-10-06 https://evidence-hub.com/study/69624-recruitment-response-rates-and-characteristics-of-5511-people2026-10-06 https://evidence-hub.com/study/69625-suicide-and-transportation-noise-a-prospective-cohort-study-from2026-10-06 https://evidence-hub.com/study/69626-effects-of-heat-waves-and-cold-spells-on-blood-parameters-a-cohort2026-10-06 https://evidence-hub.com/study/69627-maternal-pregestational-or-gestational-diabetes-and-childhood2026-10-06 https://evidence-hub.com/study/69628-patient-acceptability-of-telehealth-medication-abortion-care-in-the2026-10-06 https://evidence-hub.com/study/69629-case-cohort-study-of-the-association-between-pfas-and-selected2026-10-06 https://evidence-hub.com/study/69631-association-of-prenatal-exposure-to-organophosphate-pyrethroid-and2026-10-06 https://evidence-hub.com/study/69632-early-life-exposure-to-ambient-air-pollution-from-multiple-sources2026-10-06 https://evidence-hub.com/study/69633-air-pollution-and-acute-kidney-injury-in-the-u-s-medicare-population2026-10-06 https://evidence-hub.com/study/69634-cancer-risk-following-residential-exposure-to-airborne2026-10-06 https://evidence-hub.com/study/69635-association-between-first-trimester-exposure-to-ambient-pm2-5-and-no22026-10-06 https://evidence-hub.com/study/69636-associations-between-residential-greenspace-and-fecundability-in-a2026-10-06 https://evidence-hub.com/study/69637-preterm-birth-and-metal-mixture-exposure-among-pregnant-women-from2026-10-06 https://evidence-hub.com/study/69638-transportation-noise-and-risk-of-tinnitus-a-nationwide-cohort-study2026-10-06 https://evidence-hub.com/study/69639-association-of-combined-exposure-to-ambient-air-pollutants-genetic2026-10-06 https://evidence-hub.com/study/69640-metabolic-signatures-of-youth-exposure-to-mixtures-of-per-and2026-10-06 https://evidence-hub.com/study/69641-prenatal-exposure-to-multiple-endocrine-disrupting-chemicals-and2026-10-06 https://evidence-hub.com/study/69642-effects-of-sociodemographic-characteristics-comorbidity-and2026-10-06 https://evidence-hub.com/study/69643-association-between-noise-and-cardiovascular-disease-in-a-nationwide2026-10-06 https://evidence-hub.com/study/69644-early-life-environmental-exposure-to-cadmium-lead-and-arsenic-and-age2026-10-06 https://evidence-hub.com/study/69645-ambient-air-pollution-and-risk-of-enterotomy-gastrointestinal-cancer2026-10-06 https://evidence-hub.com/study/69646-long-term-exposure-to-air-pollution-and-incidence-of-myocardial2026-10-06 https://evidence-hub.com/study/69647-source-specific-air-pollution-including-ultrafine-particles-and-risk2026-10-06 https://evidence-hub.com/study/69648-prenatal-exposure-to-air-pollution-and-pre-labor-rupture-of-membranes2026-10-06 https://evidence-hub.com/study/69650-early-outcomes-and-complications-following-cardiac-surgery-in2026-10-06 https://evidence-hub.com/study/69651-associations-of-pre-and-postnatal-air-pollution-exposures-with-child2026-10-06 https://evidence-hub.com/study/69652-ambient-air-pollution-in-relation-to-sars-cov-2-infection-antibody2026-10-06 https://evidence-hub.com/study/69653-stair-climbing-and-incident-atrial-fibrillation-a-prospective-cohort2026-10-06 https://evidence-hub.com/study/69654-an-updated-evaluation-of-atrazine-cancer-incidence-associations-among2026-10-06 https://evidence-hub.com/study/69655-long-term-exposure-to-transportation-noise-and-risk-for-type-22026-10-06 https://evidence-hub.com/study/69656-the-association-between-residential-green-space-in-childhood-and2026-10-06 https://evidence-hub.com/study/69657-abstaining-from-annual-health-check-ups-is-a-predictor-of-advanced2026-10-06 https://evidence-hub.com/study/69658-reference-values-for-accelerometer-metrics-and-associations-with2026-10-06 https://evidence-hub.com/study/69659-child-survival-and-early-lifetime-exposures-to-ambient-fine2026-10-06 https://evidence-hub.com/study/69662-a-new-opportunity-for-innovative-inflammatory-bowel-disease-research2026-10-06 https://evidence-hub.com/study/69663-adolescent-police-stops-self-harm-and-attempted-suicide-findings-from2026-10-06 https://evidence-hub.com/study/69664-diesel-exhaust-exposure-and-cause-specific-mortality-in-the-diesel2026-10-06 https://evidence-hub.com/study/69666-prenatal-exposures-to-perfluoroalkyl-acids-and-associations-with2026-10-06 https://evidence-hub.com/study/69667-residential-proximity-to-oil-and-gas-development-and-birth-outcomes2026-10-06 https://evidence-hub.com/study/69668-ambient-fine-particulate-matter-air-pollution-and-risk-of-weight-gain2026-10-06 https://evidence-hub.com/study/69669-estimated-transfer-of-perfluoroalkyl-substances-pfas-from-maternal2026-10-06 https://evidence-hub.com/study/69670-long-term-air-pollution-genetic-susceptibility-and-the-risk-of2026-10-06 https://evidence-hub.com/study/69671-early-risk-factors-and-emotional-difficulties-in-children-at-risk-of2026-10-06 https://evidence-hub.com/study/69672-role-of-intensive-inpatient-rehabilitation-for-prevention-of2026-10-06 https://evidence-hub.com/study/69673-long-term-exposure-to-air-pollution-and-covid-19-vaccine-antibody2026-10-06 https://evidence-hub.com/study/69674-a-cross-lagged-analysis-of-emotion-regulation-peer-problems-and2026-10-06 https://evidence-hub.com/study/69675-associations-between-aircraft-noise-exposure-and-self-reported-sleep2026-10-06 https://evidence-hub.com/study/69676-exposure-to-manganese-in-drinking-water-during-childhood-and2026-10-06 https://evidence-hub.com/study/69677-air-pollution-and-progression-of-atherosclerosis-in-different-vessel2026-10-06 https://evidence-hub.com/study/69678-folic-acid-supplementation-and-the-association-between-maternal2026-10-06 https://evidence-hub.com/study/69679-impact-of-long-term-exposure-to-wind-turbine-noise-on-redemption-of2026-10-06 https://evidence-hub.com/study/69680-fine-particulate-matter-and-poor-cognitive-function-among-chinese2026-10-06 https://evidence-hub.com/study/69681-long-term-greenspace-exposure-and-progression-of-arterial-stiffness2026-10-06 https://evidence-hub.com/study/69682-long-term-exposure-to-ultrafine-particles-and-incidence-of2026-10-06 https://evidence-hub.com/study/69683-mechanisms-of-impact-of-alcohol-availability-interventions-from-the2026-10-06 https://evidence-hub.com/study/69684-association-between-kawasaki-disease-and-prenatal-exposure-to-ambient2026-10-06 https://evidence-hub.com/study/69685-exploratory-research-on-asthma-exacerbation-risk-factors-using-the2026-10-06 https://evidence-hub.com/study/69686-associations-between-high-temperature-heavy-rainfall-and-diarrhea2026-10-06 https://evidence-hub.com/study/69687-household-fuel-use-and-the-risk-of-gastrointestinal-cancers-the2026-10-06 https://evidence-hub.com/study/69688-alcohol-consumption-and-the-risk-of-heart-failure-the-suita-study-and2026-10-06 https://evidence-hub.com/study/69689-exposure-to-road-traffic-noise-and-incidence-of-acute-myocardial2026-10-06 https://evidence-hub.com/study/69690-prenatal-exposure-to-phthalates-and-newborn-telomere-length-a-birth2026-10-06 https://evidence-hub.com/study/69691-association-of-long-term-exposure-to-transportation-noise-and-traffic2026-10-06 https://evidence-hub.com/study/69692-long-term-air-pollution-exposure-genome-wide-dna-methylation-and-lung2026-10-06 https://evidence-hub.com/study/69693-land-use-change-and-cardiometabolic-risk-factors-in-an-urbanizing2026-10-06 https://evidence-hub.com/study/69694-early-biological-aging-and-fetal-exposure-to-high-and-low-ambient2026-10-06 https://evidence-hub.com/study/69695-associations-of-trimester-specific-exposure-to-bisphenols-with-size2026-10-06 https://evidence-hub.com/study/69696-long-term-exposure-to-ambient-fine-particulate-matter-pm2-5-and-lung2026-10-06 https://evidence-hub.com/study/69697-drinking-water-salinity-and-raised-blood-pressure-evidence-from-a2026-10-06 https://evidence-hub.com/study/69698-long-term-exposure-to-ambient-fine-particulate-matter-and-chronic2026-10-06 https://evidence-hub.com/study/69699-long-term-exposure-to-wind-turbine-noise-and-risk-for-myocardial2026-10-06 https://evidence-hub.com/study/69700-hypoxemia-and-prone-position-in-mechanically-ventilated-covid-192026-10-06 https://evidence-hub.com/study/69701-satisfaction-in-parturients-receiving-epidural-analgesia-after2026-10-06 https://evidence-hub.com/study/69702-green-space-visits-among-adolescents-frequency-and-predictors-in-the2026-10-06 https://evidence-hub.com/study/69703-re-traffic-injury-prevention-paper-titled-injury-patterns-in-motor2026-10-06 https://evidence-hub.com/study/69704-correction-to-sex-differences-in-childhood-cancer-risk-among-children2026-10-06 https://evidence-hub.com/study/69705-correction-to-coronavirus-disease-2019-breakthrough-infection-and2026-10-06 https://evidence-hub.com/study/69707-corrigendum-to-association-between-abcc8-ala1369ser-polymorphism2026-10-06 https://evidence-hub.com/study/69708-retraction-statement-role-of-resolvin-d1-in-psoriasis-before-and2026-10-06 https://evidence-hub.com/study/69709-association-of-ambient-air-pollution-and-temperature-exposure-with2026-10-06 https://evidence-hub.com/study/69710-outdoor-exposure-to-artificial-light-at-night-and-breast-cancer-risk2026-10-06 https://evidence-hub.com/study/69712-genotoxicity-in-patients-on-long-term-proton-pump-inhibitor-therapy2026-10-06 https://evidence-hub.com/study/69714-retracted-article-antepartum-and-postpartum-uterine-artery-impedance2026-10-06 https://evidence-hub.com/study/69716-lung-cancer-risks-associated-with-occupational-exposure-to-pairs-of2026-10-06 https://evidence-hub.com/study/69719-incidence-and-risk-factors-of-surgical-site-infection-in-abdominal2026-10-06 https://evidence-hub.com/study/69720-total-effective-xenoestrogen-burden-in-serum-samples-and-risk-of2026-10-06 https://evidence-hub.com/study/69721-association-between-mustard-oil-consumption-and-thrombocytopenia-a2026-10-06 https://evidence-hub.com/study/69722-antibody-response-of-covid-19-vaccine-in-subjects-after-renal2026-10-06 https://evidence-hub.com/study/69724-a-nested-case-control-study-of-serum-per-and-polyfluoroalkyl2026-10-06 https://evidence-hub.com/study/69725-risk-of-cancer-in-children-of-parents-occupationally-exposed-to2026-10-06 https://evidence-hub.com/study/69726-synthetic-phenolic-antioxidants-and-their-metabolites-in-follicular2026-10-06 https://evidence-hub.com/study/69727-lifestyle-factors-and-urine-levels-of-organophosphorus-flame2026-10-06 https://evidence-hub.com/study/69728-coordination-between-respiration-and-swallowing-in-patients-with2026-10-06 https://evidence-hub.com/study/69729-the-diesel-exhaust-in-miners-study-dems-ii-temporal-factors-related2026-10-06 https://evidence-hub.com/study/69730-examination-of-gaze-behaviour-in-social-anxiety-disorder-using-a2026-10-06 https://evidence-hub.com/study/69731-early-prenatal-exposure-to-air-pollutants-and-congenital-heart2026-10-06 https://evidence-hub.com/study/69733-self-rated-health-and-oral-health-in-type-2-diabetic-patients-a-case2026-10-06 https://evidence-hub.com/study/69734-unconventional-oil-and-gas-development-exposure-and-risk-of-childhood2026-10-06 https://evidence-hub.com/study/69735-letter-to-the-editor-virtual-mckenzie-extension-exercises-for-low2026-10-06 https://evidence-hub.com/study/69736-per-and-polyfluoroalkyl-substances-and-risk-of-myocardial-infarction2026-10-06 https://evidence-hub.com/study/69737-disinfection-by-products-in-drinking-water-and-bladder-cancer2026-10-06 https://evidence-hub.com/study/69738-association-between-residential-proximity-to-viticultural-areas-and2026-10-06 https://evidence-hub.com/study/69739-prenatal-exposure-to-glyphosate-and-its-environmental-degradate2026-10-06 https://evidence-hub.com/study/69740-associations-of-hyperglycemic-emergency-and-severe-hypoglycemia2026-10-06 https://evidence-hub.com/study/69741-associations-of-evolutionary-concordance-diet-and-lifestyle-pattern2026-10-06 https://evidence-hub.com/study/69742-evaluation-of-a-gene-environment-interaction-of-pon1-and-low-level2026-10-06 https://evidence-hub.com/study/69743-a-raw-deal-the-intersection-of-the-immunocompromised-cat-influenza2026-10-06 https://evidence-hub.com/study/69744-patterns-of-nutrient-intake-in-relation-to-gastric-cancer-a-case2026-10-06 https://evidence-hub.com/study/69745-food-quality-score-and-risk-of-breast-cancer-among-iranian-women2026-10-06 https://evidence-hub.com/study/69746-maternal-plasma-perfluoroalkyl-substances-and-miscarriage-a-nested2026-10-06 https://evidence-hub.com/study/69747-eating-habits-associated-with-overweight-and-obesity-case-control2026-10-06 https://evidence-hub.com/study/69748-the-critical-role-of-commercial-analytical-reference-standards-in-the2026-10-06 https://evidence-hub.com/study/69749-nociceptive-reflex-in-patients-with-schizophrenia-a-case-control-study2026-10-06 https://evidence-hub.com/study/69750-an-interactive-web-based-dashboard-to-track-covid-19-in-real-time2026-10-06 https://evidence-hub.com/study/69751-the-association-between-consumption-of-dairy-originated-digestion2026-10-06 https://evidence-hub.com/study/69752-women-s-involvement-in-household-decision-making-and-nutrition2026-10-06 https://evidence-hub.com/study/69753-comments-on-a-recent-case-control-study-of-malignant-mesothelioma-of2026-10-06 https://evidence-hub.com/study/69754-risk-factors-for-first-attack-of-febrile-convulsion-case-control-study2026-10-06 https://evidence-hub.com/study/69755-long-term-air-pollution-exposure-and-amyotrophic-lateral-sclerosis-in2026-10-06 https://evidence-hub.com/study/69756-non-alcoholic-fatty-liver-and-vitamin-d-levels-in-extremely-obese2026-10-06 https://evidence-hub.com/study/69757-micro-rna-biogenesis-genes-ago1-and-gemin4-single-nucleotide-variants2026-10-06 https://evidence-hub.com/study/69758-bladder-cancer-and-water-disinfection-by-product-exposures-through2026-10-06 https://evidence-hub.com/study/69759-fast-protocols-for-charging-a-three-spin-chain-quantum-battery2026-10-12 https://evidence-hub.com/study/69761-effects-of-prenatal-pm10-exposure-on-fetal-cardiovascular2026-10-06 https://evidence-hub.com/study/69762-prenatal-serum-concentrations-of-brominated-flame-retardants-and2026-10-06 https://evidence-hub.com/study/69763-evaluation-of-clinical-characteristics-and-outcomes-of-obstetric2026-10-06 https://evidence-hub.com/study/69764-calcium-channel-blocker-use-and-the-risk-for-prostate-cancer-a2026-10-06 https://evidence-hub.com/study/69765-going-for-three-what-is-the-role-for-triplex-testing-for-hsv-1-hsv-22026-10-06 https://evidence-hub.com/study/69766-the-effects-of-bacille-calmette-guerin-immunization-and-contact2026-10-06 https://evidence-hub.com/study/69767-smoking-as-a-risk-factor-for-dry-socket-complication-a-case-control2026-10-06 https://evidence-hub.com/study/69768-cd123-and-mxa-expression-in-a-case-of-annular-erythema-associated2026-10-06 https://evidence-hub.com/study/69769-a-case-control-study-of-maternal-polybrominated-diphenyl-ether-pbde2026-10-10 https://evidence-hub.com/study/69770-irregular-meal-and-migraine-headache-a-scoping-review2026-10-06 https://evidence-hub.com/study/69771-case-commentary-long-term-fosmanogepix-use-in-a-transplant-recipient2026-10-06 https://evidence-hub.com/study/69772-mental-health-considerations-for-children-quarantined-because-of2026-10-06 https://evidence-hub.com/study/69773-the-impact-of-imperfect-vaccination-on-infectious-disease2026-10-06 https://evidence-hub.com/study/69774-both-emotional-and-neutral-contexts-increase-feeling-of-knowing2026-10-06 https://evidence-hub.com/study/69777-myopericytoma-on-the-nasal-turbinate2026-10-06 https://evidence-hub.com/study/69778-leishmania-an-urgent-need-for-new-treatments2026-10-06 https://evidence-hub.com/study/69779-the-elusive-allure-of-a-rapid-host-blood-signature-for-tuberculosis2026-10-06 https://evidence-hub.com/study/69780-creating-sets-of-similar-nanoforms-with-the-ecetoc-nanoapp-real-life2026-10-06 https://evidence-hub.com/study/69781-correction-prevalence-predictors-and-characteristics-of-waterpipe2026-10-06 https://evidence-hub.com/study/69782-hepatitis-c-virus-hcv-infection-in-malaysia-findings-from-a2026-10-06 https://evidence-hub.com/study/69783-association-between-atopic-dermatitis-and-eosinophilic-esophagitis-a2026-10-06 https://evidence-hub.com/study/69784-financial-toxicity-in-cancer-patients-treated-with-radiotherapy-in2026-10-06 https://evidence-hub.com/study/69785-retracted-article-umbilical-cord-diameter-in-the-prediction-of-foetal2026-10-06 https://evidence-hub.com/study/69786-suicide-prevention-training-among-occupational-groups-a-cross2026-10-06 https://evidence-hub.com/study/69789-hypertension-and-its-physio-psychosocial-risks-factors-in-elderly2026-10-06 https://evidence-hub.com/study/69790-performance-assessment-of-four-hiv-self-test-devices-in-south-africa2026-10-06 https://evidence-hub.com/study/69792-ovomucoid-specific-igd-increases-in-children-who-naturally-outgrow2026-10-06 https://evidence-hub.com/study/69793-digital-self-presentation-and-adolescent-mental-health-cross2026-10-06 https://evidence-hub.com/study/69794-correction-to-potential-influence-of-menstrual-status-and-sex2026-10-06 https://evidence-hub.com/study/69804-a-cross-sectional-study-on-internet-addiction-among-students-of-kmct2026-10-06 https://evidence-hub.com/study/69805-tenofovir-disoproxil-fumarate-may-not-cause-renal-and-bone-toxicity2026-10-06 https://evidence-hub.com/study/69806-variation-of-optic-nerve-types-in-different-age-quartiles-on-two2026-10-06 https://evidence-hub.com/study/69807-association-of-erythrocyte-sedimentation-rate-with-treatment-outcome2026-10-06 https://evidence-hub.com/study/69808-evaluation-of-reticulin-fibrosis-in-benign-hematologic-disorders-in2026-10-06 https://evidence-hub.com/study/69809-sensitivity-of-amoxicillin-clavulanic-acid-in-diabetic-foot-ulcers-a2026-10-06 https://evidence-hub.com/study/69810-diagnostic-accuracy-of-the-clinical-assessment-of-chorioamnionitis2026-10-06 https://evidence-hub.com/study/69811-sleep-quality-and-psychological-distress-among-undergraduate-students2026-10-06 https://evidence-hub.com/study/69812-metal-ceramic-prosthesis-pitfalls-a-clinical-cross-sectional-study-at2026-10-06 https://evidence-hub.com/study/69813-occupational-determinants-of-varicose-veins-insights-from-a-cross2026-10-06 https://evidence-hub.com/study/69814-effectiveness-of-ultrasonography-in-detecting-metacarpal-fractures-at2026-10-06 https://evidence-hub.com/study/69815-sleep-disturbance-and-daytime-sleepiness-among-undergraduate-medical2026-10-06 https://evidence-hub.com/study/69816-knowledge-and-practices-of-diabetic-patients-regarding-foot-care-a2026-10-06 https://evidence-hub.com/study/69817-prevalence-of-anemia-in-pregnant-women-attending-a-healthcare2026-10-06 https://evidence-hub.com/study/69818-journal-data-sharing-policies-and-its-impact-in-publications-a-cross2026-10-06 https://evidence-hub.com/study/69819-patient-driven-limitations-in-dental-implant-therapy-a-cross2026-10-06 https://evidence-hub.com/study/69820-p0493-patient-satisfaction-with-ibd-undergoing-colonoscopy-a2026-10-06 https://evidence-hub.com/study/69821-evaluating-non-alcoholic-fatty-liver-disease-in-individuals-with-and2026-10-06 https://evidence-hub.com/study/69822-morphometric-analysis-and-variations-of-the-hard-palate-in-human-dry2026-10-06 https://evidence-hub.com/study/69823-a-cross-sectional-study-on-psychiatric-assessment-in-patients-with2026-10-06 https://evidence-hub.com/study/69824-magnitude-of-hearing-loss-concerning-the-site-of-tympanic-membrane2026-10-06 https://evidence-hub.com/study/69825-impact-of-pre-pregnancy-bmi-on-short-term-maternal-and-perinatal2026-10-06 https://evidence-hub.com/study/69826-a-cross-sectional-study-on-the-accuracy-of-volume-assessment-of2026-10-06 https://evidence-hub.com/study/69827-doppler-ultrasound-detection-and-grading-of-portal-vein-thrombosis-in2026-10-06 https://evidence-hub.com/study/69828-association-of-high-agatston-coronary-artery-calcium-score-with2026-10-06 https://evidence-hub.com/study/69829-a-cross-sectional-study-on-visceral-fat-estimation-by-computed2026-10-06 https://evidence-hub.com/study/69830-the-perception-of-smile-arc-and-buccal-corridor-in-medical-and-dental2026-10-06 https://evidence-hub.com/study/69831-incidence-of-nephropathy-after-spontaneous-bacterial-peritonitis-in2026-10-06 https://evidence-hub.com/study/69832-enhancing-reporting-quality-using-the-preferred-reporting-items-for2026-10-06 https://evidence-hub.com/study/69833-assessing-emotional-intelligence-among-future-health-care2026-10-06 https://evidence-hub.com/study/69835-factors-affecting-the-non-adherence-to-inhalational-medication-in2026-10-06 https://evidence-hub.com/study/69836-caring-for-carers-biopsychosocial-burden-in-caregivers-of-persons2026-10-06 https://evidence-hub.com/study/69837-knowledge-attitude-and-practices-regarding-contraception-among2026-10-06 https://evidence-hub.com/study/69841-a-cross-sectional-study-on-abortions-and-associated-risk-factors-in2026-10-06 https://evidence-hub.com/study/69844-incomplete-reporting-and-spin-in-acupuncture-randomised-controlled2026-10-06 https://evidence-hub.com/study/69845-effects-of-oral-minoxidil-on-nails-a-cross-sectional-analysis2026-10-06 https://evidence-hub.com/study/69846-a-cross-sectional-study-of-knowledge-attitude-and-practices-regarding2026-10-06 https://evidence-hub.com/study/69847-association-of-atopic-dermatitis-with-dyslipidemia-in-adolescents-a2026-10-06 https://evidence-hub.com/study/69848-discrimination-and-sleep-health-among-transgender-women-of-color-in2026-10-06 https://evidence-hub.com/study/69851-prevalence-of-addictive-internet-use-and-its-correlates-among-urban2026-10-06 https://evidence-hub.com/study/69852-school-environmental-contamination-of-methicillin-sensitive2026-10-06 https://evidence-hub.com/study/69855-plantar-load-distribution-with-centers-of-gravity-balance-and2026-10-06 https://evidence-hub.com/study/69856-visual-perception-and-cognitive-functioning-in-mci-and-mild-alzheimer2026-10-06 https://evidence-hub.com/study/69857-public-perception-of-the-role-of-pharmacists-and-willingness-to-pay2026-10-06 https://evidence-hub.com/study/69858-asian-flush-gene-variant-increases-mild-cognitive-impairment-risk-a2026-10-06 https://evidence-hub.com/study/69859-association-of-short-term-exposure-to-air-pollution-with-depression2026-10-06 https://evidence-hub.com/study/69860-diabetic-kidney-disease-in-bangladesh-a-cross-sectional-study-on2026-10-06 https://evidence-hub.com/study/69861-adherence-to-the-guideline-for-reporting-evidence-based-practice2026-10-06 https://evidence-hub.com/study/69862-lower-regional-urbanicity-and-socioeconomic-status-attenuate2026-10-06 https://evidence-hub.com/study/69863-evaluation-of-restless-leg-syndrome-in-patients-with-non-dialysis2026-10-06 https://evidence-hub.com/study/69864-association-between-short-term-exposure-to-ambient-air-pollutants-and2026-10-06 https://evidence-hub.com/study/69865-heat-exposure-and-cause-specific-hospital-admissions-in-spain-a2026-10-06 https://evidence-hub.com/study/69866-ethylene-oxide-exposure-increases-impaired-glucose-metabolism-in-the2026-10-06 https://evidence-hub.com/study/69867-association-of-sociodemographic-factors-and-dietary-preference-with2026-10-06 https://evidence-hub.com/study/69868-obsessive-compulsive-disorder-its-contributing-factor-and-its2026-10-06 https://evidence-hub.com/study/69869-prevalence-of-obesity-with-its-associated-modifiable-risk-factors2026-10-06 https://evidence-hub.com/study/69870-association-of-claustrophobia-in-patients-referred-for-mri-with2026-10-06 https://evidence-hub.com/study/69871-the-pattern-of-maxillary-cleft-alveolus-in-patients-from-khyber2026-10-06 https://evidence-hub.com/study/69872-association-of-abo-and-rh-blood-group-with-dengue-infection-a-cross2026-10-06 https://evidence-hub.com/study/69874-a-cross-sectional-study-to-assess-the-socio-economic-impact-of-falls2026-10-06 https://evidence-hub.com/study/69875-c5-inhibition-with-eculizumab-prevents-thrombotic-microangiopathy-in2026-10-06 https://evidence-hub.com/study/69876-cervical-epidural-hematoma-a-case-series-highlighting-uncommon-causes2026-10-06 https://evidence-hub.com/study/69877-the-evolution-of-fragility-setting-the-terms-norman-yoffee-editor2026-10-06 https://evidence-hub.com/study/69881-a-case-series-of-spouses-undergoing-rapid-micro-induction-technique2026-10-06 https://evidence-hub.com/study/69883-contralateral-preoperative-templating-for-fracture-reverse-total2026-10-06 https://evidence-hub.com/study/69884-preventable-deaths-involving-medicines-a-systematic-case-series-of2026-10-06 https://evidence-hub.com/study/69885-varicella-like-exanthem-as-a-specific-covid-19-associated-skin2026-10-06 https://evidence-hub.com/study/69886-generalized-morphea-after-covid-19-vaccines-a-case-series2026-10-06 https://evidence-hub.com/study/69887-a-cluster-of-ten-uterine-anomalies-observed-in-a-single-center-over-a2026-10-06 https://evidence-hub.com/study/69888-clinical-and-dermoscopic-findings-of-cutaneous-metastases-a-case2026-10-06 https://evidence-hub.com/study/69889-psychosis-as-a-side-effect-of-covid-19-vaccine-administration-a-case2026-10-06 https://evidence-hub.com/study/69890-erratum-covid-19-related-multisystem-inflammatory-syndrome-in2026-10-06 https://evidence-hub.com/study/69894-withdrawn-biologic-therapy-for-psoriasis-during-the-covid-19-pandemic2026-10-06 https://evidence-hub.com/study/69895-successfully-treating-hypercalcemia-secondary-to-subcutaneous-fat2026-10-06 https://evidence-hub.com/study/69897-preventable-deaths-involving-medicines-in-england-and-wales-2013-22-a2026-10-06 https://evidence-hub.com/study/69898-takotsubo-syndrome-a-rare-entity-in-patients-with-covid-19-an-updated2026-10-06 https://evidence-hub.com/study/69899-withdrawn-a-case-series-of-stent-thrombosis-during-the-covid-192026-10-06 https://evidence-hub.com/study/69900-the-bairnsdale-ulcer-mycobacterium-ulcerans-in-an-urban-victorian2026-10-06 https://evidence-hub.com/study/69901-deciphering-the-scream-of-silence-diagnostic-dilemma-of-psychosis-in2026-10-06 https://evidence-hub.com/study/69902-octreotide-for-gastrointestinal-bleeding-in-hereditary-hemorrhagic2026-10-06 https://evidence-hub.com/study/69903-treatment-of-mesh-associated-abscess-using-an-incision-free-technique2026-10-06 https://evidence-hub.com/study/69904-a-case-series-of-esophageal-lichen-planus-an-underdiagnosed-cause-of2026-10-06 https://evidence-hub.com/study/69905-subvalvular-aortic-stenosis-subaortic-stenosis-a-case-series2026-10-06 https://evidence-hub.com/study/69906-leveraging-thematic-relationships-between-verbs-and-nouns-for-noun2026-10-06 https://evidence-hub.com/study/69907-tinea-incognito-with-folliculitis-like-presentation-a-case-series2026-10-06 https://evidence-hub.com/study/69910-preventable-suicides-involving-medicines-before-the-covid-19-pandemic2026-10-06 https://evidence-hub.com/study/69911-patent-foramen-ovale-management-challenges-a-case-series2026-10-06 https://evidence-hub.com/study/69912-b103-15-lifting-the-weight-of-hypoxemia-a-case-series2026-10-06 https://evidence-hub.com/study/69913-low-vision-rehabilitation-program-in-patients-with-myopic-macular2026-10-06 https://evidence-hub.com/study/69914-targeting-phonology-or-semantics-to-improve-reading-aloud-response2026-10-06 https://evidence-hub.com/study/69915-multiple-aortic-valve-papillary-fibroelastomas-a-case-series-of2026-10-06 https://evidence-hub.com/study/69916-two-patients-with-resistant-immune-thrombocytopenic-purpura-and2026-10-06 https://evidence-hub.com/study/69918-differentiating-pnes-from-epilepsy-a-case-report2026-10-06 https://evidence-hub.com/study/69919-understanding-recognizing-and-managing-functional-speech-disorders2026-10-06 https://evidence-hub.com/study/69920-po-042-case-series-of-consultation-liaison-patients-with-anorexia2026-10-06 https://evidence-hub.com/study/69921-ferritin-guided-therapeutic-plasma-exchange-tpe-administration-in2026-10-06 https://evidence-hub.com/study/69922-a-case-series-of-rapid-progressive-fibrotic-lung-disease-as-a-sequela2026-10-06 https://evidence-hub.com/study/69923-comparing-the-role-of-relative-and-absolute-humidity-in-heat-related2026-10-06 https://evidence-hub.com/study/69924-coexistence-of-multiple-sclerosis-and-alzheimer-disease-pathology-a2026-10-06 https://evidence-hub.com/study/69926-abstract-976395-case-series-covid-19-infection-causing-new-onset2026-10-06 https://evidence-hub.com/study/69927-myoelectric-elbow-wrist-hand-orthosis-with-active-grasp-for-patients2026-10-06 https://evidence-hub.com/study/69928-new-trend-of-cardiac-myxoma-case-series-and-systematic-review2026-10-06 https://evidence-hub.com/study/69929-corticosteroids-for-critically-ill-covid-19-patients-with-cytokine2026-10-06 https://evidence-hub.com/study/69930-esophagectomy-postallogenic-hematopoietic-stem-cell-transplantation2026-10-06 https://evidence-hub.com/study/69931-gastrointestinal-histoplasmosis-a-case-series-from-a-non-endemic2026-10-06 https://evidence-hub.com/study/69932-rs1-a-multi-centered-case-series-highlighting-the-clinical-use-and2026-10-06 https://evidence-hub.com/study/69933-sat-485-variations-in-the-time-course-of-pembrolizumab-induced2026-10-06 https://evidence-hub.com/study/69934-abstract-1004302-covid-19-pandemic-collateral-damage-in-treatment2026-10-06 https://evidence-hub.com/study/69936-developmental-delay-in-children-with-x-linked-ichthyosis-a-case-series2026-10-06 https://evidence-hub.com/study/69937-clinical-dermatoscopical-response-of-glycyrrhizinic-acid-0-1-spray-in2026-10-06 https://evidence-hub.com/study/69938-transplantation-of-human-neural-progenitor-cells-npc-into-putamina-of2026-10-06 https://evidence-hub.com/study/69940-restoration-of-autonomic-cardiovascular-regulation-in-spinal-cord2026-10-06 https://evidence-hub.com/study/69941-a-case-of-bilateral-linear-and-annular-lupus-panniculitis-following2026-10-06 https://evidence-hub.com/study/69942-speech-and-feeding-improvements-in-children-after-posterior-tongue2026-10-06 https://evidence-hub.com/study/69943-cognitive-behavioural-therapy-for-anorexia-nervosa-cbt-an-202026-10-06 https://evidence-hub.com/study/69944-matters-of-the-heart-antibiotic-prophylaxis-for-prevention-of2026-10-06 https://evidence-hub.com/study/69946-giant-prolactinomas-case-series-and-review-of-the-literature2026-10-06 https://evidence-hub.com/study/69950-robot-assisted-bladder-diverticulectomy-in-adults-a-systematic-review2026-10-06 https://evidence-hub.com/study/69952-insights-into-management-of-camurati-engelmann-disease-a-case-series2026-10-06 https://evidence-hub.com/study/69953-a-case-of-erythema-elevatum-diutinum-with-pyoderma-gangrenosum2026-10-06 https://evidence-hub.com/study/69954-effect-modifications-of-overhead-view-and-eye-level-urban-greenery-on2026-10-06 https://evidence-hub.com/study/69955-intensive-treatment-for-persisting-rhotic-distortions-a-case-series2026-10-06 https://evidence-hub.com/study/69956-bacteremia-caused-by-leuconostoc-species-6-case-series2026-10-06 https://evidence-hub.com/study/69957-safety-concerns-reported-by-coroners-following-fentanyl-patch2026-10-06 https://evidence-hub.com/study/69958-a-tangled-tale-trichobezoar-in-a-young-patient-with-undiagnosed2026-10-06 https://evidence-hub.com/study/69959-risk-adjusted-comparison-of-survival-in-chronic-myelomonocytic2026-10-06 https://evidence-hub.com/study/69960-p1218-first-population-based-case-control-study-showing-a-16-fold2026-10-06 https://evidence-hub.com/study/69964-retraction-basel-khalil-ibrahim-borghol-and-akhilanand-chaurasia2026-10-06 https://evidence-hub.com/study/69968-rimegepant-in-airplane-headache-treatment-a-case-report2026-10-06 https://evidence-hub.com/study/69969-management-of-female-para-urethral-cyst-with-dyspareunia-a-case-report2026-10-06 https://evidence-hub.com/study/69972-mogamulizumab-associated-rash-a-challenging-case-report-and2026-10-06 https://evidence-hub.com/study/69973-kudo-k-kubota-y-toki-t-et-al-childhood-acute-myeloid-leukemia-with-5q2026-10-06 https://evidence-hub.com/study/69974-diabetic-ketoacidosis-in-undiagnosed-acromegaly-a-case-report-and2026-10-06 https://evidence-hub.com/study/69975-the-rare-thoracic-complication-perforation-of-gastric-fundus-ulcer-a2026-10-06 https://evidence-hub.com/study/69976-self-quarantine-in-responding-to-covid-19-outbreak-in-lagos-nigeria-a2026-10-06 https://evidence-hub.com/study/69977-bone-metastases-from-primary-neuroblastoma-i-123-mibg-a-case-report2026-10-06 https://evidence-hub.com/study/69978-shoulder-injury-related-to-covid-19-vaccine-administration-a-case2026-10-06 https://evidence-hub.com/study/69979-a-case-report-of-a-modern-day-scurvy2026-10-06 https://evidence-hub.com/study/69980-combination-of-msat-and-korean-medicine-for-managing-foot-drop-due-to2026-10-06 https://evidence-hub.com/study/69981-pancreatic-cystic-lymphangioma-case-report-and-literature-review2026-10-06 https://evidence-hub.com/study/69982-digeorge-syndrome-a-case-report-of-a-child-with-attention-deficit-and2026-10-06 https://evidence-hub.com/study/69983-low-frequency-centromedian-thalamic-nuclei-deep-brain-stimulation-for2026-10-06 https://evidence-hub.com/study/69984-gastric-synovial-sarcoma-a-case-report-and-literature-review2026-10-06 https://evidence-hub.com/study/69985-subacute-thyroiditis-in-the-course-of-coronavirus-disease-2019-a-case2026-10-06 https://evidence-hub.com/study/69986-anterior-transolecranon-fracture-dislocation-with-an-associated2026-10-06 https://evidence-hub.com/study/69987-cor-triatriatum-dexter-in-children-literature-review-and-case-report2026-10-06 https://evidence-hub.com/study/69988-giant-sacral-schwannoma-a-case-report2026-10-06 https://evidence-hub.com/study/69989-deltoid-defect-from-a-trans-deltoid-synovial-cyst-in-a-patient2026-10-06 https://evidence-hub.com/study/69990-generalized-rash-and-bilateral-retinal-necrosis-in-an-adult2026-10-06 https://evidence-hub.com/study/69991-a-case-of-delayed-axillary-artery-aneurysm-after-reverse-shoulder2026-10-06 https://evidence-hub.com/study/69992-could-tocilizumab-be-an-attractive-therapeutic-option-for-elderly2026-10-06 https://evidence-hub.com/study/69994-complete-transections-of-the-coracobrachialis-and-short-head-of2026-10-06 https://evidence-hub.com/study/69996-fatal-scorpion-envenomation-a-case-report2026-10-06 https://evidence-hub.com/study/69997-delayed-diagnosis-of-esophageal-actinomycosis-a-case-report2026-10-06 https://evidence-hub.com/study/69999-editorial-comment-to-robot-assisted-laparoscopic-partial-nephrectomy2026-10-06